cell_line_id,drug_id,response
YH-13,46224516,2.974421814944524
LOU-NH91,4788,5.956614254075031
F-36P,387447,-5.355947455324157
NCI-H1568,16038120,0.8714631615296456
HCC1395,piperlongumine-MST-312 (1-1 mol-mol),3.2935373524347367
BT 231,11222830,1.6058632892311393
B-CPAP,11485656,2.2559715729134204
BT 231,11257553,0.9476459380105656
WM88,44566777,0.3234477725678444
RERF-LC-MS,44489675,3.7548789887197183
SNU-1041,49850262,3.58208919293894
OAW28,969516,2.7253654251657573
NCI-H2141,44607531,0.9529479495419324
Ku812,439501,-2.3195298765386587
KYSE-450,148124,3.78473118264584
SH-10-TC,JQ-1-vorinostat (2-1 mol-mol),1.234462104491608
Ishikawa (Heraklio) 02 ER-,2874250,5.7101812906802465
BT-474,107970,2.4195219689765266
OCI-AML-5,44462760,4.107193204955279
YKG-1,11178236,-5.715271869049359
BT 245,15953870,3.843140095574177
TCCSUP,168313016,5.913828803978875
Ku812,11222830,0.9056809830950744
OAW28,72193861,2.7871547903709266
JHUEM-3,5351362,1.1758589986338386
KMS-20,73707438,0.304623121226347
A4/Fukuda,42642645,-1.373677794386147
SK-MEL-28,11612883,5.069449441061208
B-CPAP,135398516,1.1534562761305718
YH-13,17755052,1.8478012162745872
Hs 746.T,100016,6.2249168538435
BT 248,25183872,-1.6442953183353304
BT 245,5978,-1.7749534353098049
WM88,2742550,4.1257519283830595
KYSE-70,24856436,0.5719980221753466
SNU-1077,54143018,3.614598545959328
RKO,262093,2.7220373961576834
Rh30,10113978,1.834294467206064
KHM-1B,46907787,-1.0017805456317357
NCI-H1184,tanespimycin-gemcitabine (1-1 mol-mol),-3.1647390307363557
PF-382,10427712,3.727131590251748
SNU-1077,11396600,4.998092576249027
PF-382,702558,2.625780781007821
Hs 746.T,alisertib-navitoclax (2-1 mol-mol),1.292067102079267
YH-13,46215462,1.6135517915003736
JHUEM-3,5746,1.6731299700891098
LOU-NH91,6450551,3.4853298595759687
NCI-H2141,3854666,2.106417752865544
KMS-20,216468,1.0997828740051716
NCI-H1184,25126798,4.109240572151415
NCI-H2196,3025986,-1.3117169221759988
BT 245,15983966,-4.244276078580228
SK-MEL-28,5328940,2.9501467839577744
OCI-AML-3,135398516,0.3979604266382172
A4/Fukuda,16725315,3.095723533871789
SH-10-TC,JQ-1-navitoclax (2-1 mol-mol),0.95850919474491
WM88,2871966,0.437969952833154
JHUEM-3,12001922,2.298963124090484
HEC-59,6623618,2.271768302871782
SNU-410,73707386,2.4851962355672956
BT 428,262093,2.2051737857299547
YKG-1,11656518,3.2950724236560456
NCI-H2141,44493528,4.465268919484744
BT 245,9911463,3.0517796790400173
RKO,4705,3.750134101835121
KHM-1B,3825829,3.6551708099406
HCC1395,25262965,0.9377161822237366
Rh30,selumetinib-MK-2206 (8-1 mol-mol),2.282409073462543
SF539,6918837,-1.7926544447707695
NCI-H1568,2828334,5.9155051642717
OPM-2,50905018,4.056598853615348
HCC38,23939,4.4320494541481805
OCI-AML-3,JQ-1-carboplatin (1-1 mol-mol),-1.7736109395797492
A4/Fukuda,5460769,3.0365194168079572
Hs 578T,16722836,0.8211658919225645
SNU-1041,400769,-0.2326567442924358
Panc 03.27,46199207,3.4061688175066034
LC-1F,46191454,2.003187133625961
TCCSUP,6505803,-2.3370703799020323
YKG-1,SNX-2112-bortezomib (250-1 mol-mol),-1.7572291199138872
EM-2,11485656,1.7010188292526576
HPAC,11960529,3.797752434904692
Rh30,409805,5.11813479987097
NCI-H2196,selumetinib-vorinostat (8-1 mol-mol),2.7260788817347965
NCI-H1568,49836020,3.1231470101883336
KYSE-450,11178236,-2.864393215026398
Rh30,selumetinib-piperlongumine (8-1 mol-mol),2.7259767960254515
SF539,46398810,1.675879123276388
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
BT 231,44202524,1.029981904128022
AU565,25154868,3.4836730381065424
NCI-H1568,11507802,1.223292685938289
JHUEM-3,carboplatin-etoposide (40-17 mol-mol),1.7705956748652891
Rh30,1716436,3.173940157275495
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253
MM1.S,16038120,-1.5361112717361085
CHP-212,44607530,0.967857781602034
SW1783,446155,0.9196184562402074
KMRC-20,446155,3.8428728494703432
KHM-1B,44185566,1.2108718099020337
RERF-LC-MS,6914657,-3.1593675222943896
KMRC-20,49850262,4.568150133018385
LOU-NH91,11719255,2.9529273796726394
Ishikawa (Heraklio) 02 ER-,148198,-2.3973242740422407
Hs 746.T,9884685,-0.72643676564829
Kasumi-2,11494412,-0.1140662522158316
BL-70,73707371,5.067539770481929
SK-MEL-28,46907787,3.835105129876131
NCI-H1568,4378219,1.8995328874154
NCI-H1568,119182,-0.8732650634834633
BT 245,322968,3.5210488546658905
RERF-LC-MS,11955716,-2.426679724944883
KMRC-20,56946209,-1.705053096437228
CHP-212,49867926,3.880113827525673
KMS-20,carboplatin-UNC0638 (2-1 mol-mol),2.6820630100068197
SNU-1041,7251185,4.4156053200679475
KHM-1B,52947716,-7.453605591404808
B-CPAP,638278,3.199746181468372
Hs 578T,9911463,4.370366906905746
SF539,selumetinib-BRD-A02303741 (4-1 mol-mol),4.342387271248252
SF539,2858523,3.000626783089259
Kasumi-2,135440466,2.9310364314773376
NCI-H2196,SNX-2112-bortezomib (250-1 mol-mol),-0.705396732926331
Ishikawa (Heraklio) 02 ER-,135398516,2.3719819376312805
BT-474,5287969,-1.430762460986159
KMRC-20,11214940,0.9068953612442124
RERF-LC-MS,637858,3.156110522031532
AU565,BRD9876-MK-1775 (4-1 mol-mol),-0.166226177958293
BT 245,2949965,2.7740961114738396
Panc 03.27,alisertib-navitoclax (2-1 mol-mol),1.0236179299310184
NCI-H2141,11222830,0.5430948751707297
OPM-2,969516,1.7213945625906069
OPM-2,56646779,4.429673228200906
HPAC,54618164,3.204433172015927
YH-13,107985,-2.561016282380613
SF539,3676137,4.118081240228259
PF-382,49850262,2.873386319481207
HCC38,9933475,1.5144379396134702
NU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),3.3161247745153277
EM-2,9803433,6.103755471970246
Ku812,selumetinib-PLX-4032 (8-1 mol-mol),-1.0900745107339422
BT-474,4261,1.7675853555355934
RKO,400769,-0.364727826621167
CHP-212,60700,-2.760742742674135
OPM-2,54619267,3.38914180731132
SF539,11656518,1.229269486951703
PK-59,5311,1.6385970042075888
SH-10-TC,71751553,4.325355534508399
NCI-H1184,11964036,0.003584927148296
NU-DHL-1,11612883,1.5610668318918748
Hs 746.T,navitoclax-birinapant (1-1 mol-mol),0.6265371084385948
KYSE-70,17759555,3.816264723168541
F-36P,piperlongumine-MST-312 (1-1 mol-mol),1.2295235789466332
BT 245,46191454,1.8526201117274133
A4/Fukuda,decitabine-carboplatin (1-1 mol-mol),0.1179398036962416
Ku812,123631,1.6677708488644187
SNU-1041,446155,2.196065442041262
M-07e,6918736,-2.525921194177125
HPAC,11427553,2.997644664481198
OCI-AML-3,navitoclax-MST-312 (1-1 mol-mol),0.4955908396950462
HCC38,selumetinib-navitoclax (8-1 mol-mol),2.4679062960439127
NCI-H1184,navitoclax-pluripotin (1-1 mol-mol),-1.2154979657843443
NCI-H2141,53392493,1.9509854243214155
OCI-AML-5,11612883,1.358832098699318
OCI-AML-5,51039095,1.9491800330311104
WM88,156422,4.087978153912544
OCI-AML-5,JQ-1-navitoclax (2-1 mol-mol),-0.5041656009214751
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238
LOU-NH91,439501,-1.197324809082114
Hs 578T,119607,4.3920496413228935
KMRC-20,107970,2.3183049291357953
SK-MEL-28,5566,3.135754874944302
Rh30,123631,2.261564941239063
TCCSUP,BRD-A02303741-navitoclax (2-1 mol-mol),3.413405866150177
Panc 03.27,46926350,-4.399892106444009
HCC1395,5566,2.4993345582861397
NCI-H1568,4788,5.820003751306211
BT 428,176870,3.6826652854362862
SW1783,doxorubicin-navitoclax (2-1 mol-mol),0.2822920316533508
MM1.S,tretinoin-navitoclax (4-1 mol-mol),4.414459370094276
OCI-AML-3,11214940,3.833782207758337
SNU-1077,54618771,3.2500418975361347
TCCSUP,alisertib-navitoclax (2-1 mol-mol),-0.001751015596035
CHP-212,241158,4.019379918122575
BT-474,4378219,-0.527763479928482
A4/Fukuda,46191454,-2.2780561859524457
WM88,11485656,3.1313220477108996
YKG-1,24180719,3.9983429760657265
PK-59,73707398,1.1955784126278513
MM1.S,119607,4.277227419584953
CHP-212,tanespimycin-bortezomib (250-1 mol-mol),-3.160295416618492
M-07e,25062766,-0.3161246631941714
Ku812,5281321,-2.365774247469062
RKO,36462,3.4370564574699185
Hs 746.T,16722836,2.255397087068725
RKO,20959075,-2.9107192765247536
YKG-1,5738263,3.956639283215739
Hs 578T,5287620,-3.7983052500332746
KMS-20,tanespimycin-bortezomib (250-1 mol-mol),-0.2140039466554119
Hs 578T,9823820,-0.0122334569918356
B-CPAP,119607,5.422554804486835
PF-382,sirolimus-bortezomib (250-1 mol-mol),-1.8345993475450983
HCC1395,54613361,-0.9285900269667972
OCI-AML-5,7251185,2.104465108834624
KMRC-20,46199207,3.496477573455405
CHP-212,9956119,2.2584012988307314
WM88,11640390,3.120373499048668
Ishikawa (Heraklio) 02 ER-,6852167,3.9423721034653423
WM88,16736978,0.830771368427228
PK-59,135398516,1.9141148521256752
KMRC-20,73707398,1.7254732299327342
Hs 746.T,135999136,4.038871397264603
Hs 746.T,10427712,4.252379653516158
HCC1395,10427712,5.236764845211121
LOU-NH91,selumetinib-GDC-0941 (4-1 mol-mol),3.122551145262448
PK-59,3081361,2.522625725891429
SK-MEL-28,4477,0.9697986591939786
OCI-AML-3,42642645,-0.8981598919505451
SK-MEL-28,1566236,1.6963201581644038
Ishikawa (Heraklio) 02 ER-,72376,-1.85894734544105
Kasumi-2,72193861,0.1525951303543335
MM1.S,JQ-1-vorinostat (2-1 mol-mol),-1.2519551841274497
CHP-212,11234052,4.2632577373531495
RERF-LC-MS,16038120,1.5599846769821624
SH-10-TC,25126798,4.207886608691474
PK-59,446155,4.009022985502684
LOU-NH91,67156097,-3.1227398262817587
BT 248,6610216,3.912037893092857
WM88,6438330,2.4861256285745497
SW1783,216239,3.3394693883957616
KMS-20,selumetinib-navitoclax (8-1 mol-mol),-1.8022181228536576
SNU-1041,31703,1.2579895191429695
KMRC-20,23725625,4.838709119621016
A4/Fukuda,5311,-0.1264358008137528
RKO,107970,2.3673735748138265
YH-13,3503,1.9021555788410789
SF539,2126,3.755804454049341
BFTC-909,54143018,0.6300785047889099
A4/Fukuda,11964036,-0.0142982917472374
MM1.S,753704,4.513964984168999
NCI-H1568,11214940,1.6761106979183067
Hs 746.T,1641662,3.675208741086048
SNU-1041,11427553,3.098482123397849
HEC-59,44607531,1.7407253225932429
Hs 746.T,JQ-1-vorinostat (2-1 mol-mol),1.164191789966899
RERF-LC-MS,5460769,5.094680634820597
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282
KHM-1B,6917907,-6.365498814306295
OPM-2,6918736,-1.006954953557461
YKG-1,5328940,2.878150949986743
BFTC-909,2949965,3.0294119536880197
M-07e,10127622,4.284261423250822
OAW28,135440466,2.5697421477630273
NU-DHL-1,9911830,2.5877421671517578
WM88,9967941,1.8416832965399297
Hs 746.T,2733526,4.190844523162775
Hs 746.T,9926054,1.836274642391939
CHP-212,12001922,1.5548125354784377
BT 245,11396600,2.7099317658056927
PK-59,4259181,0.3924216394548331
EM-2,72193861,0.0589646743248264
NCI-H1568,25161177,4.305259269080427
OCI-AML-3,5278396,3.07120081813041
HCC38,11427553,3.5132083489222374
PF-382,54143018,-0.5673202131057219
CHP-212,53232,1.1177687959098626
NCI-H1184,675434,4.064084455802343
F-36P,4788,3.754579692530656
AU565,56963564,-0.3705062094323867
OCI-AML-3,5311281,0.9777615017465112
Kasumi-2,71304818,2.3604520648914136
Ishikawa (Heraklio) 02 ER-,5280436,4.342849342052085
PF-382,56946209,-4.827856930300663
Kasumi-2,25126798,3.908076551751955
CHP-212,3136844,3.658159698366908
SF539,3025944,4.088264008981447
WM88,246676,-1.5613699028719277
OPM-2,49793307,-4.879066461483742
Kasumi-2,3503,1.0805615825532868
Rh30,16065773,3.1401130855020045
SF539,BRD-A02303741-navitoclax (2-1 mol-mol),2.7425485852442866
BT 248,71729975,1.811306833980593
WM88,5311,1.282294734802592
OCI-AML-3,1641662,2.7462704687712955
B-CPAP,11964036,2.6070306321605794
KMS-20,UNC0638-navitoclax (1-1 mol-mol),1.0394785462110392
BT-474,46398810,2.669949274416558
JHUEM-3,2749,1.4776762851815068
SF539,16659841,3.270548926893477
KYSE-70,11152667,0.5949086715112851
HCC1395,24180719,4.262412177650308
Kasumi-2,11507802,0.0513516992758086
SNU-1041,65064,5.585928507045206
SH-10-TC,3025986,-0.8693278224015641
A4/Fukuda,11175137,1.0544671313881684
Panc 03.27,49836020,2.722888568283256
KHM-1B,25062766,1.5737082616521652
SH-10-TC,374536,-2.970225566327119
NCI-H2196,11234052,3.928077608663913
NU-DHL-1,56973724,1.6300802460905772
SNU-201,navitoclax-MST-312 (1-1 mol-mol),0.2168719770962565
NCI-H2141,11178236,-4.449050637755491
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355
OAW28,52912189,1.8010258653688298
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186
TCCSUP,613753,3.3276324574262595
CHP-212,9933475,1.62096657373816
AU565,53232,3.892352285865555
NCI-H2196,tanespimycin-bortezomib (250-1 mol-mol),0.7510452056774047
Hs 578T,1317464,3.667513167501283
TCCSUP,11175137,3.3484208163516587
Rh30,44507138,1.7426007408880442
NCI-H1568,decitabine-carboplatin (1-1 mol-mol),4.2821372470380545
OCI-AML-3,9927531,5.116735976562035
BT 428,4378219,1.777728517709583
JHUEM-3,JQ-1-navitoclax (2-1 mol-mol),0.0762751623217084
RKO,16741245,1.399079485469943
PF-382,16115403,-5.914744850998346
NCI-H2196,selumetinib-navitoclax (8-1 mol-mol),1.095045622861524
Hs 746.T,9967941,5.034718112121984
OCI-AML-3,2858523,2.9558321208354745
PF-382,11640390,2.579258356674951
Panc 03.27,24964624,2.5561015467035166
KHM-1B,6918837,-4.542516260541086
PK-59,3543504,4.224524740043423
NCI-H2196,navitoclax-sorafenib (1-1 mol-mol),0.5695286135435994
SH-10-TC,36462,3.008828443008953
MM1.S,5566,3.0863542301618905
BT-474,613000,0.1403309753048933
OCI-AML-5,11707110,-0.4942364624128215
BT 231,5113032,4.671277876610016
NCI-H1568,23635314,-3.8228905075414055
SNU-1041,navitoclax-MST-312 (1-1 mol-mol),2.0535756716257274
CHP-212,11657048,4.160018523895633
B-CPAP,2733487,6.302381879581772
B-CPAP,73707398,1.14773007898321
JHUEM-3,148124,-5.835498657888768
F-36P,439501,-3.1981830153040223
NU-DHL-1,6450551,1.9014057000217284
NCI-H2196,17755052,1.7337201570380638
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556
WM88,navitoclax-pluripotin (1-1 mol-mol),-1.773572347563518
TCCSUP,2742550,3.882646249663198
M-07e,123631,2.224332296346811
OAW28,9915743,2.8675584787684456
M-07e,72199292,-0.2833056415879429
NCI-H1568,49793307,-3.5648882234860895
OCI-AML-5,10074640,3.0450164267054163
CHP-212,navitoclax-PLX-4032 (1-1 mol-mol),2.1537411090085303
F-36P,24797083,0.9430750906805656
NU-DHL-1,53232,2.540653358624638
RKO,11964036,1.8153618806471208
RERF-LC-MS,25102847,0.6953191965745218
A4/Fukuda,5287969,-2.571307610380136
NCI-H1568,24856436,-0.7402646666066086
MM1.S,12001922,1.2922454576478266
HCC38,BRD-A02303741-navitoclax (2-1 mol-mol),0.9876146390411188
OAW28,25062766,3.2225198305631464
Kasumi-2,2828334,5.794074438385768
HCC1395,25102847,3.577398706060495
EM-2,439501,-2.360437246727397
HPAC,327653,3.5480126625924804
SNU-1077,4261,2.6699673905919696
BT 231,46199207,1.5189461629253225
SNU-410,9936388,2.1346646723856444
KHM-1B,25195348,3.649934480073114
F-36P,9444,4.08511047896454
SF539,10184653,1.7813996446939269
F-36P,15547703,2.366853340094686
NCI-H2196,9935249,1.3463658676393593
B-CPAP,ISOX-bortezomib (250-1 mol-mol),0.9973864966848812
Panc 03.27,2746,4.351064714114301
BT 248,53481919,4.127258509947241
BT 245,5280436,3.2619777265426633
RERF-LC-MS,984333,0.876742343627688
OCI-AML-5,24772860,-2.398738215353767
KYSE-450,2749,3.233270096277708
RKO,4259181,-0.4049041326260317
SNU-1077,44543605,4.154950294832259
OCI-AML-3,2742550,2.8792511739592728
KYSE-70,vorinostat-carboplatin (1-1 mol-mol),2.3289614094858813
CHP-212,44491742,3.750067652008212
SK-MEL-28,4788,5.8874743333158985
KYSE-70,3025944,3.9400169946897226
SK-MEL-28,2858523,3.231693296931409
Ishikawa (Heraklio) 02 ER-,16741245,1.9407743846617116
YH-13,1566236,1.6600939078751014
OPM-2,24180719,3.7347961717129383
SW1783,52912189,3.916642045529953
A4/Fukuda,4915,4.811112690158961
BT 245,JQ-1-vorinostat (2-1 mol-mol),1.251473973168844
KMS-20,11612883,1.7611738578766285
SW1783,675434,4.251921967331538
SNU-1077,9926054,3.1436307505327123
M-07e,44607531,1.3758697387280097
A4/Fukuda,2729026,2.569130626356953
OCI-AML-5,426756,4.417916029786897
PF-382,decitabine-navitoclax (2-1 mol-mol),-2.1904802536786305
Ku812,753704,4.676427896259273
WM88,3062316,2.1229821812528837
MM1.S,10302451,3.7035556434363808
Rh30,71304818,2.610288824753235
EM-2,selumetinib-PLX-4032 (8-1 mol-mol),1.9541263800189412
NCI-H1568,BRD-A02303741-navitoclax (2-1 mol-mol),5.689804602568574
F-36P,148124,-6.364948087395455
OCI-AML-5,11717001,4.158466016962978
Hs 746.T,44819697,0.5248937982027082
EM-2,10385095,1.5140639606504105
OCI-AML-3,107970,1.3143182352551162
NCI-H1568,72199292,0.3941551729128716
BFTC-909,11612883,3.5324782187628827
YH-13,702558,5.825874792265712
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106
BFTC-909,969516,2.723005004244225
Rh30,24797083,1.0241715610481392
SK-MEL-28,409805,5.67996042379304
TCCSUP,44819697,-0.8958892266160017
TCCSUP,44507138,1.5092098612229228
SF539,53232,2.519991468251329
PF-382,54454,2.1316538534788196
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447
SK-MEL-28,11485656,3.743045528473451
OCI-AML-3,122327,3.841438647128669
A4/Fukuda,25161177,3.5710974046751804
Panc 03.27,4096211,1.8202397652014064
OPM-2,208908,1.37961789198716
KHM-1B,123631,2.5623362967553858
Ishikawa (Heraklio) 02 ER-,5470400,-1.7110072975424768
SNU-201,49766530,0.2558718668414946
KMS-20,54619267,3.8128952871152046
SNU-1077,vorinostat-carboplatin (1-1 mol-mol),3.2108686769377717
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957
Hs 746.T,148198,-2.6846160081126422
BT-474,selumetinib-UNC0638 (4-1 mol-mol),3.841331730037967
B-CPAP,675434,3.8124437970633194
OCI-AML-3,11960529,4.219497733443069
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642
M-07e,9866186,-1.554580805772736
EM-2,73707386,5.173636041104296
OAW28,216345,3.8770767977792913
SNU-410,navitoclax-gemcitabine (1-1 mol-mol),1.1003468489248285
Panc 03.27,carboplatin-UNC0638 (2-1 mol-mol),3.848000797008923
HPAC,637858,2.270663033055596
PK-59,17759555,4.419467770520212
PK-59,262093,2.249881918634125
OCI-AML-3,462382,-0.2206137854507715
F-36P,54626689,5.186614622996473
BT 245,36314,-4.128140431647543
YH-13,11427553,1.71791693691315
Kasumi-2,11427553,1.2029720763459597
NU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-5.858735676299637
MM1.S,136227924,2.5395832269167027
SF539,docetaxel-tanespimycin (2-1 mol-mol),-4.4379333242133
OCI-AML-5,10113978,3.2543858640467525
MM1.S,24901704,2.7745891166557786
M-07e,5281321,-1.2025758750392068
SH-10-TC,9926054,2.8749564288273604
KHM-1B,136227924,1.9174951940989704
JHUEM-3,6505803,0.6198707712073951
CHP-212,252682,6.81869669726544
Rh30,5460769,3.928559830912204
KMRC-20,16038120,1.6460192975899484
BT 248,navitoclax-birinapant (1-1 mol-mol),0.9680614151724524
Panc 03.27,11178236,-6.331698265211454
Hs 746.T,6450551,4.310918640042312
BL-70,5460769,4.3376670104082455
CHP-212,23582824,-1.1333796461356596
KMRC-20,216468,5.240233090076588
NCI-H1184,123631,2.4940596417666847
PF-382,24856436,-1.472575782331219
TCCSUP,9967941,4.9073920600623415
F-36P,11175137,2.1868285044806433
Rh30,4477,0.8477865796365409
OAW28,322968,3.926433659329745
Rh30,15547703,3.2621126497282877
SNU-1077,11640390,2.9587298758438316
BT-474,2949965,2.6422197621158476
TCCSUP,136227924,3.28330337763218
NU-DHL-1,11213558,3.5998210227089036
SF539,10410894,2.254370966764811
SNU-1077,23725625,5.509681038807162
A4/Fukuda,46926350,-6.021657358635238
Hs 746.T,9956119,4.049049545233031
YKG-1,16720766,0.8883100647238013
EM-2,3081361,0.2661922010636506
HEC-59,71466445,5.0373269237544465
SK-MEL-28,6184667,2.5329996148763163
EM-2,675434,3.9125250021588776
F-36P,44819697,-2.361192365773356
BL-70,5351362,0.303271262675596
Panc 03.27,56946209,-5.167630953675598
Hs 746.T,15953870,3.143153585235011
Panc 03.27,71304818,2.4066769744988674
B-CPAP,5566,3.019933897494269
MM1.S,44202524,1.2152140209200315
B-CPAP,15953870,3.3315928326884756
LOU-NH91,637858,2.168731257760998
F-36P,2708,4.819851744198275
KMS-20,navitoclax-MST-312 (1-1 mol-mol),0.8684749204516451
Ku812,17759555,3.312444984916292
RERF-LC-MS,54626689,4.221264321270605
B-CPAP,219104,3.4420114060064084
PF-382,72734382,3.7745831304753894
HCC38,11719255,3.1879283504605587
YH-13,49766530,-0.8723369372860722
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647
NCI-H1184,23582824,-0.918130083814542
OAW28,227681,3.168890693964491
NU-DHL-1,6252,-2.10817374162043
MM1.S,42642645,-0.2096887803746246
LOU-NH91,24771867,3.0978851297923895
OCI-AML-5,selumetinib-piperlongumine (8-1 mol-mol),1.671934470999923
NCI-H1568,65628,3.926137474064237
KMRC-20,5281321,0.8825507605959158
OPM-2,4915,5.457147549775398
KYSE-70,serdemetan-SCH-529074 (1-1 mol-mol),2.076858890087622
TCCSUP,219104,4.0410651584060435
Hs 746.T,3385,6.006199210412755
NCI-H2141,5335621,3.900211580589631
BT 245,135659046,4.182181998244751
OPM-2,216239,1.2934585013066655
SNU-1077,25183872,-0.8765596964039514
RERF-LC-MS,135398516,2.452363199699896
NCI-H1568,107970,1.680617581032042
CHP-212,3101542,4.402427523763786
KMS-20,44185566,1.377137905176795
WM88,60750,2.1204357555167404
HPAC,46191454,1.587022097089941
WM88,73707398,1.223752817996938
SH-10-TC,25154868,5.212478179531951
WM88,9911830,1.6479325280433286
HCC1395,44202524,1.5137915548442566
CHP-212,4477,0.5289163662085682
BL-70,23725625,4.3309462151785025
TCCSUP,4096211,2.136030263591951
CHP-212,400769,-0.8950914712180946
LOU-NH91,crizotinib-PLX-4032 (2-1 mol-mol),1.9615360492611609
OPM-2,piperlongumine-MST-312 (1-1 mol-mol),0.9476168525414524
KHM-1B,2874250,4.780971307568023
KHM-1B,44495899,-1.7944693078792426
Rh30,24180125,3.823310947482733
PK-59,119607,5.342601752409214
NCI-H2196,219104,3.876716468841501
BL-70,9956119,3.204414932459714
OPM-2,10231331,0.6444733525039235
ML-1 [Human thyroid carcinoma],5291,4.042812106600411
KYSE-70,285033,-2.195981319752621
YH-13,5311,2.0479305445727083
NCI-H2141,10113978,2.725042735615023
BT 428,6610216,3.3816789870982547
OCI-AML-5,3689413,0.2797126247075585
B-CPAP,168312962,-2.242670395698556
JHUEM-3,637858,1.8218805135289704
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
NU-DHL-1,2733526,3.27744677089757
RERF-LC-MS,135999136,4.400683337930441
M-07e,53393127,4.209159763625011
SNU-410,445643,4.054123599301381
NCI-H2196,100016,7.101599749729703
KHM-1B,11647372,-0.566073234789779
KMS-20,5351362,0.6433164049464225
EM-2,17755052,1.3448724806729475
BT 231,25262965,-1.2332084401819954
SNU-1077,5281321,-1.036948413736443
Kasumi-2,54143018,-2.3900299530010405
TCCSUP,25126798,3.72552014127361
BT 245,9884685,1.0158676742482895
SH-10-TC,67156097,-0.6637308209395751
OCI-AML-5,72376,-3.850369846099864
KMS-20,374536,-2.9179307309900553
RKO,168312962,-2.5117583451491012
OPM-2,JQ-1-vorinostat (2-1 mol-mol),-2.42287599285764
OAW28,216239,4.152270593115834
TCCSUP,5738263,3.424558088510442
SF539,46843906,2.6895390724819253
F-36P,3025986,-1.286215975867841
Ishikawa (Heraklio) 02 ER-,1750826,-0.2156732013128532
TCCSUP,241158,3.99107653461265
NCI-H1184,6252,-2.396014909590076
YH-13,6917907,-5.576575659474619
NU-DHL-1,54143018,-3.6528405777406743
PK-59,16722836,1.3763942653664631
F-36P,6918328,-2.195368020697059
RKO,10074640,2.8357111382750646
PF-382,6450551,1.027271835386555
AU565,44507138,1.5217719455679517
BT 231,navitoclax-MST-312 (1-1 mol-mol),0.961597338682918
CHP-212,5311281,0.9276330825530472
HCC1395,72734382,6.009663296484976
Hs 746.T,3062316,1.2949724135335163
KHM-1B,54454,3.744465591598654
A4/Fukuda,tanespimycin-gemcitabine (1-1 mol-mol),-4.973874531854187
CHP-212,BRD-K55473186,4.43546777807134
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836
PK-59,11507802,3.057258453235266
OPM-2,3825829,3.9075204590636226
BT 231,9826308,-1.6750260757425828
JHUEM-3,156414,0.1798690531293942
BT 248,5329102,2.143317374155595
TCCSUP,4259181,1.0116551093848198
HPAC,5351362,2.660758628048565
MM1.S,9926054,1.5897504862532963
NCI-H2141,11364421,2.0747380244729534
BT-474,2746,-1.392865413318883
OAW28,11977753,-1.87780111267196
NCI-H2196,9884685,-0.5196236885071903
Kasumi-2,5278396,3.160923329427041
BL-70,1716436,2.25517721544058
EM-2,11640390,2.734685742129265
NCI-H2196,462382,0.2193107143390405
KMS-20,navitoclax-PLX-4032 (1-1 mol-mol),2.7801553034248543
YKG-1,5282054,4.677565101895448
BT 245,11317348,1.822035958732133
AU565,52912189,3.2475583793468994
RKO,11612883,3.106052261550285
Kasumi-2,4917,2.8909802401946565
HPAC,46224516,3.9876568941614825
TCCSUP,16725315,3.821087103273168
OAW28,11152667,0.0990704789630026
KMRC-20,9926054,2.16526453404653
NU-DHL-1,45279963,-1.229232320472187
NCI-H2196,46843906,5.015379400435743
LOU-NH91,navitoclax-birinapant (1-1 mol-mol),-1.5910791983061243
HCC38,3062316,2.52300747713386
LOU-NH91,4521392,4.279385220000522
Hs 746.T,135421197,2.8198811275725206
Ishikawa (Heraklio) 02 ER-,15953870,3.735200947814725
NCI-H2141,tanespimycin-bortezomib (250-1 mol-mol),0.6080837341051074
OCI-AML-5,25183872,-0.9054498401912954
LOU-NH91,65064,5.187256751294022
Hs 746.T,tretinoin-navitoclax (4-1 mol-mol),4.186019348574341
Hs 578T,selumetinib-UNC0638 (4-1 mol-mol),1.9702136339732368
OCI-AML-5,613000,1.0362616859688938
HEC-59,11625818,3.6987369471909384
BT 231,9956119,4.178379846125992
SK-MEL-28,navitoclax-sorafenib (1-1 mol-mol),2.0059633351475847
BT 231,6918736,-3.5534251513743245
NCI-H1184,241158,3.551679636073963
Ku812,156422,3.166038236669379
SK-MEL-28,9911830,3.7902815277231663
BT 428,135659046,3.573763038343519
TCCSUP,156422,3.9310929272005466
SH-10-TC,selumetinib-tretinoin (2-1 mol-mol),5.475300114137392
YH-13,alisertib-navitoclax (2-1 mol-mol),-1.4191269033717964
B-CPAP,5281321,-1.80536114011693
WM88,46199207,3.641445250320943
OAW28,46224516,2.3854099680927523
SNU-410,selumetinib-tretinoin (2-1 mol-mol),5.355783152241833
KMS-20,119182,-0.7060386970592318
LOU-NH91,23635314,-2.2216361010230545
Ku812,49836020,4.574644913995472
HCC38,10427712,3.8626206817311792
B-CPAP,11404337,-1.1633647036433346
KMRC-20,135411,1.924751982395428
SNU-1041,44543605,4.191273771699204
OCI-AML-3,15547703,3.072693199602156
Kasumi-2,60750,-5.618830215487252
HCC38,6610355,5.462682040878877
SNU-1077,5746,2.5393754891550877
B-CPAP,navitoclax-piperlongumine (1-1 mol-mol),1.412897736514235
OCI-AML-3,3552672,1.465033531899638
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808
KYSE-450,alisertib-navitoclax (2-1 mol-mol),2.776253910680575
NU-DHL-1,11609586,2.2389796491819345
YH-13,10113978,4.558059650015548
WM88,3854666,1.7326705708463876
HPAC,24951314,1.4914793809750515
EM-2,3689413,-2.767286284866434
LOU-NH91,vorinostat-carboplatin (1-1 mol-mol),3.369896826709664
NU-DHL-1,23635314,-3.800545586452872
CHP-212,56649450,0.9507913801767756
SF539,11626560,1.8375334326150123
BT-474,9935249,3.4097501700576016
BT 248,16725315,3.27587483179283
NCI-H2196,16065773,1.68391794165687
HEC-59,5278396,3.16477778345837
CHP-212,65064,4.907641795785695
Kasumi-2,1716436,2.2552230484948477
KHM-1B,5351362,0.671182618644872
Panc 03.27,10427712,4.428338837066214
NCI-H2196,11238147,1.627026342332458
BL-70,6918328,-2.6266198654040736
RERF-LC-MS,26596,-1.2372341703529914
BT 231,6917907,-4.654838950959951
Kasumi-2,24821094,1.7820431474601306
Hs 746.T,52947716,3.075053827551718
OCI-AML-5,tretinoin-navitoclax (4-1 mol-mol),-1.191495191780958
BT-474,5329102,1.970759400596869
HPAC,9825149,1.7471843493436008
WM88,23582824,0.2519040511513284
CHP-212,5287969,-2.456015883481266
Hs 578T,5460769,5.961368196562113
AU565,44137675,3.533476650788096
BFTC-909,439501,-2.4866456286351095
BT-474,16741245,4.691064785740931
EM-2,54686904,3.6007215473828262
SNU-410,crizotinib-PLX-4032 (2-1 mol-mol),2.9016544319911084
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192
M-07e,168313016,3.928570731388112
Ishikawa (Heraklio) 02 ER-,5351362,1.1794354622901426
BT 428,25262965,-1.4038141839062968
NCI-H1568,72734382,4.159676082420196
MM1.S,sirolimus-bortezomib (250-1 mol-mol),-3.4112466986615475
RERF-LC-MS,11657048,4.330866638894723
PF-382,9908783,6.451315520536067
BT 231,11964036,1.0298920297542395
EM-2,444795,-0.7982281742747948
EM-2,1239801,3.6689505066978856
OPM-2,3503,1.0860674816661569
BL-70,12001922,1.3949690705923978
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111
NCI-H2196,9866186,1.9502165119024617
F-36P,9956119,2.2251243859436007
Hs 578T,JQ-1-MK-0752 (1-1 mol-mol),0.953779468846384
EM-2,4477,0.8508652896707716
BT 248,docetaxel-tanespimycin (2-1 mol-mol),-0.0329319446366538
AU565,5329102,2.0441914674842008
NU-DHL-1,5566,3.1581307498814923
LOU-NH91,navitoclax-MST-312 (1-1 mol-mol),-1.3828767553270485
YKG-1,selumetinib-JQ-1 (4-1 mol-mol),2.6528510984038864
A4/Fukuda,3385,2.3595203579832553
CHP-212,carboplatin-UNC0638 (2-1 mol-mol),4.194457757850316
MM1.S,159324,2.619931466693083
KMRC-20,57330099,4.053303525305033
BT 245,44137675,3.3906511834655517
Kasumi-2,25227462,-2.512802493882235
HCC1395,5278396,3.2620632103524407
EM-2,11152667,-2.11262389342865
OCI-AML-3,3025944,3.75811078384682
PF-382,11964036,0.0769506444989081
AU565,53393127,4.519828407362072
BFTC-909,15547703,3.647732910564925
SK-MEL-28,637858,2.5948993681356276
M-07e,selumetinib-BRD-A02303741 (4-1 mol-mol),2.9315477953458657
LOU-NH91,241158,4.097895358021133
SNU-1077,246676,5.4377451130468435
SNU-410,9915743,1.505425413193383
SH-10-TC,3689413,0.5157614607297105
OPM-2,selumetinib-navitoclax (8-1 mol-mol),2.2674041559669917
Hs 746.T,72376,-2.369545000940401
BT 231,65628,6.2549230990110605
Kasumi-2,5311281,1.4543587988632989
OAW28,51039095,2.7471743585791075
B-CPAP,46191454,1.9154724168312085
OCI-AML-5,alisertib-navitoclax (2-1 mol-mol),-1.6392491160576177
TCCSUP,16722836,1.624255919263104
SK-MEL-28,119607,5.84656156074382
SNU-410,selumetinib-JQ-1 (4-1 mol-mol),4.312736206352891
Hs 578T,44632017,1.3871296355017106
JHUEM-3,5280436,2.4008394960632327
Hs 578T,16038120,1.4928787936956216
LOU-NH91,54618771,2.8270991446030593
HPAC,10074640,2.486484742555952
AU565,46926350,-5.126810871510528
NCI-H2141,24901704,2.994716938343026
RERF-LC-MS,4477,-0.1141702320643991
RERF-LC-MS,16659841,3.453543705685564
NU-DHL-1,49766530,-4.7275009055236445
Hs 746.T,9825149,2.0030769684728744
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016
TCCSUP,2733526,3.083222005706137
NCI-H2196,11626560,2.454469144602936
CHP-212,6252,-4.463289647133771
Hs 578T,46926350,-4.561402428949595
WM88,selumetinib-vorinostat (8-1 mol-mol),-2.7855359401178825
OCI-AML-5,46191454,-0.7479550210113308
RKO,24772860,-3.046302255649564
BT 248,tanespimycin-gemcitabine (1-1 mol-mol),-1.6636234476811602
KMS-20,3081361,1.7600848114221452
KYSE-70,24785538,1.5800117539652696
SNU-1041,44259,0.6434504938068205
RERF-LC-MS,676352,1.6328584527608256
BFTC-909,107970,2.2861723254681774
NCI-H2196,227681,2.9500887888561103
B-CPAP,16038120,1.2112783851664366
OPM-2,446155,0.7744505725193765
NU-DHL-1,11175137,1.9777455594143565
PF-382,1750826,-5.215741275914632
BT 231,46224516,2.839811565474086
BL-70,72376,-4.691044096332686
SH-10-TC,56963564,0.8404374023294454
PK-59,10127622,4.10543481734972
RERF-LC-MS,25262965,-1.1343637554659964
HPAC,5282054,5.622784443033657
PK-59,10296883,3.535365595306604
NCI-H2141,31703,-0.596545768058805
M-07e,10231331,3.7072976059744134
Hs 746.T,10410894,3.435207452273933
KMS-20,44491742,3.719914001289463
NCI-H1568,9907093,3.7800753982052697
Ishikawa (Heraklio) 02 ER-,selumetinib-MK-2206 (8-1 mol-mol),4.937900564286944
Ishikawa (Heraklio) 02 ER-,selumetinib-vorinostat (8-1 mol-mol),2.5379736482823625
NU-DHL-1,5329102,1.5398804917088604
CHP-212,11213558,0.882375888745774
A4/Fukuda,24180719,2.900503133545593
PF-382,16725315,0.8059260614794377
Rh30,24964624,1.7674573276394296
Kasumi-2,9823820,3.05022407511669
Ku812,119182,-3.854816046340745
Hs 746.T,613753,3.195092000384868
Panc 03.27,24951314,2.496529295298963
NCI-H1568,25102847,1.8020479238639409
TCCSUP,4477,1.3083766641686785
BT-474,46199207,3.4607401610316315
BT 248,6914657,-2.576788872604972
OAW28,71466578,4.4029072721322455
HEC-59,656346,1.691678127235366
NCI-H1568,11497983,3.872384435522252
LOU-NH91,675434,4.5447066201437325
HEC-59,tanespimycin-gemcitabine (1-1 mol-mol),1.6450285301047622
WM88,2746,2.5770363002684555
OPM-2,9823820,1.0965123517529505
F-36P,73707398,-0.2227517759229556
MM1.S,46907787,-0.8682718758201811
SW1783,selumetinib-MK-2206 (8-1 mol-mol),4.242449786456935
M-07e,31703,-2.1726501850823503
OAW28,10302451,2.68651474445359
HCC1395,107970,2.2035026306442616
Kasumi-2,57330099,4.668594265491518
OAW28,327653,3.155680016062074
SF539,6914657,-6.2311827891537295
BT 231,selumetinib-decitabine (4-1 mol-mol),4.831366469856365
Kasumi-2,4578,4.103424218787652
A4/Fukuda,148124,-6.6912736941139865
SW1783,409805,4.510325829942446
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496
SNU-1041,54619238,6.430089237391173
KYSE-70,135440466,2.892957215680813
BT 248,327653,3.4402013175237394
RERF-LC-MS,23725625,5.011639185934848
PK-59,selumetinib-tretinoin (2-1 mol-mol),4.429549180241363
TCCSUP,JQ-1-carboplatin (1-1 mol-mol),4.7242319921213225
CHP-212,9825149,0.4190287141491888
BL-70,6918878,-0.6389305360603534
Ku812,10113978,1.4581505574303557
BL-70,54678924,0.8901465088327226
Hs 746.T,156414,1.629229892534377
SF539,71729975,3.876423931998654
HEC-59,44489367,4.567961623859816
BT 245,6610355,5.432985905088436
OCI-AML-3,1566236,1.4852754357905558
OPM-2,9907093,3.786753386665246
KHM-1B,9936388,-7.3262126051433425
EM-2,16115403,-5.530153949171169
PF-382,5978,-2.969199585988814
M-07e,72734382,2.9824212687795386
NCI-H2141,1750826,-3.802393947501651
F-36P,25227462,-1.9338667335731956
WM88,2858523,3.098150145883955
A4/Fukuda,11977753,-3.131569873612884
JHUEM-3,73707398,1.3541053482659346
Ku812,11717001,2.262913045686641
YKG-1,16725315,5.438032591098022
PF-382,3384730,1.4668655115256852
RERF-LC-MS,11152667,0.0782441689403026
MM1.S,451668,2.3967499935955083
Ku812,selumetinib-piperlongumine (8-1 mol-mol),-1.2433230226916236
F-36P,12003241,-0.4333234421592413
BT 231,11497983,1.445602899433163
OCI-AML-3,444795,-5.04160255125036
Ishikawa (Heraklio) 02 ER-,44632017,1.1398248872275398
OAW28,44607531,1.5392912313773788
BT-474,72734382,6.44619867306352
Kasumi-2,5280436,2.9235164089126884
Hs 746.T,11647372,2.465229288669105
SNU-410,5351362,1.914695347942371
OPM-2,46215462,1.142494911690201
NU-DHL-1,44607531,1.8072861510407077
NU-DHL-1,1716436,2.341384326057666
Ku812,10385095,1.0609410330256543
PK-59,5287620,-2.358394278164014
HCC38,104842,-4.681213719580364
SH-10-TC,6918736,-1.1025073834906862
A4/Fukuda,676352,1.592410759121419
OPM-2,68056272,3.036834126647856
SNU-201,168312962,3.645037306354494
KMS-20,5291,3.4295110430475204
KYSE-70,7251185,4.369311092923008
Kasumi-2,9868037,2.67651294484719
HCC1395,10184653,2.593954298437522
OCI-AML-5,6252,3.1602433901464617
RERF-LC-MS,45279963,3.7797867340420215
KMS-20,4259181,-0.0713242382704696
Ishikawa (Heraklio) 02 ER-,11214940,1.485318631794352
M-07e,969516,2.3812178061576152
BT 231,9866186,2.37208042417243
BT 245,selumetinib-navitoclax (8-1 mol-mol),0.6574227652928758
CHP-212,3038522,1.4946356008244173
LOU-NH91,1566236,3.241690914019502
SNU-1077,2828334,5.956147733949382
SNU-1077,16725315,4.11344687119358
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629
AU565,tretinoin-navitoclax (4-1 mol-mol),4.550367433205839
F-36P,BRD-K55473186,1.7794978116408715
NCI-H1568,8515,2.0721444777555327
M-07e,44607530,1.6851596388669938
WM88,11396600,2.133090606668807
OPM-2,3634881,2.0291765129520467
TCCSUP,159324,3.967918889169363
Kasumi-2,5284616,2.846557055185116
A4/Fukuda,71466380,2.851115718652883
Kasumi-2,65628,2.2018759133614987
BL-70,navitoclax-PLX-4032 (1-1 mol-mol),1.5629414992919883
PK-59,tanespimycin-gemcitabine (1-1 mol-mol),0.2161926210498007
AU565,6918328,-1.0169109160359904
HCC38,15983966,-3.041074412430134
Hs 578T,decitabine-navitoclax (2-1 mol-mol),0.7166177902778488
SNU-410,60700,1.1252925895676047
BT 428,12003241,-1.1639537703903158
NU-DHL-1,9444,2.485842478800355
Ku812,36314,-5.058801255345217
SW1783,24785538,4.897756498421733
CHP-212,crizotinib-PLX-4032 (2-1 mol-mol),0.7923090596778691
KYSE-70,26596,-1.4453873864890578
Kasumi-2,10296883,1.6134498936175832
KMS-20,tretinoin-carboplatin (2-1 mol-mol),3.6685354299569486
SF539,135659046,3.181821233210504
NU-DHL-1,68056272,3.3268540806967493
YH-13,10427712,4.6201171639095815
Panc 03.27,44491742,4.225898186806888
OCI-AML-3,46398810,1.5588239661216956
HCC1395,24951314,1.73028841912136
Kasumi-2,46191454,0.4638336944386738
KMS-20,439501,-3.5751856752548985
KYSE-70,176870,5.518340217914711
SK-MEL-28,25105715,3.414843394812394
SNU-410,9952709,3.376212866877076
KMS-20,54678924,1.6750524513499827
SH-10-TC,navitoclax-PLX-4032 (1-1 mol-mol),3.151155845161334
NCI-H1568,3552672,1.826953477138791
NCI-H2141,702558,5.7260304864861
CHP-212,BRD-A02303741-navitoclax (2-1 mol-mol),3.024657138125717
BT 428,11317348,1.729852202559467
PF-382,452548,-2.9455036686626657
KMS-20,11178236,-2.952639968854244
NCI-H2141,11640390,0.7146031104511708
SW1783,24964624,3.0506533345729245
KHM-1B,68056272,3.2538841376284973
NU-DHL-1,67156097,-2.718460958664846
PF-382,carboplatin-UNC0638 (2-1 mol-mol),1.6704329476660973
KMS-20,2746,0.7437630311682376
Rh30,24856436,0.3671805009879282
YKG-1,11238147,1.8492898998590992
RERF-LC-MS,44202524,1.2785968032229695
BT 245,4261,1.712743889137908
Hs 746.T,327653,2.7924805493418567
OPM-2,11612883,1.2708799210561326
NCI-H1568,6610216,3.52063980115584
SNU-410,168313047,3.899299713338225
NCI-H1184,JQ-1-navitoclax (2-1 mol-mol),-0.1444006190217481
OCI-AML-5,72734382,3.635102952924055
NCI-H1568,6918736,-3.5744965026463893
BL-70,10127622,5.23578313272671
NU-DHL-1,46215462,1.671878123602452
Rh30,11222830,1.587943626688637
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
RKO,4917,3.097539294413192
KMS-20,421610,2.181473098974352
TCCSUP,tanespimycin-gemcitabine (1-1 mol-mol),-2.519262130533681
OAW28,10296883,4.314409366833216
HPAC,71466578,4.522992642641298
B-CPAP,11626560,1.847886697389426
Kasumi-2,2749,0.3805959448623131
EM-2,104842,-5.088532634753969
F-36P,89183176,3.776226370950465
OCI-AML-3,285033,-5.841172915821109
HCC38,selumetinib-PLX-4032 (8-1 mol-mol),4.802944863656439
A4/Fukuda,3062316,0.4248767517614322
BT 245,11427553,3.2699623966803095
LC-1F,11214940,1.5185776138941756
NCI-H2141,72193861,-0.7188891646801329
OAW28,5113032,5.506773811436986
F-36P,44137675,4.491528939355425
HPAC,6505803,-1.845067175670312
JHUEM-3,56949517,5.9204241100501775
HCC38,136227924,2.8991930932960983
SNU-410,selumetinib-piperlongumine (8-1 mol-mol),3.55824799020592
BL-70,46224516,3.2218121103831874
OAW28,11404337,-1.5682838378564492
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821
BL-70,4477,-0.2570064199786133
Panc 03.27,5746,0.9166255443037716
Ku812,54649381,2.9639483445767087
HPAC,54619267,4.28836977306654
OCI-AML-3,24771867,-2.5790177528114695
SF539,16736978,2.0915382548726353
Ku812,676352,0.8509371863711478
KMS-20,9549297,1.1298438503478845
KHM-1B,11228183,3.292556863347854
BT-474,5470400,-1.6719646710059382
PF-382,9868037,2.2881920680680756
BT-474,262093,2.736655857570439
BT 248,9866186,3.3997152825838515
B-CPAP,2729026,3.008270694147531
BT 248,135440466,3.298497559431859
BT 248,decitabine-navitoclax (2-1 mol-mol),1.3496925152518875
TCCSUP,702558,5.6887223150764035
HCC1395,216345,3.9878524809281575
HEC-59,selumetinib-vorinostat (8-1 mol-mol),2.380555243275298
KMRC-20,4917,2.994813665263991
Ku812,2729026,1.365537555600546
KHM-1B,16038120,-2.393017359341735
NCI-H2141,11656518,0.8776819904041233
NU-DHL-1,54596490,5.416894183216897
Panc 03.27,71680916,5.330789055220918
Rh30,5311,0.8896272205838921
KHM-1B,11364421,-5.203168306963344
NCI-H2141,15547703,2.9149614597599336
OCI-AML-5,24964624,3.0368882140164706
TCCSUP,44589607,3.4904966961167516
NCI-H2141,44486219,4.216089617672754
F-36P,3676137,6.311128443133313
KMRC-20,JQ-1-navitoclax (2-1 mol-mol),2.637620979600235
BL-70,24180719,3.1504599403729947
KHM-1B,400769,-0.7563953043015217
NCI-H2141,navitoclax-sorafenib (1-1 mol-mol),-0.326942902419027
NU-DHL-1,5284329,2.6170218668943632
SNU-201,3081361,2.910482511753326
HPAC,JQ-1-vorinostat (2-1 mol-mol),0.8375008386550251
NU-DHL-1,46174525,2.6554261934954546
Ku812,16720766,-0.9300961810556406
SNU-410,56973724,4.480117895611675
YH-13,57519531,2.0380151734661185
M-07e,2858523,2.6095499454231916
RKO,969516,2.537841036798478
SW1783,66577038,3.5105114202230396
HEC-59,6610355,5.600254780088887
EM-2,25195348,0.7775461956090843
OAW28,637858,2.2776250733597085
A4/Fukuda,19582717,0.7629696429231957
TCCSUP,2858523,3.01661264260951
KYSE-70,25150857,2.5963104301055258
A4/Fukuda,selumetinib-PLX-4032 (8-1 mol-mol),2.453113132843287
SF539,44241473,5.236379084530278
KHM-1B,216345,3.77132854777876
BL-70,148198,-4.761980486191778
KMS-20,446155,2.015814928352595
Rh30,doxorubicin-navitoclax (2-1 mol-mol),-1.1617204449740124
KMRC-20,selumetinib-BRD-A02303741 (4-1 mol-mol),6.461263224770076
NCI-H2141,10410894,3.259760102573628
KMS-20,24889392,-0.8715030564449404
BT 231,25150857,2.438916563397748
HCC38,4917,4.390285648637397
NU-DHL-1,3025986,-0.9340926836685216
LOU-NH91,17759555,3.0310153631552295
HCC38,4788,5.9865939895016895
Kasumi-2,24856436,-1.5154163657154227
Rh30,selumetinib-vorinostat (8-1 mol-mol),2.333625325238172
SH-10-TC,2113511,6.352339806182634
SF539,JQ-1-UNC0638 (2-1 mol-mol),0.3445992267657
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383
KHM-1B,carboplatin-UNC0638 (2-1 mol-mol),1.8078700282440656
KYSE-70,11396600,3.829938839575827
OCI-AML-5,56973724,0.7117064555205065
SF539,11455910,0.0331728686867912
KMS-20,246676,4.441835225578849
LOU-NH91,24964624,2.935669445800335
CHP-212,135984461,1.9564066999314385
BT 245,doxorubicin-navitoclax (2-1 mol-mol),-1.4892094322491367
KMS-20,262093,1.6065117070445694
OPM-2,11427553,0.184758700497643
EM-2,10231331,-1.453053484988338
NCI-H2141,46191454,0.6181925539330494
HCC1395,navitoclax-pluripotin (1-1 mol-mol),-1.7357993371141909
BT 248,568763,0.252168352363544
Kasumi-2,409805,3.7279902229812114
AU565,1566236,1.7493429265082687
OCI-AML-3,409805,3.723467633820993
BT 428,5284373,2.202230893689752
LOU-NH91,15547703,3.808438680736899
HEC-59,67156097,1.02354485927243
BT 428,969516,2.361614928218663
KMS-20,969516,2.5083831299130233
PK-59,44607531,1.8440573981852608
SNU-1041,alisertib-navitoclax (2-1 mol-mol),1.315765639690898
NU-DHL-1,15983966,-4.432229151645776
SF539,3081361,1.6013360559039176
SK-MEL-28,10296883,3.852008110979885
Panc 03.27,36462,1.4276751747001344
EM-2,60168763,3.2027005396891144
LOU-NH91,navitoclax-gemcitabine (1-1 mol-mol),-1.5749911209291652
KHM-1B,24901704,2.862700156831434
Hs 746.T,46926350,-4.647433614544131
YH-13,44202524,1.4196385072137423
HCC38,44819697,-0.8645635181797371
NCI-H1184,serdemetan-SCH-529074 (1-1 mol-mol),0.2432627882363648
BFTC-909,44507138,2.8704731321552734
M-07e,10410894,3.0473630281827884
YH-13,56963564,0.220500691161984
SNU-410,1716436,0.8857926852405207
KYSE-450,11640390,4.647540881608271
Panc 03.27,72376,-2.292926146495575
BT 245,219104,3.873499987829312
B-CPAP,selumetinib-piperlongumine (8-1 mol-mol),4.578396816065636
WM88,11507802,0.8558765178069282
SH-10-TC,24964624,3.2732547303845325
SW1783,107970,3.037635999927972
LOU-NH91,vorinostat-navitoclax (4-1 mol-mol),-1.0050592172430175
LOU-NH91,54618164,4.244208934703923
NCI-H1184,11234052,4.487027735455144
KYSE-70,656346,0.9492660515895844
OAW28,446155,3.9986810531407486
SW1783,16725315,5.184633472906502
NU-DHL-1,44185566,1.0271500895351358
KMS-20,11507802,0.6395655511000325
PK-59,9903786,2.9850600541065764
BT-474,16659841,1.9752439898909544
LC-1F,5566,3.184833235332795
BFTC-909,9936388,1.702123766125507
F-36P,5284616,2.6318514901590815
KMRC-20,24856436,1.166150223062635
BT 248,JQ-1-UNC0638 (2-1 mol-mol),2.2588808320886917
F-36P,445091,4.242720143658069
OAW28,148198,-3.8662210541116977
SH-10-TC,JQ-1-UNC0638 (2-1 mol-mol),1.5414740224774004
SNU-1041,docetaxel-tanespimycin (2-1 mol-mol),2.429356552764135
SK-MEL-28,73707386,4.4832416514767335
LOU-NH91,656346,1.0077735762311986
WM88,5328940,1.7563948689729754
OPM-2,67291369,1.773293288142809
B-CPAP,60700,-0.0698828360303767
NCI-H2196,568763,0.0200948416979818
TCCSUP,erlotinib-PLX-4032 (2-1 mol-mol),3.460916777406278
OCI-AML-3,11719255,1.2061640100686095
HCC38,56963564,0.5497209118923907
Rh30,2945648,2.4452105022447874
NCI-H2196,11640390,3.376461379028689
OAW28,11485656,3.2643123414600645
A4/Fukuda,9927531,3.7257201794253776
HPAC,vorinostat-navitoclax (4-1 mol-mol),2.5071003996685524
BL-70,227681,2.673225674910627
SH-10-TC,16659841,4.609972311547471
TCCSUP,5702613,2.0782660791611045
KYSE-450,selumetinib-vorinostat (8-1 mol-mol),4.7047853515595515
Kasumi-2,5978,-3.933681438293164
SNU-1077,448949,1.5791911231397144
SNU-1041,serdemetan-SCH-529074 (1-1 mol-mol),2.863786986106665
Panc 03.27,56649450,3.626927880450345
PF-382,216239,2.163237785332069
NU-DHL-1,9868037,1.5827566273106026
KYSE-450,54618771,1.2705031609145587
WM88,11612883,2.532266748226118
KYSE-70,327653,3.7336437717951103
BT 428,11404337,-0.9400136442546092
OAW28,9825149,1.8591620922463772
SNU-410,52912189,3.911818983756416
NCI-H2141,3689413,-3.646913366295815
RERF-LC-MS,3543504,3.1700226881436193
OPM-2,selumetinib-piperlongumine (8-1 mol-mol),2.005304394078306
HCC38,2749,1.592473717911126
KYSE-450,3025944,4.332360551153181
NU-DHL-1,23582824,0.4052084507324015
PF-382,51039095,2.24186796125132
M-07e,9935249,0.4541689416973374
NCI-H1184,135421197,-1.5924558307630432
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258
NCI-H2196,5460769,6.02637664184288
BT-474,10322450,2.780600319023071
HPAC,6914657,-3.028079483275025
Panc 03.27,navitoclax-birinapant (1-1 mol-mol),-0.0316174609327905
MM1.S,25183872,-3.313227348504023
NU-DHL-1,9926054,1.5745053582273782
PK-59,3854666,3.1918550803858783
M-07e,322968,1.07726505175304
NCI-H2141,60750,-2.01836494276962
NCI-H2196,2871966,0.5480832953186193
WM88,123631,3.012202336898036
NCI-H2141,piperlongumine-MST-312 (1-1 mol-mol),1.375002366263996
OCI-AML-3,24856436,-0.3543274567395222
MM1.S,36462,-0.6145210813224762
NCI-H2141,53495165,-4.7551616985490845
KMRC-20,9915743,2.261900740642606
OCI-AML-3,52947716,1.903643902076933
EM-2,46943432,-0.289227345087642
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842
SF539,tretinoin-navitoclax (4-1 mol-mol),2.6465654261890617
KYSE-70,9840324,6.215387239369238
SW1783,10074640,3.756288001729743
Panc 03.27,439501,-1.8758236187541328
LOU-NH91,2733487,6.3296049393179485
NU-DHL-1,11167602,2.239253055046329
Ishikawa (Heraklio) 02 ER-,11485656,3.3351822196084937
HCC38,89928392,0.8720749341819153
OCI-AML-5,4917,3.5816259552735024
SW1783,2749,2.9108764618452456
M-07e,5278396,2.5466183338057418
Kasumi-2,637858,0.3812755763700117
M-07e,SNX-2112-bortezomib (250-1 mol-mol),-2.8758228111631
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816
HCC38,11455910,0.8868705732454679
Kasumi-2,SNX-2112-bortezomib (250-1 mol-mol),-2.9653989283259805
HCC1395,11175137,1.785494325725619
Kasumi-2,426756,1.7072417198911318
SF539,9956119,2.7951996654139664
JHUEM-3,675434,4.342307372828434
CHP-212,24951314,0.3669909582693081
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486
OCI-AML-5,568763,1.6587777807485085
OCI-AML-5,6438330,2.4309834619120085
Panc 03.27,11494412,0.9108991016924464
NU-DHL-1,24748573,1.9153474255246443
LOU-NH91,2126,5.273491801207327
HCC1395,selumetinib-BRD-A02303741 (4-1 mol-mol),5.692953690184119
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459
Kasumi-2,10184653,1.2356790109659648
NCI-H1184,10427712,1.9345506841191928
Ishikawa (Heraklio) 02 ER-,ISOX-bortezomib (250-1 mol-mol),0.4177142884347778
RERF-LC-MS,9907093,3.840365222907794
HEC-59,25262965,-1.8232309032614689
SF539,6184667,1.7310938600147268
A4/Fukuda,135928012,2.23734461349398
CHP-212,5284616,3.1311942842548164
KMS-20,6852167,1.0361135786452058
SNU-1041,ISOX-bortezomib (250-1 mol-mol),1.4843803037526522
BT 248,123631,2.103805835203493
OCI-AML-3,24775005,4.411957250777116
SNU-1077,5351362,2.377712922072383
NCI-H1184,52912189,0.0724751943595539
SF539,5280436,3.2977322800026463
SF539,10385095,0.5044778211988786
Panc 03.27,15953870,3.638466820116044
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895
BT-474,24964624,1.5512185008829114
Rh30,tanespimycin-gemcitabine (1-1 mol-mol),-4.183516560131942
NU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),-0.9508883032540202
SH-10-TC,375860,-0.0293228358206677
OCI-AML-3,16736978,0.1564082075070513
EM-2,9868037,1.5238018435010934
KHM-1B,2708,5.139604125220885
Kasumi-2,24779724,5.733659143451784
BT 428,ISOX-bortezomib (250-1 mol-mol),-0.7964078251606408
BFTC-909,9826308,0.9467806471528852
EM-2,23635314,-2.706936191522549
Ku812,tanespimycin-gemcitabine (1-1 mol-mol),-4.681338743201834
SNU-1077,44589607,2.849893862801054
Hs 578T,135875424,3.578631345262118
BT 428,24771867,1.0803852417882902
SNU-201,675434,4.987962334164484
AU565,5311,0.7700744364318666
JHUEM-3,44589607,2.4392094892280256
JHUEM-3,1641662,3.5057723557690994
Panc 03.27,24901704,3.6863960634096142
EM-2,6914657,-6.98803706958939
M-07e,136227924,2.437184343955499
JHUEM-3,3385,5.069071278506237
KMRC-20,5311,1.9500827374985197
BFTC-909,159324,4.114702101808939
PK-59,11455910,1.1021180024981292
Hs 746.T,2126,5.42384032716843
OAW28,71751553,5.303505748888211
M-07e,11427553,1.7755263661857674
TCCSUP,44493528,4.420877523389051
KMS-20,11364421,0.7913102999239922
PF-382,11152667,-1.8592814828562831
NCI-H1568,26596,-1.690126811671561
BT 231,135411,2.441426423284162
Rh30,72376,-2.634380263722336
BFTC-909,15953870,3.192835350037467
KMRC-20,6450551,3.0929190017182058
NU-DHL-1,19582717,3.0772227336893505
TCCSUP,568763,0.1575730969992337
BFTC-909,5746,0.5111824642409613
OCI-AML-5,doxorubicin-navitoclax (2-1 mol-mol),-2.752383978265147
YH-13,53232,2.004863331527642
NCI-H1568,5329102,1.5348278867114138
HPAC,11485656,1.4709930999197478
HPAC,5278396,3.368311885659657
EM-2,638278,2.909773103124752
B-CPAP,67291369,2.842700694962032
Ishikawa (Heraklio) 02 ER-,5281321,0.3871069593768498
Hs 578T,6450551,1.3860110692780143
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587
BFTC-909,44819697,-0.8003395289407239
Ishikawa (Heraklio) 02 ER-,16725315,4.616784128225617
A4/Fukuda,4917,1.915641979161103
BT 231,613753,2.9717663600509105
JHUEM-3,2945648,3.2473991596932414
HCC1395,17759555,3.549187883588968
YH-13,9911463,4.412003433189975
Panc 03.27,11626560,1.5702287896304294
RERF-LC-MS,6918837,-3.051376318733669
A4/Fukuda,16736978,-0.5754825114210159
Ku812,46943432,4.280814189443877
OAW28,119607,5.347849335106357
TCCSUP,16736978,1.6866417014298338
BFTC-909,148198,-2.03933057080943
NCI-H1184,11719255,2.5863797337562797
JHUEM-3,67291369,5.224174655514004
Ku812,89183176,4.102616384722936
SH-10-TC,439501,0.97642019578469
TCCSUP,3552672,2.292298404994988
NCI-H1184,119607,1.0037542191284663
SNU-1077,1242560,3.950980625831431
OAW28,9935249,3.684332158484572
KMRC-20,24180125,2.1292230700197874
Ishikawa (Heraklio) 02 ER-,5282054,4.057233493104327
HPAC,selumetinib-GDC-0941 (4-1 mol-mol),0.9383091275833384
OAW28,49850262,3.3861243312442264
RKO,51037431,1.443783779144223
Panc 03.27,9926054,1.7808185952102251
SK-MEL-28,9956119,4.5331880736005745
OPM-2,2871966,-0.6940984937409527
RKO,16038120,2.1201165412688385
Rh30,984333,-1.047774302113909
NU-DHL-1,400769,-1.0687598831956515
PF-382,3689413,-3.8661032289286488
Ishikawa (Heraklio) 02 ER-,374536,4.692637268182497
KHM-1B,4378219,1.8511847617722708
NCI-H1568,208908,1.6425276108518176
BT 428,10113978,3.275570081153744
TCCSUP,5278396,3.4986676958942304
YKG-1,11955716,-0.8727721700650264
PF-382,selumetinib-UNC0638 (4-1 mol-mol),3.164054400704207
KYSE-70,9926054,2.326174845830733
OCI-AML-5,serdemetan-SCH-529074 (1-1 mol-mol),1.4313874059156644
CHP-212,72734382,1.763122858648806
SF539,54618164,4.674024000945265
RKO,67156097,-1.3338800856316015
YKG-1,6918328,0.8877093194372333
YKG-1,carboplatin-UNC0638 (2-1 mol-mol),3.500732763699647
F-36P,5311281,1.509160048617295
Ishikawa (Heraklio) 02 ER-,11404337,-0.8066309120452816
Hs 746.T,42611257,3.306850698467919
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816
OAW28,4521392,4.353680801577448
M-07e,carboplatin-etoposide (40-17 mol-mol),-0.00937876272057
NU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),3.261247948908544
NU-DHL-1,5746,-1.4660940923303851
RERF-LC-MS,24951314,1.4075693116182684
OAW28,54596558,4.423614985335385
HCC38,piperlongumine-MST-312 (1-1 mol-mol),1.3145074221099555
KHM-1B,navitoclax-sorafenib (1-1 mol-mol),2.457676578610422
BT 248,54454,4.901618168416747
TCCSUP,52912189,5.693268432248509
SNU-1041,5280436,4.291149780087334
EM-2,72734382,2.631696900533306
BL-70,3634881,3.1931653241532945
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968
WM88,5287620,-2.6531801922086324
PF-382,24785538,-0.3675574083063133
BT 428,445091,4.296908052102406
Kasumi-2,119607,5.143919911790516
BL-70,24978538,1.0917319721230725
YH-13,11152667,0.725065654418547
Rh30,46215462,1.624810270770748
SNU-201,5282054,3.777632075691056
OPM-2,1750826,-5.079410714013139
KMS-20,46174525,2.556560760455921
PK-59,serdemetan-SCH-529074 (1-1 mol-mol),2.1395317563235547
RKO,16013152,4.038378204585466
CHP-212,46224516,3.6846472510628634
WM88,10385095,0.3545398644716653
SF539,24775005,3.2878443565215987
CHP-212,11404337,-1.6031269960117245
OCI-AML-3,71751553,4.438951947729107
Kasumi-2,sirolimus-bortezomib (250-1 mol-mol),-0.078386775418122
BT 248,53495165,3.0905684330313803
KMS-20,89183176,2.765105860834293
PF-382,44632017,0.9401237974673988
PK-59,448949,1.7401007059453664
KMS-20,10410894,2.165253537613353
NCI-H1568,9933475,1.8521331470520848
M-07e,675434,4.212265198228163
RKO,5738263,3.4166283525852523
SF539,doxorubicin-navitoclax (2-1 mol-mol),-1.7413374971116728
OPM-2,53481919,3.0492738202957206
BL-70,219104,3.782107238138709
BT 231,11977753,-1.6609283077108818
BL-70,44543605,3.7067897585544474
TCCSUP,107970,2.506866971737107
KYSE-70,20959075,-2.927604227069557
NCI-H2196,168312962,1.5721139265406416
Kasumi-2,selumetinib-tretinoin (2-1 mol-mol),7.516580529144076
SNU-1077,42642645,1.1218523174966224
WM88,9935249,1.762742740497851
SF539,24180719,2.4860980350614073
OCI-AML-5,11238147,2.6343413544695005
LC-1F,54454,-2.2374662615380716
PF-382,89928392,-0.2076371550725149
PK-59,613753,3.2991610676424683
OAW28,3081361,1.8855664708831448
BT 248,51039095,3.103752706938284
EM-2,25183872,-2.3695394170263873
NCI-H2141,25062766,3.25542734014078
Ku812,piperlongumine-MST-312 (1-1 mol-mol),1.051865706808779
BFTC-909,654092,0.6323398211983356
Hs 578T,42642645,1.0573459465672317
KMS-20,11234052,3.409972208267674
A4/Fukuda,54618771,0.259551202975953
Ku812,11214940,0.086295431184551
LOU-NH91,11178236,-2.353397629942184
LOU-NH91,24180125,2.532676427085935
F-36P,44241473,6.465065982538859
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453
SW1783,10427712,4.612980278868
RERF-LC-MS,25154868,3.293982375318642
B-CPAP,6450551,2.6982491790934824
CHP-212,7326481,2.627792857158644
Ku812,441298,2.016526434026497
Kasumi-2,25161177,3.916701757551495
KMRC-20,168312962,-1.9289630106650897
OPM-2,5702613,2.283159730657738
OAW28,23725625,6.509051762822527
BT 248,53232,4.253838861384023
PF-382,2841722,3.918402091561414
SF539,100016,5.965471494853995
NCI-H1568,10410894,1.924104691976128
SNU-410,5746,1.216315476176319
YH-13,5329102,1.6719454710321933
Hs 578T,46398810,1.9014053371976471
Rh30,46907787,2.5511013191395913
NCI-H1184,crizotinib-PLX-4032 (2-1 mol-mol),1.4632398422143968
RKO,11640390,5.295981617059328
HCC1395,16741245,5.491973313221888
BT 245,SNX-2112-bortezomib (250-1 mol-mol),-1.4733817260772628
OAW28,5311281,1.8509970799423736
KMS-20,119607,4.302564368851616
NCI-H2196,24964624,1.301207680253256
OAW28,374536,3.018534312402979
MM1.S,46191454,-0.4947942037268417
KYSE-450,2729026,3.1949435983644414
Panc 03.27,25262965,-1.3083186636771766
MM1.S,9907093,3.622673002337576
BT 248,3634881,2.1213928087500413
KHM-1B,638278,3.418404486503754
KMRC-20,9935249,4.274093683443108
YH-13,24753719,4.493928762122736
CHP-212,piperlongumine-MST-312 (1-1 mol-mol),0.8623081919669667
OCI-AML-5,135875424,2.7043595166369694
OPM-2,5328940,0.8145180628284293
Hs 578T,409805,3.1145560968207806
OCI-AML-5,10322450,3.661053822054087
SNU-201,crizotinib-PLX-4032 (2-1 mol-mol),2.3409652458180608
SNU-410,49766530,1.0142633339399836
HPAC,3689413,3.007667333136724
HPAC,24180719,3.1450066824835705
Rh30,49793307,-1.9650441219299208
OCI-AML-5,11497983,-3.8669317677968937
Panc 03.27,6610216,4.487781163899809
KMS-20,400769,-2.039979438204604
M-07e,3062316,2.02640684758155
BT 248,25150857,2.3784591591930635
TCCSUP,11640390,3.766989584853525
Panc 03.27,89183176,4.965875859016029
SW1783,31703,0.5342280043570855
F-36P,46843906,1.6251282704795698
RERF-LC-MS,107985,-3.0933260647006215
BT 245,56963564,-0.2019842219541239
SH-10-TC,6918638,1.0653110676660122
BL-70,2742550,3.282580596685524
PF-382,44819697,-3.258888383810068
SNU-201,11364421,1.75730312319987
Panc 03.27,11485656,1.610276290455132
KMRC-20,navitoclax-pluripotin (1-1 mol-mol),-0.4667071263611014
Hs 578T,25154868,3.9391285775022657
B-CPAP,9903786,2.2781712830719316
KYSE-70,11964036,0.6479741930424838
LOU-NH91,15983966,2.104720476479653
PK-59,5281672,4.383076932761096
BT 231,10427712,3.904289947290795
HCC38,carboplatin-etoposide (40-17 mol-mol),1.6966279618156803
Rh30,2708,3.4393006223316744
KHM-1B,56946209,-4.323127458316883
BT 231,8515,4.035696345547394
NCI-H1568,23582824,0.2708211860244319
BL-70,24901704,2.168876631276131
Ishikawa (Heraklio) 02 ER-,44484440,3.323935553013314
Panc 03.27,54619267,4.216385044404775
OCI-AML-5,5280436,3.6543118089226896
BT 428,9911463,3.0361887786890693
Ku812,4788,3.899894541585596
RERF-LC-MS,46907787,3.883745984979501
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593
SH-10-TC,25062766,2.1432068701554616
YKG-1,11427553,2.5425746736996735
ML-1 [Human thyroid carcinoma],327653,3.144384021244803
BL-70,42642645,0.4499383926542911
EM-2,11717001,3.7743930376002903
SH-10-TC,4917,3.774320210555272
M-07e,46224516,1.6916772806910565
Rh30,637858,1.50729974182792
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206
EM-2,selumetinib-navitoclax (8-1 mol-mol),-2.780709091593194
SH-10-TC,23725625,4.867813864770382
NCI-H2196,24821094,2.944901568408147
JHUEM-3,25262965,-1.508664614514094
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059
F-36P,44607530,2.028742001356227
SNU-1077,73707438,4.486121622695642
Rh30,9840324,5.670422157843055
M-07e,54454,3.652421971654798
KHM-1B,25105715,2.694355871197866
WM88,11228183,2.8486312022614975
Kasumi-2,107985,-4.524149027848321
WM88,637858,1.8355107233516577
B-CPAP,salermide-PLX-4032 (12-1 mol-mol),4.772900953481165
HCC38,462382,0.1642730244966233
KHM-1B,9926054,1.3720275885206477
EM-2,654092,0.2037691142536942
PF-382,49766530,-3.617209334662046
WM88,67291369,2.6435751471840057
OPM-2,444795,4.04932788863876
NU-DHL-1,11485656,2.738678590842112
EM-2,9444,3.5010735912788347
NCI-H1568,11485656,1.8106242285910237
HPAC,5329102,1.960559615228007
CHP-212,44589607,2.1019512258013364
Hs 578T,135398516,1.4054759385422304
B-CPAP,6438330,1.022180565528926
EM-2,11455910,-0.237589126916505
RERF-LC-MS,5282054,4.065617468844444
MM1.S,46843906,0.846343121160042
SNU-1077,11175137,2.980099739351046
BL-70,445091,3.026839890200595
OCI-AML-5,119607,5.202375314001171
RKO,25150857,2.5785304193211247
Hs 578T,24978538,0.2959020838046572
HCC1395,16722836,1.3758108036999237
BT 245,6918736,-3.031459019744447
EM-2,ISOX-bortezomib (250-1 mol-mol),-0.6418039969855289
WM88,SNX-2112-bortezomib (250-1 mol-mol),-2.5725731757645316
HPAC,66577038,0.980567963058146
NCI-H2196,navitoclax-pluripotin (1-1 mol-mol),-1.8973046756413603
PK-59,9911830,2.647954789959704
M-07e,11494412,-0.4352811650560824
KMRC-20,carboplatin-UNC0638 (2-1 mol-mol),3.446275029594072
Kasumi-2,36314,4.106836250050073
SF539,375860,-0.4378698388059482
OAW28,5278396,3.588828047742794
LOU-NH91,10127622,4.686411868973226
NCI-H1184,1750826,-5.8442940630809455
BT-474,5280436,5.035267700610863
SNU-201,11152667,1.3436502466257625
YH-13,5328940,2.7108571472659073
Ku812,12001922,1.5776657122495092
RERF-LC-MS,11640390,2.8932892314821927
KMS-20,23725625,4.884759798123119
WM88,24901704,3.4303059895735157
ML-1 [Human thyroid carcinoma],675434,4.374805668496918
SNU-1077,1716436,3.6351328790412993
PK-59,SNX-2112-bortezomib (250-1 mol-mol),-0.9848957324018716
KMRC-20,969516,3.471126157495644
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444
BL-70,151289,0.2907862937624431
KMRC-20,44507138,4.202309918297686
OPM-2,24748573,1.2641689672749945
PK-59,71304818,2.6517258875319705
F-36P,16722836,-0.5703306684955751
KMS-20,4578,4.142060591748304
YKG-1,1239801,4.465183015374798
TCCSUP,5479543,3.29896380845353
RKO,19582717,4.345992572306107
KMS-20,5287620,-2.1955252828905745
SK-MEL-28,5329102,2.8419143811814913
CHP-212,9967941,2.1651091583388493
KMS-20,5282054,2.484171809252808
NCI-H2196,409805,3.7550378026386104
MM1.S,4917,3.2531292975138033
Ku812,72734382,3.515851965175783
NU-DHL-1,11257553,-0.7159264357065991
RKO,107985,-4.24085601271806
OCI-AML-3,JQ-1-navitoclax (2-1 mol-mol),-3.8082643589515626
KMS-20,selumetinib-piperlongumine (8-1 mol-mol),1.0367675116667423
KHM-1B,5311,0.4270442632867264
M-07e,11238147,1.4915429170835286
SH-10-TC,ISOX-bortezomib (250-1 mol-mol),0.2706587562485681
Ku812,24771867,-1.2789053732108495
JHUEM-3,24856436,-1.5627880989652547
SF539,25161177,5.227921335860274
A4/Fukuda,46398810,1.5683404384737003
NCI-H2196,46926350,-4.167074628499051
Kasumi-2,44462760,0.6612462691358557
PF-382,selumetinib-GDC-0941 (4-1 mol-mol),0.8543427357308107
Ku812,5281672,3.8217692077235
KHM-1B,16741245,2.621472982126402
BFTC-909,16038120,1.74161234898449
SF539,1750826,-3.058718862660788
BT 248,alisertib-navitoclax (2-1 mol-mol),-0.6283307077190651
HEC-59,637858,1.9276997282278596
NCI-H2196,5278396,3.4596143682869105
Ku812,JQ-1-navitoclax (2-1 mol-mol),-1.1866145933539507
BT 248,89928392,0.7552276073317185
KMS-20,56946209,-4.641611942860024
EM-2,613753,2.692845752770078
KHM-1B,135421197,0.982032972009238
SF539,11640390,3.628112258998275
OCI-AML-5,4261,0.3817823205873663
Panc 03.27,6918328,0.9523034421807132
F-36P,selumetinib-MK-2206 (8-1 mol-mol),0.8527414288582023
SNU-1077,5281672,4.971178348467827
TCCSUP,216239,2.7641054306818265
Hs 578T,25183872,-0.902598688524268
BFTC-909,4261,3.835594401773327
BT 428,119182,-0.1725624897830351
BT 245,57519531,1.5304257987507106
OCI-AML-3,216239,1.3611213061462868
KMS-20,4096211,1.0816474439893842
NCI-H2196,445091,4.169552115461836
WM88,9866186,0.3673934470747829
MM1.S,3038522,4.409032122825541
Hs 746.T,11234052,4.118575118638505
OPM-2,72376,-3.1510357921092376
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393
OCI-AML-5,36462,-0.4701169998838825
BT 245,decitabine-navitoclax (2-1 mol-mol),-0.3555263751398617
KHM-1B,11213558,1.7651393697887354
OCI-AML-3,6610216,3.7243231461323463
OAW28,11612883,3.952715585132085
HCC1395,11497983,6.027741242681516
NU-DHL-1,25150857,0.917723720261522
BT 428,1750826,-1.0084849946266714
AU565,176870,1.580958212812136
BT 231,11178236,-5.272107320950198
OAW28,44185566,1.918306011480311
F-36P,25195348,1.1127392098506137
KYSE-450,4261,3.512938253123631
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184
KMS-20,24951314,0.1651472976854425
MM1.S,24180125,2.972534828152793
YH-13,969516,2.628286868310954
Panc 03.27,9911830,2.184033870746351
JHUEM-3,1716436,2.9039249840267747
OCI-AML-5,15547703,3.025801730212256
Panc 03.27,decitabine-navitoclax (2-1 mol-mol),3.2057729823465064
BT 428,selumetinib-tretinoin (2-1 mol-mol),3.9972651302997098
TCCSUP,selumetinib-PLX-4032 (8-1 mol-mol),3.752056719076424
NCI-H2141,107985,-3.815362487743321
YH-13,16722836,2.280757149111382
PF-382,selumetinib-navitoclax (8-1 mol-mol),0.0511061030946494
SNU-410,4261,2.585559189633419
BT 245,4259181,0.4559580659670063
Hs 578T,navitoclax-birinapant (1-1 mol-mol),-2.819753477255606
KYSE-450,16722836,3.1649590100923732
SF539,45279963,3.2464007819640583
NCI-H2196,11152667,0.1681584585599158
SW1783,44489675,4.313226705523417
EM-2,erlotinib-PLX-4032 (2-1 mol-mol),2.7971047089601218
Hs 746.T,42642645,-4.287124320079624
NCI-H2141,25150857,0.4297799385689878
PK-59,53232,3.176863249466792
TCCSUP,262093,2.756857712955527
NCI-H2141,11214940,2.1683380986267893
HCC1395,72376,-0.9102820551490692
BT 248,25262965,0.9142276489527752
HCC38,107970,1.6777687706047888
OAW28,navitoclax-gemcitabine (1-1 mol-mol),-0.0926576582551772
PK-59,6505803,-0.3559678115713951
BT 248,54618771,0.8718785044821341
SH-10-TC,25150857,3.111508660370526
SNU-1077,doxorubicin-navitoclax (2-1 mol-mol),-0.1731301626607988
HCC1395,17755052,1.7523730031625009
YH-13,119607,5.844423836114236
Panc 03.27,vorinostat-carboplatin (1-1 mol-mol),4.423705413743932
F-36P,135999136,1.2589377775362909
B-CPAP,54639701,4.512705510925618
WM88,docetaxel-tanespimycin (2-1 mol-mol),-4.5648065767059585
OPM-2,439501,-4.648238189793765
SW1783,16038120,2.009287788618318
KMS-20,148198,-4.371887061655697
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025
Kasumi-2,11178236,-5.568204380320254
SK-MEL-28,12001922,1.76503761159643
Ku812,51037431,1.3532968628760291
BFTC-909,52947716,3.1995758728854224
KHM-1B,656346,0.4212696332998811
TCCSUP,3676137,3.9595379052816857
BT 245,16725315,3.3086628671976026
BT 245,selumetinib-UNC0638 (4-1 mol-mol),3.762551103580104
RERF-LC-MS,44486219,4.018485879154908
Hs 578T,52947716,0.3471316432286684
JHUEM-3,71304818,2.5781925675355586
AU565,11214940,0.9865925706012508
NCI-H1568,5281321,-2.717480517336961
M-07e,44491742,3.818170293843834
A4/Fukuda,25183872,-2.565081518812491
BT 231,11455910,0.2900866749520439
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697
OPM-2,216468,0.7655721379939343
BT 248,46398810,1.9244684206215508
BL-70,4705,3.4398242170879723
LOU-NH91,60700,-0.2604526525302556
NCI-H1568,3136844,4.658915015928919
RKO,5311,2.326095881991792
RKO,57330099,4.8516025997257275
OAW28,JQ-1-MK-0752 (1-1 mol-mol),2.4765621370980875
RERF-LC-MS,16736978,2.30801467798398
AU565,44462760,4.31661778136252
NCI-H2141,8515,4.27499486698666
KMS-20,9823820,3.101769645887986
BT-474,135875424,5.915453425364125
KMS-20,5311037,3.3328695016599132
RKO,124202324,3.4391315101947386
BL-70,navitoclax-MST-312 (1-1 mol-mol),0.7407791841877768
B-CPAP,3854666,1.7042245826351512
SNU-1077,9935249,3.485135676518772
CHP-212,6917907,-6.1104124586294155
NCI-H1184,11647372,-0.3516545552333142
Ishikawa (Heraklio) 02 ER-,navitoclax-piperlongumine (1-1 mol-mol),3.301350382542222
SNU-1041,452548,3.547456383142519
OAW28,6918878,3.220005605820797
NCI-H1184,11977753,-3.307833204252994
KHM-1B,54626689,4.681502909310955
LOU-NH91,9884685,4.047485572984955
SNU-201,4477,0.3959533772266498
KMRC-20,SNX-2112-bortezomib (250-1 mol-mol),0.4424721588448694
KYSE-70,54619267,5.587983352589812
SNU-410,262093,2.9879613961382363
KMS-20,6610355,3.4776734350028784
OCI-AML-3,57519531,1.5772736107051897
NCI-H1184,SNX-2112-bortezomib (250-1 mol-mol),-2.373844296677595
HEC-59,3854666,1.7819501596078249
BT 245,73707438,1.8182629031547448
SF539,44607530,0.9511382642775598
Kasumi-2,JQ-1-vorinostat (2-1 mol-mol),-0.9081345169636283
SNU-201,17755052,4.017684412524892
KYSE-70,46843906,3.5210263801871498
NCI-H1568,71466445,4.632148673172368
Kasumi-2,135875424,2.5938758238859494
OCI-AML-3,5113032,4.860640377238594
BL-70,2126,3.660389407033696
CHP-212,5328940,1.506363778899298
KMS-20,24772860,-2.355954669463017
B-CPAP,76446078,4.324455702979326
M-07e,53495165,-3.631668734418104
RKO,51039095,3.7257826703811014
NCI-H2196,104842,-3.366426853767071
LOU-NH91,3503,2.9647844947930397
SF539,6610216,3.974614801985701
CHP-212,44632017,0.2168146878911479
KYSE-70,selumetinib-navitoclax (8-1 mol-mol),3.975968679943077
KYSE-450,15983966,1.931035725285284
OAW28,439501,-0.9322268226633188
OAW28,9935249,3.684332158484572
BT 248,322968,2.9090533378149535
EM-2,44185566,1.6118602372774802
SH-10-TC,selumetinib-PLX-4032 (8-1 mol-mol),4.500163524249213
Kasumi-2,11257553,-0.3952076481824682
Rh30,1750826,-3.669896354124373
PF-382,5281672,3.504573563810081
BT 248,11364421,0.4256883677591794
BFTC-909,54618164,4.281231487810877
Ku812,25154868,3.035500592962472
WM88,9933475,2.452111559410642
OAW28,17759555,2.4276686354020223
SF539,676352,1.6554067162537418
F-36P,5328940,1.0447195004483243
Hs 578T,11977753,-4.6288422517406955
KYSE-70,25262965,-2.1035778811550836
OPM-2,selumetinib-MK-2206 (8-1 mol-mol),1.6316326577463918
OCI-AML-3,6918638,-1.4001290252615282
TCCSUP,10427712,4.456401436086168
BFTC-909,25062766,1.7422044094415416
CHP-212,54618305,4.169241448375394
OCI-AML-5,10302451,3.871014497085743
OCI-AML-3,5311,-0.0421118684352751
MM1.S,9936388,-7.097218801181761
YH-13,135411,1.4167541971469908
A4/Fukuda,72967,3.695839205584607
NU-DHL-1,42642645,1.3661891975131202
Kasumi-2,11485656,1.64011250363507
EM-2,452548,-2.6957113410425757
KMRC-20,44819697,1.1580347805946598
KYSE-70,docetaxel-tanespimycin (2-1 mol-mol),-4.718411789937545
PF-382,8515,3.0389731440801224
BFTC-909,136227924,2.3418993883842134
OCI-AML-5,selumetinib-tretinoin (2-1 mol-mol),-2.1934063173445177
BT-474,navitoclax-piperlongumine (1-1 mol-mol),2.588623904770276
SNU-1041,5566,3.479822050874736
JHUEM-3,135421197,1.4304571308518408
TCCSUP,4917,2.9384011746955467
BT 245,vorinostat-navitoclax (4-1 mol-mol),-1.0149929699055316
PF-382,126941,-3.067039026453267
Hs 746.T,10385095,0.9219781932462268
YKG-1,72376,-2.105331743762953
BFTC-909,6918837,-1.9878509916437357
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025
HCC38,44137675,2.198094439035749
KYSE-450,5311,3.212765544074189
Panc 03.27,selumetinib-vorinostat (8-1 mol-mol),3.66722901648523
BT 428,9927531,4.812195201637174
MM1.S,71680916,5.174704169094283
SF539,24797083,0.4526611461759284
Hs 746.T,9866186,2.3362188337863183
KMRC-20,selumetinib-PLX-4032 (8-1 mol-mol),4.800972275106229
NCI-H2141,44137675,3.3995034631285472
Ku812,4261,0.3259044550005565
KMS-20,44137675,3.5747690218783075
OPM-2,637858,0.8070227403937857
BT 428,6852167,2.9431146688699275
A4/Fukuda,44137675,1.307300702935143
YKG-1,71680916,5.750185341340424
JHUEM-3,60750,-4.544308288368568
SF539,73707398,1.0308821565374424
BT 245,6505803,1.0921416598826974
OCI-AML-5,31703,-2.5092878644649015
SF539,23582824,-0.2198249685001801
A4/Fukuda,11719255,2.014724282446697
NCI-H1184,10113978,3.0461662369056866
YKG-1,17755052,1.8826754774817915
KHM-1B,107970,1.817903354032074
RERF-LC-MS,3503,1.2198018250646854
HPAC,124202324,2.956256349444794
Rh30,46398810,2.099231362064927
BT 245,24775005,3.45379033795863
NCI-H1568,25227462,1.3523005990409367
EM-2,168312962,0.0825365101853149
NCI-H1184,262093,1.9402045938209425
SNU-1077,73707398,1.6899308948113645
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644
SF539,6918638,1.218816827551867
F-36P,5329102,1.0717618201026256
Ku812,navitoclax-sorafenib (1-1 mol-mol),0.8229949370688716
BT 245,10427712,4.3445169798264995
SF539,15953870,3.263207389755282
OPM-2,11152667,-1.3080541002664456
SW1783,2742550,4.177993888768022
CHP-212,45279963,3.203255121177776
OCI-AML-5,23582824,1.2562752293663728
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906
NU-DHL-1,10127622,1.0560175006999375
KMS-20,6914657,-2.6641551420146277
KYSE-70,10427712,2.9549225300897977
B-CPAP,tanespimycin-bortezomib (250-1 mol-mol),1.6177879591056448
SNU-201,1242560,3.753981298650207
B-CPAP,54143018,-0.4654948157340908
Ku812,44819697,-2.8694764464804727
RKO,46907787,4.104881837237831
NCI-H1184,135398516,0.9543054616885768
Hs 578T,168312962,1.4287092560486083
Kasumi-2,5281321,-3.5035572972621916
BL-70,44486219,3.219570345569174
OCI-AML-5,46224516,2.1584308495734867
BT 245,135440466,2.1626976795757544
KYSE-70,44632017,1.4611535882953923
RERF-LC-MS,11222830,1.7620759794741472
LOU-NH91,25154868,5.6992218929630205
BL-70,2871966,-2.3372219579695845
NCI-H1568,11647372,0.9090690740398496
Ku812,20959075,-3.7806985906685298
BT 245,9840324,6.212048874713068
CHP-212,selumetinib-BRD-A02303741 (4-1 mol-mol),-4.549038820936692
SNU-410,selumetinib-vorinostat (8-1 mol-mol),3.953798700676283
Hs 578T,44486219,4.2149951307862565
M-07e,208908,2.1879937354126486
B-CPAP,216468,4.208328548217155
PF-382,54618771,-0.2642287573533248
HEC-59,16722836,1.7453989598253288
SF539,25262965,0.0170335462798406
PK-59,107970,2.298393992220364
MM1.S,BRD-A02303741-navitoclax (2-1 mol-mol),2.21025426960287
SF539,53495165,-1.7347604840136983
OCI-AML-3,5746,-2.468508390736249
HCC38,54619267,3.7133700629962103
JHUEM-3,613753,3.1171376971266715
SF539,3634881,2.419481014685841
SW1783,56649450,2.1130846621058756
BT 231,5978,-3.907360667865921
CHP-212,5738263,3.533668867708309
OAW28,11626560,1.7877294085158288
NCI-H2196,52912189,4.301458553623822
NCI-H1568,9884685,-0.6579514975056241
KYSE-70,3689413,0.9447440025313596
M-07e,navitoclax-birinapant (1-1 mol-mol),-4.205006937927519
Hs 746.T,erlotinib-PLX-4032 (2-1 mol-mol),3.4336299511398973
NCI-H1568,10184653,1.3826991243685076
BL-70,6184667,1.5361606437335469
SF539,11719255,2.415885825794134
SH-10-TC,9927531,5.280985634466932
BFTC-909,49850262,4.237463012213885
HCC38,25195348,4.036247457421969
OCI-AML-5,2945648,3.186100299995045
NCI-H2196,tretinoin-navitoclax (4-1 mol-mol),1.6328627422920303
SNU-1077,66577038,3.753869643566382
BT 231,5335621,4.988733991945575
SNU-410,4259181,1.1619078924950006
SF539,5284616,2.797909464914647
Kasumi-2,navitoclax-sorafenib (1-1 mol-mol),-1.696804912117395
JHUEM-3,49766530,1.26691736539767
BT 245,53481919,4.235316494892971
SNU-201,2749,3.1217432122028095
BT 245,docetaxel-tanespimycin (2-1 mol-mol),-4.12456817717388
HCC38,selumetinib-UNC0638 (4-1 mol-mol),5.68482104297804
WM88,135659046,3.481693995509175
CHP-212,JQ-1-carboplatin (1-1 mol-mol),-0.8333787356849307
Hs 746.T,135659046,3.4161599287064925
KMS-20,25262965,-3.079526617825105
RKO,4261,2.924548439505643
SF539,24901704,2.077858553177028
OCI-AML-3,10385095,0.7580975177780899
AU565,60750,-2.174078373186638
NCI-H2141,5978,-3.3132951141973868
NU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),3.0745710267326545
PF-382,11404337,-1.5613133934389778
BT 231,24772860,-2.67844720532028
BT-474,2828334,6.091191740016621
SW1783,72193861,3.9823565234230314
NCI-H2196,3634881,2.9670016791535567
SNU-201,2841722,5.408371569781436
KYSE-450,72193861,3.11569572197334
RKO,56946209,-3.445993729976747
SF539,148198,-6.422680321892083
BL-70,25262965,-4.598224959005904
F-36P,49793307,-4.29454366268948
Rh30,2729026,2.434020683854525
BT 231,5287620,-4.392060219454981
BT 245,44607531,1.525096692433067
PF-382,12003241,-3.7051147214471114
Panc 03.27,448949,2.2004142065371735
BT 245,4477,0.3069843021708344
JHUEM-3,11626560,1.99367774368363
SH-10-TC,3676137,5.532656710643243
Rh30,322968,2.066849123770197
NCI-H1184,6918736,-3.9846786019543106
SF539,15547703,3.038141832537276
Rh30,5351362,2.060604448161626
RERF-LC-MS,25227462,0.8140348385016122
HCC38,119607,6.02504999944063
Ku812,10127622,-2.476292288821415
NCI-H1184,24797083,1.6957787457119384
A4/Fukuda,6252,-3.645065834912594
OCI-AML-3,piperlongumine-MST-312 (1-1 mol-mol),0.8105501596433557
NCI-H2141,JQ-1-navitoclax (2-1 mol-mol),0.4638123576377208
TCCSUP,3081361,3.015590001754395
B-CPAP,piperlongumine-MST-312 (1-1 mol-mol),1.4552601260130695
KMS-20,2733526,2.652352860912795
ML-1 [Human thyroid carcinoma],2126,5.801287401499987
HEC-59,5287620,-1.874499257224998
NCI-H2141,5287620,-3.162405828285628
Ku812,1641662,2.247994905759536
JHUEM-3,9825149,1.9567262398291672
MM1.S,decitabine-navitoclax (2-1 mol-mol),0.5929032240981287
MM1.S,selumetinib-JQ-1 (4-1 mol-mol),-0.6106024148084398
NCI-H2141,15983966,-6.190401925755334
SF539,3025986,-1.0860147813868546
SW1783,10385095,3.137926014779676
RERF-LC-MS,6505803,-0.6931241555509828
NCI-H2196,15983966,1.8218709695683244
CHP-212,5311,-0.2220009915211749
SH-10-TC,1750826,0.6718584500881611
SF539,71751553,4.845342915681748
OCI-AML-3,24797083,1.0783273053110551
Hs 578T,navitoclax-MST-312 (1-1 mol-mol),-0.0660980675340075
Hs 746.T,11656518,3.3776140948246596
AU565,135421197,1.4743648854968991
KMS-20,docetaxel-tanespimycin (2-1 mol-mol),-5.71277411020647
BT 248,11612883,3.485439835170839
YH-13,54454,3.0632699075103926
Ku812,10090485,4.033633081547376
NCI-H1568,44185566,2.743919877007031
NU-DHL-1,11955716,-1.5402141200018542
BT 428,104842,-4.933536114536035
A4/Fukuda,23582824,-0.7377224087572002
BT 248,9927531,4.7076279917818225
PF-382,selumetinib-MK-2206 (8-1 mol-mol),1.294147913599038
JHUEM-3,72376,-0.5180259776203506
NU-DHL-1,11455910,-0.2130419418137634
Hs 746.T,tanespimycin-gemcitabine (1-1 mol-mol),2.084411020887993
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622
SK-MEL-28,16725315,5.297717320845617
ML-1 [Human thyroid carcinoma],426756,5.157831333984941
SF539,11507802,0.8173734074149668
BT 248,1714884,3.688077995610216
MM1.S,6610355,3.8482790769850017
Ku812,54618305,3.744773275517672
SNU-201,5311281,2.210737763804048
BT 245,selumetinib-vorinostat (8-1 mol-mol),2.5548993263736235
WM88,3011155,4.0380917147816735
BT 248,3854666,2.6170510866367955
M-07e,4917,2.66279817441993
PK-59,2729026,2.543125862606278
SW1783,25262965,3.8156807624637734
BT-474,637858,2.300118260965066
OAW28,25126798,4.214847534438453
HPAC,15547703,3.1054631364584333
PF-382,6918328,-1.623099323121265
RKO,36314,-4.63858923378885
NCI-H2196,6917907,-5.567517154484654
SNU-410,73707398,2.675607708519287
Rh30,selumetinib-PLX-4032 (8-1 mol-mol),2.669445241650138
F-36P,446155,1.8210679426416845
NU-DHL-1,44137675,1.8440314002595644
Rh30,208908,2.9220858792796696
NCI-H2196,45279963,3.688829316366392
KMRC-20,10302451,3.571501385736242
RERF-LC-MS,219104,4.628133490361187
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203
WM88,3025944,4.150834708748225
NCI-H2196,25150857,2.627315289860304
AU565,navitoclax-birinapant (1-1 mol-mol),2.4267027556232836
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941
OCI-AML-5,3384730,1.677278929310923
BT 248,9549297,1.6274014594604191
CHP-212,1750826,-0.1919184626564722
CHP-212,25150857,2.804771921118992
OPM-2,vorinostat-carboplatin (1-1 mol-mol),1.8335119611994213
Hs 746.T,4096211,2.1197659987188833
CHP-212,5113032,5.428536919174101
SH-10-TC,15953870,3.972353196131568
LC-1F,123631,2.3886359626980593
NCI-H2141,44202524,1.8225359422126788
CHP-212,16741245,5.350889913977214
JHUEM-3,3025986,1.6667845040040876
Kasumi-2,44566777,1.2078773885517011
BL-70,tanespimycin-gemcitabine (1-1 mol-mol),0.6672148858471749
BFTC-909,2842253,5.585220688564769
Ku812,6914657,-6.377173707713946
BFTC-909,10410894,3.671861694905457
JHUEM-3,46943432,2.585182446151882
SNU-1077,135440466,1.2504033920677526
TCCSUP,3815108,3.0276070568390208
YKG-1,selumetinib-PLX-4032 (8-1 mol-mol),3.9991996258306384
NCI-H1568,6918878,3.5715267618547832
CHP-212,24856436,-1.6990935228233717
NU-DHL-1,7251185,0.290516417532148
KYSE-450,11625818,5.066786117132594
BT 428,135411,-0.3033533624025099
Rh30,25126798,3.65695077556033
Ku812,25062766,1.6116262467918423
Ku812,135875424,4.708872885868404
KYSE-70,3081361,2.4267899196210982
RKO,168313200,3.1169425006108455
BT-474,5494449,3.9630082118199303
OPM-2,73707438,4.146852269482474
YKG-1,9935249,4.562558251006297
JHUEM-3,46907787,-0.2270381387910647
YH-13,carboplatin-etoposide (40-17 mol-mol),2.297149147603289
SK-MEL-28,969516,4.521483044042875
M-07e,71680916,6.225080246082909
M-07e,374536,-3.22677285376951
BT 248,1750826,0.7778964775949998
B-CPAP,3081361,3.333044863505124
RERF-LC-MS,10302451,4.085913110869725
B-CPAP,3825829,3.169966347621692
NCI-H1184,24772860,-3.360348296731845
OPM-2,107985,-4.911691484457119
OCI-AML-5,135659046,3.671994608621507
SW1783,2871966,1.533691405345237
LOU-NH91,46843906,2.60442098689998
BT 245,285033,-1.4017098727124946
SH-10-TC,984333,0.9987949659394082
SK-MEL-28,crizotinib-PLX-4032 (2-1 mol-mol),1.1574831287891294
PF-382,65628,3.430221294092043
PF-382,123631,2.005412532111485
BL-70,216345,2.625508445674338
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943
BT-474,JQ-1-UNC0638 (2-1 mol-mol),1.494130967754263
OPM-2,6450551,0.7106995413225735
F-36P,1750826,-1.9122301239542712
RERF-LC-MS,46191454,1.934559197398404
SF539,9444,4.192195040935243
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167
OCI-AML-3,1239801,3.2950093501413367
BT 245,9825149,1.25050062624055
SNU-1041,JQ-1-vorinostat (2-1 mol-mol),1.7296124502823982
PK-59,24785538,0.9732990059034498
F-36P,135398744,6.4039586130062505
BL-70,4788,3.805930105932329
LOU-NH91,6918736,-0.749268328982244
WM88,2828334,5.964783254820016
CHP-212,135398738,2.6972265322269204
TCCSUP,650361,4.871702860557827
NCI-H1184,12001922,1.2105425311897628
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834
KMS-20,17755052,-0.5934612903297498
KHM-1B,SNX-2112-bortezomib (250-1 mol-mol),-3.421333600529768
Panc 03.27,crizotinib-PLX-4032 (2-1 mol-mol),1.3545307644613849
M-07e,16659841,0.768516643976221
Panc 03.27,216345,4.651935924955669
KYSE-450,216239,1.9385995729786167
OCI-AML-3,168313016,3.888373508395693
Ku812,10302451,-2.0253572962014617
KMS-20,71466578,2.1821979344467537
B-CPAP,216345,4.206842261809917
Hs 746.T,11228183,2.131045927963142
SNU-1077,54618164,4.137569965283994
Panc 03.27,54454,2.8192739901219657
SW1783,selumetinib-BRD-A02303741 (4-1 mol-mol),5.401452883960348
MM1.S,168313016,2.515366642859788
KYSE-450,tanespimycin-bortezomib (250-1 mol-mol),0.2570143843515884
SF539,24753719,4.7612365798691405
Panc 03.27,54613361,0.1493963824676892
Ku812,11152667,-2.1041122356576127
SH-10-TC,44607531,1.9964692030296003
NU-DHL-1,72199292,-0.8745527817020163
OCI-AML-3,5329102,1.322955514914574
Panc 03.27,6184667,3.3297779362075577
BT 428,4096211,1.6396351662368742
Hs 746.T,17755052,1.100223561197604
MM1.S,51037431,1.8715826956664352
A4/Fukuda,9840324,5.782088483619631
LOU-NH91,BRD-K27188169-navitoclax (2-1 mol-mol),-1.3161602950159492
Panc 03.27,3552672,1.7656463536678069
OCI-AML-3,11234052,3.931110193807589
BFTC-909,24978538,2.589526114093726
HPAC,262093,3.184189581983291
KYSE-450,60700,2.353056656519086
F-36P,5291,3.4889891635837884
Kasumi-2,25262965,-2.503194884241619
EM-2,44241473,5.57361084178171
Hs 578T,11228183,1.5379513853725482
B-CPAP,6610216,4.017338863517876
F-36P,17755052,1.0539195463747784
WM88,11404337,0.2884415241135956
LOU-NH91,3136844,4.41334270983783
AU565,135659046,3.967998335471068
SF539,12003241,-2.026733754371074
BT 428,6252,3.8655394364718942
Kasumi-2,55508,1.5459922299360274
NU-DHL-1,637858,-0.1721952663561851
Ku812,sirolimus-bortezomib (250-1 mol-mol),-4.706863759104448
AU565,24775005,3.4802015368768657
PF-382,25150857,0.9357192544570664
EM-2,5291,-1.9747162854934268
OCI-AML-3,selumetinib-piperlongumine (8-1 mol-mol),-3.849060957245659
KYSE-450,439501,-3.185322034462323
PK-59,136227924,3.43326158684526
Hs 746.T,selumetinib-GDC-0941 (4-1 mol-mol),0.5116122127806854
PF-382,262093,0.5149344400111652
CHP-212,3385,2.1835274292453457
BT 231,carboplatin-UNC0638 (2-1 mol-mol),3.849827727585169
YH-13,JQ-1-navitoclax (2-1 mol-mol),1.7926263588909668
BT 231,44607531,0.3540469053779969
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804
NCI-H1568,446155,2.3736727750277455
BL-70,984333,-0.4179478182129084
OAW28,285033,-1.6788024908058845
LOU-NH91,6918837,-1.6936529516603684
PK-59,44589607,2.088701753410863
BT 248,9911830,3.0671224453630326
Rh30,25150857,2.7301985134664735
A4/Fukuda,375860,-1.1918610484687095
Kasumi-2,56973724,0.9281139851854971
NCI-H1568,11152667,-1.392140833696634
NCI-H2196,9926054,1.658766361497933
Hs 746.T,piperlongumine-MST-312 (1-1 mol-mol),1.5690428471985516
KHM-1B,JQ-1-MK-0752 (1-1 mol-mol),-0.8214903492404299
BL-70,navitoclax-birinapant (1-1 mol-mol),1.527300243259167
Hs 578T,374536,2.5763562012085712
RKO,71304818,0.9175289508752972
KYSE-450,24797083,1.908715906165
NU-DHL-1,71466578,1.9656918552747795
AU565,11955716,1.5670888997114951
NU-DHL-1,16659841,3.4914634927740456
SF539,9826308,-0.4997268921639499
HCC38,3503,2.526745200864793
SW1783,11964036,1.4624651747986186
MM1.S,1716436,2.248600681663511
Hs 578T,71304818,2.2269809807228045
SW1783,6610355,5.017799798077197
Kasumi-2,52912189,-0.393622705419007
SNU-1041,654092,0.0319383578355842
HEC-59,selumetinib-JQ-1 (4-1 mol-mol),2.9499197232125907
HCC38,984333,1.0475041645105343
Ku812,57519531,1.8933058292523095
PF-382,6918736,-2.107719564435389
A4/Fukuda,11626560,-1.03034976821798
BT 245,5282054,3.505769359703823
OAW28,5460769,4.044755256654475
Kasumi-2,JQ-1-UNC0638 (2-1 mol-mol),-0.8323708292538591
SNU-1077,452548,1.172143593642621
NU-DHL-1,11317348,1.955778298078063
EM-2,sirolimus-bortezomib (250-1 mol-mol),-5.681511220612078
RKO,3038522,3.342495330103654
KMS-20,3543504,3.2520128843169096
SNU-201,44589607,4.110575708097037
Panc 03.27,10184653,1.4156361179052694
OAW28,54619267,3.96587417417148
OPM-2,148198,-4.827513159673032
BT-474,73707398,1.0474698976362606
SK-MEL-28,5351362,1.7510141514144195
M-07e,2733487,6.473479608077406
KMRC-20,322968,4.283184334248703
Ishikawa (Heraklio) 02 ER-,57519531,3.260489602351445
HEC-59,67291369,2.661143441077051
RERF-LC-MS,23582824,0.1470987082457378
M-07e,11178236,-2.158930584505498
Kasumi-2,11609586,-0.6223010091545076
Ku812,serdemetan-SCH-529074 (1-1 mol-mol),1.0312018024481138
NU-DHL-1,2949965,1.9624818198288896
BFTC-909,452548,0.7682850038212578
NCI-H2196,6914657,-2.9930947685401175
MM1.S,11626560,0.5945750260073711
SW1783,tanespimycin-gemcitabine (1-1 mol-mol),1.8572225726753877
RKO,54678924,1.753529637740366
AU565,54618164,4.092787142183454
M-07e,11507802,-0.4544609235578523
Panc 03.27,9825149,2.315225672745904
BT 245,119607,5.434935491757685
Panc 03.27,docetaxel-tanespimycin (2-1 mol-mol),-5.830909460793216
JHUEM-3,136227924,3.0400208358424243
WM88,10231331,-4.286644172681502
YKG-1,151289,1.726340360462664
OCI-AML-5,54613361,-0.5811199022984626
Ishikawa (Heraklio) 02 ER-,67156097,-1.7291512235486406
KHM-1B,6918736,-1.6456969223035287
PF-382,6917907,-6.431709944016271
PF-382,44241473,4.707549872781651
KYSE-70,11507802,1.463595053056406
Hs 578T,selumetinib-GDC-0941 (4-1 mol-mol),1.92507246829287
NCI-H1568,5566,2.911706555521376
NCI-H2196,11167602,1.792156355999927
TCCSUP,3025944,4.64601572000857
SW1783,400769,1.007590054280138
RERF-LC-MS,11964036,1.6707185338079893
A4/Fukuda,11507802,0.3746235533355334
WM88,6852167,1.647257119536929
KYSE-450,57519531,6.208309628107499
Hs 578T,19582717,2.9757590940176746
KYSE-70,3634881,3.4536977245329363
CHP-212,16725315,3.185307902302812
TCCSUP,24771867,2.435510206237169
OCI-AML-5,9926054,1.291118063021603
Ku812,49793307,-4.102016019806379
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948
LOU-NH91,4705,2.8449970854381945
HEC-59,135421197,2.778714880666289
NCI-H1568,44632017,0.9967277604489184
PK-59,doxorubicin-navitoclax (2-1 mol-mol),-0.5069735777128803
MM1.S,65064,3.292120648020702
OPM-2,9825149,0.9763440152106764
BFTC-909,3689413,0.9841636034152118
JHUEM-3,123631,1.8940321800775008
Kasumi-2,11317348,0.9834435800612674
AU565,44607530,-0.2063452249558506
CHP-212,erlotinib-PLX-4032 (2-1 mol-mol),3.470497784444788
NCI-H2196,55508,1.786873384167788
NCI-H2196,11625818,4.261163910611455
NU-DHL-1,11640390,3.61397071522667
M-07e,5280436,3.7367498625324433
OPM-2,46174525,3.627220507837432
AU565,9866186,0.5690553044247834
MM1.S,107970,1.483055719195773
Hs 746.T,60700,0.5376986560432159
OAW28,1750826,-3.338956149870334
Ku812,42642645,-2.294133807161646
BT 428,vorinostat-navitoclax (4-1 mol-mol),-0.9989641301857834
KHM-1B,44489675,3.585809473125015
Ishikawa (Heraklio) 02 ER-,navitoclax-pluripotin (1-1 mol-mol),0.2772952365006154
PK-59,46199207,3.049912543808079
HPAC,5566,2.7431164341200716
BL-70,6610355,3.548909316534324
SK-MEL-28,31703,0.4439696500586977
JHUEM-3,148198,-4.085540837584063
CHP-212,51037431,3.82114114890829
SH-10-TC,23582824,1.423612167511814
BT 245,24901704,3.4690715705542416
LOU-NH91,3815108,3.3787088400125422
BT 248,selumetinib-PLX-4032 (8-1 mol-mol),4.4451180166492765
BT 245,6436223,-5.553533241536654
BT 231,3136844,3.641211375202356
SNU-1077,3854666,3.1308724985393255
HEC-59,73707398,1.404942401725486
HEC-59,15953870,2.7298961378439497
TCCSUP,168313047,2.4299018394791507
SNU-1041,675434,5.4071210491280235
EM-2,3552672,1.7664111300031236
OPM-2,45279963,2.6394525890823335
SNU-1041,216345,4.648039167899871
Panc 03.27,5351362,1.0639217983195437
PF-382,73707398,0.3361294473850881
YKG-1,11625818,4.5202694072392715
HEC-59,654092,-0.3182456575828493
KMS-20,10302451,2.7224697614535662
KHM-1B,6623618,1.2635861125154564
YKG-1,24951314,2.313291828558588
OPM-2,3136844,3.3377711403827783
YH-13,11175137,1.3907833057777284
F-36P,753704,4.385108951205176
M-07e,327653,2.415097194547363
RKO,23635314,-2.140231911981244
KYSE-70,10302451,3.1884398798129525
KMS-20,2828334,5.046366077488849
SF539,60700,-3.506506897271602
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436
NCI-H1184,selumetinib-navitoclax (8-1 mol-mol),2.6113679893789543
OAW28,5566,3.0868855994062137
A4/Fukuda,49766530,-0.1813275565198268
A4/Fukuda,753704,3.7176461109746897
SK-MEL-28,selumetinib-piperlongumine (8-1 mol-mol),1.8874017474559768
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
SF539,23725625,5.199616438597248
Hs 746.T,1242560,3.34360235369221
BT 428,5281321,2.045733777438055
NCI-H1184,24856436,0.0911188864465356
OAW28,753704,4.708152366597851
MM1.S,89183176,2.023432778974028
SNU-1077,selumetinib-piperlongumine (8-1 mol-mol),4.266694584287947
Hs 578T,72193861,-0.3927552345770934
OCI-AML-3,11626560,0.1141350527781128
OAW28,44185566,1.918306011480311
KMRC-20,119607,3.891658736403049
OAW28,24821094,3.6183900250040497
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433
SH-10-TC,104842,-0.6739830978768858
NCI-H1184,73707386,2.391798435242647
A4/Fukuda,4521392,3.820585335578038
MM1.S,15953870,5.481933437473156
OCI-AML-3,11977753,-3.3128300758967293
HCC38,5335621,4.005113947716145
Hs 746.T,156422,4.668114022242904
HCC1395,11364421,-4.961149723078427
SNU-410,5328940,0.3575452772415965
BT 231,66577038,1.1906091660005256
KYSE-450,11404337,-0.7664225185438103
BL-70,71466578,2.156107237531416
YH-13,crizotinib-PLX-4032 (2-1 mol-mol),1.6930776874276643
RERF-LC-MS,4096211,1.8582313750529689
TCCSUP,5329102,2.310933732009281
SW1783,JQ-1-MK-0752 (1-1 mol-mol),2.969975074260421
NCI-H2196,10302451,3.953927189909324
BT 245,3825829,4.258245820597346
EM-2,44507138,0.6117655762346116
M-07e,24772860,-3.1909203278132803
NCI-H1568,2874250,4.364133169191667
NCI-H2141,salermide-PLX-4032 (12-1 mol-mol),5.378096581839581
BT 245,16038120,0.491051079838287
OPM-2,46191454,-0.9534482392265864
OCI-AML-3,decitabine-navitoclax (2-1 mol-mol),3.369473591635205
M-07e,15983966,-4.9392279262209735
RERF-LC-MS,46843906,4.323049782377064
Kasumi-2,151289,0.8385264971723331
M-07e,24856436,-1.8269094418879783
NCI-H1568,9866186,-0.23967308205821
TCCSUP,selumetinib-MK-2206 (8-1 mol-mol),3.0080662514608845
PF-382,2708,3.3018060761805774
M-07e,44632017,0.5834279665148785
KHM-1B,JQ-1-navitoclax (2-1 mol-mol),-1.1171420900170967
SF539,5311,1.7990759900663726
OPM-2,9911830,2.101419447334853
MM1.S,44632017,1.7374394851414656
NCI-H2196,46398810,2.3379328388716933
YKG-1,11497983,4.151175156243401
Ku812,5566,2.0197817582135604
NCI-H1184,navitoclax-piperlongumine (1-1 mol-mol),0.7853329451569396
SNU-1041,16741245,6.305045874574024
SF539,10026128,4.850110020898141
KHM-1B,crizotinib-PLX-4032 (2-1 mol-mol),0.397018981574428
KMS-20,123631,1.7522842668396212
BFTC-909,5287620,-2.871557478653834
Rh30,9444,4.571677053292836
SW1783,44137675,4.848183688866269
TCCSUP,11364421,-0.436162091200716
M-07e,45100481,4.363152202423216
Hs 578T,11626560,1.4095594854147386
HCC38,445091,4.127860643806722
BT 231,10113978,2.8106622809877697
BFTC-909,72376,-1.4314875177558029
BT 428,25062766,2.445496816920869
NU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),0.3575264561509241
Ku812,23635314,-2.972505773411878
JHUEM-3,decitabine-navitoclax (2-1 mol-mol),1.4663119083269864
SNU-201,10113978,3.8993909122615737
BT 245,JQ-1-carboplatin (1-1 mol-mol),4.46215850472978
NCI-H1568,702558,5.469457182473135
NCI-H1568,36314,4.092621701538515
SH-10-TC,9444,4.347062902815548
OCI-AML-3,400769,-1.9546151139873045
TCCSUP,9887053,4.648275902812988
A4/Fukuda,54618164,3.3817410387547575
PF-382,1641662,3.045007940950309
AU565,11960529,4.91307375329511
JHUEM-3,10184653,-0.5579332946391967
NCI-H2196,89928392,0.9846890779790316
Hs 746.T,11640390,3.243646452699682
BT 428,60750,-4.5752474299452
NCI-H1568,doxorubicin-navitoclax (2-1 mol-mol),-2.631367093813306
BT 231,24180125,2.6727981322820664
BL-70,9887053,3.905138852796042
OCI-AML-5,637858,1.7330578787515938
NCI-H1184,5287620,-2.167902125351809
NCI-H1184,65628,3.2450245277105867
Ishikawa (Heraklio) 02 ER-,36314,2.7572740805853537
BFTC-909,5328940,1.2290524134113243
JHUEM-3,11977753,-1.6991682637887386
Rh30,navitoclax-gemcitabine (1-1 mol-mol),-3.260957550046349
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418
KMRC-20,1716436,3.2166067738770603
F-36P,24180125,3.032691070219076
RERF-LC-MS,24797083,0.2985814331764478
Rh30,6252,-1.366915926398568
SW1783,54626689,3.693361817042254
WM88,16722836,2.797862622900647
PK-59,24753719,4.213783257625297
EM-2,3384730,-0.2905465628746882
KYSE-70,135398744,6.338938630156892
Rh30,5746,1.6258694636844016
YH-13,126941,-0.9334172609353208
PF-382,4788,5.110775522740739
KYSE-70,4261,1.9447398866595849
KMS-20,10296883,2.054648014794474
LC-1F,23939,-1.3848866383054934
PF-382,46398810,1.1284565194471994
OAW28,753704,4.708152366597851
SNU-1077,5282054,4.106676604062682
NU-DHL-1,2871966,-1.1503582820032332
OCI-AML-3,375860,-0.5721607544660736
RKO,6918736,-1.762610939534952
SNU-1077,1641662,3.616725979118272
WM88,11609586,2.829921286131093
BT 245,9935249,1.99402432106235
PK-59,selumetinib-MK-2206 (8-1 mol-mol),1.1938726567560958
KHM-1B,6252,-0.4471831766807136
BT 245,637858,1.8554051464132844
JHUEM-3,54619267,4.18158873864993
Rh30,44185566,2.990343072642105
B-CPAP,10322450,5.621210843033534
Kasumi-2,2858523,3.136381143278692
OCI-AML-3,23635314,-4.69634024144564
JHUEM-3,24180719,2.8866781738980296
PF-382,9926054,1.6899693166343082
PF-382,16722836,0.500687178002076
KMS-20,15953870,2.7543869132459378
JHUEM-3,navitoclax-gemcitabine (1-1 mol-mol),-4.401646931667728
OCI-AML-3,10113978,2.929079911569785
Kasumi-2,53232,4.135119610512006
BT 428,135999136,1.4549412998786355
HEC-59,10385095,1.2806197233190435
F-36P,448949,1.3773610878049587
Kasumi-2,71466380,3.646549475683979
A4/Fukuda,445455,4.756694709293823
BL-70,66577038,3.015758333388709
EM-2,2874250,4.711647199479682
WM88,1716436,1.3012798597851012
RKO,6918328,0.803085247134139
SF539,9936388,-8.641778658087059
CHP-212,JQ-1-vorinostat (2-1 mol-mol),-1.1535947728497378
PF-382,4259181,-0.6205773881868614
B-CPAP,3503,2.2508501900255213
EM-2,446155,1.0094413215344786
LOU-NH91,JQ-1-vorinostat (2-1 mol-mol),0.7101877793592652
M-07e,25195348,0.9925869893558332
Kasumi-2,24951314,-0.5780068322267972
SK-MEL-28,11152667,4.172027715871216
WM88,carboplatin-UNC0638 (2-1 mol-mol),3.655040736440434
LOU-NH91,452548,2.191181432305291
JHUEM-3,3634881,3.291927205293922
SF539,JQ-1-carboplatin (1-1 mol-mol),0.897119179584113
SF539,327653,3.3770394007544953
OCI-AML-3,4578,4.240250604697332
Hs 746.T,644241,2.8412475305578786
WM88,5470400,-2.3165923990771633
TCCSUP,3854666,3.617075113283279
OPM-2,tretinoin-navitoclax (4-1 mol-mol),3.1299009016579253
BT 231,23582824,-0.2870757560130124
BT 428,285033,-2.2884561902812135
HCC38,navitoclax-sorafenib (1-1 mol-mol),1.0325164985333095
M-07e,9933475,1.7096805702782245
TCCSUP,54618164,4.281824636120867
NCI-H2141,56946209,-5.4825258903848955
Hs 746.T,4259181,1.0284627919078262
PK-59,5328940,1.5878650798878486
KHM-1B,969516,2.482442021285449
M-07e,11455910,0.9135610826931194
AU565,tanespimycin-gemcitabine (1-1 mol-mol),-2.222908317148695
BL-70,25105715,3.4567852601956486
LOU-NH91,123631,3.064358892537756
Rh30,448949,2.1869494282342
SF539,216239,1.8940195388550165
HPAC,1750826,1.6406973192362595
OCI-AML-5,11213558,0.3056084762497069
NCI-H2141,148124,-3.613831420136023
NCI-H2196,25105715,3.6444532249762154
KMS-20,72193861,0.4494795381256313
BT 248,76446078,4.2307608716074565
LOU-NH91,JQ-1-UNC0638 (2-1 mol-mol),1.6963345544096158
YH-13,vorinostat-carboplatin (1-1 mol-mol),4.1657170851740855
HCC1395,9907093,3.8658186651464495
BT 231,44819697,-0.2882260639592227
PF-382,36314,2.7349440998972296
HCC1395,2729026,1.652245896591493
Kasumi-2,6436223,-4.213376684231403
RKO,136227924,3.256787131627037
B-CPAP,400769,-0.8210838787379329
OPM-2,107970,1.3408908225452507
M-07e,navitoclax-MST-312 (1-1 mol-mol),-0.3327775361876073
SH-10-TC,9911463,4.344994867688331
KMS-20,51037431,4.06192441494652
LOU-NH91,6610355,5.077923698507978
M-07e,selumetinib-vorinostat (8-1 mol-mol),1.3971239600856724
SH-10-TC,6450551,4.176066692793308
BFTC-909,56946209,-2.8280109825858943
F-36P,2733526,2.8578336314026855
A4/Fukuda,11404337,-2.650657466190433
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913
LOU-NH91,66577038,3.4622279905398052
Kasumi-2,3543504,3.4583921680412413
LOU-NH91,5311281,1.0411900413843744
BFTC-909,11404337,0.4468911705694049
Hs 746.T,25105715,3.22813009197114
F-36P,3634881,2.9926990074647266
NCI-H1184,9866186,0.0276853729484068
A4/Fukuda,24951314,0.2081517019188384
NU-DHL-1,16720766,-1.0246097126306042
SNU-1041,135875424,4.844300116851518
PF-382,11485656,2.17330616168877
LOU-NH91,54678924,3.1162234647683205
NCI-H2196,navitoclax-gemcitabine (1-1 mol-mol),-2.7913497270940684
Ku812,16115403,-5.456092150194313
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495
Hs 578T,7251185,1.6129743628066195
BL-70,46174525,3.678496948543182
NCI-H2141,6914657,-2.4618803151938597
NCI-H1568,tretinoin-navitoclax (4-1 mol-mol),4.46686431300974
NCI-H2141,46926350,-5.833766963931078
BT 428,46174525,1.8458447975466572
BT 248,4477,0.1181412005602309
BT 231,7251185,1.587898220909823
Rh30,9911830,2.2640217333409693
B-CPAP,44137675,4.622984618218968
BT 248,24753719,4.394714770526552
NCI-H1568,52947716,-4.502411459776945
NCI-H2141,24951314,0.967715107912746
RKO,148198,-2.1467795088860875
Kasumi-2,448949,-0.5395388127141975
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384
F-36P,2742550,3.2568507775815525
BT 248,11647372,0.9807519416972552
JHUEM-3,9933475,1.155072791617945
BT 245,6914657,-5.090126903325334
NCI-H2196,135875424,2.980052195607556
Hs 578T,9915743,0.6778530093725601
OAW28,89183176,4.823946494889004
NCI-H2196,2858523,2.766357843525286
CHP-212,89183176,1.6988803038848117
Hs 578T,2729026,2.9288913287231617
SNU-1041,9936388,0.8457601319500153
HPAC,3854666,3.57580848834068
PK-59,5278396,3.6603402814377946
SF539,25227462,1.1630748735531866
BT 428,11717001,2.1851156946735544
BFTC-909,46224516,1.8849058086882595
Kasumi-2,7251185,0.9050560163252253
BFTC-909,12003241,-0.8371396827795129
OCI-AML-5,16725315,5.294193393068877
Kasumi-2,135411,-1.6102115279025644
NU-DHL-1,168312962,2.5247820941481183
Rh30,23725625,6.598497989762034
B-CPAP,5311,1.0199016089886117
OPM-2,9911463,3.091122447781221
NCI-H1568,82146,4.486561599154294
KYSE-450,navitoclax-PLX-4032 (1-1 mol-mol),4.746447722583796
KMS-20,4521392,3.4103323634767775
TCCSUP,71466578,6.231469242081688
BFTC-909,6917907,-4.2174557642594035
BT 248,selumetinib-MK-2206 (8-1 mol-mol),1.8493949286996905
YKG-1,16736978,1.5030984389697135
HEC-59,3815108,2.3440811095363157
Ishikawa (Heraklio) 02 ER-,10184653,2.033470800520247
BT 231,46191454,2.248528460239281
YKG-1,9866186,4.262068146062729
HCC38,2708,5.0858320495730975
KYSE-70,4477,1.3887255745641551
SF539,56949517,4.748779906195386
CHP-212,439501,-3.066647647836344
EM-2,11683005,3.277898416947604
AU565,119607,5.010456243294951
OCI-AML-3,4705,3.3295764443297475
SNU-201,16725315,5.191850752587297
PK-59,6623618,3.4905373489762916
TCCSUP,24748573,1.7257440496514025
WM88,5287969,-2.3825057366025577
AU565,168312962,1.8906319972872971
MM1.S,4259181,0.3083006728289762
NCI-H1568,57519531,1.3161148530355309
YKG-1,24901704,4.300110329432471
M-07e,409805,3.874432405180439
Hs 746.T,445091,4.217865140947406
Ku812,8515,2.860455557749638
BT-474,9444,4.286677111819373
OAW28,16725315,3.4000122970226196
EM-2,56946209,-5.032503801004039
KHM-1B,decitabine-navitoclax (2-1 mol-mol),0.777035437815577
BL-70,JQ-1-UNC0638 (2-1 mol-mol),0.2478853325669071
SNU-410,119607,5.439579130308592
KHM-1B,46398810,2.0305727625963756
BT 245,11238147,3.258472399798465
M-07e,26596,-2.7882078019466725
Rh30,656346,0.8082144351793682
PF-382,9956119,2.18852743102483
M-07e,57519531,2.2642047128363436
NCI-H2141,3038522,0.7382583225298122
NCI-H1184,219104,2.204168998915773
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096
KYSE-450,9444,4.430571093374375
CHP-212,56949517,4.195960446227694
OCI-AML-3,10127622,-2.259350793096325
RERF-LC-MS,8515,3.770178660744851
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773
KHM-1B,24951314,0.1876551064877586
PF-382,66577038,2.531906234689114
PF-382,24180125,1.6002910588088834
Rh30,10427712,3.600364770281647
BT-474,24797083,-0.7545481038692331
BT 245,16722836,1.659253387533303
NCI-H2196,216345,3.725264077729943
F-36P,tretinoin-carboplatin (2-1 mol-mol),6.005914815255201
BL-70,9927531,3.241092589782463
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904
Hs 746.T,44589607,3.093536647364133
BFTC-909,9907093,4.635414583134371
OAW28,5287969,-1.4958665626980858
SK-MEL-28,3854666,3.183656457854027
SF539,15983966,-3.97733563141033
PK-59,2746,3.5698867833367585
Kasumi-2,44489675,3.5763019986617106
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549
OCI-AML-5,753704,5.127293617772583
BT 428,11175137,2.170481617676556
NU-DHL-1,5460769,0.1990382783266381
BT 248,6505803,-0.8385222866943476
OPM-2,25062766,1.526966504091227
OCI-AML-3,10296883,3.1586909460466455
LOU-NH91,6918878,5.623996708869271
Hs 746.T,11494412,3.539724142394036
KMS-20,11222830,0.8671541561907014
OPM-2,54618164,3.637238343412542
KMS-20,31703,-1.639291403660424
SNU-410,11175137,3.709605708174979
B-CPAP,448949,0.8631671075369705
YH-13,2746,3.803826628530811
SW1783,135411,2.3314592986122453
SK-MEL-28,JQ-1-navitoclax (2-1 mol-mol),2.6430063634081877
Ku812,644241,-5.729959790836442
HCC38,4259181,0.7320315366357028
RERF-LC-MS,5281321,-2.2570738048063257
YKG-1,49867926,5.593368072360718
SF539,11317348,2.653231871522483
PF-382,89183176,-2.8788143153394476
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246
Hs 746.T,148124,-1.248919853815242
B-CPAP,11175137,3.0252495703695668
NU-DHL-1,135875424,2.8057790902603665
F-36P,2949965,2.03934423775658
Ishikawa (Heraklio) 02 ER-,52912189,4.8748873520604805
M-07e,11404337,-0.615837130994534
BT 245,selumetinib-piperlongumine (8-1 mol-mol),4.075741848963224
BT-474,54618795,3.829674991008482
OCI-AML-5,11178236,-2.630277850116007
RERF-LC-MS,168313016,4.277512101574917
Hs 746.T,5113032,4.583198795872279
RKO,24856436,0.2423564692967549
MM1.S,4096211,2.0079042529830673
CHP-212,71466578,1.548824360090077
BT-474,4096211,2.989985915544493
PF-382,tanespimycin-gemcitabine (1-1 mol-mol),-4.545409531146979
HCC38,637858,1.176311415615167
BT-474,135421197,1.065092434126716
A4/Fukuda,10410894,1.64506751408979
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
Hs 746.T,11238147,1.9336579827704583
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028
PK-59,1716436,2.606347183959893
HEC-59,piperlongumine-MST-312 (1-1 mol-mol),1.507849018732575
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857
NCI-H2196,9933475,1.7695395866475931
SNU-1041,17759555,3.5968144623625564
SNU-1077,44241473,4.729716696280308
Ku812,9907093,3.786730640592808
BT 428,5494449,0.5844518768808629
LOU-NH91,8515,5.2113767400480775
A4/Fukuda,tretinoin-carboplatin (2-1 mol-mol),3.3716994915899945
LOU-NH91,60750,2.5426597160889823
TCCSUP,44259,0.3711906611875216
B-CPAP,selumetinib-JQ-1 (4-1 mol-mol),2.8675411473634917
AU565,decitabine-navitoclax (2-1 mol-mol),2.1782806047891095
KHM-1B,57519531,1.9307254851504612
BL-70,53325874,4.777899366926801
BT 245,1714884,3.4976834364725784
SNU-1041,6918837,-2.102072324703645
YKG-1,156414,1.711503789054189
A4/Fukuda,54619267,3.184419267966046
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342
KHM-1B,11626560,-0.6143155119678699
YKG-1,44589607,3.192854738782174
NU-DHL-1,3676137,5.3250743483320395
KHM-1B,vorinostat-carboplatin (1-1 mol-mol),1.1385799517319026
B-CPAP,11152667,-0.1979921497288642
NCI-H1184,25062766,2.416288920274495
SNU-1077,638278,3.5420439981494254
Hs 746.T,119607,5.502857512886853
TCCSUP,5281321,-1.6830882813028205
BT 428,3062316,2.1273862607852423
F-36P,3543504,3.2168651709779565
RERF-LC-MS,2749,2.1448012118135176
B-CPAP,5113032,5.349013734099232
KYSE-70,10113978,1.960067513789881
HEC-59,753704,5.615717275253642
B-CPAP,9967941,2.4730364955418853
BFTC-909,11364421,-5.034674750215906
RKO,11396600,3.504834935214814
HEC-59,3025986,-0.565652371724413
F-36P,66577038,2.3349416842561697
SH-10-TC,54613361,0.0878513675313513
AU565,9915743,-3.6885201415408098
OAW28,25262965,-0.9519808245592094
NU-DHL-1,24785538,1.0329892667677911
SF539,25105715,3.397362341594616
PF-382,11175137,1.0890287092924258
Rh30,135999136,4.27956770229102
RERF-LC-MS,375860,-0.2896823379882159
BT 428,3465537,1.041948856740563
KHM-1B,4917,2.355684811244976
Ku812,11656518,-1.0903190853859568
KHM-1B,24964624,-1.4057417627664983
NU-DHL-1,5291,3.690421399928162
Hs 746.T,46199207,3.1784127581922603
SNU-1041,159324,4.667459378229219
PF-382,676352,1.5594037701134436
LOU-NH91,16038120,-0.2213795856096394
OCI-AML-3,60700,-2.908365949873296
KYSE-70,51039095,3.5490987853947247
OAW28,46843906,3.2241568449076556
F-36P,2858523,2.6013714757914306
HCC38,6450551,3.434449022219302
BL-70,selumetinib-MK-2206 (8-1 mol-mol),1.8077322352371348
OCI-AML-5,51037431,1.447191423303699
BT 428,135421197,1.0281432833092603
BFTC-909,3385,6.578023483143935
NCI-H1184,1242560,3.379586866486488
KYSE-70,159324,1.7590392520862297
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286
CHP-212,11455910,-0.0664645017636666
MM1.S,piperlongumine-MST-312 (1-1 mol-mol),1.4350664876301185
SNU-201,448949,2.0448399665580825
SK-MEL-28,46191454,3.2888923577411333
Hs 746.T,25154868,5.0103123099771665
BT 245,46199207,1.6379088450164898
Ishikawa (Heraklio) 02 ER-,44607531,1.9403149482163755
WM88,445091,4.183753962171531
NCI-H2196,10231331,5.621753201885216
OAW28,49793307,-1.8076729764727852
KMRC-20,10127622,5.270569456722755
OPM-2,4261,-0.9911458583810344
SF539,5291,3.503530356529322
EM-2,9825149,1.6158891239406794
Kasumi-2,BRD9876-MK-1775 (4-1 mol-mol),0.2372012332768771
M-07e,24797083,0.4612895137626135
WM88,89183176,4.687438402771627
OAW28,piperlongumine-MST-312 (1-1 mol-mol),2.526870142360867
PF-382,selumetinib-JQ-1 (4-1 mol-mol),-1.2412031100333754
SK-MEL-28,serdemetan-SCH-529074 (1-1 mol-mol),2.401587214304783
OCI-AML-5,JQ-1-UNC0638 (2-1 mol-mol),-0.3080122277817761
HCC1395,44819697,0.8204556351360472
LOU-NH91,JQ-1-MK-0752 (1-1 mol-mol),2.239144963977278
TCCSUP,selumetinib-UNC0638 (4-1 mol-mol),4.619962365310146
AU565,24753719,4.632017214490639
B-CPAP,vorinostat-navitoclax (4-1 mol-mol),0.850582052340713
KMS-20,46943432,0.2963080368709872
OPM-2,19582717,1.9960397366001383
BT 245,53232,4.832235937520063
HEC-59,107985,-3.77739031414332
OCI-AML-5,227681,3.7633111626705498
EM-2,2749,1.1269594060065131
NU-DHL-1,24180125,2.343403566122717
M-07e,11647372,0.7444657788820951
RKO,441298,2.3183923582018107
Ku812,44202524,1.0653964547956452
JHUEM-3,23725625,5.000845948938622
WM88,selumetinib-navitoclax (8-1 mol-mol),-3.280371110843596
SK-MEL-28,3062316,3.6672926372166
OPM-2,122327,3.690232587907526
KMS-20,4705,2.611307391977677
Ku812,24180125,2.3184854542342217
OAW28,54649381,3.786658613217657
BT 245,49766530,0.0902413739193597
Panc 03.27,216239,2.3730227913665467
YH-13,89928392,1.3765832739802537
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422
KMRC-20,11427553,3.4952779275874826
BT 248,9935249,2.246614582121965
BT 231,151289,0.783350278693398
PK-59,54454,2.804023256585933
SNU-410,4788,5.443682840985445
SNU-1077,JQ-1-navitoclax (2-1 mol-mol),0.5291421057412008
OPM-2,9444,2.5095115053941557
Hs 746.T,675434,4.57065975294799
AU565,5282054,3.2331302005717153
KMRC-20,3062316,1.6707904711783064
NU-DHL-1,5470400,3.3692959530783155
PF-382,44259,0.4010800943421826
NCI-H1568,16720766,0.7309820541773976
AU565,carboplatin-etoposide (40-17 mol-mol),1.7469100851636217
SNU-410,159324,4.304183383322186
KHM-1B,72376,-2.838745131270772
OAW28,25227462,0.9824255132553372
NCI-H2196,vorinostat-carboplatin (1-1 mol-mol),3.574656939494639
NCI-H1568,salermide-PLX-4032 (12-1 mol-mol),5.036103452561945
NCI-H1184,navitoclax-sorafenib (1-1 mol-mol),-1.2002922303663592
KYSE-450,serdemetan-SCH-529074 (1-1 mol-mol),2.594112814660752
NU-DHL-1,11719255,1.476075031302051
M-07e,16725315,3.0033221270164634
KYSE-70,JQ-1-vorinostat (2-1 mol-mol),1.448223728209247
EM-2,5281672,4.351440429265676
BT 245,60700,-3.5416994906871917
SNU-410,selumetinib-UNC0638 (4-1 mol-mol),4.632512677939061
KHM-1B,vorinostat-navitoclax (4-1 mol-mol),0.9297533405267338
MM1.S,25262965,-3.9211538227137432
KMRC-20,17755052,4.273856933322851
NCI-H2141,71304818,2.2585864376095555
NU-DHL-1,11964036,-0.3211090677795742
SNU-201,10302451,2.8885993041273643
PF-382,3062316,-2.906652546684618
SH-10-TC,53481919,3.9183055565005978
Kasumi-2,selumetinib-BRD-A02303741 (4-1 mol-mol),4.464770515691229
OAW28,10302451,2.68651474445359
OPM-2,selumetinib-GDC-0941 (4-1 mol-mol),1.4008173274482878
PF-382,136227924,2.0859082008018084
NCI-H1568,4259181,0.5766231269303183
WM88,375860,-0.1387933856952615
YKG-1,16038120,1.8317392999750344
BT 245,11977753,-0.2716819809439988
NCI-H2141,42642645,0.5006578232699423
PK-59,374536,3.3895651049795483
OAW28,4096211,1.5501495805084426
OPM-2,2729026,2.502425703285658
M-07e,25262965,-3.09338362705107
OAW28,9956119,4.544482925716663
NCI-H1568,9444,4.259676436179719
BT 231,675434,3.4479777489994805
F-36P,5460769,6.312488647887553
CHP-212,5282054,3.4064500635624406
BT-474,54618771,0.7682511511531626
MM1.S,3543504,4.234419040105733
BT 428,11178236,-5.187797814465357
BL-70,BRD-A02303741-navitoclax (2-1 mol-mol),2.0318218732369773
SNU-201,136227924,3.0451171975506903
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344
CHP-212,2746,0.548553476305332
KHM-1B,246676,1.870399937828377
SF539,135421197,1.037431947377599
NU-DHL-1,46224516,2.2701616013146655
PF-382,984333,-1.854257938200321
SNU-1077,erlotinib-PLX-4032 (2-1 mol-mol),3.997115114671339
CHP-212,5351362,1.063053568330328
Kasumi-2,selumetinib-MK-2206 (8-1 mol-mol),1.1378728727000402
BT-474,9933475,1.7460232354724812
A4/Fukuda,25154868,2.544294393199085
NU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),-1.1533967446161832
EM-2,crizotinib-PLX-4032 (2-1 mol-mol),-0.3862356461307706
BT 245,5281321,-1.5902093938584612
WM88,11214940,1.924991552806045
Hs 746.T,8515,4.584865642264335
OAW28,72193861,2.7871547903709266
TCCSUP,9549297,3.547573054741186
BT 428,11612883,3.704058274003065
RERF-LC-MS,246676,4.480243243269967
BT-474,16720766,5.022875767961635
NCI-H1184,969516,2.4521343602029426
Hs 746.T,24901704,-3.3383440685769252
KMS-20,637858,0.4496747428654858
BL-70,11152667,-0.9992900741194192
OCI-AML-3,60750,0.7339059828464308
BT 248,12001922,0.9128950259060647
NCI-H2141,241158,3.8240614308547327
PF-382,46224516,1.3839719713771603
SNU-1041,doxorubicin-navitoclax (2-1 mol-mol),0.5565987112640827
OAW28,5287620,-1.6233190690502424
NU-DHL-1,10385095,-0.0540424655836512
BFTC-909,7326481,3.4905195575106527
A4/Fukuda,9908783,4.281950187885367
MM1.S,JQ-1-navitoclax (2-1 mol-mol),-0.6640240653642139
A4/Fukuda,10231331,-0.0070700765814584
KMS-20,5335621,4.346191921531872
KYSE-450,241158,4.285328470501583
SH-10-TC,carboplatin-etoposide (40-17 mol-mol),3.8858662519286664
Kasumi-2,446155,3.789762475260846
KMS-20,ISOX-bortezomib (250-1 mol-mol),0.1513994172758227
SH-10-TC,107970,3.078551044723764
KMS-20,decitabine-navitoclax (2-1 mol-mol),-0.178300212626614
CHP-212,6610355,3.4335664227449194
NCI-H1184,54618771,1.2504018594222124
HCC38,11494412,0.4416317556150596
AU565,31703,-1.2264921928318224
KMS-20,23635314,-2.706306797828618
AU565,sirolimus-bortezomib (250-1 mol-mol),0.9370118878253954
SH-10-TC,5328940,1.8415690315943964
Kasumi-2,24772860,-3.0702303943568197
PK-59,135440466,1.9897186815972312
SNU-201,637858,3.034279619559701
HCC38,3025944,4.295861224609199
BT 231,73707398,1.611870726926167
OAW28,3854666,2.969576020962734
HEC-59,969516,2.5107445458123268
Rh30,selumetinib-GDC-0941 (4-1 mol-mol),1.4659883817366972
HPAC,9936388,0.8938610961333106
BT 428,53325874,4.630334381106429
RERF-LC-MS,67156097,-1.006688958645714
OCI-AML-3,11494412,-0.6961081339076156
Hs 746.T,4578,4.776470563737851
SH-10-TC,51037431,2.306997667737765
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769
SNU-201,17759555,3.8376644759982534
OCI-AML-5,19582717,4.093171634191387
Kasumi-2,2733526,2.6717950038671003
YH-13,327653,3.132127686900927
F-36P,49867930,6.1506617063580205
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457
OCI-AML-5,15983966,-4.520860533724387
OCI-AML-5,46907787,-0.4591254686274671
HEC-59,6610216,4.527816739997527
Kasumi-2,45279963,3.7710739544623233
EM-2,11317348,-0.6974590187495013
EM-2,doxorubicin-navitoclax (2-1 mol-mol),-4.532480294264066
Ku812,selumetinib-decitabine (4-1 mol-mol),-3.2860234073960126
YH-13,4259181,0.5149162893859401
MM1.S,327653,2.336208515323047
OCI-AML-5,44137675,3.8877087798647474
JHUEM-3,409805,6.053062138585062
BL-70,46943432,1.6957346866180731
Kasumi-2,1714884,3.668347649937234
HCC38,3081361,1.9497697775073644
CHP-212,2113511,5.852777274652266
OCI-AML-3,148198,-5.6942586662557035
LC-1F,122327,1.3616284484209198
LOU-NH91,11609586,3.3390226168587716
SH-10-TC,11626560,2.6239879608447336
M-07e,2708,3.697368711030294
KMS-20,72199292,0.0792134976648957
EM-2,decitabine-carboplatin (1-1 mol-mol),-2.7296859063042658
OAW28,5311281,1.8509970799423736
NCI-H2196,6610216,4.474259778958852
M-07e,119182,-3.9145036134579096
SF539,52912189,0.594338957036255
RKO,176870,5.862868084879783
Ku812,3025986,-0.7700675438788807
KMRC-20,51039095,3.0958869754937424
NCI-H1568,11719255,3.5544275615483087
NCI-H2196,60700,0.2390746064329909
M-07e,25183872,-1.7763648181594862
CHP-212,9926054,1.886787046066781
BT-474,9926054,2.0382536553726207
YH-13,selumetinib-GDC-0941 (4-1 mol-mol),2.117878884448022
BL-70,5281672,4.828353413029609
Kasumi-2,156414,1.0465549823430256
OCI-AML-5,387447,-3.8231326026403223
KMRC-20,72193861,2.2130895784665148
MM1.S,126941,-0.9459288946859304
M-07e,51037431,3.0576513421676492
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843
Ku812,17755052,2.1126549747307535
Hs 578T,selumetinib-JQ-1 (4-1 mol-mol),1.8752949809426225
OCI-AML-5,107985,-4.549772728055964
BT 428,10302451,3.296855722335022
BT 428,374536,-2.5752106252331113
F-36P,selumetinib-PLX-4032 (8-1 mol-mol),1.4374450103461651
Hs 746.T,9823820,4.3110282288486275
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671
RKO,11222830,1.6656419736189183
WM88,carboplatin-etoposide (40-17 mol-mol),3.8916725096581457
Rh30,25183872,-0.9527975369870616
Rh30,44137675,2.780115728259252
SF539,66577038,2.975973060606957
JHUEM-3,3025944,4.153124126537803
SNU-410,11626927,1.6107071257394243
BT 245,3676137,5.948892437693733
BT 248,67156097,4.587573075901519
OCI-AML-3,52912189,-2.968970956432224
Rh30,135440466,0.5808315702959496
HPAC,10184653,1.5071697668086086
KMS-20,285033,-4.372488793803924
F-36P,54143018,-1.3895975294341516
BT 428,selumetinib-vorinostat (8-1 mol-mol),0.9101675495588571
RKO,44491742,4.905526099010324
B-CPAP,9911463,3.799628401356715
OAW28,3689413,-1.4375749125930504
KYSE-70,107970,2.5727619321994353
Ishikawa (Heraklio) 02 ER-,5287620,-1.536457961348177
OCI-AML-5,10385095,0.6242077157368962
OCI-AML-3,selumetinib-navitoclax (8-1 mol-mol),-3.285304866011813
SNU-201,10184653,1.707993871871787
RKO,216345,4.0768365061219525
JHUEM-3,46215462,1.722719915047943
NCI-H1184,46199207,3.177157530883506
WM88,119182,-1.9529455953156227
Panc 03.27,4788,5.500882288724768
SH-10-TC,11228183,5.336053249933155
F-36P,42642645,0.6290792205748662
F-36P,11364421,-5.822340620557665
BT 245,44819697,-3.0488114017320056
BT-474,216345,4.410451323758934
OPM-2,selumetinib-UNC0638 (4-1 mol-mol),2.327180479574148
OPM-2,262093,0.5720462757198622
Ishikawa (Heraklio) 02 ER-,20959075,-3.257755435634251
YH-13,3062316,-1.0789668620002044
PF-382,4915,5.4300848417035725
HCC1395,15953870,3.420071190653329
M-07e,9911463,2.8967882241025995
SF539,10302451,2.624022513021108
KYSE-70,11609586,2.827625452517046
F-36P,16720766,-0.5694610734161567
LOU-NH91,navitoclax-sorafenib (1-1 mol-mol),-0.9074262006529596
KMRC-20,4788,5.828719135556259
Panc 03.27,49793307,-4.124641339151584
SNU-410,46215462,2.633935756506869
WM88,16038120,2.573463821885578
BFTC-909,44202524,2.4582417316930916
M-07e,72193861,0.090585978668539
A4/Fukuda,7251185,1.076285820033946
JHUEM-3,24753719,4.082083068058561
MM1.S,67156097,-2.2685663617789045
HCC38,navitoclax-PLX-4032 (1-1 mol-mol),0.6051077744266667
SH-10-TC,3081361,3.629473035749828
SF539,3385,1.3053252400719229
JHUEM-3,9936388,-3.506110274235372
AU565,107970,1.9067452119355752
Panc 03.27,107970,2.945998932112281
BT 428,65628,3.929247019179895
F-36P,BRD-A02303741-navitoclax (2-1 mol-mol),0.9323482933380044
AU565,11626560,1.628517095800036
SNU-1041,44487061,4.4087831219352
KHM-1B,navitoclax-MST-312 (1-1 mol-mol),1.4754840901416553
RKO,9926054,1.883626680074333
LOU-NH91,20959075,-3.4746906487579494
Ishikawa (Heraklio) 02 ER-,11222830,1.865706051670166
Kasumi-2,5281672,3.402650415017694
BL-70,445455,3.8442246869997874
OPM-2,136227331,3.7431952210756014
MM1.S,135421197,1.5136201913497214
Kasumi-2,44486219,4.4104720165674145
PK-59,2858523,3.1716449824221846
B-CPAP,16725315,3.8186556720671025
Hs 746.T,11707110,-1.3467006339869272
SNU-201,60750,5.746901401335854
KMRC-20,5566,3.02131820134641
Ku812,5335621,4.179509612142592
YH-13,52912189,2.2271959636109693
OCI-AML-5,25126798,0.359482807970865
NCI-H1184,16736978,1.0237545322221642
A4/Fukuda,4578,3.815086457915261
Panc 03.27,327653,3.706156295956661
HCC1395,44620216,5.342063763617237
KMS-20,10127622,1.0951348794097868
SNU-410,25102847,4.090843732211577
F-36P,6436223,-4.329523478491274
SF539,5978,-5.613486711901469
AU565,89928392,2.1536851128845904
YKG-1,46843906,3.149273077560738
BT 428,5282054,2.391287109666509
PK-59,135411,1.4779223783785622
Ku812,JQ-1-vorinostat (2-1 mol-mol),-1.169942743430711
M-07e,3543504,3.456851761689949
SNU-1041,168313047,3.282425277945656
NCI-H1184,3384730,2.4621329600758557
OCI-AML-5,24785538,0.7038456811372414
NU-DHL-1,6914657,-3.9631462733451426
A4/Fukuda,JQ-1-MK-0752 (1-1 mol-mol),-0.933197038878086
Panc 03.27,984333,1.3550845738662751
BT 231,100016,7.4946101776766385
EM-2,3825829,2.7385006031441947
OCI-AML-3,9444,3.894616990828137
KYSE-450,100016,6.589468110151047
BT 428,54618771,1.9125909448822425
BL-70,262093,2.9607019791616387
LOU-NH91,216468,5.562373540734892
HCC1395,135421197,5.533531628940142
NU-DHL-1,613753,2.5066251808010716
Kasumi-2,53495165,-3.989635350263354
SF539,24180125,3.915045335194428
SNU-1041,16722836,1.6910912780658602
KMS-20,71466380,4.301818086320641
SF539,5113032,4.5569437183020485
SNU-410,6623618,2.459466082690638
HPAC,docetaxel-tanespimycin (2-1 mol-mol),-5.9364761690836785
PK-59,3025944,4.881913785381984
SF539,31703,-1.523395674641048
KMRC-20,24771867,3.994101826039686
PF-382,3011155,1.384120809938285
RERF-LC-MS,6918328,0.3946668064090056
YKG-1,60700,3.1326853541806603
BT-474,208908,1.2669153849419446
Hs 578T,5281672,4.312882509780768
Rh30,6450551,2.3909694704118847
A4/Fukuda,5284329,2.3119801528783244
MM1.S,25022340,4.192040904321215
YH-13,5287620,-2.012457236382429
SNU-1041,3689413,2.0809742429378133
Ishikawa (Heraklio) 02 ER-,3689413,0.6231985481364082
MM1.S,9903786,2.841249590923514
AU565,6610355,3.967539400054512
PF-382,44491742,5.368678247108403
BT 428,24797083,1.0535104552635692
BFTC-909,25126798,3.8219929141120166
NCI-H1568,vorinostat-carboplatin (1-1 mol-mol),1.5719417416558872
Kasumi-2,12003241,-2.245419673861097
MM1.S,216345,1.7407707889539985
Ishikawa (Heraklio) 02 ER-,56963564,0.444961258730385
RKO,24779724,5.847036108864024
CHP-212,6914657,-5.107435025099619
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865
BFTC-909,637858,2.264716830291231
M-07e,selumetinib-MK-2206 (8-1 mol-mol),2.1104943180933833
Hs 746.T,25161177,4.0910841247548495
OPM-2,54765302,3.66991118627716
WM88,erlotinib-PLX-4032 (2-1 mol-mol),-0.7779624716425658
KYSE-70,selumetinib-JQ-1 (4-1 mol-mol),2.626623407119128
Rh30,44589607,1.8175275189818576
OPM-2,navitoclax-sorafenib (1-1 mol-mol),1.274845961219173
OAW28,BRD-A02303741-navitoclax (2-1 mol-mol),1.4319695403367312
Panc 03.27,selumetinib-decitabine (4-1 mol-mol),5.210960672050997
BT 248,208908,1.7719462620560902
Ku812,5328940,-1.8378811939347264
JHUEM-3,11455910,0.589239225317042
PK-59,107985,-3.7968575257166495
Hs 578T,11222830,1.1404967075205834
SK-MEL-28,4705,3.074639735007158
TCCSUP,24978538,1.7362039378241625
B-CPAP,56963564,-0.6464241889145811
F-36P,25262965,-1.6391732709802074
Panc 03.27,selumetinib-JQ-1 (4-1 mol-mol),2.6440242769241338
OAW28,10184653,1.1706980363621209
HEC-59,44493528,4.437244076863349
NU-DHL-1,100016,6.7557445252971355
HPAC,56946209,-4.616516594507286
Hs 578T,9866186,1.138967710356464
NCI-H2196,148198,-4.10304845693827
BL-70,4521392,3.921091079428795
SF539,alisertib-navitoclax (2-1 mol-mol),-0.0974409144974691
AU565,123631,0.0519428975879534
LOU-NH91,11640390,4.567382593568383
OCI-AML-3,42611257,2.9477468693667452
PF-382,6918878,-0.2369499162228823
YKG-1,7326481,5.641592853625606
OPM-2,2858523,3.124441680057984
JHUEM-3,10231331,1.902547404227762
M-07e,4915,4.689767362775219
JHUEM-3,11178236,-4.530100852296816
Ku812,451668,-0.4735095751840026
BL-70,216468,-0.0354793973912826
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286
SK-MEL-28,doxorubicin-navitoclax (2-1 mol-mol),0.6137176516261809
SH-10-TC,selumetinib-GDC-0941 (4-1 mol-mol),2.294004150887064
A4/Fukuda,1716436,2.785785051354721
WM88,44185566,3.0268051280481143
BT 428,3676137,4.612104849545454
NU-DHL-1,12001922,1.2463642245780415
KYSE-70,2729026,2.877153539650856
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
Hs 746.T,JQ-1-navitoclax (2-1 mol-mol),1.982119105709388
OAW28,6610216,3.9661844518771185
OAW28,selumetinib-navitoclax (8-1 mol-mol),1.984152872487984
YKG-1,tanespimycin-bortezomib (250-1 mol-mol),0.0684440375972302
WM88,2749,2.473800448881491
PK-59,25183872,-1.376264663358824
HCC1395,3025986,-0.8085623727923272
MM1.S,11396600,2.9620457472616533
Hs 578T,3062316,-3.7450895381939513
KMS-20,49793307,-3.879201058014154
KYSE-70,5311281,3.780874632943925
BT 245,piperlongumine-MST-312 (1-1 mol-mol),1.2906691199722635
Kasumi-2,400769,-1.337956311995758
KMS-20,9907093,3.4459916472834644
OCI-AML-3,44566777,-0.9187555190660432
OCI-AML-3,8515,2.0861016142229705
JHUEM-3,12003241,-2.0090653802187197
YKG-1,285033,-2.298749012962292
BT-474,25150857,1.8900102984180611
JHUEM-3,6252,0.1180194376173669
RERF-LC-MS,11717001,4.567893424272946
BT-474,5351362,1.9632331500406337
CHP-212,11507802,0.3536910942553585
HEC-59,10074640,3.4891050441983977
Panc 03.27,24821094,3.7571740741942734
TCCSUP,135398516,1.0514197344839231
EM-2,24978538,-1.4072388078314022
BT 245,56946209,-4.793980648010386
RERF-LC-MS,11977753,-0.575574044510787
BT 248,4705,2.6318547262793386
Panc 03.27,702558,5.647338258385266
SF539,613000,2.586710034954353
RERF-LC-MS,445455,4.41080153827665
SW1783,2746,4.238030101530504
BT 428,24753719,4.392925021958881
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214
HCC38,6918878,4.595452272806682
NCI-H2141,64971,5.353907696860243
HCC38,23725625,5.095206918244174
OAW28,JQ-1-vorinostat (2-1 mol-mol),0.5545971801402327
OAW28,24821094,3.6183900250040497
BT 231,11152667,1.8482025461380396
RERF-LC-MS,135984461,4.284403636339015
PF-382,navitoclax-pluripotin (1-1 mol-mol),-4.412096991385023
MM1.S,2858523,3.054704671957027
HEC-59,446155,3.193485402690318
BL-70,navitoclax-sorafenib (1-1 mol-mol),1.4006405429635704
WM88,25062766,1.890801728324104
NCI-H1184,53392493,1.17722946128239
SH-10-TC,448949,3.0430873375340113
NU-DHL-1,216345,1.6023590479795808
BT 231,9915743,1.2683297871302317
OCI-AML-3,10410894,3.1234681995877893
OCI-AML-5,46215462,3.2620278887513177
NCI-H2196,387447,-3.892291433138439
SF539,136227331,3.3252279599925085
BT-474,7251185,1.7589614347966274
BFTC-909,168313047,1.967772312792883
PF-382,6505803,0.1218702134100329
Ku812,6252,-2.9657002300116924
BFTC-909,71466380,5.267829049221599
PF-382,selumetinib-PLX-4032 (8-1 mol-mol),4.556490015738598
HPAC,107985,-3.4399957064086677
Panc 03.27,44486219,4.325760089749128
MM1.S,3815108,1.971538783457294
Hs 746.T,24772860,-4.073131112062665
NCI-H2196,46199207,3.1204303685784924
SK-MEL-28,selumetinib-GDC-0941 (4-1 mol-mol),1.495892975780676
WM88,8515,4.23444504306986
BT 245,9952709,2.755806227678446
OAW28,135411,2.218427323792269
KMRC-20,16722836,1.4149264521986569
MM1.S,10410894,1.8770933860256032
EM-2,52947716,-2.5073624642123167
SF539,serdemetan-SCH-529074 (1-1 mol-mol),2.2539127331776077
CHP-212,52947716,2.868868341494895
CHP-212,104842,-6.268765191244842
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037
OCI-AML-3,3025986,-4.4513624671472245
KMS-20,3038522,2.067228476552794
BT-474,51039095,3.2297139059794304
NU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),-1.7668259453714923
RKO,9911830,2.9376280530386123
BT 248,702558,5.9883095131036495
Ku812,446155,2.2243145788030496
OCI-AML-5,44632017,1.109881904906041
KHM-1B,135398738,4.5070735955788255
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283
BL-70,9911463,2.445001964287348
JHUEM-3,49867930,4.330872123250684
KYSE-70,navitoclax-piperlongumine (1-1 mol-mol),2.418726808753935
BL-70,56946209,-6.627919179294834
AU565,25227462,0.9575642046813388
OAW28,9915743,2.8675584787684456
KMRC-20,89928392,2.0741009557442487
NCI-H2196,11364421,2.593323450287881
Hs 746.T,navitoclax-MST-312 (1-1 mol-mol),1.117736772047138
Ishikawa (Heraklio) 02 ER-,selumetinib-JQ-1 (4-1 mol-mol),4.45456930685315
OPM-2,26596,-3.75281027154887
BT 428,675434,4.849249419991457
SK-MEL-28,6914657,-2.0042888154328344
Kasumi-2,46224516,1.9043930771708657
M-07e,44507138,1.1072987242664103
MM1.S,53392493,1.575283610163411
SW1783,136227924,2.7676121780420364
Panc 03.27,2858523,3.2775089831976296
Ku812,9967941,3.019856322262854
BT 231,216345,3.594728608215129
BT-474,selumetinib-decitabine (4-1 mol-mol),5.393570192734038
BL-70,10302451,3.7691675443398247
BT 428,11707110,-3.885075850112563
SH-10-TC,445091,4.803508322714603
Panc 03.27,carboplatin-etoposide (40-17 mol-mol),2.678480640425287
SF539,navitoclax-PLX-4032 (1-1 mol-mol),2.1497325977392636
KMS-20,135423438,1.13023072719564
KMRC-20,12001922,1.7493187520827975
RKO,31703,-1.8438289452025527
KYSE-70,54618771,1.1170424016733127
OAW28,11175137,3.6697867992343607
NCI-H1184,51039095,1.7494978062060262
SW1783,374536,1.729044945983793
A4/Fukuda,5394,2.6676913787283305
NU-DHL-1,46191454,-0.6723674281273057
SH-10-TC,26596,-1.1215294696679303
NCI-H1568,24772860,2.3104914540479324
SH-10-TC,3634881,3.7236759338138223
Kasumi-2,9826308,-0.3836015857314186
KHM-1B,375860,-0.460638651136882
NU-DHL-1,46843906,1.439459382050455
Hs 578T,135411,1.812912718027184
B-CPAP,3543504,4.96016997847966
AU565,54618795,2.974070020268914
HCC38,navitoclax-MST-312 (1-1 mol-mol),0.3016213620890158
EM-2,15983966,-4.601363841124929
M-07e,148124,-5.941925680697441
M-07e,6436223,-4.694236368251399
BFTC-909,9915743,2.0959000942543025
SNU-1041,6852167,3.3738029338506093
NCI-H1568,285033,-1.965656578387781
RERF-LC-MS,5311281,3.366561586065275
SF539,24856436,-1.421470853407074
OAW28,17755052,1.3145864766951243
RKO,26596,-1.341584325458414
KMS-20,9956119,3.554120536013074
SW1783,10322450,4.230470764848986
BL-70,6450551,2.0470532076134105
BT 231,241158,3.4112394985232517
PF-382,4521392,4.102056118448562
BT 245,3503,1.1172167951544103
WM88,11152667,-0.5209926910891152
HPAC,24785538,0.2871283285939084
KHM-1B,selumetinib-PLX-4032 (8-1 mol-mol),4.453771782553302
NU-DHL-1,2749,0.1316403537643747
Hs 578T,54618771,1.0464366040522988
Hs 578T,49793307,-2.710480158954178
HEC-59,135875424,3.434837292372321
RERF-LC-MS,4705,3.292681011259135
SF539,71304818,2.242612100692728
Ishikawa (Heraklio) 02 ER-,9967941,2.9619779098103427
YH-13,4788,5.883867811277833
KYSE-450,erlotinib-PLX-4032 (2-1 mol-mol),3.596980184500655
JHUEM-3,6917907,-5.718303772695704
BT 248,56963564,4.0439806336642175
HEC-59,11455910,1.03172730185298
RERF-LC-MS,89928392,3.2509495975064193
BL-70,49836020,4.386780315181427
BT 231,107985,-2.768732072411436
BT 245,5311,1.2295057752213503
Ku812,11609586,1.4051049600539705
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594
B-CPAP,19582717,5.278680589390403
YH-13,11238147,2.49094347137922
SH-10-TC,9840324,5.745944022990774
NCI-H1568,3825829,3.749474944576795
SNU-1077,JQ-1-vorinostat (2-1 mol-mol),1.661185971145615
SK-MEL-28,656346,3.623925904090985
BFTC-909,46901937,4.445112058189045
OPM-2,2708,4.148168261065231
NU-DHL-1,67291369,-1.3620718957318685
F-36P,10113978,2.938429796709092
SF539,54619267,4.325836901582148
Hs 746.T,4917,3.0788589387092653
Hs 746.T,navitoclax-pluripotin (1-1 mol-mol),0.0788074720848261
SNU-201,52912189,3.6947902944998248
MM1.S,5287620,-1.6558303438795536
SW1783,24180719,4.7795575092347535
HCC38,46926350,-4.359294014180652
KMRC-20,4096211,2.631082680972026
SNU-201,148198,-1.525453793244306
SNU-201,12003241,-1.0113776062533857
PK-59,73707386,3.024684722161558
JHUEM-3,135659046,3.4797526976334003
SK-MEL-28,72193861,3.1864248921579716
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425
BT 248,46199207,1.879415157386071
F-36P,11222830,1.0877280395075004
MM1.S,2749,2.045600082739513
OAW28,5287620,-1.6233190690502424
A4/Fukuda,56973724,1.7857996527787343
HPAC,44486219,4.256024197319219
OCI-AML-5,16065773,3.7140725248079063
HPAC,753704,5.003257435746307
SNU-1041,54454,1.8647230505776595
OCI-AML-5,10231331,3.33754223031549
B-CPAP,8515,3.305571052734727
PK-59,46843906,3.798000448481125
Hs 746.T,104842,-1.1621338948116866
SF539,25195348,1.0596246311568
NCI-H2196,11175137,2.3593427528873367
F-36P,135423438,1.517615115973094
NCI-H2141,11485656,1.4987808894190335
SNU-1077,124202324,3.0238569925896113
Hs 578T,676352,1.318744476332936
SNU-1077,3385,5.110303692270896
SF539,5282054,3.5125630378284667
HCC38,doxorubicin-navitoclax (2-1 mol-mol),-1.8734383017754477
BT 231,89183176,6.185556760142526
B-CPAP,11497983,6.291424169078015
NU-DHL-1,9549297,1.597119849266011
RKO,25102847,3.0524897378806033
OAW28,46174525,4.143540766033049
SNU-1077,10385095,2.8092985891088444
HCC38,24797083,1.9458334929114791
BT 245,2733526,2.6638967927808
KHM-1B,71466380,4.706065807266485
EM-2,5280436,3.676532372124792
BT 245,135421197,1.3239460835535384
BT 231,BRD9876-MK-1775 (4-1 mol-mol),1.5153004262805043
SF539,decitabine-carboplatin (1-1 mol-mol),4.471103195582989
NCI-H1184,carboplatin-etoposide (40-17 mol-mol),-0.7371075378638994
SW1783,navitoclax-gemcitabine (1-1 mol-mol),2.361367842252142
PF-382,73707440,6.113676619987129
BT 231,1641662,3.1147772490578367
SW1783,46199207,2.830132612084652
BFTC-909,36462,4.374665451212183
RKO,24901704,3.90150667551114
WM88,10296883,3.749160769987803
HEC-59,71304818,2.649076682305967
KYSE-450,135875424,4.8684130020868235
JHUEM-3,salermide-PLX-4032 (12-1 mol-mol),5.032698879914003
HEC-59,9444,4.503543270225088
M-07e,6914657,-7.740249444268788
SNU-1077,selumetinib-MK-2206 (8-1 mol-mol),3.771389515092964
NU-DHL-1,104842,-6.390742979780276
SF539,decitabine-navitoclax (2-1 mol-mol),2.637439217970881
NCI-H1568,10385095,0.5241849666466598
OCI-AML-3,12001922,1.0955211063319066
Ku812,654092,-1.4885664585268723
NU-DHL-1,136227924,1.2519389073848997
NU-DHL-1,carboplatin-etoposide (40-17 mol-mol),0.2003297158995997
SNU-1077,4917,3.55336300375808
BT 245,3854666,0.2943168101858666
RERF-LC-MS,5351362,3.2669953777859493
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163
NU-DHL-1,54618164,4.2613527063162895
BL-70,54619267,1.964639048540383
SK-MEL-28,piperlongumine-MST-312 (1-1 mol-mol),2.3735820734622006
NCI-H1568,23725625,5.336887169251221
M-07e,9887053,4.2278025595712805
NCI-H1184,3081361,2.5820841923834266
NCI-H2196,49836020,4.894055204627393
NCI-H2141,BRD-A02303741-navitoclax (2-1 mol-mol),0.5729119356073521
PF-382,12001922,1.3621804177433754
KMS-20,1242560,1.3747443997814042
LOU-NH91,9911830,2.650870613913377
Panc 03.27,11238147,1.953870200646336
BT 231,16722836,1.9952000932002232
PF-382,375860,-0.9454794315487792
Hs 578T,5978,-3.069845906500996
Panc 03.27,11656518,1.355433457554943
EM-2,702558,3.075187865867784
PF-382,26596,-2.06856872789975
HCC38,135398516,1.5389390181310032
RERF-LC-MS,123631,2.7610356359897104
Panc 03.27,ISOX-bortezomib (250-1 mol-mol),0.3888312467656759
OAW28,navitoclax-birinapant (1-1 mol-mol),0.270639577142551
B-CPAP,10074640,3.043104069078904
HCC38,11364421,-1.314810752778665
BFTC-909,24748573,2.672786285704278
Kasumi-2,5746,-4.326746041624573
Panc 03.27,10127622,4.369522702570287
NCI-H2196,23725625,5.5749698382050745
TCCSUP,246676,4.500819346374967
OAW28,12001922,1.8847589611064504
KMS-20,71304818,2.1480627398937284
RKO,44507138,3.480554434186059
SF539,72193861,-0.071360284593044
SNU-410,16219061,4.841279874811069
YH-13,49793307,-1.1961754726416267
KMS-20,135440466,0.075801610820689
OCI-AML-5,11955716,-1.8077297420442444
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991
NCI-H1568,44491742,3.692908194165655
PK-59,4788,5.839932555913688
NU-DHL-1,24775005,3.519869888834562
Ku812,72376,-3.225507267019729
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888
JHUEM-3,6438330,2.8220582505283613
Hs 746.T,5287620,1.3564880559321577
SW1783,9936388,2.9056540363277796
BT 245,11257553,1.0028677037168507
OPM-2,selumetinib-JQ-1 (4-1 mol-mol),-1.0917216914210384
Rh30,11396600,3.5985518110360997
SNU-201,23725625,5.827806176814622
WM88,11647372,0.5903039408099033
WM88,53232,3.263292275732624
Kasumi-2,9915743,-0.5759730647314978
PK-59,54649381,3.782815852131327
SNU-1041,2828334,6.858526140794877
NCI-H1184,104842,-8.060817884518736
LOU-NH91,135411,2.1671070624345674
PK-59,168313047,2.046331898255323
M-07e,2729026,2.126841336529776
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732
WM88,16065773,1.9730840443725808
WM88,salermide-PLX-4032 (12-1 mol-mol),0.7047387289249247
NCI-H1568,445091,4.097432324473231
HPAC,6918878,3.2093475857065035
AU565,4378219,1.7809295710052302
OCI-AML-3,selumetinib-MK-2206 (8-1 mol-mol),-2.7372433595359085
OCI-AML-3,11178236,-3.4386515331091396
OCI-AML-3,46224516,0.8617898876930248
BT 428,156414,0.1234393926344954
RKO,104842,-2.5196749638548
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167
BT-474,10074640,2.8837759942336154
SW1783,54618164,3.832878612817737
OPM-2,11455910,0.7503761469114726
BFTC-909,53232,2.9810373365160316
NCI-H2196,969516,2.524235953647809
Ishikawa (Heraklio) 02 ER-,15547703,3.498658285601613
NCI-H1568,5287969,-2.4053225408736405
Kasumi-2,navitoclax-PLX-4032 (1-1 mol-mol),-2.139769926295153
OCI-AML-3,JQ-1-vorinostat (2-1 mol-mol),-4.049816657325239
KHM-1B,176870,4.52912328100578
AU565,12003241,-0.6235660341918571
EM-2,16725315,4.043608466348368
Panc 03.27,24785538,1.7350807985123995
SK-MEL-28,24180125,3.6660135560508142
JHUEM-3,9911830,1.9490536022519651
SF539,3062316,-1.76598803310592
SNU-410,42611257,5.381169628383128
SK-MEL-28,10074640,3.547996724828609
OCI-AML-3,68056272,3.249000448767872
OCI-AML-5,46174525,3.826015964067294
OPM-2,56973724,2.552424788495835
A4/Fukuda,25227462,-5.883792654516593
Panc 03.27,148124,-5.205294633058992
CHP-212,sirolimus-bortezomib (250-1 mol-mol),-0.2954884064996527
SH-10-TC,44589607,4.230548106674036
KHM-1B,doxorubicin-navitoclax (2-1 mol-mol),-2.1386947262651907
OAW28,42642645,0.9360886571737812
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
OAW28,44819697,-1.5562690526140308
YH-13,151289,0.8746416780528874
SK-MEL-28,selumetinib-tretinoin (2-1 mol-mol),2.7944825477960062
OAW28,navitoclax-MST-312 (1-1 mol-mol),0.8340042464828235
JHUEM-3,24771867,1.4074983371644816
MM1.S,44185566,2.164095245238619
RKO,216468,3.08027711257304
BT 231,969516,2.2770309929553245
Panc 03.27,9903786,3.06546007586267
KYSE-70,107985,-3.298359335305578
WM88,46926350,-4.237061889252627
SNU-201,31703,-0.4285465758172568
BT-474,16038120,1.745205754757483
PK-59,6610216,4.292036954059538
BFTC-909,82146,3.493415453952883
YH-13,66577038,3.5409561648626293
OPM-2,6184667,1.6391974127027074
KHM-1B,navitoclax-birinapant (1-1 mol-mol),2.2294776266179057
HCC1395,9927531,6.948950349672662
NCI-H2141,11404337,-1.2716473405568056
SW1783,5738263,4.365489196720114
OCI-AML-3,25195348,1.2661654957401784
SF539,24951314,1.5641800235140235
BFTC-909,25105715,3.3944682152224455
Kasumi-2,4788,5.288898541322949
HCC38,44566777,0.3526573103081515
KMS-20,5311,0.5424141236542899
NCI-H2196,49766530,-0.5620796478121586
PF-382,tretinoin-carboplatin (2-1 mol-mol),4.943732821506593
KHM-1B,446155,3.672634684818232
OPM-2,25154868,3.783948059993976
OAW28,252682,6.460081465786461
BT 245,24772860,-2.1859286876708035
OCI-AML-5,613753,3.327641444193277
Ishikawa (Heraklio) 02 ER-,42642645,4.32459394836607
NU-DHL-1,56646779,5.05824342116676
BT 245,selumetinib-JQ-1 (4-1 mol-mol),1.4299884719020757
SW1783,46843906,3.6277750541017304
RERF-LC-MS,54613361,-1.445874788963763
BT 428,6914657,-5.3524044733018545
CHP-212,5284373,2.484941285000462
YKG-1,71466578,5.303115926973424
M-07e,8515,3.3739706216827368
YH-13,11977753,-2.376684100731715
OCI-AML-3,421610,1.6384155228815007
NU-DHL-1,5328940,1.0877052650240928
BT 245,439501,-4.061461225365729
YH-13,44185566,3.169017423167434
BT-474,navitoclax-pluripotin (1-1 mol-mol),-1.0742415040750295
OCI-AML-5,25062766,-0.1237833348340284
HEC-59,9936388,2.590780507756847
KYSE-450,25195348,3.344057018387479
SNU-1041,135421197,3.0593389422379293
SNU-1077,44607531,1.618519036163535
BFTC-909,56963564,-0.1720168824982637
BT-474,71466578,5.057515667312464
Ku812,6918878,1.294263756548978
BL-70,25227462,-4.5523710064643215
AU565,156422,4.303267692822867
HPAC,252682,6.061218636370354
SF539,1239801,4.247259889123834
BT 248,72199292,1.1105829108074048
KYSE-70,56963564,0.3897414986371327
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082
Ku812,60700,0.4505355107695148
WM88,44491742,3.817934383194013
KYSE-70,9935249,3.427959003246725
Rh30,3634881,2.3382390746847546
YKG-1,6505803,-0.4747915631752394
WM88,219104,3.5936263766668075
Kasumi-2,selumetinib-piperlongumine (8-1 mol-mol),1.718006716449046
KYSE-450,6918837,-1.1193045710295215
Ku812,navitoclax-birinapant (1-1 mol-mol),0.1805704585034357
KMS-20,piperlongumine-MST-312 (1-1 mol-mol),0.9360765316980608
KYSE-450,16065773,3.8243324962121914
NCI-H1184,navitoclax-PLX-4032 (1-1 mol-mol),-1.0656258163328896
BT 245,23725625,4.903326466569384
BT-474,11178236,-2.771887611960671
NU-DHL-1,11717001,3.5993200450588634
EM-2,67291369,0.0780231307731271
Rh30,navitoclax-piperlongumine (1-1 mol-mol),1.5924861251596143
Panc 03.27,6450551,3.0934821428896755
KYSE-70,66577038,3.0162273972396005
SNU-1077,89928392,2.605284731621756
RKO,135875424,3.829354185480349
NCI-H2196,selumetinib-GDC-0941 (4-1 mol-mol),2.5915120385322505
Ishikawa (Heraklio) 02 ER-,15983966,-3.783445074049707
Rh30,24821094,2.7289920286178817
SNU-201,44507138,1.587331228229894
Rh30,71680916,4.451581973417285
NCI-H1568,24180125,3.319632294157453
B-CPAP,124202324,2.5126269670225994
SW1783,4917,3.480222092567203
OPM-2,11977753,-4.6820583055789
Kasumi-2,selumetinib-GDC-0941 (4-1 mol-mol),-0.6309006264211411
BT 248,navitoclax-MST-312 (1-1 mol-mol),0.9766831627739164
PF-382,176870,2.767344828111714
SK-MEL-28,54678924,3.6337720025858
HCC1395,navitoclax-MST-312 (1-1 mol-mol),1.0613123523621433
BL-70,tretinoin-carboplatin (2-1 mol-mol),4.251242777297078
Ku812,9908783,4.70753642591378
A4/Fukuda,16741245,4.963846947143099
KMRC-20,erlotinib-PLX-4032 (2-1 mol-mol),4.001025542089447
KYSE-70,tanespimycin-gemcitabine (1-1 mol-mol),0.2674613674270346
OAW28,11364421,1.0555351676055402
SNU-1077,crizotinib-PLX-4032 (2-1 mol-mol),3.011939718165651
F-36P,71751553,4.682679613514395
RKO,46199207,3.448070090368443
RERF-LC-MS,2874250,4.628157945253743
CHP-212,15983966,-4.35455125052923
A4/Fukuda,navitoclax-gemcitabine (1-1 mol-mol),-5.146642660406073
AU565,navitoclax-piperlongumine (1-1 mol-mol),2.020927074963466
BT 248,9936388,1.117792201973615
JHUEM-3,11507802,1.602059691207095
M-07e,5284329,2.458633341487727
LOU-NH91,44589607,2.878199319266369
TCCSUP,44137675,4.277803621948158
SK-MEL-28,2828334,6.345313377915581
NCI-H2141,16038120,0.0642256659717389
PF-382,5278396,3.0663374884499266
PK-59,25126798,3.821997486892315
LOU-NH91,10385095,0.9698085069900604
NCI-H1568,24785538,0.5698046292147018
RERF-LC-MS,3025944,4.157794890121567
Hs 578T,16736978,0.818401151457852
WM88,446155,2.2227240353677336
SNU-1077,6505803,4.592101417459953
KMRC-20,9936388,1.9781775187030703
OCI-AML-3,10302451,3.3891751896775655
MM1.S,11427553,1.612283358238567
HCC1395,3634881,3.8014769072676664
SW1783,11656518,1.104179519424249
OAW28,crizotinib-PLX-4032 (2-1 mol-mol),2.110933622393645
PK-59,49850262,4.589372067197883
F-36P,11626560,0.1654219236827562
HCC38,selumetinib-piperlongumine (8-1 mol-mol),4.317102798621174
Ku812,46907787,-1.7178287271779615
OCI-AML-3,11657048,5.776677302814366
JHUEM-3,216239,3.5503687215719753
YKG-1,71304818,3.690747374674459
SNU-410,16065773,3.008979038574157
Ku812,25150857,2.8984825229110207
KYSE-450,5282054,4.505957787336516
NCI-H1568,2746,2.7741418395417163
Hs 578T,57519531,3.3392169210995037
NCI-H1184,11612883,2.5347099636264043
A4/Fukuda,4788,3.9402862208503753
BT 231,5746,3.025901776181892
SNU-1041,tanespimycin-bortezomib (250-1 mol-mol),1.783117356671438
TCCSUP,49793307,-2.5102688291438557
NCI-H2141,7326481,2.886619111386419
BT 245,9549297,1.7416110131046505
BT-474,1714884,-1.571527251532903
NU-DHL-1,66577038,2.8657572180523823
YH-13,11507802,0.9123185813590028
AU565,4477,0.8975719043136093
BL-70,11626560,1.7888372729982045
EM-2,navitoclax-pluripotin (1-1 mol-mol),-5.569606835425678
NU-DHL-1,54626689,4.007312828770784
WM88,3136844,5.917870427875155
BT-474,9911463,4.372266907871184
MM1.S,24753719,4.473744821146246
HCC1395,doxorubicin-navitoclax (2-1 mol-mol),-0.4853624938208291
HCC1395,66577038,2.8146176556686737
OPM-2,44607531,0.9426576866563848
JHUEM-3,9911463,3.690046931710037
LOU-NH91,UNC0638-navitoclax (1-1 mol-mol),-2.1290518505040854
BT 231,44197249,1.909514175256433
BT 231,2842253,6.1602070790049686
JHUEM-3,11647372,1.3241580348573647
PF-382,6610355,4.684201543631857
SF539,216345,3.6548053411240495
YH-13,9884685,0.7618617096747208
EM-2,24785538,0.2968622582319973
KMRC-20,selumetinib-navitoclax (8-1 mol-mol),4.19466226338092
Hs 578T,241158,4.135038700144079
SNU-1077,219104,4.067743553544223
NCI-H1568,vorinostat-navitoclax (4-1 mol-mol),0.9474025116898376
LOU-NH91,5281321,-2.3527775967876097
Kasumi-2,9866186,-1.4043484015282397
Hs 578T,375860,-0.1045522991963771
EM-2,19582717,2.5090702070062645
B-CPAP,72193861,0.4999551540918637
JHUEM-3,135440466,2.593247362323112
Hs 746.T,6852167,2.617948339328731
YH-13,46191454,1.7299937465263655
B-CPAP,60750,0.8198284894100664
B-CPAP,6505803,1.185723298587951
KMRC-20,49766530,-1.4976923868030616
SNU-201,11625818,5.953763430672131
NCI-H2141,19582717,2.9510824517887104
BT 245,73707398,1.0043109985849346
SNU-201,252682,6.5224160466691385
OPM-2,3038522,1.4393753112244685
BT 231,44607530,0.7605443532273843
HPAC,4788,5.670873670707526
BFTC-909,5282054,4.21714099973987
BT 231,3676137,5.434962025277539
OCI-AML-3,46215462,1.637959340211835
JHUEM-3,107985,-4.163953976414814
A4/Fukuda,45279963,1.9027034071047564
LC-1F,4917,4.035799676590424
JHUEM-3,5394,4.24440634345612
Hs 578T,11167602,4.417478222776911
BFTC-909,6505803,-2.7076869289136147
F-36P,57519531,2.8558433563561247
NCI-H1568,439501,-2.6831567396736022
HEC-59,6917907,-5.558260286946822
PF-382,135440466,1.8528493259308645
OPM-2,23582824,0.3145394278485406
AU565,637858,2.0174799842455364
BT 231,56946209,-3.0167288688316276
Ku812,60750,-5.176437907735511
BT 248,selumetinib-BRD-A02303741 (4-1 mol-mol),5.279106159978606
BT 231,107970,1.486990449957834
B-CPAP,12001922,1.695452056973735
KMS-20,25161177,3.641930132688034
F-36P,11257553,0.1743733377465893
SH-10-TC,JQ-1-MK-0752 (1-1 mol-mol),1.1643321153960025
OPM-2,15953870,2.653227585048534
KYSE-450,246676,4.496442396396831
SNU-1077,10113978,1.921238205807409
BT 248,tretinoin-navitoclax (4-1 mol-mol),2.6015159736685187
CHP-212,71304818,2.1843672004508794
OCI-AML-5,374536,1.0007173198232775
BT 231,6610216,3.7441566513120863
KYSE-450,24964624,3.228483882418733
HCC1395,25150857,2.1548531691136112
B-CPAP,11364421,-3.632311492746059
YH-13,16065773,2.7841843870151086
Ku812,11485656,2.1573639541519474
YH-13,11626560,1.8964713919919112
NCI-H2141,135421197,1.2037655567537868
Panc 03.27,168313200,2.5506827880834075
M-07e,9927531,3.229988201288456
NU-DHL-1,9911463,3.294428726772871
SNU-1077,10427712,5.108868018236591
WM88,3634881,3.735946485199438
SNU-1041,5278396,4.651233477572841
CHP-212,6184667,3.256853625624448
A4/Fukuda,72193861,-0.8043632874402014
Ku812,selumetinib-MK-2206 (8-1 mol-mol),-1.6716664417855296
EM-2,selumetinib-GDC-0941 (4-1 mol-mol),-2.656123106456353
Kasumi-2,44137675,1.606596454570492
OCI-AML-3,17755052,0.1465655760965259
JHUEM-3,54618771,0.1338872502491787
EM-2,11404337,-1.9269330473502917
RKO,119182,-2.4803685643523
Rh30,60700,-0.304733080200955
F-36P,1714884,4.3216859955761215
F-36P,6918837,-4.502105191229977
F-36P,BRD-A02303741-carboplatin (1-1 mol-mol),6.404979858036225
Rh30,9907093,3.5417435873943557
NCI-H1184,24771867,-3.092988191409792
BT 245,24753719,4.292609421440975
KYSE-70,11485656,2.2230455690794404
Ku812,11178236,-3.734217026428133
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084
A4/Fukuda,3689413,-1.7998697854540155
RERF-LC-MS,104842,-3.024577047260716
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004
SK-MEL-28,53232,4.789899773327052
KMRC-20,6852167,4.09361379982572
Rh30,10127622,3.1734436780546407
SNU-410,serdemetan-SCH-529074 (1-1 mol-mol),2.261970221653438
Hs 746.T,10231331,1.9624435442246329
BFTC-909,11228183,3.298719229946038
SH-10-TC,156414,3.265122378656891
KHM-1B,702558,3.340125476799818
Hs 746.T,2130404,3.675456737459349
AU565,49766530,1.448288738772077
RKO,322968,3.8471310775605216
KHM-1B,11238147,1.9683528585931505
CHP-212,5281321,-3.239776165884136
B-CPAP,439501,-2.790842155958922
BT 231,3038522,1.5792586852803552
YH-13,9903786,3.849279075978848
BT 231,246676,5.655367787950382
Ku812,49850262,3.2075768806895324
Hs 578T,24901704,3.4360262828054795
M-07e,10184653,1.5197773438007427
AU565,16038120,1.417918520815656
BL-70,serdemetan-SCH-529074 (1-1 mol-mol),1.4674836468280683
BT 248,262093,2.0571072545208926
SF539,4378219,1.830086902499326
RERF-LC-MS,11178236,-5.98494163410248
HEC-59,3038522,5.390120521111538
NCI-H2196,53495165,-2.0762198960151688
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316
NCI-H1568,168313200,3.516432771095034
JHUEM-3,10385095,1.0184545903744842
EM-2,3136844,3.483556500959754
EM-2,10127622,-0.9976296227368824
Ku812,10077130,3.943478130533959
BFTC-909,11178236,-2.4757289909406683
Hs 578T,4378219,1.7715862558235798
Ku812,25183872,-1.9764593240115311
SK-MEL-28,6610216,4.386997968475678
OCI-AML-5,2871966,1.0944676917017695
A4/Fukuda,123631,1.573225246333458
NCI-H1568,168312962,2.190321562510239
HCC1395,3815108,2.5394556958425696
BT 245,71751553,4.246004451264995
OCI-AML-3,4261,-0.7002148253599602
BT 428,1714884,3.3561714156544618
SF539,151289,0.9968622519335693
F-36P,selumetinib-JQ-1 (4-1 mol-mol),-1.0872575264771165
NCI-H1184,3025944,3.541007267299365
HCC38,241158,4.477022319117719
NCI-H1568,89183176,4.755399227223714
Panc 03.27,24180719,4.985905389709271
B-CPAP,24856436,0.7730146540222972
TCCSUP,12001922,1.8065976043630063
KMS-20,54618164,3.4319678497850705
WM88,241158,3.766898171789964
Kasumi-2,216239,2.0875832120118605
HEC-59,3825829,4.170328417295255
NU-DHL-1,9884685,-1.1010004281847865
KMS-20,JQ-1-UNC0638 (2-1 mol-mol),-0.883173015839936
BL-70,46907787,0.0819976049687394
WM88,136227924,2.639448330236639
Kasumi-2,16722836,0.3444985018145829
M-07e,100016,5.065678373530031
OAW28,135928012,4.847644989583831
CHP-212,702558,5.3908690995542194
NCI-H1184,54618164,3.853145757284716
HCC38,676352,1.7326781454397098
YH-13,24772860,-1.8932225377928673
BT 428,135398516,2.6845925452826367
KHM-1B,10427712,2.4564060072092486
Panc 03.27,16038120,1.4076540065897587
M-07e,46191454,-0.223370973034729
BT 428,23725625,4.442933224116811
OCI-AML-5,11427553,0.2097304338318313
F-36P,9884685,0.0275163434096536
CHP-212,46926350,-4.472460351842097
Ku812,1750826,-2.479099984818899
BT 248,52947716,0.6891318567706715
AU565,23635314,-4.115690790244737
YKG-1,25161177,5.080655083918658
NU-DHL-1,2729026,2.5099936780211674
EM-2,salermide-PLX-4032 (12-1 mol-mol),4.91632742782472
TCCSUP,5311281,1.9794455257416368
Ku812,57330099,2.587307401238269
AU565,3465537,1.0667310492419344
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409
Kasumi-2,54619267,3.817493003311882
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979
WM88,doxorubicin-navitoclax (2-1 mol-mol),-1.3202013727307549
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422
SF539,11647372,0.1364544950678034
ML-1 [Human thyroid carcinoma],216345,4.790115930225849
Kasumi-2,119182,-4.8733294561059255
BT 428,11222830,0.8286486262937305
Hs 746.T,208908,2.7050398265676443
MM1.S,2746,1.322857724988492
NCI-H2141,5282054,2.67743559079366
BL-70,11228183,2.5330037208173293
A4/Fukuda,10127622,0.8035335483112384
AU565,374536,-0.7311314672583101
PF-382,52912189,-0.6597239458297713
KMS-20,44507138,1.4113768398696636
MM1.S,148198,-3.54523038003387
Kasumi-2,57519531,1.2182883326717542
SNU-201,6450551,2.1280306234882107
OCI-AML-3,54618771,-1.4994430738546511
HCC38,5978,-4.20385103837506
YH-13,5351362,2.4271787200041066
Ku812,3503,1.4349303332326306
HCC1395,71304818,2.5457102052538865
JHUEM-3,71751553,3.8384920336488384
Rh30,71466445,3.123064034579754
KYSE-450,25183872,-0.8618407646936664
NCI-H2196,11719255,3.5704161949085167
HCC38,6914657,-2.7773605068048406
YKG-1,44491742,4.005192115909779
JHUEM-3,24180125,3.5826346710476256
BT 231,navitoclax-pluripotin (1-1 mol-mol),-1.1237359287095805
AU565,3634881,4.304518749556461
OCI-AML-3,327653,2.492530436962648
B-CPAP,navitoclax-birinapant (1-1 mol-mol),0.9967286045428472
MM1.S,9911830,2.728285435741644
M-07e,135398516,0.978179976435953
NU-DHL-1,15953870,2.3700996174311095
BL-70,selumetinib-GDC-0941 (4-1 mol-mol),0.4791238256413206
SK-MEL-28,JQ-1-carboplatin (1-1 mol-mol),4.173721186553183
YH-13,24901704,3.58648266528955
OPM-2,24821094,1.5161257655930716
RKO,54619267,4.028311361432676
SK-MEL-28,219104,4.539871765849737
KMS-20,151289,1.001427412715124
PK-59,36462,2.3986313317590384
PF-382,44202524,1.2151421852046318
M-07e,11609586,2.4171649116596945
Ishikawa (Heraklio) 02 ER-,135999136,1.8759825202501337
OAW28,53232,2.960609854482466
RKO,6505803,-0.9276151073099124
BT 231,JQ-1-vorinostat (2-1 mol-mol),2.270844957283103
BT 428,5287969,-2.0247564794792643
Hs 746.T,6918638,0.8539034237562276
SF539,10074640,2.2789640038336394
EM-2,vorinostat-navitoclax (4-1 mol-mol),-0.9285406159532198
A4/Fukuda,24771867,-3.7385177445932585
Kasumi-2,12001922,1.274437651383908
KMRC-20,400769,-0.3273926657641918
OAW28,252682,6.460081465786461
NCI-H2141,7251185,1.1097437331817688
TCCSUP,11228183,2.2108434625291937
MM1.S,navitoclax-gemcitabine (1-1 mol-mol),-5.407415705446715
SK-MEL-28,452548,3.305743794456603
NCI-H1568,613753,3.056586098825006
SW1783,322968,0.9146856362556636
B-CPAP,135421197,1.178862358485884
BT 245,5287620,-3.6022603888175664
A4/Fukuda,241158,1.407426277414268
Rh30,3854666,3.1387459352284752
KYSE-450,969516,2.907932259173941
SNU-201,selumetinib-MK-2206 (8-1 mol-mol),2.8900157971243723
NCI-H2141,5113032,4.522763627161634
OCI-AML-3,tanespimycin-gemcitabine (1-1 mol-mol),-0.0429165162463884
Hs 746.T,1716436,3.4161576933705833
A4/Fukuda,135398516,0.099848878431286
LOU-NH91,4259181,1.0248896787271708
TCCSUP,11656518,3.701677280495769
PF-382,6438330,0.2212428462176163
NCI-H1568,16741245,4.262204040009308
Hs 746.T,11152667,-0.4528987545325829
BT 428,136227331,3.9646009077151456
NCI-H1184,44607530,1.0166404736044716
OPM-2,148124,-6.3849256320012575
Rh30,JQ-1-carboplatin (1-1 mol-mol),0.2476583684107503
LOU-NH91,11175137,1.9157928307161511
Panc 03.27,2729026,3.0654719444491554
SK-MEL-28,4261,2.2324553955764115
KMS-20,16736978,-0.5263513628668083
BT 248,11494412,3.557230805764516
BT 231,JQ-1-carboplatin (1-1 mol-mol),2.3175217406535156
BT 428,4917,2.014701262119917
BL-70,9444,3.5094293918060546
Panc 03.27,409805,5.782459205310856
SF539,16065773,1.5731134772148812
CHP-212,56963564,-1.553236157303252
SNU-410,2113511,5.407902803226252
SNU-1041,54649381,4.319213604857619
Ishikawa (Heraklio) 02 ER-,5311,1.3231498429720774
YH-13,19582717,5.382815759701368
OCI-AML-3,56649450,2.1652375331336056
OCI-AML-3,10077130,2.374043367196255
PF-382,9884685,-1.5269409733501682
BT 231,10385095,0.727650114829806
SH-10-TC,6610355,3.5879338232464164
BT 428,BRD-K55473186,4.152685201590297
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397
YKG-1,409805,3.8056431996277578
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159
Ku812,9803433,4.326144725372532
SNU-410,2858523,3.324908447024432
OAW28,168312962,3.352489814007426
Ishikawa (Heraklio) 02 ER-,656346,1.2848156729993665
Panc 03.27,135875424,4.313798765654786
NCI-H2196,6918878,4.601623274509383
SF539,11955716,-1.5322335585538187
SNU-1077,24856436,1.1327276677914395
A4/Fukuda,10322450,2.3588003127389277
ML-1 [Human thyroid carcinoma],4261,2.09291450929782
OCI-AML-5,36314,4.118789453330597
SH-10-TC,9933475,2.789809363380352
WM88,5284616,3.0023900575232196
B-CPAP,637858,2.2733284631239044
YH-13,3825829,4.007616735103447
AU565,16736978,1.4090353018278403
CHP-212,65628,3.7734320584498744
HCC1395,637858,2.957827547978506
EM-2,448949,0.7616308638229187
Hs 578T,2746,2.072712678704015
LC-1F,11964036,1.10861444336414
NCI-H1184,107970,2.059526895608455
OAW28,24951314,0.5571772807313425
JHUEM-3,11214940,2.2051675280444742
HCC1395,439501,-2.37120422712219
Panc 03.27,9967941,3.8829933424959617
TCCSUP,11455910,2.681471740921846
Hs 746.T,11964036,3.1044647292786074
YKG-1,9907093,5.058925928948357
SNU-1077,BRD-K58730230,4.372466359234828
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722
MM1.S,11977753,-3.342519732711574
BT 231,5311,3.1751753679830337
NCI-H1568,9935249,0.3822057580098375
BFTC-909,11507802,1.7199271215311116
YKG-1,2126,5.813283713723567
SH-10-TC,44566777,0.114208891223776
Ku812,ISOX-bortezomib (250-1 mol-mol),-0.3300342480244748
AU565,375860,-0.7785666069738753
BT 245,11717001,4.30673965068864
SNU-201,navitoclax-pluripotin (1-1 mol-mol),-1.1391414627045988
SF539,selumetinib-piperlongumine (8-1 mol-mol),3.2935785565458424
CHP-212,46843906,1.366453984485707
OCI-AML-3,31703,-4.495870947678322
RKO,3815108,2.4813915623878264
BFTC-909,448949,2.818327130228084
SNU-201,73707398,1.6082219150055517
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305
KYSE-70,4096211,2.254549645630953
Kasumi-2,72734382,3.1758679904650715
Rh30,15983966,-3.2679119201957474
Kasumi-2,322968,1.3079365029289678
F-36P,24964624,2.456724302627339
Rh30,docetaxel-tanespimycin (2-1 mol-mol),-2.1701978462226483
KYSE-450,9907093,5.309173304412392
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623
KMS-20,9915743,0.2569666585707142
NCI-H2141,54618771,0.6862443380441183
SF539,5278396,3.068667570965669
SW1783,44607531,2.045163268443033
M-07e,10302451,3.6544835870370815
SK-MEL-28,selumetinib-JQ-1 (4-1 mol-mol),-0.6682697886543986
SF539,107985,-2.833720447652478
OCI-AML-5,9884685,0.3245592636969091
F-36P,7326481,4.962276141349654
CHP-212,135875424,3.192345870347938
B-CPAP,decitabine-navitoclax (2-1 mol-mol),0.863745737663407
KHM-1B,637858,1.18497480261582
YKG-1,25102847,1.9293075860384323
RKO,135440466,3.093117295091816
B-CPAP,20959075,-3.002686370695369
M-07e,445643,3.3918576131265525
KMS-20,9926054,1.4765400556600523
RERF-LC-MS,445643,4.345437949323675
OPM-2,46199207,2.048842595102616
JHUEM-3,5281672,4.359631538089034
NCI-H1184,107985,-3.039102604454098
JHUEM-3,36462,1.2759724443128675
OPM-2,5311281,1.024044758253736
OPM-2,3385,3.5898560550490837
A4/Fukuda,984333,-0.4165614363108865
SW1783,11238147,3.3496391304042747
BT 245,6918837,-2.1752341240473463
SNU-1077,568763,0.523765917176441
OCI-AML-5,11222830,1.7251889034485914
A4/Fukuda,selumetinib-MK-2206 (8-1 mol-mol),0.2592073552888009
PF-382,erlotinib-PLX-4032 (2-1 mol-mol),3.234247711308871
OAW28,SNX-2112-bortezomib (250-1 mol-mol),0.074441727324656
SW1783,46191454,4.39093757555096
YKG-1,327653,3.641218936705474
BT 428,5113032,1.9536793565337365
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354
TCCSUP,24856436,0.0318600345010346
BT 248,10410894,2.478264779428893
Rh30,11717001,4.273043339214574
SNU-410,3062316,3.762819620859109
Kasumi-2,3854666,0.5999676074569762
KMS-20,9911463,2.8485967740948284
HPAC,3025986,-1.0467266233399015
SW1783,24797083,1.3978272138606742
YH-13,24821094,3.938816405741356
AU565,57519531,1.889615726213954
SNU-1077,3025944,4.915661762266775
M-07e,11964036,0.1080423228992628
F-36P,11955716,-1.7667530597393375
F-36P,123631,2.4818634169449862
OCI-AML-3,216345,0.9938148587833724
OAW28,15953870,5.078636607909671
OAW28,71466578,4.4029072721322455
JHUEM-3,4788,5.970103009227808
SF539,2842253,5.830632520958069
HCC1395,15983966,-4.366216859230639
HCC1395,9935249,3.722590461759625
LOU-NH91,erlotinib-PLX-4032 (2-1 mol-mol),3.00809922416846
M-07e,3025944,3.985555012312276
HCC1395,46398810,2.1217235606386
RERF-LC-MS,10296883,4.230661493555322
OCI-AML-3,72376,-3.90818695074758
Kasumi-2,2949965,2.010544177145751
BT 248,navitoclax-sorafenib (1-1 mol-mol),1.2094722993885498
SH-10-TC,11175137,3.7106669923678384
BT 248,421610,3.3246840566564484
Kasumi-2,25102847,1.9985292692576584
BT 248,119182,0.6885021238666414
BL-70,25062766,1.33763593621968
OAW28,25102847,1.9718431113444057
Rh30,51039095,1.526707792481728
EM-2,11396600,2.356094145041023
OCI-AML-5,168313016,4.3654687962480345
RKO,11238147,3.3996395604326977
F-36P,10184653,-0.1127126256435277
Panc 03.27,46191454,1.6640561312719555
NCI-H2141,46907787,2.646319689052489
HCC38,9911463,3.9831039186193022
OAW28,168313016,5.164256635335989
JHUEM-3,2729026,3.1174609282377643
NCI-H1184,4261,0.8273199153256079
KMS-20,53393127,3.681479767939244
YKG-1,tretinoin-navitoclax (4-1 mol-mol),5.641897635503529
PK-59,44202524,4.081343809973839
KYSE-70,6610216,4.087252338732691
NCI-H1568,44566777,1.438409258191859
BT 231,4578,4.741281810211192
NCI-H1568,72193861,1.9818580959671683
A4/Fukuda,11178236,-5.149024442366163
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049
OCI-AML-3,448949,1.502389677567667
M-07e,49766530,-2.4452167818324813
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482
ML-1 [Human thyroid carcinoma],4788,6.371899932480547
BT 428,3136844,3.909056651603449
Rh30,5281672,5.790320243774243
B-CPAP,6918837,-2.529046056121727
TCCSUP,1750826,0.4362415979696089
KHM-1B,49793307,-3.3171088772826707
KHM-1B,serdemetan-SCH-529074 (1-1 mol-mol),1.1284922177320384
Ishikawa (Heraklio) 02 ER-,135875424,3.942443711237878
Ishikawa (Heraklio) 02 ER-,124202324,2.794171738884469
SF539,salermide-PLX-4032 (12-1 mol-mol),2.8378152204226836
Kasumi-2,6505803,-2.445084849944434
Kasumi-2,5311037,4.15499666746129
KMS-20,4261,-1.121015461502452
BL-70,11427553,1.533759356522513
WM88,4259181,-0.1240754339586
NCI-H1184,selumetinib-vorinostat (8-1 mol-mol),2.335103631077057
PF-382,439501,-2.5741395884768377
Hs 746.T,3465537,2.483002821893036
SNU-1041,vorinostat-carboplatin (1-1 mol-mol),3.858582043619226
BT 428,25105715,3.661945595355312
BL-70,selumetinib-piperlongumine (8-1 mol-mol),4.5321038967199785
SNU-201,11238147,4.073498501435634
RKO,5328940,1.7974237645790871
KYSE-450,23635314,4.2538404105785
JHUEM-3,erlotinib-PLX-4032 (2-1 mol-mol),2.2984461725658227
OCI-AML-3,135984461,4.624808466912499
PF-382,10113978,2.3756082009494066
A4/Fukuda,23725625,4.971593284778653
SNU-201,452548,5.3855733856312655
JHUEM-3,71466578,5.427578922178693
BFTC-909,24785538,3.0409365635840433
HEC-59,4788,5.848331688118573
EM-2,71304818,1.7794610904559571
M-07e,ISOX-bortezomib (250-1 mol-mol),-1.1977458756793775
NCI-H2196,alisertib-navitoclax (2-1 mol-mol),-0.8975502745226123
OPM-2,navitoclax-gemcitabine (1-1 mol-mol),-1.0437605792762972
NU-DHL-1,10296883,3.6667794076879594
KMS-20,46907787,-1.3444114814530854
M-07e,16065773,1.8270744824842864
Ku812,16725315,3.503963255457298
Kasumi-2,675434,3.537694279705698
PK-59,675434,4.323322110216469
SH-10-TC,262093,3.640204599057082
NCI-H1184,637858,1.2845311841937697
NU-DHL-1,9823820,3.2683941347540704
BT 428,644241,1.7841818020413711
AU565,15547703,3.2970552657128325
NCI-H1184,49850262,2.3725140132862865
SF539,89928392,1.1675794201375844
NCI-H2141,4788,5.1083821816451485
BT 248,24748573,2.3039416185334556
Panc 03.27,9936388,-5.075789023716421
OCI-AML-5,136227924,1.61818972770755
NCI-H1568,navitoclax-sorafenib (1-1 mol-mol),1.4784994486098395
B-CPAP,89183176,5.401425967113139
HEC-59,11404337,-0.8184180849969249
B-CPAP,52912189,3.2590712280352583
LOU-NH91,100016,8.416108067142021
KMS-20,42642645,0.7493716009663114
Hs 746.T,2729026,3.0660188808380613
KYSE-450,9926054,1.8553044985655331
HCC1395,selumetinib-vorinostat (8-1 mol-mol),3.6842342409301305
LC-1F,23635314,-4.318365527396311
RKO,1641662,3.3091455873155367
PK-59,9935249,3.732455742727782
SF539,409805,5.790114720226367
CHP-212,10385095,0.0488360201020664
PK-59,241158,4.280180443060871
SNU-1077,24785538,1.8612325565822845
B-CPAP,67156097,-1.5064504611567109
SH-10-TC,9907093,4.576604089845363
NCI-H1568,5282054,2.3545727551586744
MM1.S,49850262,1.6998908770625267
AU565,navitoclax-gemcitabine (1-1 mol-mol),-2.716980570642507
Ku812,10074640,-0.7535750701578889
BL-70,135875424,1.380668609611053
B-CPAP,11507802,1.067948865191383
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641
B-CPAP,JQ-1-vorinostat (2-1 mol-mol),1.1019909807743078
JHUEM-3,doxorubicin-navitoclax (2-1 mol-mol),-0.4258116964299857
RKO,9823820,5.913042612438718
NCI-H1184,selumetinib-MK-2206 (8-1 mol-mol),0.5990895224261371
SNU-1077,3543504,4.1557787883322606
B-CPAP,4096211,1.3547168629560964
RERF-LC-MS,135875424,2.839581382146162
NCI-H1568,676352,1.7505105304855018
NU-DHL-1,5287620,-2.1832991437877056
OAW28,71466445,4.188405368682896
OAW28,2746,2.637952220594215
BT 248,5328940,2.875094995002875
Kasumi-2,16219061,1.087081093705916
BT 245,25227462,1.3932006167455824
PF-382,selumetinib-piperlongumine (8-1 mol-mol),2.6362885856450724
HPAC,46199207,3.1721891880682884
AU565,53392493,1.7262495119460306
NU-DHL-1,11152667,-2.1433741052472493
Panc 03.27,2113511,5.754686334698323
Hs 746.T,53232,0.7830919167817963
SNU-201,11427553,2.7455653950979975
JHUEM-3,navitoclax-MST-312 (1-1 mol-mol),0.9253762892816542
MM1.S,10127622,5.107569305905412
MM1.S,51039095,1.544841271457304
HEC-59,322968,3.684054916023494
SNU-1041,49793307,-1.5303788359209585
BT 231,36462,1.8404297564151428
SK-MEL-28,tanespimycin-gemcitabine (1-1 mol-mol),3.7506715255055343
F-36P,selumetinib-UNC0638 (4-1 mol-mol),0.7530896389049895
BT 248,156422,4.367304785746438
Ku812,6917907,-6.404390397127188
CHP-212,10410894,1.7703665477949868
SNU-201,9911463,4.2984017961299035
BT 428,selumetinib-GDC-0941 (4-1 mol-mol),0.5287087065167606
NCI-H1568,9915743,-0.8427224057935273
EM-2,selumetinib-vorinostat (8-1 mol-mol),-1.2351306123509636
SNU-410,9887053,4.621800309440906
JHUEM-3,6852167,2.2177056670449105
SNU-201,carboplatin-UNC0638 (2-1 mol-mol),3.5408435507646727
KMS-20,448949,1.7182131870831587
EM-2,44489675,3.67502861339959
OAW28,3025944,4.579278298637093
YKG-1,11485656,3.6397536658143865
Hs 578T,53495165,0.2959365562774053
AU565,568763,-0.2996152351915113
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729
SK-MEL-28,10385095,3.2557901504831306
M-07e,decitabine-navitoclax (2-1 mol-mol),-1.8833791786128584
OAW28,11222830,1.7030270245193828
KYSE-450,753704,5.119991159407921
NCI-H1568,JQ-1-MK-0752 (1-1 mol-mol),3.5105249308751363
BT 231,387447,-4.897581630448022
OAW28,10074640,2.8656652346665545
OPM-2,24964624,1.0133948666397414
AU565,6610216,3.647426232490327
YH-13,6438330,2.6622356468059736
MM1.S,23725625,4.074862026328633
BL-70,285033,-5.743109213261159
NU-DHL-1,24180719,3.951276464233685
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
CHP-212,serdemetan-SCH-529074 (1-1 mol-mol),2.185180197860873
M-07e,selumetinib-UNC0638 (4-1 mol-mol),2.2692249695485702
BT 245,11178236,-5.256571205029804
SF539,9866186,-1.1784053961495549
Hs 746.T,ISOX-bortezomib (250-1 mol-mol),2.484872972398841
BT-474,969516,4.025898131725855
HCC1395,20959075,-3.2154278515372092
Panc 03.27,44632017,0.911998850567064
MM1.S,44493528,4.254687888851587
SW1783,441298,4.0307638761656435
Ishikawa (Heraklio) 02 ER-,439501,-2.4484029207577347
Hs 746.T,9549297,2.130233455969201
OCI-AML-5,72199292,1.4593464514898349
SNU-1077,10231331,3.484337251970082
EM-2,262093,0.7558915053093321
BFTC-909,216239,2.6603594422751136
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657
A4/Fukuda,613753,2.966875582154842
BFTC-909,3465537,1.8561429441463555
OAW28,168313016,5.164256635335989
BL-70,11167602,1.611057170206316
NCI-H2196,23582824,0.0031262133916387
SH-10-TC,selumetinib-vorinostat (8-1 mol-mol),3.8714348747997978
TCCSUP,42642645,1.035198778312657
SNU-410,JQ-1-vorinostat (2-1 mol-mol),2.832976615115517
YKG-1,6184667,4.226622972803886
KYSE-450,676352,2.3888034274358536
HCC38,12003241,1.828137629090711
Panc 03.27,2874250,6.079438103714139
MM1.S,262093,0.96316485237803
BT 428,36462,0.8626568513499365
F-36P,31703,-0.6948335920003059
Hs 578T,6852167,0.7100294177326232
Hs 746.T,24978538,2.1888247017201654
BT 231,9444,4.577261476802596
JHUEM-3,53495165,-0.1231717709866977
LOU-NH91,9866186,2.5706791809917258
YKG-1,5311,2.0355380974233928
NCI-H1184,12003241,-1.9901297280698445
YH-13,piperlongumine-MST-312 (1-1 mol-mol),1.341145556901202
NU-DHL-1,10427712,3.994515346710207
NU-DHL-1,54613361,-0.5915809815117075
Ishikawa (Heraklio) 02 ER-,9911830,3.5571735826815827
BT 248,54678924,1.5069949057557903
KMS-20,135984461,4.215331371407202
KHM-1B,387447,-5.058175638788416
HPAC,24180125,3.1939061719051196
NCI-H2196,11485656,1.855781545293995
MM1.S,9956119,2.8192181838045354
YKG-1,36462,2.1375754999523915
OPM-2,119182,-0.8289962289267476
Ku812,BRD-A02303741-navitoclax (2-1 mol-mol),1.860548372203261
SNU-410,568763,0.5638832743704459
HEC-59,doxorubicin-navitoclax (2-1 mol-mol),-0.4538364914148684
OCI-AML-3,decitabine-carboplatin (1-1 mol-mol),4.775941982064005
JHUEM-3,16741245,6.249739610131302
CHP-212,613000,0.0979012055222068
M-07e,5311,-0.4970241735087603
SF539,25126798,3.558928885650203
JHUEM-3,31703,-0.6822507945895134
Ishikawa (Heraklio) 02 ER-,73707398,1.818794277396009
EM-2,322968,3.3859770558700917
Ku812,135398516,0.808826921913188
PF-382,11612883,1.3339433579277435
OCI-AML-3,5470400,1.41718415612833
OCI-AML-5,3854666,0.9845193843983524
CHP-212,56946209,-4.5854285527003835
NCI-H2141,navitoclax-MST-312 (1-1 mol-mol),0.4872411818328662
OCI-AML-5,135421197,2.371407792163204
A4/Fukuda,doxorubicin-navitoclax (2-1 mol-mol),-2.572338922039687
HPAC,24797083,2.51717137300105
SK-MEL-28,ISOX-bortezomib (250-1 mol-mol),1.2537607855267825
OAW28,216239,4.152270593115834
SH-10-TC,613753,4.68039126903767
JHUEM-3,60700,-1.4869792409383875
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857
KMRC-20,5280436,3.9328974141799615
OAW28,25102847,1.9718431113444057
HEC-59,5460769,4.548370162463851
BT 231,136227924,3.1954768658582378
PF-382,11625818,1.6689494002323595
Panc 03.27,676352,2.377402419982325
Rh30,11977753,-1.7264934581382996
HCC38,1716436,2.920829794336956
NCI-H1184,51037431,4.28853651371731
Hs 578T,9444,4.1039466101812145
KHM-1B,135411,-0.0530336141709349
M-07e,JQ-1-carboplatin (1-1 mol-mol),-0.796008398970337
BT-474,11609586,2.8976331962463484
M-07e,24978538,-1.4632209202157045
Hs 746.T,6438330,2.616267365375142
SNU-1077,53232,1.8565166460541551
KHM-1B,6184667,4.636571439855277
YKG-1,25062766,3.484547068129602
Ishikawa (Heraklio) 02 ER-,carboplatin-etoposide (40-17 mol-mol),3.7008294636817953
Kasumi-2,10427712,4.152130511624211
BT-474,54649381,0.0597394528158466
LOU-NH91,24951314,1.380037957351277
NCI-H1568,10302451,3.040030486332468
KMS-20,168312962,2.0534985084126895
NCI-H2196,73707398,1.0531590450327926
SF539,9907093,3.8198522822567655
B-CPAP,6918878,1.5397343685525162
BT 245,2871966,0.3854225071557604
SNU-1077,3503,2.435554549347499
YKG-1,JQ-1-vorinostat (2-1 mol-mol),1.103772140957631
Hs 746.T,66577038,2.749555163491561
KYSE-70,262093,3.701785722517592
NU-DHL-1,6436223,-6.457204193178952
NCI-H1184,444795,4.437911221112586
NCI-H1568,10113978,1.8126489257310032
Kasumi-2,44507138,0.9761318750595236
B-CPAP,445643,3.9372212515223985
TCCSUP,54626689,3.911629715273472
NU-DHL-1,445455,3.2773220789700397
NU-DHL-1,46943432,0.1764476025909112
B-CPAP,49793307,-2.3843688094258453
Kasumi-2,136227924,1.9658135956042504
WM88,sirolimus-bortezomib (250-1 mol-mol),-0.0026242391338407
Hs 746.T,carboplatin-etoposide (40-17 mol-mol),4.308259100846355
HCC38,36462,1.0526574988311552
BT 245,5328940,1.7328762596340126
PF-382,ISOX-bortezomib (250-1 mol-mol),-0.6876277836304979
TCCSUP,6610216,4.746461050840166
Ku812,71680916,4.360628354999314
RKO,5291,3.391339544898264
YKG-1,10427712,4.433579193557295
TCCSUP,2130404,3.221967733361771
Ku812,11427553,-0.0025143076889682
BL-70,54454,1.588743268461788
OPM-2,2113511,3.5660346238413565
SH-10-TC,11404337,0.4880521649819775
Kasumi-2,JQ-1-carboplatin (1-1 mol-mol),-0.6879782047787374
BT 231,1242560,1.9176620778179092
LOU-NH91,11213558,0.661761515775888
BT 248,54649381,3.7327878949357394
KYSE-450,400769,-0.8881298454848809
Ishikawa (Heraklio) 02 ER-,vorinostat-navitoclax (4-1 mol-mol),1.7219462559221677
SK-MEL-28,11178236,-2.69133483363241
TCCSUP,122327,4.306454567710715
TCCSUP,71304818,2.998111065090722
HCC1395,ISOX-bortezomib (250-1 mol-mol),0.5387626203549701
BT 245,25062766,2.884724273285125
HCC1395,219104,3.8635332094357273
EM-2,9903786,1.526711348749508
OAW28,24951314,0.5571772807313425
Panc 03.27,16725315,4.805103256241736
HCC1395,68056272,4.544979894765759
EM-2,6438330,0.7853695251483882
BT 428,67156097,-0.2408897526562682
A4/Fukuda,969516,2.117405484631732
Ku812,11612883,2.6120187815621128
SNU-1077,JQ-1-carboplatin (1-1 mol-mol),3.099930951012761
OAW28,387447,-4.631995500074297
SNU-1077,17759555,4.679973171236535
YKG-1,5978,-2.4789766194906857
A4/Fukuda,135411,0.1560078623072997
BL-70,49867930,4.256018342065751
KHM-1B,3025986,-1.4274880637865957
M-07e,2871966,-0.6925279394079676
TCCSUP,89183176,6.470181866122735
HEC-59,11178236,-4.304312237876789
BT 248,5460769,4.810999932000391
MM1.S,49836020,3.8296017324588942
RERF-LC-MS,44566777,0.4059341966526995
OAW28,5329102,1.8792475137868745
B-CPAP,54649381,3.6438923395842298
SF539,135984461,4.130188481564332
OCI-AML-3,3543504,4.333171602747592
HEC-59,5280436,4.023552117641809
SK-MEL-28,24951314,3.07054519973718
Rh30,selumetinib-UNC0638 (4-1 mol-mol),3.4063782039201342
Panc 03.27,53392493,3.0152130283878447
OAW28,25150857,2.5691026408672957
HPAC,702558,5.73352550916801
SNU-1041,5291,3.7521103090570658
BT 231,25126798,4.168162999601456
NU-DHL-1,89928392,-0.986320160270056
Hs 746.T,44566777,-0.838167384907767
OAW28,24797083,1.7501511491860735
M-07e,11257553,-0.0574313268314686
PK-59,135984461,4.560793597848683
NCI-H2196,carboplatin-etoposide (40-17 mol-mol),2.735187739238785
A4/Fukuda,322968,1.909418940393303
WM88,44632017,0.8992428386665361
KHM-1B,JQ-1-UNC0638 (2-1 mol-mol),-0.1764853483992549
NCI-H1184,56649450,1.584876744143
HEC-59,4477,0.2825650886335308
TCCSUP,387447,-4.825347113965475
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083
EM-2,445091,4.152274461764609
BL-70,9933475,1.9835060019643609
PF-382,decitabine-carboplatin (1-1 mol-mol),-0.7722926629328009
NU-DHL-1,11404337,-3.826325924415509
NCI-H2196,4477,0.6802059191436985
BT 428,5328940,1.4635647958516325
SNU-410,5738263,4.149808710658432
HEC-59,135398516,1.8027183299723355
BL-70,5311,-0.1034724571388567
KMRC-20,5287620,-2.9460819990219687
Rh30,16038120,-0.357969248496178
KYSE-450,17755052,4.184551596541284
BT 231,445455,4.768132256347899
OCI-AML-3,135440466,1.3759383562820315
Ishikawa (Heraklio) 02 ER-,54454,2.5170293087952924
NCI-H2196,1566236,1.8128230891442871
PF-382,11427553,0.9124764521092824
B-CPAP,6918736,-2.2080588410094215
TCCSUP,135421197,2.510598154952076
LC-1F,5284329,2.7270006829905986
B-CPAP,2113511,4.9053992251679475
BT 248,3503,0.874016545693445
MM1.S,56649450,0.693428636347353
TCCSUP,4261,0.2387476158798516
SW1783,5278396,3.782003108499985
HEC-59,23635314,-1.1783128815176516
HCC1395,135984461,4.308264403922993
BT 231,9803433,3.874869742331583
NU-DHL-1,56946209,-8.095759228151296
SF539,5351362,1.1304414550964104
LOU-NH91,327653,3.620861790086289
F-36P,25102847,2.172104661450956
SK-MEL-28,446155,4.354539024748469
KMS-20,selumetinib-BRD-A02303741 (4-1 mol-mol),1.4575031822908706
KYSE-450,5351362,2.5381052639488715
Panc 03.27,6918878,4.786533174573136
OCI-AML-3,3038522,2.0264363766829554
TCCSUP,72734382,5.972631043229241
M-07e,151289,0.7139069324508128
PF-382,10184653,0.9152232637437828
HCC38,10074640,3.5855995468862365
JHUEM-3,24797083,1.6596290623884384
SF539,11494412,-0.7610024681264586
A4/Fukuda,60700,-1.3381290141173086
A4/Fukuda,serdemetan-SCH-529074 (1-1 mol-mol),0.8122212024039632
OCI-AML-5,285033,-4.654873254266394
LC-1F,4259181,-1.2761645262124546
SH-10-TC,148198,-3.7737897444404993
YH-13,24180719,3.7478543768890136
Kasumi-2,984333,-0.6107639841292208
KMS-20,5278396,2.5832332460860328
BT 248,135659046,3.5168747963796636
Hs 746.T,82146,4.437689667580065
Ku812,168313016,4.091505378923506
OCI-AML-5,3025986,-2.304348483167741
BT 248,10074640,2.9402331094049265
AU565,9868037,3.1053436778875843
KMS-20,16038120,-1.0263302002463832
KHM-1B,23725625,4.172132187038291
OCI-AML-3,11625818,2.8180622144271856
BT 248,71304818,1.6499217451033
MM1.S,selumetinib-MK-2206 (8-1 mol-mol),-0.3870286118827264
OCI-AML-3,3081361,2.7060463384450317
PF-382,107985,-3.9923551873687497
MM1.S,444795,4.170246109552412
RERF-LC-MS,3689413,0.4263782886644774
SNU-1041,11485656,2.4138197522707383
SF539,16725315,3.19850826981026
HEC-59,124202324,2.530609322042915
RERF-LC-MS,46199207,3.61094494328213
KYSE-70,navitoclax-MST-312 (1-1 mol-mol),1.2159582620106
BFTC-909,4096211,2.208598833058293
OCI-AML-5,3081361,3.7965716066151822
RKO,219104,3.7756995047121658
AU565,54678924,2.5293429329053763
NCI-H1184,10074640,3.0751124382273005
OPM-2,tretinoin-carboplatin (2-1 mol-mol),4.37691141446878
RKO,24753719,3.882573791668401
BFTC-909,6610216,4.898578232775107
KMS-20,25154868,4.103093703114607
M-07e,24180125,2.673847094626436
AU565,72193861,-0.1764123403705666
SK-MEL-28,11427553,4.064061219701421
NCI-H1184,67156097,-2.425848282884062
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168
HCC1395,168313047,1.8448369118689896
A4/Fukuda,56649450,0.8497740308893211
BT 428,66577038,3.041559321565452
KMRC-20,15547703,3.8030034015972807
Hs 578T,148124,-8.012392121848073
OCI-AML-3,25102847,2.425849477833333
AU565,613000,0.5241513608694668
TCCSUP,72193861,1.75237754953521
HEC-59,11609586,2.831770613757472
OCI-AML-3,25126798,3.605383850717214
SNU-1077,selumetinib-PLX-4032 (8-1 mol-mol),4.363264972999689
Panc 03.27,445643,3.967678442008976
NU-DHL-1,57519531,1.3873329303321325
KHM-1B,5291,3.0747502676954896
OAW28,selumetinib-MK-2206 (8-1 mol-mol),3.6165441684706736
Kasumi-2,2742550,3.256021563602066
NCI-H1184,135928012,3.766245125513684
M-07e,9826308,-1.0461882668091174
TCCSUP,9825149,2.319100468711196
BT 245,4096211,1.456957883337208
NCI-H1568,216345,3.8344110950672823
EM-2,5351362,1.0011283588399362
M-07e,12001922,1.0816677732760167
TCCSUP,2729026,2.469162640243315
JHUEM-3,2733526,4.298291920613589
RKO,12003241,-0.2410566552434749
Kasumi-2,285033,-4.713748931161676
BT 231,71751553,4.584826391566352
YKG-1,5291,4.1211092927325526
BT 245,148198,-4.884445563516914
HPAC,148198,-2.210118845880014
NU-DHL-1,241158,2.9356865238845313
BT 248,44566777,-0.50911829246694
SF539,8515,4.265018963639613
KYSE-70,5287620,-1.7159794680358271
B-CPAP,135440466,2.00446155370997
F-36P,3384730,1.3914993071875197
JHUEM-3,55508,4.845811825088739
OCI-AML-3,100016,6.665392900980702
Hs 746.T,11317348,4.337828956449315
Ku812,24785538,1.196998208063896
TCCSUP,675434,5.391055260540043
OAW28,5280436,5.165372214799318
F-36P,52947716,-5.789736160824408
OPM-2,JQ-1-UNC0638 (2-1 mol-mol),-3.4645520478530516
TCCSUP,4788,5.506988938595266
BT 248,3465537,1.7130202551321618
EM-2,carboplatin-etoposide (40-17 mol-mol),0.4343055701986091
NCI-H1568,11656518,0.902462789439692
HEC-59,2708,5.041277924172512
KYSE-70,11427553,3.0124804015996185
M-07e,2828334,5.790954406560645
OCI-AML-3,11497983,-4.177614891817384
KYSE-70,navitoclax-pluripotin (1-1 mol-mol),-0.6013562023885967
CHP-212,15953870,3.2458137168318983
BT 248,5311,3.0798190942417363
BT 428,9825149,2.3400066362524297
OCI-AML-3,9887053,0.3982822517551575
Hs 578T,24964624,0.9960070078297976
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647
KHM-1B,119182,-1.6156103715295518
BT 428,25183872,-1.6758373608436137
BT 245,6852167,3.061843713920685
NCI-H1568,selumetinib-decitabine (4-1 mol-mol),4.70224066359239
WM88,107970,2.1698352778486987
SNU-201,selumetinib-piperlongumine (8-1 mol-mol),5.39655793834941
BT 428,serdemetan-SCH-529074 (1-1 mol-mol),1.657658062234635
PK-59,tretinoin-navitoclax (4-1 mol-mol),4.640786679832576
Ishikawa (Heraklio) 02 ER-,400769,-0.1175018825878183
Kasumi-2,11214940,0.2886545067447796
NCI-H2141,60700,-0.9012624508890452
HCC1395,159324,2.879244601573153
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235
NCI-H2141,26596,-3.569863113976208
F-36P,5287969,-1.7559228223470844
RERF-LC-MS,16725315,4.583339442818838
SW1783,selumetinib-decitabine (4-1 mol-mol),5.3087613304483225
MM1.S,9915743,0.5251517896588939
AU565,2871966,0.5985779022023225
HEC-59,409805,5.86459561757921
WM88,54619267,3.804042040446783
SH-10-TC,10385095,3.3084843138225715
HEC-59,11497983,4.170315075743152
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367
SK-MEL-28,4259181,1.166453283270818
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564
AU565,6918736,-3.127988177088939
F-36P,71466445,1.2079369849052677
BT 248,10184653,1.5665149744328004
BT 245,44632017,1.566469903011254
Panc 03.27,25150857,2.8860009079367264
SW1783,sirolimus-bortezomib (250-1 mol-mol),2.8566656968780313
BFTC-909,5566,2.8568699448622263
Hs 746.T,168313200,2.2627857100827216
HCC1395,448949,1.7998067340664885
SF539,UNC0638-navitoclax (1-1 mol-mol),2.2023146643666323
BT 231,11656518,0.8253260548414221
PF-382,11507802,0.1200647165763234
AU565,81146,6.247262332137589
HCC1395,123631,2.5426622552621714
Rh30,6914657,-5.043294062009707
EM-2,52912189,-1.288934793699787
KMS-20,23582824,0.2531987788293798
Panc 03.27,4259181,0.909110974092044
Rh30,219104,3.3403678210936287
KMRC-20,676352,2.4695752697730056
Ishikawa (Heraklio) 02 ER-,25183872,-0.6917709030872379
SNU-201,241158,5.535356896703898
Hs 578T,3384730,3.6580519735071806
MM1.S,1750826,-2.8354438151746972
NU-DHL-1,5280436,2.443749482827121
Hs 578T,10385095,1.132741293219766
Panc 03.27,5281321,-2.323322455506624
BL-70,SNX-2112-bortezomib (250-1 mol-mol),-3.068181248197223
NCI-H1568,67291369,4.628091486396258
AU565,57330099,4.7929461834362606
MM1.S,702558,5.540826177817469
NCI-H1568,1566236,1.6523344134899465
BT-474,676352,2.116262035138264
Ishikawa (Heraklio) 02 ER-,3854666,1.1543280454894709
OAW28,124202324,1.9264961190623875
OPM-2,2949965,2.476405976050771
Panc 03.27,2949965,2.630151083845868
Panc 03.27,46843906,4.116457822893869
NU-DHL-1,135999136,3.842512591140382
M-07e,15953870,2.2360986630595705
BL-70,44137675,1.137889636668751
CHP-212,2828334,5.88072146052828
BT 231,71304818,1.847354010337541
OCI-AML-3,11640390,2.8633333351732024
B-CPAP,16720766,-0.0542134941135855
KYSE-450,12001922,2.3081029542586027
HEC-59,168313047,2.036519127297958
HCC38,5291,3.9369940691114738
OAW28,135875424,4.470041991889524
A4/Fukuda,crizotinib-PLX-4032 (2-1 mol-mol),-0.0418615820710858
RERF-LC-MS,3825829,3.876424055067748
OAW28,46398810,2.3633613380182386
F-36P,11485656,2.0495534401946647
KMRC-20,31703,0.9785031203773554
SF539,5329102,1.5729222878136029
A4/Fukuda,135398738,0.2588260022635366
HPAC,452548,-0.0808083158517497
NCI-H1568,JQ-1-navitoclax (2-1 mol-mol),1.9826778797664537
OPM-2,462382,-0.5185214646773461
NCI-H2196,11404337,1.3261557854884771
EM-2,11626560,-1.0290770254948465
Hs 746.T,68056272,3.712064204587605
BT 231,serdemetan-SCH-529074 (1-1 mol-mol),1.476559552958794
Ishikawa (Heraklio) 02 ER-,49793307,-2.7249248164875945
YKG-1,6450551,3.4208466602547833
HCC1395,selumetinib-tretinoin (2-1 mol-mol),5.579887489783047
BT 245,9826308,1.4872493836837797
SF539,navitoclax-piperlongumine (1-1 mol-mol),1.805753462968184
RKO,452548,0.942587279069954
SF539,446155,1.5612752979886544
LOU-NH91,3854666,2.9087049696787544
HCC38,15547703,3.330732038097093
NCI-H2141,9823820,3.354495977029652
MM1.S,5281672,3.0676410234065745
OAW28,52912189,1.8010258653688298
NCI-H1568,tretinoin-carboplatin (2-1 mol-mol),4.637834792559274
AU565,salermide-PLX-4032 (12-1 mol-mol),3.909685759147712
BT 231,tanespimycin-gemcitabine (1-1 mol-mol),1.670938832130248
WM88,25102847,1.5958660493043813
HCC1395,54618164,3.623383383409561
HEC-59,3384730,3.112117850594504
SF539,2871966,0.3943318332274005
HPAC,71304818,2.810235792588869
SNU-1077,selumetinib-GDC-0941 (4-1 mol-mol),2.4598192677484163
WM88,11427553,2.3620236185690895
OPM-2,24951314,0.2222837933942169
Kasumi-2,208908,2.161160996454662
NCI-H1568,46398810,2.1853633940590966
LC-1F,11507802,0.7557821420923536
EM-2,57519531,1.5127108352469103
TCCSUP,11485656,2.4858219651419966
HCC38,24821094,3.2471602145326086
Hs 578T,107970,1.821405074078983
SNU-201,24772860,-0.9879678739727498
A4/Fukuda,11228183,1.827405863351363
BT 245,9967941,5.489848387677759
Hs 578T,selumetinib-BRD-A02303741 (4-1 mol-mol),4.397028025338394
BT 231,5329102,1.8966299328740657
OPM-2,72193861,0.7906161175639799
WM88,135875424,3.748879677238851
LOU-NH91,3689413,0.742189593443008
Hs 746.T,45279963,3.542347161364756
NCI-H1568,9887053,3.9549233487650666
WM88,16741245,4.843663710325918
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552
KYSE-450,53392493,3.727068470803864
F-36P,selumetinib-piperlongumine (8-1 mol-mol),0.8828234525060702
SNU-1041,1750826,1.3860396057554656
BL-70,135659046,3.3949027184182707
SF539,JQ-1-navitoclax (2-1 mol-mol),0.5515785836007664
JHUEM-3,44607531,1.2858255597158714
AU565,613753,3.214352381260741
MM1.S,23635314,-2.389508847734426
KHM-1B,54619267,2.762925132943408
HEC-59,44259,1.9508961297456733
KYSE-70,ISOX-bortezomib (250-1 mol-mol),1.0092839144289247
A4/Fukuda,135999136,4.178898868342667
PK-59,vorinostat-carboplatin (1-1 mol-mol),3.4183134687002528
F-36P,9803433,6.317271663301622
TCCSUP,53481919,3.87542192202802
Hs 746.T,3384730,3.258566845628988
F-36P,51039095,2.487902780352121
Hs 578T,24856436,-1.776468549174137
Panc 03.27,5460769,1.9093660486325057
SH-10-TC,17755052,3.6574782563444854
HPAC,selumetinib-MK-2206 (8-1 mol-mol),0.5039714346254408
B-CPAP,753704,5.841811531303964
Ishikawa (Heraklio) 02 ER-,24772860,-2.041697460836392
EM-2,159324,-0.2491393012788013
YKG-1,52947716,3.285514356728494
JHUEM-3,5284329,2.110035493064706
TCCSUP,409805,5.441662511172961
SF539,1566236,1.697367188486211
SNU-1077,serdemetan-SCH-529074 (1-1 mol-mol),3.0247217263802493
CHP-212,selumetinib-JQ-1 (4-1 mol-mol),-3.8376268074181312
YH-13,1750826,-2.081763837802431
OCI-AML-3,51037431,1.4405769688235943
OAW28,24856436,0.1607500363529794
OCI-AML-3,2126,3.4496429259403576
Rh30,11612883,1.6627178077704654
CHP-212,11485656,1.772260285582149
YKG-1,637858,1.419948249294149
Ku812,JQ-1-carboplatin (1-1 mol-mol),-1.5108430449944463
M-07e,45279963,2.126522521828783
NU-DHL-1,42611257,3.173167598663498
Kasumi-2,24785538,0.7031648291020229
Ku812,24856436,-0.802197411924791
SF539,44607531,1.4805513890450512
SNU-410,71304818,2.7164754232119592
BT 245,400769,-0.589559634740479
TCCSUP,vorinostat-navitoclax (4-1 mol-mol),0.9791138752454284
OPM-2,60750,-2.943046758118922
Hs 746.T,selumetinib-piperlongumine (8-1 mol-mol),4.227996766958039
AU565,selumetinib-piperlongumine (8-1 mol-mol),3.265854364361565
RERF-LC-MS,3062316,3.070306969339253
Ku812,3634881,2.5120056948653
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081
KMRC-20,46907787,3.5898907650473855
OCI-AML-5,71466445,1.573445404531825
HEC-59,9911463,4.219022102468233
Hs 746.T,71304818,3.5242068801751207
OCI-AML-5,11364421,-5.630057375647543
YH-13,2828334,6.017888903931418
OPM-2,navitoclax-PLX-4032 (1-1 mol-mol),2.9114134564638037
Hs 578T,89928392,0.9824384779268356
BT 428,9903786,3.72207082245763
AU565,selumetinib-MK-2206 (8-1 mol-mol),1.4284909775011103
HEC-59,11364421,-2.831687221885721
PK-59,9915743,1.423625885080464
SNU-410,3634881,2.7982886839663306
M-07e,637858,0.673950959080143
A4/Fukuda,12003241,-4.192136354440014
SF539,3384730,1.03759179550133
MM1.S,53495165,-2.546366748086311
TCCSUP,637858,2.4470905671949996
BT 428,decitabine-navitoclax (2-1 mol-mol),0.1303056330200717
AU565,4578,4.456552707084199
M-07e,11234052,2.396473193279626
A4/Fukuda,71680916,4.641498651595925
KHM-1B,65628,3.60559222842334
JHUEM-3,135999136,3.851371077820259
SNU-410,3081361,3.495134945884435
NU-DHL-1,2742550,3.0949121408680886
SW1783,docetaxel-tanespimycin (2-1 mol-mol),2.8206189802593733
M-07e,10427712,4.007237274698217
RKO,227681,3.9032876810461814
Rh30,3038522,3.617506959636815
CHP-212,tretinoin-navitoclax (4-1 mol-mol),1.1163916388505235
F-36P,7251185,1.8592585927365437
BT 245,UNC0638-navitoclax (1-1 mol-mol),-0.0358626825022054
BT 248,1716436,2.58950342299198
KMRC-20,11964036,1.4818667570891622
NU-DHL-1,24771867,-3.1166811668070844
BFTC-909,2130404,3.366307483642889
BT 248,675434,4.340673839490162
KMS-20,54649381,1.58560475565201
RKO,25195348,3.4491832635970585
OPM-2,6918878,0.2719026340750923
JHUEM-3,10427712,3.927913743220514
BT 428,doxorubicin-navitoclax (2-1 mol-mol),-2.0978990539886597
JHUEM-3,969516,2.813689928123323
OAW28,4788,5.61832216329738
SNU-1077,151289,4.212022708260447
Hs 578T,446155,2.7390561530758712
MM1.S,3081361,2.3105527639319097
CHP-212,44607531,0.2771827950521252
CHP-212,135659046,3.126756855928974
PK-59,54618164,4.180437133735424
PK-59,568763,0.0204915362777041
BL-70,462382,0.3052995837122734
BT 245,53495165,1.770570777726093
NCI-H2196,10296883,4.157958831010532
EM-2,148198,-3.744081167157371
SNU-201,5280436,3.6880139713518902
SNU-201,44185566,3.0758301910867876
OAW28,2749,3.2113189756487683
BT 428,135440466,3.5920664282237937
WM88,72376,-1.8252050716004635
Hs 746.T,24951314,1.3868132087927074
M-07e,3025986,-1.6341857024345028
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057
YH-13,11404337,1.1602704800571209
F-36P,135421197,1.230502256000523
YH-13,123631,3.7042761573264023
JHUEM-3,44632017,0.7509807689525367
BT-474,6918328,-0.5266276697105013
BT 245,10410894,2.9810995953961585
Panc 03.27,637858,2.5511694826514204
Rh30,vorinostat-carboplatin (1-1 mol-mol),2.803874827983833
NCI-H2196,tretinoin-carboplatin (2-1 mol-mol),4.668481210662539
M-07e,11175137,2.066959580295321
Rh30,16725315,3.181229075012051
OAW28,285033,-1.6788024908058845
YH-13,4521392,4.421044887945657
YKG-1,5281321,0.1990106510793085
BT-474,71304818,2.2290172486305835
BFTC-909,5281672,4.401358042981416
SNU-1077,11964036,1.4394318176037413
OAW28,446155,3.9986810531407486
BT 428,4578,5.08813255057657
HEC-59,65064,5.561111725657719
PF-382,5280436,3.3535132704910784
CHP-212,3465537,1.2207374723965898
NCI-H1184,56946209,-4.321983709055122
LOU-NH91,16725315,5.120050781978422
SW1783,9823820,5.69470825765173
NCI-H1568,56946209,-4.312547212322036
WM88,676352,1.6900676240685844
BT 231,216239,1.7435663351679715
F-36P,11640390,2.9241471553218408
OAW28,227681,3.168890693964491
Panc 03.27,5328940,0.8668938964401957
AU565,5978,-4.241011158819041
BL-70,11609586,2.0873748566820187
CHP-212,11175137,1.006232897572794
HCC1395,67156097,-1.9501686636259723
SNU-1077,409805,6.04127283545163
NCI-H2196,11955716,-1.4144609162020292
KHM-1B,11222830,0.8303711779930824
BL-70,2749,0.441585520699734
PF-382,navitoclax-gemcitabine (1-1 mol-mol),-3.611460525938325
BT 248,9911463,2.7908107916357436
OCI-AML-5,6918878,0.1560698403777357
NCI-H2141,navitoclax-piperlongumine (1-1 mol-mol),0.3115210773019538
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045
Ku812,374536,1.5029739319713498
SNU-1077,9868037,3.077547755538649
F-36P,2842253,5.772324984676271
SF539,25062766,1.2381389436565498
LOU-NH91,9926054,3.1176474597994908
BT 231,docetaxel-tanespimycin (2-1 mol-mol),-5.5909552152720865
Rh30,10410894,3.011449058935436
Hs 746.T,3825829,4.406834891425848
AU565,4096211,1.4857810053347718
OCI-AML-5,151289,1.2016464671740443
M-07e,23635314,-3.1503531477842524
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402
OAW28,107970,2.4537130721494105
BT-474,2749,2.8022471756459484
EM-2,24180719,2.561541498353381
F-36P,10410894,2.953395042792216
HCC1395,24180125,2.442140570538284
BT 245,46843906,3.7085671186163847
OPM-2,72199292,0.0645754970830883
Ku812,219104,2.2435781346241743
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922
Hs 746.T,11214940,1.2221539328232642
TCCSUP,11964036,1.9073082077869936
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324
SH-10-TC,3062316,3.650362229668977
Kasumi-2,227681,1.7835466743963533
BL-70,25102847,1.907744289637189
Panc 03.27,151289,0.9445463147016118
OCI-AML-5,60750,1.3221004148568731
SF539,10296883,3.7658288303305976
RKO,3689413,3.093382349703003
OPM-2,44185566,1.967847411757682
HCC1395,5280436,4.568652564418053
BT 428,72376,-2.9842268279103523
KHM-1B,5281672,4.060074282228128
HCC38,6852167,2.687362191349945
HPAC,285033,-2.126426896403282
Rh30,42642645,0.94638035992519
Hs 578T,71466445,2.0883073445743574
TCCSUP,19582717,3.018222004156177
CHP-212,vorinostat-carboplatin (1-1 mol-mol),1.614211753149006
BT 428,10127622,0.916398468380164
SK-MEL-28,568763,0.9297123705024438
Hs 578T,71751553,3.352664213062509
OPM-2,285033,-4.309653599496783
BL-70,24821094,1.608346489648936
NU-DHL-1,44486219,3.982254697079296
SNU-1077,3689413,-1.655364429789056
M-07e,54613361,-1.8003637806145572
KMS-20,24821094,3.078317328475283
SW1783,1750826,3.2712130388919856
KMRC-20,24753719,4.050847735561683
Hs 578T,3503,2.3299292088441805
JHUEM-3,navitoclax-pluripotin (1-1 mol-mol),-0.8037196434989965
HEC-59,126941,-1.4697838612551597
MM1.S,24964624,-1.3172140659784457
SNU-1041,11497983,5.125569180911029
A4/Fukuda,3503,1.0521499831923595
MM1.S,439501,-1.8322200924082088
CHP-212,4259181,-0.6960023833337013
LOU-NH91,2708,7.798658787946165
OPM-2,alisertib-navitoclax (2-1 mol-mol),-2.0231135401510967
RKO,119607,4.75876667689532
YH-13,navitoclax-pluripotin (1-1 mol-mol),0.1454276161313981
TCCSUP,SNX-2112-bortezomib (250-1 mol-mol),-2.4004107919331967
WM88,9903786,2.087799458877892
KHM-1B,selumetinib-piperlongumine (8-1 mol-mol),1.0909589836207738
BL-70,11964036,0.1728364668283487
Kasumi-2,135984461,1.6284116850001094
SH-10-TC,5311,2.0414409062060943
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671
HCC1395,5328940,1.3242892141935398
BL-70,675434,3.4054050026023437
NCI-H1184,168312962,1.982945662004331
A4/Fukuda,57519531,1.5811593813701257
KHM-1B,3081361,2.464663283347417
BFTC-909,104842,-1.584917163766509
SNU-1041,107985,-1.9009359266781765
BT 245,navitoclax-birinapant (1-1 mol-mol),0.4983707655364911
SNU-410,10385095,2.9494153659427145
CHP-212,613753,3.130014153757032
SNU-410,72967,3.703184158128847
NCI-H2141,selumetinib-GDC-0941 (4-1 mol-mol),1.801687772031887
PK-59,10410894,4.837367755211167
Rh30,57519531,1.764713997903996
BFTC-909,5278396,3.473037688340168
NCI-H1568,6918837,-3.937828464321892
OCI-AML-5,52912189,0.105398938487207
HCC38,5281321,0.6657272617476873
OPM-2,4788,3.799883557086963
BT-474,445643,4.151203362993443
BL-70,54626689,2.3891090820704894
WM88,selumetinib-JQ-1 (4-1 mol-mol),-2.6351532870485017
KMS-20,6918638,-0.8366604804869239
NCI-H1184,4096211,1.4666810389770486
NCI-H2141,374536,3.0901566665241003
MM1.S,6852167,1.3787685421812157
PK-59,46191454,2.034431145284872
M-07e,navitoclax-gemcitabine (1-1 mol-mol),-3.733514327182123
EM-2,56973724,1.178632716679734
BL-70,5284616,3.3698796273836193
OPM-2,44819697,-1.6539436611429392
SNU-1077,3634881,3.0237658175436204
BT 231,568763,1.0361089634192413
SF539,11485656,1.8649737443723855
SH-10-TC,54143018,1.203204710211507
YH-13,72376,-1.189178232069283
SNU-410,53481919,3.7558264491034294
OCI-AML-3,selumetinib-PLX-4032 (8-1 mol-mol),-3.0477390973495915
SF539,5951923,5.228397463824485
TCCSUP,15953870,3.2845347165405623
NCI-H1568,5311037,3.1621369524545155
BT-474,selumetinib-vorinostat (8-1 mol-mol),2.752458488334215
BT 428,16038120,1.2716805707784735
M-07e,5281672,3.3686820540173703
YH-13,637858,2.290172126875016
BT-474,12001922,1.0320072484034275
AU565,46398810,1.9802808058059196
NCI-H2141,UNC0638-navitoclax (1-1 mol-mol),0.371334188919835
F-36P,675434,3.58895421560475
A4/Fukuda,11238147,1.0973923844128086
OCI-AML-3,44607530,1.0046379356270865
BT 245,3634881,2.5111674809966917
OCI-AML-5,12003241,0.3941324977706439
JHUEM-3,135411,-0.5185169275916
SNU-201,navitoclax-piperlongumine (1-1 mol-mol),1.6173335965071562
EM-2,JQ-1-vorinostat (2-1 mol-mol),-0.909104012081008
MM1.S,44607531,1.436632189629932
OCI-AML-3,BRD-A02303741-navitoclax (2-1 mol-mol),2.612172363436024
SF539,26596,-2.288089999638428
OCI-AML-5,5738263,3.9467259378852217
HEC-59,15547703,3.5660454336611687
SF539,16038120,0.889897204295874
M-07e,3081361,1.7984071379254782
BT-474,44507138,1.8666732185093835
TCCSUP,3385,5.839871573766512
YKG-1,16722836,2.573532003620113
KYSE-70,9911830,3.1951659700149886
RKO,448949,2.722052887717566
BT 248,11228183,2.0159399448324065
Kasumi-2,decitabine-navitoclax (2-1 mol-mol),-3.2819175731867927
YH-13,25062766,1.542076592026761
HCC38,5280436,3.047612425418446
BT 428,89928392,0.9038531733585348
KMS-20,1716436,2.462007785368903
KMS-20,4477,-0.4884463728422688
SF539,44185566,2.0579628999661117
OAW28,25183872,-1.003855010480259
LC-1F,216239,1.3698899562243778
NCI-H1568,6252,-1.964470857288188
F-36P,5311,0.420593160532594
Panc 03.27,208908,1.752141941262645
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295
CHP-212,16038120,-1.2819103073678393
B-CPAP,24951314,0.9268221935923368
BT 245,navitoclax-piperlongumine (1-1 mol-mol),0.2591253706551492
HEC-59,16038120,1.4465874567414203
NU-DHL-1,374536,0.7676256966435839
OCI-AML-3,46199207,1.8182781191254096
BFTC-909,3676137,5.055523871435828
A4/Fukuda,1750826,-3.1003590099134284
MM1.S,16720766,-1.4015692069091197
F-36P,11717001,3.933635402889622
BT 248,tretinoin-carboplatin (2-1 mol-mol),4.674619984359253
OAW28,51039095,2.7471743585791075
PF-382,1242560,1.4811412739619612
BFTC-909,2841722,4.3094465275997536
KMS-20,4915,4.238712853992716
HCC1395,56963564,0.1535503172434383
HCC1395,25126798,3.8635449343940658
KYSE-450,135411,0.9240917820052414
SNU-410,5470400,3.911537970275405
OCI-AML-3,46926350,-6.18212546634352
Hs 746.T,6917907,-5.479756121736865
OPM-2,327653,2.4944005218311984
HCC1395,3854666,1.6089767843252074
NU-DHL-1,44462760,1.663932260819044
BT 231,24964624,3.107401580540733
OCI-AML-3,9911830,1.5756891476630688
BT-474,252682,6.526561935140207
HCC1395,168312962,2.7175827137673783
BT-474,16065773,3.7600936753389185
CHP-212,462382,-0.0164570327732329
RERF-LC-MS,24964624,3.0594292113466515
WM88,9444,3.9137728066708903
OCI-AML-5,4096211,1.560656938778753
SNU-201,60700,5.499042156322019
SK-MEL-28,JQ-1-MK-0752 (1-1 mol-mol),3.9574265003121942
Ishikawa (Heraklio) 02 ER-,65064,3.244346029256265
Kasumi-2,1641662,2.7685254402742183
TCCSUP,445643,3.731151770896645
BT 245,53393127,4.870864218023685
Rh30,selumetinib-JQ-1 (4-1 mol-mol),0.2603507581444004
NCI-H1184,2729026,2.2031194120356665
BT-474,11234052,-0.4387843312017337
Kasumi-2,UNC0638-navitoclax (1-1 mol-mol),-2.8195604802601197
LC-1F,SNX-2112-bortezomib (250-1 mol-mol),0.5123094899017103
LC-1F,6450551,3.424607175453027
OCI-AML-3,11455910,-0.2153245710553746
OAW28,carboplatin-UNC0638 (2-1 mol-mol),3.4332779723405182
OAW28,6852167,2.294169410796982
SF539,9926054,1.722417855539817
OCI-AML-3,71466445,1.081217761566199
OAW28,16065773,3.4526029247448973
LC-1F,11175137,3.4992365596861013
KHM-1B,9866186,-0.1943937509034402
SNU-1077,54649381,3.672520779647441
BFTC-909,44137675,3.23817368119839
PF-382,168313016,4.6371186800984745
RERF-LC-MS,2858523,3.0171071482923826
BT 428,46191454,1.6030530915907617
TCCSUP,10127622,5.496019179334474
OPM-2,12001922,1.1641343868089369
SH-10-TC,5329102,3.708557914826514
F-36P,10074640,2.646000171966742
SNU-1041,1242560,3.324284399080554
BT 245,168313200,2.0916764208189895
YH-13,46907787,2.497821160225489
RERF-LC-MS,11485656,1.5190166417661397
OAW28,56946209,-4.450705744661636
BT 248,24889392,1.8419989874192408
A4/Fukuda,439501,-3.252400391503616
MM1.S,119182,-3.364464438003169
SH-10-TC,4521392,4.0952597783647855
BT-474,216239,-0.679594966407617
HCC1395,24856436,-0.3338159425949173
OPM-2,9926054,1.8132463747821628
SF539,9549297,3.209839506985017
KMRC-20,3503,3.139785484201302
NCI-H1184,16065773,1.884562998535412
SF539,56973724,2.7207033026610974
OCI-AML-3,vorinostat-navitoclax (4-1 mol-mol),0.6811353759421706
Ishikawa (Heraklio) 02 ER-,446155,2.267956510309626
NU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),1.8134352324623328
KMS-20,57519531,0.5319259109001735
SK-MEL-28,6450551,3.516250339851913
PK-59,9929138,7.561658238332544
NCI-H1184,2858523,3.161860804842481
NU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.810384781380506
HCC1395,374536,3.7621836205411823
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999
RKO,6610216,3.958403220086871
PK-59,5460769,5.2141758944681635
MM1.S,71466578,0.9736156366581122
Hs 746.T,5328940,1.5635792322660471
KYSE-450,56649450,5.522708558477712
SNU-1077,6852167,3.093534637774652
PK-59,66577038,3.1901947150333143
YH-13,23635314,-3.92693267445326
JHUEM-3,119182,-2.573328710047057
A4/Fukuda,23635314,-5.004930640559638
OCI-AML-5,439501,-3.3473386459158583
NCI-H2196,9907093,4.24927144304412
Ku812,6438330,1.0615071756734653
BT 428,tanespimycin-bortezomib (250-1 mol-mol),-1.9102610894463772
OAW28,9825149,1.8591620922463772
OCI-AML-3,107985,-5.918636177044622
PF-382,24901704,1.4040004124632075
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883
Hs 578T,4261,1.1611621044832152
NCI-H1568,568763,0.1547040002068053
Hs 578T,9926054,1.6885826482167057
HCC1395,44607531,1.5083337379281383
HEC-59,11964036,0.9201827797214556
CHP-212,25062766,1.7892203394850372
SNU-201,216468,5.216997496754179
NCI-H1568,3038522,2.281352774411324
PK-59,3062316,-0.1787843302655138
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634
KYSE-70,11404337,0.2060464556058333
Hs 578T,11609586,1.538961604127559
JHUEM-3,11494412,-0.7196564295735808
Hs 578T,6610355,3.495270041903825
YKG-1,3825829,4.427024688096871
OPM-2,11955716,-2.9191891869850015
OCI-AML-3,selumetinib-decitabine (4-1 mol-mol),-3.082948144527254
PF-382,44543605,4.965650989009794
EM-2,17759555,3.526161730665297
YKG-1,3465537,3.622087306802616
F-36P,10385095,0.4233873484016709
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152
Ishikawa (Heraklio) 02 ER-,5746,1.6591878070365718
KHM-1B,104842,-4.441757010359471
YKG-1,44137675,3.325068196687256
M-07e,227681,1.972352831549466
NCI-H1568,9911463,2.564901149372131
AU565,11507802,1.2242731086346843
RKO,2828334,5.934464187728916
SH-10-TC,36314,-5.350937301483837
HEC-59,2729026,3.005812203323877
MM1.S,4521392,4.203260754264018
Ku812,5738263,2.3129138144842236
RERF-LC-MS,24180719,3.6010609924552455
PK-59,65064,4.451099764682022
MM1.S,9866186,0.3210827277460168
KHM-1B,52912189,-0.4693344925919332
BL-70,637858,1.0884199185060726
TCCSUP,5470400,0.0875702939988733
Panc 03.27,25227462,-0.1338254407355364
HEC-59,73707386,3.788415137761945
MM1.S,JQ-1-MK-0752 (1-1 mol-mol),-0.6005566068077197
OCI-AML-5,44185566,1.7232556197356577
RKO,387447,-4.452540898932811
OCI-AML-3,3136844,3.750330367397955
Hs 746.T,7326481,2.6402620178792953
SF539,BRD-K55473186,4.334676081622515
YH-13,168312962,3.022410497071698
M-07e,5494449,-0.1234295552145659
KHM-1B,15983966,1.6900305517060583
Ku812,6918736,-3.1871453727372514
SNU-1041,17755052,3.0585499621282617
EM-2,107985,-4.199278116415869
RKO,11427553,3.456895276763714
Rh30,246676,4.974323438581708
NCI-H1568,3634881,3.2529386900783024
TCCSUP,9911463,4.056352676279941
SK-MEL-28,322968,3.9440584072931375
Kasumi-2,tanespimycin-gemcitabine (1-1 mol-mol),-5.446919177897971
KMRC-20,55283,3.082017581412527
HCC1395,49766530,0.1887726422432668
HCC1395,11609586,2.719311044446534
PK-59,387447,-2.937224287200573
YKG-1,107985,-2.4631339535317993
SK-MEL-28,387447,-4.492461513664045
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933
SNU-1077,262093,2.74279505858148
M-07e,4477,0.5182722057441879
BT 245,54618164,4.011070558028337
BFTC-909,6438330,3.0201113942824436
Ishikawa (Heraklio) 02 ER-,selumetinib-UNC0638 (4-1 mol-mol),5.032208541868087
OPM-2,7251185,0.5721351512480617
BL-70,erlotinib-PLX-4032 (2-1 mol-mol),3.5337828449441155
KMS-20,2858523,2.998494544090686
OAW28,71304818,3.062868675930112
Panc 03.27,4705,3.85101081283364
Rh30,SNX-2112-bortezomib (250-1 mol-mol),-2.554403913168537
NCI-H1568,15953870,3.42403550557497
F-36P,4261,-0.0770989167686455
OCI-AML-3,2746,0.9833779922081392
Hs 746.T,salermide-PLX-4032 (12-1 mol-mol),5.512542069173419
SH-10-TC,123631,3.696400652332888
Hs 746.T,5281321,-2.8012235599519633
Ishikawa (Heraklio) 02 ER-,31703,-0.9306031873157388
BL-70,57519531,1.9168409207708168
SNU-1077,15547703,3.1840803381638114
NCI-H2196,6918638,0.6945006285388182
KYSE-70,89928392,5.113782206339635
KMS-20,11238147,1.9305174496673645
BL-70,25183872,-1.2048653353544163
NU-DHL-1,135398516,0.2609599699484601
OAW28,24797083,1.7501511491860735
AU565,66577038,2.656766135213886
A4/Fukuda,54143018,0.5698360241890451
CHP-212,25195348,2.528431491559579
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102
HCC38,46199207,3.658414499263324
BL-70,613753,3.182597921563727
SK-MEL-28,73707398,1.5724586228934123
BT 428,216345,2.5172942638537172
YKG-1,25154868,5.653220601909001
M-07e,9915743,1.0767758822983564
Kasumi-2,11497983,-3.4342418883602406
NU-DHL-1,24821094,1.4406945146133665
BT 231,25227462,1.0248438263873367
BT 245,753704,4.7847711717833725
Panc 03.27,JQ-1-navitoclax (2-1 mol-mol),3.0660127314551984
OAW28,16065773,3.4526029247448973
OAW28,9840324,5.735695909737487
OCI-AML-3,11317348,2.6233532207072305
YKG-1,3552672,2.1988515508502764
KYSE-70,44185566,2.2395157674699875
BT-474,2729026,-1.442822039182543
PF-382,16736978,2.1192377766227355
MM1.S,5278396,3.253514832421593
LOU-NH91,25150857,3.1116403082593096
WM88,11175137,1.7930307646924912
NU-DHL-1,selumetinib-decitabine (4-1 mol-mol),-0.5267480512116699
OPM-2,56963564,0.1507827744052812
Ishikawa (Heraklio) 02 ER-,6914657,-4.4920284110068005
KYSE-70,SNX-2112-bortezomib (250-1 mol-mol),-1.0131042472486071
HEC-59,452548,0.5283838098576249
RERF-LC-MS,3854666,0.8294073497518095
OAW28,6918878,3.220005605820797
BT 248,24775005,3.1653639365719553
BT 428,44589607,1.8173716428837667
JHUEM-3,71466380,3.72716664389838
NCI-H1184,11404337,-0.3594338062101045
OAW28,ISOX-bortezomib (250-1 mol-mol),-0.0669520264254744
HPAC,5460769,1.6003677750846823
MM1.S,ISOX-bortezomib (250-1 mol-mol),-0.3446289417675626
NCI-H1568,11222830,1.5738139714037271
BT 428,31703,-1.9162450248977527
OCI-AML-3,55283,3.2127908201588866
M-07e,9967941,3.7665488995922023
OAW28,53232,2.960609854482466
OAW28,navitoclax-PLX-4032 (1-1 mol-mol),0.8085168342151391
Hs 578T,1285940,4.344496375315107
BL-70,11178236,-8.806764994464224
Rh30,23582824,0.4178728104014625
SF539,5328940,1.185373887783132
A4/Fukuda,5287620,-3.30087759062066
BT-474,11626560,2.7704511406858816
RERF-LC-MS,36462,1.1230283698314445
WM88,67156097,-1.6539070582735074
PF-382,72193870,1.048942272028045
HPAC,54618771,1.6074763393424083
BT 231,49766530,0.2532028472914431
BT-474,25154868,3.519987079039203
EM-2,9926054,0.5147420382885298
F-36P,44543605,4.123878115098561
YH-13,46926350,-4.088990629945516
SW1783,9911830,2.094357885918856
OCI-AML-3,16722836,0.3536997649930222
Hs 746.T,11427553,2.8949150585842456
NCI-H1568,969516,2.3539842482072353
SNU-1077,216345,4.12510316244265
BL-70,11213558,1.3630964830412176
AU565,73707398,1.1644887368044523
HCC1395,89928392,2.303938038779328
Hs 578T,11625818,4.327142123211574
OCI-AML-3,24964624,2.1586836881810787
Ku812,19582717,3.1020544900029297
YKG-1,49766530,1.555111020821771
BT-474,409805,3.72373361463483
NCI-H1568,1641662,3.419317894706959
KHM-1B,148198,-5.169783546510426
YH-13,5113032,4.871050749600929
SH-10-TC,4578,5.111565538452925
NCI-H1184,24901704,2.5457347882166137
OCI-AML-5,16659841,1.6239699766075435
HEC-59,159324,3.11725748747758
YKG-1,216239,3.3317563893959377
Panc 03.27,135984461,6.251236630594111
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743
LOU-NH91,9956119,4.571782850484356
SNU-201,72376,3.1392231496418344
NCI-H2141,9866186,0.7357629978207985
YH-13,148198,-2.7695139562786526
SK-MEL-28,7326481,2.655717270384107
F-36P,49836020,5.768901368593018
RKO,3503,2.683687073265507
SNU-1077,44819697,-0.6774807829742782
BT-474,11640390,3.7432363625318095
M-07e,carboplatin-UNC0638 (2-1 mol-mol),2.660819212935752
Hs 746.T,123631,2.5050529413121096
RKO,11719255,3.406006587740275
BT 248,53392493,1.7075191079379444
TCCSUP,9935249,4.183000192911627
TCCSUP,16720766,3.8833621535211074
SF539,156414,1.5385171897873895
Hs 746.T,52912189,3.1695345080691224
M-07e,24771867,-2.7746773188378815
RERF-LC-MS,44493528,4.358183394704722
OAW28,17755052,1.3145864766951243
KYSE-70,208908,2.5295165235288004
AU565,11647372,-0.7623159020318493
Kasumi-2,24978538,-3.812533145701136
B-CPAP,6610355,5.531584540000207
SNU-410,5281321,2.485920789712051
KHM-1B,17759555,2.7813398800723914
SNU-1077,322968,3.904848920505325
Kasumi-2,24180719,3.447908092121991
EM-2,11167602,0.236246568519281
AU565,219104,2.449004695507307
Panc 03.27,148198,-3.6739287682620967
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375
NCI-H1184,11228183,-1.667860169950695
KMRC-20,16725315,4.64742637635284
CHP-212,5460769,-1.533156489217473
TCCSUP,1716436,3.07523463483741
Panc 03.27,7326481,2.39262583617847
BT 245,5738263,3.5833049599191904
Panc 03.27,16720766,0.4308158660046845
F-36P,5746,1.7141399363090042
WM88,23635314,-3.874424487871336
OAW28,168313047,2.064989846569142
EM-2,5281321,-5.504931625223739
PK-59,3552672,2.0271262154915006
OAW28,5311,0.8600755425080211
NCI-H1568,44486219,3.435494584556288
WM88,1750826,-3.1070979651336996
SW1783,44197249,1.0547858460239052
SK-MEL-28,16722836,3.336821512402233
KYSE-450,31703,1.0169298465386034
BT 245,11404337,-1.7449999203479594
Ishikawa (Heraklio) 02 ER-,10385095,1.7165210430114106
WM88,2945648,2.558991767991921
NCI-H1568,46199207,1.8853593558521984
HPAC,219104,4.6384599938270945
Kasumi-2,9933475,1.7570111474767809
Panc 03.27,salermide-PLX-4032 (12-1 mol-mol),5.940250996983668
JHUEM-3,vorinostat-navitoclax (4-1 mol-mol),0.4967396803260017
F-36P,1641662,2.007818199487881
B-CPAP,44489367,4.992783705245297
BT 245,11228183,1.197191358466469
ML-1 [Human thyroid carcinoma],421610,2.367130129227347
OAW28,65064,5.229460149894731
SNU-410,vorinostat-carboplatin (1-1 mol-mol),3.785435190126395
OCI-AML-3,9840324,5.580864837086038
AU565,carboplatin-UNC0638 (2-1 mol-mol),2.4152389485219503
MM1.S,71304818,1.9525205980727691
Panc 03.27,25105715,3.554551714720272
MM1.S,11222830,1.7404282204181818
NU-DHL-1,44819697,-0.6868539952356948
SF539,9887053,4.243548054334724
AU565,10184653,-2.737102807310711
RKO,123631,2.6120370559458155
AU565,11228183,3.2105327090314133
NCI-H1184,16725315,3.2435389926048535
KMRC-20,5311281,2.943166998255785
TCCSUP,60700,-0.1040459377874521
OCI-AML-5,1716436,3.7983029660077015
CHP-212,17755052,-0.0616579918779597
OCI-AML-5,4477,1.4678686453696332
M-07e,446155,3.7052591081457495
HCC38,7251185,1.5784374307002922
KYSE-450,56963564,2.961228752582631
BT 231,6438330,0.5385307594180988
OAW28,11455910,2.4986666790908583
TCCSUP,446155,1.4238340154074924
SH-10-TC,navitoclax-pluripotin (1-1 mol-mol),0.3112225174386118
NCI-H2196,9911463,3.768579820818315
OCI-AML-5,9825149,2.325416093402282
KHM-1B,11964036,-0.558883521071404
BT 231,selumetinib-piperlongumine (8-1 mol-mol),3.547649746778795
SF539,4477,-0.2990330117959373
BT-474,11222830,2.404178531972794
AU565,navitoclax-pluripotin (1-1 mol-mol),-0.1402455429535511
KMRC-20,135440466,2.836143933224848
Hs 578T,24821094,1.458604060007181
LOU-NH91,BRD-A02303741-navitoclax (2-1 mol-mol),0.4254312881757893
JHUEM-3,15983966,-2.060822886631061
KMS-20,8515,3.454893590517526
KYSE-70,11625818,4.1356453826336965
PF-382,124202324,0.9608672552424454
OPM-2,11175137,1.4890519960627426
KYSE-70,9936388,-4.915846401119174
MM1.S,107985,-4.097612409872881
EM-2,5311281,-0.3191081114029532
A4/Fukuda,168313200,2.9572494196719723
Kasumi-2,54678924,1.0609274738962189
AU565,3689413,0.8257687517728082
MM1.S,52947716,-4.198321546878978
Kasumi-2,11977753,-3.013388327331023
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112
Ku812,46199207,2.6759001741675372
KHM-1B,107985,-4.92843539421015
OCI-AML-5,5329102,1.5700306786682534
Kasumi-2,5329102,1.6326140590430216
BL-70,44241473,3.571507575113122
M-07e,252682,6.991683535809202
OAW28,3815108,1.950790900509605
NCI-H1568,44202524,1.0522971592210668
BT 428,446155,4.139353973623935
KMRC-20,72376,-0.7899915244048435
LOU-NH91,285033,0.7293222441785373
OCI-AML-5,selumetinib-GDC-0941 (4-1 mol-mol),0.4941119496058851
Kasumi-2,tretinoin-carboplatin (2-1 mol-mol),2.8935059772434792
BT 428,219104,3.143766971234363
OAW28,16722836,1.5279923407751788
Ku812,carboplatin-etoposide (40-17 mol-mol),2.1492601350964606
KYSE-450,11609586,3.5646213291444324
KYSE-450,9911463,4.540289012412596
KYSE-450,5280436,3.3266706371790264
OCI-AML-3,JQ-1-UNC0638 (2-1 mol-mol),-3.448312405561265
SK-MEL-28,tanespimycin-bortezomib (250-1 mol-mol),0.8284351953237586
KYSE-450,25227462,-0.8054559419348748
BL-70,54596558,4.1306313024355115
M-07e,JQ-1-navitoclax (2-1 mol-mol),-1.6433932349943263
Hs 746.T,216345,3.943932639151402
SH-10-TC,702558,5.731426955656403
KMS-20,1750826,-2.803513511799702
BT 245,54678924,1.80603004006958
YH-13,51039095,2.0739005868490983
PK-59,10074640,3.125062946800061
OAW28,135398516,2.0767833136681437
Ishikawa (Heraklio) 02 ER-,1641662,3.5375112855478537
SNU-410,53232,5.169029067220494
NCI-H1568,262093,2.8880881470868585
BT 245,100016,6.42627295768896
TCCSUP,9926054,2.5470676869748763
MM1.S,10385095,0.5772741744912003
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936
OCI-AML-5,15953870,3.896531488259219
KHM-1B,71680916,4.347689376486287
HCC38,72376,-1.557323694649438
NCI-H2141,selumetinib-MK-2206 (8-1 mol-mol),3.731700750364904
SNU-1077,11626560,2.319948092502867
A4/Fukuda,46943432,-0.0927442133672991
HCC38,31703,-1.0899343986139851
SNU-410,11214940,3.0275654815549893
KMS-20,107970,1.4633641977001968
CHP-212,11612883,1.0677800796012251
EM-2,vorinostat-carboplatin (1-1 mol-mol),0.735454843392886
OAW28,637858,2.2776250733597085
KHM-1B,452548,-2.125621480774164
AU565,11317348,4.006750700524709
BT 428,6438330,1.457733766033089
MM1.S,24772860,-3.323759307224156
OCI-AML-5,17755052,1.036074661048784
WM88,135421197,2.6537583925781054
NCI-H2196,136227924,2.7386742576768643
EM-2,16741245,3.905133451750692
KYSE-450,374536,3.719128608597957
TCCSUP,3825829,3.3137008216702686
JHUEM-3,984333,1.0108560453058717
KYSE-450,11612883,5.465517956514392
Kasumi-2,navitoclax-pluripotin (1-1 mol-mol),-2.9755028456871866
B-CPAP,151289,0.3803775246447248
Rh30,decitabine-navitoclax (2-1 mol-mol),1.8014507376543905
B-CPAP,10427712,4.570782311965759
RKO,126941,-5.081226966265268
YKG-1,89928392,2.561295118158604
OCI-AML-3,10184653,0.7581249021168595
CHP-212,24785538,-1.7073854094833394
YKG-1,9927531,5.706988241233545
B-CPAP,JQ-1-UNC0638 (2-1 mol-mol),3.2358489904077974
SH-10-TC,24951314,1.2915924268873922
TCCSUP,107985,-3.010766846655704
JHUEM-3,25150857,3.0323392073827
OAW28,168312962,3.352489814007426
EM-2,10074640,-0.0580664533105797
Panc 03.27,49766530,0.7469851659716551
Rh30,navitoclax-pluripotin (1-1 mol-mol),-1.252881294398406
RERF-LC-MS,54618164,3.9158352593779377
BT 428,11257553,0.3310775523045738
OPM-2,9887053,1.8393709016316329
KMS-20,doxorubicin-navitoclax (2-1 mol-mol),-1.6675584741193203
RKO,25154868,3.654559992823761
Hs 746.T,25062766,1.8604741466695505
KYSE-70,6918878,2.8589087884624673
RKO,54618164,4.0326978900214705
LOU-NH91,676352,2.464978676736505
KMS-20,24753719,3.26753514652521
M-07e,24785538,0.8662477615072814
NCI-H1184,168313047,1.7126991389647774
BT 245,11707110,-1.4423058674160945
HPAC,11964036,1.4486738464840103
MM1.S,11964036,-0.3067716332960522
SNU-1041,11964036,1.9011161734347517
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766
KMS-20,44202524,1.4561593053704711
KYSE-70,675434,4.695192974207532
OCI-AML-3,135423438,2.310750023126374
BT 248,24180125,1.9773901044414168
RERF-LC-MS,11609586,3.546222239883878
WM88,613753,3.1861338999107955
A4/Fukuda,selumetinib-tretinoin (2-1 mol-mol),0.1306282538246569
HPAC,5281672,4.4276266392186985
SK-MEL-28,11609586,3.4405879062717384
Ishikawa (Heraklio) 02 ER-,5978,-1.6873060331336611
WM88,26596,-3.3679469356752465
BT 231,53392493,1.6468096436822095
NCI-H1568,3854666,0.7326561551321923
Kasumi-2,selumetinib-navitoclax (8-1 mol-mol),-1.4155555334459644
HCC38,44489675,3.6543711829464782
OCI-AML-3,644241,1.351301385486736
AU565,9927531,4.912755977802547
Ishikawa (Heraklio) 02 ER-,6917907,-4.484514294841452
BT 231,52947716,-7.785739717906248
SH-10-TC,23635314,-3.3545358928499875
SF539,448949,0.5600320112814784
MM1.S,navitoclax-birinapant (1-1 mol-mol),0.4533704477118982
BT 231,9926054,1.8669465776815437
Panc 03.27,5311,0.408493671622263
SNU-201,24180125,3.798087696111674
HCC1395,JQ-1-vorinostat (2-1 mol-mol),2.0887109457594843
OAW28,4261,1.5275003221448853
TCCSUP,6917907,-5.896507975955653
HEC-59,2828334,6.058776957092327
WM88,327653,3.149247099835907
B-CPAP,3038522,3.5963516655253907
A4/Fukuda,ISOX-bortezomib (250-1 mol-mol),-0.2493422793699864
Rh30,241158,3.625038807076232
OPM-2,serdemetan-SCH-529074 (1-1 mol-mol),1.0013874340560274
SF539,644241,2.736795870753983
SNU-201,JQ-1-vorinostat (2-1 mol-mol),1.4083085546445149
NCI-H2141,5311,1.9712098921962324
SH-10-TC,6914657,-3.13548968585465
BT 428,11955716,-1.491025984916854
BT 248,135999136,1.3787773380664552
RKO,25105715,3.388469834531371
OCI-AML-5,5328940,1.5659230621997835
BL-70,3025944,3.8719561397351794
B-CPAP,selumetinib-MK-2206 (8-1 mol-mol),4.4400365262321175
NCI-H2141,227681,1.754183050977489
NCI-H1568,448949,1.6827994040181535
SNU-1077,24901704,2.743135685281435
MM1.S,54639665,4.38877596087519
SNU-1077,44137675,3.7361071963131858
HPAC,2858523,2.945377282144897
B-CPAP,375860,-0.8507879875115774
Hs 746.T,16013152,3.957984678898451
OPM-2,135421197,1.341685947169011
Hs 578T,53392493,1.9182233526590489
M-07e,4788,3.891350647303211
BT 248,11317348,2.524808263877468
BT 248,11257553,3.3794437157400754
YH-13,10410894,5.153853208310613
Kasumi-2,44491742,3.800345149395397
OPM-2,5281321,-3.721370442971226
SF539,168312962,3.6488542113401614
TCCSUP,6914657,-4.082102009024434
BT-474,568763,0.2186181191806771
KMS-20,5287969,-1.7447232595261333
SF539,6438330,1.6386797479013289
B-CPAP,241158,3.71370211344078
M-07e,JQ-1-UNC0638 (2-1 mol-mol),-1.0196845692665113
HEC-59,52912189,3.154788196636812
KMS-20,9911830,3.122947091608452
WM88,56946209,-3.1912288394703516
SF539,9911463,3.3415175792660854
OAW28,16725315,3.4000122970226196
MM1.S,15547703,2.467235317270649
Hs 746.T,24821094,3.464925750924337
NU-DHL-1,1750826,-5.605759271082352
OCI-AML-5,9823820,3.912331125465742
BT 245,19582717,3.826422257929177
BT 245,71466380,4.447315165962252
YH-13,26596,-1.6020780091570677
KMS-20,3025986,-0.9941815226128248
HEC-59,vorinostat-carboplatin (1-1 mol-mol),3.218166977139841
NCI-H2196,9936388,1.3718542945695429
BL-70,24785538,-0.3698566864943237
NU-DHL-1,262093,0.667372891927881
A4/Fukuda,216468,0.7779788317268376
B-CPAP,10410894,1.808776781971955
F-36P,4378219,5.856796743395766
Rh30,107985,-3.1857089602300563
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117
BT 248,3025986,2.9298231166336297
SNU-1041,3062316,-1.037515182977543
OPM-2,docetaxel-tanespimycin (2-1 mol-mol),-6.145766231617617
HCC1395,54618305,4.96091768508178
OCI-AML-3,11175137,1.2374974913988015
Hs 746.T,serdemetan-SCH-529074 (1-1 mol-mol),2.617353721200671
LOU-NH91,doxorubicin-navitoclax (2-1 mol-mol),-1.426641258307621
JHUEM-3,7251185,2.4520470437863633
RERF-LC-MS,4521392,4.229663793191115
BL-70,387447,-4.876140012040821
SF539,57330099,3.5033572869669327
BT 245,6918638,0.7917501577559235
OCI-AML-3,11507802,1.0323450907767044
OCI-AML-3,5328940,0.942507218076941
KYSE-450,5291,4.139799755765828
KMS-20,1641662,2.6653075673908564
BT 231,11494412,-1.440888792525865
YH-13,11364421,-5.428256768560988
NCI-H1568,3025944,3.938114410703908
HEC-59,44202524,2.968383319657213
NCI-H2196,BRD-A02303741-navitoclax (2-1 mol-mol),1.0936575847090833
NCI-H1568,46174525,4.305444868539079
AU565,5566,3.0303294385930584
NCI-H2196,3136844,4.700396199483259
RERF-LC-MS,10074640,3.277461458690314
LC-1F,6918837,-5.204885591530448
NCI-H1568,54596558,4.146513733670967
KYSE-450,3025986,1.0073883663070609
HCC38,11977753,-1.1122128221006415
TCCSUP,44185566,2.4741695937363506
SNU-1041,piperlongumine-MST-312 (1-1 mol-mol),2.962571602072922
SF539,46174525,5.071115867258652
Ku812,5311,0.5445817614844265
M-07e,24180719,3.310103046671316
NCI-H2141,25102847,3.4439771099678067
BT 245,16065773,1.9991493943013103
SF539,46215462,1.5811922555633615
Kasumi-2,216468,0.9994844042695143
HPAC,119607,5.660830547131289
Ku812,72193861,-0.3622836093760774
HPAC,71466445,3.833476052590533
KYSE-450,219104,4.59986524517568
Hs 746.T,285033,-2.445804633076632
Kasumi-2,54649381,3.5158481033233593
JHUEM-3,46843906,1.571826663819454
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189
YKG-1,54454,1.2493986655314475
NCI-H2141,2945648,2.397519872214969
WM88,vorinostat-carboplatin (1-1 mol-mol),3.1042381009149533
PF-382,17755052,0.5460645234403898
Ku812,10410894,1.977948047331864
NCI-H1184,2749,1.9704280710142503
SNU-410,31703,0.3801043016179601
NU-DHL-1,246676,5.479524719053534
SK-MEL-28,168313047,3.5931899532955147
EM-2,1641662,2.445375440071548
YKG-1,613753,3.3129091754262827
SNU-1041,2874250,6.008229590776241
Rh30,11497983,4.3946260233399395
RERF-LC-MS,119182,-0.645974794966856
KMRC-20,387447,-3.930757262228924
NU-DHL-1,9825149,2.2287917110137445
F-36P,3503,1.0513249627994985
BFTC-909,54618771,2.8225313881877545
HPAC,6852167,3.682014733747655
BT 428,selumetinib-navitoclax (8-1 mol-mol),-0.6596829505842847
Panc 03.27,11455910,0.4781856768651555
BT 231,135440466,2.185903365184472
NCI-H2141,9915743,0.5832119024567368
KMRC-20,25126798,4.0465189677431646
OCI-AML-5,24856436,-0.1341697549723038
BT 245,68056272,3.625560234921114
OCI-AML-5,3503,1.1400404192790063
M-07e,BRD9876-MK-1775 (4-1 mol-mol),0.0486617701005815
SF539,56946209,-5.157192597253952
B-CPAP,navitoclax-pluripotin (1-1 mol-mol),-1.221055695527546
SF539,44566777,1.5412322768682447
BL-70,1750826,-1.802527285487936
NCI-H1184,16038120,0.0457272257069018
RKO,1716436,3.795795915163565
Hs 578T,sirolimus-bortezomib (250-1 mol-mol),0.4812309444002518
Rh30,3062316,0.4459915779163591
HCC1395,135875424,6.03600729555728
Kasumi-2,6914657,-5.1533998646952925
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204
CHP-212,46199207,2.730721736650764
F-36P,119607,4.041722893470021
TCCSUP,2126,3.8917278062770566
Panc 03.27,4261,3.0194838792138765
A4/Fukuda,216239,1.5760740052804734
BL-70,5284373,1.18157742300716
NCI-H1568,2945648,2.136721092573253
OCI-AML-5,241158,3.967364233011896
PK-59,sirolimus-bortezomib (250-1 mol-mol),-0.7779015062858902
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644
SNU-1077,52912189,3.050441247854127
HEC-59,vorinostat-navitoclax (4-1 mol-mol),1.846427143893299
RERF-LC-MS,44632017,0.7768655843829712
PF-382,20959075,-3.2590708818446306
NU-DHL-1,4917,3.040548897529803
LOU-NH91,54619267,4.2625648850210665
HCC38,JQ-1-carboplatin (1-1 mol-mol),1.2340294143226358
Panc 03.27,375860,-0.1725632287380341
NCI-H2196,salermide-PLX-4032 (12-1 mol-mol),4.1865361035845865
SNU-201,51039095,0.6920205790863657
BT-474,5311,1.174442596677797
MM1.S,9825149,-1.0079549399990844
NCI-H1184,452548,-3.5564859014209755
BT 428,107970,1.3396670576098808
JHUEM-3,6610355,5.669271936988945
BT 248,5479543,3.7849708026150406
SNU-201,24951314,1.4181033171785602
EM-2,4261,-0.5172381692194212
MM1.S,52912189,-0.6988954799800143
OPM-2,375860,-0.7230228450862618
F-36P,5566,2.9396690394541247
SNU-410,16725315,5.702499180940271
TCCSUP,984333,0.6886079351975192
Ku812,36462,1.322759060978493
KHM-1B,6918289,1.9648890084430677
A4/Fukuda,675434,3.712142385749843
BL-70,44462760,3.784467360242468
SNU-1041,46191454,2.9035291260622644
OCI-AML-5,8515,3.17727630785645
NCI-H1184,9935249,3.235256645331142
KHM-1B,carboplatin-etoposide (40-17 mol-mol),0.9308702262934592
BT 428,10385095,1.1753953127951546
SH-10-TC,135999136,5.659373349051974
NU-DHL-1,1641662,2.8640618258666626
CHP-212,11609586,3.1422371898929464
HPAC,135875424,4.409126746837932
BFTC-909,6918736,-1.9066217610366931
Hs 746.T,168312962,3.981879251861778
HPAC,11364421,2.133771574146984
BT 231,51039095,2.769148833687662
Hs 746.T,24775005,3.3861498674216772
NU-DHL-1,11364421,-5.372844831594239
LOU-NH91,17755052,2.4120102833965844
BT 245,24748573,2.027135549432793
HCC1395,1716436,5.630836115528551
Kasumi-2,89183176,5.250973362639219
OPM-2,445643,3.4082912819673536
Rh30,selumetinib-tretinoin (2-1 mol-mol),6.6275287916571175
SH-10-TC,1242560,4.52367229107733
NCI-H1568,24951314,0.6613293075425478
RKO,9936388,0.8183869926163714
YH-13,11494412,0.8602319711686647
NCI-H2196,613753,2.5500329829670743
PF-382,JQ-1-MK-0752 (1-1 mol-mol),-3.722439254577736
AU565,selumetinib-PLX-4032 (8-1 mol-mol),5.080870453516365
YH-13,6918638,0.7209706519949683
KYSE-450,23582824,2.052408979108203
Ku812,3038522,2.027577923639431
JHUEM-3,10127622,2.8781923679536483
AU565,6436223,-4.706952881213825
PF-382,65064,3.049277713091966
SH-10-TC,4259181,1.4387365857426029
EM-2,57330099,4.044972147931683
BL-70,24889392,2.7925021187675347
F-36P,2746,1.451851668810028
MM1.S,100016,6.180279624553647
Rh30,2828334,5.686258660175146
JHUEM-3,24951314,0.8857360965099368
SH-10-TC,56946209,-1.8391157272823084
SH-10-TC,9956119,4.166827737062868
NU-DHL-1,439501,-3.591448694271343
Panc 03.27,doxorubicin-navitoclax (2-1 mol-mol),-0.6739439327693196
Ishikawa (Heraklio) 02 ER-,11626560,3.103376247750202
KMRC-20,11152667,-0.0779110822248748
BFTC-909,216345,4.226804426652683
HPAC,9926054,1.8309217170446392
NCI-H1568,16013152,3.794215458313736
M-07e,9868037,1.7477051770285184
Kasumi-2,6610216,3.59110037414398
PF-382,156414,0.6060441396240198
B-CPAP,4261,1.9002738315508088
BL-70,327653,2.5776654277541216
KHM-1B,selumetinib-JQ-1 (4-1 mol-mol),-1.6661106827496956
MM1.S,5978,-3.473474877410116
KHM-1B,5280436,3.274905702190878
A4/Fukuda,5351362,0.320845740356061
HEC-59,31703,-0.9637192021470534
OAW28,2708,5.3328257603707545
EM-2,JQ-1-MK-0752 (1-1 mol-mol),-1.5705915306299
BT 245,25183872,-1.3096475816145912
KHM-1B,54639665,4.391144139421017
BT 231,3634881,1.5000447182815708
JHUEM-3,SNX-2112-bortezomib (250-1 mol-mol),-2.1324896838955865
RERF-LC-MS,65064,5.274588293813746
OCI-AML-5,BRD9876-MK-1775 (4-1 mol-mol),0.5140645091149194
A4/Fukuda,151289,0.1986917338936865
OCI-AML-3,3689413,-2.4390268193517275
KYSE-70,11455910,0.6771697782379181
Ishikawa (Heraklio) 02 ER-,navitoclax-MST-312 (1-1 mol-mol),1.1559299989129663
OPM-2,7326481,2.643641332780412
Ishikawa (Heraklio) 02 ER-,11228183,3.862532073536606
Ku812,selumetinib-UNC0638 (4-1 mol-mol),-0.6885180767604759
MM1.S,navitoclax-piperlongumine (1-1 mol-mol),0.7235910010394726
PK-59,11625818,4.318844179291863
Panc 03.27,5281672,4.430851326305821
Kasumi-2,216345,1.8251746878221435
Panc 03.27,51039095,3.412697774197469
KMS-20,46215462,1.529319856062388
Kasumi-2,56649450,1.224051068091054
Panc 03.27,16722836,2.8262909380318275
BT-474,25126798,4.312317804172833
BL-70,54765302,2.5634021165639775
NCI-H2196,5566,3.038939976931748
HCC1395,24964624,1.2345344139943837
BT 245,25105715,3.758279367316379
EM-2,54649381,2.8073338680672646
NU-DHL-1,7326481,2.7791277258100804
HEC-59,5746,1.4655214918589947
SW1783,7251185,1.718988263559794
NCI-H1568,25126798,3.633705991567496
YH-13,46843906,3.1529849009094604
BT 231,285033,-2.1752872094301923
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356
BFTC-909,3552672,4.498195948808332
OPM-2,5470400,-0.1217933569770787
KYSE-70,387447,-2.8804562370412765
OCI-AML-3,navitoclax-piperlongumine (1-1 mol-mol),0.8888669795507311
Rh30,11625818,3.784809773464016
A4/Fukuda,selumetinib-BRD-A02303741 (4-1 mol-mol),0.8807124285351838
RKO,5566,3.2270609816668308
WM88,25105715,3.537255329201673
KYSE-450,71466380,4.437575150411749
Kasumi-2,168312962,2.3104598884340515
Panc 03.27,11612883,3.317722614689879
Hs 746.T,23582824,-0.2015882106025564
HCC38,73707398,0.9482703589784276
Rh30,9825149,1.4932911507863562
OAW28,3825829,4.635564939734502
RERF-LC-MS,5746,1.1068525081764873
SW1783,45279963,3.6721383023604095
SH-10-TC,66577038,3.3068577194215205
SNU-1077,6610216,4.195845914467317
KYSE-70,124202324,2.186627813347476
F-36P,10302451,3.5545884157395604
KMS-20,54618795,2.973934546624762
SH-10-TC,piperlongumine-MST-312 (1-1 mol-mol),3.2368245494566805
WM88,2708,4.944801067626519
NCI-H1568,31703,-1.6950574450364193
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731
HCC1395,5746,0.904445972818365
M-07e,49793307,-4.534889447024052
MM1.S,135875424,3.0538620465615587
TCCSUP,5335621,5.467256858897498
BT-474,12003241,-0.1629967020972257
NCI-H2196,JQ-1-carboplatin (1-1 mol-mol),4.258041583976656
SF539,208908,1.982441475653256
CHP-212,9927531,5.318398541001747
SNU-1041,11609586,3.5857726278380673
HCC38,6918638,0.6464158254242791
OCI-AML-5,216468,0.3633622510449871
RERF-LC-MS,3025986,-0.71270364092759
Panc 03.27,2871966,-0.6727142352508662
Kasumi-2,4261,-0.415942894249068
RKO,1750826,1.760307875609834
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653
CHP-212,11222830,1.3096535549577006
JHUEM-3,11364421,-3.5393469216245528
NCI-H1568,44819697,-2.651253194329211
SF539,9935249,2.423475425325452
Ku812,4259181,-1.0914400455544095
BL-70,4259181,-0.5589889707355735
F-36P,53393127,4.024744387389786
BFTC-909,3081361,3.110656330811392
TCCSUP,10074640,2.6482462102155737
BT 428,12001922,1.1406957911423092
WM88,49766530,-2.7931642846980336
BT 245,107970,1.8345714144721337
OCI-AML-3,374536,-2.867379826725216
SH-10-TC,crizotinib-PLX-4032 (2-1 mol-mol),2.5753888584502977
YKG-1,72734382,5.141211314394623
NCI-H2196,9840324,7.0432033294133
F-36P,erlotinib-PLX-4032 (2-1 mol-mol),3.074743235382559
OCI-AML-5,docetaxel-tanespimycin (2-1 mol-mol),-3.7763789418846234
Rh30,9915743,1.5349254277578692
BL-70,11364421,-5.8837177307057384
F-36P,375860,-1.097600146187803
KMRC-20,5746,0.6434885523366748
PK-59,tanespimycin-bortezomib (250-1 mol-mol),-0.1370541411444133
M-07e,25102847,2.5807812337891973
PF-382,56963564,-0.2593011060525333
SF539,44202524,1.2344769857738371
MM1.S,JQ-1-UNC0638 (2-1 mol-mol),0.1865642255881416
PF-382,53232,2.4647050421770005
EM-2,25262965,-3.0481622823448062
YKG-1,24753719,4.608335607306647
BL-70,36462,0.1930899985409087
SK-MEL-28,9936388,2.4934378473061902
M-07e,3825829,3.009769948939105
OCI-AML-3,44819697,-1.811373018004116
Panc 03.27,9866186,0.6134538555079257
Ku812,44632017,0.624416259441737
EM-2,136227924,2.1746228564853864
KMRC-20,15983966,1.928995908058428
BT 231,selumetinib-JQ-1 (4-1 mol-mol),1.4143353306589224
NU-DHL-1,3384730,0.9179743420778778
KHM-1B,2742550,3.1994406451662045
JHUEM-3,216468,3.6909323550175306
M-07e,doxorubicin-navitoclax (2-1 mol-mol),-1.7756974437717608
SNU-410,9911463,3.9048002645235536
HEC-59,54618305,4.716446309240821
PK-59,216468,4.7266352471722
RERF-LC-MS,216468,3.2358353560937267
EM-2,9549297,0.993917303802332
Hs 746.T,2113511,5.938659643506246
KYSE-450,9911830,2.46681001783931
JHUEM-3,72734382,4.371348191869517
SW1783,24821094,3.387006787045153
OAW28,12003241,-0.542287488877267
HEC-59,374536,0.818288588895378
HCC1395,6918736,-2.5294366914443636
HPAC,6184667,6.35533276039357
SNU-201,135411,5.421260593446126
BT 428,tanespimycin-gemcitabine (1-1 mol-mol),-4.211638249912254
YKG-1,navitoclax-PLX-4032 (1-1 mol-mol),5.471845288851878
OCI-AML-5,65064,5.734375001374169
KMS-20,9887053,4.355785993783173
Hs 578T,11178236,-0.9234802637355484
OCI-AML-3,9933475,1.811626509215977
AU565,5284616,2.6982931675931914
TCCSUP,2945648,3.149020866253819
A4/Fukuda,387447,-5.631039688913266
B-CPAP,613753,3.3144945395536003
M-07e,11228183,0.6654372819046053
CHP-212,24772860,-3.0897154891470455
BT 231,36314,3.0965255782115975
KYSE-450,10296883,4.225795837642371
KHM-1B,2729026,0.9110795955585352
BT-474,24951314,1.21944439748011
F-36P,vorinostat-navitoclax (4-1 mol-mol),0.0936538678270467
Rh30,67291369,1.3011912028926262
YKG-1,439501,-3.197548465236136
SH-10-TC,2746,4.061240756381498
SNU-201,3689413,-1.5340531054377644
NCI-H2141,2113511,5.226588318143507
SNU-1041,24772860,-0.8525392758250607
TCCSUP,5287620,-1.0602115166818715
HCC38,2828334,6.884174418810532
Rh30,4521392,4.539496114546622
B-CPAP,BRD-K27188169,4.5022536360254986
M-07e,16038120,0.8122159888936795
WM88,9956119,3.916347800394832
OCI-AML-5,969516,2.8770171009328473
CHP-212,9884685,-1.3335734130600392
OAW28,9884685,1.3567472374362477
NU-DHL-1,375860,-1.1724229979544771
RKO,9956119,3.3077949428120195
LC-1F,11485656,1.8871769166571817
SF539,49867930,4.3730716554773235
WM88,285033,-2.026580483841063
Ishikawa (Heraklio) 02 ER-,4096211,1.7596203562054105
A4/Fukuda,46215462,1.453707580765341
Hs 746.T,46843906,3.169241605789521
WM88,400769,-0.2938647004336271
BT 428,52947716,0.8492719052726573
SNU-201,docetaxel-tanespimycin (2-1 mol-mol),0.8341314829164951
RKO,56649450,4.8662264096692684
OAW28,123631,1.649178742735097
YH-13,16720766,0.962389750080769
RERF-LC-MS,46174525,5.020740506928848
BL-70,23635314,-4.20617770509949
NCI-H1184,4705,5.16871662983158
OAW28,23582824,0.6142488529896691
KMRC-20,alisertib-navitoclax (2-1 mol-mol),1.9342461303816385
BT 428,71304818,2.642150513795867
CHP-212,67156097,-3.340460010095774
EM-2,alisertib-navitoclax (2-1 mol-mol),-5.257896390644833
Kasumi-2,23582824,0.0696466908969853
BT 428,60700,-3.595237401616721
OAW28,984333,0.3792215902143511
Rh30,10385095,1.4974792753109163
PF-382,23635314,-2.865470025294806
BT 248,148198,-3.920391313180545
Ku812,6450551,-2.2531779420040694
KYSE-450,25102847,3.9805771767576057
SH-10-TC,11364421,-5.440791172650507
KMS-20,6252,-0.1616795629584481
KYSE-450,23725625,7.184930321255073
BT-474,9915743,-4.144721850714229
OCI-AML-3,10427712,3.624269318979139
KMS-20,4788,3.707173211304455
SF539,6918328,-0.3520383633660662
OCI-AML-3,5281321,-2.074328340130251
SH-10-TC,446155,1.1040696286796237
NU-DHL-1,216239,2.6087015234421056
PF-382,9907093,3.754844367394135
HPAC,15983966,1.8843331853863956
F-36P,navitoclax-piperlongumine (1-1 mol-mol),0.6141351089742836
NCI-H2196,400769,-0.7636011739353321
CHP-212,11178236,-2.7637496562619703
Ku812,25195348,0.9000183512628003
F-36P,54678924,1.179428459556987
OAW28,44493528,4.631141764792384
RERF-LC-MS,24785538,0.8057743011820994
EM-2,216239,1.5333286082024875
CHP-212,5335621,4.2880495026105265
WM88,135440466,1.5669770869641448
BFTC-909,644241,3.062866082016443
MM1.S,navitoclax-MST-312 (1-1 mol-mol),0.8830386124411814
HCC38,10127622,5.752697635136126
OCI-AML-5,46398810,0.4221902195684626
A4/Fukuda,9887053,3.945623871756388
F-36P,984333,-0.2854829807548078
Ku812,24180719,2.5562197151601413
BT 231,24856436,0.2940047595538051
SF539,11396600,2.4945499602014487
AU565,4259181,-0.781957409712965
RKO,4477,1.7070595719756474
KMS-20,1714884,3.609076510233281
SNU-1077,selumetinib-tretinoin (2-1 mol-mol),4.583316472072012
SK-MEL-28,148198,-1.1695105826491254
OCI-AML-3,5311037,3.701436674084322
KMRC-20,9911463,4.198821616328526
OCI-AML-5,53392493,1.7213308352245025
HPAC,100016,6.325474069382135
HCC1395,5978,-1.6178469829714162
BT 231,72734382,4.2322845309109525
KYSE-450,44819697,-0.2732564479087796
B-CPAP,sirolimus-bortezomib (250-1 mol-mol),1.6590312282318416
MM1.S,6918837,-5.0481223249904525
BT-474,17755052,0.9203330645401162
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103
BT 231,doxorubicin-navitoclax (2-1 mol-mol),-0.8698078592776621
F-36P,568763,0.0975794581096625
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
AU565,3503,2.743681155949089
SH-10-TC,44137675,4.3516313621704
SH-10-TC,5738263,4.359134068688322
KYSE-70,46907787,2.9670215892594793
WM88,5978,-3.8492586507879247
YH-13,426756,4.439847465268924
BT-474,1716436,2.941904750150848
NCI-H1184,23635314,-2.3197549843850647
KHM-1B,11178236,-5.183518181224002
B-CPAP,15547703,2.731541485710416
HCC1395,322968,4.15640717781431
WM88,12001922,1.5033741634608095
OCI-AML-3,11152667,-2.175996552901593
WM88,4261,0.9563265737345212
SF539,568763,-0.1587178935899355
Kasumi-2,702558,4.897760229735286
NCI-H2196,46191454,2.1547084719943825
Hs 746.T,4477,0.4767615913093777
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731
NCI-H1184,26596,-3.790175824084468
CHP-212,salermide-PLX-4032 (12-1 mol-mol),4.962026622582135
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557
OCI-AML-5,5978,-3.7659958201675954
TCCSUP,52947716,2.97003679265922
LOU-NH91,5311,1.697115177859265
WM88,57519531,2.101819221796682
KYSE-450,vorinostat-carboplatin (1-1 mol-mol),4.263576896954741
BT 245,24964624,2.33257975283963
Kasumi-2,4477,0.978376283081578
OAW28,3634881,3.2370607224140473
OPM-2,15547703,2.634316496996711
JHUEM-3,serdemetan-SCH-529074 (1-1 mol-mol),2.060029544610104
HPAC,11238147,3.0445651465820007
Hs 746.T,56649450,2.8967388840588195
A4/Fukuda,4477,0.5783674149898913
Ku812,55283,1.038914433795577
BT 231,3062316,2.541779191079674
BT 245,57330099,3.6959757169322094
YKG-1,53232,1.050815302448319
SF539,11404337,-0.0923032150573938
BT 231,15953870,3.368838744296408
Ku812,126941,-4.2292627127122575
F-36P,15953870,2.011519160758859
RERF-LC-MS,10113978,3.210216765519601
B-CPAP,3025944,4.582050785449419
NCI-H1568,44137675,2.485428235347338
OAW28,135875424,4.470041991889524
B-CPAP,11214940,0.8407381176330342
TCCSUP,25150857,2.738156002354857
YKG-1,25126798,4.0055488213659185
YH-13,2708,5.143963890139275
M-07e,49836020,-3.7990494796960337
Hs 578T,54613361,0.5247907724986515
SF539,72734382,5.710474447466601
BL-70,2828334,4.595844476293796
BT 248,4917,1.8494335305709009
Ku812,9929138,4.0796690015060095
AU565,JQ-1-carboplatin (1-1 mol-mol),2.695919157809604
TCCSUP,6852167,2.775293027732918
SNU-1077,6918837,-2.0302065892211916
SF539,216468,4.034624291224008
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553
KYSE-70,2858523,3.054228167220651
SNU-1041,5746,2.3679334181918925
SF539,135875424,2.4028504168317473
BT-474,54619267,4.173724245021032
OCI-AML-5,2949965,2.596272508010776
YKG-1,31703,-1.4076263674107627
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902
F-36P,46926350,-4.248535974571272
WM88,45279963,3.79784340528105
YKG-1,9933475,2.2328524578213007
SNU-1041,11404337,0.704382749568953
SH-10-TC,2874250,4.694104787948738
B-CPAP,alisertib-navitoclax (2-1 mol-mol),-0.5748876741449156
SNU-1041,11152667,-0.085013189644464
Hs 578T,136227924,2.600789152961688
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643
PK-59,12001922,1.7937436025082794
OCI-AML-3,49766530,-3.0415372602627375
KHM-1B,ISOX-bortezomib (250-1 mol-mol),-0.0879001565107233
OCI-AML-5,9866186,-0.3004148672929633
SNU-410,409805,5.168065352202116
KMS-20,navitoclax-birinapant (1-1 mol-mol),1.2609328237028008
OAW28,24785538,1.1869022382798196
PF-382,24753719,2.156979591404902
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971
CHP-212,11238147,1.8609254346553183
KHM-1B,409805,3.6418621708763945
Ishikawa (Heraklio) 02 ER-,5328940,2.177666679733807
BT 231,31703,-0.5942880064496666
AU565,54596558,3.073830584555768
HCC1395,44589607,3.6871835828791935
PF-382,selumetinib-BRD-A02303741 (4-1 mol-mol),5.510058878321319
BT 248,444795,4.817055384579841
Ishikawa (Heraklio) 02 ER-,9926054,2.558951101727927
OPM-2,10296883,2.7550650350156474
KYSE-70,44202524,1.884457998669868
Kasumi-2,46907787,-1.0712711351942366
CHP-212,119182,-3.389585583366707
WM88,44607531,1.7801621195644357
YH-13,10127622,5.098767589051213
HCC38,11507802,1.0105969728694564
KMRC-20,135398516,5.837743145524966
SNU-1077,136227924,3.612132735883527
SNU-201,4788,5.888606067051913
PF-382,54649381,2.3884242532831768
Ishikawa (Heraklio) 02 ER-,5566,3.698429042799287
BT 248,216345,4.501699374414374
RERF-LC-MS,16741245,3.282184197465347
EM-2,6184667,1.814788941735608
YH-13,3689413,-1.970237829798131
SH-10-TC,11455910,0.8075465879192946
SW1783,252682,7.233019917696589
SF539,navitoclax-sorafenib (1-1 mol-mol),1.515354296874044
NU-DHL-1,426756,2.782423692029965
OCI-AML-5,23635314,-2.631146766638807
LOU-NH91,9903786,3.184012464559237
HCC38,5328940,1.6801956388879478
HEC-59,3503,1.2665463399058563
LOU-NH91,57519531,4.764819520424852
OAW28,51037431,5.214608262969992
SH-10-TC,4788,5.909210265229812
B-CPAP,446155,2.447419494553645
SF539,3854666,0.2673517991428248
A4/Fukuda,5281321,-4.090150251628595
Hs 578T,6438330,2.4499293132214586
RERF-LC-MS,2746,3.2731211053052647
CHP-212,5291,4.065558151922889
KMS-20,11719255,0.9257373719636144
BL-70,JQ-1-vorinostat (2-1 mol-mol),-0.2738410859246512
KYSE-450,168313200,3.958386537902572
NCI-H1184,71466578,2.198318187513619
ML-1 [Human thyroid carcinoma],441298,2.939924630100921
RKO,46843906,3.289277038806309
OCI-AML-3,25150857,1.0236087303055508
BL-70,969516,2.232240050236675
B-CPAP,9826308,0.1917945613788681
EM-2,24901704,0.1328091631221168
SK-MEL-28,vorinostat-navitoclax (4-1 mol-mol),4.020713865160522
NU-DHL-1,JQ-1-navitoclax (2-1 mol-mol),-1.983484883677281
BT 231,BRD-K55473186,1.86151309583958
SK-MEL-28,71304818,2.250424055187842
HCC38,44202524,1.5119982263514986
JHUEM-3,2746,2.584117066729092
Kasumi-2,46926350,-4.426429724391801
WM88,55283,3.954158610092566
KMRC-20,46224516,2.3490422835427944
NCI-H2196,65064,5.281095711365324
OAW28,54649381,3.786658613217657
BT 231,11238147,3.25397322060028
MM1.S,241158,2.058054746242757
Ku812,387447,-5.271865105209625
JHUEM-3,5311,1.4380933979235233
BT 428,421610,3.0025644151069595
KYSE-70,46398810,2.5990171625416916
Rh30,15953870,3.023446559735349
BL-70,54618305,3.7838693082643977
SK-MEL-28,9911463,4.538912500786334
RKO,4096211,2.0568907070726397
NCI-H1568,57330099,4.373464200171548
BT 248,selumetinib-piperlongumine (8-1 mol-mol),3.781064018131383
A4/Fukuda,400769,-1.555916482707746
SNU-201,9935249,4.988925782011606
F-36P,23725625,5.61536820400509
BT-474,UNC0638-navitoclax (1-1 mol-mol),3.2058314272138477
Rh30,11364421,-7.294250217601554
WM88,3025986,-1.4466610189139042
SNU-201,24785538,1.5876772369860332
A4/Fukuda,15547703,2.4441609561923547
Ku812,navitoclax-pluripotin (1-1 mol-mol),-5.237528282763509
F-36P,4259181,-1.8222583165697372
RKO,89928392,1.6264666324972337
BFTC-909,984333,1.0937084793466407
BT-474,navitoclax-sorafenib (1-1 mol-mol),1.4046735768982208
HPAC,25062766,2.4890973622332924
OPM-2,54143018,-0.7196855693728514
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714
LOU-NH91,44632017,2.871860814691948
BT 245,11234052,5.204468802593213
NU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),-0.7283867124282789
BT 428,5479543,4.050320279667783
SNU-1077,9936388,2.8901032001990954
PF-382,11626560,-0.1561430168366412
Hs 746.T,9911463,4.2317998219247785
OCI-AML-5,67156097,-1.6380562809479722
TCCSUP,400769,-0.9121100031738296
Panc 03.27,25102847,2.803123493223153
BT 428,2742550,3.051967949404776
B-CPAP,71304818,2.781278016768635
OCI-AML-3,156414,1.0676156487977742
PK-59,53392493,2.658462092997055
SH-10-TC,46843906,3.946546012816719
A4/Fukuda,176870,1.9874765150136215
BT 231,2858523,2.7852446227054375
NCI-H1568,erlotinib-PLX-4032 (2-1 mol-mol),1.5802949352112503
RERF-LC-MS,42642645,-0.4358765804877467
F-36P,6852167,2.0711670211251016
Rh30,4261,1.850948548894918
BT 245,54619267,4.214911597646626
CHP-212,JQ-1-UNC0638 (2-1 mol-mol),-1.8633116536094043
A4/Fukuda,selumetinib-vorinostat (8-1 mol-mol),0.52731023294293
BFTC-909,10385095,0.9839595624316404
Hs 746.T,BRD-A02303741-navitoclax (2-1 mol-mol),2.859955822350447
SNU-410,644241,3.406569838152794
KMS-20,46191454,0.3124251362481014
SF539,55508,4.727617915120432
MM1.S,135928012,3.410124861289675
BL-70,25126798,3.845787050807038
SF539,16219061,3.124474327572297
EM-2,24771867,-3.6193575560618063
Rh30,11485656,2.766839981757524
Kasumi-2,71751553,4.151047970892257
SK-MEL-28,51039095,3.7679772711161887
Hs 578T,675434,4.12165871613525
YKG-1,46215462,1.7714075060920065
YH-13,6914657,-1.321976768912636
SNU-410,2742550,3.711358313306516
BL-70,16720766,2.1052818123565205
SNU-410,445091,4.250092701444509
BT 428,44486219,4.295230339940746
HCC38,25126798,4.150551232499606
KMRC-20,15953870,3.781161229519325
KYSE-450,6918638,1.5500469019976144
NCI-H1568,2858523,2.9099207435493306
SH-10-TC,216468,4.125422993115773
PK-59,16725315,3.300439701422596
BT 231,5566,2.2220572851516605
OPM-2,44491742,3.727542800888903
BT 231,6918837,1.7982873040726883
AU565,1242560,3.5510894145829286
KYSE-450,9915743,1.0249516523129705
B-CPAP,5738263,3.3747888621680207
YKG-1,5280436,2.781391544714978
RKO,46224516,2.430810450928805
OCI-AML-3,3634881,2.253907329817893
NCI-H2196,1641662,3.0151623618946073
NCI-H1568,216239,1.54277692538335
Hs 578T,702558,5.42498591861228
TCCSUP,JQ-1-navitoclax (2-1 mol-mol),2.4798341578974568
EM-2,3503,1.278771391805642
WM88,122327,5.642317579876299
HCC38,135928012,3.818186297448824
BT 428,2749,1.0613938203741178
YKG-1,UNC0638-navitoclax (1-1 mol-mol),2.987622235126213
BT 245,navitoclax-PLX-4032 (1-1 mol-mol),0.016412534354773
Rh30,3025986,-0.5190933027995079
HEC-59,1750826,-2.1784615903276063
BT 428,148198,-5.072102147760655
KHM-1B,5746,0.0152063150708083
Hs 746.T,10296883,4.016339774932521
Hs 578T,9907093,3.772149636626181
BFTC-909,5329102,1.9658448878596055
BT 248,piperlongumine-MST-312 (1-1 mol-mol),1.560142448953329
OCI-AML-5,5351362,1.110844709291166
BFTC-909,3634881,3.6308731463535704
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402
SF539,2749,0.9972456277180648
BT-474,navitoclax-birinapant (1-1 mol-mol),2.9328916572004182
OAW28,123631,1.649178742735097
KMS-20,JQ-1-navitoclax (2-1 mol-mol),-1.501822959559956
SH-10-TC,24821094,4.010112009392642
F-36P,11396600,3.0952958144122724
M-07e,56946209,-5.880707113487372
KMS-20,vorinostat-navitoclax (4-1 mol-mol),0.2184557123667096
BT 245,11612883,3.133910870711437
HCC1395,11507802,1.9755427742676157
KYSE-450,44589607,3.132602917923117
KMS-20,7251185,1.0924387988239983
NCI-H2196,16038120,1.6358868780865434
Hs 578T,11364421,0.5874369826371434
NU-DHL-1,46398810,1.6641868117973977
HCC38,alisertib-navitoclax (2-1 mol-mol),-1.55931389408745
OAW28,53392493,2.314719178940984
KHM-1B,89928392,-0.1592315561663482
YH-13,selumetinib-piperlongumine (8-1 mol-mol),4.547014115194958
SF539,73707438,4.098722810092626
KMRC-20,60700,0.7111086892810461
WM88,11625818,3.761179167285338
M-07e,44486219,4.259719634443208
SF539,selumetinib-JQ-1 (4-1 mol-mol),1.3049218182358
KYSE-450,148198,-3.4919685284150876
BT 428,122327,5.820143762592548
Hs 746.T,SNX-2112-bortezomib (250-1 mol-mol),-2.6201963302293634
OAW28,409805,4.888216855585461
NCI-H2196,9911830,2.2031508018887775
M-07e,navitoclax-sorafenib (1-1 mol-mol),0.2115979417731712
M-07e,serdemetan-SCH-529074 (1-1 mol-mol),1.445862673264192
LOU-NH91,136227331,3.865245001267085
HEC-59,3476986,5.080138584084452
M-07e,6438330,0.9772207796641188
NU-DHL-1,6610355,3.4648292160050373
SNU-1041,676352,2.998470789649809
OCI-AML-5,25102847,1.8006356723242716
MM1.S,73707386,0.9217883452214084
BT-474,6450551,3.807989218091122
F-36P,11213558,0.4261945217851935
WM88,navitoclax-sorafenib (1-1 mol-mol),2.097548923937461
YH-13,60700,1.6423447574414731
HCC38,11175137,2.566648811702885
SNU-1041,selumetinib-GDC-0941 (4-1 mol-mol),1.9285895192057112
M-07e,19582717,2.741856461756573
HPAC,12001922,1.477818112094615
F-36P,54618795,2.814651179040886
RKO,11404337,-0.3534280477619294
KMS-20,9866186,-0.9814068490558976
Panc 03.27,erlotinib-PLX-4032 (2-1 mol-mol),4.31413529152754
BT 248,73707398,1.2475621750333084
HPAC,9915743,0.7621805259187995
NCI-H1568,24901704,3.012455129702266
Panc 03.27,24856436,-1.9091583117000053
MM1.S,46174525,3.3961962324765764
A4/Fukuda,7326481,2.3355820774301206
AU565,23582824,-0.1593812680979049
NCI-H1184,9956119,2.976326036938235
WM88,7251185,2.72361085825504
SNU-1077,sirolimus-bortezomib (250-1 mol-mol),1.9799689406124936
HCC38,45279963,4.152996936198811
EM-2,navitoclax-piperlongumine (1-1 mol-mol),-1.0985554017060852
SW1783,5335621,4.352005875752797
OAW28,navitoclax-birinapant (1-1 mol-mol),0.270639577142551
KYSE-450,9936388,-0.9236320595886032
OPM-2,445091,3.996829176942573
LOU-NH91,3025986,-0.3413799803632848
OPM-2,10385095,0.6586756349946576
SW1783,10296883,3.940377993774996
KMS-20,44819697,-0.2921256349223009
LOU-NH91,selumetinib-BRD-A02303741 (4-1 mol-mol),5.795599914262683
OPM-2,5351362,0.2459388559982981
WM88,24180719,-1.3725016624195774
KMS-20,135398744,7.132407790781497
HEC-59,navitoclax-pluripotin (1-1 mol-mol),-0.7860780380495387
BT 231,208908,1.596713590369486
KMS-20,selumetinib-GDC-0941 (4-1 mol-mol),-0.2221231396150395
BT 245,44607530,0.9122791762683272
OCI-AML-3,53392493,1.8380727867418052
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765
EM-2,6610216,3.792859820218109
YKG-1,1566236,3.4432239781359577
NU-DHL-1,17755052,-0.6529178657406193
NCI-H2141,46224516,0.8921554207434305
Rh30,12003241,-2.0054573943466876
BT-474,4259181,0.7470813596666142
KYSE-450,5278396,4.032614684188798
Hs 746.T,11955716,-2.2272583285262217
SNU-410,2949965,3.270281469540299
BL-70,46398810,2.7771856954656156
NCI-H2196,1750826,-2.217599309139437
KMS-20,24901704,1.7542686332224908
NCI-H2141,6918837,-4.39487071769081
NCI-H2196,7326481,1.7906925626524095
HCC38,3854666,0.590612515412198
CHP-212,24775005,3.1948798170693804
A4/Fukuda,JQ-1-carboplatin (1-1 mol-mol),-0.863856573463552
NCI-H1568,445455,4.330931204553833
A4/Fukuda,25102847,0.4372365282678318
WM88,crizotinib-PLX-4032 (2-1 mol-mol),-1.2040566766548473
Rh30,3081361,2.2338434032183168
HPAC,4259181,0.8473544462478222
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117
M-07e,71466445,0.4211698315737406
LOU-NH91,12001922,2.55699926148122
Panc 03.27,17755052,2.0484773677912287
OCI-AML-3,11238147,1.3879298123049009
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
BFTC-909,5738263,3.1091802601858185
BT 428,9549297,1.6281936648906872
SF539,sirolimus-bortezomib (250-1 mol-mol),0.2813071974909388
SNU-410,613753,3.149166551262791
BT 428,24180125,3.179416514721958
HEC-59,44486219,4.348021614186593
AU565,5470400,-3.0594075513818995
HCC1395,2828334,6.457908230276132
NU-DHL-1,25227462,-4.640207660582911
KHM-1B,89183176,4.960393231670367
Panc 03.27,374536,2.153951960619146
YH-13,135398516,1.589784182396859
NU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),-1.21461572309572
Kasumi-2,42611257,3.9292605095902857
YH-13,53495165,2.0012799986886822
BT 428,11485656,2.0550266467475407
TCCSUP,selumetinib-piperlongumine (8-1 mol-mol),4.721141400278082
A4/Fukuda,1641662,2.3667755294261297
KYSE-450,10302451,4.575458638647607
BT 428,327653,2.894003003794866
BT 248,11455910,-0.0312737668402554
MM1.S,23582824,0.1697868743152248
B-CPAP,168313016,4.426367892913076
EM-2,2858523,2.390692109930202
JHUEM-3,19582717,4.119791714394987
Hs 578T,322968,2.614332791225192
HCC1395,BRD-A02303741-navitoclax (2-1 mol-mol),-0.1602114998062966
NU-DHL-1,54618771,-0.7819429035186433
BT 245,46398810,2.1794326255658216
SNU-1041,selumetinib-vorinostat (8-1 mol-mol),3.508880149625294
BT-474,45279963,3.78766481136503
AU565,piperlongumine-MST-312 (1-1 mol-mol),1.980808732390433
M-07e,11719255,1.0115178484600462
SNU-201,24901704,3.6017532516404533
YH-13,409805,5.8043407056117395
SNU-1077,9903786,3.350516769184116
Rh30,285033,-0.7605419407244874
Hs 578T,25022340,0.1098528983053902
YKG-1,erlotinib-PLX-4032 (2-1 mol-mol),4.830623769808739
LOU-NH91,piperlongumine-MST-312 (1-1 mol-mol),1.9465172211690425
KYSE-70,73707398,2.029692143461395
Ku812,11497983,0.3868240418152458
RERF-LC-MS,24821094,3.899392046553833
HCC1395,selumetinib-decitabine (4-1 mol-mol),5.825750595774783
SNU-1041,vorinostat-navitoclax (4-1 mol-mol),1.3101580474951262
BT 245,2749,1.407270592041472
OCI-AML-3,4788,4.589180249807933
Kasumi-2,5291,3.833785516332381
AU565,46843906,2.01919943296107
Ishikawa (Heraklio) 02 ER-,sirolimus-bortezomib (250-1 mol-mol),0.8957919072189129
KMS-20,6438330,0.8417749626453567
Hs 578T,448949,0.65689021667513
KYSE-70,44486219,3.9722791166403657
NCI-H2196,5287620,-1.274089396814246
BT 428,216239,2.223507048360596
SH-10-TC,25102847,3.474130753178712
Ishikawa (Heraklio) 02 ER-,136227924,3.2224664141246806
OPM-2,11656518,2.629079922396914
Rh30,11964036,0.3993471127070453
NCI-H2141,72376,-3.2162362628289736
Hs 746.T,89928392,1.2265862150508082
KMS-20,71751553,3.937106268474675
M-07e,3038522,1.6229817412185583
BL-70,16065773,2.979695080010742
WM88,81146,2.066069543787698
BFTC-909,46907787,2.3649992203474515
OPM-2,navitoclax-pluripotin (1-1 mol-mol),-2.4334437397089053
PK-59,54618771,0.2590305123117813
Hs 578T,24797083,0.9079885222180378
BT 248,11960529,3.73553983344596
RKO,135411,0.3039750611139232
F-36P,24821094,3.119617575443437
A4/Fukuda,JQ-1-vorinostat (2-1 mol-mol),-1.448511600529376
TCCSUP,135875424,4.238752084680578
MM1.S,selumetinib-decitabine (4-1 mol-mol),4.192899101848816
JHUEM-3,BRD-A02303741-navitoclax (2-1 mol-mol),1.9782784213984352
EM-2,445455,3.5474546202591015
YKG-1,375860,0.0929787084961373
KYSE-450,5329102,3.4097073656415615
OCI-AML-5,25105715,3.841346610580515
YH-13,selumetinib-BRD-A02303741 (4-1 mol-mol),4.816369737179264
NCI-H2196,sirolimus-bortezomib (250-1 mol-mol),-0.2528324189743298
RERF-LC-MS,322968,4.758979615786181
Kasumi-2,9911830,1.88551459110434
Kasumi-2,25105715,3.2709711323954536
Rh30,613753,2.614525462064555
HCC1395,44241473,5.106557721006339
AU565,56946209,-4.483098881483793
BT 248,25195348,5.391578709053811
OPM-2,1566236,0.7571858740606694
CHP-212,216468,0.8944728241168552
BL-70,5281321,-3.6138358202234255
NCI-H1184,4521392,4.280641015853346
EM-2,6918736,-1.8299091651129848
BFTC-909,BRD-K27188169,5.152610673434624
OCI-AML-5,49766530,0.2957365675241968
BT 248,11404337,-1.3909400551472375
M-07e,JQ-1-vorinostat (2-1 mol-mol),-1.2782212302375242
Hs 578T,2874250,-0.221421960184094
SF539,6918736,-1.352397505308771
WM88,3503,1.8916850052283736
TCCSUP,15983966,0.2515630787348941
KMRC-20,sirolimus-bortezomib (250-1 mol-mol),1.830355580923548
A4/Fukuda,25105715,3.290295740743095
YKG-1,9956119,4.349400441756489
AU565,11612883,2.0019521527087982
MM1.S,9911463,3.396498541948332
Hs 578T,44202524,1.197712090115475
BT 231,54678924,1.6000701573616207
NCI-H2141,52947716,2.855398251923389
Ishikawa (Heraklio) 02 ER-,613753,3.335868497846011
BT 231,24753719,4.299852690221636
OAW28,10184653,1.1706980363621209
KYSE-450,49766530,0.7642756518369849
EM-2,5978,-3.5604067015936223
A4/Fukuda,136227924,1.9204852137512072
SNU-1041,219104,4.122120369089227
OCI-AML-5,42611257,3.4642334657158864
HCC38,6438330,1.435782840848416
YKG-1,4917,3.898835828558946
Hs 746.T,44137675,2.823828860726613
F-36P,51037431,2.339373613406673
Panc 03.27,16013152,5.37387418697898
WM88,selumetinib-UNC0638 (4-1 mol-mol),-3.0849534834121277
AU565,262093,2.3992948308197093
KYSE-450,navitoclax-MST-312 (1-1 mol-mol),1.0440074090451137
SNU-201,753704,6.85124399622587
SH-10-TC,46907787,1.9589503619322264
WM88,65064,5.304058799659636
OAW28,11404337,-1.5682838378564492
BT 245,10296883,3.705541909006873
BT 245,selumetinib-decitabine (4-1 mol-mol),6.897297339382343
Kasumi-2,11455910,-0.3707966959989963
Panc 03.27,11977753,-1.256043088508452
BL-70,9907093,2.5400383449396524
MM1.S,44589607,1.0331036343158948
OCI-AML-3,10074640,3.211877478155605
BT 245,11625818,4.365584281287599
NCI-H1184,3038522,4.116163941571875
OCI-AML-3,11955716,-2.900369876070268
YH-13,6918837,-2.973076414332095
KMS-20,68056272,3.2246681172521083
JHUEM-3,16065773,2.082298261843068
KYSE-70,216468,2.031191966418552
RKO,44607530,2.6096687798301677
BL-70,4378219,1.987736854074977
HCC38,100016,6.688694515924342
A4/Fukuda,11647372,-0.68075141177871
CHP-212,107970,1.5459012913024066
EM-2,54618164,3.877558145692375
Hs 746.T,4788,6.044326275100727
OPM-2,25126798,3.830489811395835
MM1.S,969516,2.341213349507295
A4/Fukuda,107985,-4.34456564276242
KYSE-450,107970,3.4899067291718717
OAW28,5351362,2.5555782345102407
SH-10-TC,969516,4.027134647437262
Hs 746.T,navitoclax-piperlongumine (1-1 mol-mol),1.9134136151107384
Hs 746.T,54596558,3.9282837260634422
KYSE-70,16736978,1.1213704825993671
BT 245,5287969,-1.6523463786351291
SH-10-TC,241158,4.192657349891415
SNU-1077,613753,3.232559060750619
BL-70,60750,0.559179440606122
SNU-1077,44259,2.0334917148068707
KMS-20,176870,2.605197587383483
SNU-201,107970,3.0289309781280287
LC-1F,46199207,-1.2996484182497314
NU-DHL-1,6438330,0.0083524547313942
KHM-1B,9840324,5.635096396232016
HPAC,613753,3.413387723962838
Hs 578T,44819697,-1.28177254372519
HCC1395,656346,0.2899412240997795
LOU-NH91,9825149,6.244850491409518
SF539,9952709,2.216028342098009
Panc 03.27,6917907,-5.8401376506655565
SNU-201,5566,3.953126976877716
MM1.S,selumetinib-BRD-A02303741 (4-1 mol-mol),3.755901339608387
PF-382,9915743,0.1930622386086079
Rh30,49766530,-2.324710777710102
OCI-AML-5,52947716,-5.476887144145345
AU565,11609586,0.8886557909894768
BFTC-909,66577038,2.856590203747272
BT 248,71576739,6.051378362255083
HEC-59,carboplatin-etoposide (40-17 mol-mol),3.479922412607952
F-36P,11404337,-0.3828282129667895
OPM-2,241158,1.7102591321182437
BT 248,107970,1.564508535325896
OCI-AML-5,262093,2.6389627250166825
WM88,11494412,0.914272881101828
NCI-H2196,56649450,3.575831287055621
Hs 578T,6914657,-4.361559967371509
OAW28,44607531,1.5392912313773788
RKO,9915743,2.8851858618766957
PF-382,44489367,4.604182803409816
MM1.S,4477,1.1148587916452
SNU-1041,71466578,4.461047474463301
YH-13,168313016,4.37029301578321
SNU-1077,25062766,2.424890615917259
Panc 03.27,11228183,3.021270108784716
PF-382,216468,0.5105473489323931
Panc 03.27,SNX-2112-bortezomib (250-1 mol-mol),-2.5939536108399586
Kasumi-2,9927531,4.453654232617923
B-CPAP,11612883,2.7358118615928366
HCC1395,25183872,-0.370542448097221
CHP-212,107985,-3.762512577622678
Hs 746.T,65064,4.75024767064505
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633
BT 245,10302451,3.8870647023268448
KMS-20,BRD9876-MK-1775 (4-1 mol-mol),0.4683519431894999
AU565,1750826,-0.6805778178680736
CHP-212,10302451,0.4952332551332477
BT 245,selumetinib-PLX-4032 (8-1 mol-mol),4.2567558134590895
Hs 746.T,11364421,-0.2429098281330267
SNU-1041,3025944,4.77471197111571
HCC38,1566236,1.6073129295205384
PF-382,11213558,1.6003517541111008
Rh30,6505803,0.7803145928661782
NU-DHL-1,16722836,0.983509194691096
KMS-20,36314,4.071326540312212
F-36P,10427712,3.928064204708117
OCI-AML-5,4788,5.898625435309337
NU-DHL-1,44632017,-0.251527549613568
BT 231,9549297,1.58576854552308
NU-DHL-1,54765302,3.7764075919835984
BT 428,5470400,1.3904243607719449
M-07e,9903786,0.8629482504426611
NCI-H2141,9903786,2.15851319161548
KYSE-70,3062316,0.8461927752800795
EM-2,tanespimycin-gemcitabine (1-1 mol-mol),-3.0412660983356665
A4/Fukuda,9826308,-1.4955537783248567
OAW28,107985,-3.5497769626209217
BT 245,375860,-0.1637313030055035
JHUEM-3,9927531,4.734556698770441
MM1.S,11640390,-0.5885267923488479
KMS-20,11964036,0.567950942976561
A4/Fukuda,6438330,0.8804707138455458
WM88,BRD-A02303741-navitoclax (2-1 mol-mol),3.5237248946513606
AU565,11485656,2.0156354686346174
RKO,9911463,3.963116579454927
KHM-1B,navitoclax-pluripotin (1-1 mol-mol),-0.8283845367813834
PK-59,148198,-2.6043559024802763
EM-2,3025986,-2.2925144441289356
SNU-410,doxorubicin-navitoclax (2-1 mol-mol),-0.6770637006876782
LOU-NH91,72376,-0.6247816475402558
Hs 746.T,9935249,2.8365347377791954
HCC38,24951314,1.6988348544267724
HEC-59,5470400,-2.068420992291403
BT-474,carboplatin-UNC0638 (2-1 mol-mol),2.4995179492753232
Kasumi-2,5494449,-3.67008601278043
Ishikawa (Heraklio) 02 ER-,51037431,1.7275160058582717
JHUEM-3,alisertib-navitoclax (2-1 mol-mol),-0.1193312559352283
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029
F-36P,445643,3.4312235548009777
EM-2,44491742,3.7753697950117897
NCI-H2141,5281321,-3.6008965234516426
RERF-LC-MS,23635314,-3.639251677232653
F-36P,docetaxel-tanespimycin (2-1 mol-mol),-5.066633140613987
Ku812,3384730,0.3528763049585885
RKO,54143018,-0.3751060369564643
RERF-LC-MS,6917907,-5.461995819879327
RERF-LC-MS,2708,5.106155932743474
SF539,46199207,2.5581705364942193
OCI-AML-3,56973724,1.776078904895424
SF539,702558,3.162113771527059
BL-70,6918837,-5.377224195339986
EM-2,375860,-0.8639645436146182
LOU-NH91,2113511,6.175446639496144
OAW28,409805,4.888216855585461
MM1.S,135984461,3.1063926235928703
RKO,9840324,5.302067215897717
HCC38,54618164,4.35878231787182
PF-382,135411,0.1083131735898056
F-36P,71729975,0.6879338879700845
RERF-LC-MS,1641662,3.403538628142178
PF-382,3825829,3.5943460783681207
CHP-212,5280436,1.694145197049091
F-36P,6918638,-0.9703997893287856
NU-DHL-1,9935249,0.0276338554577939
JHUEM-3,5287620,-0.1251284465973
Kasumi-2,5287620,-1.535744105024607
NU-DHL-1,tretinoin-navitoclax (4-1 mol-mol),-1.9043556508131567
SNU-1077,71304818,2.134778117100761
NCI-H2196,25227462,1.371419334428288
NCI-H1568,11964036,0.8982081488420575
RERF-LC-MS,36314,3.6884025033565897
SH-10-TC,72193861,1.5625985553664596
SNU-201,400769,-0.3387443390958615
HPAC,piperlongumine-MST-312 (1-1 mol-mol),2.7702013440580004
LOU-NH91,2828334,6.123728588021327
OPM-2,BRD-A02303741-navitoclax (2-1 mol-mol),2.1588596939971625
YH-13,56649450,3.222212852506819
CHP-212,24821094,3.480224347677434
KMS-20,54618305,3.8048007259852543
KYSE-450,16038120,1.4472769553293552
SK-MEL-28,107970,3.16887671769628
YH-13,9911830,3.324457602349572
M-07e,126941,0.8623328105887933
Kasumi-2,JQ-1-navitoclax (2-1 mol-mol),-2.2721346445712896
OCI-AML-5,navitoclax-gemcitabine (1-1 mol-mol),0.3664966187206792
SNU-410,2945648,2.7462799977690553
MM1.S,5311281,2.465283429832392
HPAC,11222830,1.9886141229882288
SH-10-TC,11507802,3.0553585897366418
PF-382,104842,-5.768830303921508
NU-DHL-1,16725315,3.081538232770875
KHM-1B,11214940,1.6917073338671202
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507
NCI-H1568,409805,3.8387714265583592
HCC1395,25062766,2.352810767665477
Panc 03.27,568763,0.4555036081229989
SW1783,25150857,3.7084233172602543
NCI-H2196,tanespimycin-gemcitabine (1-1 mol-mol),0.7152170968183438
PF-382,16720766,-1.1055655551486072
RERF-LC-MS,11234052,4.094456859515875
Rh30,675434,4.190994907053549
KYSE-70,23635314,-2.258343718513796
BT 428,44607531,1.0296265544892458
BL-70,375860,-0.623761093700038
OCI-AML-3,7326481,2.34593435653685
OAW28,613753,3.2856198284724742
SF539,7251185,1.8205284874436192
KYSE-450,11222830,1.7445073399277342
B-CPAP,selumetinib-vorinostat (8-1 mol-mol),2.3348701814890904
SNU-201,5746,2.3160688058878365
SNU-410,5278396,4.096328342813296
OCI-AML-5,2729026,3.1376692394463506
Hs 578T,72199292,1.9075398929583456
AU565,439501,-2.8703859168743384
F-36P,262093,1.6746033026960565
RERF-LC-MS,15983966,-4.090154567310139
PF-382,vorinostat-carboplatin (1-1 mol-mol),1.5687292736817784
M-07e,10113978,2.768023285369418
NCI-H2196,selumetinib-PLX-4032 (8-1 mol-mol),4.877773132144448
OCI-AML-3,24951314,-0.0003599018339768
B-CPAP,1641662,2.641871424967457
RERF-LC-MS,73707398,2.0319367406190483
KMS-20,15983966,1.6874259889880727
NCI-H2196,44185566,2.222671889502554
HEC-59,serdemetan-SCH-529074 (1-1 mol-mol),2.4705392826200914
JHUEM-3,11427553,3.7742021606504417
PF-382,44197249,4.457184218022553
Ku812,2126,4.384485550053496
LOU-NH91,46907787,1.567116016960845
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135
Rh30,73707438,4.285767346497992
NCI-H1568,71466578,4.264938806787537
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386
KMS-20,16725315,3.260760916795047
M-07e,44566777,-1.6094028497834465
BT 231,46398810,1.6531513820578414
BFTC-909,11167602,2.8757137848929006
SNU-1077,46907787,0.7852146377897988
BFTC-909,375860,-1.1901103647211757
TCCSUP,25262965,-1.8774141116985676
NCI-H1568,3081361,2.134244125445247
EM-2,73707440,3.768751115811406
OCI-AML-5,984333,1.0098675877648833
Hs 578T,15547703,1.4696559864727858
CHP-212,selumetinib-tretinoin (2-1 mol-mol),-4.397644405837299
KMRC-20,6610355,5.471217304519157
RERF-LC-MS,66577038,3.051572744120707
M-07e,148198,-7.025596172971479
BT 245,44507138,1.830901740816437
KMS-20,navitoclax-sorafenib (1-1 mol-mol),1.3745359370236474
KYSE-70,3854666,1.6457032232411275
BL-70,168313200,1.5744509256656225
BT-474,piperlongumine-MST-312 (1-1 mol-mol),1.7797685168179331
YKG-1,5329102,2.298479401722923
BL-70,9549297,1.64150590187432
WM88,4521392,4.290499070738736
YH-13,10074640,3.684344080158783
WM88,56973724,3.9128117732060663
NCI-H2196,JQ-1-navitoclax (2-1 mol-mol),-1.246024702980578
SH-10-TC,44241473,4.426083440248119
OPM-2,11719255,1.0053781432887028
OCI-AML-5,carboplatin-etoposide (40-17 mol-mol),0.1925189337985636
HEC-59,1641662,3.785576868717973
LOU-NH91,9911463,4.226439837654448
Ishikawa (Heraklio) 02 ER-,24180719,4.095355158461072
BT 245,2126,5.061422430889494
M-07e,262093,1.9323160486424649
LOU-NH91,selumetinib-JQ-1 (4-1 mol-mol),1.3495947131381103
Kasumi-2,15953870,2.7617758274096404
BT-474,984333,2.0670916302778486
PF-382,73707438,4.86482182399275
LOU-NH91,9936388,-6.294191236399446
MM1.S,60700,-1.118985990176223
KYSE-70,119607,5.065055719995064
NCI-H1568,216468,4.700562763036761
A4/Fukuda,637858,0.8198578842358093
OCI-AML-5,44484893,-1.471515960662938
BT 245,tanespimycin-bortezomib (250-1 mol-mol),-0.2118058496398642
HEC-59,17755052,0.9491364601479918
SNU-410,9825149,2.9542974265583526
BT 231,3543504,4.192158652157851
RERF-LC-MS,216345,4.25766275770173
MM1.S,613753,2.867673919869975
KMRC-20,136227924,3.298573049161518
BL-70,100016,3.880189960258483
NCI-H1568,49867930,4.553956635433513
KYSE-450,637858,3.2826178661178003
SW1783,10302451,4.263014004956648
KMS-20,5746,-0.3166262639193328
AU565,10385095,1.377392665812461
SNU-1041,119607,5.93029468334495
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917
Panc 03.27,2733526,4.30690190403446
A4/Fukuda,salermide-PLX-4032 (12-1 mol-mol),4.8455357298985655
EM-2,11214940,1.101102942521854
SNU-201,2708,5.983864957841762
CHP-212,5746,-4.377311079732396
JHUEM-3,216345,4.287312793215803
SF539,5738263,3.647048629199091
SK-MEL-28,441298,3.154659413422743
BT 245,12003241,-0.4272477548788383
Ishikawa (Heraklio) 02 ER-,SNX-2112-bortezomib (250-1 mol-mol),-1.5625671079019574
AU565,5351362,0.5336942302969934
NCI-H1568,10074640,3.1711026687004855
SNU-410,54649381,4.343480855108173
SNU-201,168313047,3.6359496663379254
NCI-H1184,44202524,1.015130749241068
M-07e,25126798,-1.890087610158487
BFTC-909,16115403,-3.993091010962378
HPAC,322968,4.523006043177416
Panc 03.27,11640390,3.4889994166227747
NCI-H1568,2708,3.449118605167301
B-CPAP,SNX-2112-bortezomib (250-1 mol-mol),0.3419783541511122
SF539,16722836,1.315642485980416
CHP-212,3689413,0.1952243777291655
OCI-AML-3,4917,2.5442971693641883
AU565,5494449,3.8187307918252262
F-36P,4705,3.5916410235221914
YKG-1,46901937,4.239285052925771
EM-2,24889392,1.2704251631454568
Hs 578T,navitoclax-sorafenib (1-1 mol-mol),1.4553071154328494
BT 248,navitoclax-PLX-4032 (1-1 mol-mol),1.075952259913776
JHUEM-3,11640390,3.9570907689150583
KYSE-450,46191454,2.021198534281789
BL-70,crizotinib-PLX-4032 (2-1 mol-mol),1.0980658850770222
SF539,5746,0.7777386338638989
OAW28,10385095,1.310156197215646
BL-70,26596,-3.7588271568583953
AU565,vorinostat-carboplatin (1-1 mol-mol),2.4881642304307463
NCI-H1184,navitoclax-MST-312 (1-1 mol-mol),0.6399874469927861
KMS-20,136227924,2.296093636743899
HCC38,1242560,3.5549405448726077
NCI-H2141,24748573,1.5274997974426574
RKO,46398810,2.934390735401444
KHM-1B,36314,1.0802720035135625
BFTC-909,1641662,3.805506520632872
OPM-2,9549297,1.1861201303789202
NCI-H2196,44486219,4.450804608419906
BT 248,445091,5.158109648340294
RKO,5278396,3.510721289362286
BT 245,65628,4.476006410833118
Hs 578T,5311,1.6134508963466494
SW1783,71304818,3.413551155589458
M-07e,11152667,-2.997128010914285
OAW28,23582824,0.6142488529896691
HCC38,10410894,2.1017529783301945
JHUEM-3,JQ-1-MK-0752 (1-1 mol-mol),0.8282420328084539
OAW28,135421197,1.4901490212875883
PK-59,216345,4.453291295697538
SH-10-TC,docetaxel-tanespimycin (2-1 mol-mol),-4.730888894978406
NCI-H1184,36462,-0.6681972686085113
Kasumi-2,46943432,0.9724659287269805
HEC-59,11234052,5.684192234749363
OCI-AML-3,salermide-PLX-4032 (12-1 mol-mol),5.061336095964608
BT 248,selumetinib-JQ-1 (4-1 mol-mol),2.943393356661563
Panc 03.27,44202524,1.7710593967408583
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179
Ku812,9826308,-0.187387651853026
NU-DHL-1,5281321,-2.700321539992985
Kasumi-2,49867930,4.763867340262508
BT 231,selumetinib-navitoclax (8-1 mol-mol),1.1755303317094543
KMS-20,49836020,5.970121389426133
BT 428,JQ-1-navitoclax (2-1 mol-mol),-0.6624158954827992
SNU-1041,SNX-2112-bortezomib (250-1 mol-mol),-0.8111734051729212
HPAC,6917907,-7.438614109073977
MM1.S,124202324,0.7291888929578118
Kasumi-2,72376,-3.459838502439841
NCI-H2141,44462760,4.283338248705393
BT 231,54143018,-0.1728200859819445
Rh30,104842,-3.281660233252379
PK-59,5311281,1.9258741170169784
OCI-AML-5,6436223,-3.9993647666662286
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333
M-07e,navitoclax-piperlongumine (1-1 mol-mol),-0.5085959618117163
YH-13,9933475,1.504253268653492
Ishikawa (Heraklio) 02 ER-,25154868,3.214649435697115
RERF-LC-MS,15547703,2.8085711207925015
Kasumi-2,selumetinib-JQ-1 (4-1 mol-mol),-0.370012591860846
RERF-LC-MS,24901704,2.6292316786888295
F-36P,9936388,-5.085386931503238
A4/Fukuda,56946209,-6.395954164738885
HEC-59,2749,2.4037073390218717
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076
M-07e,46398810,-0.5058710104804632
SNU-1041,10385095,2.492918478264542
SNU-201,135440466,2.611960162702963
Panc 03.27,11955716,-2.259430176191755
Kasumi-2,2729026,2.278256361901275
Kasumi-2,23725625,0.6917734152233637
EM-2,168313016,4.389317398313489
SF539,54678924,1.2476819079209422
RKO,6917907,-7.36544436443182
RKO,73707398,0.9128481241529548
BT 248,2949965,2.620236046838219
KMS-20,24785538,-1.6506772000571488
LOU-NH91,5351362,1.6461408289790205
YH-13,24951314,1.6254044283291555
BT-474,6852167,2.8360260364208707
NU-DHL-1,25062766,1.3260870058815484
KMS-20,71466445,3.065213582457146
RKO,44819697,-0.2126149769206573
B-CPAP,135875424,3.307629887397838
OCI-AML-3,SNX-2112-bortezomib (250-1 mol-mol),-4.201394867442666
RKO,656346,1.2468664563159324
NU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),-2.727717397237378
SH-10-TC,5280436,3.2081776192232883
A4/Fukuda,5329102,0.822909221294871
MM1.S,4788,5.213003022570621
A4/Fukuda,216345,2.739557201577506
Ku812,675434,3.5526828376641952
OPM-2,54626689,3.88605573030338
WM88,55508,4.449450223540471
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308
EM-2,4917,2.90750751627937
WM88,10427712,3.9485944819968064
Ku812,16722836,-0.2272484724796736
RERF-LC-MS,5329102,2.8374518121885637
Hs 746.T,7251185,2.975002563711463
SH-10-TC,erlotinib-PLX-4032 (2-1 mol-mol),3.464206303579515
SW1783,selumetinib-JQ-1 (4-1 mol-mol),4.8105600035571126
SNU-201,2828334,6.147785973134118
HPAC,10302451,3.6769046300144543
MM1.S,216468,1.1892471991509614
BT 245,11609586,3.46233196553391
Kasumi-2,24901704,2.1856500624020994
EM-2,9887053,2.8609234444384968
AU565,11977753,-1.5018138963846497
M-07e,16720766,-1.5592597258922802
KHM-1B,25150857,0.9778770077521932
PK-59,24856436,1.6787268247901606
AU565,7326481,2.6950900258123256
PF-382,327653,2.393380485895892
Panc 03.27,9907093,4.526414334582481
NCI-H2196,4788,5.261610065518375
HEC-59,12001922,2.684343539817944
RKO,16065773,3.3120716405166615
BT 248,676352,1.654368845250315
Panc 03.27,36314,-6.4972989488520145
BFTC-909,2708,5.254338200716292
BL-70,25195348,2.3236791758863156
BFTC-909,11175137,1.859642091823866
SNU-201,387447,-3.8008865458092704
F-36P,613000,1.342172826912998
OPM-2,136227924,1.7425170628423947
B-CPAP,11396600,0.7084279408075309
WM88,6918638,-0.228247400007117
NCI-H1184,67291369,1.29335758232607
NCI-H2196,2746,3.7981769416630193
Panc 03.27,10296883,3.962678998629819
KHM-1B,44259,0.3168726025779862
B-CPAP,246676,4.303313026788405
NCI-H2196,46907787,3.906560872378596
Hs 746.T,53495165,0.4526198303339481
F-36P,44632017,-0.4733607400877447
OAW28,navitoclax-piperlongumine (1-1 mol-mol),0.6841862022765504
SK-MEL-28,216239,1.7130315366514903
BT 245,9803433,4.398096619195385
SK-MEL-28,654092,0.5441939646786474
JHUEM-3,53481919,3.899932689537149
Rh30,17759555,2.5057498795791626
SF539,119607,5.330074057823079
SW1783,448949,1.229106792188085
KYSE-70,16038120,2.0286855638164054
Kasumi-2,54626689,4.779746030866953
A4/Fukuda,piperlongumine-MST-312 (1-1 mol-mol),1.0662246579823889
PF-382,10385095,1.1317259097020056
HCC38,52912189,2.5185565888874204
KMS-20,6918837,-5.417214970743668
A4/Fukuda,5282054,2.418862118344995
AU565,46191454,1.308540851634407
Hs 746.T,3503,3.2696314447224712
KYSE-70,11364421,-0.2598881855214042
AU565,26596,-1.0644098452654434
AU565,24821094,-3.121521346886189
SF539,5284373,2.3802646906930485
OAW28,11364421,1.0555351676055402
BL-70,2708,4.5281737147612375
SH-10-TC,119607,5.879128266099095
Ishikawa (Heraklio) 02 ER-,676352,3.012239531301171
OCI-AML-3,73707398,-0.3023697675289024
SW1783,5460769,4.078393209152703
PK-59,ISOX-bortezomib (250-1 mol-mol),0.9805258280125868
RKO,135421197,1.472175761257966
BL-70,46926350,-5.521424806122161
NU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.314430194898088
BT 231,45100481,4.488075297577812
Hs 746.T,11396600,2.998642785885706
Kasumi-2,6438330,0.3381981879114322
BL-70,selumetinib-JQ-1 (4-1 mol-mol),2.011932316177293
HCC1395,676352,1.6797544489619816
PK-59,219104,3.4307179305896893
CHP-212,navitoclax-gemcitabine (1-1 mol-mol),-5.221462678087285
BL-70,10322450,2.4597869877226004
RKO,3825829,4.017808531984142
SNU-201,126941,6.053611812698271
Rh30,16720766,2.0856670371519286
BT 231,4521392,5.527630016590695
LOU-NH91,4261,2.7247094190978007
B-CPAP,26596,-2.034534215785694
SH-10-TC,148124,-4.410168498577838
WM88,11977753,-3.0077743621723534
EM-2,5328940,-1.1077888625100492
CHP-212,navitoclax-MST-312 (1-1 mol-mol),0.4364051700180216
YKG-1,66577038,3.063547577829753
OCI-AML-3,4521392,4.258525360169483
RKO,5280436,4.655813696583822
BT-474,selumetinib-JQ-1 (4-1 mol-mol),0.4588027273781878
Rh30,3025944,3.981880609225583
Ku812,9549297,1.3276484644733737
KYSE-450,5287969,-1.404660564702432
B-CPAP,9840324,3.889396997757569
M-07e,42642645,0.4654557328978623
B-CPAP,11427553,2.722415626304352
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139
KMRC-20,carboplatin-etoposide (40-17 mol-mol),4.439397714943588
RKO,54618771,2.3159310195777985
KYSE-70,9887053,4.5630363901990565
NU-DHL-1,11238147,1.5129277124969711
OCI-AML-5,23725625,2.639310838913358
OAW28,11214940,1.4072727029323666
EM-2,51039095,1.6623475768684022
OPM-2,24771867,-0.0082042750480303
RERF-LC-MS,5287969,-2.0564845219287555
YH-13,2749,2.5667946574986473
KMRC-20,vorinostat-carboplatin (1-1 mol-mol),3.852034524239012
HCC38,3634881,3.3125541565907906
EM-2,10427712,4.911491808144047
BL-70,135984461,4.106594232964942
Kasumi-2,3081361,2.7656675201923555
HPAC,5281321,-0.636617605605341
NU-DHL-1,227681,1.656422659669183
EM-2,42642645,-2.0665859943713207
YKG-1,24772860,-1.277942485629484
BT 428,10184653,-0.1229780329138256
M-07e,2842253,6.002550176160011
SNU-201,124202324,3.023604570779493
F-36P,9823820,3.346943023702952
Kasumi-2,46843906,1.3893397569967554
BT 428,25126798,3.982301536443088
NCI-H2196,445643,3.9437089022876446
M-07e,2742550,2.9985200083609014
KHM-1B,126941,-4.224902593800319
LC-1F,72193861,1.0734976553210598
MM1.S,3385,3.993221582004266
SNU-1041,51039095,3.7298751626401105
NCI-H1568,45279963,3.534456091536717
F-36P,11238147,1.3988161261802263
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815
OAW28,10385095,1.310156197215646
SNU-1041,24785538,2.0701514129282783
BFTC-909,51037431,4.63288955594681
Panc 03.27,8515,4.616547975522318
HPAC,44607531,1.610135438936828
OCI-AML-3,10322450,2.261433742122515
Panc 03.27,11404337,-0.4411804077325879
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506
OCI-AML-3,2113511,4.874351732451874
PF-382,46191454,0.6842895726793522
NCI-H1184,20959075,-3.7029386447776873
NCI-H1184,6505803,-0.2982079096547607
Hs 746.T,49793307,-4.962476440741396
KYSE-450,SNX-2112-bortezomib (250-1 mol-mol),-1.628342695469425
NU-DHL-1,9956119,0.6553979418631676
F-36P,8515,2.752757057086389
AU565,11178236,-4.26632575473861
A4/Fukuda,5291,3.6218734753047226
Ku812,vorinostat-carboplatin (1-1 mol-mol),2.0345642738218386
SNU-201,selumetinib-navitoclax (8-1 mol-mol),2.412823623773042
NU-DHL-1,5479543,3.232300897170713
NU-DHL-1,8515,3.2734160853720105
TCCSUP,10302451,3.6876382718765206
HCC1395,sirolimus-bortezomib (250-1 mol-mol),4.6634118808153735
Kasumi-2,168313016,3.99242446715415
NCI-H2141,6252,4.415772256987539
BT 231,439501,-3.8677572824685913
SNU-201,5311,0.9328944841576527
CHP-212,135440466,0.1425566532719697
Hs 746.T,doxorubicin-navitoclax (2-1 mol-mol),-1.6001052167343943
PK-59,9967941,4.046263495690824
SH-10-TC,445643,4.8609335511455525
Kasumi-2,3011155,3.05813684599445
BL-70,71466445,1.4229248120179192
SNU-410,444795,5.209490058147456
NU-DHL-1,5738263,2.6843790569826536
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482
Rh30,erlotinib-PLX-4032 (2-1 mol-mol),3.6341359249902543
BT 245,3689413,-2.318316316051159
SNU-1041,89928392,2.307297175479487
KMS-20,72734382,2.4480499103893707
BT-474,11364421,-0.0894588011516199
Kasumi-2,107970,1.3663131605888186
RKO,24180719,5.308193040989237
SNU-201,2729026,3.0674801010491484
BT 231,135398516,1.9379766729159449
Hs 746.T,107970,2.1679941354436196
YH-13,568763,0.2718115041974417
Ku812,54143018,-0.9918104054999368
Hs 746.T,322968,2.822194631628747
RERF-LC-MS,753704,5.128075002459309
PF-382,159324,-2.108239526563577
HEC-59,16741245,4.351887837098854
HCC38,327653,2.8237453360302576
OAW28,navitoclax-gemcitabine (1-1 mol-mol),-0.0926576582551772
A4/Fukuda,erlotinib-PLX-4032 (2-1 mol-mol),1.6869811830916113
NCI-H1568,9926054,1.8156743035592564
Ku812,445091,4.27375620690436
SF539,11152667,-2.173581814614824
SH-10-TC,11612883,3.187800382516327
Panc 03.27,6438330,2.7274770112671245
AU565,156414,-1.7188953203880928
OAW28,selumetinib-BRD-A02303741 (4-1 mol-mol),5.828946434943108
SF539,16013152,3.768432455806556
SF539,168313200,1.6661816240555782
YKG-1,216345,4.618368772629755
AU565,navitoclax-sorafenib (1-1 mol-mol),2.1956268758246225
F-36P,57330099,4.197284693809706
AU565,5328940,1.3384832652905083
MM1.S,24856436,-0.1487659765377816
Ishikawa (Heraklio) 02 ER-,104842,-0.9454178220793432
SW1783,24779724,3.9128595943603544
M-07e,11625818,4.014474586719338
EM-2,10113978,1.9036707680665137
NCI-H2196,2828334,5.764644279727248
OAW28,68056272,3.642995313586114
A4/Fukuda,15983966,4.102938700353478
Hs 578T,11175137,0.7023984315595475
RERF-LC-MS,136227924,4.560045704487339
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386
NCI-H1184,71466445,-0.0738213816478361
AU565,2746,2.9112036552039737
OAW28,2828334,6.258958244852924
BL-70,216239,1.5508661974153728
BFTC-909,3815108,3.5118939741133075
F-36P,135984461,3.5381976593553444
KHM-1B,67291369,-0.148329679394903
OCI-AML-3,15953870,2.1290082500420833
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542
SW1783,216345,3.5979971294588147
F-36P,72193861,-0.5214112723589638
AU565,72199292,-0.5217195589045935
OAW28,11427553,3.602344276440211
KYSE-450,44607531,1.4871997171976696
Kasumi-2,176870,2.2683953361762166
HCC38,11612883,3.587998888038339
HCC38,docetaxel-tanespimycin (2-1 mol-mol),-5.918045351369405
SNU-1041,10427712,5.031504088389917
OCI-AML-3,57330099,4.735160462627119
NCI-H1184,11152667,-1.0488387695368542
HCC38,400769,-1.0909458460810812
OAW28,5311,0.8600755425080211
OAW28,452548,1.2278646078369797
SK-MEL-28,44185566,3.1920858927006983
OAW28,24180719,4.377592888188756
WM88,10127622,-2.362128523017262
MM1.S,44137675,2.286622980046456
Kasumi-2,71466578,1.9217240593305729
Ishikawa (Heraklio) 02 ER-,168313047,3.560742746409877
EM-2,5566,2.536621200798827
PK-59,selumetinib-vorinostat (8-1 mol-mol),2.306892423893395
HEC-59,375860,0.0781671745466512
HCC38,753704,4.841240703007911
Hs 578T,285033,-3.774463449254444
KYSE-450,24771867,3.24164368139856
MM1.S,168312962,-0.6288845561945676
NCI-H1184,9903786,1.9169497440885477
SF539,SNX-2112-bortezomib (250-1 mol-mol),-2.8372291884695326
F-36P,vorinostat-carboplatin (1-1 mol-mol),1.774978167214653
SF539,9911830,1.1022803108352155
M-07e,54626689,5.790335744168427
SW1783,2945648,3.5321993021385367
BT 231,2828334,5.869700584711845
KYSE-70,25126798,3.963979956832577
YKG-1,25105715,3.7815729862100578
BT 428,3384730,-1.1186762550581884
KMS-20,25195348,3.35080522486854
OCI-AML-3,sirolimus-bortezomib (250-1 mol-mol),0.125209205535959
KHM-1B,selumetinib-GDC-0941 (4-1 mol-mol),-0.3982194737494156
WM88,16659841,4.287152610314046
HEC-59,49766530,-0.0916228108387451
KMRC-20,3543504,4.387857873550899
KMS-20,54626689,3.7959086868633016
OPM-2,6438330,0.5735051923287856
Panc 03.27,135440466,2.6714437431029077
NU-DHL-1,2945648,1.372163089409248
NCI-H2196,10127622,5.304286944275269
HCC38,vorinostat-carboplatin (1-1 mol-mol),4.094089472052597
Panc 03.27,5287620,-1.946367639008724
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763
Hs 578T,60700,1.76048111675249
KMS-20,613753,2.7781873523971687
BL-70,49766530,-0.8526727850489186
SF539,122327,5.038371430182477
AU565,6918837,-4.408945103298963
BFTC-909,44493528,4.370300807083883
SH-10-TC,10184653,1.777641043215407
Hs 746.T,16736978,1.3903995280887576
NU-DHL-1,16736978,-0.1858099364077559
CHP-212,3081361,2.468337486284355
KMRC-20,3854666,4.622266524166492
SF539,17755052,0.186903454349707
WM88,10302451,3.9540346970245337
SF539,6436223,-5.188827537901569
SH-10-TC,5460769,3.8511006484967223
NCI-H1184,3634881,2.490427657524908
YKG-1,3081361,3.493822674928686
HPAC,36462,3.2094999713867103
Hs 746.T,5280436,2.2728017751194916
Ku812,135984461,1.927355885078453
KMRC-20,selumetinib-vorinostat (8-1 mol-mol),2.4254013680145663
KHM-1B,216468,0.1436700661739532
Panc 03.27,1716436,3.682679734224979
WM88,24180125,3.83387165557686
YKG-1,11507802,1.2532518288313863
NCI-H1184,5566,3.0589910893677414
F-36P,54618164,3.98982096718309
B-CPAP,3384730,0.948588967959913
YH-13,71466578,4.92268847622802
Hs 746.T,67291369,5.431234932140099
Rh30,9935249,3.355243286720757
HCC1395,5311,2.2980143583563937
BT 245,sirolimus-bortezomib (250-1 mol-mol),0.5347503794304393
F-36P,322968,3.387114888877606
WM88,11222830,1.5971749036000245
Kasumi-2,6918878,1.1877992835952844
BT-474,11656518,4.352795984756395
KMS-20,445455,4.148068578484743
BL-70,702558,4.540498132517817
BT 428,25102847,3.205053945341453
Ishikawa (Heraklio) 02 ER-,119607,3.862626387874781
KHM-1B,3854666,1.0178761505547558
KMS-20,46224516,1.6732996169077097
F-36P,9952709,2.731832265125769
BL-70,11977753,-4.652069340753655
YH-13,4261,1.8145650392112695
B-CPAP,46224516,3.1901698351737537
OAW28,tretinoin-navitoclax (4-1 mol-mol),1.3460784377141035
Kasumi-2,10127622,5.115736544584973
SH-10-TC,5281321,-2.074815143322556
BT 428,9884685,1.1692312726776757
SNU-1077,24951314,1.2105006017046815
KHM-1B,42642645,-0.1657476945294937
BT-474,44607530,0.9150345861602176
EM-2,46191454,0.0243782691276438
KYSE-70,12003241,-1.4257688129039825
F-36P,3136844,2.947834525735439
BT-474,11485656,2.39208559559141
HCC1395,25154868,4.601472986866129
SNU-1077,54454,1.8410579173588877
Hs 578T,89183176,3.26496972678991
OCI-AML-3,ISOX-bortezomib (250-1 mol-mol),-0.1277402971804833
JHUEM-3,25161177,4.259933261360218
MM1.S,656346,0.8966007785283742
BT 231,11955716,-1.141744294588506
KYSE-70,selumetinib-UNC0638 (4-1 mol-mol),3.25629169074294
Hs 746.T,24964624,3.0183904733405797
Panc 03.27,navitoclax-gemcitabine (1-1 mol-mol),-2.4462935301350406
HCC1395,24785538,1.8502535907941853
KMRC-20,10074640,3.028506289108157
OCI-AML-3,36462,-1.1325661730855037
A4/Fukuda,46907787,-1.6446005772830188
Hs 746.T,135423438,3.2102823304550463
NCI-H2196,44566777,0.5134368328370353
HPAC,selumetinib-BRD-A02303741 (4-1 mol-mol),1.811082430330792
PF-382,445455,3.8799836217704664
KMRC-20,doxorubicin-navitoclax (2-1 mol-mol),0.9051296535641696
NCI-H1184,selumetinib-GDC-0941 (4-1 mol-mol),2.1589965755168152
NCI-H1568,54613361,-1.9115789745186575
CHP-212,44819697,-1.6518707265894472
BT 231,5351362,1.0136890217616688
Ku812,navitoclax-gemcitabine (1-1 mol-mol),-4.518116419352301
B-CPAP,100016,6.506572981316216
MM1.S,637858,1.1030416488426389
KYSE-70,46174525,4.613744209458669
BT 248,44241473,4.372252470027867
NCI-H1568,crizotinib-PLX-4032 (2-1 mol-mol),1.1920351291695386
Kasumi-2,46215462,1.2219116069395664
SNU-1077,168313047,3.2162291034503703
Panc 03.27,54596490,4.426950175549895
Hs 746.T,984333,1.4869903576736765
BFTC-909,11427553,2.7610941057010754
Rh30,135398744,6.322590827161508
F-36P,45279963,2.167893190826844
BT 245,613753,3.2537695034625327
AU565,445643,3.872431437053606
SF539,carboplatin-UNC0638 (2-1 mol-mol),3.439871222147057
NU-DHL-1,46907787,-1.3567156835247356
JHUEM-3,54678924,2.6121200810285514
KMS-20,JQ-1-MK-0752 (1-1 mol-mol),-0.7766502176752437
RKO,135398516,4.318914396092429
OCI-AML-3,selumetinib-tretinoin (2-1 mol-mol),-4.0203186552410815
PK-59,crizotinib-PLX-4032 (2-1 mol-mol),1.9792405847759436
BL-70,445643,2.036378899687512
A4/Fukuda,25195348,0.8993846970771071
OPM-2,2746,0.9082445461467812
M-07e,71304818,1.4315750452100475
KYSE-70,322968,3.381611542483835
OCI-AML-3,72734382,2.673694917248653
BL-70,4261,-0.7783018083443106
OAW28,71304818,3.062868675930112
BT 245,448949,2.080098144104233
NCI-H1568,54454,3.61375646412465
OCI-AML-5,11257553,-0.6645168737625776
SNU-1077,44493528,3.708438186415119
TCCSUP,9840324,5.608027140401768
JHUEM-3,446155,0.9122645957865936
PK-59,6918837,-2.1043378222911464
AU565,crizotinib-PLX-4032 (2-1 mol-mol),2.690947224555452
F-36P,219104,2.5737623705635557
NCI-H2141,6918736,-3.145103622909066
SF539,9884685,-0.5281104713803977
OCI-AML-3,doxorubicin-navitoclax (2-1 mol-mol),-4.658737308473008
Ku812,656346,0.2651161677447766
HPAC,2828334,6.007488340857104
NCI-H1184,10184653,0.3623732317795434
KYSE-450,57330099,4.469167864214201
OCI-AML-3,6438330,0.4126587371287552
SNU-1041,5351362,1.2768302258961368
NCI-H1184,docetaxel-tanespimycin (2-1 mol-mol),-6.811596799147555
BT 248,285033,1.6288115150650024
HPAC,10113978,2.0094548037354527
F-36P,136227924,2.476842028434826
Kasumi-2,613000,1.0071641049539857
YH-13,24856436,1.6547595238479382
KYSE-450,12003241,-0.0119879221972118
SW1783,9967941,5.280203655099816
SNU-1041,10074640,3.7080494942065423
SF539,24748573,0.9472280680221892
ML-1 [Human thyroid carcinoma],6252,2.036085666454029
KYSE-70,135411,1.9014599224142343
OAW28,327653,3.155680016062074
NCI-H1568,5291,3.770643134542437
NCI-H2141,10184653,0.679379935551907
HCC38,12001922,1.9391245494676863
Ku812,11404337,-0.6784609129861706
Rh30,8515,3.718568437073075
LOU-NH91,2746,5.002248002286792
SW1783,54618771,3.657201070811366
EM-2,65064,3.0153349881122606
PF-382,44489675,3.595955687856044
NU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),1.578778354574034
PF-382,57519531,1.1953154667352015
NCI-H1568,11427553,2.9296384487881166
BT 245,17755052,1.5011622664122757
EM-2,46224516,2.354338209526668
Rh30,ISOX-bortezomib (250-1 mol-mol),0.964000346377984
BT-474,25161177,4.318824573781677
YH-13,6610216,4.911134346587397
BT 245,676352,1.8753588664748664
AU565,15983966,1.7541662071439053
RERF-LC-MS,262093,3.104487938727744
OCI-AML-3,9826308,-0.98383824229858
RKO,5460769,5.660789679983863
MM1.S,5351362,1.350784459153801
NCI-H2141,vorinostat-navitoclax (4-1 mol-mol),0.0220141352147058
BT 248,10427712,4.022427006719253
EM-2,6623618,2.037623696140749
PF-382,6918837,-4.619504053552648
A4/Fukuda,44202524,1.0259860145116777
RKO,11485656,2.16906736756012
M-07e,docetaxel-tanespimycin (2-1 mol-mol),-4.678877641741065
A4/Fukuda,44185566,1.3030950937163224
NU-DHL-1,9927531,5.134600574788464
KYSE-450,10184653,1.1641913359919105
KMRC-20,241158,6.296391412542069
Kasumi-2,54618771,-0.6876381814105375
BL-70,6852167,-1.1490016051859089
KHM-1B,46191454,-0.9954887816979984
BT 428,5978,1.459738910059954
EM-2,5282054,3.4933663428366417
AU565,11222830,1.6780695218323665
OAW28,71466445,4.188405368682896
LC-1F,5291,4.05076567679632
Ishikawa (Heraklio) 02 ER-,navitoclax-gemcitabine (1-1 mol-mol),1.238528181550802
OCI-AML-5,702558,5.37870079475497
BT 245,16219061,2.483085433457608
SF539,54618771,0.9520052550930058
BT-474,6914657,-3.008944666894224
BT 231,44620216,3.924479857389375
BT 428,51039095,3.0771615487260977
SNU-201,SNX-2112-bortezomib (250-1 mol-mol),-0.5145589715688712
OAW28,24856436,0.1607500363529794
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295
SH-10-TC,serdemetan-SCH-529074 (1-1 mol-mol),3.0907250827658688
LOU-NH91,46215462,2.06389335978863
BT 245,44486219,4.564101901235062
TCCSUP,JQ-1-UNC0638 (2-1 mol-mol),6.070182975256097
Panc 03.27,54678924,1.7599719183147824
Rh30,54613361,3.544163262071929
SNU-410,11317348,2.4812575600243933
HCC1395,6623618,1.9648841213431016
BT 428,3025944,4.463058119543337
OPM-2,42642645,-0.4905470491794313
OAW28,11214940,1.4072727029323666
HEC-59,6505803,0.8725276425647639
NCI-H2196,5746,1.1091460635978256
Hs 746.T,36462,3.4545901563724075
NCI-H1184,24951314,0.509325610287818
BT 231,6436223,-5.476432215723778
A4/Fukuda,1242560,1.4412010240031818
A4/Fukuda,72199292,-0.4044306818473915
OPM-2,10113978,1.3298356496360293
OPM-2,54618771,0.7318105179081044
HCC1395,3543504,4.796228677971328
OCI-AML-5,24901704,2.3734103392808654
HEC-59,4259181,0.197589789871654
JHUEM-3,navitoclax-PLX-4032 (1-1 mol-mol),1.9088785204953056
F-36P,374536,0.4233765448194311
NCI-H1568,ISOX-bortezomib (250-1 mol-mol),0.1016439372832729
KMS-20,9903786,1.7377090782754483
OAW28,44607530,1.1070032957823266
BL-70,11640390,3.0208984761128574
BT 428,208908,2.06929748575706
YH-13,446155,1.265827677839166
BT 231,25154868,3.3431445160715927
Ku812,81146,4.292819669950478
Hs 578T,73707398,0.3948619170486216
NCI-H2141,3634881,3.1690236174553585
HCC1395,5311281,2.89331930696188
TCCSUP,216468,4.422415170962146
SNU-201,10127622,4.665033244908399
BT 245,11626560,1.7100370824048363
OPM-2,6918837,-6.102124609605729
SNU-201,654092,-0.3059555613335444
Kasumi-2,5470400,-0.4099593110944021
KYSE-450,25126798,4.042128905943723
EM-2,44197249,2.692484862904757
KMS-20,40482356,4.999111533237927
BT 231,piperlongumine-MST-312 (1-1 mol-mol),1.6356177811620207
BT 428,1716436,2.552784613335119
B-CPAP,5978,-2.928384954309986
NU-DHL-1,46199207,3.5516049097640243
HPAC,54678924,1.8561933550327976
NU-DHL-1,11234052,4.39505697792573
OPM-2,52912189,-3.1407059889083424
BT 245,6438330,1.320789290711093
PF-382,2113511,5.305319424437295
KYSE-70,31703,-0.0860185315527888
Hs 746.T,135398738,5.267711785938934
BL-70,9967941,2.9606360281465633
LOU-NH91,2858523,2.98680776080117
SH-10-TC,2858523,3.111955399162426
RERF-LC-MS,65628,5.693639897620667
OPM-2,676352,1.691725548140899
BT-474,71729975,2.721564385291622
NCI-H1568,1716436,2.664872339798973
YH-13,676352,1.7621508381493205
TCCSUP,135999136,4.392620213932673
RKO,44185566,2.4837284923488063
WM88,24771867,4.963554195247929
BT 245,445091,5.914097889907909
Ku812,tretinoin-navitoclax (4-1 mol-mol),0.7122097782880589
HPAC,selumetinib-UNC0638 (4-1 mol-mol),1.8200541185814632
SW1783,44185566,3.100049600805726
NCI-H1568,46907787,2.5747387573296425
B-CPAP,navitoclax-MST-312 (1-1 mol-mol),0.2564145417879402
A4/Fukuda,6450551,1.0528971846899622
Rh30,5566,3.1777284256436427
Panc 03.27,3062316,-1.111132472951664
BT 231,3689413,-1.816097223149399
BT 248,sirolimus-bortezomib (250-1 mol-mol),0.4320618504093114
MM1.S,71466380,2.0255927209587545
BT-474,24180125,2.5464678025826077
OPM-2,10074640,2.1693178922200813
OPM-2,5738263,2.0935625564909737
SNU-1077,49766530,-1.9738465664800544
SF539,24785538,1.1616917641832667
BT 428,navitoclax-sorafenib (1-1 mol-mol),-0.0980408532530621
BT 428,11396600,2.03305192481219
Rh30,navitoclax-sorafenib (1-1 mol-mol),1.5684696096182007
Rh30,24772860,-2.9400063424346574
NCI-H1184,52947716,-5.613041301406408
M-07e,71466578,1.74036140165496
MM1.S,20959075,-2.7728358796049
BFTC-909,6914657,-4.61933610547547
BT 428,11626560,2.01118984130693
SNU-201,4917,3.5355655638709313
NCI-H1568,11626560,1.7284579168385834
HPAC,89183176,4.52247739398777
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757
Hs 746.T,11404337,-0.7817772551225204
OPM-2,51037431,4.229346700902662
EM-2,9952709,2.613630089148927
BT 231,11640390,3.090982905572894
BL-70,119607,3.8264541390064575
B-CPAP,49850262,4.514828878116323
A4/Fukuda,67156097,-3.3575882698535526
B-CPAP,9936388,2.314754665986152
NCI-H1568,135398738,4.732110826035958
HCC38,23635314,-3.269554438991392
M-07e,selumetinib-navitoclax (8-1 mol-mol),0.3594242166486681
Hs 746.T,24748573,4.0348301094522405
BT-474,753704,5.766357478861722
HCC1395,JQ-1-UNC0638 (2-1 mol-mol),1.3845299276438443
SNU-1041,4259181,1.3907235712067347
KMRC-20,637858,2.2731698678706027
OPM-2,55283,2.954343465689474
BL-70,1239801,3.4788502877624357
F-36P,3825829,2.646240330618036
MM1.S,16725315,3.2712240196505165
SNU-201,selumetinib-vorinostat (8-1 mol-mol),2.4684445780418023
EM-2,219104,1.7252421196805654
OCI-AML-3,6918328,-4.04542140242001
HPAC,49793307,-3.0278757543441097
PF-382,54619238,4.57773905156779
BT-474,1750826,-2.4258542316821443
PK-59,BRD-A02303741-carboplatin (1-1 mol-mol),4.4659430516991145
BT 428,19582717,3.674276995141217
B-CPAP,12003241,-1.7111954205398938
OCI-AML-3,44489675,3.675383998277318
NU-DHL-1,11494412,-1.1621345375437304
A4/Fukuda,613000,-0.1954730319333323
B-CPAP,10127622,5.805135395633265
SH-10-TC,11222830,1.9257045640321548
SNU-1041,selumetinib-JQ-1 (4-1 mol-mol),3.895658717247031
BT 248,3384730,2.3830241448741987
LOU-NH91,11625818,5.704636625331963
Kasumi-2,selumetinib-vorinostat (8-1 mol-mol),0.9890334474484956
SH-10-TC,135984461,4.500134355480999
AU565,selumetinib-JQ-1 (4-1 mol-mol),3.812986745391109
KMRC-20,11404337,0.8151706043014814
OPM-2,6918638,-1.573449675489913
Ku812,44489367,4.131127961346879
OCI-AML-5,135440466,-0.4990579394246729
YH-13,9907093,4.406851873711971
A4/Fukuda,451668,-0.3897468918932548
Hs 578T,151289,1.1375137613734745
CHP-212,135999136,3.677189987225608
BT 245,serdemetan-SCH-529074 (1-1 mol-mol),1.604944963016723
NCI-H1568,4477,0.3996701755478256
EM-2,123631,2.3525769389373816
BT 428,2842253,6.319982584211996
SNU-201,tanespimycin-bortezomib (250-1 mol-mol),1.2194348373634587
LOU-NH91,25062766,1.8056251936091945
Panc 03.27,176870,4.852253261369462
BFTC-909,4259181,-0.0277162117211437
KMS-20,selumetinib-decitabine (4-1 mol-mol),0.7829332375750434
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943
SNU-201,54649381,3.8467571339725097
PF-382,31703,-3.3313130558613864
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015
BT 428,navitoclax-PLX-4032 (1-1 mol-mol),0.8709631832027047
PF-382,54686904,2.766917504531429
Hs 746.T,107985,-3.710644419417041
SK-MEL-28,107985,-2.7940500151600296
WM88,44486219,4.4101496773663
M-07e,25227462,-4.517666723219549
YH-13,11222830,1.7805573322131083
NCI-H2141,25183872,-1.7111424136725184
RKO,439501,-1.8401322759847645
OCI-AML-3,25105715,3.5663156525686026
Hs 746.T,tanespimycin-bortezomib (250-1 mol-mol),-0.2857851889987055
LOU-NH91,5566,3.288881685822646
NU-DHL-1,71304818,2.6808989156503467
OCI-AML-3,23725625,3.1556136122260865
NU-DHL-1,107985,-5.852649208769622
M-07e,89928392,0.178694060348623
Ishikawa (Heraklio) 02 ER-,44819697,-1.0059186995092202
TCCSUP,10385095,1.359914637472657
M-07e,3503,1.1916077196017127
HPAC,2729026,1.6597744308968356
BT 231,16725315,3.17212658675725
NCI-H1184,55508,2.2833030511951873
BL-70,57330099,4.434094098426466
Ishikawa (Heraklio) 02 ER-,637858,2.5781304421684847
OAW28,6610216,3.9661844518771185
KMS-20,984333,0.9930989474187464
WM88,168313200,2.778601670140009
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588
HPAC,44819697,-0.5019591739785682
KYSE-70,11497983,4.3699696445826035
WM88,72193861,1.5960771175685142
PK-59,24951314,1.3549218223785395
NCI-H1568,11955716,5.84501437277453
HEC-59,11427553,3.984305268991984
Hs 746.T,24856436,0.2456273310367837
MM1.S,12003241,-0.8577985614667851
KMS-20,11707110,-4.269527722527802
SH-10-TC,65064,5.503769278334664
OPM-2,9952709,2.422518614873216
NCI-H2196,36462,0.5304143478440299
F-36P,carboplatin-UNC0638 (2-1 mol-mol),3.5835517234153076
EM-2,4259181,-0.3573100934145777
KHM-1B,24748573,1.6722296150954905
EM-2,25126798,2.5402836706971628
PK-59,5978,4.943835389639869
RERF-LC-MS,5278396,3.382202757419261
F-36P,4521392,3.975306023502133
M-07e,16722836,-0.6336741381307209
LOU-NH91,3025944,4.356407657994756
Panc 03.27,1242560,3.686163045625838
OCI-AML-5,44507138,1.2751551464880897
Hs 746.T,54143018,5.341200312649281
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826
RERF-LC-MS,24889392,5.73600211591012
OCI-AML-3,9936388,-8.90406813186184
KHM-1B,54143018,-0.2893377484312812
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764
M-07e,tanespimycin-bortezomib (250-1 mol-mol),-0.2341108641615783
F-36P,227681,3.7382992922650824
OCI-AML-5,10172275,3.79340943917399
BFTC-909,6918289,3.427790661189136
OCI-AML-3,46943432,-2.0174912276907637
NCI-H1568,25150857,2.4294918673251416
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904
Hs 746.T,56946209,-5.104166573285598
OCI-AML-3,6610355,3.3522807171842204
BFTC-909,6918328,0.6354681535452512
Hs 578T,4521392,4.243682299379431
WM88,66577038,3.306807869422002
HCC38,54618771,2.492060866479401
OCI-AML-3,navitoclax-gemcitabine (1-1 mol-mol),0.8976540383843732
BT-474,10113978,3.14664409379935
RERF-LC-MS,73707371,5.9060077591992375
BT 245,10231331,3.905394007999992
NCI-H1568,11455910,-0.0792581795853734
M-07e,11612883,1.6383267644864548
Panc 03.27,42642645,1.34765843522779
RKO,15547703,3.988071110220001
OPM-2,9933475,-1.3895511853659537
Hs 578T,11494412,1.776688404069291
A4/Fukuda,24964624,-0.76967256635286
PK-59,9956119,3.699648332900661
RKO,10127622,3.209405126939437
KMS-20,9929138,5.867169727564362
HPAC,25262965,0.4116499023727146
OAW28,3634881,3.2370607224140473
SNU-1077,100016,6.64200464659652
SH-10-TC,selumetinib-JQ-1 (4-1 mol-mol),1.9837436435885376
A4/Fukuda,168313016,2.0147776130358253
RERF-LC-MS,10184653,1.661334722418144
BT 231,42642645,0.5530706708925721
WM88,6505803,-1.994136504003607
B-CPAP,11640390,4.47725622860835
NCI-H2196,3062316,3.6506552915490262
HPAC,54649381,4.046091120445625
KHM-1B,24785538,-3.445065947322119
CHP-212,carboplatin-etoposide (40-17 mol-mol),0.0168821402853516
RKO,216239,1.9979551619375524
A4/Fukuda,10113978,1.900139268592958
KMS-20,135928012,3.091470628632976
SW1783,3825829,4.196997387332537
B-CPAP,24180719,2.0507449605485033
BT-474,vorinostat-carboplatin (1-1 mol-mol),3.1997108313196336
OCI-AML-3,3825829,3.7401641430818855
KHM-1B,753704,4.849440364052096
HEC-59,6918837,-2.4267490005484276
NU-DHL-1,44202524,1.452274997974498
BT 248,11656518,0.6524098808252552
YH-13,25227462,0.7870312069105344
SNU-410,25150857,2.4715330033988696
KMS-20,5113032,5.7855573183073785
SK-MEL-28,11656518,2.5099458397006145
BL-70,11612883,1.8511164264219664
B-CPAP,5280436,3.7013840992858986
BT 245,44491742,4.161467905313556
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885
YH-13,9935249,4.648604322917456
MM1.S,67291369,-0.2087334312967911
OCI-AML-3,54626689,4.470214284670753
BT 428,11497983,4.077786737924683
RKO,6610355,5.147293026177706
Panc 03.27,15547703,2.847204137799657
BL-70,navitoclax-gemcitabine (1-1 mol-mol),0.7163851614182694
KMRC-20,5278396,3.577157973061421
B-CPAP,5278396,3.4451534548070804
NU-DHL-1,decitabine-navitoclax (2-1 mol-mol),-3.2385891621120786
OPM-2,SNX-2112-bortezomib (250-1 mol-mol),-3.9902018365290752
NCI-H2196,3825829,4.206354506385182
SNU-410,9866186,3.967328187802507
OCI-AML-3,56946209,-6.964287496799676
OCI-AML-3,252682,5.83898658366456
KHM-1B,44632017,0.9077135445845732
YH-13,1242560,3.390662173618847
Ku812,4917,2.1486710085794907
KHM-1B,135984461,4.335909278526869
OAW28,docetaxel-tanespimycin (2-1 mol-mol),3.524507000700441
BT-474,3854666,3.675072420225406
F-36P,11625818,4.163837003749958
KHM-1B,1716436,3.4645640712789545
Ku812,6610355,4.836489952876677
BT 248,54626689,4.44361910749143
KHM-1B,374536,2.314533071976094
SH-10-TC,44486219,4.783829432677871
Ishikawa (Heraklio) 02 ER-,135411,1.0348224013117624
RERF-LC-MS,2871966,0.0193381278585586
Ku812,66577038,1.5928904454568968
EM-2,3038522,3.0912713103893092
B-CPAP,doxorubicin-navitoclax (2-1 mol-mol),0.582190958380646
YKG-1,135440466,3.3595523458828582
OPM-2,5287969,-2.4106191892149185
SH-10-TC,24753719,4.195244142324667
TCCSUP,57519531,2.9959744097146803
SNU-1041,3543504,4.393335790159402
OCI-AML-3,82146,-1.156514008538712
SW1783,11175137,2.286839278211157
WM88,984333,4.504683999610223
HEC-59,11396600,4.681293728583163
B-CPAP,11609586,4.122165381910798
TCCSUP,54454,2.1286318992115523
EM-2,49793307,-4.620835637641334
SK-MEL-28,selumetinib-vorinostat (8-1 mol-mol),1.183939454839272
M-07e,285033,-4.498567211303036
NCI-H1568,12003241,-1.4870303892505918
NCI-H1184,9840324,5.4733932573087865
BL-70,UNC0638-navitoclax (1-1 mol-mol),1.3205011863889164
OCI-AML-3,50905018,4.141422970853829
HPAC,11497983,4.0027472845681515
KYSE-450,6918328,1.5468903828461986
HCC38,24772860,-1.637699125532294
AU565,selumetinib-decitabine (4-1 mol-mol),5.684619389149027
BT-474,46215462,-0.6292881317207447
KMS-20,45279963,3.236905004417033
EM-2,10410894,3.1257591597738057
YH-13,11178236,-3.430618404279131
KHM-1B,9911830,2.660270688725906
Ku812,5280436,2.864612594738688
MM1.S,navitoclax-pluripotin (1-1 mol-mol),-0.4741986975069364
EM-2,3476986,6.360745127157406
A4/Fukuda,11497983,-1.0595923666648657
NCI-H2196,44607531,1.4318185061669224
EM-2,selumetinib-MK-2206 (8-1 mol-mol),-0.7380584462293082
PK-59,327653,2.872249707318676
BT 245,11494412,1.2412391063444357
BT-474,285033,1.1385337895542051
PK-59,23582824,0.9321651251989737
HCC38,135440466,3.040649700798949
Kasumi-2,16725315,3.214174294489856
OCI-AML-3,71680916,3.9387679049468662
A4/Fukuda,25150857,1.0832866246256998
F-36P,25161177,4.314066575280123
NCI-H1568,9903786,2.4011050725962115
BT 245,9956119,4.332681087090165
SNU-201,3825829,6.229287802510879
OCI-AML-5,vorinostat-navitoclax (4-1 mol-mol),-0.1481946673582673
HPAC,73707398,1.2360196797474063
BT 245,56649450,2.8360361021464153
Ishikawa (Heraklio) 02 ER-,135984461,4.462174661404989
OCI-AML-3,44493528,4.354469059332478
KMS-20,sirolimus-bortezomib (250-1 mol-mol),-0.3833823463346493
OCI-AML-5,selumetinib-MK-2206 (8-1 mol-mol),1.559609014445038
A4/Fukuda,448949,1.1686862984883333
BL-70,24748573,0.2316526202491049
OCI-AML-5,9911463,4.375280736441336
F-36P,53232,0.800098170999657
MM1.S,6918328,-1.8285057660481956
OCI-AML-5,5282054,4.213169919550947
Ku812,9911463,3.2535027234043428
OAW28,2746,2.637952220594215
Ku812,65064,2.9938168255221234
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561
CHP-212,11977753,-2.078540982070844
RKO,11497983,5.954072388877685
LOU-NH91,56963564,0.9665729866263152
Kasumi-2,11960529,3.120745126362072
OPM-2,25195348,0.9238255530721258
M-07e,216345,3.055244078925537
AU565,54143018,-0.7127893506095456
BT 428,57519531,1.7002973533738803
Panc 03.27,71751553,4.542100190957626
A4/Fukuda,3825829,2.918538307685252
RKO,60700,-0.2024014556335324
AU565,10322450,3.206832643999438
MM1.S,654092,-1.4935807523777964
BT 231,9935249,0.8788796020104754
WM88,24856436,-0.0891608575529825
HEC-59,5566,3.2238031529382503
KMRC-20,3689413,-2.0293333018936877
F-36P,5278396,1.755453997739571
B-CPAP,568763,0.5693864802501477
Ishikawa (Heraklio) 02 ER-,6623618,2.4883091663995573
Ishikawa (Heraklio) 02 ER-,54686904,4.48248797889717
KYSE-70,135398516,2.3739819683449697
PF-382,25062766,1.5708468674433018
NCI-H1568,3689413,-2.0602171008804935
KYSE-70,23582824,2.6933165956875964
YH-13,984333,1.552799653388661
WM88,navitoclax-gemcitabine (1-1 mol-mol),-0.1692870837870824
SNU-1077,44185566,3.0312162489563
SK-MEL-28,448949,3.238404607580412
EM-2,2742550,3.298238405542188
SF539,54649381,3.7800507892247337
NCI-H2196,11647372,1.2888238257400464
NCI-H1184,2828334,4.189450986247214
Hs 746.T,5284616,3.097035289506831
SF539,46943432,2.0271543904998746
WM88,selumetinib-decitabine (4-1 mol-mol),-3.434119492903465
SH-10-TC,sirolimus-bortezomib (250-1 mol-mol),0.4964962482728405
NCI-H1568,54618164,3.652866089784218
Ishikawa (Heraklio) 02 ER-,serdemetan-SCH-529074 (1-1 mol-mol),2.9825928207078265
BT 231,9840324,6.772243442572783
JHUEM-3,16659841,3.9599472358481536
SF539,135999136,1.70209400272594
BFTC-909,31703,-0.9928331583982526
SNU-201,159324,4.275700676511976
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673
NCI-H1568,9936388,-8.53108348301746
BT 231,156414,0.9770079511825466
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306
SNU-1077,BRD-K99584050,5.679511546826054
JHUEM-3,448949,0.998183231629742
KHM-1B,73707438,4.044668520699287
M-07e,135999136,1.658429474822417
LC-1F,208908,-2.6224603493914116
WM88,9915743,1.087537207724937
RERF-LC-MS,11719255,3.775646564562419
HCC38,51039095,3.721369027179063
BT 428,11625818,4.823879668280646
BT 248,10385095,1.1706577035646757
NCI-H1184,6623618,1.9813921864303763
Panc 03.27,54596558,4.465904427588448
B-CPAP,2858523,3.8252210780622753
Ishikawa (Heraklio) 02 ER-,2749,1.9668009666104345
SNU-1041,44819697,4.696120986428178
LC-1F,vorinostat-carboplatin (1-1 mol-mol),3.977330013570287
SNU-410,15547703,3.390802226431956
HEC-59,9868037,3.1649055297895483
BT 248,3543504,4.235039119755324
OCI-AML-3,4477,0.3031317586461088
Rh30,9967941,3.902827442671368
NCI-H2196,135999136,3.7154561762942353
SNU-410,11404337,1.1102019570699369
Hs 578T,387447,-4.966638212642196
OAW28,SNX-2112-bortezomib (250-1 mol-mol),0.074441727324656
TCCSUP,135423438,2.289740320598626
NCI-H1568,60700,-0.8736945480852499
BT 428,JQ-1-carboplatin (1-1 mol-mol),-0.3144310627215171
Ku812,71466445,2.9617943038056858
NCI-H1568,53232,2.5527200815554587
NCI-H1568,56963564,0.2273202395709376
KMS-20,11977753,-3.0017304932885525
HCC1395,10074640,2.847951032775489
KMS-20,JQ-1-vorinostat (2-1 mol-mol),-0.6306779482230097
PK-59,11238147,2.718340913580302
Hs 578T,1566236,1.5797547304061297
MM1.S,vorinostat-carboplatin (1-1 mol-mol),1.8626350946674588
F-36P,53392493,1.6104194986145994
KYSE-70,5329102,1.9375891375175784
SF539,2945648,2.8527116162154353
EM-2,navitoclax-PLX-4032 (1-1 mol-mol),-0.42768980992465
LOU-NH91,89928392,1.577129115434841
JHUEM-3,11404337,-0.7844272598135029
SK-MEL-28,3815108,3.819854777392354
TCCSUP,3689413,0.6301346851622357
SF539,11214940,4.4904347227847845
F-36P,9868037,2.720274888315988
RERF-LC-MS,44819697,-0.3406635094896507
Panc 03.27,BRD-A02303741-navitoclax (2-1 mol-mol),3.595594200982221
Ku812,5978,-3.250465069954706
OCI-AML-3,5284616,2.990677250744112
WM88,6450551,3.000697940838796
SF539,65064,4.983930962156341
SF539,6610355,4.186308559739079
Hs 746.T,54626689,4.6397128820346545
SNU-1077,3062316,-1.266961456390888
NCI-H2196,753704,4.611974031868
AU565,9933475,1.5968241540352486
KYSE-450,135421197,2.3081928088852774
EM-2,100016,3.5566389909433913
BT-474,11152667,2.684788398514369
RERF-LC-MS,44607531,1.5104561529736475
F-36P,tanespimycin-bortezomib (250-1 mol-mol),-0.3225177069442169
NCI-H2196,49793307,-3.360777131062058
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337
BFTC-909,49867926,6.076136735210805
NCI-H2196,25062766,3.6284236406218806
EM-2,11175137,-0.0823473660124878
A4/Fukuda,126941,-4.18863393868508
Panc 03.27,11657048,4.395937851793667
Hs 746.T,4705,3.427191561764603
KMS-20,5460769,-0.4034471516809727
NCI-H1568,42642645,1.4281976900349445
CHP-212,156414,1.607333676424714
OAW28,4261,1.5275003221448853
LOU-NH91,11485656,3.2972382499502935
PK-59,6852167,1.7961367286330785
NU-DHL-1,16065773,1.845713529586983
KHM-1B,135398516,0.0363584972585632
OCI-AML-3,44137675,1.272952344759978
SF539,2708,3.2874630457066103
RERF-LC-MS,25062766,1.7296886540377192
BT 248,2742550,4.585670765822412
NCI-H2196,4917,3.304725030213262
HCC1395,44185566,2.615695329349714
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955
BT 231,71680916,5.057074088100034
A4/Fukuda,6610216,3.4719570509087445
AU565,navitoclax-MST-312 (1-1 mol-mol),1.5837862455188414
NU-DHL-1,156414,1.5243299906287209
OCI-AML-3,216468,-1.487051655992129
BT 231,4378219,1.1996674528146534
SW1783,9911463,3.515685844560525
BT-474,49766530,-0.1663339170498422
SH-10-TC,6438330,3.0073077146983014
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645
KHM-1B,49766530,-2.233986045015649
BT-474,2858523,3.2359721267668338
MM1.S,54613361,-0.4658763422564649
KYSE-450,selumetinib-JQ-1 (4-1 mol-mol),2.8795541061049104
RERF-LC-MS,44543605,4.169252612552019
BT 231,44486219,4.544633724020731
SF539,3552672,1.9155568088960504
BT 245,176870,4.326082130585301
OPM-2,25161177,3.2493247866394497
KYSE-450,54143018,5.589609383601229
SNU-1077,11364421,-1.165916970108604
SNU-410,11626560,2.524815752682962
Ishikawa (Heraklio) 02 ER-,selumetinib-GDC-0941 (4-1 mol-mol),4.857183586946226
BFTC-909,46199207,3.2760821272908753
Hs 578T,148198,-5.652583246713905
KMS-20,erlotinib-PLX-4032 (2-1 mol-mol),2.78905431504454
Kasumi-2,123631,2.0188728462797885
KHM-1B,46224516,1.9552041904833992
OCI-AML-3,36314,-6.809171649725695
AU565,445455,4.9301368045011955
HCC1395,selumetinib-UNC0638 (4-1 mol-mol),4.110750455749224
Panc 03.27,10113978,5.529968312191359
NU-DHL-1,65628,2.3268847474457317
KMS-20,135875424,2.456374257858295
OCI-AML-3,6918837,-6.1001312993935235
Kasumi-2,67156097,-2.3799018148926363
NCI-H2141,6918638,0.0318107940340185
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006
M-07e,445091,4.269249954040153
A4/Fukuda,6852167,0.513003696591474
AU565,71466380,5.723316888337632
OPM-2,selumetinib-PLX-4032 (8-1 mol-mol),2.3146569091496847
KMRC-20,4521392,5.860934935010035
B-CPAP,44632017,0.6151309315152113
BT 248,65628,4.438815715072134
BFTC-909,126941,-2.0975077483758415
KMRC-20,6918328,1.7545350572530505
KMS-20,10184653,1.4307527517519167
JHUEM-3,11228183,1.908121000076068
NCI-H2196,6438330,1.983062396246339
KHM-1B,11396600,1.492899305921399
OAW28,89928392,1.6809049325642302
OPM-2,1242560,2.912152501304371
WM88,5278396,3.739694557269865
F-36P,56963564,-1.5146326698639885
NCI-H2196,10113978,3.0563703037525563
YKG-1,56946209,-4.319334777154593
NCI-H1184,159324,2.6311703367057735
AU565,12001922,1.255153902569356
NU-DHL-1,11657048,4.264544687406424
MM1.S,3689413,-0.3922685663675629
A4/Fukuda,16659841,2.2699989015311437
NCI-H1184,navitoclax-birinapant (1-1 mol-mol),-1.6244289757751649
JHUEM-3,72193861,1.179960039265137
BL-70,44607530,1.3906618918136224
Rh30,65064,4.473400899002483
Hs 746.T,3081361,2.629089622108149
JHUEM-3,25183872,-2.161840052649104
Hs 746.T,1566236,1.9781542235751777
JHUEM-3,4378219,2.140768713132357
HEC-59,11626560,1.9626480821004375
PK-59,11152667,-0.441675469971464
OCI-AML-5,68056272,3.273198140957602
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745
B-CPAP,702558,4.9966107855915025
CHP-212,25183872,-3.423385497517024
PK-59,10184653,1.3879688044305338
YH-13,selumetinib-tretinoin (2-1 mol-mol),4.993849877011519
Rh30,66577038,3.0829283966665666
Ku812,44487061,4.391820137967094
BFTC-909,2945648,3.347829093032643
NU-DHL-1,5278396,3.036483105356944
OAW28,2871966,-1.501513911524366
Panc 03.27,5284616,3.395951401773127
F-36P,navitoclax-pluripotin (1-1 mol-mol),-1.2293372555397408
OCI-AML-5,6914657,-4.691318166690598
Ku812,24772860,-3.654878232310525
TCCSUP,71680916,5.285506040868583
WM88,5460769,5.637392858071443
NCI-H2196,16736978,1.688501420337765
LOU-NH91,31703,0.5806868540812907
NCI-H1568,SNX-2112-bortezomib (250-1 mol-mol),1.539717951588267
NCI-H1184,11175137,1.4506620497778688
ML-1 [Human thyroid carcinoma],613753,2.773006926215127
NCI-H1184,JQ-1-vorinostat (2-1 mol-mol),-0.1689466079495752
F-36P,11178236,-5.377845501416466
WM88,216345,2.6539539596852832
SF539,5281321,-2.202189901262438
KMS-20,6610216,3.669058069013872
TCCSUP,25102847,1.617856098484916
M-07e,9907093,3.183561562511975
M-07e,5351362,1.1216571365003567
NCI-H2196,navitoclax-MST-312 (1-1 mol-mol),-1.5400105854314718
Hs 746.T,9903786,3.9786506562957857
CHP-212,46943432,0.8435958840220231
SH-10-TC,4915,4.4873145327623165
SNU-201,42642645,0.8167686700637609
Ishikawa (Heraklio) 02 ER-,3825829,3.6769006859587465
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898
OAW28,5329102,1.8792475137868745
WM88,44137675,2.7368794575153297
CHP-212,5329102,1.5596413811393564
TCCSUP,5746,1.7637111796176403
TCCSUP,56946209,-3.1340499895794487
HEC-59,5738263,2.927589060820849
SW1783,3062316,3.7843864001460585
BT 245,168313016,5.350977355116985
HEC-59,selumetinib-MK-2206 (8-1 mol-mol),3.505751626567778
Hs 578T,45279963,3.679484147560198
SNU-1077,327653,3.4488214544204108
NCI-H1568,637858,1.7833024505225796
HPAC,11977753,-2.1694262680091647
SH-10-TC,71304818,2.623426250805098
EM-2,6917907,-6.1647478737517085
SW1783,11427553,2.7214554119768253
EM-2,445643,3.306384486011016
SK-MEL-28,15983966,3.2325576409024306
SH-10-TC,vorinostat-navitoclax (4-1 mol-mol),1.8573800720783624
WM88,9927531,4.19876481787408
M-07e,23582824,1.2567884413455463
BT 248,crizotinib-PLX-4032 (2-1 mol-mol),2.0944776626354145
Rh30,2841722,3.877400289186595
WM88,navitoclax-MST-312 (1-1 mol-mol),0.2225229653528475
NCI-H1184,JQ-1-UNC0638 (2-1 mol-mol),0.2682275466719458
SNU-1077,46398810,3.015075111637921
HPAC,89928392,1.4293004279776904
MM1.S,16741245,2.4226245621755016
KMS-20,25102847,2.4151614593065687
SF539,24771867,1.191281674737788
JHUEM-3,23582824,-0.0189879977252751
KYSE-70,15547703,3.259406085484829
LOU-NH91,168313200,3.810508485111527
KMRC-20,4259181,0.4653117276954742
NU-DHL-1,969516,2.257710289132893
NCI-H1568,selumetinib-PLX-4032 (8-1 mol-mol),3.6289743773432463
M-07e,6252,-2.4917513212756743
SNU-1077,31703,0.2109886329086631
F-36P,25150857,2.3824721304499525
HEC-59,168312962,0.7910780148254808
BL-70,JQ-1-navitoclax (2-1 mol-mol),0.9082811735719324
HEC-59,56946209,-3.4586465616097115
NCI-H2196,11497983,3.9569492222692486
RERF-LC-MS,46926350,-4.177207395055215
MM1.S,5311,0.1972006182392905
BT-474,11497983,4.161539514044278
CHP-212,SNX-2112-bortezomib (250-1 mol-mol),-3.483691820004818
Hs 746.T,57519531,4.019299052372805
BT 231,selumetinib-BRD-A02303741 (4-1 mol-mol),4.927656372252654
YH-13,71304818,3.292650030763082
OCI-AML-5,2749,1.8866677486589416
A4/Fukuda,3038522,1.5780319148667876
PK-59,3025986,-0.9792937784046736
OCI-AML-3,selumetinib-vorinostat (8-1 mol-mol),-2.4724160390070775
Hs 578T,5291,3.890279554245784
OPM-2,451668,-1.14063259637223
PK-59,656346,3.7782879142380223
OCI-AML-5,71466578,3.0542675133703043
NCI-H1184,568763,-1.4027820322774178
A4/Fukuda,49793307,-5.572580515048152
HPAC,104842,-2.029183898860438
NCI-H1568,11234052,4.07711650557102
KMRC-20,5738263,3.585563727578386
CHP-212,navitoclax-piperlongumine (1-1 mol-mol),1.046764914596096
HCC38,46191454,1.871395469364849
SNU-1077,135875424,3.798963502018643
OCI-AML-3,426756,3.262354468882222
KMRC-20,serdemetan-SCH-529074 (1-1 mol-mol),2.30805961058782
SK-MEL-28,3503,2.655926478699229
RERF-LC-MS,6450551,1.967154760545028
NCI-H2196,5328940,2.5017536033861636
F-36P,44185566,1.4240664943948855
B-CPAP,2742550,3.2183332694531677
WM88,piperlongumine-MST-312 (1-1 mol-mol),1.2677993928143405
CHP-212,11152667,-1.2052121008957308
BT 248,448949,1.935087924253196
YH-13,navitoclax-MST-312 (1-1 mol-mol),0.5038954748118908
SF539,6505803,-2.26727491960267
NCI-H2196,6918837,-3.014537811847841
YH-13,216239,3.5317850372057875
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604
Panc 03.27,10302451,2.8157600725630285
Hs 746.T,11485656,1.8868493516636309
M-07e,12003241,-1.0456216878354962
M-07e,6610355,4.801428196018308
Hs 746.T,2746,3.181547233706405
BT-474,54618164,4.811471489444681
SH-10-TC,219104,5.972139545321541
BT 231,BRD-A02303741-navitoclax (2-1 mol-mol),1.5568540270534312
BL-70,3384730,0.8581268367118473
WM88,60700,0.1586114412807986
ML-1 [Human thyroid carcinoma],119607,6.010030667993389
NCI-H1184,23725625,1.7631759370386808
CHP-212,44137675,1.82018000392081
Ku812,421610,4.009209669697973
WM88,71466380,6.059100138430469
Ishikawa (Heraklio) 02 ER-,6918837,-2.157882723850199
M-07e,451668,-0.7243038236089275
Panc 03.27,24753719,4.289669652814175
M-07e,44819697,-3.638077249984544
PF-382,9936388,-6.688930185968071
WM88,42642645,0.6445252364672451
Hs 746.T,12003241,0.0057336203254279
OCI-AML-5,11455910,0.2167444305252664
NU-DHL-1,54618795,3.1409617958317613
KMS-20,selumetinib-MK-2206 (8-1 mol-mol),-0.1303266651447604
Hs 746.T,9911830,2.0393711728362742
BT 428,JQ-1-vorinostat (2-1 mol-mol),1.3063332491607542
B-CPAP,71466380,5.72068384087767
OPM-2,984333,-0.0237710386013994
F-36P,400769,-1.0160755777091484
BT 428,11167602,1.02406203093047
JHUEM-3,11955716,-2.212927745337121
NCI-H1184,53495165,-0.4368789773633023
OAW28,44493528,4.631141764792384
NCI-H1184,327653,2.728641844903854
Kasumi-2,44202524,1.2131871054756846
PF-382,24951314,-0.325943641902455
CHP-212,10322450,3.626434944218361
SNU-1077,navitoclax-MST-312 (1-1 mol-mol),0.8913326642927005
SF539,11609586,2.890542664621997
Hs 746.T,docetaxel-tanespimycin (2-1 mol-mol),-3.1001409090640633
Hs 746.T,24180125,3.39079368613673
EM-2,4521392,3.5405967764389605
SK-MEL-28,445091,4.3007151256708465
SNU-410,11485656,3.512018724098686
NU-DHL-1,9866186,-1.5869624207218205
B-CPAP,3025986,-0.4402744991779203
OCI-AML-5,57330099,4.172360006855885
KHM-1B,65064,3.270159834561764
BL-70,12003241,-2.1974938808167477
HCC38,carboplatin-UNC0638 (2-1 mol-mol),3.967929549456712
SNU-1077,1750826,-2.704976435926544
HPAC,5311,1.6917803616350957
HEC-59,107970,2.7080521474876353
M-07e,alisertib-navitoclax (2-1 mol-mol),-1.779160184437099
SH-10-TC,56949517,5.718073548295289
NCI-H2196,246676,4.3795263450239466
NCI-H2196,16659841,5.310980792885838
OAW28,1750826,-3.338956149870334
Kasumi-2,613753,2.4327594137588235
SNU-1041,selumetinib-navitoclax (8-1 mol-mol),1.7433526063921374
PF-382,5284373,-1.433673800360202
F-36P,10127622,0.8562286429943948
OPM-2,10127622,2.4771662101119194
NCI-H2141,49766530,-3.0033448616594174
RKO,24951314,1.467797052763695
Hs 746.T,3136844,4.217176926190934
OPM-2,erlotinib-PLX-4032 (2-1 mol-mol),3.4874212858880314
KMS-20,navitoclax-pluripotin (1-1 mol-mol),-1.7464713167457526
NU-DHL-1,24964624,0.3458888815745198
TCCSUP,57330099,4.986462210926318
M-07e,135984461,4.142111283006845
NU-DHL-1,9967941,3.65346263984122
OPM-2,16065773,1.0643824527623371
BFTC-909,11656518,3.71751997684089
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992
KMRC-20,24901704,3.0273609194565276
HPAC,3038522,4.207675587859784
BFTC-909,49793307,-2.946331542038894
EM-2,60700,-3.203493517629244
KYSE-450,49793307,-1.8889821153375816
Hs 746.T,2949965,2.5911017339457376
HEC-59,52947716,-4.468416270060415
SF539,54618795,3.1497169107131944
OPM-2,216345,2.3930113976289364
SNU-1077,12003241,-1.4220834787906382
NU-DHL-1,10231331,-1.2748802736904843
KHM-1B,151289,0.8227956110380268
Rh30,11455910,-0.173986116803538
BFTC-909,46398810,2.674147192871529
SNU-410,46398810,3.389038831665408
JHUEM-3,25062766,2.815080247550529
BT 231,446155,3.92416274511038
NU-DHL-1,327653,2.351197542951544
OCI-AML-5,104842,-5.52397744608637
YKG-1,3025944,4.339643197163568
JHUEM-3,44607530,0.7859330404111782
SH-10-TC,11178236,-1.091819922208369
SH-10-TC,10113978,3.8415691317550817
KYSE-450,66577038,3.5261008260070232
OPM-2,3543504,2.699241331915609
TCCSUP,selumetinib-tretinoin (2-1 mol-mol),7.288595889127544
BT-474,119607,5.335680183602822
YH-13,462382,1.032048022649818
OCI-AML-3,9823820,3.798730066756636
JHUEM-3,16736978,2.3431874736146483
PF-382,5311281,0.0181022265462825
NCI-H1568,11175137,2.3278621292073067
CHP-212,44462760,3.688271154574206
PF-382,54619267,3.0349882951687124
Panc 03.27,5738263,4.073885064574103
YKG-1,135421197,3.1079510852519343
BT 428,2871966,-0.987943438034776
BL-70,107985,-2.6237617688158044
NCI-H1568,44607531,1.2688225542701184
Kasumi-2,439501,-3.441659601561783
SK-MEL-28,24964624,3.0237245783497144
SH-10-TC,3503,2.8690160569101177
MM1.S,3025986,-1.7222159842477116
HEC-59,9887053,4.859779160998265
F-36P,969516,2.435122967405124
Hs 578T,25126798,3.6480087721755208
BT 231,46215462,1.880784914249253
NCI-H1184,3025986,-0.9159753736061448
BFTC-909,1716436,3.115342072857748
TCCSUP,carboplatin-etoposide (40-17 mol-mol),3.482858760059233
JHUEM-3,selumetinib-GDC-0941 (4-1 mol-mol),0.9560042848605832
NCI-H1568,alisertib-navitoclax (2-1 mol-mol),0.1984676648447771
KYSE-70,67156097,-2.3379446798215127
EM-2,8515,3.0626946322597495
HCC1395,42642645,0.5743147089668765
Hs 746.T,46215462,1.5005815456113627
EM-2,11364421,-4.990723119793736
NCI-H2196,crizotinib-PLX-4032 (2-1 mol-mol),2.7011125549758703
KMS-20,carboplatin-etoposide (40-17 mol-mol),1.5141675555174716
Kasumi-2,piperlongumine-MST-312 (1-1 mol-mol),0.99360798269259
YKG-1,56973724,4.73671500707
NCI-H1184,5311281,0.6148174654774908
Rh30,568763,0.0447634760099069
F-36P,11507802,0.4820601188446026
M-07e,selumetinib-decitabine (4-1 mol-mol),0.3299645760965073
LOU-NH91,400769,-0.4518117512524929
BT 231,46926350,-3.728380335496617
BFTC-909,3025944,6.464154930724253
NU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),2.559491717642415
NCI-H2196,25154868,4.017183037799215
AU565,49836020,5.742264990221176
TCCSUP,753704,5.368261344163991
OPM-2,3676137,3.169610101166173
KHM-1B,44137675,2.3063788474236957
KYSE-450,tanespimycin-gemcitabine (1-1 mol-mol),0.8586762777270994
OCI-AML-5,9933475,1.7649021696450673
BT 248,salermide-PLX-4032 (12-1 mol-mol),3.4628856053275623
KMRC-20,navitoclax-piperlongumine (1-1 mol-mol),2.618402251211732
KYSE-70,6610355,4.961596413135767
SNU-1077,10127622,3.7411047555393937
OAW28,159324,2.7212056331712584
YH-13,5284373,3.689481808678744
Ishikawa (Heraklio) 02 ER-,375860,-0.5414643002476628
TCCSUP,42611257,3.7923980265844417
BT 248,5284373,1.9481267041892785
M-07e,375860,-0.7306719237293631
BL-70,10074640,2.9827949799937974
OPM-2,16659841,1.643311806599576
SNU-1041,11364421,0.4809927528184007
OPM-2,613753,2.6904302784099845
PF-382,71466445,1.9189761436188
Rh30,11626560,1.009995552955629
OPM-2,carboplatin-UNC0638 (2-1 mol-mol),3.55532531474596
SF539,23635314,-2.6621769118066516
EM-2,15953870,2.1302046604776246
A4/Fukuda,decitabine-navitoclax (2-1 mol-mol),-0.552282956789893
PK-59,46398810,2.7267384193552138
EM-2,24964624,0.883710786600826
SH-10-TC,selumetinib-piperlongumine (8-1 mol-mol),4.535411229523672
SF539,24964624,1.5849083379984652
NCI-H1568,71680916,4.3779497666633915
BT 231,11404337,-1.7001463923522222
OPM-2,selumetinib-vorinostat (8-1 mol-mol),1.6127891772049152
NCI-H2141,71466380,4.2522013405166845
F-36P,24856436,-0.3460726773190385
BL-70,24772860,-2.823895341725822
YKG-1,12001922,2.2090036010272533
F-36P,40482356,5.08817235841337
KYSE-450,135999136,4.777760732357945
SNU-1041,44137675,3.693690220724039
SW1783,54678924,1.5903593535652931
NCI-H1184,44137675,0.6567498041405646
Ku812,15953870,2.600365830737877
OAW28,969516,2.7253654251657573
KHM-1B,55283,0.1410687049284859
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136
OPM-2,135659046,2.7260896342727396
PF-382,11178236,-3.5800251896914217
JHUEM-3,tretinoin-navitoclax (4-1 mol-mol),2.088193706968422
SNU-201,selumetinib-JQ-1 (4-1 mol-mol),2.2194070686066936
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837
Ishikawa (Heraklio) 02 ER-,2113511,6.44696553925794
RKO,60750,-2.2331483998906654
CHP-212,54618164,3.610920674376875
HEC-59,docetaxel-tanespimycin (2-1 mol-mol),1.0930728747777247
B-CPAP,444795,4.737983928137852
NCI-H1184,11396600,3.277329955302312
Kasumi-2,46199207,3.5720995907025803
Hs 578T,5351362,1.1025720970657964
BT 231,2871966,-0.0780326916631559
YKG-1,3634881,3.332049721322664
Panc 03.27,2749,1.5209865034838173
BT 245,11175137,2.6042649387575416
BFTC-909,421610,2.763760389372973
CHP-212,2126,3.521473976640406
SNU-1041,25262965,1.8385732329989617
SH-10-TC,25227462,0.5393634765398699
OCI-AML-3,46843906,-0.726678553925118
HCC1395,16038120,0.4783270227763867
RERF-LC-MS,17755052,1.8057357372617977
Kasumi-2,11719255,0.7919357371697194
Ishikawa (Heraklio) 02 ER-,25150857,3.52195802323882
SNU-410,6918289,3.0262320223327137
Ku812,46174525,2.0497895392537133
Hs 578T,2858523,3.1861124676909167
Hs 746.T,carboplatin-UNC0638 (2-1 mol-mol),3.4732218236946917
Ishikawa (Heraklio) 02 ER-,135421197,3.044962376223266
TCCSUP,89928392,1.641879388054528
LOU-NH91,44137675,3.1585262513685612
BT-474,1641662,3.939390004584476
NCI-H2141,3503,1.502890257577659
BT 248,637858,2.256250159493538
BFTC-909,400769,-0.3884900564724624
OCI-AML-3,44607531,0.9749271338875156
NU-DHL-1,135928012,0.9972695617711916
OAW28,24901704,3.441244042276163
BT 248,11222830,0.9088188698521174
CHP-212,15547703,3.0798005678636353
F-36P,15983966,-4.937765850847769
Hs 578T,3025944,3.797746443766106
KYSE-450,3062316,2.5043987549881725
KHM-1B,327653,2.4267430839124455
NCI-H1568,374536,1.2941902477204823
BT-474,11175137,2.6766646309892668
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624
OCI-AML-3,49836020,4.587745933093821
AU565,25195348,3.492226581515367
BT 428,9933475,1.589178678018796
YKG-1,2729026,3.207992670398629
TCCSUP,selumetinib-GDC-0941 (4-1 mol-mol),1.9950465927761605
JHUEM-3,135398516,1.8272445804379944
SNU-201,erlotinib-PLX-4032 (2-1 mol-mol),5.557669329714272
OCI-AML-3,44462760,1.9613578150902309
SNU-1077,2733487,8.302697103942196
F-36P,107985,-4.433418239536547
OCI-AML-3,46191454,-3.518642139127663
NCI-H2196,24951314,2.079668529735556
PF-382,11396600,2.839145334831077
SNU-201,6914657,-3.5339445523329043
BT-474,44486219,6.193461879921216
OCI-AML-3,9915743,0.4173420308342337
OCI-AML-5,89928392,1.490186880785511
KHM-1B,71304818,1.1498757447247578
CHP-212,5978,-3.291232307768633
Ku812,44137675,4.859064076132382
OAW28,9907093,4.094861416701174
SF539,246676,6.084250396214504
BT 428,82146,3.6863025741457136
PF-382,9549297,1.2295304859743053
CHP-212,44566777,-0.3632398488321025
KMS-20,49766530,-1.2962307066769267
M-07e,selumetinib-tretinoin (2-1 mol-mol),-0.1759517577627258
M-07e,54618771,0.3587170705521248
KMRC-20,9907093,5.120567595099458
CHP-212,11719255,4.061461208951987
A4/Fukuda,24748573,1.3032837048402657
RKO,568763,0.6942409100068829
WM88,2733526,4.251409744588183
NU-DHL-1,3081361,1.944566373471897
KMS-20,11167602,1.9500667412435135
TCCSUP,5280436,3.7871287976810097
OCI-AML-5,selumetinib-BRD-A02303741 (4-1 mol-mol),2.485441558692337
Kasumi-2,25183872,-1.7482434423211834
BFTC-909,135411,0.8518885281649031
BT 245,selumetinib-GDC-0941 (4-1 mol-mol),1.6158024411915433
KMS-20,2842253,5.9707742385710825
BT 428,alisertib-navitoclax (2-1 mol-mol),-3.444908865078719
PF-382,25183872,-2.3437313264330433
NCI-H1568,5281672,4.0091617833462125
Hs 578T,5329102,1.5945683112911315
NCI-H1184,49836020,5.907287846852096
OPM-2,doxorubicin-navitoclax (2-1 mol-mol),-1.5033566295439995
KMS-20,387447,-4.754784447636382
BFTC-909,10113978,3.8739618499623094
OCI-AML-5,123631,3.6316819730596968
OCI-AML-5,400769,-0.5190188681391671
Rh30,119182,-2.463181766020395
OAW28,148198,-3.8662210541116977
YH-13,73707398,1.2587835012572517
CHP-212,89928392,0.6862744142430759
JHUEM-3,6184667,4.426778969637119
JHUEM-3,navitoclax-birinapant (1-1 mol-mol),1.0161278928892854
BT 231,15983966,-4.704937406433679
HEC-59,387447,-4.738073441707704
A4/Fukuda,702558,5.147225783500614
M-07e,54678924,1.3204818074841385
SF539,2949965,2.7185790269908003
KYSE-70,5566,3.0340425256076813
SNU-1041,2749,3.556849148485535
NCI-H1568,selumetinib-navitoclax (8-1 mol-mol),2.553812274921004
RKO,375860,-0.2095842697906711
Hs 746.T,122327,4.172135351320871
Panc 03.27,60700,-0.9388956699365006
NU-DHL-1,10184653,1.6775776447141315
OAW28,72376,-0.5739552302850919
BT-474,44185566,2.6477895780146743
NCI-H2196,5351362,0.9590493194542128
JHUEM-3,3689413,-0.6367758327679763
M-07e,46199207,2.819158697951094
NCI-H1184,72193861,0.760095383146164
BT 245,11657048,4.3799644982814705
KYSE-70,53392493,3.454381994737171
RERF-LC-MS,56946209,-3.4945734927118552
TCCSUP,44607531,1.6121278568791757
WM88,252682,6.016207597868279
HCC38,135875424,3.1024594516018453
OAW28,crizotinib-PLX-4032 (2-1 mol-mol),2.110933622393645
Panc 03.27,4917,3.6647818618890136
NCI-H1184,46191454,1.3966649888194955
SW1783,9926054,2.85460969526429
EM-2,11507802,0.9121443646543244
YKG-1,selumetinib-tretinoin (2-1 mol-mol),4.056935710637763
SNU-410,piperlongumine-MST-312 (1-1 mol-mol),2.815517080376454
OCI-AML-3,135875424,2.9827106176181735
KYSE-70,439501,-1.7979650249976522
Rh30,67156097,1.205754833353233
BL-70,72193861,-0.1681364807949174
WM88,5280436,1.711660370369443
NCI-H1184,375860,0.2561611360303955
CHP-212,25227462,-2.1793235245514464
HCC1395,11152667,-2.038239333441405
HEC-59,3543504,4.248120274707718
KMS-20,44566777,-0.0659077616958368
BT 248,72193861,2.013908806167315
BT 428,JQ-1-MK-0752 (1-1 mol-mol),-0.1467022602363411
TCCSUP,82146,3.724750281671297
SNU-410,3552672,2.350497419185323
BT-474,52912189,2.882295201715931
Panc 03.27,6918837,-1.6782167157082732
OPM-2,65064,2.528451354351822
HEC-59,10184653,1.5577442193366342
PF-382,5335621,3.7996740659180688
F-36P,60700,0.347286231231826
NCI-H1568,53392493,1.829675716879907
NCI-H2141,9887053,1.2732501453263714
BT 231,9911463,2.979244544193708
BT 248,4378219,1.4454405763629643
KMRC-20,6505803,2.060614018584274
BT 428,11214940,3.9719128201938183
BT 231,UNC0638-navitoclax (1-1 mol-mol),5.638389329843739
HEC-59,3025944,4.48929407338263
HEC-59,24180125,5.1543604770288525
SNU-201,4259181,2.400409530902911
SK-MEL-28,42642645,1.6429344569807516
B-CPAP,6918289,2.3955979884135856
SNU-410,11238147,4.1399661512250825
KMRC-20,44589607,3.662166795510174
F-36P,25154868,4.282769924726218
KMRC-20,44241473,4.734926633770504
KYSE-450,2871966,1.4934903304989255
NCI-H2196,135411,1.1857241282325688
BFTC-909,5978,-2.385180460490498
M-07e,168312962,1.0248603227926945
Ishikawa (Heraklio) 02 ER-,54618771,0.8456906583173794
NCI-H2141,73707398,-0.0854879625434804
SF539,119182,0.3961519921597609
Kasumi-2,327653,2.4977161394914953
LOU-NH91,44185566,3.062522771292805
HEC-59,24964624,2.233459932976455
BT 428,444795,3.9327551144919584
YH-13,selumetinib-decitabine (4-1 mol-mol),4.949176752890973
LOU-NH91,23582824,0.7266398713670753
BT 428,6184667,4.121619595077629
OCI-AML-5,vorinostat-carboplatin (1-1 mol-mol),1.864199026240566
Hs 746.T,11625818,4.444571262928036
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615
B-CPAP,5329102,2.213007712516747
BFTC-909,10127622,5.216996592058982
Ku812,11626560,-1.6024532092090518
KYSE-70,54143018,-0.2928055682999507
OCI-AML-3,7251185,1.487279317390843
HEC-59,20959075,0.0024625692282093
HCC38,44607530,1.1634574217152571
Hs 746.T,selumetinib-MK-2206 (8-1 mol-mol),1.615125914557671
Ku812,124202324,0.8874162884237986
HCC1395,12001922,1.575765193583952
PF-382,46907787,-1.0517755055208098
WM88,6918328,-0.6809786131401041
F-36P,46174525,1.9220505685064824
BT 428,387447,-4.747611518769308
BT 245,54596558,4.562249989788446
EM-2,168313047,1.9831222374962645
Rh30,46199207,3.4376952596979904
BL-70,6252,1.946355243802352
PF-382,3543504,2.094275160861191
Kasumi-2,11656518,-0.8040408639715576
NCI-H2196,16741245,6.1680058110219464
NCI-H1568,3385,5.30334090203815
TCCSUP,11427553,2.2113489694115054
KHM-1B,25126798,3.5572512627861053
BT 428,46398810,1.87301725051414
NCI-H2141,3136844,3.528867669857209
SNU-1077,3815108,2.841716747219865
KYSE-450,navitoclax-pluripotin (1-1 mol-mol),0.3166156605789935
SW1783,19582717,6.868976405767061
HEC-59,11222830,1.820804610276155
OCI-AML-5,5281321,-1.8544222785408
Ishikawa (Heraklio) 02 ER-,387447,-4.209171325852115
WM88,25150857,3.0820472548222613
BFTC-909,11485656,2.882750602975944
F-36P,1716436,1.9099514352495048
Hs 578T,66577038,2.7610295772050626
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245
SH-10-TC,selumetinib-decitabine (4-1 mol-mol),5.601226642984457
SNU-201,119607,5.906938632917369
BT 245,BRD-K55473186,1.9544137558001504
OAW28,51037431,5.214608262969992
PK-59,44137675,3.067468574429604
HCC1395,31703,0.4178572688597259
SNU-410,8515,4.263852404046252
OCI-AML-3,135659046,3.507210713812752
RERF-LC-MS,10427712,4.250983789220692
OCI-AML-3,151289,0.4572055287124533
A4/Fukuda,selumetinib-GDC-0941 (4-1 mol-mol),-1.0916711617769086
JHUEM-3,53325874,6.0975695003093575
WM88,9907093,4.017166005574772
NU-DHL-1,4788,5.7470913378244
NCI-H1568,navitoclax-pluripotin (1-1 mol-mol),-0.6791877741589081
JHUEM-3,9907093,4.0816850757258765
CHP-212,alisertib-navitoclax (2-1 mol-mol),-4.31339166545084
YKG-1,15547703,3.315188658721057
M-07e,107970,1.522491308202342
SF539,65628,3.9792533711127582
A4/Fukuda,6918638,-1.9449982869755031
OAW28,11152667,0.0990704789630026
BFTC-909,9868037,3.24226767674478
RKO,24964624,3.0430796891613903
OPM-2,100016,3.804278037815123
SNU-1041,navitoclax-gemcitabine (1-1 mol-mol),1.2590013330504797
Kasumi-2,5282054,2.4598760030877553
NCI-H1184,426756,5.770981000639741
OCI-AML-3,613753,2.680880531658494
MM1.S,73707438,4.7017263774156
PF-382,3025944,3.98071208263538
OAW28,navitoclax-sorafenib (1-1 mol-mol),1.7172583203628091
NU-DHL-1,445091,4.453700475457089
OPM-2,4096211,1.0315429789467454
NCI-H2196,3854666,0.3982979522037077
OCI-AML-3,tanespimycin-bortezomib (250-1 mol-mol),-0.5201119154164948
SF539,10172275,5.0855442389334105
KYSE-450,navitoclax-sorafenib (1-1 mol-mol),2.514511411707921
KYSE-450,53232,2.6046887103681993
BT 231,navitoclax-gemcitabine (1-1 mol-mol),1.6263064761694177
OPM-2,3025944,3.8735985412418943
KMS-20,216345,3.908471127762827
KHM-1B,67156097,-2.0770884732643493
SK-MEL-28,262093,2.757579366484628
PF-382,6252,-3.946421345482259
RKO,53392493,2.7606647137416616
BL-70,441298,2.513786017423342
NCI-H1184,124202324,1.0522080128834868
OAW28,5566,3.0868855994062137
M-07e,10385095,1.243871367579541
OPM-2,3854666,0.6659331794855328
F-36P,44462760,5.063696789337612
BL-70,44491742,3.343909693711406
F-36P,selumetinib-vorinostat (8-1 mol-mol),0.7634512600897306
OPM-2,2130404,2.9720984033823896
MM1.S,selumetinib-GDC-0941 (4-1 mol-mol),0.5513447190034949
Kasumi-2,3689413,-2.6905586087263043
SF539,135411,-0.8521595547181242
BL-70,decitabine-navitoclax (2-1 mol-mol),1.5105286804090974
BFTC-909,3025986,-2.0399601309440336
Hs 746.T,JQ-1-UNC0638 (2-1 mol-mol),2.240140554615103
A4/Fukuda,2945648,2.3216808345706035
BT 231,51037431,3.8591271021277023
Rh30,36314,2.143398289560825
NCI-H2196,4521392,4.3091281409507
YH-13,44566777,0.4820262026960841
SW1783,44241473,6.157052132127655
BT 245,1716436,2.617302091979337
OCI-AML-5,72193861,1.19518286561091
YKG-1,67156097,0.6160547787763923
Hs 746.T,448949,1.798979121986945
F-36P,71466380,3.4604908744094547
RERF-LC-MS,57519531,1.5399611647939
SNU-201,9907093,6.409980849302422
OAW28,42642645,0.9360886571737812
Rh30,227681,3.1500772812287243
NCI-H1184,9825149,1.9875866670816853
KYSE-70,5978,-0.772629381148284
BL-70,selumetinib-decitabine (4-1 mol-mol),4.992507473312116
A4/Fukuda,44819697,-1.7397384839387715
BT 428,53232,4.277150367073074
NU-DHL-1,44566777,0.8504751325231436
BT-474,11396600,4.260974029786902
KYSE-450,11494412,3.783526385415406
CHP-212,135423438,1.6303147778889178
HCC1395,65064,5.126452504004059
NU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),-0.0840641688117376
Hs 746.T,446155,1.8034244994109616
NCI-H1568,327653,2.9538763640308403
BL-70,selumetinib-tretinoin (2-1 mol-mol),5.001505723139261
Panc 03.27,44607531,2.160912069298394
Ku812,decitabine-carboplatin (1-1 mol-mol),0.163228689649063
Panc 03.27,24772860,-2.519509286862241
SW1783,25126798,4.288989102632611
TCCSUP,322968,4.50290577769941
OCI-AML-5,44202524,1.7016631889676193
M-07e,6505803,0.1015429750426806
KMS-20,135398516,0.4779911076393339
KHM-1B,5460769,1.8331932839616616
KMRC-20,1750826,-3.609233849414064
HCC1395,44507138,3.2405043303240397
CHP-212,16722836,0.7737021499805148
HCC38,tanespimycin-gemcitabine (1-1 mol-mol),-2.7770696427051433
Hs 578T,6918736,-3.5008609275156157
YH-13,11625818,3.6537350019321897
OAW28,selumetinib-UNC0638 (4-1 mol-mol),3.3800048421879314
NCI-H1184,216468,-1.6413803848937505
EM-2,11178236,-5.1422610388736665
PF-382,44137675,2.4985862116087283
EM-2,4378219,1.33062111232141
Rh30,5282054,3.453724259654483
BT 428,11364421,-5.7306732460234295
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956
BT 231,11626560,1.8260261727964369
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997
KMRC-20,2729026,2.964214452435718
RERF-LC-MS,5328940,2.240356815676024
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805
A4/Fukuda,53232,1.4709221708336295
NCI-H2141,11228183,0.3108248457834477
B-CPAP,104842,-3.0909198505111144
PK-59,637858,1.5777202295297317
A4/Fukuda,252682,6.117343290485243
TCCSUP,644241,2.2463977673648823
B-CPAP,selumetinib-PLX-4032 (8-1 mol-mol),2.742765597384798
NU-DHL-1,9826308,0.2321848028640403
BT 231,24978538,1.0231185350753884
MM1.S,6252,-0.7116460334368461
Panc 03.27,3081361,2.664730396096379
Panc 03.27,25195348,2.637699707106788
PK-59,carboplatin-etoposide (40-17 mol-mol),3.6001862575499963
HEC-59,3634881,3.724711013249292
OCI-AML-3,969516,2.310798422052016
JHUEM-3,16038120,1.0371557886260865
YH-13,44589607,3.382953504149869
Ku812,2708,3.4695310575636262
LC-1F,sirolimus-bortezomib (250-1 mol-mol),1.5648585655869938
M-07e,439501,-3.111960923766982
RKO,17755052,3.988455753476612
BT 245,5460769,4.174087021944073
WM88,6610355,4.02828236771203
RKO,5351362,1.5688417029382893
RKO,53232,4.485666667988006
OAW28,2729026,2.5871569751548047
NCI-H2196,7251185,1.6452707723691744
PF-382,JQ-1-vorinostat (2-1 mol-mol),-1.4348852294654668
HCC1395,11640390,4.2020330051380475
NCI-H1184,6450551,1.2392500168696166
Panc 03.27,5470400,-0.6152237074943745
Kasumi-2,11625818,2.3070585930223477
A4/Fukuda,5284616,3.229953451024844
HCC38,53232,5.180951489740862
Rh30,10302451,2.982588909550782
SH-10-TC,24771867,4.350364270890339
Panc 03.27,9911463,4.350526382797422
PF-382,67156097,-2.0916414621390387
YH-13,135440466,3.138970949638139
RKO,53495165,0.8925500623489324
KMS-20,26596,-2.568893435013116
NCI-H1568,11228183,4.140816994678141
HPAC,135999136,4.37957376504402
PF-382,219104,1.153997513178665
SH-10-TC,285033,-1.3011761440690752
Panc 03.27,5479543,4.407361878164038
LOU-NH91,322968,3.304915281144932
TCCSUP,3062316,1.2176043198217033
PF-382,10074640,2.4256064634454884
NCI-H1568,71576739,4.4464222538448075
OPM-2,6610355,3.590135914900994
SNU-410,56649450,5.277680976167386
PK-59,16038120,0.424356092272954
BFTC-909,5311281,3.2468587214362175
KMRC-20,11175137,3.0694696383235645
BT 231,2708,5.0363775155854915
EM-2,25105715,2.9279198996979012
RKO,135999136,6.045591123054076
TCCSUP,navitoclax-PLX-4032 (1-1 mol-mol),2.317230132678856
Hs 746.T,252682,5.8069865510984044
NCI-H1568,219104,4.078417481216408
SH-10-TC,10322450,5.299988243449435
KMS-20,54613361,-1.869220280650564
PK-59,5282054,3.7039273712270417
A4/Fukuda,31703,-2.1013190360416147
HCC38,11222830,1.7907829050084474
PK-59,702558,6.286075132274527
MM1.S,5743,-3.388771568562768
Hs 578T,25227462,-0.6770918092895333
LOU-NH91,6917907,-5.4115573726076125
Ku812,54619238,3.9506340253533834
A4/Fukuda,16722836,0.6102638619225811
KYSE-70,24821094,5.190593902676824
SNU-1041,11178236,-2.4108089470123364
KYSE-70,10385095,0.9665013844498838
M-07e,46215462,1.4578728192410948
PK-59,11626560,1.5487054283870785
A4/Fukuda,1566236,1.4071330472860828
Ishikawa (Heraklio) 02 ER-,tanespimycin-bortezomib (250-1 mol-mol),-0.660556469573982
SH-10-TC,6917907,-5.458510183370581
KHM-1B,262093,0.9728016968076376
RKO,445091,4.342692134156949
Hs 746.T,5329102,1.68252240430311
SNU-1077,6918328,0.7978049082152888
Ishikawa (Heraklio) 02 ER-,654092,0.6103847361282962
AU565,16065773,1.4318565791423328
JHUEM-3,25102847,2.3185210507030423
OAW28,3503,2.6573145013500743
NCI-H1184,227681,3.0726626501466687
JHUEM-3,4259181,0.9034843084512042
OPM-2,3081361,1.5210485339307265
YH-13,44819697,0.6102500342217575
Panc 03.27,25183872,-1.3786969464177432
Ku812,262093,1.3423418533813145
OAW28,676352,1.7843387493833531
F-36P,46191454,0.986768186878591
CHP-212,4705,3.1318410503879717
BL-70,11234052,1.9719776597991716
YH-13,5746,2.3705459380305256
HCC1395,446155,3.6120159930407993
Hs 746.T,3676137,4.618765493146564
BT-474,148124,-3.6450938662304457
KYSE-70,15983966,-0.1847866067827735
B-CPAP,16722836,1.2819939562752407
SH-10-TC,49766530,2.645691737420763
OPM-2,24978538,1.9225155298388676
HEC-59,9903786,2.2541518083702172
Ishikawa (Heraklio) 02 ER-,168312962,-2.090684383571494
A4/Fukuda,10074640,2.009206402328629
OCI-AML-5,decitabine-navitoclax (2-1 mol-mol),1.0653876697218485
BL-70,71680916,3.996645637261445
HCC38,5460769,2.8026336362460307
KHM-1B,24753719,3.787412928700261
SF539,445091,3.820067439228608
RKO,11455910,0.1271196393609195
BT 231,16741245,4.335557928697965
MM1.S,54649381,2.997921024059072
PF-382,107970,1.4805149558229411
KYSE-70,2828334,5.886367586734188
PF-382,24180719,4.536989460755837
BT-474,5328940,0.3712314850757322
A4/Fukuda,24785538,-4.18833617701787
BL-70,55283,2.474226715465206
Ku812,10184653,0.6444023558931821
SH-10-TC,6918328,0.4473668037214207
YH-13,375860,-0.5335760796053879
SNU-201,135875424,3.4476242027363715
KMS-20,11404337,-1.24048912938788
Panc 03.27,241158,4.5818896655025165
MM1.S,9935249,3.6617301245150498
SW1783,11396600,4.918648417758992
HCC1395,2841722,4.859486857242075
BL-70,1566236,1.7416130953011706
SF539,5287969,-1.7419223666366572
PF-382,9903786,1.7632578420268197
Kasumi-2,36462,-1.2000537391874553
OCI-AML-5,6917907,-6.765969198009278
NCI-H2141,1239801,3.421013419300982
BL-70,60700,-1.946832848912328
LOU-NH91,11364421,-1.522672653311712
JHUEM-3,4521392,4.310671824232587
Panc 03.27,73707398,1.02648838548017
TCCSUP,25154868,4.544338525999724
RERF-LC-MS,24856436,0.2419222597799965
SNU-1041,107970,2.962273906034501
NCI-H2141,16219061,-1.7218011853772266
M-07e,24779724,5.840780932705825
F-36P,6438330,1.055678334446746
HCC1395,54649381,3.677425180977059
NCI-H1568,89928392,1.1949851991515912
OAW28,9933475,1.6622343224708085
YH-13,25154868,5.479535858900875
RERF-LC-MS,9840324,5.508232790936476
OAW28,10427712,4.195688642509306
BT 231,11609586,2.8386132576771548
PF-382,135398516,1.2279645894951243
SH-10-TC,5287620,-3.880408217943691
SH-10-TC,51039095,3.651959118465862
RKO,89183176,-5.254565057669901
Hs 578T,BRD-A02303741-navitoclax (2-1 mol-mol),0.6248157345645136
OCI-AML-5,53232,2.1540288968607126
NU-DHL-1,1566236,-0.7944323454419335
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484
LOU-NH91,446155,1.33101507486467
SNU-201,613753,3.1579991203177675
Hs 746.T,44607531,1.52256391682419
Rh30,60750,-4.15122866597221
KYSE-450,24785538,3.6513103906304942
PF-382,451668,-1.5679120589003597
KMS-20,54143018,-0.774941821803654
NCI-H2196,675434,4.09798893066179
OPM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.6034498457254175
F-36P,11234052,3.4123035226721035
F-36P,52912189,-0.3399802306262523
NCI-H1568,15547703,3.0519937502167744
HCC38,5282054,2.658641945411799
Rh30,44241473,4.682131674115786
JHUEM-3,3552672,2.367816133632433
BL-70,9884685,-1.719750861009791
SH-10-TC,11955716,-0.0929144848437772
YKG-1,3854666,1.2272418792594904
EM-2,11234052,2.240921099902987
Ku812,24964624,1.8261107869601476
SH-10-TC,42642645,1.5802745475369844
PK-59,24821094,3.619889091404484
JHUEM-3,176870,1.3855141369022577
Ku812,5284616,-4.419466580952263
KMS-20,568763,-0.7936979653536971
KYSE-70,24964624,1.4483005111507754
Kasumi-2,tretinoin-navitoclax (4-1 mol-mol),-1.7233092596957704
NCI-H2196,11609586,-0.1760954501629771
SF539,1641662,3.001281709092091
KHM-1B,54686904,3.578603716754377
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622
M-07e,444795,0.671881702750201
NCI-H1184,11683005,3.765663288236595
SNU-1077,2708,5.365576184997209
NCI-H2141,216239,2.025237104034106
SH-10-TC,2828334,6.461339071759297
Ku812,9926054,1.5145588468111315
BT 231,46907787,1.384655777142133
EM-2,11228183,-1.0600895832199164
B-CPAP,1716436,3.297193822138579
KHM-1B,26596,-2.1296194509234576
BT 245,44589607,2.158681314242706
Hs 578T,6918837,-5.140349614832409
HEC-59,11485656,2.515586983262965
SNU-410,16722836,2.2984599379265536
HCC38,5394,4.35262525181405
OCI-AML-5,navitoclax-piperlongumine (1-1 mol-mol),0.3914541743647581
OCI-AML-5,24951314,0.3463582226919024
BT 248,3081361,2.663958705985954
RERF-LC-MS,44241473,4.536869636330491
SK-MEL-28,selumetinib-BRD-A02303741 (4-1 mol-mol),3.6626824854303086
SF539,11427553,1.911717552312056
F-36P,3081361,3.1232778040570177
OAW28,carboplatin-etoposide (40-17 mol-mol),4.113933024401999
SF539,9903786,2.8297220739955993
RKO,44202524,1.4476976505001866
Hs 578T,216468,4.6837022950014555
NCI-H2196,374536,1.665092888364934
WM88,11955716,-2.6004261691633404
JHUEM-3,ISOX-bortezomib (250-1 mol-mol),0.3929052937941742
LOU-NH91,44241473,5.33179348194517
NCI-H2196,285033,-1.99799167768555
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923
AU565,9911463,3.1332064122278687
HPAC,6918328,0.1588623002373002
SH-10-TC,53392493,3.67053787296422
MM1.S,navitoclax-sorafenib (1-1 mol-mol),3.1642933402407705
Kasumi-2,3385,2.4314400955221576
Rh30,159324,2.8052037123345572
MM1.S,5280436,3.932437851404913
B-CPAP,123631,2.319451820706569
Rh30,serdemetan-SCH-529074 (1-1 mol-mol),2.240216088189228
BL-70,11455910,0.0297014164053517
Kasumi-2,135398744,8.02054113805855
BT 231,11234052,3.9481879292065143
NCI-H2141,navitoclax-gemcitabine (1-1 mol-mol),-1.9660455888334976
KMS-20,24779724,4.331285550613222
OCI-AML-3,16741245,3.4376711290388164
CHP-212,2729026,2.2835805648547742
BT 245,9936388,0.9041726045525886
KMRC-20,vorinostat-navitoclax (4-1 mol-mol),1.5374427074415018
KMS-20,676352,1.1111615273565725
F-36P,JQ-1-navitoclax (2-1 mol-mol),-0.882935111364826
HCC38,19582717,3.2516669465285313
Ishikawa (Heraklio) 02 ER-,53232,3.2781803661222573
BT 245,3062316,3.257896048072906
OCI-AML-5,26596,-1.736130608355082
EM-2,54454,1.3046523625606918
Ishikawa (Heraklio) 02 ER-,3384730,2.22085280352865
RERF-LC-MS,5311,1.7201713868016182
Hs 578T,44566777,1.7104293235870285
BFTC-909,24180125,2.699370118217823
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091
OCI-AML-5,SNX-2112-bortezomib (250-1 mol-mol),-2.926618678268304
PK-59,11977753,-3.3691065724699247
SH-10-TC,6918878,4.206721688790107
Ishikawa (Heraklio) 02 ER-,4788,5.988608898736073
SNU-1041,3815108,3.860091892451264
OCI-AML-5,11494412,0.989113534938917
KYSE-450,3825829,4.738351974491715
YKG-1,168313200,2.942374611054984
TCCSUP,135440466,1.783942290366752
HEC-59,6918878,2.72911788137472
Ku812,638278,2.0428029041013387
Ishikawa (Heraklio) 02 ER-,6918878,3.724210290974002
LOU-NH91,16722836,1.148829534310261
Kasumi-2,374536,-0.2175337956908027
RERF-LC-MS,54619267,3.9836959677109354
KHM-1B,51039095,0.918931317329286
BT 248,5566,1.2795658146577915
F-36P,49766530,-1.869404688444432
Panc 03.27,262093,3.23349895733636
TCCSUP,5351362,1.0787076559340512
RERF-LC-MS,11364421,-3.8493036468537265
NU-DHL-1,6918736,-3.063185007693412
Hs 746.T,10172275,3.7312834132135153
BT 428,400769,-1.0780976491085523
A4/Fukuda,alisertib-navitoclax (2-1 mol-mol),-3.158247130795727
SNU-201,54454,0.5476909681598214
M-07e,6918837,-5.51921108058235
NCI-H2141,25227462,-1.6548850187250064
OPM-2,11640390,0.8264429779628358
BT-474,2842253,6.448948533112355
OAW28,71466380,4.3449274646859495
LOU-NH91,24785538,0.7950573935003075
BT 245,selumetinib-BRD-A02303741 (4-1 mol-mol),6.290408046736785
BT 231,2945648,1.1439671928728303
TCCSUP,9444,3.681679510708516
NCI-H1184,446155,3.872300017712347
KYSE-450,462382,0.9133555690572344
NCI-H1568,6438330,1.052967118553252
BT-474,JQ-1-vorinostat (2-1 mol-mol),0.6571571542487842
Ishikawa (Heraklio) 02 ER-,navitoclax-sorafenib (1-1 mol-mol),4.342881691852438
SW1783,126941,4.818238928893187
Kasumi-2,445091,5.553993217061133
SH-10-TC,5311281,3.3937558652116135
NCI-H2196,selumetinib-tretinoin (2-1 mol-mol),5.104481765597801
OCI-AML-3,crizotinib-PLX-4032 (2-1 mol-mol),0.8720766969868333
SW1783,445091,3.700343726063664
KMRC-20,selumetinib-GDC-0941 (4-1 mol-mol),2.922820897966577
Ishikawa (Heraklio) 02 ER-,17759555,4.376728261208328
BT 231,11485656,1.3713674681165906
HCC1395,1750826,-1.7893277990975585
KMS-20,44607530,1.038063034852437
SNU-1077,selumetinib-BRD-A02303741 (4-1 mol-mol),4.189870854212877
HCC38,5351362,1.2106567283791851
CHP-212,11656518,0.8459514412637019
OAW28,3025986,-0.5681838773369163
KYSE-70,135875424,3.720063911223788
PF-382,25262965,-1.7427075899260709
LOU-NH91,36462,3.2256365983613677
JHUEM-3,9823820,4.364466770521466
Panc 03.27,54618771,0.0634128871766815
HPAC,409805,4.12816985614744
M-07e,tanespimycin-gemcitabine (1-1 mol-mol),-3.6149672075148738
Hs 578T,3689413,-0.3709013801718254
BL-70,208908,1.6555507379042316
M-07e,10322450,3.3333673801284944
Kasumi-2,ISOX-bortezomib (250-1 mol-mol),-0.8608455854799354
Kasumi-2,6918328,-2.1918789082401355
OAW28,49766530,-0.5315014966120291
SNU-1077,54619267,4.150403156100443
NCI-H1184,44632017,0.6654688319935298
RKO,675434,4.252493680505022
NCI-H1568,navitoclax-piperlongumine (1-1 mol-mol),1.526760839095053
OAW28,89183176,4.823946494889004
NCI-H1568,60750,-4.838669884752028
SNU-410,44185566,2.969073299040733
BT-474,JQ-1-carboplatin (1-1 mol-mol),5.214986891454346
NCI-H2141,11427553,1.952160850951577
NCI-H1568,selumetinib-piperlongumine (8-1 mol-mol),3.9234194964704185
Ku812,25126798,3.6375519347650047
KMS-20,selumetinib-PLX-4032 (8-1 mol-mol),2.2500774116215196
Hs 578T,carboplatin-etoposide (40-17 mol-mol),3.813744876580244
Kasumi-2,vorinostat-navitoclax (4-1 mol-mol),-2.345570206946048
PK-59,11364421,1.7201977931210124
RERF-LC-MS,675434,4.646232548137413
B-CPAP,46199207,2.9698252348312963
A4/Fukuda,2708,3.0461577581065007
BT 231,9907093,3.3527056362522525
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565
YKG-1,serdemetan-SCH-529074 (1-1 mol-mol),2.571956215465782
SW1783,46907787,3.9046818317286944
OCI-AML-3,675434,4.2532796311490495
YH-13,135875424,4.585935280505426
B-CPAP,3815108,2.49779395406492
Ishikawa (Heraklio) 02 ER-,56946209,-2.553802996373868
NCI-H2196,375860,-0.2759858226988109
RERF-LC-MS,168312962,0.3496483928324376
KYSE-70,6918328,0.2213620303324437
SNU-1041,9967941,2.774492939999155
Ku812,135421197,1.6654017400601815
SK-MEL-28,51037431,2.176317274658726
Kasumi-2,vorinostat-carboplatin (1-1 mol-mol),1.2501182531177977
Kasumi-2,2746,1.0036072682129122
BFTC-909,374536,2.594742723017773
NCI-H1184,44493528,4.250778003560126
SNU-410,46907787,3.7701283534171894
Rh30,25102847,2.016379402647938
KYSE-70,44819697,2.67312291481412
Rh30,5470400,-1.4731883637027927
YKG-1,tretinoin-carboplatin (2-1 mol-mol),6.38208471298272
SNU-410,JQ-1-MK-0752 (1-1 mol-mol),4.372486852577463
HEC-59,selumetinib-UNC0638 (4-1 mol-mol),5.63678641711579
SNU-410,25062766,2.3113825383295277
Panc 03.27,53495165,-2.693207393702177
BT 245,7251185,1.9708124814214532
NCI-H1568,71304818,2.2110745175145876
BT 245,9926054,2.9422912383021393
SF539,11612883,2.0930175228596037
BT 245,46224516,2.4010349649397535
Hs 578T,327653,3.3344882806614304
YH-13,6918328,0.5686815123232866
SNU-1077,11152667,0.5302678511241536
HPAC,135421197,1.2085727097221448
YKG-1,decitabine-navitoclax (2-1 mol-mol),4.796036772567169
RKO,44589607,3.597229089573096
KMS-20,3136844,4.071065919144672
SNU-201,3062316,1.530713822142154
SW1783,15547703,5.783856550562672
KHM-1B,54619238,4.434806888853119
NU-DHL-1,ISOX-bortezomib (250-1 mol-mol),-0.6058420278393776
OCI-AML-5,71729975,1.116439955291679
M-07e,71466380,2.7290806616895873
Ishikawa (Heraklio) 02 ER-,2708,5.818927723833249
BFTC-909,51039095,2.7594177275421403
RKO,72376,-2.4980018930037673
HEC-59,24180719,4.505272708588429
M-07e,4578,4.20291628590564
WM88,439501,-1.2543537382039465
JHUEM-3,462382,0.2090920186451843
OCI-AML-5,16722836,0.1586445131061709
BT 248,5284616,2.1714532824885473
OAW28,24901704,3.441244042276163
F-36P,148198,-5.732875507822739
NCI-H2141,9967941,2.059770503708986
KYSE-450,72376,0.4386506850457716
HCC38,25183872,-1.93338130862332
EM-2,56963564,-0.7650007492247998
KMS-20,24856436,0.4598512604017683
NCI-H2196,2708,5.089402115486791
BT 248,12003241,-0.5635987052840526
MM1.S,36314,1.7843068012903331
A4/Fukuda,285033,-4.063528792592557
PK-59,159324,2.910821247421296
PF-382,374536,2.6185584915406137
KHM-1B,241158,2.5921165995346565
OAW28,serdemetan-SCH-529074 (1-1 mol-mol),2.2159278934374416
PF-382,2858523,2.2172889178765733
A4/Fukuda,11152667,-2.4230854517211977
BT 428,3825829,4.221207301902304
KHM-1B,73707398,-0.6689954941559422
TCCSUP,navitoclax-pluripotin (1-1 mol-mol),-0.7480541514950738
KYSE-450,6917907,-5.14733530155551
OCI-AML-5,446155,2.0269350338443206
F-36P,6610355,4.511719479094167
SF539,135423438,0.8139499502196877
BT 231,17755052,0.1174554749728617
BT 428,54618164,4.165032933518285
B-CPAP,24785538,1.7494023419831553
PF-382,216345,3.312440656550695
KMRC-20,4261,2.986732904038728
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743
SH-10-TC,89928392,1.6010873402534291
Rh30,6438330,0.8801301762048657
JHUEM-3,439501,-2.1632963006772075
SNU-410,44491742,4.2778322604140815
WM88,6918736,-0.0933916116973415
HCC1395,6917907,-5.828612096094566
YH-13,65064,5.536237996349119
NCI-H2141,11455910,0.8457435139245203
HCC38,9926054,1.7712684565891563
BT-474,11625818,4.464740550266185
OCI-AML-3,4096211,1.2609155719008585
OPM-2,49867926,3.883283056469906
LOU-NH91,54649381,2.7277802519486514
SNU-410,55508,1.9955747333320328
AU565,ISOX-bortezomib (250-1 mol-mol),0.4986344136338663
BL-70,24753719,3.6587703277512182
SNU-201,3854666,4.676040623574546
Panc 03.27,753704,5.926668113139356
NCI-H1568,54618771,0.8004506686595156
M-07e,3854666,0.4503079747875654
F-36P,4096211,-1.055742957147646
OPM-2,6610216,3.8953919440086575
M-07e,piperlongumine-MST-312 (1-1 mol-mol),1.1448869216801318
AU565,JQ-1-UNC0638 (2-1 mol-mol),2.17780253884304
BT 428,1566236,1.6245492383600229
OCI-AML-3,JQ-1-MK-0752 (1-1 mol-mol),-1.9454774668927977
M-07e,46907787,-1.2673876445941157
SF539,44462760,4.654163176504964
KMS-20,11494412,0.3854055603119042
SK-MEL-28,11455910,1.7343524639503471
CHP-212,46398810,2.4282031061642684
RKO,71680916,5.910552922648844
MM1.S,tanespimycin-gemcitabine (1-1 mol-mol),-5.682330250440317
SNU-1041,crizotinib-PLX-4032 (2-1 mol-mol),2.201850584230551
NCI-H1568,5738263,3.2402226460817323
BT-474,327653,3.3375355192094025
BT 231,54618164,4.074270092547043
F-36P,56973724,0.8082785050993208
BT-474,23725625,5.1212073734478905
EM-2,5746,-1.46677141692504
BFTC-909,73707398,1.325657316242966
OCI-AML-3,11364421,-5.807549071897675
OCI-AML-3,6852167,1.22318237293595
TCCSUP,11152667,-1.0569561728619483
PF-382,613753,3.2428568441024535
JHUEM-3,tanespimycin-gemcitabine (1-1 mol-mol),0.4827162107337145
JHUEM-3,387447,-4.484924580522653
BT-474,16725315,5.23176741451846
BT 245,2828334,6.142751716210638
NCI-H2196,UNC0638-navitoclax (1-1 mol-mol),0.6687398915022545
Rh30,crizotinib-PLX-4032 (2-1 mol-mol),1.328695815354453
A4/Fukuda,54596558,4.022693113590735
SK-MEL-28,6917907,3.4714209878856463
M-07e,erlotinib-PLX-4032 (2-1 mol-mol),3.212562510904607
SF539,12001922,1.3704910391128322
CHP-212,25154868,4.268118722368051
A4/Fukuda,44543605,3.1271044447490235
B-CPAP,57519531,4.004957994093651
BFTC-909,6623618,2.802037410677928
Hs 746.T,126941,-2.9496893958682704
HPAC,SNX-2112-bortezomib (250-1 mol-mol),0.0215047996430148
F-36P,46199207,2.368310242564922
PF-382,11497983,-3.782661101953355
RKO,11214940,1.6564081526645635
B-CPAP,36462,2.9049699830233733
Hs 578T,216345,2.3150210318776727
OCI-AML-5,53393127,3.387979474518676
Ku812,selumetinib-tretinoin (2-1 mol-mol),-1.3123873210444326
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559
NCI-H2141,6438330,1.463265855419944
A4/Fukuda,168312962,0.589698091471745
BT 231,44589607,2.029786796315878
SNU-201,11404337,0.8622736318146181
Panc 03.27,2742550,3.7369111271801234
HCC1395,46199207,2.925005157587912
KYSE-450,3503,2.083749354383258
OPM-2,3062316,1.3077504545650411
KMRC-20,104842,-2.088943206569887
SF539,44819697,-3.4306992197500255
KYSE-70,216345,3.953496119268799
KYSE-450,11485656,2.990129749938368
BT 231,5287969,-1.6363137435441206
LOU-NH91,73707398,1.1540810865513749
PF-382,168312962,-0.0454286282986012
Ishikawa (Heraklio) 02 ER-,46191454,2.4738901058464204
Rh30,969516,1.2851987267674885
Kasumi-2,135423438,1.5853456579896534
SNU-410,44589607,2.943866613731922
BL-70,navitoclax-pluripotin (1-1 mol-mol),-1.2530479921751427
NCI-H1184,46943432,1.3653708283217592
OAW28,54619267,3.96587417417148
SK-MEL-28,227681,3.6340510763763367
AU565,1716436,0.9342430141979629
PF-382,10302451,0.8944755236764494
NCI-H1184,selumetinib-UNC0638 (4-1 mol-mol),2.788092021955956
JHUEM-3,navitoclax-sorafenib (1-1 mol-mol),2.1125645356258067
NCI-H2141,24771867,3.9346248515537448
HCC38,9907093,4.40091017817399
OCI-AML-5,11175137,0.9114827560197298
AU565,53495165,0.1395352595616783
OCI-AML-5,5278396,3.6917072385585223
Hs 578T,4096211,1.6974657584114197
NCI-H1568,135999136,4.3721543597322405
BL-70,16659841,3.786061249884811
KYSE-70,9967941,5.193135802047497
Hs 578T,12003241,-1.9219753364875385
NCI-H1568,67156097,-1.7914617240991686
TCCSUP,126941,-3.009230192575239
WM88,5282054,3.68378715977232
Ku812,54454,3.828644257456088
OCI-AML-3,serdemetan-SCH-529074 (1-1 mol-mol),0.8793575689388927
Rh30,navitoclax-MST-312 (1-1 mol-mol),0.3244472428986708
Hs 746.T,11175137,2.714887034443607
TCCSUP,navitoclax-birinapant (1-1 mol-mol),2.81500851801963
NU-DHL-1,135398738,5.717285469146395
BT 245,11455910,0.6053339220870597
BL-70,2858523,1.906782150349085
BT 245,2729026,1.7990947371771515
Rh30,5328940,1.901889304893028
RKO,9903786,4.184024439899693
KHM-1B,12003241,-0.9345261470540068
Rh30,16722836,0.8754402305277004
BT 248,24772860,-1.8114686790878316
Ishikawa (Heraklio) 02 ER-,vorinostat-carboplatin (1-1 mol-mol),3.535417221406592
Ku812,11175137,1.3138431643712536
NCI-H1568,984333,0.7198134332239758
BT-474,doxorubicin-navitoclax (2-1 mol-mol),0.1763146949851393
HCC38,10385095,1.2215690544753306
A4/Fukuda,67291369,-0.3870993856905487
OPM-2,151289,0.8971834485048114
SF539,6252,2.539418639524388
B-CPAP,2749,3.278243683054658
NU-DHL-1,176870,2.457037183526244
OAW28,24753719,4.434201172795376
CHP-212,44486219,3.511853352792089
Kasumi-2,11238147,1.8873340406507049
OPM-2,1317464,3.5924971065959244
NCI-H1568,4917,1.9457015565482707
YH-13,52947716,-5.569011726742263
Rh30,4096211,2.2545596863737503
HCC1395,72193861,0.4375580308783435
YH-13,9926054,1.834128888426512
HPAC,44632017,0.9414612199607072
NCI-H1568,navitoclax-gemcitabine (1-1 mol-mol),-4.7036832419339865
AU565,10296883,3.47614106437246
RERF-LC-MS,46398810,3.3112335021243977
SF539,3503,1.023946445304806
NU-DHL-1,9907093,3.5839802480186713
EM-2,9911463,2.8916487141843974
Hs 746.T,15547703,2.9697891753078647
NCI-H1568,selumetinib-tretinoin (2-1 mol-mol),5.145646184067631
BT 231,25062766,2.4033358829343476
OAW28,613753,3.2856198284724742
PK-59,11612883,2.5414084557448287
Hs 746.T,6610216,4.135271582579114
A4/Fukuda,72376,-3.4342601152101473
Ku812,637858,1.0891915977996414
M-07e,9825149,1.8142721991753523
LOU-NH91,409805,5.248055334811583
OAW28,44489675,3.928609606447794
Hs 578T,24180719,3.880022267469775
LOU-NH91,16720766,0.888730139062919
Rh30,1566236,1.5669773851253712
Panc 03.27,104842,-2.9318051182485245
LC-1F,72376,-0.0109403701760618
BL-70,3081361,3.3980584001103797
SK-MEL-28,selumetinib-UNC0638 (4-1 mol-mol),1.787760879928494
KMS-20,60750,-4.802924293659105
JHUEM-3,44566777,0.519060461143849
B-CPAP,54454,-0.0949556487225395
PK-59,676352,2.541338758475476
Kasumi-2,5738263,2.363328574896373
Ku812,375860,-0.7042833930454624
HPAC,42642645,0.7543377157238116
JHUEM-3,52912189,0.7560422531750342
OCI-AML-3,135421197,1.1151677608997974
A4/Fukuda,9903786,0.7546004224414102
KHM-1B,54649381,3.5405814758079117
M-07e,4096211,0.6763156272284697
OAW28,6918837,-3.92509053266304
OPM-2,carboplatin-etoposide (40-17 mol-mol),2.4358856749484596
BT 248,9952709,2.726522372177628
RKO,11717001,3.92417498432234
B-CPAP,5460769,4.36425483182296
SNU-201,9903786,3.5619464236544336
BL-70,5479543,2.280363155735732
LOU-NH91,52947716,2.984350097195249
OAW28,1641662,3.6011202742070014
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759
EM-2,selumetinib-UNC0638 (4-1 mol-mol),1.4950817552190026
BT 428,11719255,3.4713354936656207
B-CPAP,4477,0.711157079816854
SNU-410,selumetinib-decitabine (4-1 mol-mol),5.423281164831714
HCC1395,23635314,-2.3123455008189375
SK-MEL-28,16038120,2.5189867530231065
TCCSUP,crizotinib-PLX-4032 (2-1 mol-mol),1.6984016449467694
NCI-H1568,241158,1.943489424131273
HCC38,5311,2.5802489907749835
KMS-20,SNX-2112-bortezomib (250-1 mol-mol),-2.8206001469797974
BFTC-909,55508,3.078625314561866
Kasumi-2,56946209,-4.865772879743349
Hs 746.T,2858523,3.2236739904367746
A4/Fukuda,3634881,2.7004024711225596
BT 231,6505803,0.1418659460842767
BT 231,24901704,2.428348103447541
NCI-H1184,5282054,2.451037167334351
OCI-AML-5,navitoclax-PLX-4032 (1-1 mol-mol),0.9783051465927562
SF539,60750,-3.745453789943656
Kasumi-2,4096211,1.078024917290252
WM88,168313016,5.2919128740723265
EM-2,66577038,2.7103883021855477
SH-10-TC,2708,5.551188338469828
NCI-H1568,3503,1.1278876480867208
SNU-201,44137675,4.106807719534647
RKO,6252,0.5352436981906653
F-36P,9927531,3.277951098444252
Kasumi-2,5566,3.0024962406609874
KMS-20,9967941,3.626187423361352
EM-2,16720766,-2.8648408364463096
AU565,9803433,4.3672163986823085
M-07e,73707398,-0.2805329031268003
OCI-AML-3,53232,2.161773120657847
Kasumi-2,24753719,3.2877720740856815
SW1783,53495165,2.348659450699313
NCI-H1184,73707398,0.6283107907901586
SF539,erlotinib-PLX-4032 (2-1 mol-mol),2.8421126789574913
KMS-20,24180125,1.3264637419284662
Ishikawa (Heraklio) 02 ER-,89928392,2.014161684087825
F-36P,serdemetan-SCH-529074 (1-1 mol-mol),1.828808135061463
NCI-H1184,60700,-2.3460845279588813
BT 248,selumetinib-vorinostat (8-1 mol-mol),3.707211778635912
HCC1395,11178236,-1.5133437931041192
OPM-2,JQ-1-MK-0752 (1-1 mol-mol),-1.5972514317296775
OAW28,piperlongumine-MST-312 (1-1 mol-mol),2.526870142360867
PK-59,56946209,-4.634234731947544
Hs 578T,15983966,1.1080093388612318
Hs 746.T,selumetinib-vorinostat (8-1 mol-mol),2.6877277725717357
NU-DHL-1,445643,3.522779359362199
SH-10-TC,9935249,3.302172172490518
BT 245,11152667,0.6307471035808881
BL-70,selumetinib-PLX-4032 (8-1 mol-mol),4.641847030525499
OCI-AML-3,136227331,4.0355343672890935
TCCSUP,BRD-K27188169-navitoclax (2-1 mol-mol),3.571342544762983
Ishikawa (Heraklio) 02 ER-,135423438,4.463987581910629
WM88,5281321,-3.2381807772763467
BFTC-909,568763,0.745825262149274
BT 231,11612883,2.9794626203224306
Rh30,54649381,3.846703886529124
JHUEM-3,selumetinib-piperlongumine (8-1 mol-mol),2.821308289195623
Panc 03.27,65064,5.238221815401685
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635
M-07e,tretinoin-navitoclax (4-1 mol-mol),-0.9016991853575128
LOU-NH91,52912189,2.021653283813576
BT 231,2749,0.9635960554956892
Hs 578T,46843906,1.9405452971753636
KHM-1B,6914657,-6.231607767095075
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677
OCI-AML-3,54618164,3.7553618842798726
Hs 746.T,54454,1.083911302199212
SK-MEL-28,53392493,3.0895758155089363
Hs 746.T,UNC0638-navitoclax (1-1 mol-mol),1.0511790307872622
BL-70,676352,1.5096826058004498
NU-DHL-1,11707110,-4.149720194824857
OPM-2,5460769,4.223891374112808
KMS-20,11214940,3.272421487084948
RKO,10427712,4.823698606341804
SH-10-TC,72376,0.4900372762985304
SNU-1077,9907093,4.090287424165682
SNU-410,2733526,4.014379171579221
NCI-H2141,44819697,-1.6766041320515142
Kasumi-2,42642645,-0.9002721123779656
Hs 746.T,1750826,-2.177176870973473
SNU-1041,3503,2.64162530792054
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898
KYSE-450,6450551,3.3363850258393124
NU-DHL-1,11214940,0.1576497417416405
CHP-212,66577038,2.808506323901767
SF539,52947716,2.4386423311018284
SH-10-TC,54626689,4.603655677944001
BT 428,72734382,4.0549357466643805
BT 248,71751553,4.279070264679743
BL-70,400769,-1.294461791739498
SF539,445643,3.7676894820893896
RERF-LC-MS,54678924,1.4734481784853186
KYSE-70,sirolimus-bortezomib (250-1 mol-mol),0.1222740684138433
LOU-NH91,1750826,-0.8784962447018205
Kasumi-2,9907093,3.255145953057051
CHP-212,71466445,1.0770121742472976
BT 245,71729975,1.93645259628117
PK-59,1566236,1.7362298213190046
OPM-2,11317348,2.0151792351474755
B-CPAP,445455,3.02228700826093
SK-MEL-28,5282054,3.2979328784688606
Ku812,3815108,1.773113304227131
BT 231,53232,4.989303060826178
BT 231,60700,3.1820566460840145
SK-MEL-28,selumetinib-navitoclax (8-1 mol-mol),1.214744577584393
SNU-1041,9926054,2.2828270152060623
Ishikawa (Heraklio) 02 ER-,4521392,4.6311388218344
BL-70,16725315,3.0452081215317355
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177
Kasumi-2,11964036,-0.3814812468505845
OCI-AML-3,2749,0.4559936923478354
KMS-20,11257553,0.1864785625212487
Panc 03.27,4521392,4.044384406306168
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202
KYSE-70,51037431,6.2873914521382765
OCI-AML-3,123631,2.981803369333831
YH-13,tanespimycin-gemcitabine (1-1 mol-mol),0.5639208789602934
A4/Fukuda,53495165,-3.058270414187161
NCI-H2141,6450551,1.2645086559888523
KYSE-70,446155,3.830415114438346
CHP-212,11955716,-2.618845027409953
M-07e,24901704,2.2887882970795626
Ku812,135398738,1.774470065203487
BT 245,644241,2.053411949495115
EM-2,9967941,3.8148268054002186
OCI-AML-3,46174525,2.35916665247491
SF539,46224516,1.728004349053643
PF-382,3025986,-1.4825966428556414
PF-382,navitoclax-sorafenib (1-1 mol-mol),-1.747600817008782
OCI-AML-5,54678924,1.7167902586214514
KYSE-70,123631,1.697265417228948
SH-10-TC,6610216,4.446804869208645
MM1.S,4378219,2.139277509194807
Panc 03.27,60750,-2.9463550527023
BT 231,53495165,-0.1742631666557167
BT 231,4259181,0.6722298764653775
OCI-AML-5,42642645,-0.9883986244862538
BT-474,24856436,-0.490913945618266
JHUEM-3,241158,4.29308217340487
KYSE-450,46398810,3.648883715738529
NU-DHL-1,11647372,-0.5414932497737441
BT-474,4578,-0.6384657388534883
BT 231,54613361,-2.071450076942706
A4/Fukuda,selumetinib-decitabine (4-1 mol-mol),-0.8212818207724355
NCI-H2141,51037431,4.326124285715651
KMRC-20,44607531,1.5618763783818437
KYSE-450,51039095,3.763234499146495
SH-10-TC,doxorubicin-navitoclax (2-1 mol-mol),0.2634400277468161
BT 248,46224516,2.5816980785990875
BT 428,439501,-3.4900182991978936
F-36P,11707110,-3.101401039709538
KYSE-70,2746,2.8005709054024224
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079
LOU-NH91,11152667,-0.304989451834292
EM-2,135875424,3.8606951218736287
EM-2,135411,0.2841826240796504
BT 231,71729975,0.8289046061054816
EM-2,navitoclax-sorafenib (1-1 mol-mol),0.1608439599369648
KYSE-450,44462760,5.018979644026392
OAW28,11964036,1.3272537866850969
SF539,49766530,-1.8483208282069583
WM88,5329102,1.5902636685700278
OPM-2,11228183,2.227238978219669
Ishikawa (Heraklio) 02 ER-,5329102,3.225884541641358
WM88,54618771,1.141068520778182
Panc 03.27,9933475,2.0146362180668724
SW1783,119607,5.1966620860731965
BL-70,5394,4.0255857442138785
ML-1 [Human thyroid carcinoma],5566,3.147714437598846
NCI-H2196,446155,5.337243146647456
PF-382,10026128,4.370506492826604
EM-2,44259,0.4246956329679421
TCCSUP,54618305,5.536232511374765
SNU-1041,23725625,6.062297558628496
PK-59,selumetinib-piperlongumine (8-1 mol-mol),2.2656122259892872
BT 245,11497983,3.4938717564559525
EM-2,6918328,-1.3437597681454934
MM1.S,6918736,-2.225977964273826
SW1783,selumetinib-PLX-4032 (8-1 mol-mol),4.758526701715075
Kasumi-2,alisertib-navitoclax (2-1 mol-mol),-2.881127323252466
BL-70,46843906,1.5539241155313153
HCC38,44486219,4.242425069280931
Kasumi-2,168313200,3.5619242662151342
KMS-20,7326481,3.962170132504471
JHUEM-3,9956119,1.291424358952468
SH-10-TC,11609586,3.591679952687895
SNU-410,2126,5.288356116373763
Rh30,44819697,-2.9182406444411773
B-CPAP,252682,6.481152760334254
BL-70,6610216,3.096911873339395
KMRC-20,452548,1.1770836669609313
BFTC-909,3384730,4.46542670181497
BT 248,984333,1.3539050434846691
BT-474,374536,3.467524619875936
NCI-H1568,11238147,2.925799577076833
A4/Fukuda,selumetinib-navitoclax (8-1 mol-mol),1.1983954877584069
RERF-LC-MS,10385095,0.7812016081678173
OCI-AML-3,53495165,-4.192274149541361
MM1.S,66577038,3.082546058901061
PF-382,11222830,1.048169261061167
KYSE-450,4578,4.488057266772786
M-07e,46843906,1.3186275874679747
Ku812,5329102,0.560653568662338
SK-MEL-28,24797083,2.1143227978428714
WM88,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.9395395427840283
YH-13,navitoclax-piperlongumine (1-1 mol-mol),2.7253521934801217
YKG-1,56649450,3.459902550410693
Kasumi-2,104842,-5.6475576104946565
CHP-212,2749,1.6745241704399625
KYSE-450,11455910,0.6287655004796859
OPM-2,9927531,3.0625153090482757
TCCSUP,ISOX-bortezomib (250-1 mol-mol),0.0880640354872425
SH-10-TC,3038522,3.761450156750067
NCI-H1568,148198,-4.9953315451672005
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816
OPM-2,135875424,2.796643273298537
NCI-H2196,1242560,3.625596554792382
F-36P,168313200,3.2109752739746886
JHUEM-3,44819697,-0.4980081314242896
A4/Fukuda,16038120,-3.113498344638628
HPAC,11152667,-1.496468536370371
OPM-2,89928392,0.3187576395153793
SNU-201,46224516,2.4326675957956554
Panc 03.27,46224516,2.9732515142206077
PK-59,selumetinib-UNC0638 (4-1 mol-mol),2.209283166348595
Kasumi-2,15983966,-4.769110499873103
BT 245,11222830,1.0250233618609572
KYSE-70,6852167,2.2981101713941814
SNU-201,selumetinib-tretinoin (2-1 mol-mol),6.508791384211245
KMS-20,3689413,-1.644811207648459
OPM-2,3689413,-4.501811354570108
BT 428,navitoclax-MST-312 (1-1 mol-mol),0.4416625098436278
BT 248,16219061,2.5057647005845354
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276
OPM-2,crizotinib-PLX-4032 (2-1 mol-mol),0.9302198277032876
Ku812,54613361,-1.6579291545050676
SK-MEL-28,salermide-PLX-4032 (12-1 mol-mol),7.2362275808894925
HEC-59,44819697,-1.3510973843483671
Kasumi-2,4259181,-0.4186991216348978
HCC1395,navitoclax-gemcitabine (1-1 mol-mol),3.140439835838234
PK-59,navitoclax-piperlongumine (1-1 mol-mol),1.4703383378883492
Panc 03.27,tretinoin-navitoclax (4-1 mol-mol),5.210351402586295
Ku812,44589607,1.98424939843821
Kasumi-2,navitoclax-gemcitabine (1-1 mol-mol),-5.447760787137567
Kasumi-2,3384730,0.4985599128931971
RERF-LC-MS,71304818,2.1402027844306986
OPM-2,4259181,-0.0185783035827133
SNU-201,66577038,3.675119287024728
YKG-1,400769,0.2933301417342049
SH-10-TC,10074640,3.834748683090748
OAW28,selumetinib-MK-2206 (8-1 mol-mol),3.6165441684706736
Ku812,11228183,0.9929327430500092
SNU-201,44486219,4.476581116633937
OPM-2,2945648,2.5610378238786367
RERF-LC-MS,107970,3.001301355490032
AU565,322968,2.504214157528526
KYSE-70,49793307,-3.275020883815728
AU565,3038522,2.241670788617941
NCI-H2196,3503,1.9344901865079576
RERF-LC-MS,9926054,1.8051014319834384
NCI-H1568,445643,3.6093957886383814
B-CPAP,5328940,1.9207769307249352
WM88,44462760,-8.460850241050691
Hs 746.T,51039095,3.027430165441565
Panc 03.27,tretinoin-carboplatin (2-1 mol-mol),4.83125802140961
OAW28,46398810,2.3633613380182386
SK-MEL-28,9825149,2.466048508580774
YH-13,JQ-1-MK-0752 (1-1 mol-mol),1.712752654360266
SNU-1077,11238147,4.353998599384084
BT-474,53495165,-0.9388154246820666
JHUEM-3,5329102,2.671357539156196
BT-474,44566777,1.2198096535563503
BT 248,82146,3.895792146901818
SK-MEL-28,400769,0.2291963522634262
SNU-410,2746,4.749931599758568
KMS-20,322968,1.9273054184406155
NCI-H1568,24180719,2.911739165396745
AU565,6918638,0.3564513775218086
SF539,44137675,2.552438639753458
KMS-20,5329102,1.4165548971793418
NCI-H2141,676352,1.850004369559142
SW1783,3689413,0.540292166648154
OCI-AML-5,11507802,1.2079080871917542
F-36P,5311037,3.722518680926946
SW1783,46215462,1.5074771125721502
HCC38,135999136,4.380203016974773
AU565,2842253,5.995707097044385
BT 248,9884685,-0.279602051509792
BT-474,11257553,3.9989599706778134
Hs 578T,11640390,3.257870797061961
KMS-20,9825149,0.2596001529902395
SF539,9927531,4.183842431586729
OCI-AML-3,1716436,3.2650114354586446
RERF-LC-MS,4917,3.617944790726347
HCC38,5746,0.4088404945107428
Hs 578T,5328940,1.5442531364287388
SF539,46907787,0.2074640579250286
BT 231,alisertib-navitoclax (2-1 mol-mol),-1.2220765646432012
SNU-1077,8515,4.803726365696702
HEC-59,2858523,3.16370887698848
Hs 578T,6918328,-0.6142559635615406
SNU-1041,9903786,3.9190312975923822
KYSE-70,6918837,-2.6267197721971582
SH-10-TC,49793307,-0.22033317517894
KMS-20,5738263,2.421562414606395
YKG-1,49793307,-1.8928162197489815
RKO,5281321,1.9988379902215376
YKG-1,sirolimus-bortezomib (250-1 mol-mol),0.0311399701967428
HCC1395,4521392,4.483180871111012
OPM-2,46224516,2.1207785622277373
SH-10-TC,45279963,4.157974130779826
KYSE-70,44493528,4.735176242945038
JHUEM-3,4096211,2.4005575794677068
NCI-H2196,135440466,3.6883717630675705
OAW28,selumetinib-JQ-1 (4-1 mol-mol),2.156145443592261
NCI-H1184,135999136,3.0982974136589143
F-36P,selumetinib-GDC-0941 (4-1 mol-mol),-0.222152579559036
NU-DHL-1,52912189,-0.4578007756599072
RKO,49793307,-1.4433237106321422
KMS-20,selumetinib-JQ-1 (4-1 mol-mol),-2.1329666207384124
NCI-H1184,9907093,2.0386820667607943
SH-10-TC,44632017,2.308446148485009
RERF-LC-MS,5291,3.9873816513243785
PK-59,55508,6.204825346541673
NCI-H1184,285033,-2.1507707458047585
Kasumi-2,44589607,0.7324041454669186
LOU-NH91,11238147,4.007302405058718
SH-10-TC,24856436,0.9241574243852908
B-CPAP,409805,5.0770120967965795
NCI-H2141,216345,2.839883434856441
A4/Fukuda,135440466,-0.9873079875011114
A4/Fukuda,9911830,0.8865121451383732
KYSE-450,3689413,-0.3124621453247139
NCI-H1184,25262965,-1.9183208413069963
OAW28,44137675,4.561686598527574
Hs 578T,56946209,-5.093561459200179
RKO,5978,-3.7617282032773582
SNU-410,9444,4.265520515009449
NCI-H1568,9908783,4.863315848037401
Ishikawa (Heraklio) 02 ER-,52947716,-5.108376694448824
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996
F-36P,JQ-1-carboplatin (1-1 mol-mol),-0.2067996802850356
KMS-20,54596558,3.850002617797552
BT 428,100016,4.306836909333982
LOU-NH91,6918328,0.1478473020386815
OCI-AML-5,25154868,3.366972476158949
HPAC,24821094,3.5426185606263108
JHUEM-3,9903786,2.091612721233031
MM1.S,3062316,1.4627062032317144
HPAC,selumetinib-navitoclax (8-1 mol-mol),1.570560722402827
HCC1395,10385095,1.414977783873619
Kasumi-2,65064,2.9473106091456467
PF-382,71304818,1.2599854334325824
OCI-AML-3,25183872,-3.151236047956492
PK-59,25154868,5.245486806165516
KMS-20,2729026,2.385777395539285
A4/Fukuda,53392493,1.8640822641046917
NCI-H1568,3062316,1.133797551734723
NU-DHL-1,11625818,2.715961384338104
SK-MEL-28,123631,2.412238783254816
KYSE-450,168312962,-1.1635814375740514
Ku812,67291369,1.446502731333229
M-07e,11222830,1.6171866252450655
BT 428,10410894,2.746869438201359
SH-10-TC,5278396,3.7440056011733818
NCI-H2196,5394,4.852260822335077
NCI-H2141,crizotinib-PLX-4032 (2-1 mol-mol),1.1461970427217916
Panc 03.27,11364421,-5.613513148451947
OCI-AML-5,24821094,3.731103434088747
F-36P,54649381,2.918510203679049
EM-2,16038120,-0.2498970863427447
NU-DHL-1,alisertib-navitoclax (2-1 mol-mol),-2.593164821561062
BL-70,49793307,-5.4853534810351405
PF-382,11656518,1.6205835275243787
NCI-H1568,24771867,2.7621066837370156
SF539,selumetinib-GDC-0941 (4-1 mol-mol),1.3644945034252027
KHM-1B,66577038,2.058186544179473
JHUEM-3,selumetinib-MK-2206 (8-1 mol-mol),2.430514274098031
BT 428,24772860,-2.503252436850905
AU565,5281321,-1.6701173206544262
BT-474,2871966,1.1907000623140442
OAW28,6918837,-3.92509053266304
PK-59,4378219,2.005391198678221
PF-382,444795,3.785413836559396
NU-DHL-1,5282054,2.5574961270689887
JHUEM-3,66577038,2.8976766456166088
Kasumi-2,44484893,-1.5195002495763423
YKG-1,5746,3.4716356966928927
Kasumi-2,4378219,6.192429128955844
OAW28,54618164,4.207465894202405
B-CPAP,6918328,-0.1092026368614908
A4/Fukuda,46224516,1.3171235816864948
PK-59,17755052,1.7138958301982952
TCCSUP,148198,-2.229154528716237
SF539,4261,3.034812096929495
NCI-H1568,11178236,-4.756412327662482
SNU-410,135984461,4.232022058920155
NCI-H1184,5278396,2.529484173705651
A4/Fukuda,5746,-1.1009867615741116
SNU-1077,5280436,3.835908210015818
M-07e,2733526,3.2424803343563804
BFTC-909,24951314,2.3445794180209565
OCI-AML-5,5311281,1.3342305799200709
PK-59,docetaxel-tanespimycin (2-1 mol-mol),0.3713076938077683
LOU-NH91,5738263,3.7277759973822726
A4/Fukuda,445643,2.2110077600401996
EM-2,2945648,-1.566594977364292
MM1.S,11625818,2.94126991090669
KMRC-20,2841722,4.772278882478543
YH-13,42642645,0.7428971462414599
SF539,25183872,-1.8165850981931693
BT 428,568763,0.9998879380091756
LOU-NH91,25126798,3.943021506059378
PK-59,73707438,4.318396616638754
Ishikawa (Heraklio) 02 ER-,11507802,1.7274893122424997
SF539,3038522,2.057800880949275
TCCSUP,54686904,5.934830892995649
NU-DHL-1,6505803,0.0102011938996583
SF539,navitoclax-pluripotin (1-1 mol-mol),-1.4182272937250473
M-07e,219104,1.8313510796740209
AU565,44185566,1.721131526136141
LOU-NH91,2729026,2.877851429076431
YH-13,SNX-2112-bortezomib (250-1 mol-mol),-1.3355072923544795
EM-2,374536,2.060592408193078
HEC-59,24753719,4.79630184603725
PF-382,637858,0.850873658302796
OCI-AML-5,10127622,3.867811738747283
SNU-1077,67156097,4.729819017533421
EM-2,4788,3.7749309389823855
SNU-201,tanespimycin-gemcitabine (1-1 mol-mol),1.3080384994104943
NCI-H1568,25262965,-4.225307409424958
RERF-LC-MS,25183872,-0.4545636564638026
F-36P,6505803,-0.1070428944453584
SW1783,219104,3.206819219402643
M-07e,navitoclax-pluripotin (1-1 mol-mol),-1.020724576888081
WM88,151289,0.8302819682103205
BT 428,168312962,2.6972045295653304
Kasumi-2,6610355,3.4850778191475342
SNU-1077,439501,-0.9206139201693064
NU-DHL-1,5281672,2.8333763139746813
PK-59,5281321,-2.3266618874871035
BT 231,16038120,0.3875963261635954
NCI-H2141,67156097,-0.6102384104992779
B-CPAP,44259,0.6950106705233007
NCI-H1184,selumetinib-piperlongumine (8-1 mol-mol),1.658153044262461
BT 231,4096211,0.5779460379075206
BT 245,3038522,2.4469235067564465
F-36P,alisertib-navitoclax (2-1 mol-mol),-0.5446087682083143
NCI-H1184,1716436,1.9697120433933637
F-36P,9840324,7.22634630161736
RERF-LC-MS,53495165,1.4938275665549956
RERF-LC-MS,2945648,2.437954541344266
HCC38,252682,6.101328548682257
Kasumi-2,66577038,2.680052495523132
B-CPAP,72734382,5.762194800032224
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896
NCI-H2141,984333,0.8014111182984605
OAW28,11609586,2.8574541529278883
BT 245,25195348,3.9905152863604663
BT 248,46907787,3.027762940742573
Kasumi-2,16720766,-0.2515973340383426
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775
SNU-1041,42642645,1.227574933871924
SF539,49846579,1.5882622372705737
Ku812,9927531,3.686533687467188
HPAC,60700,2.331779610526212
AU565,11494412,-0.7938994603064
F-36P,JQ-1-UNC0638 (2-1 mol-mol),-0.2349092718581727
NCI-H2196,54596558,4.173463220229992
M-07e,2746,0.8814107880911471
M-07e,selumetinib-PLX-4032 (8-1 mol-mol),4.75094566610205
SNU-1077,3384730,1.7373502464877797
Hs 746.T,462382,3.638417812530333e-05
NU-DHL-1,9803433,4.595964480668706
HCC1395,208908,2.541866592035047
BT-474,44607531,1.2154263025955123
HCC1395,107985,-4.4491862214991595
BT-474,42642645,1.6083573501039448
RKO,3025986,-0.6013959236761957
KYSE-70,6918736,-3.61435843984592
AU565,9952709,2.716124716701941
YH-13,7251185,2.541379459758288
SF539,selumetinib-PLX-4032 (8-1 mol-mol),2.9753691858714575
OAW28,selumetinib-vorinostat (8-1 mol-mol),2.294734084050853
BFTC-909,10302451,3.622269240471498
RERF-LC-MS,11497983,4.204546577264711
CHP-212,19582717,2.3334411804573416
Ishikawa (Heraklio) 02 ER-,4259181,-1.51348893728215
HCC38,6917907,-5.374977080157785
HCC38,262093,3.049385257949274
PK-59,5280436,3.786862266766158
BL-70,11222830,1.3948178080828
KHM-1B,36462,-0.5615447034427615
Rh30,10184653,1.5410830450934925
SNU-1077,51039095,2.124353715617282
B-CPAP,4917,2.9839600010766896
AU565,44819697,-0.774785052988496
BT 231,selumetinib-GDC-0941 (4-1 mol-mol),1.8101702553232384
OCI-AML-3,135999136,4.040843396784286
M-07e,176870,2.4935528839633507
HPAC,5328940,1.0779657588294422
KMRC-20,54619267,4.002299235726132
NU-DHL-1,6184667,2.420250013348629
Rh30,5281321,0.2470151037259378
OAW28,4259181,0.9119817479539226
SF539,136227924,2.8154987155907905
MM1.S,crizotinib-PLX-4032 (2-1 mol-mol),1.0198368521760113
BL-70,5278396,2.8786795004806423
Panc 03.27,23582824,0.577877406919201
OAW28,60700,1.95920843974679
SNU-1041,71304818,3.333526575869799
KMRC-20,36462,3.67134556506655
BT 428,57330099,3.668978742066668
KMRC-20,46398810,2.3963620862507717
OCI-AML-5,168312962,-1.2125968794488602
NU-DHL-1,56649450,3.732895044014296
AU565,11152667,-0.8659767610796402
BT 231,12003241,-1.271590527231957
NCI-H2196,10427712,4.30218788390281
CHP-212,71680916,4.11184371898559
NCI-H2196,5470400,-0.4294053972599648
NCI-H2141,JQ-1-vorinostat (2-1 mol-mol),0.910210767000062
HEC-59,10302451,4.030247099665508
EM-2,16722836,0.9486105699557424
OCI-AML-3,67156097,-2.972990940578762
BL-70,24964624,-1.1124128112825205
WM88,ISOX-bortezomib (250-1 mol-mol),0.1403409581346969
SNU-1041,44607531,3.521462117190238
SNU-1041,tanespimycin-gemcitabine (1-1 mol-mol),3.0548418305747793
KHM-1B,6438330,0.7214920302496746
NU-DHL-1,36314,-4.32042645892424
Kasumi-2,71680916,3.663022593238377
NCI-H2141,11175137,1.848035095587383
SH-10-TC,10302451,4.984172634394984
KYSE-450,5566,4.0898855069679785
SNU-410,15983966,3.3602937700468005
MM1.S,25154868,3.9012655265230127
NU-DHL-1,31703,-3.2392931195383756
NU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-4.786935307033958
EM-2,10322450,3.0285960061439865
BL-70,ISOX-bortezomib (250-1 mol-mol),0.075637503210552
SF539,3465537,2.1777468091875125
MM1.S,8515,6.088299107521539
KMS-20,3465537,0.9285591790497558
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912
SNU-1041,44241473,4.422105933247079
BT 428,46907787,0.0171893573997719
BL-70,54618164,2.8033577999904633
HCC1395,5351362,2.540726879911438
YH-13,12001922,2.42245560318508
NCI-H2196,44589607,1.6622704758621747
JHUEM-3,24772860,-1.1550826746578151
SW1783,11719255,3.4036440848936063
BFTC-909,2749,2.0212973698927184
BFTC-909,3062316,2.03384364484094
OCI-AML-5,3543504,5.572529857188522
HCC1395,3025944,4.386856306900804
PF-382,25102847,1.62616859805539
BL-70,9823820,3.7654146719430406
PK-59,444795,4.575943921838248
SNU-410,ISOX-bortezomib (250-1 mol-mol),1.5203140246930864
CHP-212,25161177,3.7429813276598782
SK-MEL-28,5311,2.6975320364679596
KMRC-20,3038522,3.6781934886194056
SF539,JQ-1-MK-0752 (1-1 mol-mol),0.6318948649394762
YKG-1,9926054,2.005416681797869
OAW28,5282054,3.6220988157242946
BT-474,176870,2.510938240066232
SNU-410,JQ-1-UNC0638 (2-1 mol-mol),3.2392922104580766
HEC-59,216345,4.296587565926405
OCI-AML-3,16219061,2.435034119279567
Kasumi-2,9952709,2.8950386128563985
F-36P,5282054,2.790703511495532
Hs 746.T,72734382,5.551782372765644
Ishikawa (Heraklio) 02 ER-,9868037,3.205963776347529
HPAC,10231331,1.4659578196353913
F-36P,23635314,-3.564510141174552
Panc 03.27,3385,3.653985675922377
MM1.S,135411,0.4705097492243096
PK-59,135421197,1.5554330287724354
Panc 03.27,23635314,-3.886300134221062
SF539,navitoclax-MST-312 (1-1 mol-mol),0.2156471617471034
EM-2,46907787,-1.6373715361565755
OCI-AML-5,selumetinib-navitoclax (8-1 mol-mol),0.1163788749913548
OAW28,53495165,3.30177539085494
HPAC,selumetinib-vorinostat (8-1 mol-mol),1.7368980324290706
OCI-AML-3,168313200,1.726224147374737
B-CPAP,1750826,-3.823823351631485
RERF-LC-MS,2729026,3.1361811776879644
MM1.S,1242560,2.8271935424204786
NCI-H2196,5282054,3.4102575601765306
B-CPAP,24901704,2.8811872687700277
BT 245,4917,2.258069794178112
BL-70,126941,-4.264612097802402
NCI-H1568,selumetinib-UNC0638 (4-1 mol-mol),2.7760221243911016
KHM-1B,BRD-A02303741-navitoclax (2-1 mol-mol),3.1307381995393153
EM-2,36314,-7.691166562033265
Hs 746.T,3689413,-1.6439550226846966
OAW28,107970,2.4537130721494105
KYSE-70,72193861,1.5917149982909504
OAW28,4477,1.0036814180565996
NCI-H2196,54619267,4.049060187101824
SNU-410,5566,3.1582064918236106
Ku812,alisertib-navitoclax (2-1 mol-mol),-1.9869824570436432
SNU-410,26596,4.2924060391829935
HPAC,navitoclax-piperlongumine (1-1 mol-mol),2.3915290060451224
Rh30,24180719,3.9836617255243
BT-474,123631,0.8995077744739307
BT 248,serdemetan-SCH-529074 (1-1 mol-mol),1.089631188997332
JHUEM-3,25227462,1.1025420912673871
HPAC,16720766,1.2619084791438226
KMRC-20,selumetinib-MK-2206 (8-1 mol-mol),3.8802648290187225
Ishikawa (Heraklio) 02 ER-,241158,3.6664689500376353
NCI-H1568,11717001,4.19629869858104
BFTC-909,3136844,3.2427360302120403
NCI-H1184,11626560,0.6629022228391719
SF539,11625818,4.190042053470209
KMRC-20,44493528,4.509843443263092
BT 231,44566777,1.5227843283968532
BL-70,3136844,3.2643251354787965
HEC-59,10427712,4.264879463820628
OAW28,445455,5.326899909172617
Panc 03.27,19582717,5.647185119267755
Panc 03.27,446155,1.597194659816849
SF539,tanespimycin-gemcitabine (1-1 mol-mol),-2.9863403068380614
A4/Fukuda,SNX-2112-bortezomib (250-1 mol-mol),-3.583227894628943
OPM-2,5479543,3.226492982806864
Rh30,BRD-K27188169-navitoclax (2-1 mol-mol),4.056218450579192
BT-474,11427553,3.656887006373197
M-07e,46174525,2.524260947011249
HPAC,216345,3.935397850921086
YKG-1,24785538,1.7282682094095363
A4/Fukuda,44632017,0.3391160528514481
WM88,135398516,-0.2818362431448623
RKO,3543504,4.836700902585943
M-07e,44589607,1.01913125610395
EM-2,5470400,3.446280344660247
OPM-2,227681,1.827584998281281
CHP-212,4917,1.9819351298873396
HPAC,3503,2.682047267969405
EM-2,54619238,5.471922272859229
EM-2,11609586,2.2105848039211384
OPM-2,53232,1.210133300080481
YH-13,44241473,5.475816552188209
BT 231,25161177,2.8778266292860355
SH-10-TC,46191454,1.7281197292437258
CHP-212,6918878,-1.2295250328780245
KMS-20,9933475,1.7150335171182485
OAW28,11497983,4.916879328733168
KMS-20,16741245,4.955396324130607
LOU-NH91,9915743,1.51930479588737
EM-2,11497983,-3.9003220208781255
BT-474,3552672,1.8381505179288655
BT 248,44185566,1.9117845458549376
KYSE-450,24856436,0.9513610633306496
OCI-AML-3,16659841,3.243277800489257
TCCSUP,10184653,2.1408620170071084
KYSE-70,637858,2.812350468450961
EM-2,5738263,2.5661728548026383
OAW28,9840324,5.735695909737487
BT 231,16736978,1.784155706767899
LOU-NH91,49793307,0.2442451207819767
MM1.S,73707398,0.3713750235386087
SF539,49793307,-4.242973153830116
SF539,2733526,2.647768601693724
BT-474,46926350,-3.6678762288963234
AU565,6505803,-0.7592801042803803
LOU-NH91,JQ-1-navitoclax (2-1 mol-mol),-0.9494893938719444
BL-70,JQ-1-carboplatin (1-1 mol-mol),0.8530226058768635
HCC38,168312962,4.236898496256957
NCI-H2141,vorinostat-carboplatin (1-1 mol-mol),3.6348780583956817
AU565,72376,-1.9935205494525805
JHUEM-3,piperlongumine-MST-312 (1-1 mol-mol),1.6448647243354275
SW1783,613753,4.7217707300915
YKG-1,4578,4.349355625393761
Rh30,5311281,0.9297302854693292
KMS-20,9935249,1.026705986562312
OAW28,5280436,5.165372214799318
WM88,448949,1.8915694334555528
BT 231,SNX-2112-bortezomib (250-1 mol-mol),-1.3655489858390828
KHM-1B,44819697,-2.627948052735268
NCI-H2141,462382,-0.2863296885059584
PK-59,25262965,-2.365413472311944
YKG-1,5311281,1.228854081788957
BT 428,3025986,-0.7916627895218987
CHP-212,100016,6.525746829388361
RKO,2708,5.0364138660049935
BL-70,46191454,0.8658935503304176
LOU-NH91,6438330,3.480541802748286
M-07e,387447,-5.072568697910827
LOU-NH91,448949,2.461672905148464
OCI-AML-3,2708,2.1936523339198137
MM1.S,25126798,3.74177726744656
KMRC-20,100016,7.210629640241846
NU-DHL-1,4521392,3.4601800103971474
SW1783,2858523,2.7249015392010425
NCI-H1568,selumetinib-MK-2206 (8-1 mol-mol),2.137801357231392
NCI-H1184,1641662,2.884795743653617
RERF-LC-MS,374536,3.716253113618047
CHP-212,UNC0638-navitoclax (1-1 mol-mol),3.0960304898677973
A4/Fukuda,15953870,2.701018205920996
SNU-201,5278396,3.90590843812104
BT-474,89928392,-0.8950458369614224
BT 428,BRD-A02303741-carboplatin (1-1 mol-mol),4.259029320114088
KYSE-450,16725315,5.267357391878718
OAW28,3503,2.6573145013500743
SNU-410,24951314,1.8571180904002205
F-36P,navitoclax-sorafenib (1-1 mol-mol),0.9327290112041924
OPM-2,5284373,2.335601496737994
LOU-NH91,5280436,5.173335280456015
SH-10-TC,56649450,3.741009228199919
BT 428,44819697,-2.8308902795698625
RERF-LC-MS,216239,1.5111459083459036
MM1.S,11485656,1.9684027845110144
Kasumi-2,11612883,1.7782552978814286
MM1.S,46199207,3.245764113166512
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609
WM88,25195348,4.241311637380961
PF-382,23939,6.138736968520051
PF-382,46199207,2.6598109327538286
NCI-H1184,387447,-3.0553961035252093
OCI-AML-5,45279963,3.8398080866126936
SNU-410,15953870,3.0110821873040607
KMRC-20,5329102,2.310119092431828
NU-DHL-1,11656518,1.0275988085654195
NU-DHL-1,53392493,1.5644562418702903
KYSE-70,53495165,0.5494520653774981
NU-DHL-1,2828334,5.350284710579576
OCI-AML-5,11719255,5.477715461275096
BT 428,44137675,3.735819095896295
Hs 746.T,25262965,-3.1605891743873076
HCC38,navitoclax-gemcitabine (1-1 mol-mol),-4.860126233903179
AU565,54626689,4.66017141288812
Hs 578T,11152667,-3.116369263954623
Ku812,9868037,1.2688072678140785
KMS-20,6505803,-0.2025622916563878
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582
NU-DHL-1,2842253,5.839459621103588
OAW28,9926054,1.976123345191561
Ku812,23725625,3.808154058237452
PF-382,409805,3.4085068464251997
JHUEM-3,56963564,0.740668258297284
Kasumi-2,54618305,4.391643278203803
BFTC-909,16722836,1.424017650466323
Hs 578T,9903786,3.085679401941195
M-07e,BRD-K55473186,1.6594747686068163
NCI-H1568,25195348,2.211268152441431
NCI-H1184,10410894,2.9677714270439433
TCCSUP,46191454,2.343192904170071
CHP-212,doxorubicin-navitoclax (2-1 mol-mol),-3.7821084470898736
KHM-1B,6852167,0.7581222087853566
HCC38,25154868,5.39614143199103
KMRC-20,44197249,3.899612901236983
OAW28,54618164,4.207465894202405
BT 248,ISOX-bortezomib (250-1 mol-mol),0.8192035269806958
LC-1F,5738263,4.064064689127115
NU-DHL-1,4578,4.105143209459994
RERF-LC-MS,10231331,0.9954911948227504
F-36P,42611257,3.2131530635037935
Hs 578T,9884685,-0.940364062265686
NCI-H1184,decitabine-carboplatin (1-1 mol-mol),4.430046787624507
TCCSUP,969516,3.191540501886845
A4/Fukuda,462382,-0.2406989279082468
NCI-H2196,53392493,1.8581644840147649
OPM-2,89183176,2.1177805080987633
NCI-H2196,erlotinib-PLX-4032 (2-1 mol-mol),3.168735127131262
OPM-2,44489675,4.196628172603179
RKO,3025944,4.391654014934833
BL-70,10184653,0.7205374209251207
Kasumi-2,241158,2.967162139629707
CHP-212,46191454,2.0095428169180156
BL-70,10427712,3.6382593350573247
SK-MEL-28,23725625,5.112081717822141
KYSE-70,10296883,3.691258417269261
Rh30,73707386,2.7421591744749745
CHP-212,409805,6.004594677417721
OCI-AML-5,148124,-5.059033950577293
BT 428,135398744,8.121810698450407
BFTC-909,5335621,5.263558209813896
BL-70,31703,-1.4211496364153742
Ishikawa (Heraklio) 02 ER-,11175137,3.4577844980974195
LOU-NH91,151289,1.7382502757713727
TCCSUP,444795,5.142441230913875
M-07e,11955716,-2.1714109744952963
JHUEM-3,5738263,3.8650839423713146
Panc 03.27,2126,4.938237638349138
YKG-1,11364421,-5.418729498974909
AU565,421610,2.258686960610045
M-07e,25154868,4.509357953587368
WM88,4477,0.2072970629408826
YH-13,doxorubicin-navitoclax (2-1 mol-mol),-1.2809581142975497
OCI-AML-3,54618305,-5.913694317144885
HCC38,6918837,-2.4953213880876204
NCI-H1184,44589607,1.7342728781712122
BT 428,2874250,-3.4115860652418504
YKG-1,6918638,1.332910318202703
TCCSUP,135411,0.4235399042489139
TCCSUP,2749,2.6496774688336004
SNU-410,24964624,4.308418997715632
JHUEM-3,65064,5.525825664639089
SNU-1077,54613361,5.090510226411371
CHP-212,126941,-4.033771845128517
NU-DHL-1,89183176,4.0895744389875155
BFTC-909,16725315,4.495652912061774
KYSE-70,969516,2.5944329315988552
YKG-1,2949965,2.7570477718162367
EM-2,126941,-4.304730515969696
NCI-H1184,119182,-3.2118953909190178
BT 245,45279963,3.911554370960284
M-07e,44489675,3.779125567526095
B-CPAP,25150857,2.3279804239835067
NCI-H2196,16722836,2.761270259219068
Panc 03.27,6610355,4.26829430412183
OCI-AML-5,73707398,0.4979905922815086
F-36P,9915743,0.3844593263484804
Rh30,5329102,1.5460375205317074
KYSE-450,135440466,3.4784789863702112
YH-13,136227924,2.93381240838723
SH-10-TC,tanespimycin-bortezomib (250-1 mol-mol),1.41172754635421
YKG-1,9887053,4.276479175493701
BT-474,3503,3.598305301985569
OCI-AML-3,445455,1.5754613227692793
YKG-1,4788,6.355492243434627
SNU-1041,25183872,3.3581024300133953
SNU-1077,2858523,3.01508829517467
NCI-H2141,5280436,1.9160950837938404
KYSE-450,7251185,3.3097037107461897
Hs 578T,24785538,1.2160381198006722
F-36P,26596,-3.451633292118186
SNU-201,25183872,0.7366620506221063
HPAC,53392493,2.93172569601273
F-36P,135398516,1.470096295547799
OCI-AML-3,3676137,4.051482367169167
EM-2,9866186,0.236649359200824
HCC38,49793307,-4.9222712662291235
NCI-H1568,54618305,4.1006341963066255
PK-59,3385,3.852360617326858
Kasumi-2,5460769,1.467216518279754
SK-MEL-28,5978,5.732425336762653
SW1783,11404337,0.7381457579106708
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124
HEC-59,crizotinib-PLX-4032 (2-1 mol-mol),2.797038256663414
BL-70,54143018,0.4529080416006092
EM-2,SNX-2112-bortezomib (250-1 mol-mol),-3.5845749303911987
OAW28,135398516,2.0767833136681437
BFTC-909,17755052,1.7621152527207813
CHP-212,156422,4.199800776405569
BL-70,19582717,2.378882197072949
SH-10-TC,selumetinib-navitoclax (8-1 mol-mol),4.525270249998576
BFTC-909,262093,3.5924629632259792
HCC38,426756,4.388558578667449
B-CPAP,44241473,5.575826833143993
SF539,637858,1.5175949767978318
OAW28,6918638,0.0048657249331401
HPAC,9911463,2.695255349587433
YH-13,3854666,0.9588236597385832
BT 428,6918878,3.9952196892532896
JHUEM-3,104842,-4.5079202546424755
HEC-59,984333,0.6955843178508071
KHM-1B,3062316,-0.287496267646507
CHP-212,vorinostat-navitoclax (4-1 mol-mol),0.2835133935312501
NCI-H1184,5281672,3.4839810130895064
B-CPAP,56946209,-3.554958382916866
A4/Fukuda,9967941,2.4411204768161983
OAW28,25154868,4.5321266568460805
BT 231,49793307,-2.782131370462149
BT 231,navitoclax-piperlongumine (1-1 mol-mol),0.9945561307668396
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112
HCC1395,44489367,5.389676649360524
A4/Fukuda,11717001,3.8123333180630103
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481
Hs 746.T,10127622,2.643824812492084
PF-382,5329102,1.0797765060108404
HEC-59,675434,4.191771283173354
BT 245,carboplatin-etoposide (40-17 mol-mol),3.681284032155918
KMS-20,156422,3.444760878114978
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
SK-MEL-28,285033,0.2575434442384768
NCI-H2141,54613361,-0.1625860111493711
WM88,25161177,1.259901969284152
NCI-H2196,25102847,3.2352061577317865
YKG-1,11707110,2.3974603193605275
OAW28,navitoclax-MST-312 (1-1 mol-mol),0.8340042464828235
BL-70,53495165,-4.404667588866244
SNU-1077,654092,-1.0014927314306907
Kasumi-2,6918736,-2.315158162333665
KYSE-70,10410894,6.372300696648814
BT 231,219104,3.245050885185789
F-36P,44202524,1.2582090673086783
BT 428,984333,0.0078078070137453
KYSE-450,11507802,4.680867496065348
BT 231,5470400,1.511774854898776
BT-474,54596558,4.171783466376785
MM1.S,11175137,1.6497782551400215
NCI-H1184,216345,3.4807070724059725
BT 231,44185566,1.0546316421769637
TCCSUP,5291,3.685939275525437
AU565,46943432,5.0196372017891555
RKO,3854666,1.2691133577357363
BL-70,71466380,3.136205381438639
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216
SNU-1041,54618771,3.2318145292931195
RKO,6918837,-1.4612228483082623
SNU-1077,637858,2.311785541808234
A4/Fukuda,selumetinib-piperlongumine (8-1 mol-mol),1.1723483513994604
BT-474,15983966,1.9736037281116576
YH-13,navitoclax-gemcitabine (1-1 mol-mol),-1.557893185204028
MM1.S,serdemetan-SCH-529074 (1-1 mol-mol),-0.1591683949873749
BT 231,676352,1.2654935128544424
BT 248,135398516,2.090653291947233
HCC1395,6918328,0.4025403379256139
KHM-1B,11625818,2.7772036353291725
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992
YH-13,107970,3.012104980277858
HEC-59,57330099,5.473847710050695
OCI-AML-5,56649450,2.9441790793611893
OAW28,135411,2.218427323792269
SNU-1077,23635314,3.6537158971816392
M-07e,4261,-0.3777955911753418
TCCSUP,2828334,6.2469193029566235
PK-59,15983966,2.1220283483139215
Hs 746.T,5351362,1.085126748212932
RERF-LC-MS,241158,4.36087401910034
KYSE-70,71304818,1.8226881659751617
HCC38,107985,-4.581327421068375
WM88,9826308,0.5645209171614324
Ku812,9825149,0.757991873961122
SF539,51039095,1.5941495610042506
Hs 746.T,46907787,3.398269102582514
BT-474,selumetinib-PLX-4032 (8-1 mol-mol),5.193614900234351
NCI-H2196,25126798,4.269550102548246
SF539,126941,-2.8509530485587065
TCCSUP,46224516,2.7201046077438793
A4/Fukuda,9549297,1.6255879909683784
HEC-59,54649381,3.861109001326165
TCCSUP,5460769,3.7572024912117103
BT 245,12001922,1.1359321871248116
NCI-H1184,3854666,1.1815941086455106
Ishikawa (Heraklio) 02 ER-,3062316,2.956789611231251
RKO,6852167,3.601912647929868
AU565,11625818,3.8205404098717457
BT 231,441298,3.0400785513458515
BT 428,24978538,-0.3373674737909561
PF-382,1716436,4.358638458244471
YH-13,15983966,-4.17863717198839
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517
JHUEM-3,327653,4.2565613639882525
SF539,selumetinib-MK-2206 (8-1 mol-mol),2.7695496094715875
NCI-H1184,46398810,1.7839327048305085
BT 428,5351362,1.220598971741878
Hs 578T,650361,5.221503033244948
KMS-20,208908,1.6387060547766314
Ku812,44607531,1.394726431566783
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872
TCCSUP,navitoclax-piperlongumine (1-1 mol-mol),2.2323075762929863
OAW28,selumetinib-navitoclax (8-1 mol-mol),1.984152872487984
NCI-H2196,11427553,3.8612375283242457
A4/Fukuda,16065773,1.900447949816596
TCCSUP,54619267,4.2789999138556425
PF-382,9967941,3.320272765089539
NU-DHL-1,3025944,4.128998199561555
EM-2,54618771,-0.9805043805831684
SH-10-TC,54454,0.4996338156971104
NCI-H2196,9823820,6.025052680161469
A4/Fukuda,374536,-1.0311095755670416
SNU-201,15547703,5.780529436127369
AU565,44489675,4.101715930322606
B-CPAP,4788,5.4024442798763905
KMRC-20,656346,3.07452123258755
Ku812,46191454,1.1353148896243908
NCI-H2141,2871966,1.2103483204311012
CHP-212,5278396,3.1469142901369587
LOU-NH91,navitoclax-PLX-4032 (1-1 mol-mol),-1.9251020200365585
OCI-AML-3,11427553,-0.838718613167052
Ku812,9444,3.739860815114633
OPM-2,71466578,1.093801721105574
NU-DHL-1,568763,-0.5697749505348572
Panc 03.27,6914657,-4.236042453971602
BT 428,24748573,2.5154789435675333
NU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-5.825890673866902
LOU-NH91,24901704,2.9181520482303585
Rh30,10231331,3.76900481174906
TCCSUP,selumetinib-BRD-A02303741 (4-1 mol-mol),5.6777204255641305
NCI-H1568,44462760,4.02669785413772
SF539,vorinostat-carboplatin (1-1 mol-mol),2.36336585394669
EM-2,6918878,-0.543914375160734
A4/Fukuda,71751553,4.0599050322296995
HPAC,10296883,3.470080354686621
RERF-LC-MS,52912189,3.970931922009392
KHM-1B,613753,3.0054296749373095
KHM-1B,3025944,3.5975685819410503
HCC1395,675434,5.252990339476983
BT 245,46174525,2.383574955486469
OAW28,11719255,3.92549874892824
RKO,10302451,3.926970734642152
WM88,6918837,-3.960088743301993
KYSE-450,11427553,3.7801306516191384
SNU-1077,5278396,3.261977388263693
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863
RERF-LC-MS,11507802,1.168612691302407
SNU-410,107970,2.3255659679492378
Panc 03.27,44543605,5.828397253497851
BT-474,44137675,3.8167632328478343
WM88,53392493,1.920733139989965
Hs 746.T,11178236,-4.335142466529318
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236
BT 428,5287620,-2.636425649332777
KMRC-20,54649381,3.798675470632658
SK-MEL-28,JQ-1-vorinostat (2-1 mol-mol),2.398214143945904
SF539,11964036,0.8812555480716474
OPM-2,46843906,-0.5330027912440064
WM88,16219061,3.2647742857827557
Ku812,2858523,2.0099200401333563
B-CPAP,44507138,1.9476690283796445
OCI-AML-5,25195348,2.388143092510493
PK-59,10231331,3.699323619498394
OPM-2,135928012,2.8826672527394956
BT 231,11364421,-5.652972875269212
HPAC,387447,-3.631275387941533
B-CPAP,51039095,2.4263361872279456
PF-382,135423438,0.1628237790601052
NCI-H2196,51037431,4.121947477446339
MM1.S,44543605,5.063671171274212
NCI-H1184,71680916,4.098452703823787
LOU-NH91,56649450,2.5557041031897705
SF539,ISOX-bortezomib (250-1 mol-mol),0.2487005267767388
SF539,25102847,1.4843193904497096
B-CPAP,selumetinib-GDC-0941 (4-1 mol-mol),1.9189461116893112
HPAC,5287620,-2.151396510084023
B-CPAP,374536,5.570137344225874
JHUEM-3,44491742,3.947686960056495
OPM-2,24775005,3.1759511003243532
Kasumi-2,44819697,-2.5261102007933154
SNU-1077,5738263,3.1464059503037576
YKG-1,2828334,6.412348563007059
RKO,6438330,2.4839059464581785
Ishikawa (Heraklio) 02 ER-,6610355,5.455627286955898
KYSE-450,selumetinib-GDC-0941 (4-1 mol-mol),2.546868719199844
RERF-LC-MS,613753,3.34976336152667
Ku812,5746,-0.7811708469290007
SF539,54626689,2.4541626708766855
HCC1395,375860,-0.7550225265126825
SNU-1041,176870,2.6261952864729294
M-07e,6852167,2.1940541155208098
Rh30,11640390,2.5265386106899723
KMS-20,135411,-0.1800034953276003
Hs 746.T,5284373,3.0688656748013563
OPM-2,11707110,-2.1571352516283113
AU565,44566777,1.2994228207825576
NU-DHL-1,24856436,-1.132887458167272
OAW28,16659841,4.936500838241895
KMS-20,65064,3.1315037554409466
Hs 746.T,25126798,3.6521705029203706
SK-MEL-28,613753,3.2736385592087527
KMRC-20,124202324,3.9491419219303943
HCC1395,452548,1.879416377034295
F-36P,46224516,2.4732424760607117
F-36P,navitoclax-gemcitabine (1-1 mol-mol),-1.0394701152082435
YKG-1,72193861,1.638693395639398
TCCSUP,piperlongumine-MST-312 (1-1 mol-mol),1.4987709869908574
F-36P,9967941,3.6395502360167655
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185
BT 428,72193861,1.1459450483713445
BL-70,56649450,1.446089685000553
SH-10-TC,168313200,3.5833535240153225
SH-10-TC,11640390,3.5123259910459548
Ishikawa (Heraklio) 02 ER-,docetaxel-tanespimycin (2-1 mol-mol),-5.003723507939257
SNU-1077,selumetinib-vorinostat (8-1 mol-mol),2.452404658166729
M-07e,53232,2.353688596326146
PK-59,11214940,1.5355548695731127
PK-59,JQ-1-vorinostat (2-1 mol-mol),1.6525916334631885
SNU-1077,10184653,2.0946597853188833
OCI-AML-5,tanespimycin-gemcitabine (1-1 mol-mol),0.403921260155381
NCI-H2196,9915743,2.494227946954125
PF-382,5460769,-0.5383889446594711
TCCSUP,2733487,6.902368396257458
AU565,16722836,1.9939850778221897
PF-382,5311,0.2704502980561536
KMS-20,2126,4.021349157282486
NCI-H1568,2749,1.8950065449811435
NCI-H2141,alisertib-navitoclax (2-1 mol-mol),0.0041358435122444
BFTC-909,10074640,3.0053798884123837
HCC38,11485656,1.880745325077396
LOU-NH91,654092,0.641619390442256
LOU-NH91,1716436,1.3649900096390022
OPM-2,702558,4.8466631372101725
BL-70,135411,-0.0441330068408555
M-07e,613753,2.369543171476294
OAW28,44491742,4.754653012158477
Rh30,124202324,1.8013183476923256
PF-382,68056272,3.167967878005275
HCC38,446155,5.8734521469455085
YKG-1,19582717,5.492201151442481
Ku812,2945648,2.863676297745722
BT-474,219104,3.3541556211233696
KMS-20,3634881,2.563355579370569
BT 231,67156097,-1.2142947199039105
M-07e,51039095,2.323964995389334
MM1.S,54618164,3.790511096311708
MM1.S,219104,2.0959225509633552
MM1.S,selumetinib-piperlongumine (8-1 mol-mol),2.4141492547305243
NCI-H2196,5287969,-0.9218693917987144
Kasumi-2,16659841,3.619219766502468
CHP-212,168313200,1.911615856976856
TCCSUP,104842,-1.1313342296159858
Kasumi-2,1750826,-5.270023181988586
A4/Fukuda,3136844,3.333855932915555
BL-70,6917907,-6.977678696531045
HCC38,216345,4.011416989579457
NCI-H2141,sirolimus-bortezomib (250-1 mol-mol),-0.1693402780002957
HCC38,322968,2.549222622051873
AU565,JQ-1-vorinostat (2-1 mol-mol),0.9003268678800701
KMS-20,126941,3.518118662895743
KMS-20,56963564,-0.3718578032159711
CHP-212,navitoclax-pluripotin (1-1 mol-mol),-1.5242738625714003
WM88,9840324,5.675113185671668
BFTC-909,9825149,2.463033939289578
Kasumi-2,44185566,0.8464196954941686
SF539,9933475,0.5324953409576078
OAW28,44489675,3.928609606447794
PF-382,11364421,-5.01539048557423
OCI-AML-3,54678924,1.251619506665293
JHUEM-3,168312962,4.321827617318254
NCI-H1184,vorinostat-carboplatin (1-1 mol-mol),2.2934441394424763
BL-70,3552672,2.0430987191782455
Kasumi-2,11152667,-1.6921100461719016
Hs 746.T,44486219,4.435456947800764
KYSE-70,68056272,3.571583007543391
SF539,54143018,-1.099127333554906
SNU-1077,5311,1.163107558524668
SF539,421610,3.0034514922655817
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784
HCC38,44495899,4.758052960509592
TCCSUP,44241473,5.1111150240253975
PK-59,42642645,0.6067807783414038
HCC1395,44259,0.4276372103530615
BL-70,8515,3.824466165102045
BT-474,4917,3.113559529931542
Kasumi-2,16038120,1.393585308421038
SF539,72199292,1.9939606105084
KYSE-450,9866186,1.0868221005132463
HPAC,6438330,3.393704478946381
TCCSUP,5311,0.9056986626797512
NU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.2606436334910045
NCI-H1184,JQ-1-carboplatin (1-1 mol-mol),-0.5864173330660996
YH-13,6918736,-3.6084117176459913
Ku812,3136844,4.770484958270985
LOU-NH91,71304818,3.9209078908272703
WM88,46843906,4.28223412010689
KYSE-70,17755052,0.9465092626724514
Hs 746.T,219104,4.31874046526179
F-36P,36314,4.061634155708799
KYSE-450,72967,3.7351940397417023
TCCSUP,676352,1.7918855242955138
MM1.S,5282054,2.5945944982730538
NCI-H1568,4578,4.166510450069308
Hs 578T,46199207,2.9852825442758393
SH-10-TC,637858,3.386044080916751
KHM-1B,16720766,-1.5556975858527622
BT 245,24856436,1.3341337214479536
SF539,11657048,3.82012123465622
Rh30,3815108,1.8421868623126207
KMRC-20,10385095,2.891783125869015
TCCSUP,6918837,-3.2032955112997623
TCCSUP,15547703,4.005095774110686
KYSE-70,46224516,2.993089177283032
NCI-H2196,702558,5.7200778724585595
KYSE-450,selumetinib-piperlongumine (8-1 mol-mol),5.043149849236574
LC-1F,16038120,0.6724731590464715
OCI-AML-3,54613361,-2.2841802964407156
HPAC,44607530,1.4628793157590303
OAW28,5746,2.6048591865024657
Panc 03.27,44185566,2.988606753906053
SNU-410,5280436,5.270883691911716
KMS-20,46398810,1.6452638403183906
M-07e,11396600,2.6873765044270463
SH-10-TC,5978,-3.067312369099808
BT 248,439501,-2.3411963573363104
KYSE-70,16722836,1.4327625680833322
NCI-H2196,10385095,0.8172347164501069
F-36P,46943432,1.5782924322919043
PF-382,5566,2.4095985038819947
BFTC-909,2733526,3.41724914482818
EM-2,6852167,0.9842346287991872
KHM-1B,11427553,0.8733560257670158
Hs 746.T,5743,3.710821164212691
Panc 03.27,44819697,0.0251051590588801
KMS-20,25062766,1.6197159272669466
KMS-20,5281321,-3.543869904687322
Rh30,216239,2.4050307074398853
SNU-410,4477,1.4283069095362575
KMS-20,5470400,3.66095099823791
NCI-H2141,44185566,2.0024497797668883
Hs 578T,15953870,4.173543051659192
HCC38,2871966,-0.7137196614890189
SNU-1077,11214940,1.023851206507241
SNU-1077,11178236,-4.2956560843661205
NU-DHL-1,285033,-4.05787074586027
NCI-H1184,42642645,-0.543529619331064
Hs 746.T,selumetinib-UNC0638 (4-1 mol-mol),2.311758394710276
NCI-H1568,4521392,3.7910777113602303
OPM-2,5282054,2.4375164125334217
NCI-H2196,3025944,4.262258512106237
MM1.S,5329102,1.1303790251840526
MM1.S,135398516,0.5060788410645305
SNU-1077,46901937,3.8594891831371503
SW1783,5287620,-1.3610825750677231
KHM-1B,654092,-1.7753167598635085
ML-1 [Human thyroid carcinoma],445643,4.241689590807037
KYSE-450,107985,-2.5991622295290413
TCCSUP,navitoclax-MST-312 (1-1 mol-mol),1.0715632013876748
SNU-1041,25154868,5.420026502005922
PK-59,322968,2.6897513308784897
Rh30,9936388,1.7390836835977532
KHM-1B,135440466,-1.206578017984145
NCI-H1184,44607531,1.2092014571263712
M-07e,selumetinib-GDC-0941 (4-1 mol-mol),-0.1227963657449235
F-36P,46398810,-0.3674107796083021
Ku812,168312962,-3.0210187912028075
F-36P,68056272,3.219612539659415
PF-382,448949,1.3962904970520496
SK-MEL-28,44589607,3.4025366741016585
BT 231,11427553,3.184979553462504
Kasumi-2,44632017,0.7335001301015701
HCC38,119182,-0.9490563989787092
BT-474,44819697,0.49146546504824
OCI-AML-3,45279963,3.663313113022171
OPM-2,16038120,-1.581922980476964
EM-2,10302451,-1.381197320031158
BT 428,3081361,1.5863318204290036
JHUEM-3,285033,-0.3033694163946592
PF-382,3634881,2.1354287574506117
BT 248,5278396,3.9189937549477545
KHM-1B,5329102,0.5280819798234874
YH-13,36314,4.085888552358508
BL-70,44566777,1.2630263651170024
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939
KYSE-70,702558,6.39879445367054
KMS-20,BRD-A02303741-carboplatin (1-1 mol-mol),5.179174708590503
BT 231,45279963,3.2637950128536413
SNU-1041,5287620,-2.8910112378730224
Hs 578T,56649450,1.611006330638189
NCI-H2196,4261,1.033156711220462
NCI-H1568,107985,-3.6136890416333665
KYSE-450,24772860,-1.687862811669867
JHUEM-3,42642645,0.9251279637473327
TCCSUP,2949965,6.201374753875732
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
BT 248,3038522,2.764297682711703
OAW28,tretinoin-navitoclax (4-1 mol-mol),1.3460784377141035
BT 248,11178236,-4.1971988945266965
HPAC,168312962,3.3423507614778756
OPM-2,selumetinib-decitabine (4-1 mol-mol),0.7585781361547917
KYSE-450,67156097,3.411841611974051
BT 231,4477,0.1513876280994911
PK-59,piperlongumine-MST-312 (1-1 mol-mol),2.100017437550193
BL-70,44632017,0.3651539360811663
AU565,serdemetan-SCH-529074 (1-1 mol-mol),1.652601677572969
SH-10-TC,6184667,5.394320314856929
BT-474,ISOX-bortezomib (250-1 mol-mol),0.9747345351804272
CHP-212,4261,-1.8427593348644984
F-36P,54596558,4.3015158184928035
Rh30,11152667,-1.7788269902081053
PF-382,selumetinib-tretinoin (2-1 mol-mol),4.149133041999036
CHP-212,148198,-4.905957419463446
HCC38,10184653,1.882536055326277
EM-2,tretinoin-carboplatin (2-1 mol-mol),-0.3885031197260502
SW1783,36314,3.6045625119114506
YKG-1,54618305,4.389332697073838
Rh30,387447,-4.304641706039777
Panc 03.27,5329102,1.596490566016948
NCI-H1568,5311281,2.6261557759532974
KHM-1B,tanespimycin-gemcitabine (1-1 mol-mol),-0.6092153686857478
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415
Ku812,44543605,3.7520401009891504
KYSE-70,doxorubicin-navitoclax (2-1 mol-mol),1.6680875974880454
WM88,46191454,1.6909845663414755
BT 231,5281672,4.741828891456126
BFTC-909,24771867,4.730369684143592
EM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),1.674677145167808
M-07e,55508,1.962782174405353
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626
AU565,46199207,2.977397460043432
CHP-212,3634881,3.111860590005791
OCI-AML-5,11626560,0.1322664115406426
Ku812,9911830,-2.227591069329418
BT 248,11955716,-0.8129800870812356
RERF-LC-MS,135411,0.496828330774242
WM88,15547703,2.932019291801755
HPAC,5311281,1.0444375324051676
BT 245,4378219,2.684006607069923
Kasumi-2,387447,-5.322857892005912
NCI-H2196,11228183,-0.5553149553175567
Panc 03.27,168312962,-1.2832784910621808
SH-10-TC,3136844,4.490496906114953
BL-70,vorinostat-carboplatin (1-1 mol-mol),1.5058252869066222
Hs 746.T,6914657,-2.777857115160203
PF-382,49793307,-4.049648642852728
OPM-2,54596490,4.128803973627264
SNU-1077,SNX-2112-bortezomib (250-1 mol-mol),1.1680740109276928
SNU-201,54618164,6.248621486824713
KHM-1B,54618305,4.409714485426553
RERF-LC-MS,53232,1.207294902086358
JHUEM-3,51039095,1.8747122064656907
YKG-1,11152667,0.85211892000732
Ishikawa (Heraklio) 02 ER-,2858523,3.33045417034977
OAW28,44486219,3.976522680156617
NCI-H1184,sirolimus-bortezomib (250-1 mol-mol),-1.8985096784471465
NCI-H2196,24978538,-1.3554766422071147
OCI-AML-3,23582824,-0.0476063503312217
BT 231,5284616,1.9452196102745216
Hs 746.T,3634881,3.0053426100930034
KMS-20,11955716,-2.0378008092304323
OAW28,JQ-1-MK-0752 (1-1 mol-mol),2.4765621370980875
KMS-20,613000,1.1345541972303637
BT 428,erlotinib-PLX-4032 (2-1 mol-mol),3.2976456828741796
NCI-H2196,11396600,3.4925760347357
Ku812,16038120,-0.3334823664980552
SF539,135440466,1.1383079175014172
Ku812,decitabine-navitoclax (2-1 mol-mol),-1.352567227704547
NCI-H2141,docetaxel-tanespimycin (2-1 mol-mol),-4.969960321292076
Panc 03.27,44566777,0.9404134907542352
Panc 03.27,1750826,-0.4453278853657903
Ku812,54618771,-0.0049031848150657
SNU-410,10074640,3.654913804713501
OPM-2,BRD-A02303741-carboplatin (1-1 mol-mol),5.621987253531824
SNU-410,322968,1.8910594675947563
SF539,54613361,-1.5545710356973723
HCC1395,11238147,3.942606100759166
BT 231,2126,3.800576280626504
AU565,168313200,1.787588028354966
B-CPAP,serdemetan-SCH-529074 (1-1 mol-mol),2.365307132566549
HPAC,3815108,2.792966622495164
PK-59,54618305,4.329681142974429
B-CPAP,5287620,-2.9540281885432735
B-CPAP,54613361,-1.5101356569841191
OPM-2,16219061,1.6139038412518538
Panc 03.27,67156097,-1.074454558265118
SF539,984333,-1.8112760815883828
BL-70,16741245,2.6150723284561694
LOU-NH91,11507802,2.1124947170440533
JHUEM-3,11609586,2.9120583794136525
OAW28,11396600,3.5740319462685535
MM1.S,227681,1.7327122613945027
SF539,4259181,0.2869057369152892
BL-70,24951314,0.2547921147569367
NCI-H1184,409805,3.865118912577075
Rh30,168312962,3.0452074351048095
HEC-59,9926054,2.31296864465942
NU-DHL-1,10322450,3.582925513183909
SF539,selumetinib-decitabine (4-1 mol-mol),4.614699351264478
KHM-1B,168312962,-1.6342091010648556
RERF-LC-MS,60700,0.497286081450591
SK-MEL-28,SNX-2112-bortezomib (250-1 mol-mol),0.1110740577987287
CHP-212,54618771,1.2694957147058317
SF539,2742550,3.134990737020823
PF-382,3854666,0.8290647153929614
NU-DHL-1,4259181,-0.8877351143250455
OAW28,675434,4.444033298399729
NCI-H2196,44819697,-0.4016420388575873
SK-MEL-28,11238147,3.8496418591646298
M-07e,decitabine-carboplatin (1-1 mol-mol),0.5442722022243683
B-CPAP,984333,-0.6051463992030891
AU565,5335621,4.583819394214033
Hs 746.T,56973724,4.791969835383503
KHM-1B,445455,4.826586800965752
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196
SNU-201,44491742,4.436109231936613
PK-59,2708,5.444161268698026
SNU-410,25126798,6.299409205192527
KMS-20,10322450,3.2597318465423353
KYSE-70,44507138,1.8487883665285316
BT 245,tanespimycin-gemcitabine (1-1 mol-mol),-1.410081063260151
Hs 578T,9933475,0.8166385194521119
OAW28,49793307,-1.8076729764727852
KMRC-20,262093,3.714553986632731
NCI-H2141,tretinoin-navitoclax (4-1 mol-mol),0.8037893826932863
NCI-H2141,969516,1.9333645115541351
A4/Fukuda,9935249,-4.132944592984893
OAW28,6918328,-0.6493981710218658
OCI-AML-5,6918638,-0.9986415463571308
HCC1395,11222830,2.0588994064442017
NU-DHL-1,1242560,3.5143861800076652
NCI-H2196,168313200,1.6514605130076123
OCI-AML-5,9956119,3.959371693435835
B-CPAP,BRD-A02303741-carboplatin (1-1 mol-mol),4.469579900896245
KMRC-20,654092,-1.274296745742125
HEC-59,54618359,4.507011101629102
BT 248,400769,-0.0166923245796401
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629
BT 245,135999136,1.3733623937615662
Kasumi-2,6450551,0.5816635943537883
AU565,4521392,3.744925242939049
NCI-H1184,11507802,0.7909372073883856
EM-2,10077130,2.6171185491302835
OCI-AML-3,11717001,1.5695422221384938
JHUEM-3,2828334,6.171677927444977
Ku812,148198,-4.150507844489635
WM88,107985,-3.5954290536778526
PK-59,124202324,2.744479074012848
KYSE-450,65064,5.6341173249680345
NCI-H2196,135659046,3.3895978567837073
BT 245,702558,4.805694350249343
NCI-H2141,1242560,4.434707151929786
PK-59,72193861,3.077938122785057
NCI-H1184,15547703,2.8555527685008992
M-07e,1242560,2.9505674644003363
HEC-59,219104,3.808606761013588
OAW28,5281321,-1.4060991234994806
SK-MEL-28,56963564,3.9128786084446543
Hs 746.T,54765302,3.968201867317426
OAW28,25262965,-0.9519808245592094
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413
KYSE-450,piperlongumine-MST-312 (1-1 mol-mol),1.338613375106185
BT-474,4788,5.968540985973044
HEC-59,ISOX-bortezomib (250-1 mol-mol),0.6842953314260042
CHP-212,1641662,2.072371828131244
BT 231,135999136,1.241486028701245
KHM-1B,2828334,5.467256536463017
OPM-2,5743,-3.6176009576451142
LOU-NH91,5328940,1.6284519107294106
OAW28,67291369,5.503883029091299
RKO,3384730,1.0492755436091918
YH-13,285033,-0.9199224136230332
MM1.S,135440466,-0.9043223941603596
A4/Fukuda,4378219,1.9024946719152895
OPM-2,23635314,-4.85335222903722
Panc 03.27,piperlongumine-MST-312 (1-1 mol-mol),2.2051461089500273
SW1783,4705,3.473081250569121
YKG-1,51039095,2.966618349513072
B-CPAP,44819697,-2.6722684986578247
SK-MEL-28,1750826,2.919051261248512
HCC38,71304818,3.819295126450316
SNU-410,53495165,4.717156527875692
OCI-AML-3,24753719,3.7261949702489496
OAW28,20959075,-3.9569108449030295
KHM-1B,9967941,3.052222735088891
CHP-212,11717001,3.691118680841665
NCI-H1184,46224516,2.231283577841433
OCI-AML-5,4578,5.905746735724853
M-07e,3634881,2.3110367864730024
NCI-H1568,5278396,3.684546625455108
A4/Fukuda,36462,-0.7730347482869518
LOU-NH91,10074640,3.3386477352477715
BFTC-909,5311,1.6846521587280363
EM-2,1750826,-3.240588616919686
BT-474,sirolimus-bortezomib (250-1 mol-mol),2.1782836856662136
BFTC-909,9927531,5.31835549136936
KMRC-20,9444,4.017663478109875
Ishikawa (Heraklio) 02 ER-,23635314,-2.020385068128092
BT 428,9915743,0.3842410251142636
KYSE-450,44486219,4.896382772199078
HEC-59,selumetinib-GDC-0941 (4-1 mol-mol),2.1993787414132675
BT-474,navitoclax-MST-312 (1-1 mol-mol),3.414870112526326
Ishikawa (Heraklio) 02 ER-,46398810,3.165672023721753
A4/Fukuda,11640390,-1.5428779369431247
A4/Fukuda,9907093,3.513986602103764
Hs 746.T,135875424,4.375354252450309
OCI-AML-5,168313200,3.898123624233607
NCI-H2196,72193861,2.4366321787924674
RERF-LC-MS,56649450,3.38813984116235
HCC38,613753,3.328239356647764
BT 245,3136844,4.20302568044611
Ku812,5351362,0.738272453823816
KYSE-450,navitoclax-piperlongumine (1-1 mol-mol),3.113777220831491
RERF-LC-MS,53392493,1.949934555719578
OPM-2,44566777,-0.9514063433103236
NCI-H1184,135984461,3.671317509665682
KMS-20,16659841,2.744899000651292
Hs 746.T,72193861,2.223097743053838
CHP-212,3854666,-0.8182055422302374
WM88,1566236,1.820047619843189
BT-474,6436223,-3.9596444363872783
Hs 746.T,44607530,2.023847747340544
SNU-1077,168312962,0.1799345841951062
EM-2,6252,-2.8093387714862796
Ishikawa (Heraklio) 02 ER-,262093,3.584751515027739
SF539,322968,4.641648660199269
RERF-LC-MS,5113032,4.48589538963195
YKG-1,4705,3.5798209595137247
OPM-2,vorinostat-navitoclax (4-1 mol-mol),0.1768151572883334
EM-2,171352865,4.3188714597460764
NCI-H1184,5351362,2.109108137147282
KHM-1B,11612883,4.120699306463628
Panc 03.27,2708,5.153947575521185
TCCSUP,17755052,2.4596977315219504
KHM-1B,72193861,0.3865062028609871
Kasumi-2,25150857,1.3589874253765015
NU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),-2.4981273247607696
M-07e,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0831722880799015
BT 231,57330099,4.453394254933213
BT 245,107985,-3.2343864047016706
OPM-2,54613361,-1.307423897840743
PF-382,navitoclax-PLX-4032 (1-1 mol-mol),-0.0589134631644863
BT 428,navitoclax-birinapant (1-1 mol-mol),-0.1607704019821585
M-07e,67156097,-2.4619061966892937
LOU-NH91,11404337,-0.9599092047687252
YH-13,5311281,1.1254096591203009
HEC-59,9911830,2.883882492883047
KMS-20,60700,-2.172769530417687
AU565,tretinoin-carboplatin (2-1 mol-mol),5.430851550447548
Ku812,1242560,2.376914084475441
WM88,11656518,-0.8973075282192997
NU-DHL-1,71466380,3.774747568676896
MM1.S,452548,-3.3591080388586816
HEC-59,262093,2.7698106992927007
Rh30,JQ-1-navitoclax (2-1 mol-mol),0.2068230757793487
LOU-NH91,135659046,3.4412725013745336
PF-382,54613361,-0.7673282016613778
PK-59,9907093,3.832557382502477
SH-10-TC,11167602,1.8651287635055684
JHUEM-3,89928392,1.4499796841793229
NCI-H1568,11167602,1.5259281753697294
Ishikawa (Heraklio) 02 ER-,81146,4.498930387849174
KMS-20,5311281,0.7208695610939495
WM88,6610216,4.233732506418395
YH-13,439501,-2.216859157731525
WM88,6917907,-5.800668225331788
NU-DHL-1,3011155,4.64596997294592
A4/Fukuda,24821094,2.016569070962388
F-36P,135875424,2.6086131482089363
SNU-1077,57519531,4.1391342628233945
SK-MEL-28,6918837,0.4014054147330933
SNU-410,24901704,1.6113592316168328
CHP-212,2949965,2.6070435816940036
KHM-1B,15547703,2.9789166957763045
OCI-AML-3,89928392,0.1892635577761659
OCI-AML-3,984333,-1.3815251237907384
B-CPAP,322968,4.123801708547431
KMRC-20,613753,3.2568220179713614
NCI-H2196,119607,4.254619025231964
ML-1 [Human thyroid carcinoma],9444,3.622178437751676
NCI-H2196,selumetinib-decitabine (4-1 mol-mol),5.169297599244918
OPM-2,salermide-PLX-4032 (12-1 mol-mol),5.221268337510566
BL-70,374536,0.8763353219715858
Rh30,selumetinib-decitabine (4-1 mol-mol),3.5163078352421224
HPAC,9956119,3.5018070224175646
BT 231,2729026,1.6518737008758786
BT 245,44202524,1.394406643911058
OCI-AML-5,46843906,1.676020054937814
Rh30,46224516,2.645337859065061
NCI-H1184,6610216,0.5829186651523776
OAW28,5113032,5.506773811436986
KHM-1B,3815108,2.9895861179131704
WM88,11964036,1.3085382214461223
NU-DHL-1,navitoclax-birinapant (1-1 mol-mol),-2.6009930383173465
BL-70,409805,3.720661860726631
SNU-410,selumetinib-PLX-4032 (8-1 mol-mol),5.535929095998468
YKG-1,676352,1.798762675179312
HEC-59,6438330,3.375221420818362
PK-59,16736978,1.3887472521411
A4/Fukuda,3011155,4.269088750580724
Kasumi-2,11626560,0.3916500490858549
B-CPAP,46398810,2.9553918901926965
NCI-H2141,16065773,1.6805021824449184
SH-10-TC,5287969,-1.7900397822900835
B-CPAP,9935249,3.6331972825505474
PF-382,17759555,3.607895848401572
Hs 746.T,56646779,5.726029208895658
LOU-NH91,11626560,1.802766880846386
Panc 03.27,9884685,1.4792691761795522
EM-2,5278396,2.293027186408837
SNU-1077,446155,2.117109617978931
JHUEM-3,81146,5.829727514086824
OAW28,selumetinib-GDC-0941 (4-1 mol-mol),0.8148216272117433
SF539,45100481,5.034110607379183
MM1.S,168313047,1.9214959854165885
RERF-LC-MS,9884685,0.4531053665233772
Hs 578T,11238147,2.0548772038979455
MM1.S,3503,2.4888642007911175
SF539,444795,3.755252396278318
OAW28,25154868,4.5321266568460805
Kasumi-2,3025986,-2.1480582997040325
BT 231,16065773,2.11797154709124
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125
KHM-1B,16115403,-6.426338372507057
TCCSUP,JQ-1-vorinostat (2-1 mol-mol),1.622320227916817
KHM-1B,10410894,4.907000133376468
NCI-H1568,25154868,2.392234118098981
MM1.S,46398810,1.896454943753355
BT 248,57330099,3.914766288587865
BT 428,1239801,5.0858766726357985
BT 248,135875424,2.546043839111523
OPM-2,5335621,3.731372916139424
SNU-410,3676137,3.9099960261396327
LOU-NH91,10302451,4.426232341068122
PK-59,5566,3.045555792882338
BT 245,65064,5.684147690973874
HCC1395,9915743,2.6383057789400746
SNU-201,decitabine-navitoclax (2-1 mol-mol),5.745356601390736
SF539,445455,5.827598780000013
NCI-H2196,148124,-1.1516038288442412
Ishikawa (Heraklio) 02 ER-,11612883,3.769065749220348
OAW28,262093,2.853078829548121
CHP-212,9840324,5.914099260063265
HCC38,168313200,3.666246615050688
BT-474,448949,2.9621815325280028
SF539,81146,6.283283936863958
JHUEM-3,375860,-0.3399174798307714
SNU-201,3503,2.892942947201173
EM-2,decitabine-navitoclax (2-1 mol-mol),-5.108854605733203
PK-59,10113978,3.7065604821837934
Ku812,176870,1.7235761174633464
BT 231,5282054,2.940849229089784
YH-13,36462,2.0221735206643743
Rh30,2113511,6.017754303620564
A4/Fukuda,5278396,2.678829799859676
LOU-NH91,24180719,4.451607655435679
B-CPAP,25126798,3.9395584253439258
SNU-201,216345,4.392836276105297
RKO,72193861,0.7735395045157347
PK-59,969516,2.8385611744423724
HEC-59,25150857,3.4360047447756843
Hs 578T,613753,3.1812778660098813
NU-DHL-1,3062316,-0.3341948851357335
OCI-AML-5,24771867,-1.900109207004394
SNU-1077,676352,2.603885974708996
KHM-1B,piperlongumine-MST-312 (1-1 mol-mol),1.4082068245453034
OCI-AML-3,16038120,-0.4217869496117484
KYSE-70,168312962,-0.2970816131627225
A4/Fukuda,24772860,-3.4983689572797307
RERF-LC-MS,60750,-4.1612389836176
RKO,100016,5.817852214634293
NCI-H2141,9840324,5.653767370492213
PF-382,6852167,1.6136489506938916
MM1.S,9887053,3.7557116412340568
WM88,44202524,1.7522241024121066
M-07e,10074640,2.5794114634637264
NCI-H2196,5291,3.64468875539448
BT 245,24978538,0.3641664207117464
SW1783,5329102,3.5851018985132663
AU565,119182,0.402305157716339
Kasumi-2,9444,3.998890232290453
BFTC-909,8515,4.73152093133166
Panc 03.27,2945648,3.104841070596821
EM-2,6505803,-0.543849671747512
SW1783,24901704,2.457662340178976
Panc 03.27,4378219,1.942503579680026
SNU-201,vorinostat-navitoclax (4-1 mol-mol),1.0461116493615308
BT-474,6610355,5.148313272691738
HCC1395,11964036,0.8365954820842884
Kasumi-2,68056272,3.4308739954935867
HPAC,serdemetan-SCH-529074 (1-1 mol-mol),1.526792881843466
Hs 578T,5281321,-3.5273150589459976
SF539,46926350,-4.3784915774606175
OCI-AML-5,71304818,1.6502213635099456
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901
PF-382,navitoclax-birinapant (1-1 mol-mol),-0.7298930011907772
YH-13,11964036,1.205712988485349
Kasumi-2,10302451,2.501538159290375
RKO,16725315,5.119694523443236
F-36P,135440466,-0.408831912253022
NCI-H2196,676352,0.8616366591067691
M-07e,navitoclax-PLX-4032 (1-1 mol-mol),-0.3080593752360824
Hs 746.T,selumetinib-BRD-A02303741 (4-1 mol-mol),2.681106816195763
SNU-1077,6917907,-0.4505142138964601
OAW28,10427712,4.195688642509306
A4/Fukuda,3081361,1.810117399969756
KHM-1B,60750,-3.330865145118168
MM1.S,selumetinib-navitoclax (8-1 mol-mol),2.538303509958093
SF539,5470400,1.793905767243159
A4/Fukuda,10302451,3.353566161735505
BT 248,5978,2.367827241369892
WM88,54618164,3.999670280417755
PK-59,4261,1.931463423718927
BL-70,5291,3.7115980434322946
BT-474,selumetinib-MK-2206 (8-1 mol-mol),3.489500256016461
B-CPAP,vorinostat-carboplatin (1-1 mol-mol),2.390336914365316
OAW28,23725625,6.509051762822527
M-07e,216468,-0.8047554695494521
B-CPAP,135984461,1.7006873444468935
BT 245,10074640,3.0792421506035774
TCCSUP,9936388,1.8313124822353004
Ishikawa (Heraklio) 02 ER-,72193861,0.7107621257665913
MM1.S,1566236,0.950221343647725
EM-2,89928392,0.3767292909268543
SNU-201,9926054,3.435558365800804
BFTC-909,3854666,1.1654585644167257
BFTC-909,9956119,4.255413767268681
B-CPAP,5470400,-0.1113879304471415
BL-70,46215462,1.6415739104331275
KMS-20,25105715,2.3755676458508277
WM88,11167602,2.5186858712876963
A4/Fukuda,71466578,0.6387062903604859
OPM-2,54618305,3.930022905522119
HCC1395,4917,2.7906626011379245
NCI-H1184,17755052,-0.3113238528830919
NCI-H1568,135440466,1.9451121966001212
NCI-H1184,148198,-3.201792375751558
F-36P,BRD9876-MK-1775 (4-1 mol-mol),-0.0751422311220989
BT 248,19582717,6.9976074882401464
HCC1395,44632017,1.8023286583359768
OAW28,3081361,1.8855664708831448
RKO,24771867,6.323343540042099
SNU-1077,selumetinib-UNC0638 (4-1 mol-mol),4.639240284834
PK-59,9911463,3.8863333115764416
M-07e,56973724,0.4176437990350909
KYSE-450,5746,2.912407446662149
NCI-H1184,11222830,0.9551490459045692
HCC1395,vorinostat-carboplatin (1-1 mol-mol),4.004167170425152
YH-13,2113511,5.759844147331347
Hs 746.T,25150857,2.1771476413707243
Kasumi-2,11955716,-2.6016781088205665
NCI-H1184,439501,-1.2905593318516702
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367
OAW28,9911463,4.007690751229585
CHP-212,JQ-1-navitoclax (2-1 mol-mol),-1.4080066490753995
BT 231,9884685,-1.167030956523576
EM-2,11647372,0.8760293943560493
BT-474,24748573,5.7475521587796266
B-CPAP,44185566,3.01783805282662
LOU-NH91,5291,3.971687681340124
NU-DHL-1,3689413,-2.5727806443741836
OPM-2,10302451,3.176323712036339
SNU-201,navitoclax-PLX-4032 (1-1 mol-mol),4.256688931065759
SNU-410,969516,3.469253654666975
EM-2,135421197,1.083301811797457
BFTC-909,89928392,2.1120581393996116
OCI-AML-3,11213558,0.8769163084101098
M-07e,72376,-3.2739890081449303
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954
OPM-2,5329102,0.9197947820907424
RERF-LC-MS,2828334,5.9123201087220325
BT 248,23582824,0.3842375588836932
SW1783,5328940,3.054752986364744
Kasumi-2,135999136,3.771420948620172
SF539,42642645,-0.0077042862761951
BL-70,9926054,1.763509439822291
A4/Fukuda,44491742,3.3943913096556444
Panc 03.27,100016,6.730276002902577
Rh30,11178236,-4.257341089707863
Kasumi-2,selumetinib-decitabine (4-1 mol-mol),-0.5593050771503721
HCC38,67156097,-0.9421844864011892
A4/Fukuda,107970,1.5574682195612295
BFTC-909,10184653,1.6906150005550105
SH-10-TC,5351362,3.172277424676322
Rh30,676352,2.337683034322569
Rh30,selumetinib-BRD-A02303741 (4-1 mol-mol),3.819108813893848
OPM-2,156422,3.8836640353636382
YH-13,23725625,5.130607279174726
SNU-1077,984333,1.7185936454570083
HCC38,3025986,-1.3839686952716872
F-36P,11964036,0.4602829644770974
OAW28,5746,2.6048591865024657
BT-474,227681,-0.5299527537092552
HCC38,216239,3.120851379408145
WM88,11719255,4.515265589591613
F-36P,9549297,1.1194969839421791
AU565,44632017,0.8977842888684593
WM88,24964624,2.3863888458976925
BT-474,107985,-3.5381874365688293
BT 248,753704,4.567621051188063
BT 231,3025944,4.323894643334333
SNU-1041,25195348,5.498924181902716
Kasumi-2,9956119,1.4541571674658873
SNU-1077,44489367,4.954217803557541
BT 248,644241,1.8454939937856112
HCC38,3689413,-2.099341250488443
BT-474,46843906,3.2767976623200648
M-07e,9884685,-1.2688501325272783
NCI-H1568,46926350,-5.085925204635643
JHUEM-3,400769,-0.5937188496683241
KMS-20,445091,4.2633800487131275
BT 245,crizotinib-PLX-4032 (2-1 mol-mol),2.460223390906092
NCI-H2196,24180125,2.6408442695810925
MM1.S,6918289,-3.2114710937619635
Hs 578T,126941,4.206503372436863
M-07e,crizotinib-PLX-4032 (2-1 mol-mol),1.3133886520893527
Panc 03.27,9935249,4.091964927593618
KYSE-450,docetaxel-tanespimycin (2-1 mol-mol),-3.366078664284114
LOU-NH91,46398810,3.045211454343731
NCI-H2196,252682,6.407643309790025
JHUEM-3,46174525,3.6850794926101504
TCCSUP,navitoclax-gemcitabine (1-1 mol-mol),0.0412224800820071
SNU-201,11175137,3.1045500761624916
NCI-H1184,11497983,-2.7734637413638894
BT 428,selumetinib-PLX-4032 (8-1 mol-mol),1.4792510835928452
SH-10-TC,57519531,4.026408643075688
SNU-1077,15953870,3.3476247633777585
BT 231,168312962,-0.3558848468638645
HEC-59,400769,-0.102433907113114
KMRC-20,3384730,3.9096966997308744
Ku812,68056272,1.369253541918081
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766
KMRC-20,51037431,3.686624478209352
JHUEM-3,5282054,4.40619299912306
YKG-1,462382,0.3807695493955695
BFTC-909,9444,3.603329432205708
OCI-AML-5,46926350,-4.42221750780303
BT 231,9967941,3.1837049402851587
Panc 03.27,51037431,3.471546153333028
HPAC,navitoclax-MST-312 (1-1 mol-mol),2.8575647912902356
AU565,11497983,3.5183187315924185
BT 231,1716436,2.0638446522523175
YKG-1,119607,6.023388476770122
NCI-H2196,44137675,3.3056043252593
NCI-H2196,19582717,4.057078580677151
SNU-1077,navitoclax-sorafenib (1-1 mol-mol),1.842498946009811
Hs 746.T,12001922,2.1881603173512936
CHP-212,6918328,-3.4154901339836665
Hs 578T,168313016,4.885965287193478
NCI-H1568,49766530,-3.205306991379519
NCI-H1184,24821094,2.59960175217542
Panc 03.27,selumetinib-BRD-A02303741 (4-1 mol-mol),4.349236763215798
YKG-1,969516,4.834181385446052
Ku812,56973724,1.3677236281972405
MM1.S,375860,-0.3099552941005813
Kasumi-2,54596558,4.023508952920703
M-07e,5746,-0.185558659746097
OPM-2,11964036,0.2409704368173301
TCCSUP,73707398,0.9718071298936178
B-CPAP,72376,-1.8039181485690416
OCI-AML-5,9826308,0.3250208671008831
TCCSUP,53232,2.5556633861706453
HCC1395,serdemetan-SCH-529074 (1-1 mol-mol),1.792892549287233
Kasumi-2,decitabine-carboplatin (1-1 mol-mol),-0.2922568730993647
WM88,navitoclax-piperlongumine (1-1 mol-mol),2.0117725563378297
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094
YKG-1,4378219,2.059610902750737
LOU-NH91,5282054,3.3765969574471315
KMS-20,156414,1.093109837922788
OPM-2,9967941,3.958466181768741
HCC38,3038522,4.350514072354952
NCI-H2141,11152667,0.4643269234046814
BT 231,637858,1.9874949933256931
HCC38,ISOX-bortezomib (250-1 mol-mol),0.0907706659356315
KMRC-20,23939,4.421386297224866
Ku812,73707386,3.1917387110464666
PF-382,serdemetan-SCH-529074 (1-1 mol-mol),1.5995010454222542
OCI-AML-3,135411,-1.6750420830550048
SH-10-TC,24797083,2.86177606334327
OAW28,6610355,6.153508691776863
EM-2,3385,1.5034173409487523
HEC-59,53232,5.92242875194768
AU565,1641662,2.8108586385203234
Ku812,24901704,-0.4203026454288152
HPAC,selumetinib-JQ-1 (4-1 mol-mol),-0.0816962643206643
KHM-1B,11404337,0.2779693874185021
YH-13,9866186,1.6052834410324497
BT 245,vorinostat-carboplatin (1-1 mol-mol),2.699793967141184
LOU-NH91,46199207,3.3608515659177147
PK-59,24964624,2.722226232789244
BL-70,6505803,0.7841621895069785
Hs 746.T,9840324,5.892549908244831
BL-70,9866186,-0.2099353347870201
BT 428,5460769,2.5146871392563845
OCI-AML-5,9911830,2.11387543619275
SH-10-TC,31703,1.044936306592756
RERF-LC-MS,148198,-3.5927713028936834
SF539,2729026,2.548731779898503
OCI-AML-5,9887053,1.7365351572910726
LOU-NH91,25105715,3.511519280721543
PK-59,10427712,6.44047406664822
NCI-H1568,9967941,2.084939505363619
NCI-H2141,4261,0.9410127704299076
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636
BT 428,1242560,3.758823907284281
YKG-1,11977753,-3.046563007641072
MM1.S,3384730,0.9083087021644016
NCI-H2196,2113511,4.953301355288937
NCI-H1568,136227924,3.032081072579533
NU-DHL-1,2858523,3.2387233611606945
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105
JHUEM-3,2858523,3.085115150010241
BL-70,5329102,2.005895068851144
Ishikawa (Heraklio) 02 ER-,10074640,3.7564128770227128
OCI-AML-5,219104,3.648280174086992
HCC1395,3062316,-0.082836936473029
NCI-H1568,10296883,3.9462373745058863
WM88,24772860,-2.263338691376954
SF539,BRD9876-MK-1775 (4-1 mol-mol),-0.024962409910424
BT 428,46926350,-4.319561662968833
BT 248,6852167,2.795606288509473
OAW28,5281672,6.00346703144391
OAW28,53392493,2.314719178940984
CHP-212,49766530,0.7165809127280346
Kasumi-2,71729975,0.1244547207122276
SNU-1041,124202324,2.8233510593349433
BL-70,25150857,1.0311244113842697
RKO,637858,2.400395947377078
BT 248,5282054,3.4340814823816324
PF-382,JQ-1-carboplatin (1-1 mol-mol),1.3162007106931592
BL-70,5746,1.312998303936864
OAW28,11612883,3.952715585132085
SNU-1077,107970,2.607215080284504
TCCSUP,selumetinib-navitoclax (8-1 mol-mol),2.911223328987063
NCI-H1568,5978,-3.194054905017319
SW1783,46174525,4.2531961544847885
OPM-2,374536,1.7033153768622478
OPM-2,24856436,-0.767009816479034
HEC-59,16720766,0.2530801339708643
F-36P,25062766,-0.2807474347511744
Rh30,17755052,0.3171405587018499
SNU-1041,12001922,3.1545507221855824
BT 231,12001922,1.144949639789655
SNU-201,969516,3.231095469539701
M-07e,24821094,3.1657519532980967
BT 248,3552672,1.5840638178238662
NU-DHL-1,52947716,2.976276735024036
MM1.S,3825829,4.169189674904385
KMRC-20,11485656,3.1191450490376673
F-36P,9935249,1.4854738782819463
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423
NCI-H2196,25183872,0.5878126410051773
NCI-H2141,3011155,4.291821232855682
PF-382,vorinostat-navitoclax (4-1 mol-mol),-0.4263827729642097
YH-13,2871966,0.9039362697940406
SW1783,5746,0.5250942021656682
KMS-20,9868037,2.1280335543005293
OPM-2,753704,3.6202062566191984
B-CPAP,24753719,4.549431908166172
OCI-AML-5,6918736,-1.228061151354363
F-36P,ISOX-bortezomib (250-1 mol-mol),-0.2185374276167514
HCC38,16065773,1.8523839022459765
OAW28,6852167,2.294169410796982
KYSE-450,JQ-1-vorinostat (2-1 mol-mol),2.5632737661829488
HPAC,44589607,2.881137107315208
OPM-2,52947716,0.8847701060718332
KHM-1B,25183872,-1.3979896685185154
CHP-212,4578,4.372615963636266
KHM-1B,31703,-2.376235984768286
HCC38,crizotinib-PLX-4032 (2-1 mol-mol),2.631939998410287
Ku812,216239,0.9318176026438576
NCI-H2196,451668,5.938571521851739
BT 245,2746,2.160904338087323
MM1.S,68056272,3.565537338229292
KHM-1B,9907093,3.851614847193926
SNU-1041,10302451,3.993130950847062
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
RKO,16722836,2.0172870973895085
LOU-NH91,3384730,3.7773271912609623
BFTC-909,124202324,2.9321657702899295
NU-DHL-1,5311,-0.0484251150139828
KHM-1B,448949,2.2712398362063575
A4/Fukuda,vorinostat-carboplatin (1-1 mol-mol),1.5546210220419645
OCI-AML-5,3038522,2.084742810312883
KHM-1B,322968,1.990474592363433
WM88,9952709,3.464483363889333
Panc 03.27,285033,-2.087244511113797
HCC38,409805,3.899400540305636
SH-10-TC,46199207,3.7847700266990354
MM1.S,11152667,-1.9350060885580451
Rh30,23635314,3.972701077567917
OAW28,25183872,-1.003855010480259
NCI-H2141,11964036,1.0257534307901135
OPM-2,9866186,1.7779199456036283
Hs 578T,vorinostat-navitoclax (4-1 mol-mol),-0.3831755955600985
SNU-1077,selumetinib-JQ-1 (4-1 mol-mol),1.9000830670563744
F-36P,9911463,3.056113876518826
SNU-201,3815108,3.3890609362793676
HCC38,selumetinib-vorinostat (8-1 mol-mol),3.9868927828285594
OAW28,10296883,4.314409366833216
HCC1395,44489675,3.906765425871048
SF539,11707110,0.172094147016845
NCI-H1568,44589607,2.521775448277625
RERF-LC-MS,4259181,-1.273108977623296
BT 248,navitoclax-pluripotin (1-1 mol-mol),-1.2956772624371633
WM88,44819697,3.752373573691184
SNU-1041,135440466,1.1383602617240547
MM1.S,44819697,-1.023018126505823
YKG-1,3689413,0.6324676509110861
KYSE-450,42642645,1.660330797131617
PF-382,119607,4.835768261227938
Rh30,53392493,2.117041671051738
MM1.S,carboplatin-etoposide (40-17 mol-mol),0.4992373169000672
PK-59,11485656,2.1797490126169823
NU-DHL-1,148198,-4.718908672184396
OCI-AML-3,56963564,-0.02395981385418
KMRC-20,44185566,2.4119459095392215
TCCSUP,vorinostat-carboplatin (1-1 mol-mol),2.1894231074754185
WM88,10184653,1.6604193428815888
Ishikawa (Heraklio) 02 ER-,216468,3.7247875690653953
BT 248,8515,3.628450909279232
OAW28,6918328,-0.6493981710218658
BT 428,54618305,4.316661671711245
BT 231,9825149,1.737111458062006
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379
KMRC-20,25062766,3.4155735971940704
WM88,17755052,0.8542928193501572
KMS-20,9444,4.5404933780509635
F-36P,3025944,3.798423785278045
HCC38,10302451,4.063640338050707
Kasumi-2,6852167,0.8229890671000598
BT 428,56946209,-4.380761985239821
Kasumi-2,11404337,-1.9658161518336
BT 428,55508,2.883090615031002
OCI-AML-3,16065773,1.5864984729626532
SH-10-TC,9866186,1.4154024227776838
OPM-2,4705,3.10353547990691
SNU-1077,selumetinib-decitabine (4-1 mol-mol),5.435287074602724
SNU-410,9911830,3.211976341536433
BT 245,44566777,1.3945602166606237
OPM-2,168313200,1.8002020874491595
OPM-2,71466445,2.165442844786418
KYSE-70,3025986,-0.3454993097331295
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435
SH-10-TC,3825829,4.654240703208267
OCI-AML-5,216345,1.9691619747094544
NCI-H2196,11977753,-2.42217056220095
SW1783,51039095,4.654055453172231
Panc 03.27,24771867,3.0819012538089106
Panc 03.27,119182,-1.0220228508610247
NCI-H2141,6610216,4.157777487639752
KMRC-20,11609586,2.572780033443364
Hs 578T,49836020,0.6847429303234678
Ishikawa (Heraklio) 02 ER-,54143018,-0.6909514864549315
BL-70,23582824,-0.592872608794646
A4/Fukuda,BRD-K55473186,4.020373973875239
EM-2,3025944,4.086764763931349
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824
HEC-59,72376,-2.033931290302613
AU565,24797083,1.2091873523376886
KMRC-20,12003241,-0.2043728031762648
OAW28,navitoclax-pluripotin (1-1 mol-mol),-0.843922258994718
SF539,16720766,-0.1257805364307158
YH-13,241158,3.687700430080618
KMRC-20,16741245,3.9826803312414527
Hs 578T,10427712,3.678269245012518
OPM-2,24889392,2.046562304125139
F-36P,44566777,-0.6583463625680355
BL-70,46199207,1.6862097994117498
B-CPAP,46907787,3.372107688619731
BT 428,4261,1.0264453227673789
M-07e,11626560,0.4994704892069844
KMS-20,753704,4.324043656881392
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616
KHM-1B,6918328,-0.972639722757723
RKO,52947716,-6.611161073849914
OPM-2,1641662,3.0681099569104653
F-36P,135411,0.818269408267781
NCI-H2141,selumetinib-UNC0638 (4-1 mol-mol),3.154785911347883
EM-2,navitoclax-gemcitabine (1-1 mol-mol),-3.0864503666385517
KMS-20,44632017,0.8974421618736498
OCI-AML-3,9907093,3.566113993406385
Panc 03.27,6852167,2.678417934109474
OCI-AML-3,25062766,1.1202365158458751
HCC38,5287620,-0.6247501743297414
Hs 578T,54143018,1.060146495657429
BL-70,11214940,1.8917952431662215
SH-10-TC,135421197,2.8631167309091556
KMS-20,53232,2.383010797318735
Rh30,136227924,4.165333500464175
OCI-AML-3,alisertib-navitoclax (2-1 mol-mol),-1.8265139401742805
NCI-H2141,2742550,3.0407478548544544
NCI-H1184,374536,2.491569591887116
CHP-212,selumetinib-PLX-4032 (8-1 mol-mol),-7.068778209097666
SNU-410,5282054,2.76012898524978
BT 248,UNC0638-navitoclax (1-1 mol-mol),1.1596436088492943
NU-DHL-1,11222830,0.1401036768079258
EM-2,24779724,4.869730500223735
BT 248,selumetinib-UNC0638 (4-1 mol-mol),4.192258549840557
Ishikawa (Heraklio) 02 ER-,17755052,4.1414597350773015
RKO,46191454,0.9841477576830012
KMS-20,44543605,3.8968998395353784
M-07e,156414,1.4173221971225267
Kasumi-2,5335621,4.247176943532892
KMS-20,BRD-A02303741-navitoclax (2-1 mol-mol),1.210365618273724
OAW28,docetaxel-tanespimycin (2-1 mol-mol),3.524507000700441
YKG-1,4477,1.5489937349359375
OAW28,JQ-1-carboplatin (1-1 mol-mol),2.7763585253391625
Hs 578T,5738263,2.468909416036009
PF-382,2949965,-4.532431292910685
HEC-59,46398810,2.762460673176694
BT 245,568763,1.30987431986763
EM-2,72376,-3.2217851669202973
Kasumi-2,44607530,0.8991199704837235
OPM-2,11609586,2.7966274513563496
Hs 746.T,44185566,2.896881537546401
EM-2,selumetinib-piperlongumine (8-1 mol-mol),0.9074120954486398
NU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.2455773179911887
HEC-59,11214940,0.9944597920612208
BL-70,135421197,0.854508793534898
KYSE-70,11612883,2.3570058511886396
NU-DHL-1,387447,-5.01713614563577
Rh30,54454,1.3074301992302186
HCC1395,11626560,2.0225938092569113
Kasumi-2,445643,3.712609595977314
NCI-H1568,462382,0.4864277786958156
BT 245,4705,2.436380122563236
F-36P,4477,-0.3532860881346318
BFTC-909,23939,4.493588141952023
Panc 03.27,9823820,4.931594576995848
PK-59,2749,1.9059239983781768
HCC1395,387447,-3.83768171987275
YH-13,JQ-1-vorinostat (2-1 mol-mol),1.6666990115178115
EM-2,3854666,1.1863120866897956
OAW28,25150857,2.5691026408672957
YH-13,10231331,5.93947704147761
Hs 578T,46907787,2.2226344570292915
WM88,49793307,-1.49117487306192
OCI-AML-5,46199207,3.8639013265988296
BT 245,54143018,-1.1109884999595483
Rh30,9929138,6.636453392237079
KMRC-20,54618771,1.1098897337437623
KYSE-450,4477,0.7200921978595938
Panc 03.27,46398810,3.051722551239374
OCI-AML-5,crizotinib-PLX-4032 (2-1 mol-mol),0.7223289813162151
BT-474,vorinostat-navitoclax (4-1 mol-mol),1.537181657379116
SK-MEL-28,9840324,5.381113811344041
KYSE-70,53232,3.7067207893488017
KHM-1B,124202324,1.1821842907851436
OCI-AML-5,selumetinib-decitabine (4-1 mol-mol),2.8156837056619204
OAW28,219104,3.640461878438656
B-CPAP,3062316,-0.9733025466609652
NU-DHL-1,2746,0.9771874808438498
BT 248,15953870,3.6832035377423216
OAW28,6610355,6.153508691776863
EM-2,49766530,-1.2569750425961423
Rh30,2749,2.4779334868021867
BT 428,54678924,1.6942851351706048
BT-474,6610216,3.6735786534145296
B-CPAP,6623618,2.626931921666511
SK-MEL-28,52947716,-6.546554666809958
Hs 746.T,2871966,1.802162177832928
OAW28,3025986,-0.5681838773369163
SH-10-TC,navitoclax-MST-312 (1-1 mol-mol),3.079238850990289
SNU-201,3385,6.458996173397068
Rh30,71466380,4.263637790196155
CHP-212,42611257,3.1547261032421927
BT 231,selumetinib-UNC0638 (4-1 mol-mol),3.6405987072594064
Kasumi-2,73707398,-0.974822208153436
OAW28,25195348,5.036760517156048
OAW28,53495165,3.30177539085494
Kasumi-2,3038522,2.07744827479205
YH-13,5738263,3.9080181125060496
KHM-1B,navitoclax-gemcitabine (1-1 mol-mol),-2.36446973278894
OAW28,46191454,1.726492969979986
OAW28,9926054,1.976123345191561
MM1.S,6918878,-0.530970823966065
HCC1395,9967941,6.350388117529132
Ishikawa (Heraklio) 02 ER-,44589607,3.631751905999827
HEC-59,4261,1.4858327028186236
PK-59,984333,0.7032656465439704
EM-2,11222830,0.9367021650420316
KMRC-20,5113032,5.593210295000311
Hs 578T,17755052,1.6608519968646018
KHM-1B,44607531,1.2480469496992657
Kasumi-2,9549297,1.4131024835139536
SK-MEL-28,25150857,3.0463129162914875
KMRC-20,52912189,4.952328418850898
SNU-1077,65064,5.355049721805472
EM-2,451668,-3.096766576184764
SF539,107970,2.309030481029931
CHP-212,637858,1.7500511895355555
PF-382,54618164,3.241191825495517
KHM-1B,24180125,1.7183751461282626
AU565,136227924,2.2371309282915184
MM1.S,3854666,1.277087835200556
HCC1395,5329102,1.9907536004364432
Ishikawa (Heraklio) 02 ER-,16722836,2.35144602605202
EM-2,44819697,-2.876879898973917
OPM-2,64971,2.0053510879561296
OPM-2,44607530,0.8834373674969361
OCI-AML-5,6918837,-5.300670010786116
CHP-212,119607,4.9582804045106075
KMS-20,5566,2.852625231328134
F-36P,24772860,-2.6351824640153763
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823
SNU-201,3634881,2.8639525080208745
SF539,439501,-3.28606941940852
SNU-410,selumetinib-navitoclax (8-1 mol-mol),4.1037718063473045
Panc 03.27,16741245,-5.858132672171157
YKG-1,JQ-1-UNC0638 (2-1 mol-mol),2.7051806168218153
YH-13,6852167,1.959387815211575
Panc 03.27,322968,4.816551572627955
Ishikawa (Heraklio) 02 ER-,6918328,0.9359121656795372
LOU-NH91,124202324,3.0671378719618283
YKG-1,123631,3.7325814546092873
NU-DHL-1,702558,5.1708042133042875
Ku812,49766530,-2.390671573618507
OPM-2,49766530,-3.767684481967312
NCI-H1568,5460769,1.1324377767406906
NCI-H1568,7251185,1.379011815458227
KMRC-20,navitoclax-gemcitabine (1-1 mol-mol),-1.4557054407433547
KMS-20,72376,-2.953076031643005
Ku812,89928392,0.3085887086853859
HCC38,156414,1.3056275729955638
NCI-H1568,72376,-1.5373297187690371
Ku812,11238147,1.619388725534285
EM-2,12001922,1.7226595490551926
NCI-H2141,5328940,2.2805358649081526
RERF-LC-MS,71751553,4.213964581210796
BT-474,crizotinib-PLX-4032 (2-1 mol-mol),3.3817413780199863
AU565,52947716,0.8422274137680903
LOU-NH91,JQ-1-carboplatin (1-1 mol-mol),1.662362738651182
SW1783,15953870,3.727401815787135
SNU-410,89928392,2.168173705495492
BT-474,5311281,4.609111809664983
EM-2,UNC0638-navitoclax (1-1 mol-mol),-0.3416252714331361
Hs 578T,4259181,0.6901225496008685
OPM-2,71466380,2.758760560312852
NU-DHL-1,46926350,-4.283271721572929
Ku812,2841722,3.36819681330492
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245
SF539,selumetinib-tretinoin (2-1 mol-mol),2.8969216636074635
HPAC,11626560,1.5439489527546706
BT 248,409805,5.374494739188799
KHM-1B,JQ-1-carboplatin (1-1 mol-mol),-0.2133455800101861
BT 428,11152667,-0.1216773247617757
NCI-H1184,9926054,1.8119934997453773
NCI-H1568,44489675,3.7863062268563064
F-36P,selumetinib-decitabine (4-1 mol-mol),-1.3332642026766797
SH-10-TC,409805,5.166085352116196
HPAC,tanespimycin-gemcitabine (1-1 mol-mol),-0.6770968017962539
SNU-1041,73707398,1.6372848153968225
Hs 746.T,53392493,4.031330654012974
BL-70,135398738,1.8817574061708424
M-07e,7251185,1.3090978543120046
NCI-H1184,11427553,2.4408398616419076
KYSE-450,73707398,1.7321370562114622
YH-13,5278396,4.665825083326453
LOU-NH91,3634881,3.4323223488487593
PF-382,568763,-0.4200136453948588
OAW28,5281672,6.00346703144391
M-07e,104842,-4.050349388718908
RKO,285033,-2.0365968290915393
YKG-1,5479543,3.551055937780437
MM1.S,49793307,-4.457847663527619
OPM-2,675434,4.053836549963459
HCC38,49766530,0.1078777234170871
Ishikawa (Heraklio) 02 ER-,11364421,-3.761750823923845
WM88,54613361,0.0848289626670102
RERF-LC-MS,11404337,1.609147033115388
YH-13,613753,3.198655088804402
NU-DHL-1,BRD-K55473186,1.794195588089048
NCI-H1568,6610355,3.436001375430949
KYSE-70,54649381,4.140433754758901
F-36P,carboplatin-etoposide (40-17 mol-mol),6.044383393273901
LOU-NH91,25195348,3.759766884877561
M-07e,448949,1.5642442539247468
EM-2,327653,2.703948215233707
JHUEM-3,676352,1.8262498856677585
B-CPAP,25262965,0.0515151425678239
BT 231,6610355,3.676503441981049
OPM-2,168313016,3.5498730155612863
KHM-1B,11497983,-3.4105993127539698
Kasumi-2,44607531,1.0542160339181526
Rh30,89928392,0.9565893807103704
HCC38,sirolimus-bortezomib (250-1 mol-mol),0.3307101764486495
HEC-59,54143018,1.1543978081681097
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277
BT 428,46199207,1.813101312958388
BT 248,2945648,2.911977762170341
SH-10-TC,5746,3.382498831711429
TCCSUP,46907787,2.977323633088547
BT 428,selumetinib-MK-2206 (8-1 mol-mol),0.8351640279653656
NCI-H2141,17755052,2.1210235069211
EM-2,5335621,3.8765763975286864
NU-DHL-1,56949517,4.418216826583101
F-36P,24951314,-0.2370026650646734
HPAC,3062316,2.1452570146360066
RKO,676352,2.3070338313311547
WM88,tanespimycin-bortezomib (250-1 mol-mol),-2.8916470647545007
OCI-AML-3,65064,5.2328257374289215
A4/Fukuda,9444,3.1818692272898423
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248
OCI-AML-3,2130404,3.3456579480042095
BT 231,9868037,3.3180720809611137
RERF-LC-MS,44185566,3.014427147988128
BL-70,2113511,3.6602711435289503
A4/Fukuda,46199207,1.9027513858957976
KHM-1B,10322450,2.734741066135324
YH-13,10184653,1.670229317933307
BL-70,51037431,1.485604330317918
HCC38,1641662,3.474207693500902
SNU-1077,alisertib-navitoclax (2-1 mol-mol),1.6049595607856426
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344
M-07e,568763,-0.5215122228241198
BT-474,613753,3.3405720065457283
A4/Fukuda,navitoclax-MST-312 (1-1 mol-mol),0.8742444067839383
NCI-H1184,135440466,2.188408273617616
CHP-212,71751553,4.254165776093673
Hs 746.T,16065773,2.1453737376625406
M-07e,5287969,-1.64695717239171
SH-10-TC,16065773,3.7439304339086
KMS-20,2749,1.3693937739963689
RERF-LC-MS,11494412,1.0302757077826894
KYSE-450,984333,1.1711925405074113
RERF-LC-MS,52947716,-5.597592816818683
MM1.S,17755052,-0.7145946453467518
Hs 578T,56963564,0.352897838827421
NCI-H1568,11625818,3.359978935972883
BT 428,73707438,3.9227425250284367
JHUEM-3,navitoclax-piperlongumine (1-1 mol-mol),0.9009633051957874
F-36P,2828334,5.827212923410168
KMRC-20,3815108,3.353399483495532
SK-MEL-28,24821094,3.6825272543365233
PF-382,135984461,1.6582229573318208
NCI-H1568,51037431,4.33384460889792
SNU-410,11719255,2.987491944445254
ML-1 [Human thyroid carcinoma],322968,3.685498672876688
F-36P,3689413,-1.7757563129439584
YH-13,4917,3.8244363131273458
PF-382,selumetinib-decitabine (4-1 mol-mol),-0.112942711472379
HEC-59,72193861,1.725955155157829
KHM-1B,4477,-0.1092447779535195
HPAC,53495165,-1.8510983681156945
KMRC-20,JQ-1-MK-0752 (1-1 mol-mol),6.181134550910211
Rh30,3503,2.2507006984644713
YH-13,11612883,3.2122521691176975
CHP-212,2874250,4.133490043885063
PF-382,navitoclax-piperlongumine (1-1 mol-mol),-0.2817270531493807
WM88,135398738,1.7703176818637385
BT 248,selumetinib-GDC-0941 (4-1 mol-mol),1.214957443871495
YH-13,89183176,4.032829383808348
MM1.S,26596,-1.4234323398175248
KYSE-450,262093,3.266752988649651
OCI-AML-3,637858,0.7817011573177973
ML-1 [Human thyroid carcinoma],176870,3.163449715300446
NCI-H1568,10127622,5.078058454742808
Ishikawa (Heraklio) 02 ER-,9936388,-5.11124273822625
RERF-LC-MS,6610216,4.063402980130349
KHM-1B,5566,2.2801989314066637
BT 245,3465537,3.867182511877691
HPAC,vorinostat-carboplatin (1-1 mol-mol),3.7699528957957407
SK-MEL-28,46199207,3.878150631525568
AU565,135875424,4.732736146663846
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403
AU565,selumetinib-UNC0638 (4-1 mol-mol),4.121266553774429
KYSE-70,44137675,3.4677446622108925
NCI-H2141,375860,-0.119191761966059
NCI-H1568,11612883,2.467781963295413
LOU-NH91,54686904,4.160622905506427
HEC-59,10127622,7.1415868103882785
EM-2,656346,-0.2667410814106692
JHUEM-3,selumetinib-tretinoin (2-1 mol-mol),1.7202316187331357
NCI-H2141,5470400,1.1536341446716574
BT 231,25102847,2.3025793027676005
AU565,11257553,-0.514738811981399
AU565,5738263,3.0246848768630334
KYSE-450,53325874,4.377584660975113
F-36P,5470400,3.982294766439691
PF-382,36462,-0.7112012842580974
NCI-H2196,navitoclax-birinapant (1-1 mol-mol),-0.0763081935341576
OAW28,439501,-0.9322268226633188
HPAC,46398810,2.894208758339167
YKG-1,10231331,5.270675851444794
EM-2,135398516,-0.16839257739994
BT 428,25154868,3.538465934069667
PF-382,44185566,1.017432682942044
HCC1395,53232,4.849673277360966
SH-10-TC,1716436,3.746754898957073
BT-474,56649450,2.265179118870839
Ku812,25105715,2.5153812758141902
Kasumi-2,753704,4.42700120937948
BT 231,135875424,2.2081545391597728
AU565,56649450,1.7738933823843377
BT 428,71466380,3.9196018251640097
OAW28,25126798,4.214847534438453
SK-MEL-28,11175137,3.580764276336763
NCI-H1568,53495165,-0.6133813456223128
BT 248,5738263,3.817096252163507
SNU-201,selumetinib-BRD-A02303741 (4-1 mol-mol),5.519563970872631
HEC-59,9907093,3.724612464528932
LOU-NH91,49766530,0.361985362717411
KMS-20,54454,4.411646924173224
NCI-H1184,135411,0.1843383199757329
OPM-2,25150857,1.3601106429565517
Kasumi-2,19582717,2.3340571924025326
OCI-AML-3,81146,4.508810075425491
SNU-201,676352,2.0724821328948857
Kasumi-2,9903786,1.7296917357536032
BT 428,16219061,1.0304344533203371
NCI-H1184,44185566,1.727995850382997
NCI-H1184,3689413,-2.309621936722181
NU-DHL-1,44607530,2.2321185489089026
HPAC,16722836,1.9387135153896464
OCI-AML-3,selumetinib-UNC0638 (4-1 mol-mol),-2.8648379369989128
KHM-1B,selumetinib-tretinoin (2-1 mol-mol),1.4198257519630046
Hs 578T,16659841,1.6684137098780842
F-36P,54613361,-1.6188973635870945
SNU-1077,9911463,3.723863128468891
BL-70,9826308,-1.2784641906838574
BT 231,23725625,5.4531092056693105
PK-59,11396600,3.5699719356694573
KHM-1B,1242560,-1.3628719812202528
RKO,24797083,0.8657042008278414
A4/Fukuda,2858523,2.415383768636832
NCI-H2141,5746,-2.488860288774875
KMS-20,decitabine-carboplatin (1-1 mol-mol),3.602021094753337
JHUEM-3,168313200,3.1500775290057543
OCI-AML-5,3062316,2.0261470360035543
BT 428,BRD9876-MK-1775 (4-1 mol-mol),0.4985737987972167
BT 231,9933475,1.574194986358974
SNU-1041,navitoclax-piperlongumine (1-1 mol-mol),4.240045682219543
BT 231,selumetinib-vorinostat (8-1 mol-mol),2.946498999717448
TCCSUP,16038120,0.8222497592988807
NCI-H2196,3384730,6.327796696484935
LC-1F,alisertib-navitoclax (2-1 mol-mol),-0.3728307217601246
Hs 578T,navitoclax-PLX-4032 (1-1 mol-mol),1.5550550793073252
HEC-59,16725315,3.822262895991909
Hs 746.T,11497983,4.40899896473173
NCI-H1184,11214940,0.5171255880392455
SK-MEL-28,3025986,1.0141621518652342
PF-382,piperlongumine-MST-312 (1-1 mol-mol),3.2738168360218727
NCI-H2196,15953870,4.97144966997748
RERF-LC-MS,44462760,4.251912039026111
KYSE-70,6914657,-2.943523310206574
NCI-H1568,6914657,-5.120590256929669
EM-2,208908,2.409817927241609
NU-DHL-1,12003241,-2.4677988287748915
HEC-59,24785538,1.5705386357026252
HCC38,135421197,1.646244202411993
NCI-H2196,54618305,4.391453781837025
BL-70,17755052,-0.9899060112718266
Hs 578T,31703,-0.7339398111619737
KYSE-70,9911463,3.4914249269651307
YKG-1,5278396,4.162705739282169
A4/Fukuda,6917907,-6.123586781218294
Hs 578T,23582824,-0.075763079696983
BT-474,241158,4.261649055387228
BT 428,54649381,3.993232750237313
Kasumi-2,15547703,3.1022786704275394
OCI-AML-3,3062316,0.62239975701538
OAW28,5278396,3.588828047742794
NCI-H1568,46224516,1.8217130718981496
Panc 03.27,5566,3.103138782013158
TCCSUP,6918878,3.6529452991011766
BT 231,54618771,0.7922646437361874
PK-59,60700,1.4957389160263024
OPM-2,135423438,0.9866001177758746
MM1.S,1641662,3.76159788149762
OCI-AML-5,11625818,4.4713114771326605
SNU-410,123631,3.457727642194212
SH-10-TC,462382,0.5255119197500744
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147
OPM-2,25183872,-4.3499490255982085
RKO,5113032,5.90165838842917
CHP-212,36314,-8.399737614483207
HCC38,26596,-1.4255018531390269
A4/Fukuda,2746,1.0000278581130588
HPAC,11234052,2.9388155294586427
SH-10-TC,73707398,1.591598537302804
SNU-410,219104,3.4374148759833782
M-07e,54596558,4.570190844497171
WM88,25126798,3.962476575139121
LOU-NH91,107970,2.5070848864255093
OAW28,168313200,4.298133692275281
BT-474,9967941,3.6699757624123808
SNU-1041,72193861,2.724949828067744
Ishikawa (Heraklio) 02 ER-,54649381,3.9004704347279566
OCI-AML-3,11222830,0.7990736253971192
SK-MEL-28,2945648,3.075728962525901
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864
OPM-2,5287620,-2.918074250075414
NCI-H2196,5329102,1.6082816521298322
Panc 03.27,72193861,1.003596175816302
RKO,11364421,1.233720517884939
KYSE-70,148198,-2.193158047226166
BT 245,31703,-1.3451878084234994
OAW28,54618771,1.1011370240470315
Ku812,SNX-2112-bortezomib (250-1 mol-mol),-3.5302001962831846
BT-474,BRD-K55473186,4.284797903527297
BFTC-909,42642645,1.561027146692027
SH-10-TC,BRD-A02303741-navitoclax (2-1 mol-mol),3.9312279545051982
NCI-H1568,5287620,-3.0605655272876104
M-07e,5978,-3.75372204030787
MM1.S,54618771,0.954891721558104
KMRC-20,16115403,-5.152191129792824
EM-2,73707398,-0.1284556019091807
TCCSUP,11647372,0.3076356003247925
OPM-2,5281672,3.1701528707347015
YH-13,selumetinib-PLX-4032 (8-1 mol-mol),4.578081619399974
Panc 03.27,3025986,-1.6300945873798087
WM88,24797083,1.176388222082712
SNU-410,168312962,2.312087634198075
Ishikawa (Heraklio) 02 ER-,51039095,4.172119129991119
BT-474,57519531,4.833122531960665
F-36P,53495165,-1.808011952813931
KMRC-20,71466380,5.209336168619487
YH-13,16736978,1.9226883316273975
BL-70,246676,4.317555715151855
OCI-AML-3,24748573,1.889924445379903
MM1.S,135999136,4.602725766791159
OCI-AML-5,135999136,3.783330102557352
KMS-20,4378219,1.896511565907232
B-CPAP,3552672,3.704866420763203
NCI-H2196,44462760,4.305386698592503
KMS-20,67156097,-1.6945401630297232
M-07e,36462,-0.4519131345392329
SNU-1077,72193861,2.5371059791462276
KMRC-20,44491742,5.411645351023098
A4/Fukuda,6918878,-0.3411937140873722
SNU-201,navitoclax-gemcitabine (1-1 mol-mol),-1.6573892969338522
HPAC,sirolimus-bortezomib (250-1 mol-mol),0.9709170992825356
NCI-H1184,5329102,1.525345557079366
YKG-1,11494412,2.049778246411874
BT 231,1750826,-1.4031111199635489
TCCSUP,3038522,3.5335989350872716
Kasumi-2,24771867,-3.1023362721742607
OCI-AML-3,1242560,3.915481050980296
BT 248,42642645,1.464081071598135
BT 428,637858,2.1785026029472454
KMRC-20,selumetinib-decitabine (4-1 mol-mol),6.46474564385979
HPAC,11609586,1.9573194801835592
BT 428,24821094,3.1016694947845687
SH-10-TC,10410894,3.34876965832812
Panc 03.27,107985,-4.41897786111236
JHUEM-3,16722836,0.6216340642191963
NU-DHL-1,53495165,-3.4420511548934973
A4/Fukuda,navitoclax-sorafenib (1-1 mol-mol),1.3354427361603598
BT 245,387447,-4.390125196959702
OAW28,15983966,1.5707780698474574
BL-70,5978,-4.245678099599997
YKG-1,71751553,4.894394979371257
NCI-H1184,24785538,0.4958490631223894
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426
F-36P,2729026,2.1465892266491915
SF539,285033,-3.6653668217695183
CHP-212,216239,1.7203779543258466
SH-10-TC,16038120,2.058144452962824
F-36P,4578,3.81890859322444
WM88,148124,-3.466813167585588
JHUEM-3,11152667,-2.492971610615099
BT 428,73707398,0.9802493689904498
EM-2,JQ-1-navitoclax (2-1 mol-mol),-1.652000923110066
SNU-201,46398810,2.529476064175241
F-36P,2871966,1.4289930371727075
TCCSUP,36462,2.278863397956304
KYSE-450,44566777,1.0165509502605254
CHP-212,9549297,1.6479676898003988
BT 248,10302451,3.817813130063646
YH-13,11955716,-0.8910132220684513
Panc 03.27,3503,2.0626537548945056
OAW28,navitoclax-piperlongumine (1-1 mol-mol),0.6841862022765504
BT 248,4788,5.6007343352714605
BT 245,446155,3.758613505986336
BT 245,11656518,1.5210228533202237
Panc 03.27,7251185,3.156358668632147
CHP-212,11625818,3.4495626258396364
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482
HCC1395,9926054,1.865398038154908
OAW28,11494412,4.413959214794941
HCC38,969516,3.0433539264074345
M-07e,9803433,4.967335750375714
BFTC-909,123631,2.8792987518934403
LOU-NH91,navitoclax-pluripotin (1-1 mol-mol),-2.6950691306043297
BFTC-909,100016,5.8134150302243865
HCC1395,5460769,2.101928934987084
OAW28,262093,2.853078829548121
HCC38,375860,-0.35863164801815
LC-1F,JQ-1-MK-0752 (1-1 mol-mol),2.096969629487688
NU-DHL-1,4261,-0.9383444517557142
OCI-AML-5,ISOX-bortezomib (250-1 mol-mol),0.1541412428203445
NCI-H1568,54619267,3.44714412714971
Rh30,71466578,4.444937888971109
A4/Fukuda,2874250,4.0164309105299685
CHP-212,285033,-1.3725398797065884
Panc 03.27,3025944,4.346978224494174
BT 248,24779724,5.957496049021181
BL-70,44202524,1.145091943092637
WM88,119607,5.231547540362232
M-07e,135440466,-0.3797407587876377
B-CPAP,navitoclax-PLX-4032 (1-1 mol-mol),1.4465369536509338
KHM-1B,9911463,3.1729521589558125
BT 428,6918638,-0.3537388396166394
NCI-H2141,1716436,2.722494708848303
Kasumi-2,969516,1.973265868556714
YKG-1,docetaxel-tanespimycin (2-1 mol-mol),-4.349420995381951
BT 231,24821094,1.227994651739791
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526
RERF-LC-MS,44491742,4.380479941679622
BT 245,6610216,4.100969243175901
HPAC,31703,-0.4614393920503492
Ishikawa (Heraklio) 02 ER-,984333,1.1633965766946808
OAW28,5335621,5.136061685098042
Kasumi-2,10385095,0.5473944457717855
BT 248,17755052,0.6696435234843453
PF-382,15547703,2.5313681976208056
OCI-AML-5,selumetinib-vorinostat (8-1 mol-mol),2.268725375318619
OCI-AML-5,selumetinib-UNC0638 (4-1 mol-mol),2.3661397586711956
BT 248,2871966,0.7814721484275546
NCI-H1184,654092,-1.7531803401326804
HEC-59,3062316,2.874557151252821
RERF-LC-MS,446155,1.000000375050646
Kasumi-2,9887053,0.7760357688642865
KMS-20,56649450,1.446370800321743
HPAC,44185566,1.3047078378574433
KHM-1B,6610355,4.543219092687797
Hs 746.T,5470400,0.2177880042676836
HEC-59,36462,2.2040301999677965
B-CPAP,2708,4.8825948055163835
M-07e,11364421,-5.690237561501415
Hs 746.T,71466445,4.972648672045977
F-36P,60750,1.9702196024292824
A4/Fukuda,54454,2.014078017992857
TCCSUP,452548,0.1947021614919304
Hs 746.T,25227462,0.8923131164053296
HCC38,23582824,0.696718006280826
Hs 578T,6505803,0.7930921136576904
TCCSUP,9823820,4.428474658115308
B-CPAP,10113978,3.7412132766741895
OPM-2,54596558,4.064764759335406
NU-DHL-1,BRD9876-MK-1775 (4-1 mol-mol),0.6044264218877945
Panc 03.27,66577038,3.0119371000301043
NCI-H1184,3825829,4.026961757949262
TCCSUP,441298,2.479401374858522
KYSE-450,1566236,2.943712788473633
BT 428,crizotinib-PLX-4032 (2-1 mol-mol),2.150996451830826
KHM-1B,72734382,4.262414843982703
BT 245,2708,6.067628010390521
SNU-1077,navitoclax-piperlongumine (1-1 mol-mol),2.376186895274424
KHM-1B,208908,2.253244414744992
F-36P,19582717,3.2626311092950333
AU565,135440466,3.093480574806016
Rh30,19582717,6.071105591881468
KHM-1B,selumetinib-MK-2206 (8-1 mol-mol),-1.0193788552435303
JHUEM-3,JQ-1-carboplatin (1-1 mol-mol),0.1044516957131188
OAW28,46191454,1.726492969979986
A4/Fukuda,11396600,-8.215434514364686
HCC38,9887053,4.311133990466573
OPM-2,tanespimycin-gemcitabine (1-1 mol-mol),-0.8527630037012235
Kasumi-2,25154868,4.0151171723744765
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916
YH-13,25262965,-2.705880227783202
Hs 746.T,11960529,4.379704418397865
OAW28,6917907,-5.603755883192341
HCC38,439501,-2.3943608626526536
OCI-AML-5,6184667,4.248629803758562
YKG-1,11222830,2.3027831380451342
Hs 746.T,10302451,3.5755968540448704
Rh30,126941,-2.205043087912717
KMRC-20,44486219,5.7591116026780815
OCI-AML-5,10184653,1.7732348574708785
SNU-201,11717001,5.996236505123365
SK-MEL-28,56946209,0.4976009870921759
PF-382,46943432,0.0711232205860505
NU-DHL-1,219104,1.8536267097184471
HEC-59,613753,3.146837488559971
Rh30,135421197,2.937313489864044
OAW28,doxorubicin-navitoclax (2-1 mol-mol),-0.325587572552389
SNU-1077,241158,4.367473186933375
RKO,11507802,1.7455765117352984
M-07e,16736978,-0.6036354608385701
AU565,46215462,1.837951563203271
Hs 746.T,439501,-2.632583453917954
Ku812,6852167,2.7508092991832016
BT 428,navitoclax-gemcitabine (1-1 mol-mol),-4.063147518351703
Hs 578T,3825829,4.12008492864824
NCI-H1568,17755052,1.5920713080731803
NU-DHL-1,11507802,0.1368599707509103
BFTC-909,25262965,-1.7887871070762158
BT 248,25154868,4.640538278810453
Hs 746.T,53481919,3.822859832717378
OPM-2,16736978,1.1906517256258733
AU565,7251185,1.9736319172199277
TCCSUP,23725625,5.945522035236543
BT 245,123631,3.2251145335322975
LOU-NH91,5278396,3.7974378044691495
BFTC-909,24964624,2.4776408698208003
OCI-AML-5,11964036,0.7727820342023788
OCI-AML-3,753704,3.688765224325768
Hs 746.T,selumetinib-tretinoin (2-1 mol-mol),5.123957096177784
Kasumi-2,4705,3.579279614719375
BT 428,15547703,2.074270824736883
SNU-1041,5311,1.5789013379777828
YH-13,11485656,3.672447929172867
NCI-H2196,JQ-1-MK-0752 (1-1 mol-mol),4.193569859205293
KMRC-20,439501,-2.469138258710991
A4/Fukuda,11234052,3.83864189929063
PF-382,selumetinib-vorinostat (8-1 mol-mol),2.136528432975779
OAW28,44486219,3.976522680156617
SH-10-TC,navitoclax-gemcitabine (1-1 mol-mol),3.523499371882714
NCI-H2141,6184667,4.803880046489373
Hs 578T,3552672,1.3654193134891055
EM-2,11238147,1.9963528541104656
OCI-AML-5,5335621,4.481219159897573
A4/Fukuda,446155,1.0805751863544764
BFTC-909,11609586,2.9417391320909134
SNU-410,16038120,1.9982059700258303
SNU-410,4378219,2.0638699890675047
SNU-1077,2945648,2.7051928991882073
M-07e,24753719,3.1748367378954025
SF539,262093,2.0596515913386786
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513
TCCSUP,11222830,1.4125339406552515
AU565,6184667,2.5363760520525247
B-CPAP,44202524,1.220918078886342
SK-MEL-28,11404337,1.5828408993005263
BT 428,426756,5.018935831662504
OPM-2,56649450,1.6365959554779024
SF539,24978538,1.3983076300277495
OAW28,BRD-A02303741-navitoclax (2-1 mol-mol),1.4319695403367312
OCI-AML-5,carboplatin-UNC0638 (2-1 mol-mol),3.368870395888388
Panc 03.27,11427553,3.0574572939659053
KMRC-20,409805,5.905260063235434
Ku812,73707438,3.988741413659523
BL-70,72734382,3.2059116741041476
EM-2,2126,3.7343849193922374
HEC-59,JQ-1-vorinostat (2-1 mol-mol),1.6522566049975471
B-CPAP,135411,1.7170212116885226
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801
BT 231,navitoclax-birinapant (1-1 mol-mol),0.9636063692056038
KMS-20,375860,-0.5673020428522673
EM-2,49850262,2.0478308693295486
PF-382,15983966,-4.881243933970009
Ishikawa (Heraklio) 02 ER-,doxorubicin-navitoclax (2-1 mol-mol),-1.2154033059078049
NCI-H1568,135411,0.4069452326541798
LOU-NH91,16065773,1.5129164046929433
AU565,24748573,1.9131971710517224
AU565,alisertib-navitoclax (2-1 mol-mol),2.3316727608646266
TCCSUP,serdemetan-SCH-529074 (1-1 mol-mol),2.1769637397515997
SNU-410,227681,3.315392640210559
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505
TCCSUP,11234052,4.361103658415106
PF-382,446155,1.656597721830262
PK-59,53495165,-1.117412066108967
JHUEM-3,219104,3.2125131432796965
BT-474,36314,-4.070081092009716
BT 231,322968,2.4744910053308096
SNU-1077,10074640,3.2926421330033837
EM-2,2733526,3.317012890377298
BT 231,navitoclax-sorafenib (1-1 mol-mol),1.1792295572203897
A4/Fukuda,66577038,2.118562328013949
Ku812,16736978,-0.4990163142068329
Rh30,119607,4.497683361773863
HEC-59,44632017,4.407217181833015
HEC-59,104842,-0.0094867736676415
LOU-NH91,11427553,1.5999683226177923
MM1.S,89928392,0.1055731132110887
F-36P,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9142285794551278
HCC1395,54619238,5.316152561519339
KYSE-70,25183872,-0.2407157689495178
BL-70,10385095,0.3917305885216868
SF539,241158,3.806550538894245
AU565,44620216,3.755834453350393
KMS-20,3676137,4.822799342742389
PK-59,3689413,-0.088836641292159
NU-DHL-1,decitabine-carboplatin (1-1 mol-mol),-0.9080396977162584
Ku812,426756,5.933292752952192
HCC38,2858523,3.0697419074638352
OPM-2,25105715,2.7306053213312027
BT 245,2945648,1.9337259429429097
YH-13,serdemetan-SCH-529074 (1-1 mol-mol),3.0020411747572098
M-07e,6918638,-1.343658816703153
HEC-59,2113511,5.992833936220329
RERF-LC-MS,12003241,-0.3897829713203344
RKO,446155,4.170579555483674
NCI-H2196,ISOX-bortezomib (250-1 mol-mol),0.2169195139979087
MM1.S,11609586,-0.4904496149826149
F-36P,UNC0638-navitoclax (1-1 mol-mol),0.5889836911302547
LOU-NH91,serdemetan-SCH-529074 (1-1 mol-mol),2.4104201077494913
NCI-H1184,9911830,2.231711312227627
NCI-H2196,11494412,3.593697279450839
SK-MEL-28,168312962,-1.5398903743512435
MM1.S,11404337,0.2422934532029092
SNU-410,24748573,4.635652434951533
AU565,17755052,-0.9729531204394496
KMRC-20,9903786,3.936421872110463
SK-MEL-28,navitoclax-birinapant (1-1 mol-mol),3.597068820497229
OCI-AML-5,12001922,1.601315163188935
HCC1395,52912189,4.415536619411951
OAW28,71680916,5.167013104004298
BT 245,216239,2.117247096540108
BT 231,72376,-2.3772293781913345
SH-10-TC,1641662,3.7777580853207473
OCI-AML-3,71466380,2.9604483563469155
KYSE-450,126941,-4.1478729331459006
Kasumi-2,16736978,0.2987482410922295
OPM-2,613000,1.2483941007528057
MM1.S,24951314,0.1961256505054842
OCI-AML-3,10231331,-4.326304119674098
Hs 578T,11647372,1.1159035186104302
PK-59,24772860,-2.599285390225259
OAW28,31703,0.1585101679236112
F-36P,151289,0.0975773513046307
Hs 746.T,135411,1.2994424668692373
MM1.S,11719255,2.0947187008170887
OCI-AML-5,2842253,5.956983870239863
SNU-1077,71680916,4.721412518258323
Ku812,984333,-1.8126254994765352
EM-2,44589607,1.501645380357905
HPAC,46843906,2.9207157898210947
Hs 578T,11955716,0.6546237163424738
SF539,JQ-1-vorinostat (2-1 mol-mol),0.5454424746711817
B-CPAP,71680916,4.790234553157112
KMS-20,44462760,0.735907586100602
Hs 746.T,navitoclax-sorafenib (1-1 mol-mol),1.6504183288652785
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
M-07e,11640390,3.285744632833025
SF539,vorinostat-navitoclax (4-1 mol-mol),1.4705483951350276
F-36P,54619267,3.337793152208533
OPM-2,JQ-1-navitoclax (2-1 mol-mol),-3.008224254673695
SH-10-TC,5566,3.3020097728796625
BT 428,2828334,6.125929922668278
SW1783,44493528,4.220460910824872
KHM-1B,selumetinib-navitoclax (8-1 mol-mol),1.5654531920852657
BT 245,49793307,-3.902983777687099
RKO,1566236,3.4833841973625725
Panc 03.27,613753,3.2622682922442494
BL-70,5284329,2.228628084216018
SNU-1077,11234052,3.386244403850262
KMS-20,16720766,-0.6400494103311998
JHUEM-3,11707110,-1.984595341250456
BT-474,44484893,6.093250422280285
B-CPAP,23635314,-2.2199735472205395
Kasumi-2,46398810,1.7112254413455064
NU-DHL-1,3465537,0.9340526955418934
NCI-H1184,3136844,4.011728616185904
Ku812,carboplatin-UNC0638 (2-1 mol-mol),2.607088734610279
Hs 578T,11964036,0.7098078018080516
KHM-1B,11485656,1.807132568777105
CHP-212,25126798,3.0842519272503757
KHM-1B,219104,1.6531557302016933
BT-474,56973724,0.3533142631615627
BT 231,15547703,2.6648625624757543
TCCSUP,24785538,1.2023292009410418
PF-382,60700,-3.3166709344214342
M-07e,11485656,1.7704573347594663
HPAC,135440466,0.917647411957344
WM88,navitoclax-PLX-4032 (1-1 mol-mol),-2.244294673310041
RERF-LC-MS,25126798,3.475546322259903
SW1783,5566,2.9899549454947305
OCI-AML-5,56963564,0.0968414977383522
SNU-1077,navitoclax-pluripotin (1-1 mol-mol),-1.01883972326763
HCC1395,135999136,4.391261806083376
WM88,23725625,4.539734330479549
M-07e,54619267,3.6974472717376856
KHM-1B,3503,2.6165416338561633
PK-59,31703,-1.0177732893436835
PK-59,24797083,1.2491720369085026
BFTC-909,44491742,4.0640318167931255
BT 248,9956119,4.3886748820117925
Ku812,JQ-1-UNC0638 (2-1 mol-mol),-1.3299079938073646
YKG-1,6914657,-2.9791287497746186
PF-382,4477,-0.0830303421102948
WM88,1641662,3.2676510701086623
OAW28,16038120,1.1273660282184277
KMS-20,11396600,3.251276500206743
M-07e,9444,3.910213755806101
NU-DHL-1,5978,-4.279769734598632
OCI-AML-5,448949,2.3375349839492143
OCI-AML-5,5746,-1.2693781953137653
KMRC-20,168313047,2.207569694794804
KYSE-70,9915743,1.2522553618909642
KMS-20,2708,3.4127805917695095
OAW28,67291369,5.503883029091299
JHUEM-3,6918837,-3.7190149351547426
MM1.S,25062766,2.021817164392542
M-07e,5335621,4.2938272060642335
NCI-H1568,9840324,5.648333485386012
JHUEM-3,135984461,1.6896934055741442
MM1.S,selumetinib-vorinostat (8-1 mol-mol),1.8050138059594567
Ishikawa (Heraklio) 02 ER-,7326481,2.346559293778367
BT 245,6918328,0.1943385135138843
A4/Fukuda,11364421,-5.769651092108399
BT 231,984333,1.3802175680857889
F-36P,24785538,1.7277135052687462
Rh30,168313047,1.8101821620809693
JHUEM-3,4477,0.8320579607559105
HPAC,24753719,4.331008763420313
KHM-1B,49850262,2.854623177297442
KMS-20,53495165,-4.499917260073859
Panc 03.27,tanespimycin-bortezomib (250-1 mol-mol),-1.5321411216647824
HCC1395,638278,3.070600169952432
TCCSUP,123631,2.272054627361115
SF539,1242560,3.791681789864431
BL-70,426756,4.348516831545145
NCI-H2141,5278396,3.682758003936548
Panc 03.27,44137675,3.8404407681111414
HCC1395,11625818,3.705681233838206
OPM-2,11497983,4.2316824511311
KYSE-450,11167602,4.298081277499996
KYSE-70,36314,1.2189527676950276
SH-10-TC,126941,-4.274265725974696
HCC1395,9877608,6.36391605144629
Rh30,JQ-1-MK-0752 (1-1 mol-mol),1.698474412418303
NCI-H1568,16065773,2.3280951044534923
OPM-2,135411,1.0006691045824918
AU565,9911830,3.457946854316075
BT 245,selumetinib-tretinoin (2-1 mol-mol),5.327283057457125
Hs 746.T,navitoclax-PLX-4032 (1-1 mol-mol),2.5467606210163445
BT 231,2742550,2.753337443391445
OCI-AML-3,19582717,2.08675388146983
ML-1 [Human thyroid carcinoma],122327,4.584045367066115
OPM-2,25102847,1.4573873057147737
YKG-1,54618771,1.607640245193468
A4/Fukuda,426756,4.168045276817785
SNU-201,638278,3.60896039463142
B-CPAP,387447,-4.237504830751881
Hs 746.T,6918328,0.3309444909690014
EM-2,24772860,-3.2482957293088535
BT 245,72376,-3.012363503164747
BT 231,56963564,-0.4890733072784103
CHP-212,676352,1.7302083684321026
AU565,9444,3.6632568473184888
KYSE-70,5460769,2.831605222646697
YH-13,selumetinib-MK-2206 (8-1 mol-mol),3.53074146528381
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068
YH-13,9915743,2.529803461221303
WM88,168312962,0.2903164879488654
RKO,16720766,-1.2722083569090707
F-36P,702558,3.4021679199463017
BFTC-909,54613361,0.5481358040879688
Panc 03.27,4477,0.4903700595748541
OCI-AML-5,148198,-5.018972426044919
AU565,4705,1.275846161151896
NCI-H2141,44491742,3.797452560506029
YH-13,3025986,-1.231894259194408
JHUEM-3,5291,4.142122999968166
RERF-LC-MS,135440466,2.007932851474071
Rh30,135398516,1.616410209868243
SF539,67156097,-1.6249990290252014
CHP-212,26596,-3.74720846369554
Ku812,10231331,-1.9439726513116764
PF-382,3038522,2.759643282415116
BL-70,3825829,2.842311799056166
Ishikawa (Heraklio) 02 ER-,46199207,3.81756219854224
OCI-AML-3,selumetinib-GDC-0941 (4-1 mol-mol),-2.601986773064445
OCI-AML-3,5280436,1.6719970306537055
NU-DHL-1,984333,0.6343201948214459
SH-10-TC,navitoclax-piperlongumine (1-1 mol-mol),3.1739844128838435
BT 231,3384730,-0.4293417636159527
HPAC,carboplatin-etoposide (40-17 mol-mol),3.435171163496098
OAW28,9911463,4.007690751229585
NU-DHL-1,24797083,0.8543647878457378
EM-2,54613361,-1.003966261926886
Hs 746.T,10074640,3.5757898244514954
KMS-20,11625818,3.818760510140028
A4/Fukuda,4705,2.104501352907832
OCI-AML-3,4378219,2.020771339620158
BT 428,24889392,1.9932163515881467
SF539,4096211,1.1700950606218037
KYSE-450,46199207,3.793080332052943
YKG-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.005827491367844
SNU-410,selumetinib-MK-2206 (8-1 mol-mol),4.346341738090566
OAW28,5335621,5.136061685098042
Ku812,44507138,1.5251260017472812
LOU-NH91,53495165,1.612116489462364
JHUEM-3,24964624,3.2759458378230724
Kasumi-2,docetaxel-tanespimycin (2-1 mol-mol),-5.507046356769771
SW1783,24951314,2.5031295891577083
OCI-AML-3,49793307,-5.3509713031514075
YKG-1,vorinostat-navitoclax (4-1 mol-mol),2.284483308866315
SF539,5494449,1.5774689724302169
Hs 578T,UNC0638-navitoclax (1-1 mol-mol),0.8451308474744694
BT 231,6918638,3.0604187031451437
Ishikawa (Heraklio) 02 ER-,11178236,-3.0689222531931875
KYSE-450,44137675,3.8479858767038944
HCC38,25102847,3.328757740579293
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723
BT 248,216239,2.185733710507839
NCI-H1568,11396600,3.496587037401377
BL-70,439501,-3.7904230490472623
NCI-H2196,selumetinib-MK-2206 (8-1 mol-mol),3.3655926927484847
OCI-AML-5,2828334,5.893978952576615
Panc 03.27,11719255,3.774445826100423
Rh30,alisertib-navitoclax (2-1 mol-mol),1.2248246049206968
KHM-1B,tretinoin-carboplatin (2-1 mol-mol),2.496287811338483
TCCSUP,24180125,2.590806345958597
BL-70,11404337,-3.370287818653298
RERF-LC-MS,6852167,1.8897499878184068
SH-10-TC,54618771,0.3960881038412169
AU565,51039095,3.3315580468624795
SNU-1077,5113032,5.013204732466425
HEC-59,136227924,4.443118393205084
MM1.S,44241473,4.365495360199436
NU-DHL-1,10302451,2.2542174061675055
NCI-H2141,9926054,1.978492871362738
OCI-AML-5,5284329,2.6520766557296676
BT 245,54618795,3.402542991199258
HCC38,56649450,4.5077756708569225
Hs 578T,25161177,3.99956765623928
SNU-201,409805,5.283587417567222
KYSE-70,5278396,3.1929088159597656
NU-DHL-1,JQ-1-MK-0752 (1-1 mol-mol),-1.024409939497564
SNU-410,navitoclax-piperlongumine (1-1 mol-mol),2.3306964040223135
HCC38,46907787,0.4227430281894037
SNU-1041,25062766,2.2586900691188654
OCI-AML-5,135411,0.2780762637388145
Kasumi-2,46174525,2.7896977924424218
TCCSUP,72376,-1.3114530344547206
AU565,148198,-3.941648532890003
Panc 03.27,9927531,5.182143526242967
KHM-1B,2949965,3.6440598201563423
CHP-212,6505803,-3.651985635286723
SNU-1077,11404337,-0.4720370259421129
OAW28,2708,5.3328257603707545
HCC1395,23939,4.485769455800419
WM88,4578,4.6184038591855145
KMS-20,navitoclax-piperlongumine (1-1 mol-mol),0.7499609373098739
SH-10-TC,135411,1.2931707023218102
B-CPAP,9907093,4.2889241184998825
M-07e,24964624,2.0031878940306447
NCI-H1568,6917907,-6.013699668749745
B-CPAP,tretinoin-navitoclax (4-1 mol-mol),3.2232408113370745
YKG-1,241158,4.094206621053088
AU565,2945648,3.081352201841014
BT-474,25262965,0.5755500886039149
Ku812,11234052,3.043132602643913
YH-13,25126798,3.838421818647453
RKO,11175137,2.9264569639519906
B-CPAP,10184653,1.9021781585872557
BT 245,3543504,4.959409053605103
JHUEM-3,5470400,-1.0427404304436252
M-07e,5291,3.550996056741161
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778
KMRC-20,selumetinib-JQ-1 (4-1 mol-mol),2.987450194991694
BT 245,navitoclax-sorafenib (1-1 mol-mol),0.0648225747142713
BT 245,navitoclax-pluripotin (1-1 mol-mol),-1.9779043115942032
A4/Fukuda,3854666,-0.0838776105349313
NCI-H1568,135398516,0.1447365774963497
JHUEM-3,25154868,4.813499652870593
F-36P,navitoclax-PLX-4032 (1-1 mol-mol),2.2332176352158744
Rh30,24753719,4.445119660878695
OPM-2,11364421,-7.162542415885671
RERF-LC-MS,12001922,2.43602915295576
BT 245,23635314,-1.7980588401926882
Ishikawa (Heraklio) 02 ER-,24951314,1.737053047356394
NCI-H1184,selumetinib-BRD-A02303741 (4-1 mol-mol),4.097737819427965
SF539,3543504,3.049224466295834
OAW28,carboplatin-etoposide (40-17 mol-mol),4.113933024401999
NCI-H1184,selumetinib-JQ-1 (4-1 mol-mol),1.001947758259214
F-36P,3854666,-0.4499689748762866
Panc 03.27,11396600,3.3574447393288547
TCCSUP,421610,3.586976807709893
MM1.S,46224516,1.4824898133481414
EM-2,2729026,1.0384588154759091
A4/Fukuda,11609586,0.4485915276425587
NCI-H1184,60750,-4.9107613152385845
SNU-1041,60700,2.669870487148092
Hs 578T,53232,2.797152193052638
KHM-1B,54613361,-1.0335550774080653
SH-10-TC,9826308,0.930031477399376
TCCSUP,6918289,2.234948683546108
BL-70,4578,4.83796972632948
SH-10-TC,44491742,3.905889235687173
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694
OPM-2,12003241,-2.9738714531294232
NCI-H1568,66577038,1.9593359628641709
NCI-H2196,6918328,0.6237166765271003
OCI-AML-5,375860,-0.4377067020305437
OCI-AML-3,11485656,1.6382059446521733
NCI-H1568,2729026,2.4592472427928795
YKG-1,6610216,4.705494965359816
PF-382,71466380,3.7425525322216746
NU-DHL-1,6610216,3.849394820990355
OCI-AML-5,135423438,1.842047430976123
BT 245,246676,4.341306530425761
MM1.S,6917907,-7.99628431454436
Panc 03.27,JQ-1-vorinostat (2-1 mol-mol),1.460185256697082
WM88,9823820,3.887606402938672
EM-2,409805,3.6085049629545543
KMS-20,66577038,2.524317684477447
Hs 746.T,71466578,6.024749864612399
SNU-1041,46199207,3.24681733553858
B-CPAP,carboplatin-etoposide (40-17 mol-mol),3.8440063702085463
BT 248,55508,3.993579478299883
SNU-201,10074640,2.9669377146624623
YH-13,24180125,3.319627413046534
SK-MEL-28,5284616,3.125378124469527
TCCSUP,carboplatin-UNC0638 (2-1 mol-mol),3.7591677104919334
BT 428,SNX-2112-bortezomib (250-1 mol-mol),-3.0058868319151406
KMRC-20,JQ-1-UNC0638 (2-1 mol-mol),2.8287414261232744
F-36P,1566236,1.4994309826223562
BFTC-909,26596,-1.7437210940555867
WM88,navitoclax-birinapant (1-1 mol-mol),2.6836606646661583
M-07e,1750826,-3.0795561570003116
OAW28,4521392,4.353680801577448
KYSE-450,24753719,4.912608563377894
KMRC-20,6610216,4.741983793565595
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937
Ishikawa (Heraklio) 02 ER-,107985,-3.239655509933191
OAW28,208908,1.9779710002494069
Kasumi-2,23635314,-3.2137156100627973
SNU-1077,374536,4.4212076979679305
B-CPAP,49766530,-2.4408790709837396
SH-10-TC,11494412,1.409264522589107
BL-70,168313016,3.7978075808944967
F-36P,24753719,4.27265638786198
NCI-H1184,3815108,1.2578508406802194
Kasumi-2,11228183,-3.3606954683588057
Kasumi-2,148124,-6.270957848916609
F-36P,9826308,-0.816867239417293
SNU-410,1750826,1.0122877021538323
OAW28,374536,3.018534312402979
SNU-201,984333,1.2168590425775658
SNU-201,6623618,2.459868079360834
F-36P,11455910,-0.4221924181382917
NCI-H1568,54678924,1.274078635657008
OCI-AML-5,1641662,3.4961634084586946
HCC1395,124202324,2.811259406423157
SNU-1041,66577038,4.037498860690602
BT 231,54619267,3.814646353416104
BT 245,16720766,1.4230320257311897
SNU-1077,11222830,1.922347947337687
SNU-1077,12001922,2.14758213265239
M-07e,11213558,0.2113042560420439
PK-59,11234052,4.666164585144223
BT-474,65064,5.2644853465541095
Panc 03.27,44493528,4.213944098974542
BT 245,135411,1.173620525211862
NCI-H2196,54618771,3.689475396494767
NCI-H1184,89183176,3.729174200324048
RKO,984333,1.1849980625737155
KHM-1B,10113978,2.248565849983048
AU565,71466445,4.046585104708946
NCI-H1568,135984461,4.216726883570129
OAW28,24978538,-0.39276463694641
AU565,11964036,0.1505437081667179
OCI-AML-5,2126,5.447371688306604
SF539,2874250,6.295568507703997
YKG-1,vorinostat-carboplatin (1-1 mol-mol),4.05575271660812
NCI-H2196,25262965,-2.3966537336075993
CHP-212,selumetinib-UNC0638 (4-1 mol-mol),-4.335907529611855
YH-13,3081361,3.4000588476390963
A4/Fukuda,54618305,3.964460418875751
Kasumi-2,49846579,-4.472892287565064
BL-70,3854666,0.0420244539233536
SH-10-TC,2871966,2.7633803623382565
NCI-H2196,3038522,4.274043965130687
BL-70,135398516,-0.1745508123290167
JHUEM-3,11625818,3.720095100303068
OCI-AML-3,72193861,0.0793566393080102
Hs 578T,selumetinib-piperlongumine (8-1 mol-mol),3.6202415943294466
SH-10-TC,5284329,1.914307618503451
BT 248,387447,-5.028656036950466
OPM-2,6917907,-6.048813777211379
OPM-2,1716436,2.6292767753294437
BT 245,984333,-0.0164888250804615
RKO,9825149,2.459088339864112
Ku812,445643,2.6180665518205046
BT 231,2949965,2.5110208922046513
SNU-201,JQ-1-navitoclax (2-1 mol-mol),1.4081573273529455
NCI-H1184,navitoclax-gemcitabine (1-1 mol-mol),-3.896892650872144
SK-MEL-28,44607531,2.134976600780572
Hs 746.T,262093,3.2071255403244097
SNU-410,6184667,3.719316299051791
SNU-1077,119607,4.993790856001467
NU-DHL-1,16013152,3.387087199942325
SF539,441298,1.510728884927333
Kasumi-2,445455,4.224989809831099
NCI-H1568,4096211,1.8643847121139272
WM88,568763,-0.3440093728814041
CHP-212,11494412,-1.604846658421623
MM1.S,5284616,-5.860014911973016
NCI-H2196,16720766,5.101090184502845
KHM-1B,erlotinib-PLX-4032 (2-1 mol-mol),2.9494241751240353
Kasumi-2,crizotinib-PLX-4032 (2-1 mol-mol),1.093787578488076
Panc 03.27,52947716,2.98386246448005
F-36P,12001922,1.376865879976315
PF-382,11609586,2.2064607585026006
CHP-212,3384730,2.2547842238707596
SNU-410,65064,3.9764329566192673
Hs 746.T,5311,1.508753607922962
KMRC-20,25183872,-0.3631829438506245
Hs 746.T,sirolimus-bortezomib (250-1 mol-mol),0.2683351273319356
SNU-1077,4477,-1.0120620923671768
KMRC-20,25195348,4.57665452186817
HEC-59,54618771,1.4246899684638197
OCI-AML-5,9935249,3.1801154078434584
F-36P,11152667,-1.3463503839028206
F-36P,9933475,1.7265747265427065
NCI-H1568,11404337,-0.63897934294681
BT 231,375860,-0.0580384195874913
BT 231,135421197,1.0763175924586934
BT 248,11427553,3.5134734510694687
OAW28,6917907,-5.603755883192341
HEC-59,46199207,3.3177304597474757
CHP-212,selumetinib-MK-2206 (8-1 mol-mol),-4.3916803345205
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445
NCI-H1568,5746,-0.0019321539800122
CHP-212,448949,1.374999609162309
Rh30,54618771,1.1038289315266856
SF539,53392493,1.7253246594854623
MM1.S,675434,3.752127211451784
NCI-H2196,24856436,0.9062316596647236
NCI-H1184,10302451,3.191848520716454
AU565,107985,-3.572249289009051
Hs 578T,JQ-1-UNC0638 (2-1 mol-mol),0.8827750270624418
YH-13,135421197,2.4430977346174165
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812
M-07e,11977753,-2.393015688712383
BL-70,5311281,0.904147680870617
HCC38,3384730,4.346789222727743
OAW28,44137675,4.561686598527574
NU-DHL-1,5311281,1.858827223103547
LOU-NH91,26596,-0.8372049149458933
KYSE-70,71466578,3.801340757329347
MM1.S,10427712,3.559662100834844
KYSE-450,16741245,5.34317896453295
SNU-1041,89183176,5.631542317752862
WM88,9825149,2.6664273076339606
BT 231,crizotinib-PLX-4032 (2-1 mol-mol),1.983526229856042
Ishikawa (Heraklio) 02 ER-,60700,1.52119076036971
YH-13,25150857,2.985150336849829
HCC38,72193861,0.8868410541493199
NU-DHL-1,6918837,-5.004297563636696
WM88,54626689,4.526788093765302
Ku812,24753719,3.51384685300995
SF539,675434,4.646875008530426
NCI-H1568,135875424,3.0063280878885967
SH-10-TC,11625818,4.986537523304683
CHP-212,44185566,2.183084349841253
SNU-1077,24964624,3.288685400990077
Rh30,11175137,2.639167145203656
HCC1395,9929138,7.007797451102856
SF539,25154868,4.846757922777188
OCI-AML-5,6610355,3.5852045475889316
M-07e,54143018,-0.3407859728888626
EM-2,71466380,4.102150803392334
BT 428,49793307,-3.4439076798113857
SNU-1077,25154868,4.181521053773788
EM-2,2841722,3.765940615435566
NCI-H1184,4788,5.875822199134224
A4/Fukuda,25062766,1.3929374396347198
RERF-LC-MS,9936388,-8.273067767637817
KHM-1B,3136844,3.849321357179878
EM-2,7326481,3.0728402573576545
SW1783,8515,3.491142478274941
NU-DHL-1,16219061,1.476487728041343
M-07e,6918328,-2.4283923626935966
TCCSUP,11178236,-5.158668289111837
BT 248,122327,5.08009478305936
HEC-59,135411,0.9538108728911344
SF539,9825149,2.2900366045202674
LOU-NH91,11222830,1.619786635706389
YKG-1,5566,3.213592507672074
WM88,24951314,1.2137805499540024
NCI-H2196,984333,1.0516114638322784
MM1.S,285033,-2.3858654705971
AU565,1239801,6.39587237663574
EM-2,65628,3.859788884791103
NCI-H2196,135984461,4.343785074544861
OCI-AML-3,9911463,2.5081471019206014
SNU-201,12001922,1.797232844479541
MM1.S,3634881,3.159855284524507
BT 428,2733526,2.631519198254746
A4/Fukuda,11625818,2.700159842549232
OCI-AML-3,11396600,2.62511537736271
PK-59,24901704,3.4146535420150053
BT 248,135411,2.4646623802818577
Panc 03.27,6918638,1.3027265452400043
SNU-1041,969516,3.7321752053277937
SH-10-TC,3543504,5.3444204413022955
SK-MEL-28,10184653,3.6821110044494056
SF539,selumetinib-UNC0638 (4-1 mol-mol),3.9589245906331314
Kasumi-2,24748573,1.468920481488018
NCI-H2141,89928392,0.5324982106296566
RKO,2858523,3.1569923390566332
Hs 578T,25262965,-4.948294387087814
SF539,11228183,3.1050293541734475
Ishikawa (Heraklio) 02 ER-,36462,2.657616435798718
Rh30,49850262,3.2961308560321996
RKO,25126798,4.002843113400742
KYSE-450,1641662,3.736286251526556
KMS-20,vorinostat-carboplatin (1-1 mol-mol),1.9283897088416788
BT 248,9825149,2.247604687491298
HCC1395,3689413,-0.620515875859175
KYSE-70,1641662,3.490090790744947
JHUEM-3,selumetinib-BRD-A02303741 (4-1 mol-mol),2.5511489796807
OCI-AML-3,44202524,1.1133116196547108
F-36P,25105715,3.27041361580791
TCCSUP,24951314,0.5782862351023664
SF539,10113978,1.3805891441937308
BT 428,68056272,3.459545144261663
PF-382,4261,0.6206870573702211
SNU-201,5281321,-0.9690824905557892
NU-DHL-1,11427553,2.3101556642862575
F-36P,409805,3.912389253799608
PF-382,2828334,5.600053849858772
BL-70,24856436,0.2332191224044315
KMS-20,25150857,1.1621716531202362
YKG-1,11167602,4.915993662125618
OAW28,5351362,2.5555782345102407
A4/Fukuda,25126798,3.529395374343333
SNU-410,navitoclax-birinapant (1-1 mol-mol),0.6582071753739827
OPM-2,2742550,2.8639715022070713
F-36P,241158,2.4015613346017113
SH-10-TC,135440466,3.2620444765539465
BFTC-909,6184667,3.207156937684644
AU565,2858523,2.8415967437488443
SH-10-TC,54618164,4.2209628595779005
KMS-20,2871966,0.6331264046561579
RKO,4788,5.372325515812119
YKG-1,44185566,3.0761735678069884
NU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.622223528982808
NU-DHL-1,3385,1.8377112991123596
WM88,5746,1.0900632219144135
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819
SNU-410,54626689,4.39404629791552
KMRC-20,3825829,4.552870179452752
Panc 03.27,31703,-0.8283690401637852
BT 231,erlotinib-PLX-4032 (2-1 mol-mol),2.6279872082288644
BT 231,3385,6.58392061343833
Kasumi-2,2126,3.96137914347523
B-CPAP,9926054,2.1103473685311043
JHUEM-3,9935249,3.4231296114502068
OAW28,11178236,-3.057015425639644
NCI-H2196,12001922,1.3300465529610377
Panc 03.27,24797083,1.0022145591761495
KHM-1B,4915,4.394677312814559
NU-DHL-1,4096211,0.6464919825454908
SF539,104842,-5.162287402795691
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172
BT 231,5281321,-2.615005478223511
A4/Fukuda,44489675,3.3968348796203003
CHP-212,11364421,-5.2657833890074555
NU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.6055293417204113
Ku812,5291,-2.2328806497489437
KYSE-450,9903786,5.350068255808832
Ku812,31703,-2.031411479408016
Hs 746.T,16038120,1.627036212784449
A4/Fukuda,12001922,1.2276815023009988
SNU-1077,5311281,2.675466174095196
RKO,66577038,3.1469091340303637
LOU-NH91,24797083,1.602297413523094
Rh30,16736978,1.9579996277555287
TCCSUP,6623618,2.4538006710515186
BT-474,9907093,4.4176259778554945
Kasumi-2,serdemetan-SCH-529074 (1-1 mol-mol),0.2929627524168506
YKG-1,8515,4.7576372381485
NCI-H1184,25150857,2.1237528719822754
RKO,3062316,2.656751778030552
TCCSUP,9952709,2.608000071984436
YH-13,4096211,1.7553390235947497
LOU-NH91,9823820,5.384931157369051
SNU-410,11396600,6.23981949111421
F-36P,doxorubicin-navitoclax (2-1 mol-mol),-0.9945665155657868
SF539,tanespimycin-bortezomib (250-1 mol-mol),-1.7404188546520216
F-36P,SNX-2112-bortezomib (250-1 mol-mol),-2.8512531965978467
BT 231,24797083,0.7348725904483493
Hs 578T,JQ-1-carboplatin (1-1 mol-mol),1.3034632234881312
NU-DHL-1,71466445,1.452037118148276
HEC-59,navitoclax-sorafenib (1-1 mol-mol),4.962086144264635
PF-382,400769,-1.377370522308466
KYSE-70,9903786,2.353212274658888
PK-59,11175137,3.384395759818981
AU565,3136844,3.8072298284959385
PK-59,11427553,2.899935057624285
Kasumi-2,11364421,-5.792134203695654
Rh30,6918878,2.298607946223957
KHM-1B,1317464,5.275687871305658
SNU-1077,400769,-0.3055004816783465
MM1.S,24797083,1.1984729512209644
SK-MEL-28,11626560,2.4011846012689424
SF539,135928012,3.885367249068042
HCC38,285033,-1.9571424164477875
CHP-212,375860,-1.8839659810914688
Kasumi-2,148198,-6.27183434225638
Kasumi-2,doxorubicin-navitoclax (2-1 mol-mol),-4.049414259936193
Panc 03.27,12001922,2.2812198135528408
NCI-H2141,navitoclax-birinapant (1-1 mol-mol),0.3709297610803734
BT 245,24821094,3.241284674882521
M-07e,11960529,4.822604222913113
F-36P,5280436,2.7648016483569253
KHM-1B,5978,-4.717973613430777
SNU-1077,navitoclax-birinapant (1-1 mol-mol),2.274223223308886
Ku812,71466380,3.9178457046107704
BFTC-909,5281321,-1.6266730162675118
Hs 746.T,vorinostat-carboplatin (1-1 mol-mol),3.703848572163216
SNU-410,2907,5.0330491490178675
MM1.S,9840324,5.541225191096644
PF-382,19582717,3.4720772442845296
F-36P,JQ-1-MK-0752 (1-1 mol-mol),-0.2106666428219584
NU-DHL-1,54678924,1.1302571335689575
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485
M-07e,25161177,3.2945697148501725
CHP-212,12003241,-2.3110623292084695
TCCSUP,decitabine-carboplatin (1-1 mol-mol),4.4091116802817325
OAW28,168313200,4.298133692275281
HCC38,66577038,3.208071313003328
B-CPAP,4259181,0.2789779013360439
PK-59,16720766,0.6877547107928741
BFTC-909,44486219,4.380685277356905
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457
SNU-1041,4261,3.2146926832530043
AU565,36462,0.154728470238132
OCI-AML-5,67291369,-0.0530382994159267
YH-13,46199207,3.8574280996782337
CHP-212,5951923,4.473959548967566
SW1783,BRD-A02303741-carboplatin (1-1 mol-mol),4.341275119932719
YKG-1,46398810,2.968837802015958
SNU-1041,11626560,2.1054356055122914
BT-474,5278396,4.234459189990672
BT 428,25150857,2.4600208880197867
SK-MEL-28,9866186,3.06280870304389
BT 428,11609586,2.660969893570498
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395
BL-70,10410894,1.874969513483346
Ku812,navitoclax-MST-312 (1-1 mol-mol),0.7208208773965746
Rh30,5280436,4.601939963864228
SK-MEL-28,vorinostat-carboplatin (1-1 mol-mol),4.275906027755069
NCI-H2141,45279963,2.6100484904465615
F-36P,9926054,1.445748070072179
SH-10-TC,15547703,3.389575804087565
OAW28,JQ-1-vorinostat (2-1 mol-mol),0.5545971801402327
SNU-410,25154868,5.048371755542739
BT 231,56649450,2.3701716466817127
Panc 03.27,9956119,3.9234123753047343
A4/Fukuda,tanespimycin-bortezomib (250-1 mol-mol),-0.1272603681833176
AU565,9840324,5.90463961449661
Rh30,carboplatin-etoposide (40-17 mol-mol),2.0715093375171465
F-36P,72199292,0.7918763584575162
F-36P,71304818,1.4076344368323763
BFTC-909,135440466,2.535274686795805
OPM-2,25227462,-6.0467342682230445
AU565,4261,1.5351844706992892
HEC-59,9967941,3.177644974462193
RKO,44632017,0.9673312213076444
MM1.S,54686904,2.8702453474373315
YKG-1,9884685,-0.1545508204895388
KMRC-20,2828334,6.318285048549249
KMRC-20,24964624,2.981124341507829
RERF-LC-MS,10410894,3.034247655874134
LC-1F,10184653,0.2326798680821824
Ku812,135440466,1.6128490007977765
OAW28,11485656,3.2643123414600645
Hs 746.T,31703,-1.3452494087889075
BT-474,168312962,1.1768547588883491
AU565,387447,-4.131425766006191
OCI-AML-5,11640390,3.444860007060472
HCC1395,60700,0.7288573679273165
YH-13,24964624,2.65969154668954
YKG-1,2746,3.802533592415727
HCC1395,136227924,3.3223803208690135
NCI-H2141,439501,-3.4118873833208676
WM88,445643,3.9178428230211138
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289
OCI-AML-3,3854666,0.3450933416643372
NCI-H1568,54626689,4.298451601405369
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464
OCI-AML-5,6450551,0.7484185711404807
Hs 746.T,54618771,0.5763857654673513
Ku812,46224516,1.585603002633456
HCC38,2113511,5.796605787416609
CHP-212,23725625,2.750616567322236
LOU-NH91,3038522,4.554088179549466
PK-59,3503,2.783654869313988
AU565,54618305,4.305835133395234
RKO,2841722,4.522769482159767
BT 248,25105715,2.686391114115495
PK-59,navitoclax-gemcitabine (1-1 mol-mol),0.5848903190241437
BFTC-909,16720766,-0.0189955240044846
EM-2,navitoclax-MST-312 (1-1 mol-mol),-0.8714466308659541
HCC1395,6610355,5.140155299946008
PK-59,71466445,3.6462946515492423
CHP-212,3025944,4.013777861428515
BT-474,25227462,1.511559645361305
A4/Fukuda,JQ-1-navitoclax (2-1 mol-mol),-1.310646692558982
NCI-H1184,decitabine-navitoclax (2-1 mol-mol),1.4840384056535776
TCCSUP,3634881,3.232096710476599
Hs 578T,51039095,1.2113429698896865
OAW28,3825829,4.635564939734502
AU565,3676137,4.605193047317769
F-36P,11214940,1.5758051938742843
NCI-H1184,11364421,-4.269740326364737
KHM-1B,168313047,1.841337582388115
KYSE-450,doxorubicin-navitoclax (2-1 mol-mol),0.7817120569576905
HCC1395,104842,-1.061687468569091
SW1783,11214940,3.7998857791777287
Hs 578T,9911830,1.8415488310129824
HCC1395,444795,5.464087524782881
Panc 03.27,BRD-K55473186,6.182156470175741
KMS-20,25183872,-1.3231637510750665
Ishikawa (Heraklio) 02 ER-,2130404,3.710615322571876
SH-10-TC,46398810,3.7604477180486895
SNU-1041,2858523,2.92455898631252
HCC1395,selumetinib-piperlongumine (8-1 mol-mol),4.523388759664774
BL-70,JQ-1-MK-0752 (1-1 mol-mol),1.1774363706839777
MM1.S,60750,-5.284473024198937
OCI-AML-3,5978,-7.330003462956273
BT 248,6184667,2.4270302543682307
AU565,54618771,1.1954147839624212
RERF-LC-MS,11175137,3.6286013190581503
YKG-1,156422,4.407092102753243
MM1.S,16722836,0.4655451922698376
NCI-H2141,10427712,3.2720502433959733
EM-2,10090485,4.7660039368476115
BFTC-909,3503,3.411270469206907
SNU-1041,selumetinib-MK-2206 (8-1 mol-mol),4.855976708867328
Ishikawa (Heraklio) 02 ER-,3025944,4.346382559998423
RKO,65064,4.5178366082525
JHUEM-3,JQ-1-vorinostat (2-1 mol-mol),-0.3430101738427754
B-CPAP,JQ-1-carboplatin (1-1 mol-mol),6.304556077558474
HEC-59,6914657,-4.241331852652213
KYSE-450,15547703,4.417668058274178
OPM-2,11647372,1.2733466761832082
OCI-AML-5,44566777,0.420406686268977
KHM-1B,54618164,3.3281109403552795
BT 245,tretinoin-navitoclax (4-1 mol-mol),0.1970229993280732
SK-MEL-28,2708,5.4002065413787275
BT 231,5738263,3.166414845208924
A4/Fukuda,9926054,1.7963505717751411
AU565,54596490,4.681317358630495
Panc 03.27,navitoclax-pluripotin (1-1 mol-mol),0.0337040624177524
PK-59,452548,0.5932890815360226
SNU-1077,44507138,3.898901958117883
NCI-H1184,31703,-3.5609400102074216
Panc 03.27,135411,0.8057922501185131
Ku812,71466578,3.661514598735973
Hs 746.T,73707371,6.050414271564246
WM88,4705,3.410375599390418
YH-13,72193861,0.945446843514748
SNU-1077,123631,2.741510645866922
NU-DHL-1,119607,5.442587797739693
Kasumi-2,54618795,2.2160859361178624
KMRC-20,JQ-1-vorinostat (2-1 mol-mol),1.7391648557061274
BT 428,2729026,1.1838320666199753
CHP-212,1242560,3.604873496073034
YH-13,54143018,0.7752211198324802
KMRC-20,5282054,4.2383021010346065
OPM-2,126941,-4.73900193491969
BL-70,16038120,1.4365840083668096
EM-2,BRD-K58730230,4.937371057145756
JHUEM-3,17755052,1.3461153893706834
PF-382,72193861,0.0573496234018987
HCC38,25150857,2.7080844558070356
Hs 578T,11214940,4.116257599594159
NU-DHL-1,25262965,-2.025747961233056
OPM-2,44632017,0.7121474472673729
SF539,carboplatin-etoposide (40-17 mol-mol),1.5231255103181107
A4/Fukuda,51037431,0.9928208538339424
TCCSUP,6184667,2.5617640060179823
WM88,11626560,1.151912825907457
Hs 578T,5311281,0.976499285633552
OCI-AML-5,49793307,-4.052207794592544
M-07e,4378219,4.605552786777074
BT-474,3689413,-0.6944310513118788
NCI-H1184,4259181,-0.769318878882707
RERF-LC-MS,54596558,4.400747096440468
F-36P,107970,1.5167035192895906
WM88,36314,-6.179948716248272
SW1783,9907093,4.435721436933663
RERF-LC-MS,135421197,1.554065103888189
SNU-201,49850262,5.673631303262336
RERF-LC-MS,4788,5.0822281264538365
BT 245,46215462,2.00474421855526
OAW28,3854666,2.969576020962734
MM1.S,72734382,3.2405632872404233
M-07e,71729975,0.4243989535522631
HCC1395,9903786,3.009593050669707
BT 248,2729026,1.163283415080523
Hs 746.T,3552672,1.65538887678465
SF539,selumetinib-vorinostat (8-1 mol-mol),3.0121970622277248
SK-MEL-28,44202524,4.379747746299274
KMS-20,1566236,0.9059478778030634
BFTC-909,11238147,5.503103761619835
SNU-410,42642645,1.7213694286184011
KYSE-450,crizotinib-PLX-4032 (2-1 mol-mol),2.9466068447817126
SF539,11717001,4.3610839531094525
OCI-AML-5,53495165,-1.7242210050395643
RERF-LC-MS,11625818,4.251014876931036
NCI-H2196,36314,4.0136571894172555
PF-382,3815108,1.747404185306998
BT-474,53393127,4.267076103609544
M-07e,984333,-2.1731057725800005
BL-70,67291369,-0.1670270915713845
BFTC-909,5291,3.495280995080932
SNU-201,72193861,3.455929858098741
Ishikawa (Heraklio) 02 ER-,638278,3.4919632376772
A4/Fukuda,5328940,-0.5379688872377596
Hs 746.T,24779724,-3.709642201579214
A4/Fukuda,9933475,1.717973727652582
YH-13,53392493,1.9898975762013085
JHUEM-3,49867926,5.961511340151968
B-CPAP,2841722,3.84496663124297
AU565,11175137,1.8234152921093247
YH-13,carboplatin-UNC0638 (2-1 mol-mol),3.6332761748484255
HCC1395,9911463,3.7308184139789855
AU565,702558,5.325524002647016
SNU-1041,44589607,4.188623500249625
YKG-1,11175137,1.824320383587359
JHUEM-3,15547703,0.8935352681781958
KYSE-70,72734382,4.428008981499565
KMS-20,15547703,2.6043322601948455
Hs 578T,tanespimycin-bortezomib (250-1 mol-mol),0.2448774923200065
NCI-H2196,56946209,-4.595653085599361
JHUEM-3,16013152,2.973379149638453
MM1.S,54143018,0.2857202786050064
BT 428,9887053,4.346878495583028
Hs 578T,5746,1.934299687732732
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874
BFTC-909,15983966,-4.834157449814871
OPM-2,135440466,0.016624870652288
SNU-410,374536,3.1902909330484985
NCI-H2141,24964624,2.084827706025728
Kasumi-2,53392493,1.5560274267449214
Ku812,216468,0.540361244163346
KMS-20,5978,-3.862125436085328
M-07e,6918878,-1.034225078902853
Rh30,11404337,-0.0362683068466765
AU565,9884685,0.3686008824574254
Hs 746.T,5738263,2.984659958038294
SW1783,16659841,3.197521836887965
BFTC-909,613000,3.1980696015333137
OCI-AML-3,9908783,4.708812764484537
PK-59,409805,4.129578188717334
F-36P,25183872,-1.7486354967000737
NCI-H2141,16736978,1.5444999235397403
B-CPAP,docetaxel-tanespimycin (2-1 mol-mol),-5.525522845954553
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488
BFTC-909,702558,5.601571619782522
NCI-H2196,9887053,4.217849754910272
Ku812,tanespimycin-bortezomib (250-1 mol-mol),-1.4793309547353497
Rh30,9926054,2.2159405572329143
OAW28,984333,0.3792215902143511
BT 245,67156097,-0.7783677327419868
KMS-20,16065773,1.6920071988630498
OCI-AML-3,6918878,-1.1888117332211317
HEC-59,5351362,1.104540172076482
OPM-2,6505803,-0.5489645461029444
SK-MEL-28,3689413,3.3385356968233744
HPAC,9935249,3.1967144578068294
Kasumi-2,3825829,3.3479634665685167
BT 428,17755052,1.5816948743911896
OAW28,9956119,4.544482925716663
CHP-212,54765302,3.6356827197819657
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473
LOU-NH91,4917,3.4124252266322297
F-36P,54454,2.519969881307033
KYSE-70,4259181,-4.187670573846372
PK-59,135875424,3.737021018611698
OCI-AML-5,54618795,3.443981493080135
OCI-AML-5,navitoclax-MST-312 (1-1 mol-mol),-0.0269136094130002
LOU-NH91,selumetinib-vorinostat (8-1 mol-mol),2.951111508603088
WM88,11455910,0.2100258474381383
OAW28,71466380,4.3449274646859495
HCC1395,4477,1.5720524125692277
YKG-1,10322450,5.46076367923885
Kasumi-2,3465537,0.5812514796989715
MM1.S,6438330,0.7925484040145825
MM1.S,2113511,3.813209914161712
SNU-1041,6610216,4.964227197665286
KMS-20,71729975,0.4297208720314417
A4/Fukuda,11707110,-3.666992219196893
F-36P,135928012,3.654174626785145
TCCSUP,439501,-2.3382973857263893
SW1783,89928392,2.216727995281777
BT 428,2708,3.3990260220989983
PF-382,6918289,-1.8568942087254432
SNU-1041,439501,-2.4187407213181085
Hs 746.T,5566,3.0759093077376725
Ku812,44185566,0.7020078390558537
JHUEM-3,selumetinib-JQ-1 (4-1 mol-mol),0.3995235416963141
OPM-2,11494412,0.3054873199299708
OAW28,702558,5.716785737298097
BT 231,1566236,1.681485280274636
BT 231,5280436,2.9983755916706225
HPAC,44137675,5.4512513150593
BT 231,5328940,1.6487838812327065
OAW28,11625818,4.459236282412159
BFTC-909,12001922,1.803559970478093
HCC1395,carboplatin-UNC0638 (2-1 mol-mol),2.91778036184259
TCCSUP,119607,5.1552378410509
AU565,54649381,3.996593912741648
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712
EM-2,tanespimycin-bortezomib (250-1 mol-mol),-0.8534548568665049
KHM-1B,10077130,2.7522927679914764
Panc 03.27,11175137,3.258893722260357
BFTC-909,9866186,1.150003196853964
Hs 578T,6917907,-5.5233475175575695
JHUEM-3,3081361,1.040739345412421
BT 248,54618795,3.2071840181570477
Kasumi-2,9935249,-0.6704419087402653
EM-2,54143018,-1.1135524777762078
BT-474,3062316,2.6991411111879566
BT-474,400769,1.050360880490644
Hs 578T,tretinoin-navitoclax (4-1 mol-mol),0.8388027991320482
WM88,16725315,5.058414011355516
KHM-1B,24856436,-0.1873560944062299
SK-MEL-28,675434,4.199457479728167
OCI-AML-5,4705,4.476386157060081
NU-DHL-1,451668,-1.5883202608860565
RKO,409805,3.580644131410829
Ishikawa (Heraklio) 02 ER-,16720766,1.1696695251654898
BL-70,3062316,-2.155183845389552
PF-382,54618305,4.182237982253296
NCI-H1568,19582717,3.4209569673427342
PK-59,25062766,2.177609157002552
EM-2,9911830,-2.087916808060928
OCI-AML-3,1750826,-3.560222731072029
YKG-1,23582824,0.6705184906158483
RERF-LC-MS,54143018,1.1379926617289184
Ishikawa (Heraklio) 02 ER-,2828334,6.021759925612071
BT 428,9926054,1.9432227600739695
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475
KHM-1B,3689413,-2.4012228391908783
F-36P,24748573,1.636470275133907
BL-70,5287969,-2.514450985702893
Hs 578T,SNX-2112-bortezomib (250-1 mol-mol),0.0257503415876099
NU-DHL-1,25126798,3.605160224623971
KMRC-20,2113511,6.253781367833113
BT 245,208908,2.1463018754155088
Kasumi-2,10113978,2.7713645825563153
HCC38,44607531,1.336806545782921
OAW28,49766530,-0.5315014966120291
Hs 746.T,crizotinib-PLX-4032 (2-1 mol-mol),-2.1840971365553212
BT 245,135875424,2.904149434910518
BL-70,3385,2.6132940399674434
NU-DHL-1,navitoclax-sorafenib (1-1 mol-mol),-1.6614414384749498
F-36P,56946209,-4.996007031858833
SNU-201,11964036,2.0363684483310376
NCI-H1184,54678924,1.4691822710343203
SF539,4578,4.594464802750392
SNU-201,11626560,2.115501524477794
M-07e,44185566,1.5344061286084618
A4/Fukuda,sirolimus-bortezomib (250-1 mol-mol),-5.340339704000633
OAW28,400769,-1.4620594490922918
F-36P,5738263,2.491155610268282
OPM-2,66577038,2.8274271292709536
YKG-1,26596,0.9408189524000934
BFTC-909,54626689,4.365294423210906
BT 248,erlotinib-PLX-4032 (2-1 mol-mol),2.9999117563905497
OAW28,5460769,4.044755256654475
SF539,11234052,3.1104537569749353
A4/Fukuda,73707398,-0.4328093310020208
EM-2,4096211,0.813037338865296
BL-70,docetaxel-tanespimycin (2-1 mol-mol),-8.255291279294335
OPM-2,ISOX-bortezomib (250-1 mol-mol),-0.1945134958657626
PF-382,5328940,0.3302899082502404
BT-474,72376,1.2968421546172433
KYSE-70,54626689,6.762622459467938
NCI-H1184,tretinoin-carboplatin (2-1 mol-mol),5.572942814639008
KHM-1B,selumetinib-UNC0638 (4-1 mol-mol),2.050672890925013
SF539,11977753,-1.5349757438855824
SK-MEL-28,3038522,4.0586102618779245
SNU-201,5281672,5.019533104703014
Hs 578T,54619267,3.7796285668980927
OCI-AML-5,122327,5.86301353258512
YKG-1,navitoclax-MST-312 (1-1 mol-mol),1.1745049441725737
NU-DHL-1,24978538,-3.3743364704490224
WM88,53495165,-1.18921944197781
OAW28,44566777,2.367961844085161
Hs 746.T,49766530,-0.4715984788298692
PF-382,387447,-5.996282081470132
KHM-1B,4788,4.7580664761718054
PF-382,9825149,1.7969028915446674
KMRC-20,54454,3.590685195653472
SH-10-TC,24901704,4.131606956721232
BT-474,3825829,4.608965089399906
KHM-1B,11640390,-1.4659593094548573
LOU-NH91,56946209,-2.032751224257796
BL-70,2746,1.4659724026992842
PK-59,3815108,2.9593126918265553
BFTC-909,656346,-0.1018552101429806
SNU-1077,753704,5.47540794782016
F-36P,10322450,3.2432615470800883
AU565,45279963,3.869118795762884
EM-2,151289,-0.364431162204513
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009
WM88,4096211,2.2839760791210177
SNU-410,3815108,3.585710847718894
PF-382,9866186,-0.181999891578736
SH-10-TC,25161177,4.47532564394493
PF-382,11228183,0.289303450699542
NCI-H1184,10127622,5.1256219015613125
PK-59,168312962,2.7802868491236743
M-07e,44241473,5.146938802474246
AU565,15953870,2.093538779145719
PK-59,285033,-1.600549303351576
KMS-20,16219061,1.4676215792149392
KHM-1B,2945648,1.137982843837139
NU-DHL-1,71729975,0.4748567113914174
BT 248,57519531,6.254880017804167
HEC-59,46191454,1.0048404220193792
LOU-NH91,alisertib-navitoclax (2-1 mol-mol),-1.2312433531350488
Rh30,2858523,3.074859546982282
CHP-212,7251185,2.026045255052444
EM-2,24753719,2.7416621660310767
MM1.S,409805,4.03743481309792
Kasumi-2,5743,-2.32743694805066
Rh30,11507802,2.1787946273713468
KHM-1B,1641662,3.357336532713352
MM1.S,25150857,1.609855553563615
A4/Fukuda,72734382,2.815137004147321
PF-382,SNX-2112-bortezomib (250-1 mol-mol),-3.001055376524997
NU-DHL-1,5351362,0.683345885255648
PF-382,46174525,2.636073374054482
PK-59,11222830,1.7075966552291613
HEC-59,5311,1.1820885577738665
HCC38,11609586,3.2607577685359552
BT-474,322968,2.123879001705676
SF539,2130404,3.7538105132797304
OCI-AML-5,11167602,2.461233339824551
HCC1395,9825149,2.295082585615583
NCI-H1568,24964624,2.125017418877952
WM88,7326481,3.6080052523834985
PF-382,60750,-4.575665185057959
OAW28,66577038,2.5027239379183666
EM-2,5329102,1.0684546513239963
CHP-212,135411,-1.4236413711587437
OCI-AML-3,2733526,4.1190439899041005
Rh30,148198,-2.9975267063849507
BT 248,5287620,-3.0713737356172484
BT-474,25102847,3.7632528736484057
B-CPAP,656346,-0.1957120455939244
HEC-59,2874250,6.296673582528175
OAW28,73707398,1.2451215877479735
EM-2,156414,0.7048874875207918
WM88,vorinostat-navitoclax (4-1 mol-mol),1.3679681542729862
F-36P,11497983,3.947190340527199
SH-10-TC,3025944,4.39017795375254
F-36P,72734382,3.3122529746268707
BT 245,54613361,-1.1650114497450532
Ishikawa (Heraklio) 02 ER-,2945648,3.12938020774275
SW1783,6252,4.426958357245536
KMS-20,serdemetan-SCH-529074 (1-1 mol-mol),1.5449813132699757
HPAC,navitoclax-pluripotin (1-1 mol-mol),0.2027572376943745
BT 428,selumetinib-BRD-A02303741 (4-1 mol-mol),0.7772774830085131
OPM-2,9826308,-1.153894104617258
TCCSUP,25105715,3.142954215629872
Panc 03.27,5278396,3.8756895111752
SNU-201,selumetinib-PLX-4032 (8-1 mol-mol),4.549152897472918
OAW28,44819697,-1.5562690526140308
YH-13,387447,-4.910282103327875
OAW28,4917,3.0899334279272046
AU565,135398516,2.596290086865212
RERF-LC-MS,151289,1.06337646711186
CHP-212,2871966,-1.4178874053235084
BL-70,44493528,3.7970898660168584
JHUEM-3,6610216,3.5445169404516763
OPM-2,46398810,1.9487214127979129
JHUEM-3,46926350,-4.346385852376475
SNU-1077,675434,5.370968264478288
YH-13,5282054,3.978961263004533
OCI-AML-3,2729026,2.3595540164480804
NCI-H2141,54619267,3.4352637389584393
NCI-H2196,6505803,0.6828723886008686
BT 428,24901704,3.8281847797817994
HPAC,676352,2.3256852459456385
BT 248,BRD-A02303741-navitoclax (2-1 mol-mol),1.4606318161646668
HEC-59,89928392,1.2663012710278465
BT 248,16736978,2.1942612442020484
Rh30,tanespimycin-bortezomib (250-1 mol-mol),0.9800677460463127
OCI-AML-3,24772860,-3.7342569883538177
RKO,5329102,2.192208184281935
Kasumi-2,salermide-PLX-4032 (12-1 mol-mol),2.944713771170232
LOU-NH91,5287620,-1.52867963951729
BT 245,selumetinib-MK-2206 (8-1 mol-mol),2.8267994061207875
PF-382,44589607,0.7007325594590731
CHP-212,151289,-0.2101258146299451
Kasumi-2,5351362,0.8391907710572402
Hs 746.T,5746,2.274816313430957
JHUEM-3,6918638,0.235039867332202
Ku812,73707440,4.534867519967767
HEC-59,25183872,-1.0487455541923985
BFTC-909,119607,6.015893315993201
TCCSUP,1641662,4.954300722612746
NCI-H1568,JQ-1-vorinostat (2-1 mol-mol),1.325801474857881
BL-70,tanespimycin-bortezomib (250-1 mol-mol),0.1795536899591847
SNU-201,5351362,2.567582069523809
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677
SK-MEL-28,44607530,2.6983056844197257
HCC1395,44137675,3.8634466393744606
EM-2,11964036,0.3424232778315904
KYSE-70,4788,5.890959200463747
BFTC-909,23725625,7.000464253417552
JHUEM-3,9926054,2.0122307954459004
NCI-H1184,25183872,-1.2904332351409744
M-07e,6450551,1.8188439597676729
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524
OPM-2,5278396,3.463635489570463
PF-382,208908,1.8787534323757689
OCI-AML-5,11609586,1.020171165587178
KMS-20,24748573,1.7452169384063008
OAW28,9911830,2.567685352724645
CHP-212,1566236,1.526376682720088
RERF-LC-MS,5566,3.05978093065268
WM88,11717001,-1.3017107512152026
Rh30,24901704,3.0973826560109488
Rh30,73707398,0.839071257859524
AU565,24951314,-0.2220635763258615
CHP-212,9866186,-1.4743165568843524
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735
B-CPAP,44493528,4.579013970980452
SF539,36314,-4.467415246608935
Rh30,2746,3.242991400457772
Ku812,5460769,3.1615206717567608
Ishikawa (Heraklio) 02 ER-,10427712,4.3109673498215555
OCI-AML-5,5566,3.5028445838856728
Kasumi-2,54618164,3.8625919459899833
NU-DHL-1,135984461,1.11873859248707
NU-DHL-1,25183872,-1.6691954521805272
LOU-NH91,36314,-6.12634068503974
CHP-212,2733526,4.039584239555464
BT-474,23582824,1.759812485094325
PK-59,1750826,-0.8335670584844378
MM1.S,65628,3.725915125304722
PK-59,11964036,2.115726774413945
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062
M-07e,17755052,0.7705358217558756
AU565,5278396,3.257778157431963
Panc 03.27,462382,1.0625872018050075
KMRC-20,42642645,1.4773611251579275
KMRC-20,10184653,1.8099581366329816
B-CPAP,168313047,2.654561497495477
OPM-2,60700,-1.448416790812607
OCI-AML-5,JQ-1-vorinostat (2-1 mol-mol),-0.27133864963949
SH-10-TC,11964036,2.8533628856782873
Ishikawa (Heraklio) 02 ER-,66577038,3.761717076144853
HCC38,46398810,3.016849804025675
LC-1F,10127622,4.7670679230737045
BT 231,6450551,2.336132555682411
M-07e,5566,2.213126408963832
SK-MEL-28,10302451,4.268902771891611
NCI-H2141,54618164,3.5839160777119723
RERF-LC-MS,72734382,4.885789692793362
BT 245,168312962,1.259279274299411
WM88,216239,1.7199892817188522
SH-10-TC,44819697,-0.3938196541547768
HCC1395,3081361,2.5677908955175033
BL-70,7251185,1.9643723905617416
OAW28,24180719,4.377592888188756
SNU-1041,24964624,3.404793392522477
OCI-AML-3,navitoclax-birinapant (1-1 mol-mol),2.780143604588472
SW1783,9927531,4.46381053918724
AU565,24856436,-0.2368560911374172
Panc 03.27,11222830,1.4112627529835695
YKG-1,3038522,1.877440168253775
OAW28,JQ-1-navitoclax (2-1 mol-mol),0.2228593574400964
HCC38,57519531,1.8178826148197669
SH-10-TC,16722836,2.53168322673593
Ku812,3689413,-1.935767376067546
OPM-2,156414,0.898749748032719
NCI-H2196,6450551,2.5404484034900894
YH-13,3634881,3.1869210851626075
EM-2,25102847,0.389101060362878
WM88,3038522,2.9683606478553783
WM88,675434,3.979836418374733
SF539,44491742,4.105649274647132
OCI-AML-3,5287620,-0.349132402447354
HCC1395,selumetinib-MK-2206 (8-1 mol-mol),2.7014947447370443
JHUEM-3,11213558,0.7503047554822161
NCI-H2141,10385095,0.6174596155985671
SH-10-TC,135875424,4.945714860516567
Ishikawa (Heraklio) 02 ER-,5278396,4.139600704573638
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024
BT 231,ISOX-bortezomib (250-1 mol-mol),-0.1116554240716208
TCCSUP,31703,-0.5078441003760595
SK-MEL-28,44819697,1.1558418850564092
CHP-212,selumetinib-GDC-0941 (4-1 mol-mol),-3.8299169042442904
SH-10-TC,11427553,3.687824417902789
AU565,2729026,2.5804084357046033
HCC38,navitoclax-pluripotin (1-1 mol-mol),-0.4405145845379326
OAW28,4477,1.0036814180565996
BT 231,10127622,3.413813945062974
LOU-NH91,375860,-0.2088041582630222
KYSE-450,136227924,3.5350495950730645
BT 231,11175137,2.548921638379501
OAW28,11178236,-3.057015425639644
Kasumi-2,67291369,1.3044869974839717
Kasumi-2,3634881,1.9476495169521624
Rh30,53232,1.1440682691890418
BT 245,441298,1.783004401721438
LOU-NH91,135440466,0.9387697781897782
LOU-NH91,72193861,1.0473212139197163
BT 245,3081361,2.7578947725363667
SNU-1077,2729026,3.1553914055465047
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586
Rh30,5287620,-1.8520612913670225
RERF-LC-MS,462382,0.9319597157341816
JHUEM-3,sirolimus-bortezomib (250-1 mol-mol),0.3977209679383447
KMS-20,53392493,1.7021821857252477
EM-2,tretinoin-navitoclax (4-1 mol-mol),-1.173394841917181
Ishikawa (Heraklio) 02 ER-,16038120,2.572715910505068
KYSE-450,56946209,-4.220503618005704
KMS-20,9936388,-8.248983770505305
Rh30,72193861,0.8039046660991305
OPM-2,5311037,3.4844810711382936
SW1783,23725625,5.078273673319168
HEC-59,2841722,4.17202705158167
AU565,25161177,3.67389505129512
OCI-AML-3,12003241,-2.086986892339566
AU565,753704,4.59624742359194
LOU-NH91,53392493,2.3846272258457737
EM-2,24748573,1.4823049660595295
SW1783,25161177,4.268571653873596
KMRC-20,66577038,2.939049648949199
Panc 03.27,selumetinib-piperlongumine (8-1 mol-mol),4.032322960433415
B-CPAP,452548,0.2886295190968743
SNU-410,selumetinib-GDC-0941 (4-1 mol-mol),3.3998532572052205
F-36P,5113032,4.480699930422071
OPM-2,navitoclax-piperlongumine (1-1 mol-mol),0.7945063119799598
SK-MEL-28,19582717,5.671095391465724
Hs 746.T,24753719,4.48003826242694
NCI-H1184,11455910,0.4610574255043957
SNU-1041,613753,5.263995610237891
BT 248,6438330,0.9229397913759128
JHUEM-3,6918328,-0.8523280762901685
Hs 578T,71576739,-4.68114345707124
F-36P,24978538,0.5891913840108932
NCI-H1568,4261,1.7177455985107426
CHP-212,25262965,-1.6856553517010435
WM88,5351362,2.083916529498225
HPAC,969516,2.5223347146165502
KYSE-70,54613361,0.0645626216296427
Hs 746.T,46398810,2.3104064324668574
OCI-AML-3,9549297,1.1273449068350485
BL-70,9952709,2.089210603605339
KMS-20,241158,1.964058176771948
RKO,2113511,4.623772297498578
SNU-1041,6918328,0.3943552583628742
Rh30,327653,2.580303479692579
MM1.S,25102847,1.6569670603022522
SF539,42611257,2.369438053162354
KYSE-70,5282054,4.279196842795529
SW1783,selumetinib-navitoclax (8-1 mol-mol),1.5346000994793692
NCI-H1568,176870,1.641159934282528
AU565,24785538,3.4507965915778387
Rh30,52912189,1.727852884308716
PF-382,135398738,1.569926041171407
KMS-20,BRD-K55473186,1.619659945853516
AU565,3854666,0.9438607721687704
YH-13,10296883,4.196539709790054
KHM-1B,docetaxel-tanespimycin (2-1 mol-mol),-6.647221860436541
A4/Fukuda,208908,1.6750686900112284
KMS-20,46926350,-4.252708447125384
OPM-2,9915743,0.7579871544404475
HPAC,25150857,2.5942097138739633
NCI-H1568,11640390,2.883529605834316
M-07e,5460769,1.3910333770062682
F-36P,16065773,1.877584922895811
TCCSUP,11396600,4.109332889227832
NCI-H2141,9911463,2.830365569007881
BT 248,168312962,0.3799536225395565
Kasumi-2,1242560,3.251932247793875
RERF-LC-MS,9933475,2.253072026550434
F-36P,216468,-1.3268661185517077
B-CPAP,654092,-0.163277958019971
KYSE-450,1716436,4.321900870881558
KYSE-450,702558,5.8139297537708
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263
NCI-H2141,9907093,3.942913672633485
Ku812,452548,-0.7948570640360005
TCCSUP,tretinoin-navitoclax (4-1 mol-mol),3.293954548754522
JHUEM-3,46199207,3.768260916649413
BT 428,11455910,0.0710771584645227
BT 248,11497983,5.371692371312494
BT 245,5351362,1.446473574669942
KHM-1B,24775005,4.409922848852168
F-36P,10231331,0.4784045802967716
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234
KYSE-70,613753,3.646356391333843
NCI-H1184,10385095,0.4197461741705012
EM-2,44137675,2.7795518520340754
WM88,104842,-2.8260014290315443
OAW28,46926350,-3.936437112233884
KMRC-20,navitoclax-MST-312 (1-1 mol-mol),3.022643345531742
Ku812,9823820,0.8448235439574285
EM-2,72193870,5.428766389712865
SH-10-TC,12003241,1.4218324467353134
Rh30,4788,5.320701938026344
NCI-H2141,10127622,5.2116121873777965
YKG-1,984333,1.4105650913207732
HCC38,44493528,4.3442022500374815
NCI-H1568,6852167,2.376266672184036
Hs 746.T,5311281,1.9993667954649672
EM-2,9840324,5.196790724641255
NCI-H1568,11609586,2.169671625299293
SF539,44632017,1.0950732195529729
HCC1395,1242560,3.939874672768198
BT 248,24964624,0.9785580517881716
Hs 746.T,6184667,2.653382571014866
RERF-LC-MS,72193861,1.0218744083195843
Hs 746.T,54619267,4.304143461636737
CHP-212,984333,0.5189190593027027
SK-MEL-28,1716436,3.730773917114669
RKO,151289,1.190219151105647
SW1783,17755052,3.585209697722452
NCI-H1568,322968,3.6220797151302673
JHUEM-3,650361,3.6848753876902767
SF539,11497983,4.935206812157441
BT 231,5291,3.599194681323513
YKG-1,10184653,2.523602968950428
Rh30,9911463,3.4097101365925786
BT 428,2949965,2.4891980575016657
NU-DHL-1,25154868,3.3783021431332085
Kasumi-2,7326481,4.035955767547482
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173
WM88,10074640,3.740591299357997
BT 248,doxorubicin-navitoclax (2-1 mol-mol),-1.9120530478094175
BT 428,selumetinib-piperlongumine (8-1 mol-mol),1.208786974802762
SH-10-TC,9911830,2.2874215720180464
SNU-1077,5566,3.5894057119663993
WM88,selumetinib-piperlongumine (8-1 mol-mol),-3.520420534339499
PK-59,25102847,1.7596066795217422
SW1783,selumetinib-tretinoin (2-1 mol-mol),5.0766221097450845
A4/Fukuda,5113032,4.450145517718883
SF539,navitoclax-birinapant (1-1 mol-mol),2.277929243582673
JHUEM-3,54618164,4.177522311849136
OCI-AML-3,9926054,1.7279388216590237
A4/Fukuda,25262965,-4.823082336145625
OCI-AML-5,BRD-A02303741-navitoclax (2-1 mol-mol),-1.845201004785756
AU565,vorinostat-navitoclax (4-1 mol-mol),1.0795272840825962
OCI-AML-3,89183176,-1.0891166773414238
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346
BT 231,10302451,3.095881087225805
BT 428,46843906,3.437949363234708
BL-70,11238147,1.4293199915504506
SNU-410,44607531,2.004577092789526
OAW28,119607,5.347849335106357
HEC-59,11238147,1.497953674235496
NU-DHL-1,9840324,6.681797282677095
KHM-1B,navitoclax-piperlongumine (1-1 mol-mol),1.2579870657882444
BFTC-909,445091,4.3207806819680625
Hs 578T,216239,1.3686847919390617
KHM-1B,46199207,2.2678395325481415
YKG-1,42642645,0.5403714198289554
Kasumi-2,60700,-3.733340750045026
NCI-H2141,9549297,1.301134546048369
A4/Fukuda,5738263,2.3624425097256676
ML-1 [Human thyroid carcinoma],151289,2.136095657957592
M-07e,5284616,-4.339951000461247
SH-10-TC,11238147,3.3633248762752324
PF-382,135875424,3.2130182861195076
BT-474,9868037,4.006182036110513
M-07e,selumetinib-JQ-1 (4-1 mol-mol),-0.078699162510743
BT 245,5566,2.6954185394923886
NCI-H1568,71751553,3.6437596116554887
ML-1 [Human thyroid carcinoma],409805,4.766723032315811
Hs 746.T,6505803,-0.4653374975150369
JHUEM-3,3136844,3.8764953159961952
Hs 578T,16065773,2.722357834222436
YKG-1,135398516,1.8406212394581116
SW1783,tretinoin-navitoclax (4-1 mol-mol),5.880695853154788
HCC38,25161177,3.816239695951089
NCI-H1184,6914657,-3.1811134561390393
B-CPAP,selumetinib-navitoclax (8-1 mol-mol),2.2794598948076525
NCI-H1184,71466380,3.1890486083857543
BT 248,6918837,-0.6138774965830072
Kasumi-2,BRD-A02303741-navitoclax (2-1 mol-mol),-1.941760845574772
SNU-1077,24180719,3.4105724970727302
OPM-2,4477,0.1075725295912922
HCC38,1750826,-1.076055093455855
Ishikawa (Heraklio) 02 ER-,452548,0.8552598580228623
SW1783,1716436,2.7857036486954567
BL-70,56973724,2.131271540643918
KHM-1B,159324,1.2436512528819574
Kasumi-2,17755052,-2.6649013271346744
OCI-AML-3,46907787,-4.468250501398446
CHP-212,44543605,5.17323885499326
Kasumi-2,tanespimycin-bortezomib (250-1 mol-mol),-1.599342036270796
BT 428,2746,2.3155764073240177
AU565,9967941,3.769081839228565
CHP-212,54454,1.3133446695618656
AU565,54765302,2.5229399839825604
BT 245,9868037,3.6125967873896543
LOU-NH91,54613361,0.2217026048603205
AU565,9935249,2.085801217703038
Hs 578T,36314,3.919857135491627
Rh30,selumetinib-navitoclax (8-1 mol-mol),2.4030980985719967
Hs 746.T,46191454,2.247539978192593
KHM-1B,25154868,3.944420162324233
PF-382,122327,5.887975915813721
OCI-AML-5,57519531,1.658840640638854
BT 231,753704,3.5842016877882945
SNU-201,1750826,-1.3481237628542908
F-36P,1242560,2.9452724039039366
Kasumi-2,26596,-3.0246532529835273
YH-13,54618771,3.881155680896358
Panc 03.27,135398516,2.329536219847431
KMS-20,89928392,-0.4430373670813298
YKG-1,46224516,1.3693431765841828
MM1.S,5460769,2.129502129742311
SNU-201,44819697,-0.528668553003158
HPAC,16038120,0.2836239802962175
Panc 03.27,selumetinib-PLX-4032 (8-1 mol-mol),3.637800033231155
BL-70,11507802,0.2904545408653984
Hs 578T,6918638,0.545294838071351
OCI-AML-3,9956119,3.368303486619896
Rh30,31703,-1.6254058550682662
KYSE-70,71466380,5.08916461895765
NCI-H1568,44493528,4.1542795967274175
NCI-H2196,123631,2.912141507598525
NCI-H1184,3503,2.4521733868439957
JHUEM-3,9866186,-0.2605829706619965
PK-59,44819697,-0.7896271162004322
Kasumi-2,54613361,-0.9648217673530566
SW1783,3854666,3.296513769962362
OCI-AML-5,216239,2.1139681681044538
AU565,5291,4.2478378741719105
BL-70,10077130,1.6843598967400104
B-CPAP,15983966,-3.675968487068789
HCC38,54613361,0.3433706073093363
NU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),-1.099094096725154
OCI-AML-5,5470400,2.1897133072203503
JHUEM-3,54765302,4.514756967791234
NU-DHL-1,9915743,0.5782531397120328
SF539,82146,2.9766155224529576
SNU-1077,387447,-4.3711527711694185
NCI-H2141,25195348,3.925037654330787
KMRC-20,2708,5.098804144930118
RERF-LC-MS,9967941,1.5454786965180345
BT 428,tretinoin-navitoclax (4-1 mol-mol),2.288831928221758
SNU-1077,216468,4.221133217458946
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123
EM-2,54626689,4.479552823135875
SH-10-TC,3854666,3.043135915172001
Ku812,46398810,0.5455073347084224
Panc 03.27,selumetinib-navitoclax (8-1 mol-mol),2.251264509201578
LOU-NH91,42642645,0.5799169530603235
KHM-1B,44486219,3.979705310962138
OAW28,675434,4.444033298399729
SW1783,11626560,2.73995450904139
Ku812,5311281,1.497944921969674
NCI-H2196,navitoclax-PLX-4032 (1-1 mol-mol),-0.5759293851720327
M-07e,44202524,1.4276289442786338
OCI-AML-3,24785538,-1.128577163965658
Panc 03.27,11214940,1.7602082132727968
OCI-AML-3,3465537,1.1544662524916731
OPM-2,400769,-3.2268127368380215
YKG-1,24821094,3.8775145827770703
M-07e,56649450,4.935348298586242
EM-2,9907093,4.162245546130596
SH-10-TC,4261,2.022670547668989
NU-DHL-1,322968,1.8618584947977044
BT 428,docetaxel-tanespimycin (2-1 mol-mol),-3.547853493396119
OCI-AML-5,1242560,4.649323200746502
NU-DHL-1,9952709,2.663459796321655
OPM-2,36462,1.377546018006998
BT 245,54649381,3.7292740708947094
SNU-201,44607531,1.5937689428322463
KMS-20,alisertib-navitoclax (2-1 mol-mol),-2.6675858557663825
SK-MEL-28,navitoclax-PLX-4032 (1-1 mol-mol),0.389238788180305
HCC38,JQ-1-vorinostat (2-1 mol-mol),0.6200560500360207
B-CPAP,55283,0.7506377686050446
OCI-AML-3,11647372,0.2732596806209076
SF539,3136844,3.725452843586701
NCI-H2196,24180719,3.828260421215232
YH-13,31703,-0.371701474811386
YKG-1,25227462,2.1847299491854533
BL-70,3503,0.771711744573245
HCC1395,6914657,-1.1939846826078475
Hs 746.T,568763,3.910294410895904
SH-10-TC,JQ-1-carboplatin (1-1 mol-mol),1.9237782728423225
KMS-20,675434,4.108652876132496
Hs 578T,400769,-1.123701649650724
HCC38,56946209,-6.309457195379835
BT 248,25227462,1.1845227545958306
SNU-201,vorinostat-carboplatin (1-1 mol-mol),3.1713457278266723
SW1783,42642645,1.5180122548711477
KMS-20,crizotinib-PLX-4032 (2-1 mol-mol),1.622375633570859
EM-2,9915743,0.5726352403116545
YKG-1,3136844,4.395647151601772
PK-59,11609586,3.2750440078364305
KYSE-450,sirolimus-bortezomib (250-1 mol-mol),1.472196995185456
B-CPAP,136227924,3.258845757188781
MM1.S,BRD-K27188169-navitoclax (2-1 mol-mol),4.93691832790379
JHUEM-3,4261,1.3734195528790931
BL-70,11656518,1.5702943838058652
SNU-410,3038522,4.435191296160253
BL-70,135928012,5.132992638925211
RKO,54454,4.6965621210229225
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096
SK-MEL-28,6918289,3.2211222821081327
MM1.S,4261,-0.3517097479501856
BT 245,5113032,4.358683416759354
RKO,25183872,-1.1635703485572924
KHM-1B,60700,-3.1057416609701463
KYSE-70,24951314,1.3178292218062186
Hs 746.T,24785538,0.6176049549317137
NCI-H2141,23582824,1.7528838229470645
HCC38,219104,2.973675006391986
WM88,9911463,3.783818746196605
NCI-H1568,73707398,1.0000031751048108
KYSE-450,24951314,3.0584617604997058
YH-13,16725315,3.2502967771135096
Rh30,439501,-1.3281255322499272
OAW28,462382,0.1410996491293406
SNU-1077,3825829,4.049018603201765
KMRC-20,5351362,2.3053530473648776
PK-59,9840324,5.820620843354779
RERF-LC-MS,51037431,2.0455212647735364
SNU-410,3689413,1.1161257107979303
KHM-1B,2749,0.8754642075989242
SH-10-TC,216239,1.75199622472128
OCI-AML-5,56946209,-4.9651243583546965
SNU-1041,3025986,-0.0114235339200318
B-CPAP,5351362,0.984097997363641
HCC1395,11396600,4.211353464920311
B-CPAP,25183872,-0.7864118052297527
HEC-59,44507138,1.7078546083957833
HPAC,navitoclax-gemcitabine (1-1 mol-mol),1.1548669874097
RKO,15953870,3.3462063589818034
A4/Fukuda,10385095,0.4549399411675465
BL-70,448949,1.382815401027792
HCC38,salermide-PLX-4032 (12-1 mol-mol),5.692325617169958
OCI-AML-5,9868037,3.637294932872617
KMRC-20,638278,3.6532270710098818
BL-70,89183176,1.3746417754606128
BFTC-909,3038522,3.685618431455981
SF539,selumetinib-navitoclax (8-1 mol-mol),2.7228502818299556
Kasumi-2,25062766,0.6905738640208902
KMS-20,3384730,1.352817423261366
YH-13,25102847,2.4303848050744747
BT 231,decitabine-navitoclax (2-1 mol-mol),1.57399454197302
SNU-410,9926054,3.256884508245376
OPM-2,135398516,1.2750707316498222
KMS-20,10231331,-0.0376220922185321
SK-MEL-28,46398810,3.208248420081512
RKO,11152667,-2.010180339323448
Ku812,tretinoin-carboplatin (2-1 mol-mol),4.0660943176260504
SNU-201,6852167,3.1416470109907535
HCC1395,selumetinib-GDC-0941 (4-1 mol-mol),2.648393552264531
JHUEM-3,5287969,-1.801278377371095
CHP-212,2742550,3.525103629838529
BT-474,9825149,2.5014805363932755
F-36P,11228183,0.9942171182975804
MM1.S,11455910,0.7825849388460823
BL-70,156414,-1.981902345453731
OCI-AML-3,tretinoin-carboplatin (2-1 mol-mol),-1.7204995543920858
AU565,erlotinib-PLX-4032 (2-1 mol-mol),2.347179893247943
NU-DHL-1,3825829,3.145887822053552
AU565,216345,2.670108206329082
NU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),-1.9945668257516072
NCI-H1568,11364421,1.3511041801335055
Ku812,11317348,-1.076361726967916
OAW28,3689413,-1.4375749125930504
YH-13,44137675,2.4918035822396973
BT 248,11609586,2.7692010936053064
BT-474,44491742,4.780448859314668
NU-DHL-1,613000,1.3520499940785358
Ku812,400769,-1.4290125405795582
NCI-H2196,serdemetan-SCH-529074 (1-1 mol-mol),2.1457952921081147
OAW28,navitoclax-sorafenib (1-1 mol-mol),1.7172583203628091
LOU-NH91,11612883,2.793800542696417
B-CPAP,107985,-3.233876642304658
EM-2,135398738,1.3513968333030475
JHUEM-3,5328940,1.161882079321021
NU-DHL-1,5494449,-1.7833520753251897
SNU-1077,16038120,0.7532653564850753
M-07e,54649381,3.683033880015157
Hs 746.T,969516,2.44773076785048
OCI-AML-3,25154868,3.142189572140774
EM-2,241158,2.6622179540907283
Panc 03.27,selumetinib-MK-2206 (8-1 mol-mol),2.228496569659798
LOU-NH91,12003241,-1.4006618643370652
KYSE-70,9907093,3.6347338213446454
HCC1395,135398516,2.706778369145805
KYSE-70,24772860,-1.2328668610311222
HEC-59,60700,1.3034070037462908
WM88,71466445,3.914580213276338
YKG-1,2733526,4.337499984532551
EM-2,156422,3.311632913489948
Ku812,3062316,-6.759416676198835
YKG-1,44607531,1.7314965452309146
Kasumi-2,51039095,2.172369026283552
OPM-2,46907787,-3.368300500627006
Ku812,26596,-2.18380806647072
KMS-20,10074640,2.509346004952602
BT 245,216345,4.350748978953408
F-36P,16736978,0.9854298556490608
BT 248,54596558,3.9995548839878503
Kasumi-2,5328940,0.1344355450802072
Hs 746.T,168313016,4.639079207564439
OAW28,25195348,5.036760517156048
OCI-AML-3,11404337,-2.717957747989526
M-07e,selumetinib-piperlongumine (8-1 mol-mol),2.064162065731385
RERF-LC-MS,5470400,2.5584942331402623
BT 248,31703,-0.7981868387763399
Panc 03.27,serdemetan-SCH-529074 (1-1 mol-mol),2.4609802714658646
Ishikawa (Heraklio) 02 ER-,246676,3.9831360741159463
JHUEM-3,5460769,0.399281620663996
ML-1 [Human thyroid carcinoma],53232,3.218931075380609
RKO,3385,4.410917651107157
TCCSUP,54649381,3.810492846864681
OCI-AML-5,16720766,-1.0573933772744335
SW1783,6918837,0.7485271513756125
NCI-H1184,16720766,-1.1588031124350997
A4/Fukuda,65064,3.1077716650538707
BT 245,11364421,-5.459811904764016
A4/Fukuda,52912189,-0.8285591911559074
M-07e,11656518,1.574634718769122
OCI-AML-5,65628,3.584711118460752
AU565,3552672,1.7684242008913282
LOU-NH91,4477,1.3512747052000795
KYSE-70,3543504,4.273044270546896
A4/Fukuda,65628,3.8428022223998366
A4/Fukuda,100016,4.8831896191852096
NCI-H2141,9927531,4.975438094968349
PF-382,9444,3.9294096917802106
TCCSUP,24889392,3.438580211915109
PF-382,5284329,4.993412059506353
HCC38,60700,-1.2260155986062138
SNU-201,6918328,0.0126751324854077
SNU-410,9935249,3.802389634291995
Ku812,7326481,1.3104376334560923
SNU-1041,10184653,0.6559380926118036
YH-13,448949,1.5692102118953517
YKG-1,25183872,-1.2785338987258574
TCCSUP,156414,2.0603521073886952
YKG-1,6917907,-5.4818958682637975
PK-59,9936388,2.2614163852650377
CHP-212,53495165,-3.416345053521876
Rh30,6852167,1.7191526949253222
KYSE-70,piperlongumine-MST-312 (1-1 mol-mol),2.4573232964304506
F-36P,126941,-4.861525312035083
JHUEM-3,2708,5.357001425929142
CHP-212,9903786,1.1399886841606115
SNU-1041,16038120,1.483594922661335
EM-2,44489367,4.304755787656308
YKG-1,crizotinib-PLX-4032 (2-1 mol-mol),1.242537511199376
F-36P,46215462,1.4444278277820295
BT 248,73707438,3.693804860778579
OCI-AML-3,44185566,0.5688867764327818
SNU-1041,409805,6.796428886349938
OPM-2,2749,1.7313419667612246
Panc 03.27,5311281,0.8421352734754648
KMS-20,JQ-1-carboplatin (1-1 mol-mol),-1.0722659574284303
EM-2,637858,1.4868695241377077
BT 245,24797083,0.9697531210706976
SNU-1041,2729026,3.2053417812735585
SH-10-TC,44202524,1.894777395973402
M-07e,36314,3.0127085340311055
KHM-1B,44489367,4.908857615770495
SK-MEL-28,9926054,3.4888277398466765
YH-13,6505803,-0.6394660445903715
SNU-201,5329102,2.317420879942377
AU565,16725315,3.19394291041594
SNU-410,25105715,3.72166229576856
HPAC,65064,5.123559135157147
OAW28,46224516,2.3854099680927523
NCI-H1184,17759555,2.451583201242318
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591
HCC38,16038120,1.0182405549184368
BT 245,11719255,3.8696223772622753
BT 248,navitoclax-gemcitabine (1-1 mol-mol),0.2474795408705132
NU-DHL-1,56963564,-0.6352344971867577
Ku812,11964036,0.5319973253616799
SH-10-TC,53232,1.939860184618306
Ishikawa (Heraklio) 02 ER-,tanespimycin-gemcitabine (1-1 mol-mol),-1.35005460579952
OCI-AML-3,24901704,1.4022664440505843
A4/Fukuda,409805,3.596796639089143
SNU-410,216239,3.0631586092825525
NCI-H2196,5335621,4.362339998326244
JHUEM-3,4917,3.131644923948968
KHM-1B,156414,1.0383008800592366
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171
SF539,11167602,1.5763974980915605
NU-DHL-1,4705,3.159533609841756
HCC38,2729026,2.6408505219922147
WM88,135411,0.6500628188796147
Ku812,702558,3.01939584442747
PF-382,tretinoin-navitoclax (4-1 mol-mol),0.5792978560561972
BFTC-909,11626560,2.2197507332783735
BL-70,53392493,1.9292536613356457
SF539,crizotinib-PLX-4032 (2-1 mol-mol),1.8440004340376177
NCI-H2141,6918328,-0.1542684641426187
M-07e,9926054,1.1111810240373077
BT 248,119607,5.038088774684491
BL-70,9915743,2.1180817838790658
A4/Fukuda,5281672,3.917758560865086
KMS-20,2949965,1.3339775316337088
JHUEM-3,9887053,4.4574978029578824
EM-2,piperlongumine-MST-312 (1-1 mol-mol),1.6562864093024436
JHUEM-3,107970,1.8006750209945723
TCCSUP,2708,4.555473359535819
KMS-20,11455910,0.7957422642794928
OPM-2,387447,-6.258797979541162
NCI-H1184,322968,2.3409645130180388
KHM-1B,44493528,1.720576936641076
Kasumi-2,5479543,2.6831620827512004
BT 248,15983966,1.8194061419836256
BT 245,262093,2.3897148405812536
WM88,4917,2.8565776597163155
Rh30,JQ-1-vorinostat (2-1 mol-mol),0.912261818047924
KYSE-70,16720766,1.38091635176305
Hs 578T,26596,-0.9561374383661984
SF539,10127622,4.044481500829827
SH-10-TC,2729026,3.3680995474277937
HCC1395,24753719,4.820074852548623
JHUEM-3,1566236,1.872999267753902
KMRC-20,crizotinib-PLX-4032 (2-1 mol-mol),2.3477359340418587
BT 231,262093,2.1267355779539043
CHP-212,16065773,-0.7416369961567537
AU565,24772860,3.3222909323637455
Rh30,56946209,-4.384087287797354
BL-70,241158,1.7812102764916156
HCC1395,9826308,0.0059878614572815
NCI-H1184,613753,2.8863745932328917
AU565,135411,0.1136824900578053
A4/Fukuda,selumetinib-UNC0638 (4-1 mol-mol),0.1859137838774149
JHUEM-3,1750826,-0.6039681461490009
BT 428,11964036,0.9395896328127812
SNU-201,3025944,4.512572828948172
TCCSUP,100016,6.5110410318476575
OAW28,11396600,3.5740319462685535
Ku812,44259,0.671540597620678
RERF-LC-MS,49793307,-1.4864117200972382
PK-59,49793307,-4.31591299867936
SW1783,676352,2.0801298645045274
F-36P,25126798,-0.7029765541824262
NCI-H2196,216239,1.875086514721885
LOU-NH91,5329102,1.7122787452562382
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004
KHM-1B,11234052,4.09724714531712
SW1783,54619267,3.631106969239044
NU-DHL-1,11178236,-4.241745516668476
OCI-AML-5,25227462,-5.481916105839454
WM88,54678924,1.068835256652833
Ishikawa (Heraklio) 02 ER-,JQ-1-vorinostat (2-1 mol-mol),2.35734859544929
WM88,1242560,3.710457393836372
Hs 746.T,241158,3.344811066724749
Ishikawa (Heraklio) 02 ER-,3543504,4.450199411331563
JHUEM-3,4705,2.325459550435627
PF-382,5351362,0.8995545334729175
Hs 578T,3634881,2.6379036281056423
SH-10-TC,44185566,3.056229335428737
PF-382,6914657,-5.488618534431668
SNU-201,11222830,3.023304495348029
KMRC-20,54618164,4.251401203478906
BT 245,11507802,1.2817333093626646
F-36P,JQ-1-vorinostat (2-1 mol-mol),-0.445429902300179
SH-10-TC,24785538,3.489412488259405
SF539,56646779,2.3266434385228667
NCI-H1568,151289,0.8908355813530987
NU-DHL-1,5287969,-2.616412522743469
Kasumi-2,49766530,-3.7396811929647513
SH-10-TC,6505803,1.0685090299796742
MM1.S,9884685,-0.9027319630033926
A4/Fukuda,4259181,-0.5702867723998835
OAW28,135421197,1.4901490212875883
Hs 746.T,19582717,3.484743432599013
KMS-20,5328940,1.431090406795279
KHM-1B,44589607,0.0686191939800993
OCI-AML-5,24797083,1.5103522966845508
SK-MEL-28,676352,2.519073281227085
M-07e,3384730,0.8799310929214723
OAW28,45279963,4.210324099066774
HCC38,6610216,4.397537915498448
HPAC,49850262,3.813210067315753
KYSE-450,46926350,-4.1870362089493804
Panc 03.27,16659841,4.812448404813986
NCI-H2196,66577038,3.1258478135097714
NCI-H1184,9915743,0.6883439734891695
NCI-H1184,5978,-2.5257726851466624
Kasumi-2,8515,3.2781378887974775
TCCSUP,3025986,0.0984647564914155
YH-13,67156097,-1.843734712267085
HCC1395,54454,4.045476650326712
AU565,42642645,1.544546710659079
BL-70,11955716,-2.5465874751710342
HCC38,11955716,-2.5908531751589727
JHUEM-3,24821094,2.2102773923138135
NU-DHL-1,119182,-3.6416118406759863
NCI-H2196,54626689,4.218847448418183
SW1783,135875424,4.794068332474245
Hs 746.T,6610355,3.950754104243487
RERF-LC-MS,54618771,0.9955970244631366
SF539,5702613,3.2712252993550384
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783
NU-DHL-1,9903786,2.0090459538270298
NCI-H2196,448949,2.080969874896837
BT 245,227681,3.853642709543238
BT 231,72193861,0.0694869722089314
OCI-AML-3,carboplatin-UNC0638 (2-1 mol-mol),3.189766555919178
Ishikawa (Heraklio) 02 ER-,24785538,3.0614053546462356
M-07e,3385,2.355072883896478
KMRC-20,49793307,-1.1812176037357236
MM1.S,11234052,4.653102386091589
BT 248,24797083,0.3482207661961916
OPM-2,selumetinib-tretinoin (2-1 mol-mol),2.843446228896377
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786
NU-DHL-1,6918638,-1.28362156468715
BL-70,56963564,-0.197768833513289
SH-10-TC,46215462,1.6495572842102135
CHP-212,10296883,3.383005137854127
SNU-1077,54618305,5.347093142592056
F-36P,6914657,-5.375535907634138
B-CPAP,6852167,2.612580501807676
Ishikawa (Heraklio) 02 ER-,151289,0.7029912025232622
OPM-2,421610,2.2409150931042072
A4/Fukuda,11427553,0.0702382308883879
YH-13,JQ-1-UNC0638 (2-1 mol-mol),2.8302570708443757
Hs 746.T,9915743,2.055973723979153
CHP-212,25102847,1.4135008934739262
HEC-59,49793307,-2.8567907181178422
Panc 03.27,11152667,-1.218178075757916
A4/Fukuda,44486219,1.5854911698245977
EM-2,20959075,-3.932803512487069
SNU-410,BRD-K27188169-navitoclax (2-1 mol-mol),4.230533690826982
BFTC-909,16219061,3.736019824418232
NCI-H1184,54649381,3.6701043575171
OCI-AML-3,119607,5.24460138744523
BT 245,11955716,-0.6906973419966477
NCI-H1568,36462,0.6787379731584755
NCI-H2141,4477,0.6084570820572538
Panc 03.27,selumetinib-UNC0638 (4-1 mol-mol),3.293604174235373
CHP-212,8515,1.882954928641981
YH-13,5978,-2.977787383275712
OAW28,4788,5.61832216329738
NCI-H2196,selumetinib-BRD-A02303741 (4-1 mol-mol),5.255349745605376
BL-70,piperlongumine-MST-312 (1-1 mol-mol),1.0771908159581614
HEC-59,5282054,3.7299272012382985
Panc 03.27,11625818,4.72181240068185
SNU-1077,navitoclax-gemcitabine (1-1 mol-mol),2.6315006611829004
BT 245,salermide-PLX-4032 (12-1 mol-mol),3.942849865511171
Panc 03.27,11964036,2.127043252669254
SNU-201,44259,0.0066241805579185
NCI-H2196,piperlongumine-MST-312 (1-1 mol-mol),2.6091021874710756
RKO,6914657,-2.9196237708628505
F-36P,5351362,0.9986608253109048
BL-70,alisertib-navitoclax (2-1 mol-mol),-1.147617877141951
HCC38,9911830,2.511221746544401
SF539,44589607,2.1989651923928375
NCI-H1568,navitoclax-birinapant (1-1 mol-mol),1.7942101393430023
BT 428,9935249,1.746513548919668
BL-70,BRD-K55473186,4.061567166335381
CHP-212,11228183,1.429134257040412
SH-10-TC,49867930,5.086777353327991
HCC1395,navitoclax-piperlongumine (1-1 mol-mol),3.3651550079648
OAW28,15953870,5.078636607909671
WM88,9926054,1.794473369640358
RKO,9908783,5.5436232623995805
HCC1395,selumetinib-navitoclax (8-1 mol-mol),4.646787741693929
B-CPAP,crizotinib-PLX-4032 (2-1 mol-mol),1.2873163572314887
PK-59,5351362,2.762271541017513
OPM-2,11485656,1.3184852346481954
NCI-H2196,327653,2.664873729838991
YKG-1,15953870,4.202012318992034
YH-13,374536,3.765039330811098
BT 231,44462760,4.224272414163622
HCC1395,54618771,2.360286103240852
NU-DHL-1,126941,-5.231246874864336
B-CPAP,5746,2.211923482717491
WM88,31703,-1.0609765961593942
LOU-NH91,6852167,3.2671273023515934
KHM-1B,439501,-2.4289183886287535
Kasumi-2,135421197,0.8154486687594628
KMS-20,107985,-4.802194252756391
Hs 746.T,637858,1.1882246907154543
Ku812,2828334,5.359664398174482
OCI-AML-3,4259181,-0.2993738011260952
KYSE-450,5328940,1.9152649667159072
F-36P,71576739,4.326981219717783
KHM-1B,16736978,0.8941116844537789
SF539,135398738,4.183953288764079
PF-382,crizotinib-PLX-4032 (2-1 mol-mol),1.1615999412597993
HPAC,3543504,3.920891448123651
HEC-59,6918736,-1.564007711854012
Hs 578T,tanespimycin-gemcitabine (1-1 mol-mol),0.5485918092351827
BT 245,navitoclax-gemcitabine (1-1 mol-mol),-2.663697742680769
RERF-LC-MS,25161177,4.303824118845859
BT-474,24785538,4.068330019911309
NCI-H2196,10410894,4.547807645747441
M-07e,426756,4.328892893137565
OPM-2,644241,1.6900050339542656
LOU-NH91,9935249,4.429052878520747
SNU-1077,6918878,4.982410606922502
RERF-LC-MS,49766530,0.7744144603938863
SNU-410,9868037,3.710526937668442
OPM-2,168312962,0.8773607091058507
OAW28,46199207,3.397949359639469
SF539,11178236,-5.337725586791056
JHUEM-3,tanespimycin-bortezomib (250-1 mol-mol),-0.0089826234091154
KYSE-70,5281321,-0.9979352327108848
KYSE-70,219104,3.9271840577372705
BL-70,4917,2.652969915338746
OCI-AML-5,44607530,2.7726087470611063
TCCSUP,decitabine-navitoclax (2-1 mol-mol),3.3142403079225073
KYSE-450,5281321,2.0309467216777657
Kasumi-2,selumetinib-PLX-4032 (8-1 mol-mol),4.8744745414665145
M-07e,2749,0.8653919915519281
WM88,selumetinib-MK-2206 (8-1 mol-mol),-2.611671429447112
NU-DHL-1,11977753,-1.9405951450279333
SNU-1041,5329102,2.9506665755190755
KMRC-20,11396600,4.3348303945761835
NCI-H2196,selumetinib-piperlongumine (8-1 mol-mol),4.48847968800222
NU-DHL-1,151289,0.4356808259590597
NU-DHL-1,50905018,3.2450154850069093
PK-59,11404337,0.8851709837592256
Panc 03.27,5113032,4.799056342211889
B-CPAP,107970,2.366266521836174
BT 248,navitoclax-piperlongumine (1-1 mol-mol),1.2015082500214636
KMS-20,11175137,2.2632484557969152
Hs 578T,67156097,-1.0679236227351572
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432
OPM-2,6918328,-2.875264730320658
M-07e,4259181,-1.9035117365658276
B-CPAP,JQ-1-navitoclax (2-1 mol-mol),0.5903029448050835
WM88,selumetinib-tretinoin (2-1 mol-mol),-3.080717099678567
BL-70,9840324,5.055554617660512
RERF-LC-MS,9908783,5.63449812951243
OPM-2,5291,3.3293230980723254
SF539,24779724,4.8810531030455415
SF539,11238147,1.3297186459142216
JHUEM-3,5113032,4.570602960344802
PF-382,doxorubicin-navitoclax (2-1 mol-mol),-3.127730367250044
KYSE-450,11626560,3.018886838641868
BFTC-909,6450551,3.0302116860685886
KMS-20,tanespimycin-gemcitabine (1-1 mol-mol),-4.135890410106922
KHM-1B,3634881,2.028654365237279
Kasumi-2,49793307,-4.053216594075624
SNU-1077,5329102,2.42663042456867
HCC38,53392493,1.9157137134217976
SW1783,25102847,3.1302980289461124
LOU-NH91,selumetinib-piperlongumine (8-1 mol-mol),4.488619060244233
TCCSUP,3503,2.528239452217975
Rh30,11427553,1.935296003619707
PF-382,11455910,1.1839598995526908
BT 231,JQ-1-navitoclax (2-1 mol-mol),0.2608339452750312
B-CPAP,BRD-A02303741-navitoclax (2-1 mol-mol),1.892651156535057
SW1783,9956119,4.824776064092986
SH-10-TC,71466578,4.4189373393536675
OPM-2,2733526,4.066729211955922
SH-10-TC,107985,-2.836230887151265
EM-2,9823820,1.336900128973145
BT 428,16722836,1.7142885941810502
BT-474,46174525,5.685934327929594
M-07e,135421197,0.940164437961766
Hs 746.T,49836020,5.866178883912361
RERF-LC-MS,445091,4.218142840499499
HCC38,148198,-4.709757817936847
BL-70,2733526,3.981273797363054
OCI-AML-3,5282054,2.389976660133605
BT 245,4788,5.2477512116504785
BT 248,24978538,0.997787879795877
WM88,72734382,5.129480040334886
NU-DHL-1,54649381,3.9562595650424375
OCI-AML-5,2746,1.486809354456374
JHUEM-3,25195348,3.355120240647269
SF539,54596558,5.2593841125490135
KMRC-20,tanespimycin-gemcitabine (1-1 mol-mol),3.002722893797395
RERF-LC-MS,1716436,4.437154842045929
KMS-20,3062316,-0.0467041684401502
KMRC-20,5328940,1.6552901694758546
Kasumi-2,navitoclax-birinapant (1-1 mol-mol),-3.1912080416511355
RKO,44137675,4.282234128328841
Ishikawa (Heraklio) 02 ER-,219104,4.233979669273785
CHP-212,42642645,-1.0126611214322565
SK-MEL-28,JQ-1-UNC0638 (2-1 mol-mol),3.2511291788687218
Hs 578T,docetaxel-tanespimycin (2-1 mol-mol),-4.876841574536891
NCI-H2196,71304818,2.1911002121892165
PF-382,15953870,2.669476849035499
SW1783,navitoclax-sorafenib (1-1 mol-mol),4.194590797982974
JHUEM-3,5281321,-2.8187581600056526
SF539,4917,2.886212068318384
SK-MEL-28,selumetinib-MK-2206 (8-1 mol-mol),1.0745935629977668
BT 231,23635314,-0.4018221578518959
NCI-H1568,5351362,0.9370615420718584
A4/Fukuda,11485656,1.5130746228374388
KMS-20,10113978,2.317809443763058
SNU-201,25150857,2.2915047293478437
Hs 578T,168313200,3.633474320966812
B-CPAP,36314,-5.684441003557772
TCCSUP,1242560,4.927972037074151
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878
MM1.S,208908,2.7600413341345225
YKG-1,11640390,4.261360521088683
KHM-1B,984333,-0.473471772340059
KMS-20,2874250,3.851287435238237
PF-382,10410894,2.6681125550608025
OAW28,12001922,1.8847589611064504
AU565,71304818,2.0398490425817144
Hs 578T,vorinostat-carboplatin (1-1 mol-mol),3.6367903282125855
OAW28,135928012,4.847644989583831
Kasumi-2,135398738,1.5778578151552838
HEC-59,66577038,3.2645438466099796
OAW28,60700,1.95920843974679
SNU-410,2828334,5.812774843866019
PK-59,51039095,2.883736730230709
KYSE-70,73707438,4.323396479680616
OAW28,46907787,2.388022074777516
TCCSUP,2841722,4.4181775283322
TCCSUP,216345,4.067577836181339
CHP-212,1716436,3.7133704430251377
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476
HPAC,navitoclax-sorafenib (1-1 mol-mol),4.01132618635378
OPM-2,56946209,-6.715247823396851
HCC1395,9911830,2.556253460545972
WM88,25183872,-1.4105754381711029
B-CPAP,10302451,2.5954421947302344
M-07e,3689413,-2.11596462386005
Ku812,107970,1.4051912271786118
TCCSUP,46199207,2.7417054506008967
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
Hs 746.T,445643,3.9388352715874846
NCI-H1184,11238147,2.9882761868190393
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155
KYSE-450,selumetinib-MK-2206 (8-1 mol-mol),3.9509923248068928
BT 245,6917907,3.833759317164153
LC-1F,51039095,-1.6954634711096623
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816
BT 248,45279963,3.7107289938294135
Panc 03.27,12003241,-0.3666669100111787
HCC1395,11404337,-0.1331965245654414
SK-MEL-28,5281321,0.8314477877227711
BT 428,3503,0.957907344028984
BT 428,5311,0.1050590840820652
KYSE-70,56946209,-4.444419695204879
BL-70,6914657,-5.949411828177137
Hs 746.T,44491742,3.728027076014932
RERF-LC-MS,71680916,4.2559060280924665
ML-1 [Human thyroid carcinoma],375860,0.003862862725961
B-CPAP,54618164,4.142992093020013
F-36P,3062316,2.069344335873667
HPAC,3025944,4.664892970232182
Kasumi-2,erlotinib-PLX-4032 (2-1 mol-mol),2.6918027963335827
BL-70,carboplatin-etoposide (40-17 mol-mol),1.182232782478284
Hs 746.T,9907093,4.351972139293681
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175
AU565,5113032,4.518377698044194
WM88,969516,2.6481635872818443
YH-13,25183872,-1.6197416035202905
SNU-201,25126798,5.911634633169378
PK-59,54619267,5.6272889715375385
SH-10-TC,60700,0.9381636853489276
OPM-2,73707398,-1.391957592490296
OCI-AML-5,11977753,-0.9319927839673248
NU-DHL-1,24951314,-0.7364467941633237
OCI-AML-3,9903786,2.1236549190588097
OAW28,135440466,2.5697421477630273
WM88,3825829,4.299563751491245
OAW28,208908,1.9779710002494069
OCI-AML-3,navitoclax-pluripotin (1-1 mol-mol),-1.1011607400459908
KMRC-20,11364421,1.2660239724990872
WM88,56963564,0.6416884695047101
B-CPAP,3689413,-2.370401360424748
OPM-2,44137675,3.238695939616315
BT 248,5494449,3.476308084030369
Kasumi-2,11396600,2.2579616248243495
JHUEM-3,3503,1.5654284668834255
KMS-20,10385095,0.7360105255887816
CHP-212,123631,2.0203773145858155
NCI-H2141,navitoclax-PLX-4032 (1-1 mol-mol),-0.5567767914409825
NCI-H1568,1242560,2.6554382745340046
SH-10-TC,12001922,3.0373903088359673
YKG-1,selumetinib-UNC0638 (4-1 mol-mol),5.486260238223351
JHUEM-3,4578,4.446889308891603
BT 245,6450551,3.220292002142508
Rh30,107970,2.354219446763589
PF-382,24978538,-1.2784497861997195
BT 248,44607531,1.181861447118321
HPAC,6623618,1.2663404517652588
BT 428,sirolimus-bortezomib (250-1 mol-mol),-0.137470191353476
KMS-20,9952709,2.6593366876189717
OAW28,carboplatin-UNC0638 (2-1 mol-mol),3.4332779723405182
SF539,73707371,2.192047905744571
KYSE-450,44185566,3.113770819226177
TCCSUP,9927531,4.77726983491798
KYSE-450,2828334,6.299741287777087
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218
Kasumi-2,JQ-1-MK-0752 (1-1 mol-mol),-0.4470190343146605
F-36P,168312962,0.828010052090368
Panc 03.27,136227924,3.110606575361216
HCC1395,5282054,4.133185676665712
RERF-LC-MS,11626560,1.1998891680987491
EM-2,53232,1.6539891887641631
SNU-1077,46199207,3.446749693577103
YH-13,72734382,5.819140658588148
A4/Fukuda,119182,-4.160589878424858
AU565,4788,5.691461260554478
SNU-1077,49850262,4.98017250965326
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435
F-36P,637858,1.1543782344326252
SK-MEL-28,5470400,1.2133275140914848
NCI-H1568,12001922,1.1909466973303815
Rh30,10074640,3.013987605460677
M-07e,6610216,4.11023848384902
Hs 746.T,11717001,4.955376375953908
Kasumi-2,10322450,3.5434418993684114
EM-2,44493528,3.698991403338848
OAW28,11609586,2.8574541529278883
KYSE-70,9444,4.1582482593031145
Panc 03.27,16736978,1.8498515725518327
OAW28,135999136,1.5944266420299655
OCI-AML-3,53481919,3.8016863308884785
OPM-2,6852167,1.7172653102666242
BT 231,327653,3.38465300707193
HCC1395,54619267,3.85596355023238
Rh30,9956119,3.961044883896035
BT 248,carboplatin-UNC0638 (2-1 mol-mol),3.451491217767034
BT 428,76446078,5.6455430214390985
OCI-AML-5,5311,0.8777907660941424
TCCSUP,3136844,3.997105269832927
HEC-59,11152667,0.382877882866184
PF-382,100016,3.957595275699552
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153
NCI-H1184,11609586,1.114258193635854
AU565,444795,4.595530435398324
KYSE-70,11238147,3.36128873589197
NCI-H2196,11964036,1.1316985612248371
Ishikawa (Heraklio) 02 ER-,126941,-3.615737340907348
WM88,16013152,4.077750665107336
SW1783,6610216,4.1970131352388265
OCI-AML-3,5335621,3.736047529108984
BT 245,navitoclax-MST-312 (1-1 mol-mol),0.1557480826210676
SNU-1041,4788,5.905953594555508
CHP-212,6450551,0.5161014031000566
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709
YKG-1,5951923,5.422075002317939
A4/Fukuda,BRD-A02303741-navitoclax (2-1 mol-mol),4.161880654149954
BT 428,46224516,2.3722957038774095
YKG-1,doxorubicin-navitoclax (2-1 mol-mol),-1.1717417104097605
KMS-20,3503,1.0882007303901744
NU-DHL-1,72734382,3.1751450889524593
BT 231,salermide-PLX-4032 (12-1 mol-mol),3.076250146625534
HPAC,5470400,3.641949985240221
Ishikawa (Heraklio) 02 ER-,6918736,-2.3716869662510462
Rh30,24951314,1.0226708713893946
SNU-1077,135984461,3.620374859792411
BT 428,15983966,-4.76517467861946
NCI-H2196,vorinostat-navitoclax (4-1 mol-mol),0.4943277521957087
RERF-LC-MS,9825149,2.3136516136403595
Hs 746.T,3038522,2.7221694618467014
OAW28,54618771,1.1011370240470315
NCI-H1568,65064,3.2204713254113373
TCCSUP,51039095,2.6276542591354723
SF539,148124,-5.79726265481526
RKO,5282054,3.8735499096789856
KMS-20,6918878,1.3372822623967346
BT 245,89928392,0.8074253191697837
YKG-1,126941,-4.127185813066353
AU565,400769,-0.800888344050601
LOU-NH91,navitoclax-piperlongumine (1-1 mol-mol),-1.482580438049138
EM-2,216345,3.1967161326562716
LOU-NH91,sirolimus-bortezomib (250-1 mol-mol),1.6256279429010452
MM1.S,5113032,5.133627737640779
BL-70,44819697,-1.5521064239372666
HPAC,4096211,1.3998712408660798
HCC1395,11427553,3.1197819165370286
AU565,227681,3.7153411694983887
NCI-H1184,tanespimycin-bortezomib (250-1 mol-mol),-0.120544891510118
BT 245,136227331,4.251360717375094
SH-10-TC,selumetinib-MK-2206 (8-1 mol-mol),3.911075471956134
NU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),-1.8169816306561488
M-07e,11214940,1.4695494113864194
OCI-AML-3,5291,3.7816377188453014
A4/Fukuda,148198,-4.99238512913244
Ku812,crizotinib-PLX-4032 (2-1 mol-mol),-1.188059714033302
NCI-H2196,11612883,4.353126670682521
BT 231,6852167,2.464272024157972
SNU-201,5978,5.2890551527977365
BT-474,89183176,6.176527180217595
NCI-H1184,46907787,0.1164433785764037
SK-MEL-28,67156097,4.393624339595105
JHUEM-3,25105715,3.001890894650566
NCI-H2141,JQ-1-UNC0638 (2-1 mol-mol),1.3375418962128351
NU-DHL-1,409805,5.5181498055430565
BT-474,5566,3.1382862233485582
BT-474,148198,-3.4060318714272984
NCI-H1184,JQ-1-MK-0752 (1-1 mol-mol),0.4754447979408664
KHM-1B,9915743,0.5787442773030028
Hs 746.T,51037431,4.3785104209821135
Kasumi-2,135398516,1.3882982648798712
Rh30,136227331,4.257101028878693
Hs 578T,44137675,3.9894487866612622
BT 428,3854666,1.1222123532361343
Ishikawa (Heraklio) 02 ER-,702558,5.602486252148638
OPM-2,5311,-0.071810443528602
BL-70,6918638,-1.5969799068966968
KMRC-20,2874250,5.815904450932631
KMS-20,44489675,3.4055865865697283
Ku812,3825829,2.937255635905749
OCI-AML-5,3825829,3.816123541795588
A4/Fukuda,11494412,-1.359408079628026
PF-382,4917,2.62124804307342
RKO,168313047,1.9322709085928884
OCI-AML-3,6450551,1.20953145501591
OCI-AML-5,46943432,1.3940665878668066
AU565,2949965,1.8156290557963255
HPAC,crizotinib-PLX-4032 (2-1 mol-mol),1.5767544943313294
BFTC-909,60750,-1.7298046099952136
BT 248,3689413,-0.3734654016267222
NCI-H2141,49793307,-5.286614238945605
BL-70,salermide-PLX-4032 (12-1 mol-mol),4.685561514122453
KYSE-450,ISOX-bortezomib (250-1 mol-mol),0.3236912354061821
RERF-LC-MS,25150857,3.1332692975488934
BT 428,44185566,2.1375030535677433
CHP-212,10231331,-5.947772300553975
A4/Fukuda,11222830,1.361211164053787
A4/Fukuda,9825149,-2.050748608979426
PF-382,25126798,3.7444046465079888
SK-MEL-28,16741245,3.085707484967514
LOU-NH91,selumetinib-UNC0638 (4-1 mol-mol),4.70852852885549
M-07e,5282054,2.5503396520946224
OPM-2,445455,3.93427157933256
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936
HCC38,4261,1.873578982843624
WM88,tanespimycin-gemcitabine (1-1 mol-mol),-1.4911571843292126
BT 248,56649450,1.4607260014057133
RKO,159324,3.5523933893017583
MM1.S,2828334,5.0723954602187735
M-07e,tretinoin-carboplatin (2-1 mol-mol),2.1958656254194597
NCI-H1184,5281321,-2.4141886373910864
NCI-H1184,6918328,-0.8236910460245728
BT 245,2858523,2.81995217169792
KYSE-70,135999136,5.194226724950964
BT-474,135440466,4.430408134137383
SNU-1077,docetaxel-tanespimycin (2-1 mol-mol),4.730062209802919
LOU-NH91,25183872,2.2713164299079627
SF539,227681,3.913765849966807
Ku812,25102847,-0.2981237407146331
Kasumi-2,6918638,-1.1951505869280743
OCI-AML-3,613000,1.815573204449892
OPM-2,9929138,4.40255967212205
BT 428,1641662,3.5622392770893216
Panc 03.27,675434,4.321172884080609
HEC-59,15983966,-2.948178027530694
Rh30,168313016,5.331123133929558
JHUEM-3,2871966,-0.6593617296607428
BT 245,151289,1.3314671382833223
Hs 578T,10296883,3.7096057485466223
SF539,36462,1.0067932013019132
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996
SK-MEL-28,216345,4.760826301733561
A4/Fukuda,11214940,3.3298423014633585
OCI-AML-5,9903786,1.179944382770948
EM-2,11625818,3.7095721741706615
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417
KHM-1B,alisertib-navitoclax (2-1 mol-mol),-2.308284106027781
Rh30,753704,4.636213241262484
KMS-20,227681,1.9958834039585385
M-07e,24951314,-0.8520917192213832
B-CPAP,66577038,3.003282888618189
BL-70,6438330,1.112568989910968
NCI-H2196,42642645,0.9699299185054828
OAW28,44491742,4.754653012158477
WM88,5291,3.9171330622131024
Hs 746.T,54618164,4.0798704781496875
TCCSUP,11238147,3.457873265179278
JHUEM-3,53232,1.973192091918428
Ishikawa (Heraklio) 02 ER-,159324,3.630524948383921
WM88,25227462,0.9550051178156213
Ishikawa (Heraklio) 02 ER-,9911463,4.4894975893783435
Rh30,135411,0.2201905263491922
NCI-H1568,56649450,2.3390116545362956
JHUEM-3,10074640,3.623642793138892
OAW28,1716436,3.318226269910468
SNU-201,alisertib-navitoclax (2-1 mol-mol),1.558233339418149
JHUEM-3,135875424,4.829807561587815
BT-474,439501,-3.058225040966164
HCC1395,49850262,4.079390587333079
Panc 03.27,969516,2.5430587293214746
B-CPAP,24772860,0.4550512643264998
OCI-AML-5,JQ-1-carboplatin (1-1 mol-mol),0.5116033389333992
OCI-AML-5,tanespimycin-bortezomib (250-1 mol-mol),-0.6942997118623143
Ishikawa (Heraklio) 02 ER-,25126798,4.156514336307419
M-07e,1566236,1.062564677028791
Panc 03.27,25154868,4.7081594812226575
EM-2,568763,-2.0070793758039307
SNU-201,2113511,7.803562688163267
NCI-H1184,46843906,1.6671327979793729
Rh30,24771867,1.970629031249306
SNU-1041,44487330,5.719023506973167
NCI-H1568,675434,4.067969537829177
OPM-2,176870,3.9257377377060383
KYSE-450,387447,-4.1038253742642725
A4/Fukuda,8515,2.244185004641864
OPM-2,11717001,3.8340096164502135
KHM-1B,5282054,1.6499895899015693
KHM-1B,5328940,1.2346884816807109
HCC38,7326481,3.183138012345676
SNU-201,89928392,2.972012053595945
HCC1395,12003241,-2.06138866466857
F-36P,selumetinib-navitoclax (8-1 mol-mol),-0.8154676755119981
NCI-H2196,168313016,5.854117563388439
HEC-59,44589607,3.1087474737882324
YKG-1,53495165,0.7600331159064647
Kasumi-2,5287969,-1.8638241340536708
OPM-2,UNC0638-navitoclax (1-1 mol-mol),2.0554805477116207
Panc 03.27,123631,2.628987490511461
A4/Fukuda,119607,3.918640768426122
WM88,4788,5.8042222954817655
OPM-2,119607,4.667002181538018
HEC-59,5329102,2.3786134387114615
SNU-410,navitoclax-sorafenib (1-1 mol-mol),2.099514335079129
Hs 578T,44489675,3.5860403592927477
CHP-212,navitoclax-sorafenib (1-1 mol-mol),1.4028029838080136
TCCSUP,25062766,2.2291298825702666
KHM-1B,25262965,-2.736326683370708
YKG-1,25262965,-2.8273978219835416
Hs 578T,156422,4.320685926340689
BFTC-909,44607531,1.7004331217528663
NU-DHL-1,10410894,0.6654652153011242
F-36P,navitoclax-birinapant (1-1 mol-mol),0.6826800507816524
NCI-H1568,2113511,4.994259934049027
CHP-212,72193861,-1.237881688182165
B-CPAP,42642645,1.2545407873532517
B-CPAP,tanespimycin-gemcitabine (1-1 mol-mol),1.3298493303497043
JHUEM-3,67156097,-2.82434151485831
CHP-212,16736978,1.1014947078884687
Panc 03.27,219104,4.127056201952444
BT 428,52912189,1.3093593708240536
PK-59,selumetinib-GDC-0941 (4-1 mol-mol),1.3854215252632525
Ishikawa (Heraklio) 02 ER-,969516,3.393138280317756
AU565,104842,-3.8153307910583014
KHM-1B,11609586,2.3896686488847343
OPM-2,5280436,1.5288125622159816
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955
WM88,serdemetan-SCH-529074 (1-1 mol-mol),2.0764084002459517
KMS-20,168313016,2.502907983030332
HCC1395,409805,3.7256484492152087
M-07e,3136844,5.145104949558255
NCI-H2141,387447,-5.685665154489107
SH-10-TC,9903786,4.254901914328344
AU565,11234052,4.466615830851295
CHP-212,4788,5.222553124847157
SNU-1077,navitoclax-PLX-4032 (1-1 mol-mol),4.284771622261252
YKG-1,1641662,3.864636587440989
CHP-212,9907093,3.4385713110688085
BL-70,9903786,1.6201088809137068
WM88,19582717,3.132635483522104
HEC-59,12003241,-0.4049011737939335
OCI-AML-5,JQ-1-MK-0752 (1-1 mol-mol),0.4600654625138994
SNU-1077,5287620,-2.139811632813461
TCCSUP,24772860,-2.3994622500716503
SNU-410,57330099,4.712287638192812
Hs 746.T,45100481,6.244317465844153
OCI-AML-5,1566236,1.6568370935553676
Panc 03.27,3854666,1.0969733528715877
OPM-2,67156097,-3.031514601372161
BFTC-909,42611257,4.384387627976705
TCCSUP,9903786,3.558837088709428
HPAC,159324,2.927164212591678
AU565,11455910,2.266336610800082
HEC-59,5335621,5.785957506088232
OPM-2,46926350,-5.934740852723627
Hs 746.T,11612883,2.320593589174117
M-07e,54618795,2.418268721415185
Kasumi-2,100016,5.973936097539331
WM88,12003241,-2.725037582616198
EM-2,387447,-6.139708254599935
KYSE-450,25150857,3.125664809349332
KYSE-450,25262965,0.1139193640059102
BT-474,136227924,2.4914554847870187
SW1783,168313200,3.606419156743755
HEC-59,44185566,2.80767697401812
SNU-1077,5328940,2.132939036215286
KYSE-450,11152667,0.9209824146572594
BFTC-909,5351362,0.3148685714677321
B-CPAP,53232,0.8188511536428992
YH-13,10302451,3.810654470358069
A4/Fukuda,71304818,1.5363144884487692
OCI-AML-5,445643,3.8095272829177618
OPM-2,11626560,0.8852338363333486
JHUEM-3,9915743,-0.9592300023642776
KMS-20,11626560,1.153431092647739
NU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),1.0467236701826856
PK-59,46224516,4.853840905200155
LOU-NH91,168313047,3.5347026371928565
NU-DHL-1,11396600,1.7686570539993816
YH-13,16038120,1.3752099545726146
YKG-1,10127622,4.916424628114341
SNU-1077,148198,-1.03431054543621
HEC-59,SNX-2112-bortezomib (250-1 mol-mol),-2.0551416270523677
PK-59,44185566,1.9144325304784533
OCI-AML-5,5460769,2.0028479546764664
YH-13,46398810,3.0158285746499645
BL-70,10113978,2.480921135885133
BT 248,11640390,5.783520002908773
NCI-H2196,44491742,4.104688837740398
HEC-59,navitoclax-MST-312 (1-1 mol-mol),1.2245282669341673
OCI-AML-5,6505803,-0.3064133467102931
Hs 746.T,46224516,1.0664845122422864
MM1.S,46943432,0.8040935349772499
NCI-H1184,24964624,0.6394088144731904
BT 231,11396600,2.44608853396947
YKG-1,107970,2.756113266406284
CHP-212,54619267,3.6876040913561057
Kasumi-2,6252,-4.69021119640851
SF539,387447,-5.002674810102925
CHP-212,135421197,1.019713131092093
BT 231,2733526,2.595012434274407
RKO,9444,4.448790979485227
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723
Hs 578T,navitoclax-piperlongumine (1-1 mol-mol),-0.0636639704560436
NCI-H1184,6918878,0.6159518781622964
Hs 578T,selumetinib-MK-2206 (8-1 mol-mol),1.8653449827504405
NCI-H2141,753704,3.4097183249500227
BT 245,71304818,2.4314094706229743
NCI-H2196,9927531,4.117400803944708
JHUEM-3,208908,2.618808068285107
Ku812,selumetinib-GDC-0941 (4-1 mol-mol),-2.0259411915786294
OAW28,3062316,-0.5042902382709098
KHM-1B,9825149,-1.748191139364394
EM-2,644241,-5.5059587558621965
KMRC-20,44259,2.7583820903803695
BT 231,10410894,2.1908311783734433
TCCSUP,5566,3.1120135973832386
SW1783,55283,4.5857048643674005
Rh30,11214940,0.7041042861496272
OAW28,66577038,2.5027239379183666
OCI-AML-5,BRD-K55473186,4.199766533026581
OAW28,24753719,4.434201172795376
KHM-1B,46943432,-0.0724756226448156
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852
F-36P,6450551,1.828299759657417
Hs 578T,753704,4.6744811674365705
SF539,navitoclax-gemcitabine (1-1 mol-mol),-3.026639158537806
SW1783,selumetinib-GDC-0941 (4-1 mol-mol),4.418761768894625
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183
EM-2,9956119,2.269870315941677
SW1783,6918328,3.3453228504618995
KHM-1B,20959075,-3.335325508403103
KMS-20,16722836,0.7293384571450807
BT 248,25126798,4.2564362718884965
OAW28,JQ-1-UNC0638 (2-1 mol-mol),1.5055699462445158
Ku812,54618164,2.681700331746246
OCI-AML-3,2871966,-1.671159881143821
OAW28,vorinostat-navitoclax (4-1 mol-mol),-0.0627411194762238
AU565,54613361,-1.6068695222158444
Panc 03.27,3038522,2.605303494783718
SH-10-TC,25183872,-1.1064876864671664
LOU-NH91,168312962,3.892175490150028
Ishikawa (Heraklio) 02 ER-,11152667,-0.2897968836684769
BL-70,15953870,1.7010227279184564
Ishikawa (Heraklio) 02 ER-,26596,-0.9802171650937824
PF-382,2749,0.594868187564988
F-36P,decitabine-navitoclax (2-1 mol-mol),-0.3122697597866437
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062
OCI-AML-5,9444,4.376394254843388
BT-474,31703,-0.5942974562653128
SH-10-TC,44607530,3.011685879578687
B-CPAP,969516,2.5464692939990834
Ku812,6918328,-1.271327436604222
OCI-AML-3,439501,-3.711408671836436
Panc 03.27,216468,3.3250275185396383
NCI-H2141,25262965,-4.414453940390296
NU-DHL-1,9933475,1.7184020266323787
Ku812,241158,2.509231607325934
JHUEM-3,11167602,2.7925879803312386
HEC-59,2945648,2.842819715781648
LOU-NH91,107985,-2.204555775629559
SNU-410,2130404,3.0092181682805297
BT 245,46907787,3.440577921160999
M-07e,sirolimus-bortezomib (250-1 mol-mol),-0.1751510828449014
KMS-20,9840324,7.129228187943907
Kasumi-2,2945648,2.1908336830751436
SK-MEL-28,2729026,2.910502254408236
SW1783,9903786,4.362374850125049
OCI-AML-5,9967941,3.964633567120488
Kasumi-2,11167602,2.198810465874189
BT-474,71751553,4.578203440139317
BT 231,4917,2.073926714601451
NCI-H2141,6610355,4.857833640308834
HCC38,JQ-1-UNC0638 (2-1 mol-mol),0.8349394699375743
Ku812,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.5255380430209794
BT 248,156414,1.4948422332158926
Hs 578T,5282054,2.7312496170441
B-CPAP,11238147,2.5075756320642197
Hs 746.T,676352,1.6888653797388262
MM1.S,15983966,1.9540047876230984
HEC-59,57519531,3.416374272935827
CHP-212,navitoclax-birinapant (1-1 mol-mol),3.0338525457391485
Hs 578T,72376,-2.162999505540748
MM1.S,56946209,-4.843485824557046
WM88,46398810,2.6084606773526806
OAW28,11175137,3.6697867992343607
NCI-H1568,135421197,1.29303587511011
JHUEM-3,5278396,3.681748267499633
SW1783,salermide-PLX-4032 (12-1 mol-mol),6.068207873844662
MM1.S,JQ-1-carboplatin (1-1 mol-mol),-0.259196457141764
PF-382,44620216,3.605530573538089
BL-70,11494412,-1.22344895039541
OAW28,vorinostat-carboplatin (1-1 mol-mol),2.457555978857692
PK-59,5470400,2.668713102290907
NCI-H2141,72734382,4.221262720059781
Panc 03.27,156422,4.488551886074375
JHUEM-3,151289,0.5456663488306489
JHUEM-3,docetaxel-tanespimycin (2-1 mol-mol),-5.20297844674981
OCI-AML-5,5494449,-4.59134324338102
OAW28,656346,0.8948255988542453
RKO,10184653,1.6814092199651305
KYSE-450,10074640,3.7244937676634735
SK-MEL-28,selumetinib-decitabine (4-1 mol-mol),2.13770336621051
HPAC,5280436,4.225907816080008
F-36P,2126,4.498073793778368
BL-70,11647372,-0.4489305273177855
F-36P,327653,3.3003434117548105
M-07e,66577038,2.2798003529845574
Hs 578T,3854666,0.9314111663705392
PF-382,3503,1.22639137886012
KYSE-70,6505803,-1.025033993677824
OCI-AML-5,11485656,1.9457799090606884
KYSE-450,1242560,3.7226437458360895
Hs 578T,67291369,1.2686610814880892
HPAC,1716436,2.4885599057590797
RERF-LC-MS,100016,6.56071523320666
HPAC,9911830,2.828349444827891
PF-382,JQ-1-navitoclax (2-1 mol-mol),-1.4600589253273593
BL-70,1641662,2.722625764471168
SK-MEL-28,24748573,5.3109310210303455
BT 245,46926350,-3.489677690297977
BT-474,10385095,2.724644688135605
F-36P,9907093,3.8826352670288857
EM-2,107970,2.208998012653241
Ku812,44486219,3.768405676871863
YH-13,44607531,1.7046203795980872
NU-DHL-1,3503,1.1771125091152093
KMS-20,6918328,-1.3033852220053452
YH-13,selumetinib-JQ-1 (4-1 mol-mol),2.881387318518872
SNU-1041,136227924,4.256354114890169
CHP-212,10427712,3.988582498091189
RKO,9935249,5.020114551473781
A4/Fukuda,17755052,-0.6813796549781841
KMRC-20,piperlongumine-MST-312 (1-1 mol-mol),2.9533358433546444
BT-474,11317348,4.426575150162044
KMS-20,52912189,-0.8192319241332332
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885
WM88,72199292,0.4532582708982832
Ku812,6918837,-4.505214094305032
OCI-AML-3,387447,-5.358475874635664
OCI-AML-3,9866186,-1.2478893935806563
CHP-212,208908,1.9027634989843003
SNU-1077,16722836,1.5669441897808989
NCI-H2196,1716436,3.3123845350009056
F-36P,216239,1.5044375551912257
PF-382,241158,3.333523301157689
M-07e,60700,-1.3286153108156844
Hs 578T,selumetinib-navitoclax (8-1 mol-mol),2.342464765891088
KMS-20,4917,2.7295029836090565
MM1.S,11364421,-5.91278520312213
Kasumi-2,568763,-0.985189730983464
Hs 578T,54626689,5.20383473755861
NCI-H2141,5287969,-2.3841806349194767
EM-2,71680916,4.582061914885755
BT 428,4788,4.272474838968475
HEC-59,11507802,1.6726641466240273
EM-2,24180125,3.3243546283066836
YKG-1,11228183,3.6918030107166784
HCC1395,16725315,3.7790836574498528
HCC38,25227462,1.2385280953429638
Rh30,46191454,2.179867492465089
F-36P,285033,-4.537676332607244
JHUEM-3,252682,5.98553052938278
KYSE-70,11214940,1.7563649507227177
HPAC,439501,-1.2049246371580666
BT 248,46215462,2.381699206499341
SH-10-TC,6852167,3.183522893329415
B-CPAP,54619267,2.2660883824751337
HCC1395,71466380,4.827391916775483
SK-MEL-28,11222830,1.7175848193972325
NCI-H1184,vorinostat-navitoclax (4-1 mol-mol),0.4109044991268749
EM-2,23725625,3.893285103124716
Panc 03.27,15983966,-4.203910734743579
Ishikawa (Heraklio) 02 ER-,4261,2.2867923164425856
WM88,89928392,1.3003610524695832
BFTC-909,11647372,1.2423847125416496
OCI-AML-5,54618771,0.4264677614075425
BT 248,11238147,1.7431248737974965
KHM-1B,11152667,-2.085888250346346
KYSE-450,6610216,4.803414401111398
KYSE-450,11364421,0.1587398851119797
BT 428,15953870,3.768281629986435
MM1.S,11612883,1.791748337852018
SNU-1077,16720766,-1.5512387650039812
WM88,71751553,5.868796186292424
WM88,5738263,3.709054551827671
BT 248,54618164,4.1848059637542585
A4/Fukuda,24901704,2.035809268681581
OAW28,11222830,1.7030270245193828
Kasumi-2,BRD-A02303741-carboplatin (1-1 mol-mol),3.1733704189118894
LOU-NH91,9868037,3.6278868560603574
WM88,451668,6.291135060042771
LC-1F,11167602,-1.348931537750626
BT 245,15547703,2.990597174142391
Hs 746.T,2742550,4.150215272270972
NCI-H2196,decitabine-navitoclax (2-1 mol-mol),1.6414205908134682
MM1.S,11238147,1.6949017998059208
SNU-201,16722836,1.4456451842632831
Ku812,135411,-0.2793980307615341
Panc 03.27,vorinostat-navitoclax (4-1 mol-mol),1.3656981571664233
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026
HCC38,5329102,2.5156186141206405
EM-2,176870,2.197088623406138
PK-59,227681,3.151090202013685
BL-70,5287620,0.2921576937230913
SNU-1077,selumetinib-navitoclax (8-1 mol-mol),2.57437827780129
AU565,9926054,0.9817648939808896
EM-2,6450551,-1.4760490148777723
A4/Fukuda,navitoclax-pluripotin (1-1 mol-mol),-2.9042967889462408
BT 428,selumetinib-UNC0638 (4-1 mol-mol),1.594617626064182
PF-382,71466578,2.892192903824988
OAW28,JQ-1-navitoclax (2-1 mol-mol),0.2228593574400964
NU-DHL-1,44489675,3.995073579717184
OPM-2,25262965,-5.528707504919602
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862
YKG-1,selumetinib-GDC-0941 (4-1 mol-mol),1.6719516399203749
NCI-H2196,6852167,2.8747705894098488
F-36P,67156097,-2.789845146939418
HCC1395,3503,3.2844526266425955
F-36P,216345,2.569444897328232
M-07e,135411,-1.7602949579736598
NU-DHL-1,23725625,1.761495354377978
WM88,126941,-4.518084659910948
OPM-2,42611257,3.2957467857000404
Rh30,5291,3.099746669684515
BL-70,15983966,4.119266131177769
KHM-1B,3384730,0.7492899060268451
BT 231,JQ-1-MK-0752 (1-1 mol-mol),1.53802210324551
BT 245,53392493,3.2440450832538343
RERF-LC-MS,5280436,-0.2566098032119844
KYSE-70,5351362,2.601126509135012
KHM-1B,16722836,0.0780331724282444
NU-DHL-1,65064,2.7159461046068545
NCI-H1568,25105715,3.512540774448481
Panc 03.27,9915743,1.9150966993651488
NCI-H1184,25102847,0.2164128951791482
BT 245,JQ-1-navitoclax (2-1 mol-mol),0.0796697322727722
B-CPAP,44589607,3.2580421536509574
Kasumi-2,selumetinib-UNC0638 (4-1 mol-mol),3.1045685976717623
EM-2,24951314,0.1753519182603239
Kasumi-2,9825149,1.9223862209950433
BT 231,9952709,2.221808237226659
BFTC-909,44185566,2.75887016136311
EM-2,JQ-1-UNC0638 (2-1 mol-mol),-0.957296000160211
HCC38,387447,-5.636972664828067
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686
OCI-AML-5,322968,4.025952386328326
JHUEM-3,11717001,4.2381597525584205
NCI-H1568,2871966,-1.5477941874243064
MM1.S,44607530,1.747529731398438
NU-DHL-1,208908,2.2448533414134864
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202
NCI-H2141,11494412,0.5114354173300891
Hs 746.T,49846579,3.466824913887102
Ku812,322968,2.754974105795659
JHUEM-3,6914657,-2.747508778776132
HCC1395,1641662,3.4409593518379236
WM88,44241473,4.4226922807314395
NCI-H2196,72376,-1.1220298906200308
HCC38,46215462,1.86212987472256
Ishikawa (Heraklio) 02 ER-,11455910,1.4574745929250947
TCCSUP,11626560,1.9975269088878715
TCCSUP,24964624,2.9604589319316985
OCI-AML-3,446155,1.5608200012955795
RERF-LC-MS,25195348,2.310586589861769
SH-10-TC,676352,3.029707739346934
KHM-1B,10302451,3.4740404834517156
BT 231,65064,5.215173744607942
BT 231,445643,3.5669441290704573
BL-70,44185566,1.5928513907686557
JHUEM-3,selumetinib-vorinostat (8-1 mol-mol),1.9362671719924216
HCC38,5278396,3.8801600776396095
HCC38,11404337,0.6997124930449434
CHP-212,9911463,2.7015843726568005
TCCSUP,17759555,3.887278594694756
HCC1395,9936388,-7.459318644951684
KYSE-450,1750826,-1.5410905710283038
WM88,176870,3.1224556244196955
KHM-1B,9826308,0.2290503887290589
BT 428,vorinostat-carboplatin (1-1 mol-mol),1.8525492351136472
EM-2,89183176,3.9809028418130463
Panc 03.27,46215462,1.5759739120298015
BT 245,JQ-1-UNC0638 (2-1 mol-mol),5.423120004675633
PK-59,navitoclax-pluripotin (1-1 mol-mol),-0.3555314837484112
LOU-NH91,tretinoin-navitoclax (4-1 mol-mol),-1.081702007915755
HPAC,123631,2.0692135017542976
RERF-LC-MS,168313200,3.896073258981905
SNU-1077,159324,3.2853516722485994
HCC38,24753719,4.142998608855599
OCI-AML-3,676352,1.5912998542118426
HPAC,23582824,0.9337324134593394
NCI-H1568,25183872,-0.3156837582718859
PF-382,salermide-PLX-4032 (12-1 mol-mol),5.272425832636036
NCI-H2141,11955716,-2.5635047086829963
CHP-212,25105715,3.3644711158567673
BT 428,2858523,3.085177452566525
OPM-2,56949517,5.349058842742104
SF539,46191454,1.070261484173304
Ku812,136227924,2.6493599225721742
HEC-59,9935249,3.547828303095583
BFTC-909,54649381,4.487285574329416
BT 428,carboplatin-UNC0638 (2-1 mol-mol),3.4445307503856557
KYSE-70,23725625,6.518030965677853
PF-382,5281321,-2.364322655239298
BT 245,54618771,0.8318467537608688
HPAC,107970,2.120634105202459
KHM-1B,44487061,4.467153172059052
KHM-1B,selumetinib-vorinostat (8-1 mol-mol),0.6358742405488887
KMRC-20,11222830,2.077538911005185
JHUEM-3,10322450,4.4054488453060525
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854
YH-13,12003241,-0.7443010060517422
B-CPAP,9929138,3.6088246512600457
NCI-H2141,123631,2.281337721685777
KYSE-450,446155,3.327914204468242
LOU-NH91,3825829,4.327670981782257
F-36P,16038120,0.8802402655466375
YKG-1,25150857,2.66438292717209
F-36P,11977753,-2.0202080021287743
YKG-1,9915743,1.478165176900873
KYSE-70,44607531,3.0404164934883733
OCI-AML-3,71466578,1.5651371755512813
PF-382,23725625,4.463043593784131
BT 231,374536,3.025650998981233
F-36P,67291369,-0.7529423650283368
OAW28,1566236,3.486252592676433
HEC-59,navitoclax-piperlongumine (1-1 mol-mol),3.344867591197674
BT-474,11964036,0.6476370496797155
EM-2,16736978,-0.6967872847426032
SNU-410,2842253,4.6284061395432
OPM-2,57519531,1.419627244644159
YH-13,6450551,2.0238267614967644
JHUEM-3,24785538,1.4267220569060222
OCI-AML-3,5351362,0.6039674496967077
EM-2,5284616,1.2010241474184842
TCCSUP,54618771,0.6448534643306117
SNU-201,16038120,0.9169473118493412
NCI-H1568,7326481,2.864470016727109
NU-DHL-1,44589607,1.1355203141192094
PF-382,72376,-3.2964560616169587
BT-474,46224516,1.598052790744367
BT 245,11485656,1.931183051045247
BT 428,9967941,4.804492876249159
JHUEM-3,15953870,4.03589819233106
NCI-H1568,5311,0.289477139532769
PF-382,11238147,1.430662922581268
Panc 03.27,5978,-2.4266395261880525
BFTC-909,23635314,-1.3241610546701814
LOU-NH91,5746,1.403252091596802
BT-474,16722836,0.0571141898785618
NU-DHL-1,10113978,2.330797013945373
LOU-NH91,docetaxel-tanespimycin (2-1 mol-mol),-3.5084138300894625
SK-MEL-28,docetaxel-tanespimycin (2-1 mol-mol),3.8902509419677105
BT 248,44491742,4.160095989296475
JHUEM-3,7326481,3.4249949592591347
SNU-1041,24951314,1.6041388509803245
NCI-H1568,carboplatin-etoposide (40-17 mol-mol),1.7182211320205656
SNU-1041,46398810,2.851944920138119
PK-59,11683005,3.780619841517865
OCI-AML-5,156414,1.749799487205322
BL-70,89928392,-1.121859532490043
OAW28,31703,0.1585101679236112
KYSE-70,5311,1.3049127753558711
TCCSUP,445455,5.141683708981469
OAW28,9907093,4.094861416701174
NU-DHL-1,107970,1.0254507421459336
NCI-H1184,72734382,3.3987815627002655
AU565,selumetinib-GDC-0941 (4-1 mol-mol),0.6894235176740465
Ku812,selumetinib-navitoclax (8-1 mol-mol),-2.189866116629726
MM1.S,5281321,-2.4935203757499997
CHP-212,10127622,-3.6893357232843074
KMS-20,12003241,-1.6984779188581272
PK-59,10302451,2.95389022276854
RERF-LC-MS,387447,-4.351660250848144
AU565,44486219,4.217962962304986
Kasumi-2,219104,1.7742372806275355
JHUEM-3,JQ-1-UNC0638 (2-1 mol-mol),-0.2276777929693784
NCI-H2196,65628,4.307213942062808
BT 231,JQ-1-UNC0638 (2-1 mol-mol),1.753830985652589
Ku812,969516,1.9833816835003693
Rh30,54618164,3.8447721242905337
YKG-1,148198,-3.345136621371903
JHUEM-3,46398810,2.3660341115843253
Rh30,24785538,0.7090674565485766
F-36P,6918736,-3.201463398863563
OCI-AML-3,66577038,2.5156126207320573
NU-DHL-1,24772860,-2.0670136915752395
HCC38,42642645,1.0705938044979555
NCI-H1568,11977753,-3.4091025242198696
BL-70,3543504,2.9942371142288287
Panc 03.27,1641662,3.2549447150843913
Rh30,6918736,2.399897615071111
NCI-H2196,4259181,0.8420736929714187
B-CPAP,65064,5.136940139923551
BT 428,3634881,2.0818785010291654
Ishikawa (Heraklio) 02 ER-,107970,3.1744092198805136
NU-DHL-1,salermide-PLX-4032 (12-1 mol-mol),3.6957030880466544
KYSE-450,2858523,3.2293705558979813
OCI-AML-3,9935249,-0.327940311351079
YKG-1,44566777,0.971285441188688
SK-MEL-28,6610355,5.590676722177881
M-07e,89183176,3.3005191781751826
BT 245,3025986,-0.5996935775765925
MM1.S,16065773,2.0312570616659125
SF539,2828334,6.046575048370249
Panc 03.27,445455,4.345466371126557
KMS-20,11647372,-0.2518820801437051
Rh30,36462,1.3156470813708137
SNU-201,piperlongumine-MST-312 (1-1 mol-mol),2.80139509764672
SW1783,53232,4.066111432329494
HCC1395,36314,-4.891251682634548
EM-2,44632017,0.2396282128038477
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332
SK-MEL-28,sirolimus-bortezomib (250-1 mol-mol),1.3552683647004444
Panc 03.27,3689413,-0.1085312900774309
Ishikawa (Heraklio) 02 ER-,3815108,3.586440325889441
KYSE-450,46843906,5.632374072388803
OCI-AML-5,66577038,3.2500076569690584
B-CPAP,BRD-K27188169-navitoclax (2-1 mol-mol),4.542627193137736
PK-59,6918328,0.1646217427066897
YKG-1,2742550,5.856053185506653
F-36P,156414,1.5553832514314012
NU-DHL-1,44507138,1.6307410381746317
YH-13,216345,4.472180809621783
HPAC,9967941,4.829732558634319
SNU-410,5329102,1.4137759041514777
RERF-LC-MS,702558,6.005509402748126
MM1.S,11507802,1.0778344524637908
KHM-1B,135875424,3.3101852288443276
Panc 03.27,11609586,3.0899871382932687
NU-DHL-1,135421197,0.761695548293036
Hs 746.T,73707398,2.6800461507251634
BT 245,51039095,2.78293299090603
HCC1395,26596,-1.834868374404667
KMS-20,12001922,1.070822318900554
Panc 03.27,selumetinib-GDC-0941 (4-1 mol-mol),1.140504717047802
CHP-212,52912189,-1.0810929380379604
KMS-20,25126798,3.810031241179322
EM-2,3634881,1.9384030512307224
BT 231,5278396,3.366305854308052
OAW28,44607530,1.1070032957823266
NCI-H1568,9825149,1.6639399446813206
LC-1F,969516,2.073716392196952
NCI-H2141,156414,1.72197296337886
YH-13,4578,5.582049884276352
A4/Fukuda,navitoclax-piperlongumine (1-1 mol-mol),0.9145762959476356
Panc 03.27,tanespimycin-gemcitabine (1-1 mol-mol),-2.0064509282045013
CHP-212,11214940,3.262093119541824
HCC1395,4788,5.85097049691497
BT-474,10184653,-1.580100616172153
Ku812,doxorubicin-navitoclax (2-1 mol-mol),-2.802907461854501
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303
Kasumi-2,9884685,-1.7492969798518767
BFTC-909,1750826,-0.1726466566192349
F-36P,3038522,1.925088588066263
Hs 746.T,16725315,3.1668203352349344
OCI-AML-5,6918328,-1.8690031425006797
SW1783,44491742,3.6997355499837217
Ku812,9887053,2.4680731307119785
NCI-H1184,54143018,-0.7262319625796602
Panc 03.27,6505803,-2.205442615727637
BL-70,15547703,2.6966857332641587
KHM-1B,135999136,4.388497598108013
Hs 578T,10184653,0.9985566190071116
Hs 746.T,vorinostat-navitoclax (4-1 mol-mol),0.9816971186782536
OCI-AML-3,16725315,3.1673542302243067
KHM-1B,4259181,-0.2095303903157825
BFTC-909,11152667,-0.3524603871752078
NCI-H1568,46191454,1.7726304550427152
PF-382,5394,4.4607333976243435
NU-DHL-1,135398744,6.409233084142903
A4/Fukuda,2871966,-1.2628046939905593
PF-382,5113032,5.313987207149933
SF539,400769,-1.0115362811049124
OAW28,135999136,1.5944266420299655
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923
Panc 03.27,5282054,3.741911242951102
KMS-20,24180719,3.3038292759957404
HPAC,25126798,3.9640935853861863
SF539,9823820,1.6245183308883937
BT 428,4705,1.6502431761366996
OCI-AML-5,3385,2.2744967666252207
BL-70,71304818,1.0895731547342402
Hs 578T,1750826,-0.6539196226040528
Ishikawa (Heraklio) 02 ER-,11964036,2.3587584382176905
SK-MEL-28,53495165,3.601883113184374
NU-DHL-1,71680916,3.5275093347477795
RERF-LC-MS,4261,2.068565192175152
Hs 746.T,216239,1.9130898781572807
SNU-1077,11427553,3.133065225486414
OCI-AML-3,6252,3.193619945083053
BL-70,2945648,2.597298634325155
BT 245,10385095,1.400283775793094
WM88,25262965,-4.3561006050680104
BFTC-909,135398516,3.047749913114312
KYSE-70,24797083,1.8843278101436565
TCCSUP,11167602,2.834914441950803
KYSE-70,11175137,2.267736133904179
JHUEM-3,56946209,-2.2727810197112364
EM-2,216468,0.6965370703572217
PK-59,selumetinib-JQ-1 (4-1 mol-mol),1.6048028888022474
Panc 03.27,45279963,3.836880201857471
Kasumi-2,9803433,4.641295101837652
OCI-AML-5,piperlongumine-MST-312 (1-1 mol-mol),1.1760139788083723
NU-DHL-1,15547703,3.0121998321464805
LOU-NH91,15953870,3.547895487506012
Rh30,654092,-2.14864984699251
AU565,135999136,4.178255303593246
BT 428,navitoclax-pluripotin (1-1 mol-mol),-1.5284405566658936
OPM-2,24753719,4.370940438199297
NU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-2.039060237587124
Panc 03.27,135421197,1.6982326506072338
AU565,23725625,4.73732544358888
RKO,11625818,4.5581118700811105
KHM-1B,11167602,5.170482443949449
BT 231,24951314,0.1132807035510326
SW1783,4788,5.6219233668192174
YKG-1,10302451,4.0412794748223835
BFTC-909,4917,2.929839520827846
JHUEM-3,selumetinib-decitabine (4-1 mol-mol),2.58389453297797
NU-DHL-1,3136844,3.805099216127406
Hs 578T,1716436,2.638927503029608
Hs 578T,46191454,0.8893144475325618
KMS-20,216239,1.7632685828356174
Hs 746.T,55508,4.3853644154012645
LOU-NH91,216345,4.715464564049095
LOU-NH91,24856436,2.045063798311017
SW1783,3552672,4.975646737829227
KYSE-450,16720766,2.1902157415608836
YH-13,10385095,0.585484965582367
OCI-AML-3,5460769,2.571994692264208
KMS-20,24964624,0.3956961700125998
RKO,5746,2.147448518007633
YKG-1,11404337,0.7038073229533129
B-CPAP,54618771,-0.888157328254987
B-CPAP,25062766,1.9365359844600436
KMS-20,navitoclax-gemcitabine (1-1 mol-mol),-5.120550360626937
A4/Fukuda,9915743,-0.3554458205966057
OAW28,5281321,-1.4060991234994806
EM-2,12003241,-5.8745734353402534
F-36P,44620216,3.708967098139917
NU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),1.2848172177454842
HPAC,doxorubicin-navitoclax (2-1 mol-mol),-0.3816511661893944
AU565,3825829,3.6732705699214105
Kasumi-2,carboplatin-etoposide (40-17 mol-mol),0.2542153417603036
SK-MEL-28,carboplatin-UNC0638 (2-1 mol-mol),3.933934894554171
BT-474,66577038,2.753381027390087
NCI-H2196,107985,-4.2483053233771875
BT 245,1750826,-2.1736985339579395
F-36P,23582824,0.7691750448344935
BT 428,UNC0638-navitoclax (1-1 mol-mol),0.5798906424997637
HCC1395,54143018,-0.185862760598365
NCI-H2141,3384730,3.3068172314775723
RERF-LC-MS,3634881,4.923247717838372
CHP-212,11396600,2.9941835804811507
Hs 746.T,2828334,6.249247567647671
B-CPAP,6914657,-4.791775338722752
KHM-1B,53232,4.4462743832167035
NU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.348913294016227
Hs 578T,4788,5.718331219681349
OCI-AML-5,54619267,3.829874955120192
OCI-AML-5,1750826,-0.8133454402765514
YH-13,ISOX-bortezomib (250-1 mol-mol),0.2310542886202235
YKG-1,44819697,0.3440551836908802
NCI-H1184,piperlongumine-MST-312 (1-1 mol-mol),0.965176775294152
B-CPAP,1242560,3.0777193347384495
NCI-H1184,15983966,1.8614405560134992
YKG-1,navitoclax-sorafenib (1-1 mol-mol),3.836400183478217
NCI-H2196,9967941,5.978937864390249
M-07e,46926350,-4.186843002179152
NCI-H2196,3689413,-2.371911217935783
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326
BL-70,107970,1.6369787903687438
KYSE-450,10385095,1.1558983027763154
YKG-1,4261,2.958862922267848
KYSE-70,2749,2.2442090130660577
PK-59,6610355,4.622942795631218
B-CPAP,2828334,5.722656317072071
BT 231,57519531,3.827063167603516
BFTC-909,650361,3.8112149600795706
BT 248,135421197,1.5349499708791383
BT 428,25161177,1.960995133539942
PF-382,3136844,3.510785171533077
WM88,11497983,4.992703963816447
B-CPAP,navitoclax-gemcitabine (1-1 mol-mol),-1.2071982143787798
KMRC-20,148198,-1.1031106323256945
JHUEM-3,5978,-4.098820252596917
Rh30,9866186,0.5403086458690595
HEC-59,638278,3.2118970961543463
WM88,409805,5.795816552441705
YKG-1,1750826,0.4616022986658529
BFTC-909,44259,1.3269924163099676
KMS-20,11656518,0.4062739381385031
KYSE-450,11955716,-2.223741431662978
NCI-H2141,71466578,4.327934229664427
BFTC-909,57519531,3.2286550647211025
AU565,46174525,5.4998307146624255
RKO,24821094,3.7157598247146977
RERF-LC-MS,448949,1.7883798522328354
MM1.S,10184653,0.1720840981643339
RERF-LC-MS,327653,4.17889189356682
OCI-AML-5,44607531,1.714133297163681
OPM-2,1285940,4.143301448340403
HCC1395,216468,5.27967708580057
KYSE-70,1750826,1.0050628158627442
BT 428,409805,5.8133328152421395
YKG-1,salermide-PLX-4032 (12-1 mol-mol),5.716825477266549
RERF-LC-MS,9903786,2.6182355767545213
OAW28,654092,-1.8070222863139416
WM88,51037431,2.2458541772043117
F-36P,11609586,2.595671819234626
Rh30,11234052,3.583621023379859
F-36P,11167602,2.0610720557550755
LC-1F,selumetinib-vorinostat (8-1 mol-mol),0.4234700662281405
NU-DHL-1,123631,1.9528798329340396
RERF-LC-MS,1242560,3.610791422912421
BT 231,26596,-1.8186756145502985
KMS-20,36462,0.8301461091099265
HEC-59,24951314,1.2425324852818316
B-CPAP,9956119,1.850613025177622
HCC38,568763,-1.686422419673561
EM-2,2828334,5.674081241050788
MM1.S,2729026,2.344981820167116
RKO,11626560,1.596896929931414
F-36P,9903786,0.2788806994422486
Ishikawa (Heraklio) 02 ER-,2729026,3.1323352085072553
OCI-AML-5,25262965,0.8856253193215364
SNU-1041,5281321,-1.1877246114515227
BFTC-909,6852167,2.133526407129769
Hs 578T,JQ-1-vorinostat (2-1 mol-mol),1.1192951050198294
NU-DHL-1,753704,3.856303412590113
KMS-20,5494449,2.3670693825128164
NCI-H1568,4705,2.022283964907955
BT 248,1641662,4.808188715890419
NCI-H2196,2945648,2.4721226408209533
Ishikawa (Heraklio) 02 ER-,44202524,1.731534383129628
BT 248,54613361,5.122685224165604
Kasumi-2,3025944,3.902952987709838
M-07e,5738263,2.2823243971471188
TCCSUP,44486219,5.057674735399276
JHUEM-3,45279963,4.172610905541947
Hs 746.T,9952709,4.418369077321286
OCI-AML-3,6505803,-0.781782964907092
PF-382,6610216,3.7963864090602737
MM1.S,9908783,5.963347561700224
BT 248,JQ-1-vorinostat (2-1 mol-mol),2.5830463890167064
EM-2,71466445,2.363063257631096
Ku812,327653,2.6105949863285436
OAW28,ISOX-bortezomib (250-1 mol-mol),-0.0669520264254744
NCI-H2141,4917,3.0352692577432503
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691
HCC1395,selumetinib-PLX-4032 (8-1 mol-mol),4.085711534340481
HEC-59,17759555,4.073003314452672
MM1.S,selumetinib-UNC0638 (4-1 mol-mol),1.889294879744257
NCI-H2196,11455910,0.991466046593156
Ku812,6505803,-1.520866948509506
BT 231,54596558,3.986857373058861
Hs 746.T,3025944,4.214990746478837
OAW28,5282054,3.6220988157242946
B-CPAP,89928392,1.5244385280363368
CHP-212,72376,-2.2066717074041793
Hs 746.T,5278396,3.764288407374094
RKO,23725625,3.9986828157613616
KMS-20,11640390,0.2250858855689749
OCI-AML-3,11228183,2.6250986478110825
BT 231,148124,-6.361454610291721
Ku812,445455,5.7620239049284505
BL-70,11396600,2.443517551582617
OPM-2,11507802,0.0988268127526858
WM88,11364421,-5.490688590276614
RERF-LC-MS,16722836,2.4162442447682193
Ku812,6623618,1.7016648351323582
HCC38,46843906,2.891096338550387
BL-70,135440466,3.153176782979536
SH-10-TC,7251185,3.431229842173433
BT-474,10302451,1.6230602382563992
BT 231,selumetinib-MK-2206 (8-1 mol-mol),2.863856190767052
F-36P,44491742,3.961170859118446
F-36P,44486219,4.258266572630148
M-07e,2949965,1.7643828582477452
JHUEM-3,44185566,2.913712358761585
OPM-2,9956119,3.674575368535915
Kasumi-2,11640390,2.994278179386077
PK-59,16065773,3.0551899426712534
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563
KYSE-70,65064,5.1318583658275205
NCI-H2141,24772860,1.0769886860974538
HEC-59,24772860,-2.0761129343585023
BT 248,51037431,4.063284976838012
SW1783,24771867,4.842203084909567
BT 428,42642645,2.2161145652022465
BL-70,5113032,4.445808177328183
KMS-20,11152667,-1.0661904813825076
OAW28,15983966,1.5707780698474574
OPM-2,11396600,1.8817984525619431
A4/Fukuda,26596,-3.7061252239164553
AU565,11656518,2.4577765871660353
BT 428,613753,2.9143775070940268
KYSE-70,3385,2.7043091028991175
KYSE-450,71304818,3.197699947963966
NU-DHL-1,9887053,0.6312128826435269
KYSE-70,11178236,-1.2639965798928303
CHP-212,56973724,1.4999137112908263
KHM-1B,1750826,-3.7148108552334977
PF-382,5284616,-4.488730736751072
NCI-H2141,49846579,-5.981860025260343
OAW28,73707398,1.2451215877479735
F-36P,2749,1.5924157491502826
Hs 578T,969516,1.8879084618364907
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411
KHM-1B,44507138,1.4720976685290608
SF539,426756,4.818547451090759
M-07e,9956119,3.480701565430401
Ku812,208908,2.1856881030512043
RERF-LC-MS,3384730,3.247206310046507
NCI-H1568,16659841,3.88074746768202
BT 248,44589607,2.2150317514642635
B-CPAP,navitoclax-sorafenib (1-1 mol-mol),1.07140085648009
OPM-2,44202524,1.1830318509158162
TCCSUP,docetaxel-tanespimycin (2-1 mol-mol),-3.3662554716877167
TCCSUP,11497983,6.1177518304262195
F-36P,104842,-2.852946463282151
BFTC-909,107985,-3.700699007813787
KYSE-450,4259181,0.2433830255631184
HEC-59,11612883,3.306557923850926
B-CPAP,24771867,2.555650366496606
CHP-212,71466380,2.971622140588121
BT 248,2858523,2.3138600326756436
OAW28,11625818,4.459236282412159
BL-70,vorinostat-navitoclax (4-1 mol-mol),0.6455256397554963
OCI-AML-3,9825149,0.7675282403595713
SW1783,11485656,3.310538702987134
HCC1395,73707398,1.348655515938351
F-36P,tanespimycin-gemcitabine (1-1 mol-mol),-0.5559323208493928
SNU-410,11222830,1.8928877943326288
OCI-AML-5,9549297,1.4528425595868948
BT 231,selumetinib-PLX-4032 (8-1 mol-mol),4.624189309726486
Panc 03.27,11234052,4.819412556928769
BL-70,5738263,2.332538641891293
OCI-AML-3,3503,1.2589342656459346
OAW28,11977753,-1.87780111267196
SF539,10427712,3.91731820186957
SF539,11257553,0.3367320269985683
SNU-1077,969516,4.920096093874863
OPM-2,11404337,-1.9830798838769188
BT 428,salermide-PLX-4032 (12-1 mol-mol),3.1520457588313824
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033
HEC-59,148198,-3.009683743491751
KMS-20,51039095,1.9722708258577504
BL-70,44607531,1.2981053721141755
SNU-1077,4259181,2.3802371330202137
NCI-H1568,387447,-3.95080818095812
F-36P,6918878,-0.3157331643976424
BT 428,5280436,3.3234949053398912
OAW28,46199207,3.397949359639469
YKG-1,navitoclax-piperlongumine (1-1 mol-mol),3.397056870192574
TCCSUP,6918328,-0.4251652651497192
Panc 03.27,selumetinib-tretinoin (2-1 mol-mol),4.684058653663167
CHP-212,6610216,3.760481483683652
NU-DHL-1,448949,-1.77397684546658
OPM-2,JQ-1-carboplatin (1-1 mol-mol),-2.077921094958442
OPM-2,44462760,2.3304413416808463
A4/Fukuda,36314,4.126705075384559
BT 428,36314,-5.043833616010499
BT 245,24180125,3.7251003604929167
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178
Hs 746.T,5291,3.8449808154297624
Hs 746.T,25183872,-0.2554932624587745
Kasumi-2,11647372,-1.94314797775666
Hs 746.T,44493528,3.791108114559063
OCI-AML-5,11396600,3.436150065828036
F-36P,11612883,1.2098537814899393
JHUEM-3,10302451,0.6588208189074596
Ku812,67156097,-2.3155423886631117
BT 245,1566236,1.7422793804281065
BT 428,24964624,2.3642345929381525
KMS-20,25227462,-3.9594980981183534
HPAC,10385095,1.6323615748888127
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317
SNU-201,46174525,4.907355020561069
F-36P,crizotinib-PLX-4032 (2-1 mol-mol),1.0889569136706556
HPAC,24964624,2.592961838300328
Panc 03.27,5287969,-2.466334386357987
NU-DHL-1,16038120,1.471185196159862
HEC-59,44484440,3.6083291111938416
WM88,24748573,1.7950247245078663
KHM-1B,6450551,1.2159742345507
B-CPAP,31703,-0.7132300755185688
OCI-AML-5,5291,3.8464146351165143
A4/Fukuda,selumetinib-JQ-1 (4-1 mol-mol),-0.1942413967070371
BFTC-909,9911463,4.114346930944119
SW1783,44566777,2.310065302579828
SF539,1285940,2.084694719582332
AU565,3025944,3.700689922668097
BL-70,73707398,0.9826136409699476
OPM-2,53495165,-4.146839218250571
HPAC,6918837,-0.9507122200950294
SF539,25150857,2.307908802702035
NCI-H1184,53232,3.9440091483459696
Ishikawa (Heraklio) 02 ER-,44507138,3.541152927968452
SH-10-TC,25262965,0.8763644277457137
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032
NCI-H2141,9825149,1.020474739209724
YKG-1,11719255,4.471587264464231
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056
BT 245,72193861,0.6235910054430077
OPM-2,8515,3.0418796641091226
SH-10-TC,15983966,-4.145909095441111
M-07e,44137675,3.272566804511678
KYSE-70,168313047,2.1859183661660624
YKG-1,11717001,4.560589494626805
WM88,selumetinib-PLX-4032 (8-1 mol-mol),-3.130163115831526
PF-382,52947716,-1.076920291398276
OCI-AML-5,selumetinib-JQ-1 (4-1 mol-mol),-0.0288655863231173
SH-10-TC,10296883,4.6565479517394355
OCI-AML-3,9952709,1.0288550369816305
HCC38,16736978,1.562452499105979
LOU-NH91,51039095,2.9779244840652295
JHUEM-3,10410894,2.717820823358908
M-07e,53392493,1.623107955813884
SF539,3825829,3.026626259970261
SK-MEL-28,89928392,1.8249955752671516
A4/Fukuda,9884685,-2.10728676228506
KMS-20,135999136,4.473937191041351
YH-13,24797083,1.5819702777514613
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644
EM-2,135440466,1.3860991816790655
OCI-AML-5,11404337,0.1912186748994763
OCI-AML-3,vorinostat-carboplatin (1-1 mol-mol),1.573298801977893
OAW28,46843906,3.2241568449076556
YKG-1,46907787,4.9363681806831075
EM-2,60750,-3.82604170032491
PF-382,2729026,0.5855884852341721
KMS-20,11485656,2.050412836201762
BL-70,451668,4.343212646512107
A4/Fukuda,44607531,1.1783204907000706
JHUEM-3,carboplatin-UNC0638 (2-1 mol-mol),5.245478023706933
SNU-201,6918837,-2.079502839614668
OAW28,11497983,4.916879328733168
RKO,10385095,1.2981289243482117
NCI-H2196,54618164,3.883343219938622
JHUEM-3,374536,-2.6551227521179115
CHP-212,46215462,1.603060682888938
OPM-2,selumetinib-BRD-A02303741 (4-1 mol-mol),2.0894009030955245
BFTC-909,2113511,5.65564772398506
NCI-H1184,66577038,3.1219233610721813
KYSE-70,452548,2.3575041584151637
LOU-NH91,24821094,3.1074025746804854
BT 428,53495165,-0.8877317090546629
MM1.S,SNX-2112-bortezomib (250-1 mol-mol),-2.3785977719805595
KMRC-20,123631,2.7325982206325503
AU565,25062766,2.0331930756167234
NCI-H2196,107970,1.7459552506758529
RERF-LC-MS,1750826,-0.5689233588179538
HCC38,navitoclax-piperlongumine (1-1 mol-mol),0.5765898052025243
NCI-H1184,tretinoin-navitoclax (4-1 mol-mol),1.5709363858808023
NCI-H1184,6918289,-1.4171623146072498
CHP-212,426756,4.380321399010382
LOU-NH91,10184653,1.5324310696398793
Ku812,168313047,1.6186365472773052
SNU-201,doxorubicin-navitoclax (2-1 mol-mol),-2.1072451833777075
PK-59,4477,2.9519162685553666
SNU-410,11964036,2.6635796405697167
BFTC-909,54619267,3.991913685478571
BT 245,66577038,2.2166864722744157
RERF-LC-MS,24772860,-2.3078196081029136
Hs 578T,navitoclax-pluripotin (1-1 mol-mol),-1.655823533126764
OCI-AML-5,60700,-2.9161103090975984
B-CPAP,5335621,5.443588151339274
A4/Fukuda,135875424,2.943838777845953
OCI-AML-3,carboplatin-etoposide (40-17 mol-mol),0.1315758865789027
PK-59,89928392,1.3322949630136172
BL-70,11719255,2.9968013610122957
YH-13,54613361,-0.2526246447247056
ML-1 [Human thyroid carcinoma],8515,2.907082200923046
F-36P,208908,2.103294720422053
B-CPAP,5311281,2.231361409647184
SNU-1041,11175137,3.1918457109712155
SNU-1077,ISOX-bortezomib (250-1 mol-mol),0.925773470547737
A4/Fukuda,6914657,-5.308594861321554
Ku812,5287620,-1.7974758930014358
OAW28,24964624,1.7856613849766505
OCI-AML-5,decitabine-carboplatin (1-1 mol-mol),4.581944374852532
OCI-AML-5,44589607,2.8984861624794545
KMS-20,46199207,2.2005860320322532
BT 428,16725315,3.4626765815418374
RKO,10296883,4.075814636405189
NCI-H2196,46215462,1.7990465329093293
YH-13,71751553,4.865573337264169
NCI-H1568,5394,4.198509108960074
AU565,2126,4.335330080531479
SK-MEL-28,44507138,4.029027628545452
KMS-20,42611257,2.1874354470841366
BL-70,2729026,2.39228879135414
YH-13,3552672,4.052352129280503
SK-MEL-28,selumetinib-PLX-4032 (8-1 mol-mol),2.641553313699231
HPAC,17755052,1.9122961967632768
CHP-212,decitabine-navitoclax (2-1 mol-mol),2.494810646698237
OCI-AML-3,11964036,-0.4067917872770206
BT 231,4788,4.836465163715281
BT 245,9933475,1.6459708164616211
KHM-1B,5284616,-7.181826614115283
NCI-H1568,5328940,0.3466597705312412
WM88,5335621,6.237111710562693
HCC38,9915743,2.4807170857977865
SF539,4788,3.861213831162074
KMS-20,11427553,1.7901611501195382
Panc 03.27,54618164,4.198880096494509
SNU-1077,17755052,2.9989648032129477
CHP-212,10184653,1.565907746620674
SNU-201,6610216,5.085362707909801
YH-13,5287969,-1.6680517760665383
NU-DHL-1,49793307,-5.248785765365087
OCI-AML-5,6852167,1.9136367887966896
NCI-H1184,49793307,-2.7161994421158444
TCCSUP,11609586,3.3577179942858737
Ishikawa (Heraklio) 02 ER-,216345,4.678844005480184
NCI-H1568,44607530,0.8979533446197012
OAW28,46174525,4.143540766033049
OPM-2,9884685,-0.7869928949425254
MM1.S,6610216,4.132453161575956
HEC-59,439501,-0.4694388725326887
OAW28,25062766,3.2225198305631464
OPM-2,51039095,-2.6866952618976434
SNU-201,24964624,2.7131305011593017
NCI-H1568,24821094,1.7576462865100984
PK-59,3634881,4.345814467593551
JHUEM-3,selumetinib-PLX-4032 (8-1 mol-mol),2.6749003586984403
BL-70,16736978,0.5451036246322358
Rh30,25195348,4.919214420192468
Hs 746.T,11719255,3.1942614718045155
KHM-1B,676352,1.5366481423958254
NCI-H2141,ISOX-bortezomib (250-1 mol-mol),-0.0675239813788297
NU-DHL-1,10074640,2.3359840831804313
SW1783,11222830,3.574830884827046
NCI-H2141,3825829,4.046208623846932
BT-474,6918638,-0.8202779774932777
BT 248,5280436,3.4551701194558935
SF539,969516,2.5473257168551666
M-07e,1716436,2.8997519254930335
BT 231,53393127,3.729984471399415
KYSE-450,285033,-1.7116882105667988
MM1.S,72193861,1.743096021733494
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523
Hs 746.T,10184653,1.540691584656012
M-07e,52947716,-2.723223258619332
PK-59,10385095,1.2934299374128844
BT 248,969516,3.2750512548532136
OAW28,3062316,-0.5042902382709098
Ishikawa (Heraklio) 02 ER-,3503,1.3945277480644842
BT 428,11656518,-0.4028199439266288
KMRC-20,216345,4.461604453697398
OAW28,navitoclax-PLX-4032 (1-1 mol-mol),0.8085168342151391
Hs 578T,JQ-1-navitoclax (2-1 mol-mol),-0.1664451954241252
SW1783,135440466,3.5592190192568114
LOU-NH91,decitabine-navitoclax (2-1 mol-mol),-0.8280147922678951
M-07e,702558,2.7226193795980755
Kasumi-2,375860,-0.7090394918812726
KYSE-450,89928392,1.680457877716282
JHUEM-3,44137675,2.2239893259289456
Hs 746.T,49867926,4.149124624474956
NCI-H2196,9952709,2.3213517494105593
SK-MEL-28,16065773,2.9091581541249223
EM-2,2733487,6.440287068757207
HCC38,6918328,0.6591880375871269
OCI-AML-3,119182,3.203619046714375
OCI-AML-5,11228183,0.1808660185721331
WM88,36462,2.778591866824928
Hs 746.T,9933475,2.037189491467031
OAW28,navitoclax-pluripotin (1-1 mol-mol),-0.843922258994718
HCC38,JQ-1-MK-0752 (1-1 mol-mol),0.9374480350197134
WM88,5284329,5.212969329993301
CHP-212,6438330,1.8545169998168576
YH-13,11455910,2.765771134789071
OPM-2,11167602,1.1745103577473592
RERF-LC-MS,24753719,5.208830602571573
HPAC,4261,2.940312111133874
Panc 03.27,25062766,1.8510174598593432
BT 428,23582824,2.346133549471676
BT-474,11955716,-1.355057261720375
B-CPAP,11222830,1.6970126110627293
BT 428,10322450,4.171296655818114
Kasumi-2,4521392,4.1748849427500625
F-36P,2945648,1.3106918687552636
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631
RKO,6450551,2.9764230599456782
F-36P,89928392,0.656396533220538
AU565,9956119,3.3766215860348368
HCC1395,11485656,2.290865171040868
AU565,148124,-5.63717967948206
YH-13,5281321,-2.463748915985143
OPM-2,11213558,0.5330056992590615
OCI-AML-3,selumetinib-JQ-1 (4-1 mol-mol),-2.716692997206964
HCC1395,4259181,0.1311462895447667
OCI-AML-5,89183176,3.8371528591900304
NCI-H2196,322968,2.2568895406205254
F-36P,24901704,2.131485573625626
KMS-20,11717001,3.5596278173639835
BT-474,10127622,6.068386930996929
NU-DHL-1,24901704,2.6374466424788356
BT 428,676352,2.1642007424607557
BT 428,10231331,-0.1978015197872311
BT 428,54619267,4.122118553601479
HPAC,6610216,3.983150861287026
KHM-1B,6918878,3.029851495909813
BL-70,4096211,1.067132457693516
KYSE-70,vorinostat-navitoclax (4-1 mol-mol),1.6518262185005994
CHP-212,4096211,1.0475872906589083
Rh30,6918837,-3.1572783556353388
RERF-LC-MS,11612883,2.474683430971872
AU565,5280436,3.6175977861549473
Panc 03.27,126941,-4.888625835306343
Ishikawa (Heraklio) 02 ER-,3025986,0.0796425766319246
Hs 746.T,24771867,4.231120208949857
AU565,11719255,4.218610599596327
Kasumi-2,navitoclax-piperlongumine (1-1 mol-mol),-3.156994425462095
NCI-H2196,71680916,5.255077714699671
Ku812,selumetinib-vorinostat (8-1 mol-mol),-1.7038187664037243
HCC1395,119607,5.3319725567837475
Hs 746.T,selumetinib-JQ-1 (4-1 mol-mol),1.3690652535230534
A4/Fukuda,24856436,-2.105951383298443
M-07e,JQ-1-MK-0752 (1-1 mol-mol),-0.8700067516181741
KYSE-70,46199207,3.0458734214111436
SW1783,16065773,5.946044884546371
Hs 746.T,23725625,5.965587525699161
EM-2,46398810,1.4546793757668337
KMS-20,104842,-4.95901486656118
MM1.S,6623618,2.4719369503455257
KMRC-20,76446078,4.8666377437919985
BT 428,11427553,3.3275114517957047
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391
HCC38,374536,2.47724645978947
Hs 578T,637858,1.2517408441018556
Rh30,3689413,-2.408934939466004
SF539,6852167,2.369096859709367
AU565,60700,-0.684074891390158
HCC1395,crizotinib-PLX-4032 (2-1 mol-mol),2.543471406396822
SH-10-TC,11152667,-0.1352620924138639
Kasumi-2,BRD-K55473186,1.9287541942318225
NCI-H2141,135999136,2.014096560063098
RERF-LC-MS,439501,-1.3704502050640626
SF539,11222830,0.6495721704540977
BT 428,selumetinib-decitabine (4-1 mol-mol),1.6180700398906596
KYSE-450,448949,2.8281207411790374
HCC38,3825829,4.30429369181038
YKG-1,44486219,4.265701062085959
ML-1 [Human thyroid carcinoma],65064,4.907366569161651
BT 248,3825829,4.117903271720201
EM-2,124202324,0.3964760545868884
KMRC-20,71304818,2.472376058947576
KMRC-20,ISOX-bortezomib (250-1 mol-mol),1.611645137466779
SNU-201,71304818,3.2567077838792726
NCI-H2196,11178236,-4.312337127657337
M-07e,25022340,-0.1322754026165153
NCI-H2196,439501,-1.9043844138508108
LOU-NH91,11964036,1.2476019563081622
RKO,5287620,-1.9975210326345276
BT 245,11214940,4.373430714456017
KYSE-450,4788,5.909868922921636
BT 245,241158,3.5873529093746828
WM88,216468,4.097342200917988
OCI-AML-3,241158,2.768035371877761
BT 248,9933475,1.8575466823142976
WM88,1239801,5.14539215787368
Panc 03.27,52912189,5.687036017467693
SF539,135398516,2.131078137574097
HPAC,400769,-1.941204804997912
KYSE-450,9840324,5.8174625933687265
BFTC-909,25183872,0.7872065650622051
PF-382,alisertib-navitoclax (2-1 mol-mol),-3.018293825143377
PF-382,148198,-4.947878541405711
BT 428,5566,2.5065261777793535
OPM-2,11238147,3.2386204402735874
NCI-H2141,11612883,3.4792871520393542
SK-MEL-28,11364421,2.320063094924172
BL-70,53232,1.6751756864648488
HPAC,12003241,0.9185778330779416
OCI-AML-3,11612883,0.9490188126195658
Kasumi-2,10410894,1.8135964606255892
SH-10-TC,216345,4.433706487742709
Kasumi-2,24964624,-0.4292953548999766
Kasumi-2,11234052,3.910537949204277
RERF-LC-MS,72376,-2.3536044208150644
BT 245,25154868,4.682351390968789
OCI-AML-5,11317348,0.9742648891712992
PK-59,1242560,3.3598439787312167
AU565,6852167,0.824199435407992
OPM-2,46943432,-1.735277326796896
Hs 578T,46174525,4.523654737816212
OPM-2,navitoclax-MST-312 (1-1 mol-mol),0.8084377370546902
EM-2,selumetinib-tretinoin (2-1 mol-mol),-2.6444679765994357
NU-DHL-1,72376,-4.025213511339456
OCI-AML-5,107970,2.8114256045372
SNU-201,9936388,2.3725441363874236
BFTC-909,11214940,1.666026285351028
NU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),-0.984371811473836
SH-10-TC,387447,-4.92778108245121
NCI-H2141,36462,2.278510684114093
LOU-NH91,selumetinib-MK-2206 (8-1 mol-mol),3.1932369628338195
BT 231,44632017,0.7872188651788097
F-36P,44607531,1.5258917718947242
BFTC-909,11317348,4.568727931072339
NU-DHL-1,135440466,3.3716397656308827
OAW28,1716436,3.318226269910468
BL-70,5282054,2.404885200456482
Rh30,1641662,3.178508328191662
A4/Fukuda,44589607,1.1710928843495056
OPM-2,71680916,3.9051822114426025
A4/Fukuda,219104,2.2512696330904447
KMS-20,10427712,4.433037209532288
F-36P,46907787,-0.7684715218448218
SNU-410,448949,2.2808641371991736
PF-382,9927531,5.462558018035092
BT 245,erlotinib-PLX-4032 (2-1 mol-mol),2.709107671122578
OCI-AML-5,2708,3.5050212712565947
HPAC,1242560,3.0483352814850453
Panc 03.27,1566236,2.3499818808083064
OAW28,11964036,1.3272537866850969
BT 245,24785538,-0.3244918741267977
OCI-AML-3,25161177,0.6301295006426848
Hs 746.T,3854666,2.6045097457620465
JHUEM-3,5311281,1.3342067232257702
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193
AU565,doxorubicin-navitoclax (2-1 mol-mol),-1.8766069789082105
Ku812,docetaxel-tanespimycin (2-1 mol-mol),-7.546538272108434
SNU-1077,72376,3.5182408095269073
BT 428,2130404,2.4494899082687107
MM1.S,3025944,3.5237417636724215
BT 428,44607530,0.8800412627899294
YKG-1,7251185,2.916667385040177
OAW28,12003241,-0.542287488877267
CHP-212,9935249,1.3663209076830405
BT 428,9823820,4.120074007569746
Ishikawa (Heraklio) 02 ER-,alisertib-navitoclax (2-1 mol-mol),2.271404512793382
HEC-59,676352,2.68510241485619
BT 245,60750,-2.2202971803272624
OCI-AML-5,2858523,3.161480594135185
F-36P,24779724,4.9138855829975565
A4/Fukuda,4261,-0.9007526332595048
YH-13,24785538,1.1754482929087915
BT 248,9967941,3.931710866923424
SF539,5566,3.0115367431942865
RERF-LC-MS,148124,-5.592640359076286
Rh30,54619267,3.952190534779683
CHP-212,24771867,-4.650090613035068
SK-MEL-28,4917,3.066656209778127
SW1783,46398810,3.5693364639360747
NU-DHL-1,25161177,3.575744569500696
EM-2,44202524,0.8025534107756613
OCI-AML-3,136227924,1.3599145322416812
SF539,1716436,2.913378639025297
M-07e,52912189,-0.5924105897308786
SNU-201,54618771,1.5381558224082674
BT 245,24951314,0.5765525749771954
CHP-212,11427553,-0.0767294741293783
SNU-1077,4788,5.080655668711155
KMS-20,9884685,-0.8480553066997102
BFTC-909,11222830,1.7098036316197358
KMS-20,73707398,-1.0592725192615595
Panc 03.27,53232,1.8063770547760587
YKG-1,4259181,0.3868166013965885
HPAC,tanespimycin-bortezomib (250-1 mol-mol),-0.5212433601902327
Ku812,9903786,1.763683139425592
TCCSUP,selumetinib-JQ-1 (4-1 mol-mol),2.2207378270123725
RERF-LC-MS,16720766,0.5604118097796991
PF-382,322968,1.8904688275492667
SH-10-TC,vorinostat-carboplatin (1-1 mol-mol),3.916917932534554
HEC-59,navitoclax-gemcitabine (1-1 mol-mol),1.5756510550530318
OAW28,107985,-3.5497769626209217
BT 248,241158,3.909930885156875
BT 248,BRD-K55473186,1.6909762369263868
CHP-212,46907787,-1.3675859090756428
M-07e,54618164,3.9701708331958585
EM-2,400769,-1.2817938109387068
KMRC-20,3025944,4.366878976688431
KYSE-70,25195348,5.534160735777195
SH-10-TC,9884685,3.631476367936063
Ishikawa (Heraklio) 02 ER-,100016,6.479675962630039
NCI-H1568,400769,-0.2296701698466811
SNU-201,4261,1.5939186211501908
NCI-H2196,5281321,-1.4968482425057177
SNU-201,439501,0.2163207704150155
TCCSUP,49867926,4.195310139581862
OAW28,5328940,1.8035592963336344
B-CPAP,676352,2.971281112098332
BT 428,6918328,-1.0441125619868274
BL-70,25161177,3.935888212136895
B-CPAP,5282054,3.7840154230687295
Ku812,568763,-0.5026436454206128
Kasumi-2,3136844,3.733604332390159
NCI-H2196,11214940,1.683915039674296
Ishikawa (Heraklio) 02 ER-,44185566,3.1940323665900645
PF-382,44507138,1.103120922160699
B-CPAP,17755052,3.4143751871388788
TCCSUP,65628,5.421928358435332
LC-1F,2126,4.718741654706531
M-07e,216239,1.812591100328752
ML-1 [Human thyroid carcinoma],676352,2.608959843452948
B-CPAP,10385095,0.9210921841581224
NU-DHL-1,60750,-6.327200330067859
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351
AU565,71751553,3.982904849419344
OCI-AML-5,navitoclax-birinapant (1-1 mol-mol),0.662967674718796
Kasumi-2,6918837,-5.725087899258232
NCI-H2141,24785538,-1.268203833925154
YKG-1,11609586,3.3937959596704523
SH-10-TC,54678924,3.4053930598112716
KYSE-70,1716436,3.404085131889099
BT-474,53392493,3.593378889832688
SNU-1041,9907093,6.231299308366514
NCI-H1184,65064,2.928681081233965
NCI-H2141,208908,1.6281532219505708
BFTC-909,4378219,4.497242068417329
BT-474,5282054,3.2430502507704366
WM88,10113978,2.079613697473588
SK-MEL-28,2749,2.6265102765061936
YKG-1,148124,-3.4477323343219637
OPM-2,31703,-1.5109362720248076
LOU-NH91,387447,-3.4249375140388247
WM88,156414,1.6850419616886465
KHM-1B,54618771,-0.6219515555388266
CHP-212,9887053,1.8136622207304371
BL-70,16722836,1.2323723338373458
Kasumi-2,451668,-1.101171086852316
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868
KYSE-70,24180719,3.52071426185984
OAW28,148124,5.441417229348929
Hs 746.T,441298,3.489756241526439
KHM-1B,11507802,0.7645643199546858
NCI-H2196,9956119,4.194968210461876
SF539,56963564,-0.1880547909604584
BT 248,613753,3.1927723368663976
KYSE-450,5113032,4.607851328424312
A4/Fukuda,56963564,-0.5107551488404702
KYSE-70,89183176,4.766828638924323
SF539,11175137,2.017622399930718
BL-70,1242560,1.2011490100589577
TCCSUP,168312962,2.9048095339563615
Hs 578T,16725315,2.858827393993907
PK-59,vorinostat-navitoclax (4-1 mol-mol),1.1814860729978631
F-36P,44507138,1.3156161082270532
BFTC-909,56973724,3.22598802973391
NCI-H1184,11485656,2.662632991644762
HCC1395,51039095,2.5898430552425875
Kasumi-2,1566236,1.00471674851072
BT-474,24901704,4.511056748122099
CHP-212,36462,-1.1784349371893996
Hs 746.T,25195348,5.5630413705170705
BT 231,44507138,2.6269002038647615
Panc 03.27,25126798,3.843216547733275
NCI-H1568,375860,-0.3746562160702436
TCCSUP,11404337,-0.4859326706611666
RERF-LC-MS,9866186,0.0636323256725951
SNU-1041,navitoclax-pluripotin (1-1 mol-mol),-1.2077032275797062
WM88,100016,6.2407728308576
CHP-212,11497983,-3.5960049694490235
Hs 578T,462382,0.070039804525336
BFTC-909,44589607,3.3115887945185496
LOU-NH91,2945648,3.130856585594597
TCCSUP,5328940,1.4303575035748048
PK-59,6438330,1.1119626905782527
HCC1395,10113978,3.5564040576223768
B-CPAP,4378219,2.1409307713074353
PK-59,15953870,6.175335011158435
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187
NCI-H2196,2126,4.169231915045233
BT 428,selumetinib-JQ-1 (4-1 mol-mol),-0.8814562357404941
KMS-20,135421197,1.5361253797366796
KMRC-20,3634881,4.3387746647694545
MM1.S,5328940,1.2024233811688534
BT 231,3854666,-0.8969243562437486
NU-DHL-1,25102847,3.3147943558623916
M-07e,135928012,3.338942058081814
AU565,selumetinib-BRD-A02303741 (4-1 mol-mol),5.383276880115408
OAW28,sirolimus-bortezomib (250-1 mol-mol),0.5300285701267512
WM88,56649450,2.7174782037521217
SNU-410,51039095,4.3195624138488835
Hs 578T,57330099,4.262619819220068
MM1.S,2708,4.3305699285872095
HEC-59,4917,3.4844810699395015
KMS-20,11609586,1.7506096338547088
RERF-LC-MS,16065773,2.958049600168222
SF539,7326481,2.919170434383445
OPM-2,5951923,4.162321290800766
OPM-2,24772860,-2.8738620885527153
CHP-212,docetaxel-tanespimycin (2-1 mol-mol),-6.143042519144637
BT 245,9911830,3.123552720106954
Hs 746.T,24797083,1.2759345459660614
OCI-AML-3,UNC0638-navitoclax (1-1 mol-mol),2.252668799817522
M-07e,135875424,2.6099381217800897
TCCSUP,46398810,2.9354899983931433
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474
Hs 578T,2742550,3.5663140561815525
BT 231,vorinostat-navitoclax (4-1 mol-mol),1.6992938438936256
OPM-2,16722836,0.349034656527362
B-CPAP,24964624,2.8727163930328863
EM-2,969516,1.690362947895492
AU565,36314,-7.774521242942876
HPAC,11175137,3.0538496475298005
SK-MEL-28,6918328,1.6260259804772523
YH-13,JQ-1-carboplatin (1-1 mol-mol),2.725669158848688
KYSE-70,3038522,4.319477989558539
JHUEM-3,10296883,4.22416361613302
LOU-NH91,3543504,4.266458043071255
KMS-20,65628,3.828249966077918
Rh30,46843906,2.732332941304265
KMRC-20,24951314,2.492306253507562
SH-10-TC,4705,3.0238585653901655
KMRC-20,6918837,-1.6564527147795
SNU-1077,9911830,1.9332136731221603
F-36P,16659841,1.075528013399748
BT 248,11396600,1.9236183524788075
KMS-20,5281672,3.173673228263361
OAW28,1641662,3.6011202742070014
TCCSUP,9866186,0.3225667435686323
RERF-LC-MS,56963564,0.3267097404636779
NCI-H2196,31703,-1.4272348459475308
HCC38,11152667,-0.905518740650514
TCCSUP,124202324,2.3353692726600173
Kasumi-2,9967941,2.996370075692804
AU565,285033,-2.964869253470222
Kasumi-2,72199292,0.0568572050486096
SW1783,5281321,-0.3453049143187137
Ku812,73707398,0.2962870044778456
OPM-2,9903786,2.6412283094975657
BFTC-909,6252,5.031852570794812
OCI-AML-3,navitoclax-sorafenib (1-1 mol-mol),1.213839657896952
Ku812,11364421,-4.941394755779054
OCI-AML-5,navitoclax-pluripotin (1-1 mol-mol),-0.7976707025067661
WM88,262093,2.979155040217876
HCC38,selumetinib-MK-2206 (8-1 mol-mol),3.7471161947327354
OCI-AML-3,11609586,0.7526495688347354
Hs 746.T,135440466,3.11604039768914
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516
EM-2,selumetinib-decitabine (4-1 mol-mol),-2.62107668612452
EM-2,46199207,2.592435124161624
KHM-1B,JQ-1-vorinostat (2-1 mol-mol),-0.1758433625327752
BT 428,56646779,6.2069674563861374
SF539,57519531,1.493804886958663
Rh30,400769,-1.3061502170228465
KMRC-20,6623618,2.3324454815197546
OPM-2,17755052,0.9533058757913144
BT-474,5287620,-2.0025894618868496
HCC1395,3038522,3.8852674857908
RERF-LC-MS,6918638,0.4520678244574614
OAW28,UNC0638-navitoclax (1-1 mol-mol),1.4894889011779118
TCCSUP,49850262,3.4610282531940615
Hs 578T,6918878,0.8422560555688274
TCCSUP,654092,0.20661025220839
WM88,JQ-1-MK-0752 (1-1 mol-mol),2.924344153515005
SF539,4705,3.4621418210440296
HEC-59,25126798,3.8993053271686056
SNU-410,24797083,2.0425337192975515
TCCSUP,16219061,3.6706292867258945
HPAC,446155,4.10748000015411
PF-382,24771867,-1.6533655868224757
Ishikawa (Heraklio) 02 ER-,409805,6.059507379777802
RKO,54649381,4.449908747747005
YH-13,16659841,3.3586443316598675
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737
RKO,10231331,2.816804700080647
Rh30,54678924,1.6486065047119527
LOU-NH91,44607531,1.3180545967249335
EM-2,119182,-4.294023679910607
YKG-1,3062316,3.550628439107019
BT 231,3552672,1.0850091366023025
BFTC-909,5280436,4.2143472852581025
SF539,19582717,5.548936804809817
KMS-20,67291369,0.8651776622015213
Hs 746.T,5282054,2.5239221810619736
NCI-H2196,2729026,2.4392536017463606
OAW28,selumetinib-UNC0638 (4-1 mol-mol),3.3800048421879314
OCI-AML-5,4259181,0.0010032377974649
NU-DHL-1,36462,-1.7187718695601946
NCI-H2196,262093,1.390749456679199
PF-382,11214940,-0.2172300020723663
Hs 746.T,25102847,-1.35806176850936
BL-70,45279963,2.711458401698186
NU-DHL-1,11228183,-3.596114572397512
Kasumi-2,3062316,1.0772152233383698
BL-70,11625818,1.8980120184603424
BFTC-909,122327,4.590877432942681
YH-13,11609586,3.847087958422487
Hs 746.T,135398516,1.2720179536301022
BT 231,3503,0.9797586267103968
MM1.S,vorinostat-navitoclax (4-1 mol-mol),0.234201323226823
F-36P,54618771,0.2911241423131909
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436
NU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),1.320938208731918
EM-2,25150857,2.2689419481266393
HEC-59,6852167,2.4613827156801937
AU565,16720766,2.906162391657848
SH-10-TC,1566236,3.879679185733888
NCI-H2196,135398516,1.3820059381137586
Ku812,2113511,4.022010912633414
BT 428,9952709,2.8094691608095257
OAW28,serdemetan-SCH-529074 (1-1 mol-mol),2.2159278934374416
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983
YKG-1,45279963,4.304411410062701
LC-1F,tanespimycin-bortezomib (250-1 mol-mol),1.261925234920199
RKO,2729026,2.3662843020346753
NCI-H1568,16736978,1.0202421307584555
TCCSUP,24753719,4.825833368668945
SF539,24821094,1.7680388640350837
OPM-2,3384730,1.6721258053175836
Ku812,5278396,2.880964948790695
Hs 746.T,9936388,2.9301322002426393
NCI-H2141,doxorubicin-navitoclax (2-1 mol-mol),-1.3882595832258189
NCI-H2196,24771867,4.181085401739465
AU565,46907787,3.197599854412173
HEC-59,49850262,4.876065479184363
B-CPAP,25102847,2.584814595115363
OCI-AML-3,24821094,3.416493494209137
Hs 746.T,selumetinib-PLX-4032 (8-1 mol-mol),3.005687498695148
SNU-1041,9911463,4.300045729883578
KMS-20,selumetinib-vorinostat (8-1 mol-mol),-0.0574541449020858
OPM-2,decitabine-carboplatin (1-1 mol-mol),3.56587263318402
SH-10-TC,151289,1.3827614252819718
HEC-59,tanespimycin-bortezomib (250-1 mol-mol),0.4869715963462457
HCC38,135411,0.5496750692519626
F-36P,100016,3.924028764616067
Panc 03.27,387447,-4.361669860899462
B-CPAP,148198,-2.876725444252461
Ku812,navitoclax-piperlongumine (1-1 mol-mol),-0.4247050049516961
M-07e,vorinostat-carboplatin (1-1 mol-mol),1.0705978468988808
NCI-H2141,25105715,3.595625950557029
M-07e,60750,-4.075775984253944
AU565,5287969,-1.6574542255158256
Ishikawa (Heraklio) 02 ER-,54613361,-0.1781833955889748
HCC1395,6852167,3.6940482841079647
AU565,71729975,2.800801196457704
BL-70,54618771,0.7229646502566096
NCI-H1568,119607,3.825066299684422
KHM-1B,119607,4.337560231303076
RKO,613753,3.427719504210608
OPM-2,53392493,1.6243275023991692
HCC38,UNC0638-navitoclax (1-1 mol-mol),1.0044709258096385
AU565,49793307,-1.974878634968376
NCI-H2196,docetaxel-tanespimycin (2-1 mol-mol),0.239815634064269
BFTC-909,11455910,1.958059547603208
BT 231,3025986,-0.400270845305179
NCI-H1184,5328940,2.135382312596483
KHM-1B,10074640,2.3153156166587783
HEC-59,1242560,3.707661983480972
WM88,387447,-5.090155290607234
OCI-AML-5,navitoclax-sorafenib (1-1 mol-mol),0.5439778586725781
WM88,11178236,-2.889806829915129
B-CPAP,6917907,-4.328736065913287
OCI-AML-3,55508,1.93485587039713
Kasumi-2,24180125,1.6711646659047346
SF539,24772860,-2.3648669148494856
AU565,9887053,5.902090445564702
NCI-H2141,12001922,1.037553574527669
A4/Fukuda,10184653,1.3612642262853822
Ku812,selumetinib-JQ-1 (4-1 mol-mol),-3.4448372792658857
OAW28,2858523,3.071437644261336
M-07e,753704,4.196177956584847
SNU-1041,637858,3.0266803479554034
SNU-1041,168312962,3.75573465587258
SNU-1041,53232,2.2136619802604964
SK-MEL-28,241158,4.1117452183175445
NU-DHL-1,446155,2.7819424460824274
NCI-H2196,119182,3.3823049149182025
PF-382,9887053,3.994345366087283
BT 245,3384730,0.4138471294371557
KMS-20,44607531,1.4954007749288158
SF539,71466380,4.199081692054065
Kasumi-2,navitoclax-MST-312 (1-1 mol-mol),-2.959240355083437
NU-DHL-1,60700,-4.437717551634179
F-36P,5494449,1.3820344603189991
OPM-2,1239801,3.3443313732590543
Hs 578T,439501,-3.2814601954597915
NCI-H2196,11222830,1.617655878644418
HCC1395,46191454,2.7602639829125017
HCC1395,654092,-0.172853790722122
EM-2,15547703,2.718861050765462
OPM-2,11178236,-3.008129792299995
LOU-NH91,119182,4.180997641513534
HPAC,24901704,2.7133195616924453
Hs 578T,11485656,1.5061337844813831
BT 428,9956119,2.323897246428331
HEC-59,135398738,6.435116318326316
MM1.S,10296883,3.0108141042121246
BT 248,JQ-1-navitoclax (2-1 mol-mol),0.658869929233474
HCC38,9444,3.5570779406659563
KYSE-70,375860,-0.042936769343065
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706
MM1.S,10113978,2.8208205912142597
Kasumi-2,11175137,1.5162390215690418
OAW28,68056272,3.642995313586114
EM-2,5460769,2.512608661279844
M-07e,241158,4.092457424530606
CHP-212,176870,4.137554706765119
KMS-20,19582717,1.3096306305639924
JHUEM-3,11485656,2.0558841747808776
A4/Fukuda,carboplatin-etoposide (40-17 mol-mol),0.4853632935092173
Hs 578T,6610216,4.144845051199694
CHP-212,644241,2.544720169894308
HEC-59,119607,3.977779319890785
BL-70,73707438,3.685493258454157
Kasumi-2,89928392,-0.7212883806223124
Ku812,156414,-0.0936884682974776
OCI-AML-5,selumetinib-PLX-4032 (8-1 mol-mol),4.36801970861221
OAW28,24964624,1.7856613849766505
F-36P,9866186,1.0260521915671856
KYSE-450,11175137,3.731022611434211
F-36P,11494412,-1.3209854958695244
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417
YKG-1,25195348,4.74888442973518
BT 248,2708,3.971792549478314
OCI-AML-5,11152667,-1.4309616874651
NCI-H1568,25062766,1.9660972036535989
NU-DHL-1,6918328,-1.9544594496437568
KMS-20,selumetinib-UNC0638 (4-1 mol-mol),0.6726182150265286
MM1.S,446155,2.5979306804829463
Ishikawa (Heraklio) 02 ER-,crizotinib-PLX-4032 (2-1 mol-mol),3.4065147100518542
YKG-1,65064,5.3416215480655875
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433
LOU-NH91,119607,5.561970464467383
BT 231,4705,1.5996652236036175
HCC38,24964624,1.1557965776426598
YKG-1,10385095,1.6490747273170454
HCC38,25262965,-1.6582823250055727
BT 428,71576739,-3.554637052889279
SH-10-TC,19582717,3.221707329176257
RERF-LC-MS,11707110,3.327368501952155
RKO,8515,4.32265921632429
BT 245,969516,2.756256935872277
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434
KHM-1B,5394,4.374287495449882
SH-10-TC,46926350,-4.411036590095516
LOU-NH91,613753,3.2819891552194327
PK-59,9887053,5.458657189600831
A4/Fukuda,4096211,1.2598455852625392
BT 231,3011155,4.4069379954556185
HPAC,72193861,2.44744255394299
SW1783,15983966,1.9735277014133552
Kasumi-2,carboplatin-UNC0638 (2-1 mol-mol),1.808252059410855
Kasumi-2,31703,-3.912318367279324
SH-10-TC,10127622,5.537702845911762
CHP-212,31703,-4.512064024898893
Ku812,56946209,-4.665200171711114
EM-2,24856436,-4.410519773297258
BT 245,10184653,1.720017419291484
BT 428,4477,0.4418546409842698
OAW28,46907787,2.388022074777516
HCC38,JQ-1-navitoclax (2-1 mol-mol),-0.1389579252394325
WM88,71466578,5.035474291175797
BT 231,123631,1.9730380102731189
YH-13,9967941,5.158466300514708
BT 248,2828334,5.879853395133371
NU-DHL-1,135411,-1.8300926299415428
KHM-1B,5311281,2.058534783362704
NCI-H1568,46215462,1.5662565779678703
Ku812,15983966,-4.686318445484671
NCI-H1184,6438330,1.3826720843613869
HCC38,10296883,4.206787389129117
NCI-H1184,71304818,2.381345807816191
KHM-1B,24772860,-4.094705330536473
PK-59,5329102,1.88282935997255
Ku812,52947716,-6.670771231809934
OAW28,4259181,0.9119817479539226
SW1783,serdemetan-SCH-529074 (1-1 mol-mol),2.8062060654486953
BL-70,selumetinib-BRD-A02303741 (4-1 mol-mol),5.080029485351211
YH-13,219104,3.421374487028668
F-36P,44589607,1.6796405733460815
OCI-AML-3,9884685,-1.3985823695443076
OPM-2,5746,0.8583790934138843
Rh30,sirolimus-bortezomib (250-1 mol-mol),1.125854390557578
OAW28,2729026,2.5871569751548047
Kasumi-2,71466445,1.815897736576068
BT-474,selumetinib-piperlongumine (8-1 mol-mol),4.424263500465941
BL-70,11175137,1.099828535603896
NCI-H2196,10184653,1.6637597644513793
NU-DHL-1,3854666,0.0415857497138207
OAW28,9884685,1.3567472374362477
Panc 03.27,3634881,3.647239349275841
Ku812,107985,-3.8161281001358778
B-CPAP,11178236,-2.8753118537912226
LOU-NH91,25102847,2.3579155704363206
JHUEM-3,selumetinib-UNC0638 (4-1 mol-mol),2.071707623752137
EM-2,9935249,2.516925866453196
TCCSUP,selumetinib-vorinostat (8-1 mol-mol),2.3847964981208305
BT 248,445643,3.6752138638176057
KYSE-450,selumetinib-PLX-4032 (8-1 mol-mol),5.261174592535557
SH-10-TC,5282054,4.682694309527452
CHP-212,374536,1.0120647544578718
BT-474,erlotinib-PLX-4032 (2-1 mol-mol),1.2405469241115237
NU-DHL-1,54596558,4.252396729652346
NU-DHL-1,6918878,-0.9557667101081658
WM88,2729026,3.0591005523609
NCI-H1184,5311,0.5506950271924242
EM-2,6918837,-4.762701360254156
RKO,25062766,2.7314931301361476
SH-10-TC,16013152,4.599771500849873
PK-59,9926054,1.7891376671835462
B-CPAP,17759555,3.7290371728281944
BFTC-909,71304818,3.116417285157316
BT 248,72376,-0.6579483524735774
WM88,24821094,3.742487763204276
HCC1395,10302451,3.312939572545873
BL-70,11485656,1.5979505669049718
SK-MEL-28,9967941,2.8664024889360644
AU565,JQ-1-MK-0752 (1-1 mol-mol),3.9179209493370175
SK-MEL-28,25183872,-1.0681222891293745
HCC38,11626560,2.335778363467763
SW1783,148124,3.5822290901632545
KYSE-70,46191454,2.1451937437577575
NCI-H1568,navitoclax-MST-312 (1-1 mol-mol),0.8258625122307741
HEC-59,5113032,4.635028157868112
KHM-1B,2733526,2.638104564736822
KHM-1B,4261,0.5935590694863259
HCC38,44632017,0.919389747635926
PK-59,104842,-1.311368852734091
KHM-1B,51037431,2.291600805718332
SH-10-TC,navitoclax-birinapant (1-1 mol-mol),3.180056316487784
PF-382,638278,2.364690037141532
LOU-NH91,11228183,0.5456186750940368
RERF-LC-MS,11238147,2.4729298726299147
JHUEM-3,11964036,1.203492429010384
TCCSUP,25183872,-1.340391088642973
SH-10-TC,135398738,5.965655211024315
MM1.S,6505803,-0.1841114080814497
EM-2,36462,-1.2083602096213608
YKG-1,9911463,4.439291278473792
NCI-H2141,148198,-5.2509826148997725
Panc 03.27,sirolimus-bortezomib (250-1 mol-mol),0.6121410442614872
NU-DHL-1,3543504,4.940281677285891
OCI-AML-3,104842,-5.959001592436564
NCI-H1184,9911463,3.5599804039419225
RKO,56963564,0.5825206420774123
RERF-LC-MS,6918736,-1.8242544668906209
SF539,6450551,0.8241072018867992
OCI-AML-3,49867926,3.770071665119433
BT 248,11175137,2.43855252671782
NCI-H2196,10074640,2.4326350017246785
SH-10-TC,25105715,3.666089831147244
Panc 03.27,89928392,1.5489827912310206
BT 231,44491742,3.9496827176131384
KMS-20,148124,-6.52302823792501
Hs 746.T,5702613,3.2215148305827483
SW1783,9933475,2.066701345248221
OCI-AML-5,5287969,-1.829334545115525
BT-474,5291,3.745657730366311
BT-474,selumetinib-GDC-0941 (4-1 mol-mol),2.0514491490730142
A4/Fukuda,3384730,1.825152720179272
Ku812,11396600,2.326776145026828
M-07e,2126,4.388458707962399
KMS-20,71680916,4.434197723022785
SH-10-TC,46174525,5.521685175526617
OAW28,2749,3.2113189756487683
SNU-1077,24180125,4.514438880816518
LOU-NH91,9907093,4.908801109640004
KMRC-20,2749,2.7463667580182816
YKG-1,carboplatin-etoposide (40-17 mol-mol),2.9316391165537943
BT 248,25161177,3.821794472212993
Kasumi-2,9926054,1.3771704127752784
Hs 578T,23635314,-3.845516246764667
NCI-H1568,16722836,1.2045551605263336
SH-10-TC,16725315,5.1603427553881955
F-36P,56649450,5.044332168880629
BT 428,5951923,5.385929406679104
TCCSUP,9911830,2.7321009507297727
NU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),-2.603408624311022
BT-474,6918837,-3.4556084826056064
OPM-2,10410894,2.9147321100270593
HCC1395,969516,3.150446807155364
YKG-1,135875424,4.553579428376037
Hs 578T,208908,2.0393032303884304
OAW28,16722836,1.5279923407751788
NU-DHL-1,3634881,1.5922727518374944
NCI-H1568,6918328,-2.169641972219076
BT 428,441298,1.4974571661607616
BT 428,322968,2.919860566395529
RERF-LC-MS,5287620,-3.2415128958876123
KMS-20,445643,3.538778449687995
PF-382,16038120,-0.1734810985157941
TCCSUP,navitoclax-sorafenib (1-1 mol-mol),3.067250196506974
NCI-H1568,11494412,0.631822071405162
A4/Fukuda,5311037,4.577970147235868
RERF-LC-MS,119607,4.38818595494476
BFTC-909,676352,2.5282943369079818
KHM-1B,73707440,5.196065246508486
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649
BT 231,119607,4.054018136262302
OPM-2,322968,0.7466819505545055
OCI-AML-3,2945648,2.310078327356549
OAW28,445455,5.326899909172617
HPAC,25183872,-2.187203437497646
NCI-H1568,6918638,-0.3782949656582497
KMRC-20,25150857,2.3131751126804616
HEC-59,72734382,5.517572515320529
Hs 746.T,navitoclax-gemcitabine (1-1 mol-mol),1.95017334230422
AU565,9936388,-7.122590364363415
EM-2,54619267,2.879241995914334
KYSE-70,60700,2.818490002790748
BL-70,navitoclax-piperlongumine (1-1 mol-mol),1.0112305824669543
A4/Fukuda,11317348,1.1392337694005448
SF539,219104,3.671344894380296
HEC-59,11175137,3.0573970470461793
Ku812,1716436,3.2496939057778738
BT 428,navitoclax-piperlongumine (1-1 mol-mol),0.1404852536322988
KHM-1B,12001922,1.027456865676835
SNU-201,46199207,3.2816054175749025
OPM-2,9935249,1.874633336412032
PF-382,656346,-0.3937515411626462
OAW28,65064,5.229460149894731
NCI-H1184,44819697,-1.476640097247048
RERF-LC-MS,285033,-2.0574538896256587
NCI-H2196,5311,2.090072668919785
BT-474,3038522,2.4341570170890447
BL-70,613000,2.3009382200572235
WM88,11238147,2.180457547739866
A4/Fukuda,5978,-3.163562671527086
OCI-AML-3,441298,2.217557694021433
PK-59,2828334,5.980207208191742
AU565,9908783,4.7252597511686965
Hs 578T,10410894,1.5170438372617343
KMS-20,5280436,3.104525764611907
AU565,216239,2.683840039589205
Rh30,374536,2.8490376580387355
MM1.S,9967941,3.082231496587742
PF-382,24772860,-3.0726224407745435
Rh30,1242560,2.2777549010257694
Hs 746.T,613000,4.26525883089552
KMS-20,52947716,2.1848836609690485
SNU-410,11609586,3.384174733170086
F-36P,5281321,-1.3256823560764706
Rh30,6918328,-0.5323471901293738
SNU-410,25195348,5.533990018784312
NCI-H1568,126941,-1.411149621431801
KMRC-20,11178236,-3.1714013325057686
BT 231,10184653,1.5482229308890267
BT 248,24951314,2.138284126904765
BT 245,25150857,2.481391794476999
HCC38,71680916,4.214883849644536
HCC38,4096211,1.6824825746623506
Kasumi-2,676352,0.386616578071509
BL-70,24771867,-2.753771697014839
M-07e,UNC0638-navitoclax (1-1 mol-mol),-0.772569020368213
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295
Hs 746.T,71680916,4.317371972163459
JHUEM-3,25126798,4.186177238809464
Hs 746.T,409805,3.593124858795494
A4/Fukuda,262093,3.0357368226896178
YKG-1,46199207,3.7186268028334
PF-382,73707386,2.646630293561946
EM-2,6918289,1.5489803726386109
A4/Fukuda,89183176,1.286008536767452
BT-474,5281321,-0.5208401507567935
NCI-H1184,656346,1.072520202624119
HCC1395,6610216,4.327049728345092
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819
OAW28,9911830,2.567685352724645
BT 245,24771867,5.283841994129179
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785
PF-382,docetaxel-tanespimycin (2-1 mol-mol),-5.687046056145867
HCC38,148124,-4.841006043756389
TCCSUP,65064,5.167716602731698
WM88,46215462,1.6840536577865086
OCI-AML-3,262093,2.331975538333622
SNU-410,400769,2.227914270938708
OAW28,322968,3.926433659329745
BT 245,135398516,2.3123017999822757
PF-382,135999136,1.3874167482573283
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507
WM88,3689413,-2.428480680194512
BT 428,6505803,-2.216718160472342
KMS-20,100016,6.235059528000449
NU-DHL-1,44491742,4.098367852004394
RKO,2749,1.3580925102381314
TCCSUP,66577038,3.1078780517410283
Rh30,6610216,4.152878640581398
KMS-20,2945648,2.3119596630463657
BL-70,446155,0.2293243067056896
OAW28,24785538,1.1869022382798196
SW1783,3503,1.7276989845578277
HCC38,11964036,1.3966083053331175
Hs 746.T,5281672,5.091139921802459
NCI-H2196,navitoclax-piperlongumine (1-1 mol-mol),-1.8905328251917093
BT 428,71729975,0.8355335318792699
NCI-H1568,123631,1.2596294102093508
KYSE-450,6505803,0.925446652115482
Panc 03.27,10074640,3.2749405727114063
LOU-NH91,3062316,-1.7568876367320156
Rh30,11238147,2.4493337724931403
Kasumi-2,56963564,-0.3250682085247875
MM1.S,24785538,-3.291318943306552
KYSE-450,6852167,3.693304163934065
Hs 746.T,4378219,1.9535167500354071
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865
NCI-H1184,208908,2.9478219293048156
Ishikawa (Heraklio) 02 ER-,6505803,-0.7712031048650526
PK-59,25150857,2.6294485310245777
OAW28,11455910,2.4986666790908583
SNU-1041,72376,-1.6909145037412106
OAW28,11719255,3.92549874892824
AU565,24180125,2.1910645714042634
EM-2,11427553,-0.0791045992261063
BT 248,3062316,2.7315660903773606
NCI-H1184,6918837,-3.982888077210837
WM88,15953870,4.011231604967574
KHM-1B,44202524,1.0053468169161075
KYSE-450,216345,4.4435224891329
Ku812,151289,0.0229500128579697
LOU-NH91,104842,-1.007764649763801
SF539,123631,1.7030857136426885
HCC38,702558,5.620545785011856
A4/Fukuda,6505803,0.0348674492980193
F-36P,613753,2.8186280637661
SF539,56649450,3.257832178779862
NU-DHL-1,2126,4.057777482675548
KMS-20,49867930,4.214222642380502
KYSE-450,119607,5.938330428290203
BT 231,11507802,1.0974082780586245
KYSE-450,6914657,-3.3347468513388994
OCI-AML-5,3634881,3.5587730820284045
NU-DHL-1,BRD-A02303741-navitoclax (2-1 mol-mol),-1.4482260747427786
F-36P,44484893,4.1243901120060915
SH-10-TC,SNX-2112-bortezomib (250-1 mol-mol),-0.4420511539679755
BT 248,vorinostat-navitoclax (4-1 mol-mol),1.3262626080799325
CHP-212,216345,1.6208821403055356
BT 231,2746,2.74381286555369
HPAC,ISOX-bortezomib (250-1 mol-mol),0.5787999383064334
OAW28,16720766,3.888951908869231
WM88,2113511,5.303711227479264
Ku812,25262965,-2.692215385678303
NCI-H1184,doxorubicin-navitoclax (2-1 mol-mol),-2.6007225522486213
A4/Fukuda,3025944,3.254701794903189
F-36P,11427553,1.8945760748158276
KYSE-70,12001922,1.7900886800743383
Ishikawa (Heraklio) 02 ER-,25262965,-0.8603136764139806
OAW28,3025944,4.579278298637093
SF539,piperlongumine-MST-312 (1-1 mol-mol),0.3137797380658941
HPAC,11404337,1.5796437577977354
F-36P,72376,-3.222256822356651
HCC38,9866186,-0.0034450121952483
SNU-1041,12003241,-1.3076188477929267
OAW28,24978538,-0.39276463694641
NCI-H1184,11625818,2.608916794962473
B-CPAP,9866186,1.8476989957521583
BT 231,25183872,-1.5553581634712852
M-07e,65064,3.2559896036010625
WM88,54143018,1.0957026128088276
HPAC,24856436,0.101110159273972
JHUEM-3,crizotinib-PLX-4032 (2-1 mol-mol),1.5838865814709002
SNU-201,11485656,3.6136965071696903
WM88,JQ-1-vorinostat (2-1 mol-mol),1.0385300983471475
OCI-AML-3,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.951949053829367
LOU-NH91,6610216,4.701575628194421
OAW28,10074640,2.8656652346665545
SF539,5460769,-0.1125532875886319
JHUEM-3,119607,5.7883083612337565
Rh30,135875424,2.415792825604233
BT 428,10427712,4.347844856094606
YH-13,vorinostat-navitoclax (4-1 mol-mol),1.848157138564096
HEC-59,alisertib-navitoclax (2-1 mol-mol),0.3148433420321543
A4/Fukuda,9911463,2.417745886609146
EM-2,66890843,2.5185741307345233
BT-474,11404337,1.3863676230346815
AU565,9549297,3.94244046983191
KHM-1B,675434,3.385795736646719
OCI-AML-5,16741245,3.666374990998614
SW1783,crizotinib-PLX-4032 (2-1 mol-mol),3.4336355505770317
LOU-NH91,44607530,2.1348137775706646
JHUEM-3,selumetinib-navitoclax (8-1 mol-mol),2.070508711347534
PF-382,135421197,0.9667662585436329
BT 245,104842,-5.23594033549698
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887
KMS-20,3025944,3.4740880117517974
PF-382,9911830,1.7810920372451895
HEC-59,241158,3.2385648758912904
HCC1395,135440466,1.6547902806573327
NCI-H1184,5460769,-0.2786372914944621
A4/Fukuda,2749,1.141581020051295
Panc 03.27,10322450,4.4639775206651295
M-07e,5328940,1.0813740146367052
HCC38,selumetinib-JQ-1 (4-1 mol-mol),2.765272906318856
YH-13,44632017,0.8741642499289622
EM-2,26596,-2.2140652847735027
PF-382,969516,2.499968363258948
SH-10-TC,54619267,4.703675260829322
KYSE-70,3503,4.330341802091645
BT 245,36462,1.2671899599855267
KMS-20,426756,4.256968107104022
Rh30,44607530,1.984376898049189
MM1.S,tanespimycin-bortezomib (250-1 mol-mol),-0.3747840615026737
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845
KMS-20,46843906,1.2536393237633636
Hs 578T,52912189,2.226730659587524
Ku812,3385,4.251256683389901
NCI-H2141,11625818,4.174649222713274
B-CPAP,44607531,1.6956688742545236
BT 428,5738263,2.4213503087370003
JHUEM-3,702558,7.162004958892963
BT 231,89928392,0.5140458062217697
M-07e,5329102,1.5378417215480298
BL-70,44589607,0.4818075182512965
A4/Fukuda,2113511,3.845432548996496
A4/Fukuda,9866186,-0.2462641713744652
OAW28,4096211,1.5501495805084426
B-CPAP,262093,2.8121848345775784
SNU-1041,56946209,-2.5783795179437266
PF-382,119182,-3.7281285699674873
HEC-59,6918328,0.131554481758699
KHM-1B,44491742,4.066156285625521
YH-13,135984461,4.0881390777757245
KYSE-70,71466445,4.079477869375345
Ishikawa (Heraklio) 02 ER-,322968,4.539754063131236
PK-59,46174525,4.871380850283114
NCI-H2141,2749,-0.1331411252809855
HCC38,448949,1.641487383607236
JHUEM-3,11238147,1.60862748454755
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982
PF-382,11234052,3.0504434330399883
Ku812,4521392,4.096251186969024
YH-13,262093,3.0071094341497826
KYSE-70,10074640,3.109810551584267
KMS-20,6918736,-1.6214038389500036
BT 248,9868037,3.916296675967623
Hs 746.T,9908783,4.909847280818455
TCCSUP,doxorubicin-navitoclax (2-1 mol-mol),-1.0692959342225303
BL-70,9911830,1.8003743616060963
SH-10-TC,100016,6.555483038363527
Hs 746.T,5287969,-2.1480853911182773
HEC-59,54613361,0.9511836269962992
OCI-AML-3,445643,3.8869366216169112
A4/Fukuda,6918328,-3.9252329494253586
SH-10-TC,6918837,-2.8992660173610543
SK-MEL-28,navitoclax-MST-312 (1-1 mol-mol),1.3794636689456534
BT 245,5329102,2.0891856734220973
NU-DHL-1,4378219,5.179201062544345
A4/Fukuda,421610,2.9916322722523425
KYSE-450,vorinostat-navitoclax (4-1 mol-mol),3.1121330202386974
BFTC-909,3825829,4.25128930140834
RERF-LC-MS,1566236,3.687566928717542
OAW28,vorinostat-carboplatin (1-1 mol-mol),2.457555978857692
YH-13,322968,2.764039711973652
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983
BL-70,136227924,2.857298369944604
Kasumi-2,10074640,2.978792769082284
BFTC-909,168312962,2.436518653578315
JHUEM-3,3543504,5.090643516033627
OCI-AML-3,54619267,3.680904963266035
EM-2,119607,5.022736466062468
EM-2,31703,-2.8442298732986213
MM1.S,135398738,3.10215639374587
NCI-H1184,6852167,1.6538062359818173
Kasumi-2,11222830,0.4757152299010318
OCI-AML-3,44632017,0.8498402783164288
KMS-20,6450551,1.8183077034001904
BFTC-909,60700,0.4554202898414442
KMS-20,44620216,3.7048661868251536
M-07e,25150857,1.249322012611384
SNU-201,54639701,5.400324994433106
NCI-H1184,89928392,0.451575170774263
Hs 746.T,15983966,-1.146690665884377
Ku812,135423438,-2.2335088833738146
PF-382,9935249,1.8009635209130423
Hs 746.T,71751553,4.777780100201024
OPM-2,219104,1.446566622432128
YKG-1,16065773,3.101018624838753
BT 248,2749,1.3146464590197295
TCCSUP,tretinoin-carboplatin (2-1 mol-mol),6.838469471858124
BT 248,44819697,-0.5101915766327456
EM-2,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0688011374607711
LOU-NH91,969516,2.9922565120136944
PK-59,68056272,3.6251333748672656
PK-59,6914657,-3.026539722055946
EM-2,11656518,-0.5456980246171458
OAW28,11427553,3.602344276440211
BT 245,BRD9876-MK-1775 (4-1 mol-mol),2.4312783718303064
Kasumi-2,2871966,-1.247169917955711
Panc 03.27,3825829,3.951952247459651
RERF-LC-MS,4578,4.625372786711685
Rh30,4259181,-0.0513529873152824
SK-MEL-28,5280436,4.781465110454219
HEC-59,44137675,2.539490901372469
KMS-20,6436223,-4.921746279888799
LOU-NH91,selumetinib-navitoclax (8-1 mol-mol),0.0322992078492161
M-07e,4705,3.81547426285279
JHUEM-3,11222830,1.7536725864229152
EM-2,9936388,-5.706813199670236
Panc 03.27,navitoclax-MST-312 (1-1 mol-mol),0.9811010058181808
NCI-H1184,36314,1.6311808171150235
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467
BT-474,445455,4.448162959211128
KYSE-70,676352,2.557270596786296
SNU-1077,135999136,1.6213426965056292
Ku812,56963564,-0.7269120722317722
HCC1395,262093,3.7391779193808254
Ku812,135999136,1.6073024160366625
MM1.S,54619267,4.994237455053685
NU-DHL-1,26596,-3.470221600864271
OCI-AML-3,6917907,-6.185839635194487
Ku812,613753,2.440420613478445
B-CPAP,159324,2.672075580393903
KHM-1B,9903786,1.5275790345873377
Kasumi-2,52947716,-3.704060756771708
PF-382,168313047,1.8210212384762663
PK-59,67156097,3.162804008850741
SW1783,44543605,3.70035976615173
SK-MEL-28,135875424,5.515491244041513
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605
A4/Fukuda,135421197,1.440002399326734
Hs 746.T,11222830,0.9626801667180844
BFTC-909,4788,5.986704833543041
KMS-20,3854666,0.6836854926820529
BT 231,46843906,3.143973287523026
OCI-AML-3,219104,2.2316749875899133
KYSE-450,613753,3.352975816171232
Rh30,9903786,2.553175737800522
PF-382,4096211,0.5237091038371171
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243
NCI-H1568,9911830,1.3917537385715242
OCI-AML-5,25150857,2.2912343167267317
JHUEM-3,9908783,4.309741990077927
OCI-AML-5,119182,4.197107721877998
EM-2,3815108,2.3099159021163858
Hs 746.T,9927531,5.239357337613853
Kasumi-2,262093,1.7604912977671856
NCI-H2196,15547703,3.1297477756310963
NCI-H1184,9967941,2.5687615696675663
HPAC,51039095,2.091818395811325
Hs 746.T,71466380,5.0363561570215385
KMS-20,54618771,0.3177440488164709
BT 245,alisertib-navitoclax (2-1 mol-mol),-2.3695244467769276
BT 248,4259181,0.8166391520482507
Rh30,3825829,3.769723551386186
HCC38,60750,-4.541348679115192
SNU-410,53392493,2.4975184570588382
BT 248,6918638,2.3802175448525844
KYSE-450,54626689,5.089860588921688
OPM-2,448949,1.278414281383
KMS-20,44486219,3.957177365137273
TCCSUP,5282054,3.8186779909070094
NU-DHL-1,72193861,-0.4414983831950781
NCI-H2196,24753719,4.748637323499507
JHUEM-3,9884685,0.8743192311633359
BT-474,serdemetan-SCH-529074 (1-1 mol-mol),2.2258755907486543
RKO,9866186,0.3829002704071885
WM88,24753719,4.471197406675096
HCC38,SNX-2112-bortezomib (250-1 mol-mol),-1.7309622444532071
Rh30,216345,4.584918001526253
LOU-NH91,24978538,-2.307670841327046
NCI-H1184,3062316,-0.0683785558755608
MM1.S,71466445,1.6605389329514368
HCC38,71751553,6.251019673223731
Ku812,2749,1.0031884353437008
Kasumi-2,49836020,6.151495097204233
F-36P,676352,0.8457962157972794
PK-59,selumetinib-navitoclax (8-1 mol-mol),1.5188657013907954
KMRC-20,11626560,2.2175468532986353
NCI-H2196,637858,1.290993907845002
BT 428,44543605,1.5827502950644723
BL-70,67156097,-3.059904551161888
BT 245,42642645,1.337897041981839
BL-70,119182,-3.5796152309711413
OCI-AML-3,25262965,-4.247816274532978
Rh30,3543504,3.863209317349861
MM1.S,10074640,2.540679060778685
Rh30,25262965,-2.05304852670602
BT 231,44137675,2.8772495475471227
AU565,446155,4.298434988536317
Ishikawa (Heraklio) 02 ER-,49850262,5.359083107897465
RERF-LC-MS,11427553,2.91041132641442
KYSE-70,selumetinib-GDC-0941 (4-1 mol-mol),1.855556078867097
M-07e,107985,-5.456968892435315
Rh30,9884685,-0.1007455789627698
SNU-201,11178236,-2.432385229087549
SNU-410,24753719,4.971492186165212
SNU-1077,vorinostat-navitoclax (4-1 mol-mol),1.5809730916962734
Rh30,168313200,3.8308139252747737
SK-MEL-28,23635314,4.127704587314434
YKG-1,selumetinib-MK-2206 (8-1 mol-mol),2.8155089157668627
OPM-2,65628,4.597670741376445
Hs 578T,107985,-4.43048214511299
B-CPAP,2126,3.7809134747205433
A4/Fukuda,46843906,1.071626560517578
NU-DHL-1,55508,4.248888595165198
M-07e,1641662,2.6189085283615356
CHP-212,135398516,1.795559331878708
SNU-1041,25126798,4.311463337559452
BT 231,702558,5.699595685518614
BT 245,119182,-0.4253634129387354
OCI-AML-5,135398516,2.9617541928038875
NCI-H1568,piperlongumine-MST-312 (1-1 mol-mol),1.2489252589958966
Hs 578T,10113978,0.71625958762072
HCC38,11497983,5.013774095955699
A4/Fukuda,71466445,1.4546499284121797
Kasumi-2,54454,5.727506476700654
NCI-H1184,ISOX-bortezomib (250-1 mol-mol),-0.0862793094765937
NCI-H1568,426756,4.294080241318686
SF539,72376,-2.558258632142047
HCC38,6505803,-2.5112247246736787
OCI-AML-3,2949965,2.4498885037460267
PF-382,654092,-2.265760863591032
Hs 578T,5287969,-2.4635321180224174
A4/Fukuda,tretinoin-navitoclax (4-1 mol-mol),2.572216751068698
SF539,9868037,3.16067122997076
Hs 746.T,4521392,4.265244917569877
RKO,15983966,1.976330033309676
PF-382,16741245,3.010878138090118
M-07e,vorinostat-navitoclax (4-1 mol-mol),-0.957169609361065
BT 428,6450551,2.056715014092832
Rh30,446155,3.6117158117742023
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024
NU-DHL-1,73707398,-1.134131669743868
YKG-1,448949,3.5998670928110745
A4/Fukuda,6918837,-6.1208599704470865
BFTC-909,54454,2.6967031082973527
OAW28,216345,3.8770767977792913
BL-70,65628,3.443552461432303
NCI-H1184,16722836,0.1781885413710777
NU-DHL-1,148124,-5.1269699362990195
CHP-212,969516,2.6672841483458396
NCI-H2141,SNX-2112-bortezomib (250-1 mol-mol),-0.5006827102512509
AU565,68056272,3.4490660549666425
KMS-20,3825829,3.171752203706611
SF539,9915743,0.9219479584552366
SF539,3689413,-2.2250008276513107
SNU-1041,72734382,4.396689886806303
Kasumi-2,9911463,3.4999156831259524
BT 428,piperlongumine-MST-312 (1-1 mol-mol),1.2822392110514311
RERF-LC-MS,7251185,3.4578262740878976
BT-474,44589607,3.8532057552594
TCCSUP,448949,2.8809822031870778
BT 245,26596,-1.3254238494846824
NCI-H2141,71680916,4.2102324890840706
M-07e,23725625,4.141912145922638
PF-382,151289,0.3016891931318033
NCI-H1568,52912189,3.4016367932827563
HCC38,vorinostat-navitoclax (4-1 mol-mol),2.5368755340578724
A4/Fukuda,3552672,1.9607713184754867
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685
M-07e,67291369,-1.4838065438742474
YKG-1,51037431,4.372919308418105
BL-70,54613361,-0.1879571568865208
YH-13,11214940,1.756237854396178
KMRC-20,selumetinib-piperlongumine (8-1 mol-mol),4.530795169334645
LOU-NH91,ISOX-bortezomib (250-1 mol-mol),1.5845315088477396
NCI-H2196,4705,3.044507714028595
SF539,374536,1.1024692735749633
OCI-AML-5,16038120,0.3051602380620072
Hs 746.T,decitabine-navitoclax (2-1 mol-mol),3.2701241677867725
KYSE-70,3825829,3.6022414485207452
F-36P,16725315,3.2108179170098854
NCI-H1568,1750826,-3.116085482779225
MM1.S,31703,-4.019307858079406
NU-DHL-1,6852167,1.5672236440525231
NU-DHL-1,49867930,4.548635442109189
HPAC,6610355,4.500272838744546
SK-MEL-28,49793307,2.4799743183356897
NU-DHL-1,11626560,1.4033689860474627
EM-2,5311,0.1746457349367139
Panc 03.27,44589607,3.15154913546752
BT 428,11228183,2.124701614700109
SF539,613753,3.180215487125264
YKG-1,6610355,5.888296552052047
SK-MEL-28,5278396,4.387256339592576
EM-2,9927531,3.4413075859413556
RERF-LC-MS,252682,6.464777279315186
HCC38,11228183,0.4431864230474353
BT 231,4261,2.0001375590966655
NU-DHL-1,5335621,3.760222495124576
F-36P,176870,2.9171808936950465
YKG-1,24180125,3.6126357196897496
NCI-H2141,9936388,-7.734442160433386
Panc 03.27,10410894,3.8145071082484105
BT 248,5351362,1.0725587198101878
OCI-AML-5,44819697,-2.0701785586828283
AU565,151289,0.4389765151464501
BT 248,6450551,3.394353011187604
LC-1F,selumetinib-JQ-1 (4-1 mol-mol),2.237558763845896
PK-59,654092,-1.052424839232504
WM88,decitabine-navitoclax (2-1 mol-mol),3.5298637644831152
JHUEM-3,vorinostat-carboplatin (1-1 mol-mol),3.3555451220625754
SW1783,selumetinib-piperlongumine (8-1 mol-mol),3.7422302368862104
SNU-410,6610216,4.607565323971714
RKO,241158,4.5302703569847305
OAW28,16720766,3.888951908869231
WM88,9884685,-1.1119542466113133
RKO,46215462,1.869666408515056
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883
EM-2,2708,2.8295072845715867
PF-382,5746,-0.5974019482348806
BT 245,ISOX-bortezomib (250-1 mol-mol),0.3438224089520051
KMRC-20,159324,3.723725061334236
RKO,54626689,4.750442055573677
PK-59,72734382,4.968787666344006
SH-10-TC,tanespimycin-gemcitabine (1-1 mol-mol),0.8873811522011354
Hs 746.T,11977753,-2.7550996268575414
SH-10-TC,11485656,3.549629960388959
CHP-212,3825829,2.095967212695281
NCI-H2196,selumetinib-JQ-1 (4-1 mol-mol),3.899366542869125
SW1783,9866186,2.9884922789438444
HCC1395,46224516,2.4400617767326405
NCI-H2141,2746,2.383841945459931
OPM-2,11222830,0.0961911151739945
BL-70,5328940,1.885897333245768
OAW28,702558,5.716785737298097
BL-70,54596490,5.069667260483249
Ishikawa (Heraklio) 02 ER-,23725625,4.767960358946382
NU-DHL-1,216468,0.3012450032871305
HCC1395,6918837,-2.0000945172409614
Ku812,11507802,0.7053087419669674
KYSE-70,11626560,2.028097573065789
OAW28,71680916,5.167013104004298
LOU-NH91,selumetinib-PLX-4032 (8-1 mol-mol),3.969843428334973
BT 428,71466445,5.17114192317244
EM-2,JQ-1-carboplatin (1-1 mol-mol),-1.2961188335461022
Kasumi-2,5311,-0.335738593661984
Ku812,10427712,4.412501870743701
BT 248,7251185,2.921625124470224
RERF-LC-MS,969516,2.2498421794663095
RERF-LC-MS,31703,0.0184985959907658
LOU-NH91,135875424,2.9424536382603215
SNU-410,439501,-1.2001719961376376
YH-13,11640390,4.546437350580995
Hs 746.T,64971,3.1277904387004805
KYSE-70,400769,-0.6610715268602807
NCI-H1568,serdemetan-SCH-529074 (1-1 mol-mol),1.1632168234026012
CHP-212,49793307,-5.147581147244845
ML-1 [Human thyroid carcinoma],216239,2.965937740464059
OAW28,11626560,1.7877294085158288
LOU-NH91,44507138,2.849532358816909
EM-2,11612883,0.7752798583093178
LC-1F,selumetinib-piperlongumine (8-1 mol-mol),3.899826922895305
Ku812,11167602,0.0017995666708742
SH-10-TC,5291,4.196257304131551
SH-10-TC,53495165,1.0377679307795626
TCCSUP,445091,4.296569463067844
LOU-NH91,54454,2.054793401572522
WM88,462382,0.3666374429898509
NCI-H1184,2746,1.0703875331333406
SNU-201,322968,4.685449436744645
SNU-1077,15983966,0.623370554406356
BT 245,44185566,2.5006343525335173
Panc 03.27,10385095,1.0322111934041436
KYSE-450,3854666,3.622949827534998
HEC-59,51039095,3.2917625973184443
NCI-H1568,54143018,1.7330311939537375
RKO,54613361,0.2998145946125954
OAW28,89928392,1.6809049325642302
YKG-1,10410894,4.5306444179161165
F-36P,sirolimus-bortezomib (250-1 mol-mol),0.0498711406572633
Kasumi-2,2842253,5.767696299842194
NU-DHL-1,49846579,4.101611336723351
SNU-1041,5282054,4.114395456868042
LOU-NH91,53232,2.5403477328432933
KHM-1B,2130404,2.712460002003977
OAW28,219104,3.640461878438656
HCC1395,2858523,3.046481108006114
F-36P,9825149,2.0951004475305055
Ku812,11455910,-0.1088527514294285
YKG-1,2113511,6.330776905666784
NCI-H1184,10296883,3.900599246219188
OCI-AML-3,72199292,0.529233872414659
BT 428,24951314,-0.4366021016990538
NCI-H2196,JQ-1-vorinostat (2-1 mol-mol),2.681444153648791
SNU-1041,5311281,4.560141689522333
PK-59,selumetinib-BRD-A02303741 (4-1 mol-mol),2.988609115043863
BT 231,54649381,3.7104884016936106
OPM-2,409805,3.1459770002319023
PK-59,400769,-1.222588595156963
YH-13,8515,4.054803825976401
MM1.S,322968,-0.5994478682175649
Ku812,119607,3.7153481440603984
RKO,42642645,1.3055497818976145
OAW28,2858523,3.071437644261336
RERF-LC-MS,51039095,3.2453184174795324
NCI-H2196,3081361,3.662444326476813
JHUEM-3,3062316,-6.331819948846577
AU565,67156097,-2.287523284177128
Ku812,24889392,3.503331691270094
BT-474,11455910,3.140407546934709
BT 248,16038120,1.7409517230791791
OCI-AML-5,71466380,3.646220624672565
Rh30,5278396,3.214465848973382
BL-70,71751553,4.162810725567264
OPM-2,24901704,1.9220236520558196
TCCSUP,12003241,-0.9458347981681208
CHP-212,6918638,-1.8920767869906776
OAW28,2828334,6.258958244852924
Kasumi-2,16065773,1.6844864290683614
Hs 746.T,11609586,3.276416447987535
NCI-H1184,2708,2.9862822870174375
F-36P,5978,-4.757316859640084
A4/Fukuda,89928392,-0.3543848103605003
OPM-2,2828334,5.82639787583413
HEC-59,5281321,0.178878950892188
HEC-59,3689413,-1.7900495461220194
RERF-LC-MS,44137675,3.373454428855253
KMS-20,219104,2.1050805629757483
OCI-AML-5,sirolimus-bortezomib (250-1 mol-mol),1.6444241054056523
KHM-1B,17755052,-0.5225933092645372
F-36P,navitoclax-MST-312 (1-1 mol-mol),0.2505662083694212
Ishikawa (Heraklio) 02 ER-,71304818,1.8773049966238269
SW1783,73707398,1.417049584359394
M-07e,56963564,-0.4733042151113727
YKG-1,1716436,3.7130114389790982
Ku812,216345,2.75636919454375
NCI-H1184,46174525,3.3924783392630076
CHP-212,54596558,4.46292090076348
B-CPAP,54619238,5.255956817941979
PK-59,12003241,-0.8874443449539482
OCI-AML-3,5738263,2.3084772314474797
F-36P,4917,2.613020518555427
KMS-20,44589607,0.4601335864045367
WM88,5566,3.005444494235366
BL-70,3689413,-1.0284037004933524
KHM-1B,5281321,-2.452020874471456
Hs 746.T,4261,1.3010670174419228
EM-2,5287620,-2.9073019025729816
